<DOC>
<DOCNO> FR940817-2-00001 </DOCNO>
<PARENT> FR940817-2-00001 </PARENT>
<TEXT>

<!-- PJG FTAG 4703 -->

<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=90 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=1 -->
&blank;/&blank;Vol. 59, No. 158&blank;/&blank;Wednesday, August 17, 1994&blank;/&blank;Notices 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Vol. 59, No. 158
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
Wednesday, August 17, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->

<!-- PJG /FTAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00002 </DOCNO>
<PARENT> FR940817-2-00001 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=50 g=1 f=1 -->
DEPARTMENT OF AGRICULTURE
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Forms Under Review by Office of Management and Budget
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
August 12, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Department of Agriculture has submitted to OMB for review the following proposal for the collection of information
under the provisions of the Paperwork Reduction Act (44 U.S.C. Chapter 35) since the last list was published. The list
is grouped into new proposals, revisions, extension, or reinstatements. Each entry contains the following information:

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) Agency proposing the information collection; (2) Title the information collection; (3) Form number(s), if applicable;
(4) How often the information is requested; (5) Who will be required or asked to report; (6) An estimate of the number
of responses; (7) An estimate of the total number of hours needed to provide the information; (8) Name and telephone
number of the agency contact person.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Questions about the items in the listing should be directed to the agency person named at the end of each entry. Copies
of the proposed forms and supporting documents may be obtained from: Department Clearance Officer, USDA, OIRM, Room
404&hyph;W Admin. Bldg., Washington, DC 20250, (202) 690&hyph;2118.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Extension
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
&bull;Federal Crop Insurance Corporation
<!-- PJG 0012 frnewline -->
Raisins_Notice of Damage and Inspection; Supplement-Tonnage Report; and Reconditioning Pool, Production-To-Count
<!-- PJG 0012 frnewline -->
FCI&hyph;63&hyph;A, FCI&hyph;819, FCI&hyph;551
<!-- PJG 0012 frnewline -->
On occasion
<!-- PJG 0012 frnewline -->
Indiviuals or households; Farms; 500 responses; 200 hours
<!-- PJG 0012 frnewline -->
Bonnie L. Hart, (202) 254&hyph;8393
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
&bull;Federal Crop Insurance Corporation
<!-- PJG 0012 frnewline -->
Request for Actuarial Change and Request For Actuarial Change
<!-- PJG 0012 frnewline -->
Continuation Sheet
<!-- PJG 0012 frnewline -->
FCI&hyph;5 and FCI&hyph;5&hyph;A
<!-- PJG 0012 frnewline -->
On occasion
<!-- PJG 0012 frnewline -->
Individuals or households; Farms; 2,000 responses; 2,000 hours
<!-- PJG 0012 frnewline -->
Bonnie L. Hart, (202) 254&hyph;8393
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
&bull;Federal Crop Insurance Corporation
<!-- PJG 0012 frnewline -->
Federal Crop Insurance Policies With Options and Optional Forms
<!-- PJG 0012 frnewline -->
FCI&hyph;505, 506, 523, 539, 541, 547, 548, 550
<!-- PJG 0012 frnewline -->
On occasion
<!-- PJG 0012 frnewline -->
Individuals or households; Farms; 27,097 responses; 6,775 hours
<!-- PJG 0012 frnewline -->
Bonnie L. Hart, (202) 254&hyph;8393
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Reinstatement
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
&bull;Rural Electrification Administration
<!-- PJG 0012 frnewline -->
Wholesale Contracts for the Purchase and Sale of Electric Power
<!-- PJG 0012 frnewline -->
On occasion
<!-- PJG 0012 frnewline -->
Businesses or other for-profit; Non-profit institutions; 165
<!-- PJG 0012 frnewline -->
responses; 990 hours
<!-- PJG 0012 frnewline -->
F. Lamont Heppe, Jr., (202) 720&hyph;9550
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Larry K. Roberson,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Departmental Clearance Officer.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20179 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3410&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00003 </DOCNO>
<PARENT> FR940817-2-00002 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Office of the Secretary</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Privacy Act of 1974; Notice of a Computer Matching Program for Federal Salary Offset</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Food and Nutrition Service, USDA.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of computer matching programs between the Food and Nutrition Service (FNS), United States Department of Agriculture
(USDA), and the United States Postal Service (USPS).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
FNS, USDA, is giving notice that it intends to conduct a computer matching program with the USPS in order to identify
USPS employees who owe certain delinquent debts to the United States Government under the Food Stamp Program administered
by FNS for food stamp benefits which they received but to which they were not entitled.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Comments must be received September 16, 1994, to be considered. Unless comments are received which result in a contrary
determination, the matching program covered by this Notice will begin no sooner than September 26, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Comments should be addressed to James I. Porter, Supervisor, Issuance and Accountability Section, State Administration
Branch, Program Accountability Division, Food Stamp Program, FNS, USDA, 3101 Park Center Drive, Room 905, Alexandria,
Virginia 22302. Comments can be reviewed at that address during normal business hours.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
James I. Porter, Supervisor, Issuance and Accountability Section, State Administration Branch, Program Accountability
Division, Food Stamp Program, FNS, USDA, 3101 Park Center Drive, Room 905, Alexandria, Virginia 22302, telephone
(703) 305&hyph;2385..
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This computer matching program is being initiated as part of an effort by USDA to increase the collection of overissued
food stamp benefits. These overissued benefits are benefits which households received but to which they were not
entitled. As part of their responsibility for administering the Food Stamp Program, State agencies are responsible
for establishing claims for these overissued benefits and for taking certain steps to try to collect those claims.
This computer match will provide otherwise unavailable information which State agencies can use to try to collect
delinquent food stamp claims owed by USPS employees and if necessary, which USDA can use to collect such claim by involuntarily
offsetting USPS employee salaries.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00004 </DOCNO>
<PARENT> FR940817-2-00002 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This Notice is being published as required by Section (e)(12) of the Privacy Act of 1974 (5 U.S.C. 552a(e)(12)), as
amended by the Computer Matching and Privacy Act of 1988 (Public Law 100&hyph;503).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The following information is provided as required by paragraph (b)(3) of Appendix I to Office of Management and Budget
Circular A&hyph;130, dated 
<!-- PJG 0034 unknown -->

<!-- PJG 0034 unknown -->
July 2, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Participating agencies:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The recipient agency is USPS. The source agency is USDA.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Beginning and ending dates:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The matching program will begin in November 1994 and continue in effect no longer than 18 months (April 30, 1996). If
within three months of that date, the Data Integrity Boards of both USDA and the USPS find that the matching program
can be conducted without change and both USDA and the USPS certify that the matching program has been conducted in compliance
with the matching agreement, the matching program may be extended for one additional year.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Purpose of the match:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 In addition to providing information to assist in collecting food stamp recipient delinquent debts, the names of
USPS employees identified through this matching program will be removed from lists of delinquent debts being referred
to the Internal Revenue Service (IRS) for collection from Federal income tax refunds. This action is required to conform
to an IRS requirement for the tax offset program. (A description of the Federal income tax refund offset program for
the Food Stamp Program is contained in a General Notice dated August 20, 1991 at 56 FR 41325&hyph;31.)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of the match:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The subject matching program will involve several steps. USDA will provide USPS a magnetic computer tape of claims
submitted by State agencies participating in the Federal tax offset program. By computer, USPS will compare that
information with its payroll file, establishing matched individuals on the basis of Social Security Numbers (SSN's).
For each matched individual, the USPS will provide to USDA the individual's name, SSN, home address, date of birth,
work location, and employee type (permanent or temporary).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
USDA will prepare lists of matched individuals according to the State agencies which established the claim for the
overissued benefits and will distribute the State lists accordingly. The respective State agencies will verify
identity and debtor status of the matched individuals by manually comparing those list of matched individuals to
their records on the debts, by conducting independent inquiries when necessary to resolve questionable identities,
and by reviewing the records of payments to determine whether or not the debt is still delinquent.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In addition to verifying debtor identity and the status of the debt, prior to USDA taking any steps to effect involuntary
offset of USPS employee salaries, State agencies will provide debtors with a 30-day written notice stating the amount
of the debt and that the debtor may repay it voluntarily by entering into a written agreement with the State agency.
Debts not repaid voluntarily would be referred to USDA for involuntary salary offset. Prior to such action, debtors
would be notified and offered an opportunity for a hearing on the debt, including the right to copy documentation relating
to the debt.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
5. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Legal authorities:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 This matching program will be conducted under the following authorities:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(a) The Debt Collection Act of 1982 (5 U.S.C. 5514), which gives authority to Federal agencies to offset the salaries
of Federal and USPS employees who are delinquent on debts owed to the Federal government;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) Office of Personnel Management (OPM) regulations, 5 CFR part 550, subpart K (Collection by Offset from Indebted
Government Employees), &sect;&sect;550.1101&hyph;1108, which set the standards for Federal agency rules implementing
the Debt Collection Act;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(c) USDA regulations at 7 CFR part 3, subpart C, which implement 5 U.S.C. 5514 and OPM regulations, and which authorize
USDA agencies to issue regulations governing debt collection by salary offset (7 CFR 3.68); and
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(d) Section 13941 of the Omnibus Budget Reconciliation Act of 1993 (Pub. L. 103&hyph;66), which amended sections
11(e) (8) and 13 of the Food Stamp Act of 1977, 7 U.S.C. 2020(e)(8), 2022, to authorize the Federal salary offset program
for the Food Stamp Program.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
6. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Categories of individuals involved:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Two groups of individuals will be involved with this matching program. One group is USPS employees. The other is individuals
who have participated in the Food Stamp Program but are no longer participating, and who owe delinquent debts for overissued
food stamp benefits for which they are not making repayments. This group is further defined in that the individuals
owe only delinquent debts resulting from inadvertent household errors and intentional Program violations. Individuals
owing claims due to State agency administrative errors will be excluded (7 U.S.C. 2020(e)(8)(C)).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
7. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Record systems used:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (a) USPS will use records from its Privacy Act system of records ``Finance Records_Payroll System, USPS 050.020,''
containing payroll records for approximately 700,000 current employees. Disclosure will be made pursuant to routine
use Number 24 of USPS 050.020, (57 FR 57515, dated December 4, 1992).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) USDA will use records from its Privacy Act system of records ``Claims Against Food Stamp Recipients_USDA/FNS_3,''
containing approximately 230,000 records. Disclosure will be made pursuant to routine use Number 4 of record system
USDA/FNS_3, (58 FR 48633, dated September 17, 1993).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
8. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Agency contact:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Inquiries about this matching program should be directed to James I. Porter, Supervisor, Issuance and Accountability
Section, State Administration Branch, Program Accountability Division, Food Stamp Program, FNS, USDA, 3101 Park
Center Drive, Room 905, Alexandria, Virginia 22302, telephone (703) 305&hyph;2385.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Signed at Washington, D.C. on August 10, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Mike Espy,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary of Agriculture.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20180 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3410&hyph;30
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00005 </DOCNO>
<PARENT> FR940817-2-00003 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Cooperative State Research Service</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Solicitation of Recommendation for Nominees to the National Sustainable Agriculture Advisory Committee</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
agency: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Cooperative State Research Service, USDA.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
action: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Solicitation of recommendations for nominees for the private sector members of the National Sustainable Agriculture
Advisory Committee.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
summary: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The U.S. Department of Agriculture is soliciting recommendations for nominees to the National Sustainable Agriculture
Advisory Committee (NSAAC), NSAAC will be appointed by the Secretary of Agriculture and will advise the Secretary
in matters related to the Sustainable Agriculture Research and Education Program, consistent with Section 1622
of Public Law 101&hyph;624 (7 U.S.C. 5812).
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
dates: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Recommendations for nominees must be received on or before September 15, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
send nominations to: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
A.J. Jones, Suite 342, Aerospace Building; U.S. Department of Agriculture/CSRS/SARE; 14th &amp; Independence
Ave., SW.; Washington, DC 20250&hyph;2260.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
documentation required: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Kindly submit a resume addressing one or more of the NSAAC membership categories listed below. Special reference
should be given to knowledge and experience in sustainable agriculture. As defined in 7 U.S.C. 3103, sustainable
agriculture is_``an integrated system of plant and animal production practices having a site-specific application
that will, over the long-term_(A) satisfy human food and fiber needs; (B) enhance environmental quality and the natural
resource base upon which the agriculture economy depends; (C) make the most efficient use of nonrenewable resources
and on-farm resources and integrate, where appropriate, natural biological cycles and controls; (D) sustain the
economic viability of farm operations; and (E) enhance the quality of life for farmers and society as a whole''_
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
Membership: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
As described in U.S. Department of Agriculture Regulation 1043&hyph;34, NSAAC shall consist of 14 public sector
and 14 private sector members. The private sector members shall be composed of:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. Four farmers/ranchers with knowledge and expertise in sustainable agriculture practices and systems_two representing
best utilization of biological applications and one each representing integrated resource management and integrated
crop management;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. One farm/ranch family member (other than a farmer or rancher) having demonstrable expertise in sustainable agriculture,
with special reference to the farm/ranch family and quality of rural life.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. One human nutrition specialist with interest or expertise in sustainable agriculture; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. Four private nonprofit organizations with demonstrable expertise in sustainable agriculture_two representing
research or demonstration in the area of best utilization biological application and one each representing integrated
resource management and integrated crop management and
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
5. Four representatives of agribusiness with knowledge and expertise in sustainable agriculture_two representing
production system inputs, one representing independent consultants, and one representing post-harvest enterprises.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
responsibilities: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
NSAAC is responsible to the Secretary of Agriculture through the Cooperative State Research Service and Extension
Service. The Specific responsibilities are to:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. Make recommendations to the Secretary of Agriculture concerning research and extension projects that should
receive funding under Subtitle B of Title XVI of the Food, Agriculture, Conservation, and Trade Act of 1990;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Promote sustainable agriculture research and education programs at the national level;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. Coordinate research and extension activities funded under Subtitle B of Title XVI of the Food, Agriculture, Conservation,
and Trade Act of 1990;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. Establish general procedures for awarding and administering resources; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
5. Consider recommendations for improving the program;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
6. Facilities cooperation and integration between sustainable agriculture, national water quality, integrated
pest management, food safety, and other related programs; and
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
7. Prepare and submit an annual report of the activities of NSAAC to the Secretary of the U.S. Department of Agriculture.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
compensation: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Members of NSAAC shall serve without compensation, but with reimbursement of travel expenses and per diem in lieu
of subsistence, as is authorized in 5 U.S.C. 5703.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
restrcitions: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Nominees selected for further consideration will be required to submit financial and organizational affiliation
disclosure statements.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
additional information: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The U.S. Department of Agriculture has special interest in assuring that women, minority groups and the physically
handicapped are adequately represented on NSAAC; and therefore, extends particular encouragement for recommendations
for nominees that are appropriately qualified female, minority, or physically handicapped candidates.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: August 12, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</DATE>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
John Patrick Jordan,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Administrator, Cooperative State Research Service.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20183 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3410&hyph;22&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00006 </DOCNO>
<PARENT> FR940817-2-00004 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Forest Service</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Suitability Study for Eight Streams and Rivers Being Considered for National Wild and Scenic River Status</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Forest Service, USDA.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Revised notice of intent to prepare an Environmental Impact Statement (EIS) and Notice of Availability of EIS.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The USDA, Forest Service, Tahoe National Forest and Lake Tahoe Basin Management Unit are preparing a Legislative
Environmental Impact Statement (EIS) to determine the suitability or non-suitability of the approximately 58.8
miles (revised from previously published 61 miles) of eight eligible streams and rivers on the Tahoe National Forest
and Lake Tahoe Basin Management Unit for inclusion in the National Wild and Scenic Rivers System. In addition to the
Wild and Scenic River suitability analysis, the EIS will evaluate the environmental effects of possible Special
Interest Area designation, a Forest Service Administrative designation, as an alternative to Wild and Scenic River
designation. Lynn Sprague, Regional Forester, Pacific Southwest Region, U.S. Forest Service, 630 Sansome Street,
San Francisco, California 94111, is the responsible official for Special Interest Area designation. Michael Espy,
Secretary of Agriculture, U.S. Department of Agriculture, Room 200&hyph;A, Adm. Bldg., Washington, D.C. 20250,
is the responsible official for recommendations for wild and scenic river designation.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Draft Environmental Impact Statement will be available for public review beginning August 18, 1994 and a copy
can be obtained by writing: Forest Supervisor, Tahoe National Forest, P.O. Box 6003, Nevada City, California 95959
or telephone (916) 265&hyph;4531. The public comment period extends through November 18, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
For additional information about the proposed DEIS, contact Phil Horning, P.O. Box 6003, Nevada City, California
95959, or telephone (916) 265&hyph;4531.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: August 1, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Judie L. Tartaglia,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Forest Supervisor, Tahoe National Forest.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20208 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3410&hyph;11&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00007 </DOCNO>
<PARENT> FR940817-2-00005 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Suitability Study of the North Fork, South Fork and Mills Rivers for Inclusion in the National Wild and Scenic Rivers
System; Pisgah National Forest (National Forests in North Carolina), Henderson and Transylvania Counties, NC</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
USDA, Forest Service.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of Intent to prepare an environmental impact statement.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Forest Service has prepared a Draft Environmental Impact Statement (DEIS) to evaluate the environmental impacts
of including suitable segments of North Fork, South Fork and Mills Rivers classified as wild, scenic, or recreational
rivers in the National Wild and Scenic Rivers System. The decision to recommend the nomination of suitable river segments
to the National Wild and Scenic Rivers System rests with the Secretary of Agriculture. The Wild and Scenic Rivers Act
(PL 90&hyph;542) reserves to Congress the authority to include rivers in the National Wild and Scenic Rivers System.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The agency invites written comments on the suitability of these rivers and recommendations related to classifying
and including them in the National Wild and Scenic Rivers System. In addition, the agency gives notice of the full environmental
analysis and decision making process that has been occurring on the proposal so that interested and affected people
are aware of how they may participate and contribute to the final decision. The Supervisor of the National Forests
in North Carolina is responsible for the preparation of the EIS. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Send written comments to Mills River System Wild and Scenic River Study, c/o Randle Phillips, Forest Supervisor,
P.O. Box 2750, Asheville, NC 28802.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Melinda McWilliams, Wild and Scenic Rivers Study Team Leader, U.S. Forest Service, P.O. Box 2750, Asheville, NC 28802,
704/257&hyph;4253.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
In 1982, the Nationwide River Inventory developed by the National Park Service, U.S. Department of Interior, identified
South Fork and Mills River as potential wild and scenic study rivers. The 1987 Final Environmental Impact Statement
(FEIS) for the Land and Resource Management Plan for the Nantahala and Pisgah National Forests determined South Fork
and Mills River to be eligible for designation with potential wild and recreational classifications for different
segments of South Fork and recreational for Mills River. (That information and additional findings will be documented
in this environmental impact statement.) The rivers were determined to be potentially suitable for designation
pending further study. A follow-up study to the Forest Plan FEIS was begun in 1989. At the request of local citizens,
through a North Carolina Congressional Delegate, North Fork was added to the study area. In November 1990, Public
Law 101&hyph;538 was passed by Congress which designated 34.8 miles of the Mills River System (North Fork, South Fork
and Mills Rivers) as a Wild and Scenic Study River. This Act excluded the segment of the Mills River from the confluence
of the French Broad River to a point 750 feet upstream from the centerline of N.C. Highway 191/280.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Environmental Impact Statement will consider the following river segments: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=38 g=1 f=1 -->
North Fork, Bottom of Hendersonville reservoir spillway to South Fork 
<!-- PJG 0114 ellipses -->
 5.9 miles
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
South Fork, Pigeon Branch in headwaters to North Fork 
<!-- PJG 0114 ellipses -->
 25.4 miles
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Mills River, Confluence North and South Forks to point 750 feet upstream from centerline of N.C. Highway 191/280 
<!-- PJG 0114 ellipses -->
 3.5 miles 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The area of consideration for each stream is a corridor a minimum of 1/4 mile from each stream bank for the entire length
of the study segment. These corridors include both public and private lands. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Significant issues identified during initial scoping include the potential for future dams along these rivers based
on past proposals for impoundments, the effects of designation on private lands, and protection of the free-flowing
condition and resource values of these rivers. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A range of alternatives will be developed based on issues and concerns raised during the study process. As a minimum,
one alternative will maintain current management with a recommendation of nondesignation for the three rivers (the
no action alternative). Other potential alternatives include: 1. Recommend designation for all eligible segments.
2. Recommend designation or nondesignation for specific segments of each river based on identified issues and 3.
Recommend designation of eligible segments with different classifications (wild, scenic, recreational) based
on identified issues. The environmental impact statement will disclose the direct, indirect, and cumulative effects
of implementing each alternative. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Public participation is important at several points during the analysis process. The first point was the scoping
process (40 CFR 1501.7). The scoping process includes, but is not limited to: (1) Identifying potential issues, (2)
identifying issues to be analyzed in depth, (3) eliminating insignificant issues or those that have been covered
by a relevant previous environmental analysis, (4) exploring additional alternatives, and (5) identifying potential
(direct, indirect, and cumulative) environmental effects of the alternatives. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00008 </DOCNO>
<PARENT> FR940817-2-00005 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
During the scoping process, the Forest Service sought information, comments, and assistance from Federal, State,
and local agencies and individuals or organizations who may be interested in or affected by the proposal. News releases
were published in local newspapers; individual letters were distributed to government agencies, organizations,
landowners along the rivers and individuals assumed to be interested in this action; and several meetings were held
in the local community along the rivers. Informal contacts through phone calls and visits have also occurred throughout
the study. Additional mailings and media releases will occur when the Draft EIS and Final EIS are completed and available
for public review.
<!-- PJG 0012 frnewline -->
The responsible official is Mike Espy, Secretary of Agriculture, Administration Bldg., 12th Street and Jefferson
Drive, SW., Washington, DC 20250.
<!-- PJG 0012 frnewline -->
The Draft Environmental Impact Statement is expected to be filed with the Environmental Protection Agency (EPA)
and available for public review by August 1994. The comment period on the draft environmental impact statement will
be 45 days from the date the EPA publishes the Notice of Availability in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
.
<!-- PJG 0012 frnewline -->
The Forest Service believes, at this early stage, it is important to give reviewers notice of several court rulings
related to public participation in the environmental review process. Upon release of the draft environmental impact
statement, projected for August 1994, reviewers must structure their participation in the environmental review
of the proposal so that it is meaningful and alerts an agency to the reviewer's position and contentions. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Vermont Yankee Nuclear Power Corp. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
vs.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
 NRDC, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
435 U.S. 519, 553 (1978). Also, environmental objections that could be raised at the draft environmental impact statement
stage, but are not raised until after the completion of the final environmental impact statement may be waived or dismissed
by the courts. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
City of Angoon 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
vs.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
 Hodel, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
803 F.2d 1016, 1022 (9th Cir. 1986) and 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Wisconsin Heritages, Inc. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
vs.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
 Harris, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
490 F. Supp. 1334, 1338 (E.D. Wis. 1980). Because of these court rulings, it is very important that those interested
in this proposal participate by the close of the 45 day comment period so that substantive comments and objections
are made available to the Forest Service at a time when it can meaningfully consider and respond to them in the Final
Environmental Impact Statement.
<!-- PJG 0012 frnewline -->
To assist the Forest Service in identifying and considering issues and concerns on the proposed action, comments
on the draft environmental impact statement should be as specific as possible. It is also helpful if comments refer
to specific pages and chapters of the draft statement. Comments may also address the adequacy of the draft environmental
impact statement or the merits of the alternatives formulated and discussed in the statement. (Reviewers may wish
to refer to the Council on Environmental Quality Regulations for implementing the procedural provisions at the National
Environmental Policy Act at 40 CFR 1503.3 in addressing these points.
<!-- PJG 0012 frnewline -->
After the comment period ends on the draft environmental impact statement, the comments will be analyzed and considered
by the Forest Service in preparing the Final Environmental Impact Statement. The final statement is scheduled to
be completed by March 1995.
<!-- PJG 0012 frnewline -->
The Secretary of Agriculture will consider comments, responses, and environmental consequences discussed in the
final environmental impact statement and applicable laws, regulations, and policies in making his recommendation
to the President regarding the suitability of these rivers for inclusion in the National Wild and Scenic Rivers System.
The decision on the inclusion of a river in the National Wild and Scenic Rivers System rests with the United States Congress.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: July 29, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Bertha C. Gillam,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Director of Environmental Coordination.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20209 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3410&hyph;11&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00009 </DOCNO>
<PARENT> FR940817-2-00006 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF COMMERCE</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>International Trade Administration</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[A&hyph;570&hyph;832, A&hyph;570&hyph;833, A&hyph;821&hyph;805, A&hyph;821&hyph;806, A&hyph;823&hyph;806]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Postponement of Preliminary Antidumping Duty Determinations: Pure and Alloy Magnesium From the People's Republic
of China and the Russian Federation; and Pure Magnesium from Ukraine
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Import Administration, International Trade Administration, Commerce.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
August 17, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Erik Warga (202&hyph;482&hyph;0922) or David Golberger (202&hyph;482&hyph;4136), Office of Antidumping Investigations,
Import Administration, International Trade Administration, U.S. Department of Commerce, 14th Street and Constitution
Avenue NW, Washington, D.C. 20230.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Department of Commerce (``the Department'') is postponing its preliminary determinations in the antidumping
duty investigations of pure and alloy magnesium from the People's Republic of China (PRC) and the Russian Federation
(Russia), and pure magnesium from Ukraine. The deadline for issuing these preliminary determinations is now no later
than October 27, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
On April 20, 1994, the Department initiated antidumping duty investigations of pure and alloy magnesium from the
PRC, Russia, and Ukraine (59 FR 21748, April 26, 1994). The notice stated that we would issue our preliminary determinations
on September 7, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On May 16, 1994, the U.S. International Trade Commission determined that there was not a likelihood that a U.S. domestic
industry was materially injured, nor threatened with material injury, by reason of imports of alloy magnesium from
Ukraine, thereby terminating the investigation of alloy magnesium from Ukraine. With regard to pure and alloy magnesium
from the People's Republic of China and the Russian Federation and pure magnesium from Ukraine, the ITC found that
there was a reasonable indication that an industry in the U.S. is materially injured, or threatened with material
injury, by reason of imports of pure and alloy magnesium from the People's Republic of China and the Russian Federation
and pure magnesium from Ukraine.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
We have determined that the remaining investigations are extraordinarily complicated within the meaning of section
733(c)(1)(B)(i) of the Tariff Act of 1930, as amended (``the Act''), and 19 CFR 353.15(b)(2). Given the non-market
economy status of all countries subject to these investigations, the nature of government ownership of the participating
companies must be clarified for each country. Additionally, these investigations involve unusually complex foreign
trading channels as well as possible sales from foreign government stockpiles. Furthermore, we have determined
that the parties concerned are cooperating, as required by section 733(c)(1)(B) of the Act and 19 CFR 353.15(b)(1),
and that additional time is necessary to make these preliminary determinations in accordance with section 733(c)(1)(B)(ii)
of the Act and 19 CFR 353.15(b)(3).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For these reasons, the deadline for issuing these determinations is now no later than October 27, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
This notice is published pursuant to section 733(c)(2) of the Act and 19 CFR 353.15(d).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: August 8, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Susan G. Esserman,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Assistant Secretary for Import Administration.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20201 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3510&hyph;DS&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00010 </DOCNO>
<PARENT> FR940817-2-00007 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>U.S. Environmental Protection Agency, Notice of Decision on Application for Duty-Free Entry of Scientific Instrument</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This decision is made pursuant to Section 6(c) of the Educational, Scientific, and Cultural Materials Importation
Act of 1966 (Pub. L. 89&hyph;651, 80 Stat. 897; 15 CFR 301). Related records can be viewed between 8:30 A.M. and 5:00
P.M. in Room 4211, U.S. Department of Commerce, 14th and Constitution Avenue, N.W., Washington, D.C.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comments: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
None received. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Decision: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Approved. No instrument of equivalent scientific value to the foreign instrument, for such purposes as it is intended
to be used, is being manufactured in the United States.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Docket Number: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
94&hyph;042. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Applicant: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
U.S. Environmental Protection Agency, Las Vegas, NV 89193-3478. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Instrument: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
ICP Mass Spectrometer, Model VG PlasmaQuad. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Manufacturer: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Fisons Instruments, United Kingdom. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Intended Use: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
See notice at 57 FR 18371, April 18, 1994. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Reasons: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The foreign instrument provides rapid multielemental analysis in both continuous-scan and peak-hopping modes
with a sensitivity to 20 MHz/ppm for Co, In, Pb, Bi, and U and an average background of &lt; 10 cps.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
This capability is pertinent to the applicant's intended purpose and we know of no other instrument or apparatus of
equivalent scientific value to the foreign instrument which is being manufactured in the United States.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Pamela Woods,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Director, Statutory Import Programs Staff.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20200 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3510&hyph;DS&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00011 </DOCNO>
<PARENT> FR940817-2-00008 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>National Oceanic and Atmospheric Administration</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Monterey Bay National Marine Sanctuary Advisory Council; Meetings</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
agency:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Sanctuaries and Reserves Division (SRD), Office of Ocean and Coastal Resource Management (OCRM), National Ocean
Service (NOS), National Oceanic and Atmospheric Administration (NOAA), Department of Commerce.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
action:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Monterey Bay National Marine Sanctuary Advisory Council Open Meeting.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
summary:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The Advisory Council was established in December 1993 to advise and assist the Secretary of Commerce in the implementation
of the management plan for the Monterey Bay National Marine Sanctuary.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
time and place:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 August 24, 1994 from 9:30 until 2:30. The meeting location will be at the Cavalier Plaza, 9415 Hearst Drive, San Simeon,
California.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
agenda:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 General issues related to the Monterey Bay National Marine Sanctuary are expected to be discussed, including vessel
traffic safety and strategic planning.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
public participation:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The meeting will be open to the public. Seats will be available on a first-come, first-served basis.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
for further information contact:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Scott Kathey at (408) 647&hyph;4201 or Elizabeth Moore at (301) 713&hyph;3141.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Federal Domestic Assistance Catalog Number 11.429, Marine Sanctuary Program.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: August 10, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
W. Stanley Wilson,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Assistant Administrator for Ocean Services and Coastal Zone Management.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20092 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3510&hyph;08&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00012 </DOCNO>
<PARENT> FR940817-2-00009 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>COMMITTEE FOR THE IMPLEMENTATION OF TEXTILE AGREEMENTS</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Extension of an Import Restraint Limit for Certain Cotton Textile Products Produced or Manufactured in Myanmar</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
August 12, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Committee for the Implementation of Textile Agreements (CITA).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Issuing a directive to the Commissioner of Customs extending a limit.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
September 1, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Ross Arnold, International Trade Specialist, Office of Textiles and Apparel, U.S. Department of Commerce, (202)
482&hyph;4212. For information on the quota status of this limit, refer to the Quota Status Reports posted on the bulletin
boards of each Customs port or call (202) 927&hyph;5850. For information on embargoes and quota re-openings, call
(202) 482&hyph;3715.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=2 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Executive Order 11651 of March 3, 1972, as amended; section 204 of the Agricultural Act of 1956, as amended (7 U.S.C.
1854).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The United States Government has decided to continue the restraint limit on Categories 347/348 for an additional
twelve-month period, beginning on September 1, 1994 and extending through August 31, 1995.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A description of the textile and apparel categories in terms of HTS numbers is available in the CORRELATION: Textile
and Apparel Categories with the Harmonized Tariff Schedule of the United States (see 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 notice 58 FR 62645, published on November 29, 1993). Also see 58 FR 41737, published on August 5, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Rita D. Hayes,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Chairman, Committee for the Implementation of Textile Agreements.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SIGNJOB>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Committee for the Implementation of Textile Agreements
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=34 g=1 f=1 -->
August 12, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Commissioner of Customs, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=3 -->
Department of the Treasury, Washington, DC 20229.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Dear Commissioner: Under the terms of section 204 of the Agricultural Act of 1956, as amended (7 U.S.C. 1854); and in
accordance with the provisions of Executive Order 11651 of March 3, 1972, as amended, you are directed to prohibit,
effective on September 1, 1994, entry into the United States for consumption and withdrawal from warehouse for consumption
of cotton textile products in Categories 347/348, produced or manufactured in Myanmar and exported during the period
beginning on September 1, 1994 and extending through August 31, 1995, in excess of 131,659 dozen.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Imports charged to this category limit for the period September 1, 1993 through August 31, 1994 shall be charged against
that level of restraint to the extent of any unfilled balance. Goods in excess of that limit shall be subject to the limit
established in this directive.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In carrying out the above directions, the Commissioner of Customs should construe entry into the United States for
consumption to include entry for consumption into the Commonwealth of Puerto Rico.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Committee for the Implementation of Textile Agreements has determined that this action falls within the foreign
affairs exception of the rulemaking provisions of 5 U.S.C. 553(a)(1).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sincerely,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=3 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=06 g=1 f=1 -->
Rita D. Hayes,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Chairman, Committee for the Implementation of Textile Agreements.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20134 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3510&hyph;DR&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00013 </DOCNO>
<PARENT> FR940817-2-00010 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Extension of an Import Restraint Limit for Certain Cotton and Man-Made Fiber Textile Products Produced or Manufactured
in Myanmar</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
August 12, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Committee for the Implementation of Textile Agreements (CITA).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Issuing a directive to the Commissioner of Customs extending a limit.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
October 3, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Ross Arnold, International Trade Specialist, Office of Textiles and Apparel, U.S. Department of Commerce, (202)
482&hyph;4212. For information on the quota status of this limit, refer to the Quota Status Reports posted on the bulletin
boards of each Customs port or call (202) 927&hyph;5850. For information on embargoes and quota re-openings, call
(202) 482&hyph;3715.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=2 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Executive Order 11651 of March 3, 1972, as amended; section 204 of the Agricultural Act of 1956, as amended (7 U.S.C.
1854).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The United States Government has decided to continue the restraint limit on Categories 340/640 for an additional
twelve-month period, beginning on October 1, 1994 and extending through September 30, 1995.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A description of the textile and apparel categories in terms of HTS numbers is available in the CORRELATION: Textile
and Apparel Categories with the Harmonized Tariff Schedule of the United States (see 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 notice 58 FR 62645, published on November 29, 1993). Also see 58 FR 41738, published on August 5, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Rita D. Hayes,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Chairman, Committee for the Implementation of Textile Agreements.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SIGNJOB>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Committee for the Implementation of Textile Agreements
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=34 g=1 f=1 -->
August 12, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Commissioner of Customs,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=3 -->
Department of the Treasury, Washington, DC 20229.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Dear Commissioner: Under the terms of section 204 of the Agricultural Act of 1956, as amended (7 U.S.C. 1854); and in
accordance with the provisions of Executive Order 11651 of March 3, 1972, as amended, you are directed to prohibit,
effective on October 3, 1994, entry into the United States for consumption and withdrawal from warehouse for consumption
of cotton and man-made fiber textile products in Categories 340/640, produced or manufactured in Myanmar and exported
during the period beginning on October 1, 1994 and extending through September 30, 1995, in excess of 93,975 dozen.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Imports charged to this category limit for the period October 1, 1993 through September 30, 1994 shall be charged against
that level of restraint to the extent of any unfilled balance. Goods in excess of that limit shall be subject to the limit
established in this directive.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In carrying out the above directions, the Commissioner of Customs should construe entry into the United States for
consumption to include entry for consumption into the Commonwealth of Puerto Rico.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Committee for the Implementation of Textile Agreements has determined that this action falls within the foreign
affairs exception of the rulemaking provisions of 5 U.S.C. 553(a)(1).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sincerely,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=3 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=06 g=1 f=1 -->
Rita D. Hayes,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Chairman, Committee for the Implementation of Textile Agreements.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20133 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3510&hyph;DR&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00014 </DOCNO>
<PARENT> FR940817-2-00011 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>CORPORATION FOR NATIONAL AND COMMUNITY SERVICE</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Meeting</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Corporation for National and Community Service.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of meeting.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Corporation for National and Community Service, gives notice under Public Law 92&hyph;463 (Federal Advisory
Committee Act), that it will hold a meeting of the Civilian Community Corps (CCC) Advisory Board. The Board advises
the Director of the CCC concerning the administration of the program and assists in the development and administration
of the Corps. This meeting of the Board will discuss the progress to date and future direction of the program. The meeting
will be open to the public up to the seating capacity of the room.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
September 11, 1994, 3:00 pm&hyph;9:30 pm.; September 12, 1994, 8:00 am&hyph;9:30 pm.; September 13, 1994, 8:00 a.m.&hyph;12:00
pm.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Hotel Del Coronado, 1500 Orange Avenue, Coronado, CA 92118.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
To assure adequate accommodation, contact Ms. Carla Sims, Protocol Officer, CCC at 1100 Vermont Avenue, NW, Washington,
DC 20525; (202) 606&hyph;5000 ext 183 or (202) 606&hyph;5256 (TDD) prior to September 1, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: August 11, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Donald L. Scott,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Director.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20188 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6050&hyph;28&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00015 </DOCNO>
<PARENT> FR940817-2-00012 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF DEFENSE</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Aneptek Corp: Partially Exclusive Patent License </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Department of the Navy, DOD.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Intent to grant partially exclusive patent license; Aneptek Corporation.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Department of the Navy hereby given notice of its intent to grant to Aneptek Corporation a revocable, nonassignable,
partially exclusive license in the United States to practice the Government-owned invention described in U.S. Patent
Application Serial No. 07/749,244 entitled ``Large Scale Purification of Contaminated Air'' filed August 23, 1991.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Anyone wishing to object to the grant of this license has 60 days from the date of this notice to file written objections
along with supporting evidence, if any. Written objections are to be filed with the Office of Naval Research (ONR OOCC),
Ballston Tower One, Arlington, Virginia, 22217&hyph;5660. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Mr. R.J. Erickson, Staff Patent Attorney, Office of Naval Research (ONR OOCC), Ballston Tower One, 800 North Quincy
Street, Arlington, Virginia, 22217&hyph;5660, telephone (703) 696&hyph;4001. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: August 10, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lewis T. Booker, Jr. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
LCDR, JAGC, USN Federal Register Liaison Officer. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20127 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3810&hyph;AE&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00016 </DOCNO>
<PARENT> FR940817-2-00013 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Department of the Air Force</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Public Scoping Meeting for Disposal and Reuse of Gentile AFS, OH </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The United States Air Force (AF) will conduct a public scoping meeting to provide a forum for public officials and the
community to provide information and comments concerning the disposal and reuse of portions of Gentile AFS, OH. The
meeting will be held September 14, 1994 beginning at 7 p.m. at the Kettering City Hall, 3600 Shroyer Road, Kettering,
Ohio. 
<!-- PJG 0012 frnewline -->
The purpose of this meeting is to identify the environmental issues and concerns that should be analyzed to support
base disposal and reuse, and solicit potential disposal and reuse alternatives for consideration in developing
the Environmental Impact Statement (EIS). In soliciting disposal and reuse alternatives, the AF will consider all
reasonable alternatives offered by any federal, state, or local government agency, and any federally-sponsored
or private entity or individual. The resulting EIS will be considered in making disposal decisions that will be documented
in the Air Force's Final Disposal Plan and Record of Decision for Gentile AFS. 
<!-- PJG 0012 frnewline -->
To ensure sufficient time to adequately consider public comments concerning environmental issues and disposal
alternatives to be included in the EIS, the AF recommends that comments and reuse proposals be presented at the upcoming
meeting or forwarded to the address below by December 1, 1994. The AF will, however, accept additional comments at
any time during the environmental impact analysis process. 
<!-- PJG 0012 frnewline -->
Please direct written comments or requests for further information concerning the base disposal and reuse EIS to:
William Myers, 8106 Chennault Road, Brooks AFB TX 78235&hyph;5318, (210) 536&hyph;3860. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Environmental Protection, Environmental Impact Statement, US Air Force, Gentile AFS, Scoping Meeting, Disposal
and Reuse, Defense Base Closure and Realignment Commission. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Patsy J. Conner, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Air Force Federal Register Liaison Officer. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20210 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3910&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00017 </DOCNO>
<PARENT> FR940817-2-00014 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Department of the Army</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Finding of No Significant Impact (FNSI) and Environmental Assessment (EA) for Realignment of Fort Monmouth, NJ</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Department of the Army, DoD.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Finding of No Significant Impact.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The proposed action implements the July 1993 Defense Base Closure and Realignment Commission's (BRAC 93) decision
to realign all Department of Army personnel and missions out of the leased U.S. Army Communications-Electronics
Command (CECOM) Office Building (Tinton Falls, New Jersey) and the Evans subpost (which is closing) onto the main
post or Charles Wood subpost of Fort Monmouth. Personnel and missions from Vint Hill Farms Station (VHFS) in Warrenton,
Virginia, will also be moved onto the main post or Charles Wood subpost as part of this action.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Since not all personnel can be accommodated in existing buildings, new facilities will be constructed. Actions to
implement this realignment include the construction of up to 7 new buildings, demolition of 5 buildings, and renovation
of 15 buildings.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Alternatives considered in the EA included:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Alternative 1: Consists of the following projects:
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
_Construction of a 16,000-square foot Intelligence and Electronic Warfare Directorate (IEWD) complex at main post.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Construction of a 3,250-square foot calibration range laboratory at the Charles Wood subpost.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Construction of a 2,600-square foot high bay facility at the Charles Wood subpost.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Renovation of 14 main post buildings.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Renovation of portions of the Myer Center (Building 2700) at the Charles Wood subpost.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Alternative 2: Alternative construction sites were identified on the Charles Wood subpost for the IEWD complex,
the calibration range laboratory, and the high bay facility. No reasonable alternative to the building renovations
at main post and the Charles Wood subpost of Fort Monmouth were identified.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Alternative 3: The No-Action Alternative. This alternative is the continuation of existing conditions without
the implementation of, or in absence of, the proposed actions. The proposed actions are required by BRAC law and must
be implemented. Therefore, the No-Action Alternative is being evaluated to provide a baseline for the other alternatives.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Alternative 2 was not selected for implementation based on the potential for significant environmental, biological
and cultural resources impacts.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Implementation of the preferred alternative (Alternative 1) will not substantially alter baseline environmental
conditions. Biological, physical, and cultural resources will not be impacted by the preferred alternative because
construction sites for new buildings are located in previously disturbed areas. The increase in the workforce at
Fort Monmouth will be largely off-set by the workforce decreases that will result from scheduled non-BRAC realignments
and Department of Defense downsizing. This workforce decrease offsets potential impacts on infrastructure such
as water, wastewater, solid waste and energy.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed realignment is expected to have an insignificant impact on the socioeconomic environment, including
total sales, employment, population and income.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Based on the EA, which is incorporated into the FNSI, it has been determined that implementation of the proposed action
would have no significant individual or cumulative impacts on the quality of the natural or human environment. Because
there will be no significant environmental impacts resulting from implementation of the proposed action, an Environmental
Impact Statement is not required.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Army plans to initiate the proposed action on or before September 16, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Copies of this EA may be obtained by writing to the U.S. Army Corps of Engineers, Mobile District, ATTN: CESAM&hyph;PD&hyph;E
(Dr. Neil Robinson), P.O. Box 2288, Mobile, Alabama 36628&hyph;0001 or by calling (205) 441&hyph;5103 within 30
days of the date of publication of this notice.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: August 9, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ADDRESS>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Raymond J. Fatz,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Deputy Assistant Secretary of the Army (Environment, Safety &amp; Occupational Health) OASA (IL&amp;E).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20125 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3710&hyph;08&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00018 </DOCNO>
<PARENT> FR940817-2-00015 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Department of the Navy</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Government-Owned Invention; Availability for Licensing</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Department of the Navy, DOD.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of Availability of Invention for Licensing.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The invention listed below is assigned to the United States Government as represented by the Secretary of the Navy
and is available for licensing by the Department of the Navy.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Request for copies of patent application cited should be directed to the Office of Naval Research (ONR 00CC), Ballston
Tower One, 800 North Quincy Street, Arlington, Virginia 22217&hyph;5660 and must include the application serial
number.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Mr. R.J. Erickson, Staff Patent Attorney, Office of Naval Research (ONR 00CC), 800 North Quincy Street, Arlington,
Virginia 22217&hyph;5660, telephone (703) 696&hyph;4001.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Patent Application 08/250,768: SILOXANES WITH STRONG HYDROGEN AND DONATING FUNCTIONALITIES; filed May 27, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: July 26, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lewis T. Booker, Jr.,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
LCDR, JAGC, USN, Federal Register Liaison Officer.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20083 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3810&hyph;AE&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00019 </DOCNO>
<PARENT> FR940817-2-00016 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Invention for Licensing; Availability</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Department of the Navy, DOD.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of Availability of Invention for Licensing.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The invention listed below is assigned to the United States Government as represented by the Secretary of the Navy
and is available for licensing by the Department of the Navy.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Requests for copies of the patent applications cited should be directed to the Office of Naval Research (ONR 00CC),
Ballston Tower One, 800 North Quincy Street, Arlington, Virginia, 22217&hyph;5660, and must include the application
serial number.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Mr. R.J. Erickson, Staff Patent Attorney, Office of Naval Research (ONR 00CC), 800 North Quincy Street, Arlington,
Virginia, 22217&hyph;5660, telephone (703) 696&hyph;4001.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Patent application 08/136,586: SURFACE-LAMINATED PIEZOELECTRIC-FILM SOUND TRANSDUCER; filed October 18, 1993;
and
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Patent application (Navy Case number 75,574): LOXANES WITH STRONG HYDROGEN BOND DONATING FUNCTIONALITIES; filed
May 27, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: July 26, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lewis T. Booker, Jr.,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
LCDR, JAGC, USN, Federal Register Liaison Officer.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20082 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3810&hyph;AE&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00020 </DOCNO>
<PARENT> FR940817-2-00017 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Partially Exclusive Patent License</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Department of the Navy, DOD.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Intent to Grant Partially Exclusive Patent License; First Choice Armor &amp; Equipment, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Department of the Navy hereby gives notice of its intent to grant to First Choice Armor &amp; Equipment, Inc., a
revocable, nonassignable, partially exclusive license in the United States to practice the Government-owned invention
described in U.S. Patent No. 5,060,314, entitled ``Multi-Mission Ballistic Resistant Jacket'' issued October
29, 1991.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Anyone wishing to object to the grant of this license has 60 days from the date of this notice to file written objections
along with supporting evidence, if any. Written objections are to be filed with the Office of Naval Research (ONR 00CC),
Ballston Tower One, 800 North Quincy Street, Arlington, Virginia 22217&hyph;5660
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Mr. R.J. Erickson, Staff Patent Attorney, Office of Naval Research (ONR 00CC), 800 North Quincy Street, Arlington,
Virginia 22217&hyph;5660, telephone (703) 696&hyph;4001.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: July 26, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lewis T. Booker, Jr.,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
LCDR, JAGC, USN, Federal Register Liaison Officer.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20081 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3810&hyph;AE&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00021 </DOCNO>
<PARENT> FR940817-2-00018 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF EDUCATION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Proposed Information Collection Requests</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Department of Education.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of Proposed Information Collection Requests.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Acting Director, Information Resources Management Service, invites comments on the proposed information collection
requests as required by the Paperwork Reduction Act of 1980.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Interested persons are invited to submit comments on or before September 16, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Written comments should be addressed to the Office of Information and Regulatory Affairs, Attention: Dan Chenok:
Desk Officer, Department of Education, Office of Management and Budget, 725 17th Street, NW., Room 3208, New Executive
Office Building, Washington, DC 20503. Requests for copies of the proposed information collection requests should
be addressed to Patrick J. Sherrill, Department of Education, 400 Maryland Avenue, SW., Room 5624, Regional Office
Building 3, Washington, DC 20202&hyph;4651.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Patrick J. Sherrill (202) 708&hyph;9915. Individuals who use a telecommunications device for the deaf (TDD) may
call the Federal Information Relay Service (FIRS) at 1&hyph;800&hyph;877&hyph;8339 between 8 a.m. and 8 p.m., Eastern
time, Monday through Friday.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Section 3517 of the Paperwork Reduction Act of 1980 (44 U.S.C. Chapter 35) requires that the Office of Management and
Budget (OMB) provide interested Federal agencies and the public an early opportunity to comment on information collection
requests. OMB may amend or waive the requirement for public consultation to the extent that public participation
in the approval process would defeat the purpose of the information collection, violate State of Federal law, or substantially
interfere with any agency's ability to perform its statutory obligations. The Acting Director of the Information
Resources Management Service, publishes this notice containing proposed information collection requests prior
to submission of these requests to OMB. Each proposed information collection, grouped by office, contains the following:
(1) Type of review requested, e.g., new, revision, extension, existing or reinstatement; (2) Title; (3) Frequency
of collection; (4) The affected public; (5) Reporting burden; and/or (6) Recordkeeping burden; and (7) Abstract.
OMB invites public comment at the address specified above. Copies of the requests are available from Patrick J. Sherrill
at the address specified above.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: August 11, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Mary P. Liggett,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Director, Information resources Management Service.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Office of Special Education and Rehabilitative Services
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=3 -->
Type of Review:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
 REINSTATEMENT
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=3 -->
Title:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
 Quarterly Cumulative Caseload Report
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=3 -->
Frequency:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
 Quarterly
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=3 -->
Affected Public:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
 State or local governments
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=3 -->
Reporting Burden:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=14 g=1 f=1 -->
Responses: 324
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Burden Hours: 324
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=3 -->
Recordkeeping Burden:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=14 g=1 f=1 -->
Recordkeepers: 81
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Burden Hours: 81
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=3 -->
Abstract:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
 This report, submitted by State Vocational Rehabilitation agencies, collects data on caseload flows which includes
persons served, rehabilitated and accepted for VR services. The Department will use the information for program
management and budgeting purposes.
<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20126 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4000&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00022 </DOCNO>
<PARENT> FR940817-2-00019 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF ENERGY</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Metal Casting Industrial Advisory Board </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Department of Energy.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of Open Meeting.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Pursuant to the provisions of the Federal Advisory Committee Act (Public Law 92&hyph;463, 86 Stat. 770) notice is
hereby given of the Metal Casting Industrial Advisory Board meeting. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Tuesday, September 13, 1994, 8 a.m.&hyph;5:30 p.m.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 University of Alabama_Tuscaloosa, 
<!-- PJG 0012 frnewline -->
Student Union Building, 
<!-- PJG 0012 frnewline -->
Tuscaloosa, Alabama 35487&hyph;0200.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Douglas E. Kaempf, Program Manager, Department of Energy, Office of Industrial Technologies (EE&hyph;23), 1000
Independence Ave. SW., Washington, DC 20585, (202) 586&hyph;5264, Fax: (202) 586&hyph;3180.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
Purpose of the Committee: The Metal Casting Industrial Advisory Board serves to provide guidance and oversight of
research programs provided under the Metal Casting Competitiveness Research Program and to recommend to the Secretary
of Energy new or revised program activities and Metal Casting Research Priorities. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Tentative Agenda 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Tuesday, September 13, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->
8:00&blank;Welcome and Introductions_D. Kaempf 
<!-- PJG 0012 frnewline -->
8:15&blank;(30 minute) Presentations of the fiscal year 1994 selected projects research activities and management
plans_C. Bates, 
<!-- PJG 0012 frnewline -->
L. Wang, 
<!-- PJG 0012 frnewline -->
J. Wallace, 
<!-- PJG 0012 frnewline -->
T. Piwonka
<!-- PJG 0012 frnewline -->
10:15&blank;Break 
<!-- PJG 0012 frnewline -->
10:30&blank;Continue Presentations of the fiscal year 1994 selected projects research activities and management
plans 
<!-- PJG 0012 frnewline -->
11:30&blank;Summary of comments and findings on the morning presentations_Board Members 
<!-- PJG 0012 frnewline -->
12:00&blank;Lunch 
<!-- PJG 0012 frnewline -->
1:00
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=14 g=1 f=1 -->
&bull;Review of findings by subcommittees_Board Members 
<!-- PJG 0012 frnewline -->
&bull;Summary of comments on the fiscal year 1994 solicitation and selection of the research proposals and any recommendations
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=16 g=1 f=1 -->
2:00&blank;Break 
<!-- PJG 0012 frnewline -->
2:30
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=14 g=1 f=1 -->
&bull;Comments and recommendations on the FY 94 selection criteria and/or operation of the metal casting program_Board
Members
<!-- PJG 0012 frnewline -->
&bull;Discussion and presentation of the recommended list of metal casting research priorities for the FY 95 solicitation

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=16 g=1 f=1 -->
4:30&blank;Public comment_Public 
<!-- PJG 0012 frnewline -->
5:00&blank;Closing comments and Adjournment_Co-Chairpersons: 
<!-- PJG 0012 frnewline -->
D. Cocks, 
<!-- PJG 0012 frnewline -->
D. Peters
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A final agenda will be available at the meeting. 
<!-- PJG 0012 frnewline -->
Public Participation: The meeting is open to the public. The Chairperson of the Board is empowered to conduct the meeting
to facilitate the orderly conduct of business. Any member of the public who wishes to make oral statements pertaining
to the agenda items should contact Douglas E. Kaempf at the address or telephone number listed above. Requests must
be received at least 5 days prior to the meeting and reasonable provisions will be made to include the presentation
on the agenda. Written statements may be filed with the Committee either before or after the meeting. 
<!-- PJG 0012 frnewline -->
Transcript: Available for public review and copying at the Freedom of Information Public Reading Room, Room 1E&hyph;190,
Forrestal Building, 1000 Independence Avenue, SW., Washington, DC between 9 a.m. and 4 p.m., Monday through Friday,
except Federal holidays.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued at Washington, DC on August 12, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Marcia L. Morris, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Advisory Committee 
<!-- PJG 0012 frnewline -->
Management Officer.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20205 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6450&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00023 </DOCNO>
<PARENT> FR940817-2-00020 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Environmental Management Site Specific Advisory Board, Idaho National Engineering Laboratory </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Department of Energy.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of Open Meeting.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Pursuant to the provisions of the Federal Advisory Committee Act (Public Law 92&hyph;463, 86 Stat. 770) notice is
hereby given of the following Advisory Committee meeting: Environmental Management Site Specific Advisory Board
(EM SSAB), Idaho National Engineering Laboratory.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Monday, August 29, 1994 from 8:30 am Mountain Daylight Time (MDT) 
<!-- PJG 0012 frnewline -->
until 6:00 pm MDT and Tuesday, August 30, 1994 from 8:00 am MDT 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
until 5:00 pm MDT. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Littletree Inn, Teton Room (208) 523&hyph;5993, 
<!-- PJG 0012 frnewline -->
888 North Holmes Avenue, 
<!-- PJG 0012 frnewline -->
Idaho Falls, ID 83401.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Idaho National Engineering Laboratory Information 1&hyph;800&hyph;708&hyph;2680 or Stephanie Jennings or Douglas
Brown, Advanced Sciences, Inc. Staff Support 1&hyph;208&hyph;529&hyph;2002.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Purpose of the Committee: The Board will continue to develop operating procedures and identify and prioritize possible
Department of Energy, Environmental Protection Agency, and State of Idaho issues for Board recommendations. There
will be information presentations to the Board regarding the Department of Energy Programmatic Spent Nuclear Fuel
Management and Idaho National Engineering Laboratory Environmental Restoration and Waste Management Programs
Draft Environmental Impact Statement. The Board will also discuss the contractor support services required for
Fiscal year 1995. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Tentative Agenda 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Monday, August 29, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->
8:00 a.m._Sign-in and Registration 
<!-- PJG 0012 frnewline -->
8:30 a.m.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=14 g=1 f=1 -->
Facilitator Introduction 
<!-- PJG 0012 frnewline -->
Old Business 
<!-- PJG 0012 frnewline -->
Housekeeping Items: Meeting Attendance Report 
<!-- PJG 0012 frnewline -->
Agenda Acceptance/Revision for Day 1
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=16 g=1 f=1 -->
9:00 a.m._Budget Committee Report 
<!-- PJG 0012 frnewline -->
9:15 a.m.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=14 g=1 f=1 -->
Budget Discussion 
<!-- PJG 0012 frnewline -->
Contractor Support Discussion
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=16 g=1 f=1 -->
9:30 a.m._Procedure Committee Report 
<!-- PJG 0012 frnewline -->
9:45 a.m._Procedure Discussion 
<!-- PJG 0012 frnewline -->
10:15 a.m._Break 
<!-- PJG 0012 frnewline -->
10:30 a.m._Revise/Accept Procedures 
<!-- PJG 0012 frnewline -->
11:30 a.m._Plutonium Vulnerabilities Report 
<!-- PJG 0012 frnewline -->
12:00 p.m._Lunch Break 
<!-- PJG 0012 frnewline -->
1:00 p.m._EPA/State/DOE Top Five Issues 
<!-- PJG 0012 frnewline -->
1:45 p.m._EM SSAB-INEL Issue Prioritization 
<!-- PJG 0012 frnewline -->
2:45 p.m._Break 
<!-- PJG 0012 frnewline -->
3:00 p.m._Continue Issue Prioritization 
<!-- PJG 0012 frnewline -->
3:30 p.m._Environmental Impact Statement (EIS) Volume 1_Purpose and Alternatives 
<!-- PJG 0012 frnewline -->
4:30 p.m._EIS Volume 1_Questions and Answers 
<!-- PJG 0012 frnewline -->
4:45 p.m._Break 
<!-- PJG 0012 frnewline -->
5:00 p.m.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=14 g=1 f=1 -->
Public Comment Availability 
<!-- PJG 0012 frnewline -->
EIS Volume 1 Discussion
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=16 g=1 f=1 -->
6:00 p.m. Adjourn Day 1 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Tuesday, August 30, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->
7:30 a.m._Sign-In and Registration 
<!-- PJG 0012 frnewline -->
8:00 a.m.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=14 g=1 f=1 -->
Public Comment Evaluation from Day 1 
<!-- PJG 0012 frnewline -->
Old Business from Day 1 
<!-- PJG 0012 frnewline -->
Agenda Acceptance/Revision for Day 2
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=16 g=1 f=1 -->
8:30 a.m._EIS Volume 2_Purpose and Alternatives 
<!-- PJG 0012 frnewline -->
9:15 a.m._EIS Volume 2_Questions and Answers 
<!-- PJG 0012 frnewline -->
9:30 a.m._EIS_Characterization of Spent Nuclear Fuel (SNF) and Waste Streams as They Affect Idaho and the INEL 
<!-- PJG 0012 frnewline -->
9:45 a.m._EIS_Transportation in Idaho 
<!-- PJG 0012 frnewline -->
10:15 a.m._Break 
<!-- PJG 0012 frnewline -->
10:30 a.m._EIS_Accident Analysis 
<!-- PJG 0012 frnewline -->
11:00 a.m._EIS_Environmental Consequences 
<!-- PJG 0012 frnewline -->
12:00 p.m._Lunch Break 
<!-- PJG 0012 frnewline -->
1:00 p.m._EIS_Cost Considerations and Trade-Offs 
<!-- PJG 0012 frnewline -->
1:30 p.m._EIS_Questions and Answers 
<!-- PJG 0012 frnewline -->
2:00 p.m._EM SSAB-INEL Open Discussion and Working Session on EIS 
<!-- PJG 0012 frnewline -->
Recommendations/Comment 
<!-- PJG 0012 frnewline -->
2:45 p.m._Break 
<!-- PJG 0012 frnewline -->
3:00 p.m.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=14 g=1 f=1 -->
Continue EIS Working Session 
<!-- PJG 0012 frnewline -->
Draft EIS Recommendations/Comments 
<!-- PJG 0012 frnewline -->
Develop/Assign Sub-Committees if Necessary
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=16 g=1 f=1 -->
4:30 p.m.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=14 g=1 f=1 -->
Confirm Next EM SSAB-INEL Meeting date(s) and Location 
<!-- PJG 0012 frnewline -->
Develop Draft Agenda Items for Next Meeting
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=16 g=1 f=1 -->
5:00 p.m._Adjourn Day 2 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A final agenda will be available at the meeting. 
<!-- PJG 0012 frnewline -->
Public Comment Availability: The two-day meeting is open to the public, with a Public Comment Availability session
scheduled for Monday, August 28, 1994 from 5:00 p.m. to 6:00 p.m. MDT. The Board will be available during this time period
to hear verbal public comments or to review any written public comments. If there are no members of the public wishing
to comment or no written comments to review, the board will continue with it's current discussion. Written statements
may be filed with the Committee either before or after the meeting. Individuals who wish to make oral statements pertaining
to agenda items should contact the Idaho National Engineering Laboratory Information line or Stephanie Jennings
or Doug Brown at the addresses or telephone numbers listed above. Requests must be received 5 days prior to the meeting
and reasonable provision will be made to include the presentation in the agenda. The Designated Federal Official
is empowered to conduct the meeting in a fashion that will facilitate the orderly conduct of business. Each individual
wishing to make public comment will be provided a maximum of 5 minutes to present their comments. Due to programmatic
issues that had to be resolved, the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 notice is being published less than fifteen days before the date of the meeting. Written comments will be accepted
at the address above within 15 days after publication of this notice. 
<!-- PJG 0012 frnewline -->
Minutes: The minutes of this meeting will be available for public review and copying at the Freedom of Information
Public Reading Room, 1E&hyph;190, Forrestal Building, 1000 Independence Avenue, SW, Washington, DC 20585 between
9:00 a.m. and 4 p.m., Monday-Friday, except Federal holidays.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
Issued at Washington, DC on August 12, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Marcia L. Morris,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Advisory Committee Management Officer.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20203 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6450&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->
 
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00024 </DOCNO>
<PARENT> FR940817-2-00021 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Environmental Management Site Specific Advisory Board, Savannah River Site</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Department of Energy.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of Open Meeting.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Pursuant to the provisions of the Federal Advisory Committee Act (Public Law 92&hyph;463, 86 Stat. 770) notice is
hereby given of the following Advisory Committee meeting: Environmental Management Site Specific Advisory Board
(EM SSAB), Savannah River Site.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Monday, August 22, 1994: 6:00 p.m._7:00 p.m. (public comment session); Tuesday, August 23, 1994: 8:30 a.m._4:00
p.m..
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The public comment session will be held at the Telfair Inn, 326 Greene St, Augusta, Georgia. The August 23 meeting will
be held at: Building 703&hyph;41A, U.S. Department of Energy Savannah River Site, Aiken, South Carolina.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Tom Hennan, Manager, Environmental Restoration and Solid Waste, Department of Energy Savannah River Operations
Office, P.O. Box A, Aiken, S.C. 29802 (803) 725&hyph;8074.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Purpose of the Board: The purpose of the Board is to make recommendations to DOE and its regulators in the areas of environmental
restoration, waste management, and related activities.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Tentative Agenda
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Monday, August 22, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->
6:00 p.m._Public Comment Session (5-minute rule)
<!-- PJG 0012 frnewline -->
7:00 p.m._Adjourn
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Tuesday, August 23, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->
8:00 a.m._Registration
<!-- PJG 0012 frnewline -->
8:30 a.m._Briefings on the high-level waste program at SRS, the board's bylaws, and the annual SRS Environmental
(Monitoring) Report for 1993
<!-- PJG 0012 frnewline -->
3:30 p.m._Public Comment Session (5-minute rule)
<!-- PJG 0012 frnewline -->
4:00 p.m._Adjourn
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
If needed, time will be allotted after public comments for old business, new business, items added to the agenda, and
administrative details.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A final agenda will be available at the meeting Monday, August 22, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Public Participation: The meeting is open to the public. Written statements may be filed with the Committee either
before or after the meeting. Individuals who wish to make oral statements pertaining to agenda items should contact
Tom Heenan's office at the address or telephone number listed above. The Designated Federal official is empowered
to conduct the meeting in a fashion that will facilitate the orderly conduct of business. Each individual wishing
to make a public comment will be provided a maximum of 5 minutes to present their comments. Due to programmatic issues
that had to be resolved, the Federal Register notice is being published less than fifteen days before the date of the
meeting. Written comments will be accepted at the address above 15 days after publication of this notice.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Minutes: The minutes of this meeting will be available for public review and copying at the Freedom of Information
Public Reading Room, IE&hyph;190, Forrestal Building, 1000 Independence Avenue, SW, Washington, DC 20585 between
9:00 a.m. and 4 p.m., Monday-Friday, except Federal holidays. Minutes will also be available by writing to Tom Heenan,
Department of Energy Savannah River Operations Office, P.O. Box A, Aiken, S.C. 29802, or by calling him at (803)&hyph;725&hyph;8074.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued at Washington, DC on August 12, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Marcia L. Morris,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Advisory Committee Management Officer.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20202 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6450&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00025 </DOCNO>
<PARENT> FR940817-2-00022 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Advisory Committee on Human Radiation Experiments</DOCTITLE>
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Department of Energy.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of open meeting.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Under the provisions of the Federal Advisory Committee Act (Pub. L. No. 92&hyph;463, 86 Stat. 770), notice is hereby
given of the following meeting: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES AND TIMES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 September 12, 1994, 9 a.m.&hyph;5 p.m.; September 13, 1994, 9 a.m.&hyph;3 p.m. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
PLACE:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Ramada Plaza Hotel, 10 Thomas Circle, Washington, D.C.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Steve Klaidman, The Advisory Committee on Human Radiation Experiments, 1726 M Street, NW., Suite 600, Washington,
DC 20036. Telephone: (202) 254&hyph;9795 Fax: (202) 254&hyph;9828.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Purpose of the Committee
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Advisory Committee on Human Radiation Experiments was established by the President, Executive Order No. 12891,
January 15, 1994, to provide advice and recommendations on the ethical and scientific standards applicable to human
radiation experiments carried out or sponsored by the United States Government. The Advisory Committee on Human
Radiation Experiments reports to the Human Radiation Interagency Working Group, the members of which include the
Secretary of Energy, the Secretary of Defense, the Secretary of Health and Human Services, the Secretary of Veterans
Affairs, the Attorney General, the Administrator of the National Aeronautics and Space Administration, the Director
of Central Intelligence, and the Director of the Office of Management and Budget. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Tentative Agenda 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Monday, September 12, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->
9 a.m._Call to Order and Opening Remarks 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
9:10 a.m._Briefing on Background Issues, Advisory Committee Members 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
10:45 a.m._Break 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
11 a.m._Briefing of Background Issues, Advisory Committee Members (continue) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12:15 p.m._Lunch 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1:15 p.m._Discussion, Status and Strategies of Document Collection and Review 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3:15 p.m._Break 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3:30 p.m._Public Comment ( 5 minute rule) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
5 p.m._Meeting Adjourn 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Tuesday, September 13, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->
9 a.m._Opening Remarks 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
9:15 a.m._Discussion, Status of Document Collection and Review 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
10:45 a.m._Break 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
11 a.m._Discussion, Status of Document Collection and Review (continued) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12:15 p.m._Lunch 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1:30 p.m._Discussion, Status of Document Collection and Review (continued) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3 p.m._Meeting Adjourned
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A final agenda will be available at the meeting. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Public Participation 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The meeting is open to the public. The chairperson is empowered to conduct the meeting in a fashion that will facilitate
the orderly conduct of business. Any member of the public who wishes to file a written statement with the Advisory Committee
will be permitted to do so, either before or after the meeting. Members of the public who wish to make a 5 minute oral statement
should contact the Advisory Committee at the address or telephone number listed above. Requests must be received
at least five business days prior to the meeting and reasonable provisions will be made to include the presentation
on the agenda. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Transcript 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Available for public review and copying at the office of the Advisory Committee at the address listed above between
9 a.m. and 4 p.m., Monday through Friday, except Federal holidays.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued at Washington DC on: August 12, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Marcia L. Morris,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Advisory Committee Management Officer.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20204 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6450&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00026 </DOCNO>
<PARENT> FR940817-2-00023 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Assumptions and Methodology Document for the Spent Nuclear Fuel Management Cost </DOCTITLE>
<!-- PJG 0012 frnewline -->
Evaluation 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Department of Energy. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of availability.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The Department of Energy has issued an Assumptions and Methodology 
<!-- PJG 0012 frnewline -->
Document for a cost evaluation of the management of Spent Nuclear Fuel, which discusses 
<!-- PJG 0012 frnewline -->
the assumptions and methodologies that will be used by the Department in preparing a cost 
<!-- PJG 0012 frnewline -->
evaluation report. The Department invites interested agencies, organizations, and the general 
<!-- PJG 0012 frnewline -->
public to provide comments on the Assumptions and Methodology Document. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 All comments on the Assumptions and Methodology Document are due by 
<!-- PJG 0012 frnewline -->
September 30, 1994. The Department will consider all comments received before preparing 
<!-- PJG 0012 frnewline -->
the Cost Evaluation Report, scheduled for release in April, 1995. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The Assumptions and Methodology Document is available in Department of 
<!-- PJG 0012 frnewline -->
Energy Public Reading Rooms and Information Locations, which are listed below. Comments 
<!-- PJG 0012 frnewline -->
should be sent to: Public Comment on the Assumptions and Methodology Document, 
<!-- PJG 0012 frnewline -->
Attention: Brooks Weingartner, DOE Idaho Operations Office, P.O. Box 1625, Idaho Falls, 
<!-- PJG 0012 frnewline -->
Idaho, 83402&hyph;1625. Copies of the Assumptions and Methodology Document may be obtained 
<!-- PJG 0012 frnewline -->
by writing to the above address, or by calling 1&hyph;800&hyph;682&hyph;5583. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Mr. Brooks Weingartner, U.S. 
<!-- PJG 0012 frnewline -->
Department of Energy, Idaho Operations Office, 850 Energy Plaza, MS 2518, Idaho Falls, 
<!-- PJG 0012 frnewline -->
Idaho, 83401, at (208) 526&hyph;7043. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 During the last fifty years, the Department of 
<!-- PJG 0012 frnewline -->
Energy has engaged in extensive nuclear energy operations that have made large contributions 
<!-- PJG 0012 frnewline -->
to our national defense and knowledge of nuclear technology. In the process, substantial 
<!-- PJG 0012 frnewline -->
quantities of spent nuclear fuel were generated. The Department must manage that spent 
<!-- PJG 0012 frnewline -->
nuclear fuel, and a much smaller amount that will be generated over the next 40 years, until 
<!-- PJG 0012 frnewline -->
final decisions about its ultimate disposition are made. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In June 1994, the Department issued the Department of Energy Programmatic Spent 
<!-- PJG 0012 frnewline -->
Nuclear Fuel Management and Idaho National Engineering Laboratory Environmental 
<!-- PJG 0012 frnewline -->
Restoration and Waste Management Programs Draft Environmental Impact Statement (SNF &amp; 
<!-- PJG 0012 frnewline -->
INEL EIS) (DOE/EIS&hyph;0203&hyph;D) for review and comment. A Notice of Availability was issued 
<!-- PJG 0012 frnewline -->
on June 24, 1994 (59 FR 32688). The SNF &amp; INEL EIS evaluates potential environmental 
<!-- PJG 0012 frnewline -->
impacts that may occur under several different alternatives for managing spent nuclear fuel 
<!-- PJG 0012 frnewline -->
over the next 40 years. 
<!-- PJG 0012 frnewline -->
Potential monetary costs associated with implementing the spent nuclear fuel 
<!-- PJG 0012 frnewline -->
management alternatives will be considered in the Department's decision-making on the 
<!-- PJG 0012 frnewline -->
alternatives identified in the EIS. The Cost Evaluation Report will also contain other 
<!-- PJG 0012 frnewline -->
information (for example, estimated costs of disposal in a geologic repository) which will be 
<!-- PJG 0012 frnewline -->
useful in the Department's efforts to establish baseline estimates for life-cycle program costs. 
<!-- PJG 0012 frnewline -->
Such information is relevant to the Department's environmental restoration and waste 
<!-- PJG 0012 frnewline -->
management responsibilities and is being consolidated into the Baseline Environmental 
<!-- PJG 0012 frnewline -->
Management Report to be issued later this year. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Cost Evaluation Report
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Department is seeking public input on the Assumptions 
<!-- PJG 0012 frnewline -->
and Methodology Document, which is to be used in preparing the Cost Evaluation Report. 
<!-- PJG 0012 frnewline -->
The Cost Evaluation Report will be made available to the public before the EIS Record of 
<!-- PJG 0012 frnewline -->
Decision is issued in June 1995. Portions of this evaluation are among the many factors that 
<!-- PJG 0012 frnewline -->
will be considered by the Department when preparing the EIS Record of Decision. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Scope of the Cost Evaluation
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Assumptions and Methodology Document 
<!-- PJG 0012 frnewline -->
presents the approach to be used in developing the cost evaluation, which has two primary 
<!-- PJG 0012 frnewline -->
purposes: to compare the monetary costs of the alternatives discussed in the SNF and INEL 
<!-- PJG 0012 frnewline -->
EIS and to explore estimated life-cycle costs to be used as relevant information to the 
<!-- PJG 0012 frnewline -->
Department's environmental restoration and waste management responsibilities. The Cost 
<!-- PJG 0012 frnewline -->
Evaluation Report will address a reasonable range of potential spent nuclear fuel management 
<!-- PJG 0012 frnewline -->
project expenses, which (depending upon the alternative) include potential costs for research 
<!-- PJG 0012 frnewline -->
and development, plant and equipment, operations and maintenance, capital/construction, 
<!-- PJG 0012 frnewline -->
decommissioning and decontamination, and potential costs associated with disposal. Some 
<!-- PJG 0012 frnewline -->
spent nuclear fuel management decisions may not be made for several years. Future selection 
<!-- PJG 0012 frnewline -->
of technologies or decisions on how to prepare some fuels for storage or disposition, for 
<!-- PJG 0012 frnewline -->
example, may significantly affect cost. Therefore, only relative predictions of these costs can 
<!-- PJG 0012 frnewline -->
be made at this time. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00027 </DOCNO>
<PARENT> FR940817-2-00023 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Assumptions: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The assumptions used in the Assumptions and Methodology Document 
<!-- PJG 0012 frnewline -->
cover three tiers: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Tier 1: Programmatic assumptions reflecting current Department policies and 
<!-- PJG 0012 frnewline -->
directives. 
<!-- PJG 0012 frnewline -->
Tier 2: Implementation of site-specific assumptions reflecting a site-specific 
<!-- PJG 0012 frnewline -->
planning basis. 
<!-- PJG 0012 frnewline -->
Tier 3: Technical assumptions based on expert knowledge and local conditions. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Assumptions will be based on: 
<!-- PJG 0012 frnewline -->
&bull;When, where, and how spent nuclear fuel will be managed and dispositioned 
<!-- PJG 0012 frnewline -->
&bull;Technologies and requirements for stabilization (including processing), storage, 
<!-- PJG 0012 frnewline -->
transport, and licensing 
<!-- PJG 0012 frnewline -->
&bull;The time frame required for various factors in managing spent nuclear fuel. 
<!-- PJG 0012 frnewline -->
&bull;Facility lifespan, upgrades, new building, decontamination and decommissioning. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Methodology: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Assumptions and Methodology Document is intended to provide a 
<!-- PJG 0012 frnewline -->
methodology for a relative comparison of costs that could be involved in Department of 
<!-- PJG 0012 frnewline -->
Energy spent nuclear fuel management. The DOE sites already engaged in spent nuclear fuel 
<!-- PJG 0012 frnewline -->
management activities will be evaluated to determine the feasibility of utilizing existing 
<!-- PJG 0012 frnewline -->
facilities and the costs of operating and maintaining those facilities. Certain functions or 
<!-- PJG 0012 frnewline -->
facilities are not available at all sites under all management strategies and alternatives. 
<!-- PJG 0012 frnewline -->
Generic facility descriptions and associated costs will be developed to fill the gap between 
<!-- PJG 0012 frnewline -->
existing and needed facilities.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
To define the possible spread of costs for each alternative. To the extent practicable, estimates 
<!-- PJG 0012 frnewline -->
will be based upon historic data; analyses of similar activities and projecting cost to provide 
<!-- PJG 0012 frnewline -->
estimates for new actions; use of estimates developed in other programs that address some 
<!-- PJG 0012 frnewline -->
aspect of spent nuclear fuel management; and expert opinion. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
DOE Public Reading Rooms 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
U.S. Department of Energy, Oakland Operations Office, 
<!-- PJG 0012 frnewline -->
Environmental Information Center, 
<!-- PJG 0012 frnewline -->
1301 Clay Street, Room 700 North, 
<!-- PJG 0012 frnewline -->
Oakland, CA 94612, 
<!-- PJG 0012 frnewline -->
(510) 637&hyph;1762, 
<!-- PJG 0012 frnewline -->
Monday&hyph;Friday: 8:30 a.m. to 5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
U.S. Department of Energy, Rocky Flats Office, 
<!-- PJG 0012 frnewline -->
Public Reading Room, 
<!-- PJG 0012 frnewline -->
Front Range Community, 
<!-- PJG 0012 frnewline -->
College Library, 
<!-- PJG 0012 frnewline -->
3645 West 112th Avenue, 
<!-- PJG 0012 frnewline -->
Level B, Center of the Building, 
<!-- PJG 0012 frnewline -->
Westminster, CO 80030, 
<!-- PJG 0012 frnewline -->
(303) 469&hyph;4435, 
<!-- PJG 0012 frnewline -->
Monday &amp; Tuesday: 10:30 a.m. to 6:30 p.m., Wednesday: 10:00 a.m. to 4:00 p.m., Thursday: 
<!-- PJG 0012 frnewline -->
8:00 a.m. to 4:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
U.S. Department of Energy, Headquarters, 
<!-- PJG 0012 frnewline -->
Freedom of Information Reading Room, 
<!-- PJG 0012 frnewline -->
1E&hyph;190 Forrestal Building, 
<!-- PJG 0012 frnewline -->
1000 Independence Avenue, SW., 
<!-- PJG 0012 frnewline -->
Washington, D.C. 10585, 
<!-- PJG 0012 frnewline -->
(202) 586&hyph;6020, 
<!-- PJG 0012 frnewline -->
Monday&hyph;Friday: 9:00 a.m. to 4:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
U.S. Department of Energy, Idaho Operations Office, 
<!-- PJG 0012 frnewline -->
Public Reading Room, 
<!-- PJG 0012 frnewline -->
1776 Science Center Drive, 
<!-- PJG 0012 frnewline -->
Idaho Falls, ID 83402, 
<!-- PJG 0012 frnewline -->
(208) 526&hyph;9162, 
<!-- PJG 0012 frnewline -->
Monday&hyph;Friday: 8:00 a.m. to 5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
U.S. Department of Energy, Chicago Operations Office, 
<!-- PJG 0012 frnewline -->
Public Reading Room, 
<!-- PJG 0012 frnewline -->
University of Illinois at Chicago Library, 
<!-- PJG 0012 frnewline -->
Government Documents Section, 
<!-- PJG 0012 frnewline -->
801 South Morgan Street, 
<!-- PJG 0012 frnewline -->
Chicago, IL 60607, 
<!-- PJG 0012 frnewline -->
(312) 996&hyph;2738, 
<!-- PJG 0012 frnewline -->
Monday&hyph;Friday: 8:00 a.m. to 10:00 p.m., Saturday: 10:00 a.m. to 5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
U.S. Department of Energy, Albuquerque Operations Office, 
<!-- PJG 0012 frnewline -->
Public Reading Room, 
<!-- PJG 0012 frnewline -->
National Atomic Museum, 
<!-- PJG 0012 frnewline -->
20358 Wyoming Boulevard, SE, 
<!-- PJG 0012 frnewline -->
Albuquerque, NM 87185, 
<!-- PJG 0012 frnewline -->
(505) 845&hyph;4378, 
<!-- PJG 0012 frnewline -->
Monday&hyph;Friday: 9:00 a.m. to 5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
U.S. Department of Energy, Nevada Operations Office, 
<!-- PJG 0012 frnewline -->
Public Reading Room, 
<!-- PJG 0012 frnewline -->
Coordination and Information Center, 
<!-- PJG 0012 frnewline -->
3084 South Highland Drive, 
<!-- PJG 0012 frnewline -->
Las Vegas, NV 89106, 
<!-- PJG 0012 frnewline -->
(702) 295&hyph;0731, 
<!-- PJG 0012 frnewline -->
Monday&hyph;Friday: 7:00 a.m. to 4:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
U.S. Department of Energy, Fernald Field Office, 
<!-- PJG 0012 frnewline -->
Public Environmental Center, 
<!-- PJG 0012 frnewline -->
JANTER Building 10845, 
<!-- PJG 0012 frnewline -->
Hamilton-Cleves Highway, 
<!-- PJG 0012 frnewline -->
Harrison, OH 45030, 
<!-- PJG 0012 frnewline -->
(513) 738&hyph;0164, 
<!-- PJG 0012 frnewline -->
Monday, Thursday: 9:00 a.m. to 8:00 p.m., Tuesday, Wednesday, Friday: 9:00 a.m. to 4:30 p.m., Saturday: 9:00 a.m.
to 1:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00028 </DOCNO>
<PARENT> FR940817-2-00023 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=15 g=1 f=1 -->
U.S. Department of Energy, Savannah River Operations Office, 
<!-- PJG 0012 frnewline -->
Public Reading Room, 
<!-- PJG 0012 frnewline -->
Road 1A, Building 703A, D232, 
<!-- PJG 0012 frnewline -->
Aiken, SC 29802, 
<!-- PJG 0012 frnewline -->
(803) 725&hyph;1408, 
<!-- PJG 0012 frnewline -->
Monday&hyph;Thursday: 8:00 a.m. to 11:00 p.m., Friday: 8:00 a.m. to 5:00 p.m., Saturday: 10:00 
<!-- PJG 0012 frnewline -->
a.m. to 5:00 p.m., Sunday: 2:00 p.m. to 11:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
U.S. Department of Energy, Oak Ridge Operations Office, 
<!-- PJG 0012 frnewline -->
Public Reading Room, 
<!-- PJG 0012 frnewline -->
55 Jefferson Avenue, 
<!-- PJG 0012 frnewline -->
Oak Ridge, TN 37831, 
<!-- PJG 0012 frnewline -->
(615) 576&hyph;1216, 
<!-- PJG 0012 frnewline -->
Monday&hyph;Friday: 8:00 a.m. to 11:30 a.m. and 12:30 p.m. to 5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
U.S. Department of Energy, Richland Operations Office, 
<!-- PJG 0012 frnewline -->
Public Reading Room, 
<!-- PJG 0012 frnewline -->
Washington State University Tri-Cities, 
<!-- PJG 0012 frnewline -->
100 Sprout Road, Room 130W, 
<!-- PJG 0012 frnewline -->
Richland, WA 99352, 
<!-- PJG 0012 frnewline -->
(509) 376&hyph;8583, 
<!-- PJG 0012 frnewline -->
Monday&hyph;Friday: 8:00 a.m. to 12:00 p.m. and 1:00 p.m. to 4:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Navy Information Locations 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Norfolk Naval Shipyard 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Chesapeake Central Library, 
<!-- PJG 0012 frnewline -->
298 Cedar Rd., 
<!-- PJG 0012 frnewline -->
Chesapeake, VA 23320&hyph;5512, 
<!-- PJG 0012 frnewline -->
(804) 436&hyph;8300, Monday&hyph;Thursday: 9:00 a.m to 9:00 p.m., Friday&hyph;Saturday: 9:00 a.m to 5:00 p.m.,

<!-- PJG 0012 frnewline -->
Sunday: 1:00 p.m to 5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Newport News Public Library, 
<!-- PJG 0012 frnewline -->
Grissom Branch, 
<!-- PJG 0012 frnewline -->
366 Deshazor Dr., 
<!-- PJG 0012 frnewline -->
Newport News, VA 23602, 
<!-- PJG 0012 frnewline -->
(804) 886&hyph;7896, 
<!-- PJG 0012 frnewline -->
Monday&hyph;Thursday: 9:00 a.m. to 9:00 p.m., Friday&hyph;Saturday: 9:00 a.m. to 6:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Kirn Library, 
<!-- PJG 0012 frnewline -->
301 East City Hall Ave., 
<!-- PJG 0012 frnewline -->
Norfolk, VA 23510, 
<!-- PJG 0012 frnewline -->
(804) 441&hyph;2429, 
<!-- PJG 0012 frnewline -->
Monday&hyph;Thursday: 9:00 a.m. to 9:00 p.m., Friday: 9:00 a.m. to 5:30 p.m., Saturday: 9:00 
<!-- PJG 0012 frnewline -->
a.m. to 5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hampton Public Library, 
<!-- PJG 0012 frnewline -->
4207 Victoria Boulevard, 
<!-- PJG 0012 frnewline -->
Hampton, VA 23669, 
<!-- PJG 0012 frnewline -->
(804) 727&hyph;1154, 
<!-- PJG 0012 frnewline -->
Monday&hyph;Thursday: 9:00 a.m. to 9:00 p.m., Friday&hyph;Saturday: 9:00 a.m. to 5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Portsmouth Public Library, 
<!-- PJG 0012 frnewline -->
Main Branch, 
<!-- PJG 0012 frnewline -->
601 Court St., 
<!-- PJG 0012 frnewline -->
Portsmouth, VA 23704, 
<!-- PJG 0012 frnewline -->
(804) 393&hyph;8501, 
<!-- PJG 0012 frnewline -->
Monday&hyph;Thursday: 9:00 a.m to 9:00 p.m, Friday&hyph;Saturday: 9:00 a.m to 5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Virginia Beach Central Library, 
<!-- PJG 0012 frnewline -->
4100 Virginia Beach Blvd., 
<!-- PJG 0012 frnewline -->
Virginia Beach, VA 23452, 
<!-- PJG 0012 frnewline -->
(804) 431&hyph;3001, 
<!-- PJG 0012 frnewline -->
Monday&hyph;Thursday: 10:00 a.m. to 9:00 p.m., Friday&hyph;Saturday: 10:00 a.m. to 5:00 p.m., 
<!-- PJG 0012 frnewline -->
Sunday: 1:00 p.m .to 5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Puget Sound 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Kitsap Regional Library, 
<!-- PJG 0012 frnewline -->
1301 Sylvan Way, 
<!-- PJG 0012 frnewline -->
Bremerton, WA 98310, 
<!-- PJG 0012 frnewline -->
(206) 377&hyph;7601, 
<!-- PJG 0012 frnewline -->
Monday&hyph;Thursday: 9:30 a.m to 9:00 p.m., Friday&hyph;Saturday: 9:30 a.m to 5:30 p.m., 
<!-- PJG 0012 frnewline -->
Sunday: 12:30 p.m. to 5:30 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Kitsap Regional Libary, 
<!-- PJG 0012 frnewline -->
Downtown Branch, 
<!-- PJG 0012 frnewline -->
612 5th Ave., 
<!-- PJG 0012 frnewline -->
Bremerton, WA 98310, 
<!-- PJG 0012 frnewline -->
(206) 377&hyph;3955, 
<!-- PJG 0012 frnewline -->
Monday&hyph;Friday: 10:00 a.m. to 6:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Suzzallo Library, SM25, 
<!-- PJG 0012 frnewline -->
University of Washington Libraries, 
<!-- PJG 0012 frnewline -->
University of Washington, 
<!-- PJG 0012 frnewline -->
Seattle, WA 98185, 
<!-- PJG 0012 frnewline -->
(206) 543&hyph;9158, 
<!-- PJG 0012 frnewline -->
Monday&hyph;Thursday: 7:30 a.m. to 12:00 midnight, Friday: 7:30 a.m. to 6:00 p.m., Saturday: 
<!-- PJG 0012 frnewline -->
9:00 a.m. to 5:00 p.m. Sun. 12:00 p.m. to 12:00 midnight 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Portsmouth Naval Shipyard 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Rice Public Library, 
<!-- PJG 0012 frnewline -->
8 Wentworth St., 
<!-- PJG 0012 frnewline -->
Kittery, ME 03904, 
<!-- PJG 0012 frnewline -->
(207) 439&hyph;1553, 
<!-- PJG 0012 frnewline -->
Monday&hyph;Wednesday, Friday: 10:00 a.m. to 5:00 p.m., Thursday: 10:00 a.m. to 8:00 p.m., 
<!-- PJG 0012 frnewline -->
Saturday: 10:00 a.m. to 4:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Portsmouth Public Library, 
<!-- PJG 0012 frnewline -->
8 Islington St., 
<!-- PJG 0012 frnewline -->
Portsmouth, NH 03801, 
<!-- PJG 0012 frnewline -->
(804) 393&hyph;8501, 
<!-- PJG 0012 frnewline -->
Monday&hyph;Thursday: 9:00 a.m. to 9:00 p.m., Friday&hyph;Saturday: 9:00 a.m. to 5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Pearl Harbor 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Aiea Public Library, 
<!-- PJG 0012 frnewline -->
99&hyph;143 Monalua Rd., 
<!-- PJG 0012 frnewline -->
Aiea, HI 96701, 
<!-- PJG 0012 frnewline -->
(808) 488&hyph;2654, 
<!-- PJG 0012 frnewline -->
Monday, Thursday: 10:00 a.m. to 8:00 p.m., Tuesday, Wednesday, Friday, Saturday: 10:00 
<!-- PJG 0012 frnewline -->
a.m. to 5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hawaii State Library, 
<!-- PJG 0012 frnewline -->
478 S. King St., 
<!-- PJG 0012 frnewline -->
Honolulu, HI 96813, 
<!-- PJG 0012 frnewline -->
(808) 586&hyph;3535, 
<!-- PJG 0012 frnewline -->
Monday, Wednesday, Friday, Saturday: 9:00 a.m. to 5:00 p.m., Tuesday, Thursday: 9:00 
<!-- PJG 0012 frnewline -->
a.m. to 8:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Pearl City Public Library, 
<!-- PJG 0012 frnewline -->
1138 Waimano Home Rd., 
<!-- PJG 0012 frnewline -->
Pearl City, HI 96782, 
<!-- PJG 0012 frnewline -->
(808) 455&hyph;4134, 
<!-- PJG 0012 frnewline -->
Monday&hyph;Wednesday: 10:00 a.m. to 8:00 p.m., Thursday&hyph;Saturday: 10:00 a.m. to 5:00 
<!-- PJG 0012 frnewline -->
p.m., Sunday: 1:00 p.m. to 5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Pearl Harbor Naval Base Library, 
<!-- PJG 0012 frnewline -->
Code 90L, 
<!-- PJG 0012 frnewline -->
1614 Makalapa Dr., 
<!-- PJG 0012 frnewline -->
Pearl Harbor, HI 96860&hyph;5350, 
<!-- PJG 0012 frnewline -->
(808) 471&hyph;8238, 
<!-- PJG 0012 frnewline -->
Tuesday&hyph;Thursday: 10:00 a.m. to 7:00 p.m., Friday&hyph;Saturday: 9:00 a.m. to 5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Kesselring Site 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Albany Public Library,
<!-- PJG 0012 frnewline -->
Reference and Adult Services, 
<!-- PJG 0012 frnewline -->
161 Washington Ave., 
<!-- PJG 0012 frnewline -->
Albany, NY 12210, 
<!-- PJG 0012 frnewline -->
(518) 449&hyph;3380, 
<!-- PJG 0012 frnewline -->
Monday&hyph;Thursday: 9:00 a.m. to 9:00 p.m., Friday: 9:00 a.m to 6:00 p.m., Saturday: 9:00 
<!-- PJG 0012 frnewline -->
a.m. to 5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Saratoga Springs Public Library, 
<!-- PJG 0012 frnewline -->
320 Broadway, 
<!-- PJG 0012 frnewline -->
Saratoga Springs, NY 12866, 
<!-- PJG 0012 frnewline -->
Monday&hyph;Thursday: 9:00 a.m. to 9:00 p.m., Friday: 9:00 a.m. to 6:00 p.m., Saturday: 9:00 
<!-- PJG 0012 frnewline -->
a.m. to 5:00 p.m., 
<!-- PJG 0012 frnewline -->
Sunday: 1:00 p.m. to 5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Schenectady County Library, 
<!-- PJG 0012 frnewline -->
99 Clinton St., 
<!-- PJG 0012 frnewline -->
Schenectady, NY 12305, 
<!-- PJG 0012 frnewline -->
(518) 388&hyph;4511, 
<!-- PJG 0012 frnewline -->
Monday&hyph;Thursday: 9:00 a.m. to 9:00 p.m., Friday&hyph;Saturday: 9:00 a.m. to 5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00029 </DOCNO>
<PARENT> FR940817-2-00023 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Other Information Locations
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Main Library, 
<!-- PJG 0012 frnewline -->
University of Arizona, 
<!-- PJG 0012 frnewline -->
Tucson, AZ 85721, 
<!-- PJG 0012 frnewline -->
(602) 621&hyph;6433, 
<!-- PJG 0012 frnewline -->
School Hours: Sunday&hyph;Thursday: 8:00 a.m. to 1:00 a.m., Friday&hyph;Saturday: 9:00 a.m. to 
<!-- PJG 0012 frnewline -->
5:00 p.m., 
<!-- PJG 0012 frnewline -->
Summer Hours: Monday&hyph;Thursday: 7:30 a.m. to 11:00 p.m., Friday: 7:30 a.m. to 6:00 
<!-- PJG 0012 frnewline -->
p.m., Saturday: 10:00 a.m. to 8:00 p.m., Sunday: 12:00 noon to 11:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Main Library, 
<!-- PJG 0012 frnewline -->
University of California at Irvine, 
<!-- PJG 0012 frnewline -->
Government Publications Receiving Dock, 
<!-- PJG 0012 frnewline -->
Irvine, CA 92717, 
<!-- PJG 0012 frnewline -->
(714) 856&hyph;7290, 
<!-- PJG 0012 frnewline -->
School Hours: Monday&hyph;Thursday: 8:00 a.m. to 7:00 p.m., Friday: 8:00 a.m. to 5:00 p.m., 
<!-- PJG 0012 frnewline -->
Saturday&hyph;Sunday: 1:00 p.m. to 5:00 p.m. 
<!-- PJG 0012 frnewline -->
Summer Hours: Monday&hyph;Friday: 8:00 a.m. to 5:00 p.m., Saturday&hyph;Sunday: 1:00 p.m. to 
<!-- PJG 0012 frnewline -->
5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Pleasanton Public Library_Reference Desk, 
<!-- PJG 0012 frnewline -->
400 Old Bernal Avenue, 
<!-- PJG 0012 frnewline -->
Pleasanton, CA 94566, 
<!-- PJG 0012 frnewline -->
(510) 462&hyph;3535, 
<!-- PJG 0012 frnewline -->
Monday, Tuesday: 1:00 p.m. to 8:00 p.m., Wednesday, Thursday: 10:00 a.m. to 6:00 p.m., 
<!-- PJG 0012 frnewline -->
Saturday: 2:00 p.m. to 6:00 p.m., Sunday: 1:00 p.m. to 5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
San Diego Public Library, 
<!-- PJG 0012 frnewline -->
820 ``E'' Street, 
<!-- PJG 0012 frnewline -->
San Diego, CA 92101 
<!-- PJG 0012 frnewline -->
(619) 236&hyph;5867, 
<!-- PJG 0012 frnewline -->
Monday&hyph;Thursday: 10:00 a.m. to 9:00 p.m., Friday&hyph;Saturday: 9:30 a.m. to 5:30 p.m., 
<!-- PJG 0012 frnewline -->
Sunday: 1:00 p.m. to 5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Denver Public Library, 
<!-- PJG 0012 frnewline -->
1357 Broadway, 
<!-- PJG 0012 frnewline -->
Denver, CO 80203, 
<!-- PJG 0012 frnewline -->
(303) 640&hyph;8845, 
<!-- PJG 0012 frnewline -->
Monday&hyph;Wednesday: 10:00 a.m. to 9:00 p.m., Thursday&hyph;Saturday: 10:00 a.m. to 5:30 
<!-- PJG 0012 frnewline -->
p.m., Sunday: 1:00 p.m. to 5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
George A. Smathers Libraries, Library West, 
<!-- PJG 0012 frnewline -->
University of Florida Library, Room 241, 
<!-- PJG 0012 frnewline -->
P.O. Box 117001, 
<!-- PJG 0012 frnewline -->
Gainesville, FL 32611&hyph;7001, 
<!-- PJG 0012 frnewline -->
(904) 392&hyph;0367, 
<!-- PJG 0012 frnewline -->
Monday&hyph;Thursday: 8:00 a.m. to 9:30 p.m., Friday: 8:00 a.m. to 5:00 p.m. 
<!-- PJG 0012 frnewline -->
Sunday: 2:30 p.m. to 9:30 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Atlanta Public Library, 
<!-- PJG 0012 frnewline -->
1 Margaret Mitchell Square, 
<!-- PJG 0012 frnewline -->
Atlanta, GA 30303, 
<!-- PJG 0012 frnewline -->
(404) 730&hyph;1700, 
<!-- PJG 0012 frnewline -->
Monday: 9:00 a.m. to 6:00 p.m., Tuesday&hyph;Thursday: 9:00 a.m. to 8:00 p.m., Friday: 9:00 
<!-- PJG 0012 frnewline -->
a.m. to 5:00 p.m., Saturday: 10:00 a.m. to 5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Reese Library, 
<!-- PJG 0012 frnewline -->
Augusta College, 
<!-- PJG 0012 frnewline -->
2500 Walton Way, 
<!-- PJG 0012 frnewline -->
Augusta, GA 30904&hyph;2200, 
<!-- PJG 0012 frnewline -->
(706) 737&hyph;1744, 
<!-- PJG 0012 frnewline -->
School Hours: Monday&hyph;Thursday: 7:45 a.m. to 10:30 p.m., Friday: 7:45 a.m. to 5:00 p.m.;
<!-- PJG 0012 frnewline -->
Saturday: 9:00 a.m. to 5:00 p.m., Sunday: 1:30 p.m. to 9:30 p.m.; 
<!-- PJG 0012 frnewline -->
Summer Hours: Monday&hyph;Friday: 8:00 a.m. to 5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Chatham-Effingham-Liberty Regional Library, 
<!-- PJG 0012 frnewline -->
2002 Bull Street, 
<!-- PJG 0012 frnewline -->
Savannah, GA 31401, 
<!-- PJG 0012 frnewline -->
(912) 234&hyph;5127, 
<!-- PJG 0012 frnewline -->
Monday&hyph;Thursday: 9:00 a.m. to 9:00 p.m., Friday: 9:00 a.m. to 6:00 p.m., Saturday: 
<!-- PJG 0012 frnewline -->
10:00 a.m. to 6:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Parks Library, 
<!-- PJG 0012 frnewline -->
Iowa State University, 
<!-- PJG 0012 frnewline -->
Government Publications Department, 
<!-- PJG 0012 frnewline -->
Ames, IA 50011&hyph;2140, 
<!-- PJG 0012 frnewline -->
(515) 294&hyph;3642, 
<!-- PJG 0012 frnewline -->
School Hours: Monday&hyph;Thursday: 7:30 a.m. to 12:00 midnight, Friday: 7:30 a.m. to 10:00 
<!-- PJG 0012 frnewline -->
p.m., 
<!-- PJG 0012 frnewline -->
Saturday: 10:00 a.m. to 10:00 p.m., Sunday: 12:30 p.m. to 12:00 midnight; 
<!-- PJG 0012 frnewline -->
Summer Hours: Monday&hyph;Thursday: 7:30 a.m. to 10:00 p.m., Friday: 7:30 a.m. to 
<!-- PJG 0012 frnewline -->
5:00 p.m., Saturday: 12:30 p.m. to 5:00 p.m., Sunday: 12:30 p.m. to 10:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Boise Public Library, 
<!-- PJG 0012 frnewline -->
715 South Capitol Boulevard, 
<!-- PJG 0012 frnewline -->
Boise, ID 83702, 
<!-- PJG 0012 frnewline -->
(208) 384&hyph;4023, 
<!-- PJG 0012 frnewline -->
Monday, Friday: 10:00 a.m. to 6:00 p.m., Tuesday&hyph;Thursday: 10:00 a.m. to 9:00 p.m.,; 
<!-- PJG 0012 frnewline -->
Saturday: 1:00 p.m. to 5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Idaho Department of Health and Welfare, 
<!-- PJG 0012 frnewline -->
Idaho National Engineering Laboratory Oversight Program Library, 
<!-- PJG 0012 frnewline -->
1410 North Hilton, 
<!-- PJG 0012 frnewline -->
Boise, ID 83706, 
<!-- PJG 0012 frnewline -->
(208) 334&hyph;0498, 
<!-- PJG 0012 frnewline -->
Monday&hyph;Friday: 8:00 a.m. to 5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Idaho State Library, 
<!-- PJG 0012 frnewline -->
325 West State Street, 
<!-- PJG 0012 frnewline -->
Boise, ID 83702, 
<!-- PJG 0012 frnewline -->
(208) 334&hyph;2152, 
<!-- PJG 0012 frnewline -->
Monday&hyph;Friday: 9:00 a.m. to 5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Shoshone-Bannock Library, 
<!-- PJG 0012 frnewline -->
Bannock and Pima Streets, HRDC Building, 
<!-- PJG 0012 frnewline -->
Fort Hall, ID 83203, 
<!-- PJG 0012 frnewline -->
(208) 238&hyph;3882, 
<!-- PJG 0012 frnewline -->
Monday&hyph;Friday: 8:00 a.m. to 4:30 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Idaho Falls Public Library, 
<!-- PJG 0012 frnewline -->
457 Broadway, 
<!-- PJG 0012 frnewline -->
Idaho Falls, ID 83402, 
<!-- PJG 0012 frnewline -->
(208) 529&hyph;1462, 
<!-- PJG 0012 frnewline -->
Monday&hyph;Thursday: 8:00 a.m. to 7:00 p.m, Friday: 8:00 a.m. to 5:00 p.m., Saturday: 
<!-- PJG 0012 frnewline -->
9:00 a.m. to 1:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
University of Idaho Library, 
<!-- PJG 0012 frnewline -->
Rayburn Street, 
<!-- PJG 0012 frnewline -->
Moscow, ID 83844&hyph;2353, 
<!-- PJG 0012 frnewline -->
(208) 885&hyph;6344, 
<!-- PJG 0012 frnewline -->
Monday&hyph;Friday: 8:00 a.m. to 12:00 midnight, Saturday: 9:00 a.m. to 12:00 midnight, 
<!-- PJG 0012 frnewline -->
Sunday: 10:00 a.m. to 12:00 midnight 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Pocatello Public Library, 
<!-- PJG 0012 frnewline -->
812 East Clark Street, 
<!-- PJG 0012 frnewline -->
Pocatello, ID 83201, 
<!-- PJG 0012 frnewline -->
(208) 232&hyph;1263, 
<!-- PJG 0012 frnewline -->
Monday&hyph;Thursday: 10:00 a.m. to 9:00 p.m., Friday&hyph;Saturday: 10:00 a.m. to 6:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Twin Falls Public Library, 
<!-- PJG 0012 frnewline -->
434 Second Street East, 
<!-- PJG 0012 frnewline -->
Twin Falls, ID 83301, 
<!-- PJG 0012 frnewline -->
(208) 733&hyph;2964, 
<!-- PJG 0012 frnewline -->
Monday&hyph;Thursday: 10:00 a.m. to 6:00 p.m, Friday: 10:00 a.m. to 5:00 p.m., Saturday: 
<!-- PJG 0012 frnewline -->
12:00 noon to 5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Main Library, Third Floor, 
<!-- PJG 0012 frnewline -->
University of Illinois, 
<!-- PJG 0012 frnewline -->
801 South Morgan, Mail Code 234, 
<!-- PJG 0012 frnewline -->
Chicago, IL 60607, 
<!-- PJG 0012 frnewline -->
(312) 413&hyph;2594, 
<!-- PJG 0012 frnewline -->
Monday&hyph;Thursday: 7:30 a.m. to 10:00 p.m., Friday: 7:30 a.m. to 5:00 p.m., Saturday: 
<!-- PJG 0012 frnewline -->
10:00 a.m. to 5:00 p.m.; 
<!-- PJG 0012 frnewline -->
Sunday: 1:00 p.m. to 9:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Documents Library, 200&hyph;D, 
<!-- PJG 0012 frnewline -->
University of Illinois, 
<!-- PJG 0012 frnewline -->
1408 W. Gregory Drive, 
<!-- PJG 0012 frnewline -->
Urbana, IL 61801, 
<!-- PJG 0012 frnewline -->
(217) 244&hyph;2060, 
<!-- PJG 0012 frnewline -->
School Hours: Monday&hyph;Thursday: 8:00 a.m. to 12:00 midnight, Friday: 8:00 a.m. to 
<!-- PJG 0012 frnewline -->
6:00 p.m., Saturday: 9:00 a.m. to 6:00 p.m., Sunday: 1:00 p.m. to 12:00 midnight 
<!-- PJG 0012 frnewline -->
Summer Hours: Monday&hyph;Thursday: 8:00 a.m. to 9:00 p.m., Friday: 8:00 a.m. to 6:00 p.m. 
<!-- PJG 0012 frnewline -->
Saturday: 9:00 a.m. to 5:00 p.m., Sunday: 1:00 p.m. to 5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Engineering Library, 
<!-- PJG 0012 frnewline -->
Purdue University, 
<!-- PJG 0012 frnewline -->
West Lafayette, IN 47907, 
<!-- PJG 0012 frnewline -->
(317) 494&hyph;2871, 
<!-- PJG 0012 frnewline -->
School Hours: Monday&hyph;Friday: 8:00 a.m. to 12:00 midnight, Saturday: 9:00 a.m. to 5:00 
<!-- PJG 0012 frnewline -->
p.m., Sunday: 12:00 noon to 12:00 midnight 
<!-- PJG 0012 frnewline -->
Summer Hours: Monday&hyph;Friday: 8:00 a.m. to 8:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00030 </DOCNO>
<PARENT> FR940817-2-00023 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Manhattan Public Library, Julliette and Poyntz, Manhattan, KS 66502, (913) 776&hyph;4741, Monday&hyph;Friday:
9:00 a.m. to 9:00 p.m., Saturday: 9:00 a.m. to 6:00 p.m., Sunday: 2:00 p.m. to 6:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Massachusetts Institute of Technology, Science Library, 160 Memorial Drive Building 14, Cambridge, MA 02139, (617)
253&hyph;5685, Monday&hyph;Thursday: 8:00 a.m. to 12:00 midnight, Friday, Saturday: 8:00 a.m. to 8:00 p.m.; Sunday:
12:00 noon to 12:00 midnight 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
O'Leary Library, University of Massachusetts, 1 University Ave, Lowell, MA 01854, (508) 934&hyph;3205, School
Hours: Monday&hyph;Thursday: 7:30 a.m. to 11:00 p.m., Friday: 7:30 a.m. to 5:00 p.m.; Saturday: 10:00 a.m. to 6:00
p.m., Summer Hours: Monday&hyph;Friday: 8:30 a.m. to 9:00 p.m., Sunday: 2:00 p.m. to 7:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Worcester Public Library, 3 Salem Square, Worchester, MA 01608, (508) 799&hyph;1655, Monday, Wednesday: 12:00
noon to 9:00 p.m., Tuesday: 10:00 a.m. to 9:00 p.m., Thursday&hyph;Saturday: 10:00 a.m. to 5:30 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bethesda Public Library, 7400 Arlington Road, Bethesda, MD 20814, (301) 986&hyph;4300, Monday&hyph;Thursday:
10:00 a.m. to 8:30 p.m., Friday: 10:00 a.m. to 5:00 p.m., Saturday: 9:00 a.m. to 5:00 p.m., Sunday: 1:00 p.m. to 5:00
p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Gaithersburg Regional Library, 18330 Montgomery Village Avenue, Gaithersburg, MD 20879, (301) 840&hyph;2515,
Monday&hyph;Thursday: 10:00 a.m. to 8:30 p.m., Friday: 10:00 a.m. to 5:00 p.m., Saturday: 9:00 a.m. to 5:00 p.m.,
Sunday: 1:00 p.m. to 5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hyattsville Public Library, 6530 Adelphi Road, Hyattsville, MD 20782, (301) 779&hyph;9330, Monday&hyph;Thursday:
10:00 a.m. to 9:00 p.m., Friday: 10:00 a.m. to 6:00 p.m., Saturday: 10:00 a.m. to 5:00 p.m., Sunday: 1:00 p.m. to 5:00
p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Ann Arbor Public Library, 343 South 5th Avenue, Ann Arbor, MI 48104, (313) 994&hyph;2333, Monday: 10:00 a.m. to 9:00
p.m., Tuesday&hyph;Friday: 9:00 a.m. to 9:00 p.m., Saturday: 9:00 a.m. to 6:00 p.m., Sunday: 1:00 p.m. to 5:00 p.m.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Zanhow Library, Saginaw Valley State University, 7400 Bay Road, University Center, MI 48710, (517) 790&hyph;4240,
School Hours: Monday&hyph;Thursday: 8:00 a.m. to 11:00 p.m., Friday: 8:00 a.m. to 4:30 p.m.; Saturday: 9:00 a.m.
to 5:00 p.m., Sunday: 1:00 p.m. to 9:00 p.m.; Summer Hours: Monday&hyph;Thursday: 8:00 a.m. to 10:30 p.m., Friday:
8:00 a.m. to 4:30 p.m., Saturday: 10:00 a.m. to 2:00 p.m., Sunday: 1:00 p.m. to 5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Ellis Library, University of Missouri, Columbia, MO 65201, (314) 882&hyph;0748, School Hours: Monday&hyph;Thursday:
7:30 a.m. to 12:00 midnight, Friday: 7:30 a.m. to 11:00 p.m., Saturday: 9:00 a.m. to 9:00 p.m., Sunday: 12:00 noon 1:00
a.m.; Summer Hours: Monday, Thursday: 8:00 a.m. to 8:00 p.m., Tuesday&hyph;Friday: 8:00 a.m. to 5:00 p.m., Saturday:
12:00 noon to 5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Curtis Laws Wilson Library, University of Missouri Library, Rolla, MO 65401&hyph;0249, (314) 341&hyph;4227, School
Hours: Monday&hyph;Thursday: 8:00 a.m. to 12:00 midnight, Friday: 8:00 a.m. to 10:30 p.m., Saturday: 8:00 a.m. to
5:00 p.m., Sunday: 2:00 p.m. to 12:00 midnight; Summer Hours: Monday&hyph;Friday: 8:00 a.m. to 10:00 p.m., Saturday:
8:00 a.m. to 5:00 p.m., Sunday: 2:00 p.m. to 10:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
D.H. Hill Library, North Carolina State University, P.O. Box 7111, Raleigh, NC 27695&hyph;7111, (919) 515&hyph;3364,
School Hours: Monday&hyph;Thursday: 7:00 a.m. to 1:00 a.m., Friday: 7:00 a.m. to 6:00 p.m.; Saturday: 9:30 a.m. to
5:30 p.m., Sunday: 1:00 p.m. to 1:00 a.m. Summer Hours: Monday&hyph;Thursday: 7:00 a.m. to 11:00 p.m., Friday: 7:00
a.m. to 6:00 p.m., Saturday: 9:30 a.m. to 5:30 p.m., Sunday: 1:00 p.m. to 11:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Omaha Public Library, 215 S. 15th Street, Omaha, NE 68102, (402) 444&hyph;4800, Monday&hyph;Thursday: 9:00 a.m.
to 9:00 p.m., Friday, Saturday: 9:00 a.m. to 5:30 p.m., Sunday: 1:00 p.m. to 5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
General Library, University of New Mexico, Albuquerque, NM 87131&hyph;1466, (505) 277&hyph;5441, School Hours:
Monday&hyph;Thursday: 8:00 a.m. to 9:00 p.m., Friday: 8:00 a.m. to 5:00 p.m.; Saturday: 1:00 p.m. to 5:00 p.m., Sunday:
1:00 p.m. to 5:00 p.m.; Summer Hours: Monday&hyph;Friday: 8:00 a.m. to 6:00 p.m., Saturday: 10:00 a.m. to 5:00 p.m.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
U.S. DOE Community Reading Room, 1450 Central Avenue, Suite 101, MS C314, Los Alamos, NM 87544, (505) 665&hyph;2127,
Monday&hyph;Friday: 8:00 a.m. to 5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Lockwood Library, State University of New York-Buffalo, Buffalo, NY 14260&hyph;2200, (716) 645&hyph;2816, School
Year: Monday&hyph;Thursday: 8:00 a.m. to 10:45 p.m., Friday: 8:00 a.m. to 9:00 p.m., Saturday: 9:00 a.m. to 5:00 p.m.,
Sunday: 1:00 p.m. to 10:45 p.m. Summer Hours: Monday, Wednesday, Thursday, Friday: 9:00 a.m. to 6:00 p.m., Tuesday:
9:00 a.m. to 10:00 p.m., Sunday: 1:00 p.m. to 9:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Engineering Library, Cornell University, Carpenter Hall, Main Floor, Ithaca, NY 14853, (607) 255&hyph;5762, School
Hours: Monday&hyph;Thursday: 8:00 a.m. to 11:00 p.m., Friday: 8:00 a.m. to 6:00 p.m.; Saturday: 10:00 a.m. to 6:00
p.m., Sunday: 12:00 p.m. to 11:00 p.m.; Summer Hours: Monday&hyph;Friday: 8:00 a.m. to 6:00 p.m., Saturday: 12:00
p.m. to 6:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Cardinal Hayes Library, Manhattan College, 4531 Manhattan College Parkway, Riverdale, NY 10471, (718) 920&hyph;0100,
School Hours: Monday&hyph;Thursday: 8:00 a.m. to 11:00 p.m., Friday: 8:00 a.m. to 6:30 p.m. Saturday: 10:00 a.m.
to 5:00 p.m., Sunday: 1:00 p.m. to 11:00 p.m.; Summer Hours: Monday&hyph;Friday: 8:30 a.m. to 6:30 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Brookhaven National Laboratory, 25 Brookhaven Avenue, Building 477 A, P.O. Box 5000, Upton, NY 11973&hyph;5000,
(516) 282&hyph;3489, Monday&hyph;Friday 8:30 a.m. to 9:00 p.m., Saturday&hyph;Sunday: 10:00 a.m. to 6:00 p.m.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Columbus Metropolitan Library, 96 South Grant Avenue, Columbus, OH 43215, (614) 645&hyph;2710, Monday&hyph;Thursday:
9:00 a.m. to 9:00 p.m., Friday&hyph;Saturday: 9:00 a.m. to 6:00 p.m., Sunday: 1:00 p.m. to 5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00031 </DOCNO>
<PARENT> FR940817-2-00023 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Kerr Library, Oregon State University, Corvallis, OR 97331&hyph;4905, (503) 737&hyph;0123, Monday&hyph;Friday:
7:45 a.m. to 2:00 a.m., Saturday&hyph;Sunday: 10:00 a.m. to 2:00 a.m.; Summer Hours: Monday&hyph;Friday: 7:45 a.m.
to 9:00 p.m., Saturday: 10:00 a.m. to 5:00 p.m.,; Sunday: 10:00 a.m. to 9:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Brantford Price Millar Library, Portland State University, 934 S.W. Harrison, Portland, OR 97201, (503) 725&hyph;4617,
Monday&hyph;Friday: 8:00 a.m. to 10:00 p.m., Saturday: 10:00 a.m. to 10:00 p.m., Sunday: 11:00 a.m. to 10:00 p.m.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Pattee Library, Pennsylvania State University, University Park, PA 16801, (814) 865&hyph;2112, School Hours:
Monday&hyph;Thursday: 8:00 a.m. to 12:00 midnight, Friday: 8:00 a.m. to 10:00 p.m., Saturday: 8:00 a.m. to 9:00 p.m.,
Sunday: 1:00 p.m. to 12:00 midnight, Summer Hours: Monday&hyph;Thursday: 7:45 a.m. to 10:00 p.m., Friday: 7:45 a.m.
to 9:00 p.m., Saturday: 8:00 a.m. to 9:00 p.m., Sunday: 1:00 p.m. to 10:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Narragansett Public Library, 35 Kingston Road, Narragansett, RI 02882, (401) 789&hyph;9507, Monday: 10:00 a.m.
to 9:00 p.m., Tuesday&hyph;Friday: 10:00 a.m. to 6:00 p.m., Saturday: 10:00 a.m. to 5:00 p.m. (Saturday hours September
to May only) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Charleston County Main Library, 404 King Street, Charleston, SC 29403, (803) 723&hyph;1645, Monday&hyph;Thursday:
9:30 a.m. to 9:00 p.m., Friday&hyph;Saturday: 9:30 a.m. to 6:00 p.m., Sunday: 2:00 p.m. to 6:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
South Carolina State Library, 1500 Senate Street, Columbia, SC 29201, (803) 734&hyph;8666, Monday&hyph;Friday:
8:15 a.m. to 5:30 p.m., Saturday: 9:00 a.m. to 1:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Clinton Public Library, 118 South Hicks Street, Clinton, TN 37716, (615) 457&hyph;0519, Monday, Thursday: 10:00
a.m. to 8:00 p.m., Tuesday, Wednesday, Friday, Saturday: 10:00 a.m. to 5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Harriman Public Library, 601 Walden Street, Harriman, TN 37748, (615) 882&hyph;3195, Monday&hyph;Thursday: 9:00
a.m. to 5:00 p.m., Friday&hyph;Saturday: 9:00 a.m. to 1:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Kingston Public Library, 1000 Bradford Way Building 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=6 f=1 -->
#
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
3, Kingston, TN 37763, (615) 376&hyph;9905, Monday, Thursday: 10:00 a.m. to 7:30 p.m., Tuesday, Wednesday, Friday:
10:00 a.m. to 5:30 p.m., Saturday: 10:00 a.m. to 2:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Lawson McGhee Public Library, 500 West Church Avenue, Knoxville, TN 37902, (615) 544&hyph;5750, Monday&hyph;Thursday:
9:00 a.m. to 8:30 p.m., Friday: 9:00 a.m. to 5:30 p.m., Saturday&hyph;Sunday: 1:00 p.m. to 5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Oak Ridge Public Library, Civic Center, Oak Ridge, TN 37830, (615) 482&hyph;8455, Monday&hyph;Thursday: 10:00
a.m. to 9:00 p.m., Friday: 10:00 a.m. to 6:00 p.m., Saturday: 9:00 a.m. to 6:00 p.m., Sunday: 2:00 p.m. to 6:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Oliver Springs Public Library, 607 Easterbrook Avenue, Oliver Springs, TN 37840, (615) 435&hyph;2509, Tuesday&hyph;Thursday:
2:00 p.m. to 4:00 p.m., Saturday: 9:00 a.m. to 12:00 midnight 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Rockwood Public Library, 117 North Front Avenue, Rockwood, TN 37854, (615) 354&hyph;1281, Monday, Wednesday, Friday,
Saturday: 10:00 a.m. to 5:00 p.m., Tuesday, Thursday: 10:00 a.m. to 8:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
General Library, University of Texas, PCL 2.402X, Austin, TX 78713, (512) 495&hyph;4262, School Hours: Monday&hyph;Friday:
8:00 a.m. to 2:00 a.m., Saturday: 9:00 a.m. to 2:00 a.m.; Sunday: 12:00 p.m. to 2:00 a.m.; Summer Hours: Monday&hyph;Friday:
8:00 a.m. to 10:00 p.m., Saturday: 9:00 a.m. to 10:00 p.m., Sunday: 12:00 noon to 10:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Evans Library, Texas A&amp;M University, MS 5000, College Station, TX 77843&hyph;5000, (409) 845&hyph;8850, School
Hours: Monday&hyph;Thursday: 7:00 a.m. to 12:00 midnight, Friday: 7:00 a.m. to 10:00 p.m., Saturday: 9:00 a.m. to
10:00 p.m., Sunday: 12:00 noon to 10:00 p.m., Summer Hours: Monday&hyph;Thursday: 7:00 a.m. to 11:00 p.m., Friday:
7:00 a.m. to 7:00 p.m., Saturday: 9:00 a.m. to 5:00 p.m., Sunday: 1:00 p.m. to 11:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Marriott Library, University of Utah, Salt Lake City, UT 84112, (801) 581&hyph;8394, School Hours: Monday&hyph;Thursday:
7:00 a.m. to 11:00 p.m., Friday: 7:00 a.m. to 5:00 p.m.; Saturday: 9:00 a.m. to 5:00 p.m., Sunday: 11:00 a.m. to 9:00
p.m.; Summer Hours: Monday&hyph;Thursday: 7:00 a.m. to 10:00 p.m., Friday: 7:00 a.m. to 5:00 p.m.; Saturday: 9:00
a.m. to 5:00 p.m., Sunday: 1:00 p.m. to 5:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Alderman Library, University of Virginia, Charlottesville, VA 22903&hyph;2498, (804) 924&hyph;3133, School
Hours: Monday&hyph;Thursday: 8:00 a.m. to 12:00 midnight, Friday: 8:00 a.m. to 6:00 p.m., Saturday: 9:00 a.m. to
6:00 p.m., Sunday: 12:00 p.m. to 12:00 midnight Summer Hours: Monday&hyph;Thursday: 8:00 a.m. to 10:00 p.m., Friday:
8:00 a.m. to 6:00 p.m., Saturday: 9:00 a.m. to 6:00 p.m., Sunday: 2:00 p.m. to 10:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Owen Science &amp; Engineering Library, Washington State University, Pullman, WA 99164&hyph;3200, (509) 335&hyph;4181,
School Hours: Monday&hyph;Thursday: 8:00 a.m. to 11:00 p.m., Friday: 8:00 a.m. to 9:00 p.m. Saturday: 12:00 noon
to 9:00 p.m., Sunday: 12:00 noon to 11:00 p.m.; Summer Hours: Monday, Thursday: 7:30 a.m. to 11:00 p.m., Tuesday, Wednesday,
Friday: 7:30 a.m. to 6:00 p.m., Saturday&hyph;Sunday: 12:00 noon to 6:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Foley Center, Gonzaga University, East 502 Boone Avenue, Spokane, WA 99258, (509) 328&hyph;4220, extension 3125,
School Hours: Monday&hyph;Thursday: 8:00 a.m. to 12:00 midnight, Friday&hyph;Saturday: 8:00 a.m. to 9:00 p.m.,
Sunday: 11:00 a.m. to 12:00 midnight, Summer Hours: Monday&hyph;Friday: 8:00 a.m. to 9:00 p.m., Saturday: 10:00
a.m. to 6:00 p.m., Sunday: 1:00 p.m. to 7:00 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Madison Public Library, 201 W. Mifflin Street, Madison, WI 53703, (608) 266&hyph;6350, Monday&hyph;Wednesday:
8:30 a.m. to 9:00 p.m., Thursday&hyph;Friday: 8:30 a.m. to 5:30 p.m., Saturday: 9:00 a.m. to 5:30 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Teton County Public Library, 320 South King Street, Jackson, WY 83001, (307) 733&hyph;2164, Monday, Wednesday,
Friday: 10:00 a.m. to 5:30 p.m., Tuesday, Thursday: 10:00 a.m. to 9:00 p.m., Saturday: 10:00 a.m. to 5:00 p.m., Sunday:
1:00 p.m. to 5:00 p.m. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued in Washington, DC on August 12, 1994. 
<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
John J. Jicha, Jr., 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Director, Office of Spent Fuel Management, Office of Waste Management, Office of Environmental Management.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20206 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6450&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00032 </DOCNO>
<PARENT> FR940817-2-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Federal Energy Regulatory Commission</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. EC94&hyph;23&hyph;000, et al.] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
The Washington Water Power Company and Sierra Pacific Power Company, et al.; Electric Rate and Corporate Regulation
Filings 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
August 9, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that the following filings have been made with the Commission: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=85 g=1 f=1 -->
1. The Washington Water Power Company and Sierra Pacific Power Company
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. EC94&hyph;23&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on August 4, 1994, The Washington Water Power Company (Water Power) and Sierra Pacific Power Company
(Sierra Power) (together Applicants) filed, pursuant to Section 203 of the Federal Power Act and Part 33 of the Commission's
Regulations, a Joint Application requesting authorization to merge and reorganize Applicants' utility operations
and to dispose of Applicants' jurisdictional facilities. 
<!-- PJG 0012 frnewline -->
Pursuant to an Agreement and Plan of Reorganization and Merger, Sierra Pacific Resources Inc., Sierra Pacific and
Water Power will merge into a new corporation, Resources West Energy Corporation (Resources West) and Water Power
and Sierra Pacific will operate as separate utility divisions of Resource West. The subsidiaries of Water Power and
Sierra Pacific Resources (excluding Sierra Pacific, but including Sierra Pacific's subsidiaries) will become
subsidiaries of Resources West. The merger will be effected through an exchange of stock, with Sierra Pacific Resources
and Water Power shareholders exchanging their shares for the right to receive shares in Resources West. 
<!-- PJG 0012 frnewline -->
Applicants have submitted the direct testimony of nine witnesses who provide, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
inter alia, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
a description of the merger, the projected benefits for ratepayers and shareholders, an explanation of how Resources
West will provide comparable service to customers, and an analysis of the effects of the merger on competition in the
relevant markets. Applicants also have submitted 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
pro forma 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
open-access point-to-point transmission and network integration service tariffs for Resources West's Water Power
and Sierra Pacific Divisions which provide a range of flexible services at rates, terms and conditions designed to
be comparable to Resources West's use of Applicants' systems.
<!-- PJG 0012 frnewline -->
Applicants have requested, in a companion motion, that the Commission adopt an alternative procedural mechanism
to expedite consideration of the Joint Application by providing for discovery and a technical conference, followed
by a paper hearing if necessary. 
<!-- PJG 0012 frnewline -->
Copies of the Joint Application have been served on the state utility regulatory commissions in Washington, Idaho,
Oregon, Montana, Nevada and California. 
<!-- PJG 0012 frnewline -->
Comment date: September 9, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=85 g=1 f=1 -->
2. North Carolina Electric Membership Corporation v. Carolina Power &amp; Light Company
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. EL94&hyph;84&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on August 1, 1994, North Carolina Electric Membership Corporation (NCEMC) and Brunswick Electric
Membership Corporation (Brunswick) tendered for filing a complaint against Carolina Power &amp; Light Company
(CP&amp;L) requesting the initiation of an investigation to determine whether CP&amp;L's present rates for wholesale
firm power to the cooperatives served under FERC Resale Service Schedule RS88&hyph;1C, are unjust, unreasonable
and unduly discriminatory and, if so, to modify those rates to a just, reasonable and unduly discriminatory and, if
so, to modify those rates to a just, reasonable level. NCEMC and Brunswick also request the Commission to set a refund
effective date at the earliest date permitted by law. 
<!-- PJG 0012 frnewline -->
Comment date: September 8, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
3. PSI Energy, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER93&hyph;700&hyph;001]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on August 1, 1994, PSI Energy, Inc. tendered for filing its compliance filing in the above-
<!-- PJG 0012 frnewline -->
referenced docket pursuant to the Commission's Letter Order issued on July 1, 1994. 
<!-- PJG 0012 frnewline -->
Comment date: August 24, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00033 </DOCNO>
<PARENT> FR940817-2-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
4. Delmarva Power &amp; Light Company
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket Nos. ER93&hyph;96&hyph;005 and EL93&hyph;11&hyph;002]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on August 2, 1994, Delmarva Power &amp; Light Company tendered for filing its compliance refund report
in the above referenced dockets. 
<!-- PJG 0012 frnewline -->
Comment date: August 23, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
5. Kentucky Utilities Company
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;209&hyph;001]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that Kentucky Utilities Company (KU) on 
<!-- PJG 0012 frnewline -->
July 19, 1994, amended its filing on June 1, 1994, in this docket to substitute a revised Exhibit II, Service Schedule
B. 
<!-- PJG 0012 frnewline -->
Comment date: August 23, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
6. Nevada Power Company
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;404&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on July 19, 1994, Nevada Power Company tendered for filing an amendment to its December 23, 1993, filing
in the above-referenced docket. 
<!-- PJG 0012 frnewline -->
Comment date: August 19, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
7. Public Service Company of Oklahoma
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;1036&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on July 13, 1994, the Public Service Company of Oklahoma tendered for filing an amendment in the above-referenced
docket. 
<!-- PJG 0012 frnewline -->
Comment date: August 23, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
8. Madison Gas &amp; Electric Company
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;1147&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on July 27, 1994, Madison Gas &amp; Electric Company tendered for filing an amendment in the above-referenced
docket. 
<!-- PJG 0012 frnewline -->
Comment date: August 23, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
9. Consolidated Edison Company of New York, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;1267&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on August 3, 1994, Consolidated Edison Company of New York, Inc. (Con Edison) tendered for filing
additional material relating to an agreement to provide interruptible transmission service for the Power Authority
of the State of New York (Power Authority). 
<!-- PJG 0012 frnewline -->
Con Edison states that a copy of this filing has been served by mail upon the Power Authority. 
<!-- PJG 0012 frnewline -->
Comment date: August 24, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
10. Northern States Power Company (Minnesota)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;1324&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on July 27, 1994, Northern States Power Company tendered for filing an amendment in the above-referenced
docket. 
<!-- PJG 0012 frnewline -->
Comment date: August 23, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
11. Northern States Power Company
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;1341&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on July 27, 1994, Northern States Power Company tendered for filing an amendment in the above-referenced
docket. 
<!-- PJG 0012 frnewline -->
Comment date: August 23, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00034 </DOCNO>
<PARENT> FR940817-2-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
12. Central Power and Light Company
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;1344&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on August 4, 1994, Central Power and Light Company (CP&amp;L) tendered for filing an amendment to
its June 10, 1994, filing of proposed Wholesale Riders 6 and 7 to its FERC Electric Tariff. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Copies of the filing have been served on the tariff customers and the Public Utility Commission of Texas. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Comment date: August 23, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
13. PacifiCorp
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;1361&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on August 1, 1994, PacifiCorp, tendered for filing, in accordance with &sect;35 of the Commission's
Rules and Regulations, an amendment to its filing dated June 14, 1994. This amended filing has been prepared to correct
the identified names and/or addresses of Chicago Energy Exchange of Chicago, Inc.; LG&amp;E Power Marketing Inc.;
Torco Energy Marketing, Inc.; and Vesta Energy Alternatives Company and to revise the Tariff in preparation for future
sales to Independent Power Marketers. Also, PacifiCorp has included fully executed Service Agreements with Enron
Power Marketing, Inc. and North American Energy Conservation, Inc. which were previously filed with the Commission
as unexecuted Service Agreements. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
PacifiCorp respectfully renews its request pursuant to &sect;35.11 of the Commission's Rules and Regulations,
that a waiver of prior notice be granted and that these Service Agreements and Tariff revisions be accepted for filing
effective on June 1, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Copies of this filing were supplied to the Public Utility Commission of Oregon. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Comment date: August 24, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
14. Puget Sound Power &amp; Light Company
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;1494&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on July 27, 1994, Puget Sound Power &amp; Light Company (Puget) tendered for filing the Agreement
for Purchase and Sale of Power (the Agreement), dated as of August 1, 1994, between Puget and Public Utility District
No. 1 of Douglas County (the District). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Puget states that the Agreement relates to the sale and purchase of on-peak capacity and associated energy and the
off-peak return of energy. A copy of the filing was served upon the District. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Comment date: August 24, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
15. Indiana Michigan Power Company
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;1495&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on July 27, 1994, Indiana Michigan Power Company (AEPSC), tendered for filing as an initial rate schedule
on behalf of Indiana Michigan Power Company (I&amp;M), a Network Transmission and Interchange Agreement between
I&amp;M and Wabash Valley Power Association, Inc. (WVPA). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Network Transmission and Interchange Agreement provides WVPA more flexible and lower cost transmission service
as an alternative to that provided by a 1988 Settlement Agreement, and permits coordination transactions between
the parties. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Copies of the filing were served upon WVPA, the Indiana Utility Regulatory Commission and the Michigan Public Service
Commission. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Comment date: August 24, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
16. Entergy Power, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;1496&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that Entergy Power, Inc. (Entergy Power), on July 27, 1994, tendered for filing a Second Amendment to a
unit power sales agreement between Entergy Power and East Texas Electric Cooperative, Inc. Entergy Power requests
waiver of the Commission's cost support and notice requirements under Section 35.12 or 35.13 of the Commission's
Regulations, to the extent they are otherwise applicable to this filing. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00035 </DOCNO>
<PARENT> FR940817-2-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Comment date: August 23, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
17. Boston Edison Company
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;1509&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on July 29, 1994, Boston Edison Company (Edison) filed a letter agreement between itself and Montaup
Electric Company (Montaup) concerning the contract (Boston Edison Rate Schedule No. 69) under which Montaup has
an 11% entitlement in Edison's Pilgrim nuclear power plant, the 1992 billings to Montaup under that contract, and
Docket No. EL94&hyph;73&hyph;000. The letter agreement provides that Boston Edison will apply the results of the
Docket No. EL94&hyph;73&hyph;00 litigation or any settlement of that proceeding to Montaup. The letter agreement
makes no other changes to the rates, terms, and conditions of the affected Pilgrim contract. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Edison states that it has served copies of this filing upon each of the affected customers and upon three other Pilgrim
power purchasers: Reading Municipal Light Department, Commonwealth Electric Company and the thirteen Massachusetts
municipal electric systems who have Pilgrim unit power purchase contracts. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Comment date: August 23, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
18. Public Service Company of New Hampshire
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;1512&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on August 1, 1994, Public Service Company of New Hampshire (PSNH) tendered for filing an amendment
(the Amendment) that would reduce rates and make other changes to the Partial Requirements Resale Service Agreement,
designated as PSNH FERC Electric Rate Schedule No. 142 (the Partial Requirements Agreement), between PSNH and the
New Hampshire Electric Cooperative, Inc. (the NHEC). The parties have requested an effective date for the Amendment
of October 1, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
PSNH states that the Amendment would make three changes to the Partial Requirements Agreement: (i) it would reduce
the amount of power the NHEC is required to purchase under the Partial Requirements Agreement in order to account for
a separate power transfer agreement between the parties; (ii) it would reduce wholesale power rates to the NHEC for
power resold to certain of the NHEC's customers or under certain of the NHEC's regulatory-approved demand-side management
programs; and (iii) it would modify record keeping requirements and audit rights to reflect the amended arrangements.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
PSNH further states that copies of the filing were served upon both parties to the Partial Requirements Agreement.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Comment date: August 24, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
19. Public Service Company of New Hampshire
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;1513&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on August 1, 1994, Public Service Company of New Hampshire (PSNH) tendered for filing an Interruptible
Power Supply Service Agreement (Interruptible Agreement) between PSNH and the New Hampshire Electric Cooperative,
Inc. (the NHEC). PSNH requests that the Commission permit the Interruptible Agreement to become effective October
1, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
PSNH states that power sold to the NHEC under the Interruptible Agreement will replace higher-priced, higher-quality
service that PSNH now provides to the NHEC under another rate schedule. Accordingly, the Interruptible Agreement
will effective reduce overall purchased power costs to be paid by the NHEC. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
PSNH further states that a copy of the filing was served upon the NHEC. In addition, PSNH also served a copy of the filing
upon the New Hampshire Public Utilities Commission. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Comment date: August 24, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
20. Public Service Company of Colorado
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;1514&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on August 1, 1994, Public Service Company of Colorado tendered for filing an amendment to its FERC
Electric Service Rate Schedule, FERC No. 47. Under the proposed amendment Public Service is seeking to revise the
points of delivery and levels of power and energy delivered for the Western Area Power Administration. This amendment
will have no impact on the rates for service under this agreement. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Public Service requests an effective date of August 1, 1994, for the proposed amendment. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Copies of the filing were served upon the Western Area Power Administration Loveland Area Office, and state jurisdictional
regulators which include the Public Utilities commission of the State of Colorado and the State of Colorado Office
of Consumer Counsel. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00036 </DOCNO>
<PARENT> FR940817-2-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Comment date: August 24, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
21. The Montana Power Company 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;1515&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on August 1, 1994, The Montana Power Company (Montana) tendered for filing with the Federal Energy
Regulatory Commission as an initial rate schedule pursuant to 18 CFR 35.13 a supplement to Rate Schedule FERC No. 027;
a Contribution in Aid of Construction Letter Agreement (Agreement) between Montana, PacifiCorp and Idaho Power
Company (Idaho) dated June 30, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Montana states that the Agreement relates to relaying equipment installed for the improved operation of the 230 kV
``AMPS'' transmission line. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A copy of the filing was served upon PacifiCorp and Idaho, Administration. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Comment date: August 24, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
22. PSI Energy, Inc. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;1517&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that PSI Energy, Inc. (PSI) on August 1, 1994, tendered for filing an Interchange Agreement, dated July
1, 1994, between PSI and Rainbow Energy Marketing Corporation (REMC). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Interchange Agreement provides for the following service between PSI and REMC: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. Exhibit A_Power Sales by REMC 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Exhibit B_Power Sales by PSI 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Copies of the filing were served on Rainbow Energy Marketing Corporation, North Dakota Public Service Commission
and the Indiana Utility Regulatory Commission. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Comment date: August 23, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
23. Commonwealth Electric Company 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;1518&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on August 1, 1994, Commonwealth Electric Company (Commonwealth) filed, under Section 205 of the
Federal Power Act, its proposed FERC Electric Tariff, Original Volume No. 1, Tariff for Firm Transmission Service
which Commonwealth proposes to become effective on September 30, 1994. The 
<!-- PJG 0012 frnewline -->
proposed tariff would provide firm transmission service over Commonwealth's transmission facilities providing
the same priority as Commonwealth's firm service to its native load customers. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Comment date: August 24, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
24. Massachusetts Electric Company 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;1525&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on August 2, 1994, Massachusetts Electric Company tendered for filing a Certificate of Cancellation
of power sales to 13 specified locations of the Massachusetts Bay Transportation Authority. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Comment date: August 24, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Standard paragraphs: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
E. Any person desiring to be heard or to protest said filing should file a motion to intervene or protest with the Federal
Energy Regulatory Commission, 825 North Capitol Street, N.E., Washington, D.C. 20426, in accordance with Rules
211 and 214 
<!-- PJG 0012 frnewline -->
of the Commission's Rules of Practice and Procedure (18 CFR 385.211 and 18 CFR 385.214). All such motions or protests
should be filed on or before the comment date. Protests will be considered by the Commission in determining the appropriate
action to be taken, but will not serve to make protestants parties to the proceeding. Any person wishing to become a
party must file a motion to intervene. Copies of this filing are on file with the Commission and are available for public
inspection. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20097 Filed 8&hyph;16&hyph;94; 8:45 am] 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;P 
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00037 </DOCNO>
<PARENT> FR940817-2-00025 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. GP94&hyph;10&hyph;000]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Railroad Commission of Texas Tight Formation Area Determinations Vicksburg Formation; Notice of Informal Conference</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
August 11, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
M Sand (Texas-112) FERC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=6 f=1 -->
#
<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
 JD93&hyph;04541T
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
R Sand (Texas-113) FERC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=6 f=1 -->
#
<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
 JD93&hyph;04589T
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
S Sand (Texas-114) FERC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=6 f=1 -->
#
<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
 JD93&hyph;04590T
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
T Sand (Texas-115) FERC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=6 f=1 -->
#
<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
 JD93&hyph;04591T
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on informal conference will be convened in the above referenced proceedings on Friday, August 19,
1994, at 1:00 PM. The conference will be held in Room No. 3400&hyph;C, at the offices of the Federal Energy Regulatory
Commission, at 825 North Capitol Street, N.E., Washington, D.C. 20426.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For further information, contact Marilyn Rand, Deputy Director, Division of Pipeline Certificates, at (202) 208&hyph;0444.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20098 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00038 </DOCNO>
<PARENT> FR940817-2-00026 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Project No. 11278&hyph;001]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Iowa Hydropower Development Corp.; Notice of Surrender of Preliminary Permit</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
August 11, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that the Iowa Hydropower Development Corporation, permittee for the Mississippi River Lock &amp; Dam

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
#
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
15 Project No. 11278, located on the Mississippi River, Scott County, Iowa, and Rock Island County, Illinois, has
requested that its preliminary permit be terminated. The preliminary permit was issued on August 6, 1992, and would
have expired on July 31, 1995. The permittee states that the project would be economically infeasible.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The permittee filed the request on July 13, 1994, and the preliminary permit for Project No. 11278 shall remain in effect
through the thirtieth day after issuance of this notice unless that day is a Saturday, Sunday or holiday as described
in 18 CFR 335.2007, in which case the permit shall remain in effect through the first business day following that day.
New applications involving this project site, to the extent provided for under 18 CFR part 4, may be filed on the next
business day.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20099 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00039 </DOCNO>
<PARENT> FR940817-2-00027 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>Project No. 11375&hyph;001 Kansas </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Tuttle Creek Hydro Associates; Notice of Surrender of Preliminary Permit </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
August 11, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that the Tuttle Creek Hydro Associates, permittee for the Tuttle Creek Project No. 11375, located on the
Big Blue River, in Riley and Pottwatomie Counties, Kansas, has requested that its preliminary permit be terminated.
The preliminary permit was issued on June 8, 1993, and would have expired on May 31, 1996. The permittee states that
the project would be economically infeasible. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The permittee filed the request on July 14, 1994, and the preliminary permit for Project No. 11375 shall remain in effect
through the thirtieth day after issuance of this notice unless that day is a Saturday, Sunday or holiday as described
in 18 CFR 385.2007, in which case the permit shall remain in effect through the first business day following that day.
New applications involving this project site, to the extent provided for under 18 CFR Part 4, may be filed on the next
business day. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20100 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M 
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00040 </DOCNO>
<PARENT> FR940817-2-00028 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. RP92&hyph;237&hyph;013]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Alabama-Tennessee Natural Gas Co.; Notice of Proposed Changes in FERC Gas Tariff</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
August 11, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on August 9, 1994, Alabama-Tennessee Natural Gas Company (Alabama-Tennessee), tendered for filing
as part of its FERC Gas Tariff, Second Revised Volume No. 1, a revised tariff sheet setting forth its firm and interruptible
transportation rates, pursuant to the settlement approved by the Commission in its letter order issued on December
30, 1993, in this proceeding. Alabama-Tennessee proposes that the tariff sheet be made effective as of September
1, 1994.
<!-- PJG 0012 frnewline -->
Alabama-Tennessee has requested such waiver of the Commission's regulations as may be necessary to accept and approve
its filing as proposed.
<!-- PJG 0012 frnewline -->
Alabama-Tennessee states that copies of its filing were served upon the Company's jurisdictional customers and
interested public bodies, as well as all the parties shown on the Commission's official service list established
in this proceeding.
<!-- PJG 0012 frnewline -->
Any person desiring to protest said filing should file a protest with the Federal Energy Regulatory Commission, 825
North Capitol Street, NE., Washington, DC 20426, in accordance with &sect;385.211 of the Commission's Rules and
Regulations. All such protests should be filed on or before August 18, 1994. Protests will be considered by the Commission
in determining the appropriate action to be taken but will not serve to make protestants parties to the proceeding.
Copies of this filing are on file with the Commission and are available for public inspection.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20101 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00041 </DOCNO>
<PARENT> FR940817-2-00029 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. QF87&hyph;128&hyph;001]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Bear Mountain Limited Partnership; Amendment to Filing</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
August 11, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On August 9, 1994, Bear Mountain Limited Partnership (Applicant) tendered for filing a supplement to its filing in
this docket.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The amendment provides additional information pertaining to the operator of the facility and Applicant's affiliation
with the thermal host. No determination has been made that the submittal constitutes a complete filing.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Any person desiring to be heard or objecting to the granting of qualifying status should file a motion to intervene
or protest with the Federal Energy Regulatory Commission, 825 North Capitol Street, NE., Washington, DC 20426, in
accordance with rules 211 and 214 of the Commission's Rules of Practice and Procedure. All such motions or protests
must be filed by September 1, 1994, and must be served on the Applicant. Protests will be considered by the Commission
in determining the appropriate action to be taken but will not serve to make protestants parties to the proceeding.
Any person wishing to become a party must file a petition to intervene. Copies of this filing are on file with the Commission
and are available for public inspection.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20207 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00042 </DOCNO>
<PARENT> FR940817-2-00030 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. RP94&hyph;223&hyph;003]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Colorado Interstate Gas Co.; Filing of Refund Report</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
August 11, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on July 20, 1994, Colorado Interstate Gas Company (CIG) filed a refund report in Docket No. RP94&hyph;223&hyph;003.
CIG states that both the filing and refunds were made to comply with the Commission's order issued May 26, 1994, in RP94&hyph;223&hyph;000
(67 FERC &para;61,230 (1994)), and that it paid these refunds on July 5, 1994.
<!-- PJG 0012 frnewline -->
CIG states that the refund report summarizes transportation refund amounts for the period October 1, 1993, through
April 30, 1994, as pursuant to ordering paragraph (D) of the Commission's May 26, 1994, order.
<!-- PJG 0012 frnewline -->
CIG states that copies of the filing have been served on CIG's transportation customers, interested state commission,
and all parties to the proceedings.
<!-- PJG 0012 frnewline -->
Any person desiring to protest said filing should file a protest with the Federal Energy Regulatory Commission, 825
North Capitol Street, NE., Washington, DC 20426, in accordance with Rule 211 of the Commission's Rules of Practice
and Procedure (18 CFR 385.211). All such protests should be filed on or before August 18, 1994. Protests will be considered
by the Commission in determining the appropriate action to be taken, but will not serve to make protestants parties
to the proceeding. Copies of this filing are on file with the Commission and are available for public inspection.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20103 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00043 </DOCNO>
<PARENT> FR940817-2-00031 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. TM95&hyph;1&hyph;24&hyph;000]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Equitrans, Inc.; Proposed Changes in FERC Gas Tariff</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
August 11, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on August 9, 1994, Equitrans, Inc. (Equitrans), tendered for filing as part of its FERC Gas Tariff,
First Revised Volume No. 1, the following tariff sheets to be effective October 1, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Third Revised Sheet No. 5
<!-- PJG 0012 frnewline -->
Third Revised Sheet No. 6
<!-- PJG 0012 frnewline -->
Third Revised Sheet No. 8
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Pursuant to Order No. 472, the Commission has authorized pipeline companies to track and pass through to their customers
their annual charges under an Annual Charge Adjustment (ACA) clause. The 1994 ACA unit surcharge approved by the Commission
is $.0024 per Mcf. Equitrans has converted this Mcf rate to a dekatherm (Dth) rate of $.0022 per Dth.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Pursuant to Section 154.51 of the Commission's Regulations, Equitrans requests that the Commission grant any waivers
necessary to permit the tariff sheets to become effective October 1, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Equitrans states that a copy of its filing has been served upon its purchasers and interested state commissions.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Any person desiring to be heard or to protest said filing should file a motion to intervene or protest with the Federal
Energy Regulatory Commission, 825 North Capitol Street, NE., Washington, DC 20426, in accordance with Section 385.211
and 385.214 of the Commission's Rules of Practice and Procedures (18 CFR 385.211 and 385.214). All such motions or
protests should be filed on or before August 18, 1994. Protests will be considered by the Commission in determining
the appropriate action to be taken, but will not serve to make protestants parties to the proceeding. Any person wishing
to become a party must file a motion to intervene. Copies of this filing are on file with the Commission and are available
for public inspection.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20104 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00044 </DOCNO>
<PARENT> FR940817-2-00032 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. RP94&hyph;354&hyph;000]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>National Fuel Gas Supply Corp; Petition To Waive Tariff Provision</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
August 11, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on August 5, 1994, National Fuel Gas Supply Corporation (National) filed a Petition for Waiver of
a provision of Rate Schedule FT.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
National requests a waiver of Section 3.2 of National's FT Rate Schedule to the extent necessary to permit National
to accept a letter of credit or alternative financial assurances acceptable to National from Iroquois Energy Management,
Inc. and Medina Power Company (the Shippers) in an amount in excess of the cost of performing the service requested
by the Shippers for a three-month period. National states that the limited financial assurances permitted by Section
3.2 would not secure National's capital cost for facilities required to serve the Shippers, and that the Shippers
fully support the instant petition. The facilities required are those proposed by Tennessee Gas Pipeline Company,
as operator of the Niagara Spur Loop Line, in Docket No. CP94&hyph;587&hyph;000.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Any person desiring to be heard or to protest said filing should file a motion to intervene or protest with the Federal
Energy Regulatory Commission, 825 North Capitol Street, NE., Washington, DC 20426, in accordance with Rules 211
and 214 of the Commission's Rules of Practice and Procedure (18 CFR 382.211 and 385.214). All such motions or protests
should be filed on or before August 18, 1994. Protests will be considered by the Commission in determining the appropriate
action to be taken but will not serve to make protestants parties to the proceeding. Any person wishing to become a party
must file a motion to intervene. Copies of this filing are on file with the Commission and are available for public inspection.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20105 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00045 </DOCNO>
<PARENT> FR940817-2-00033 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket Nos. RP94&hyph;87&hyph;000, et al. RP94&hyph;346&hyph;005 and RS92&hyph;45&hyph;000, et al.]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Natural Gas Pipeline Company of America; Docketing</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
August 11, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that the ``Stipulation and Agreement on Recovery of Gas Supply Realignment and Account No. 858 Costs from
G Customers'' submitted on August 3, 1994, by Natural Gas Pipeline Company of America (Natural) in Docket Nos. RS92&hyph;45&hyph;000,
RP94&hyph;87&hyph;000, et al., RP94&hyph;86&hyph;000, RP94&hyph;179&hyph;000, and RP94&hyph;252&hyph;000,
has been docketed in Docket Nos. RP94&hyph;346&hyph;005 and RP94&hyph;87&hyph;000, et al. This docketing is consistent
with the ``Notice of Redocketing Filings and Compliance Filing and Establishment of Restricted Service List,''
issued August 4, 1994, in Docket Nos. RS92&hyph;45&hyph;000, RP94&hyph;87&hyph;000, et al., RP94&hyph;346&hyph;000,
and RP94&hyph;346&hyph;004, concerning certain settlements filed by Natural Gas Pipeline Company of America (Natural)
and related materials.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20106 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00046 </DOCNO>
<PARENT> FR940817-2-00034 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. GT94&hyph;60&hyph;000]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Northwest Pipeline Corp.; Proposed Changes in FERC Gas Tariff</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
August 11, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on August 8, 1994, Northwest Pipeline Corporation (Northwest) tendered for filing as part of its
FERC Gas Tariff, the following tariff sheets, with a proposed effective date of September 8, 1994:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Third Revised Volume No. 1
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Second Revised Sheet No. 375
<!-- PJG 0012 frnewline -->
Second Revised Sheet No. 377
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Northwest states that the purpose of this filing is to update Northwest's Index of Shippers. Columbia Power has notified
Northwest of its intent to terminate its Rate Schedule TF&hyph;1 agreement number F&hyph;103 effective March 31,
1995, and Washington Energy Marketing, Inc. has assigned its Rate Schedule SGS&hyph;2F contract demand to Washington
Energy Gas Marketing Company and to Cabot Oil and Gas Trading Corporation effective May 1, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Northwest states that a copy of this filing has been served upon all of Northwest's jurisdictional customers and affected
state regulatory commissions.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Any person desiring to be heard or protest said filing should file a motion to intervene or protest with the Federal
Energy Regulatory Commission, 825 North Capitol Street, N.E., Washington, DC 20426, in accordance with Sections
385.214 and 385.211 of the Commission's Rules of Practice and Procedure. All such motions or protests should be filed
on or before August 18, 1994. Protests will be considered by the Commission in determining the appropriate action
to be taken, but will not serve to make protestants parties to the proceeding. Any person wishing to become a party must
file a motion to intervene. Copies of this filing are on file with the Commission and are available for public inspection
in the Public Reference Room.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20107 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00047 </DOCNO>
<PARENT> FR940817-2-00035 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. TM94&hyph;2&hyph;37&hyph;003]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Northwest Pipeline Corp.; Proposed Change in FERC Gas Tariff</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
August 11, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on August 8, 1994, Northwest Pipeline Corporation (Northwest) tendered for filing as part of its
FERC Gas Tariff, Third Revised Volume No. 1, the following tariff sheets with a proposed effective date of October
1, 1994:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=25 g=1 f=1 -->
First Revised Substitute Third Revised Sheet No. 5
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
First Revised Substitute Third Revised Sheet No. 5&hyph;A
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
First Revised Sheet No. 19
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Original Sheet No. 19&hyph;A
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
First Revised Sheet No. 102
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Second Revised Sheet No. 224
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Third Revised Sheet No. 225
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Northwest states that the purpose of this filing is to comply with the Federal Energy Regulatory Commission's (Commission)
directives in the Order Granting Rehearing, dated July 8, 1994, in Docket No. TM94&hyph;2&hyph;37&hyph;002. Northwest
states that it has revised its tariff to reflect the appropriate maximum rate for volumetric releases of capacity
and has revised its rate sheet to include a separate statement of the maximum rate applicable to the reservation component
of volumetric releases. Northwest has also filed tariff language to reflect the treatment of Gas Research Institute
(``GRI'') surcharges in discounted capacity release transactions.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Northwest states that a copy of this filing has been served upon all intervenors in Docket No. TM94&hyph;2&hyph;37&hyph;002,
upon Northwest's jurisdictional customers, and upon affected state regulatory commissions.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Any person desiring to protest said filing should file a protest with the Federal Energy Regulatory Commission, 825
North Capitol Street, N.E., Washington, DC 20426, in accordance with Section 385.211 of the Commission's Rules of
Practice and Procedure. All such protests should be filed on or before August 18, 1994. Protests will be considered
by the Commission in determining the appropriate action to be taken, but will not serve to make protestants parties
to the proceeding. Copies of this filing are on file with the Commission and are available public inspection in the
Public Reference Room.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20108 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00048 </DOCNO>
<PARENT> FR940817-2-00036 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. RP94&hyph;355&hyph;000]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>City Utilities of Springfield, Missouri v. Williams Natural Gas Co.; Notice of Complaint</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
August 11, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on August 5, 1994, City Utilities of Springfield, Missouri (CU) filed with the Commission a complaint
against Williams Natural Gas Company (WNG) and motion for expedited relief pursuant to Section 5 of the Natural Gas
Act (NGA)
<FOOTCITE>1</FOOTCITE>
 and Rules 206 and 212 of the Commission's Rules of Practice and Procedure.
<FOOTCITE>2</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. &sect;717d.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
2
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
18 CFR 385.206 and .212.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
CU, an LDC customer of WNG, asks that the Commission investigate and either summarily rule on or, alternatively, set
for hearing WNG's application of the right of first refusal provision in its tariff.
<!-- PJG 0012 frnewline -->
CU seeks an order from the Commission finding that: (1) bids made by Tartan Energy Company (Tartan) for CU capacity
on WNG were not bona fide bids; (2) WNG erred in requiring CU to match the Tartan bids; and (3) WNG wrongly awarded Tartan
the right to acquire 69,460 Dth of CU's 79,460 Dth of firm transportation capacity.
<!-- PJG 0012 frnewline -->
Any person desiring to be heard or to protest said complaint should file a motion to intervene or a protest with the Federal
Energy Regulatory Commission, 825 North Capitol Street, NE., Washington, DC 20426, in accordance with Rules 214
and 211 of the Commission's Rules of Practice and Procedure 18 CFR 385.214, 385.211. All such motions or protests should
be filed on or before September 12, 1994. Protests will be considered by the Commission in determining the appropriate
action to be taken, but will not serve to make protestants parties to the proceeding. Any person wishing to become a
party must file a motion to intervene. Copies of this filing are on file with the Commission and are available for public
inspection. Answers to this complaint shall be due on or before September 12, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20102 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00049 </DOCNO>
<PARENT> FR940817-2-00037 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. RP94&hyph;360&hyph;000]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Tariff Filing</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
August 11, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on August 9, 1994, Overthrust Pipeline Company (Overthrust), tendered for filing as part of its FERC
Gas Tariff, First Revised Volume No. 1&hyph;A, Second Revised Sheet No. 58, to be effective August 1, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Overthrust states that tariff sheet is being filed pursuant to 18 CFR 154.63(a)(1) and as follow-up to Overthrust's
tariff filing in Docket No. MT94&hyph;14&hyph;000, revises Section 11.1(c) of the General Terms and Conditions
of Overthrust's tariff to facilitate operations under Order No. 566.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Overthrust states that it seeks Commission waiver of 18 CFR 154.22 so that the tendered tariff sheet may become effective
August 1, 1994, the proposed effective date of Overthrust's tariff filing in compliance with Order No. 566.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Overthrust states further that this filing was served upon its jurisdictional customers and interested public service
commissions.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Any person desiring to be heard or to protest said filing should file a motion to intervene or protest with the Federal
Energy Regulatory Commission, 825 North Capitol Street, NE., Washington, DC, 20426, in accordance with Rules 385.211
and 385.214 of the Commission's Rules and Regulations (18 CFR 385.211 and 385.214). All such motions or protests should
be filed on or before August 18, 1994. Protests will be considered by the Commission in determining the appropriate
action to be taken, but will not serve to make protestants parties to the proceeding. Any person wishing to become a
party must file a motion to intervene. Copies of this filing are on file with the Commission and are available for public
inspection.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20109 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00050 </DOCNO>
<PARENT> FR940817-2-00038 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. RP94&hyph;359&hyph;000]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Questar Pipeline Co.; Tariff Filing</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
August 11, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on August 9, 1994, Questar Pipeline Company, tendered for filing as part of its FERC Gas Tariff, First
Revised Volume No. 1, Third Revised Sheet No. 71 and Second Revised Sheet No. 72, to be effective August 1, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Questar states that these tariff sheets revise currently effective tariff provisions to facilitate Questar's operations
under Order No. 566.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Questar states that it seeks Commission waiver of 18 CFR 154.22 so that the tendered tariff sheets may become effective
on August 1, 1994, the effective date of Order No. 566.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Questar states further that this filing was served upon its jurisdictional customers and the Wyoming and Utah Public
Service Commissions.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Any person desiring to be heard or to protest said filing should file a motion to intervene or protest with the Federal
Energy Regulatory Commission, 825 North Capitol Street, N.E., Washington, D.C. 20426, in accordance with Rules
385.211 and 385.214 of the Commission's Rules and Regulations (18 CFR 385.211 and 385.214). All such motions or protests
should be filed on or before August 18, 1994. Protests will be considered by the Commission in determining the appropriate
action to be taken, but will not serve to make protestants parties to the proceeding. Any person wishing to become a
party must file a motion to intervene. Copies of this filing are on file with the Commission and are available for public
inspection.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20110 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00051 </DOCNO>
<PARENT> FR940817-2-00039 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. RP94&hyph;357&hyph;000]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Texas Eastern Transmission Corp.; Proposed Changes in FERC Gas Tariff</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
August 11, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on August 8, 1994, Texas Eastern Transmission Corporation (Texas Eastern), tendered for filing
as part of its FERC Gas Tariff, Sixth Revised Volume No. 1, the following tariff sheets, with a proposed effective date
of October 1, 1994:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=25 g=1 f=1 -->
First Revised Sheet No. 206
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sheet Nos. 207&hyph;210
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Second Revised Sheet No. 216
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Texas Eastern states that by this filing, it proposes to grant, effective October 1, 1994, customers under Rate Schedules
CDS and FT&hyph;1 enhanced transportation rights with respect to deliveries and receipts in Texas Eastern's Market
Zones 1, 2 and 3. Texas Eastern states that it proposes to add new Sections 13 and 15 to Rate Schedules CDS and FT&hyph;1,
respectively. Pursuant to the enhanced transportation rights contemplated by these new tariff provisions, Texas
Eastern proposes to increase transportation rights for customers paying rates pursuant to Section 3.2 of Rate Schedules
CDS and FT&hyph;1.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Texas Eastern states that the proposed tariff provisions will permit qualifying customers to deliver gas in one Market
Zone up to the lesser of customer's MDQ or the sum of customer's maximum daily contractual entitlements on the 24-inch
line, the 30-inch line, the Texas Gas Transmission Corporation loop, and the Trunkline Gas Company loop applicable
to the upstream Market Zone in which the delivery is to be made without necessarily impacting or limiting, as is the
current situation, its capacity rights in a downstream Market Zone.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed effective date of the tariff sheets is October 1, 1994, a date which corresponds to the date that necessary
changes to Texas Eastern's scheduling procedures and computer information systems can be implemented to accommodate
the proposed tariff changes.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Texas Eastern states that copies of the filing were served on firm customers of Texas Eastern and interested state
commissions.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Any person desiring to be heard or to protest said filing should file a motion to intervene or protest with the Federal
Energy Regulatory Commission, 825 North Capitol Street, NE., Washington, DC 20426, in accordance with Rules 211
and 214 of the Commission's Rules of Practice and Procedure. All such motions or protests should be filed on or before
August 18, 1994. Protests will be considered by the Commission in determining the appropriate action to be taken,
but will not serve to make protestants parties to the proceeding. Any person wishing to become a party must file a motion
to intervene. Copies of this filing are on file with the Commission and are available for public inspection.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20111 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00052 </DOCNO>
<PARENT> FR940817-2-00040 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. RP94&hyph;358&hyph;000]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Transcontinental Gas Pipe Line Corp.; Proposed Changes in FERC Gas Tariff</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
August 11, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on August 8, 1994, Transcontinental Gas Pipe Line Corporation (TGPL) tendered for filing certain
revised tariff sheets to its FERC Gas Tariff, Third Revised Volume No. 1, enumerated in Appendix A attached to the filing.
The tariff sheets are proposed to be effective as set forth in Appendix A to the filing.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
TGPL states that the purpose of the filing is: (i) to set forth in TGPL's Volume No. 1 tariff the rates and charges under
Rate Schedule FT&hyph;R applicable to capacity released under incremental firm transportation services which
have been assigned or converted from Section 7(c) service to firm transportation service under Part 284 (hereinafter
referred to as ``Converted Services''); and (ii) to set forth the appropriate minimum rates under Rate Schedule FT
for such Converted Services.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
TGPL states that copies of the instant filing are being mailed to customers, State Commissions, and other interested
parties.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Any person desiring to be heard or to protest said filing should file a motion to intervene or protest with the Federal
Energy Regulatory Commission, 825 North Capitol Street, NE Washington, DC 20426, in accordance with Sections 385.214
and 385.211 of the Commission's Rules and Regulations. All such motions or protests should be filed on or before August
18, 1994. Protests will be considered by the Commission in determining the appropriate action to be taken, but will
not serve to make protestants parties to the proceeding. Any person wishing to become a party must file a motion to intervene.
Copies of this filing are on file with the Commission and are available for public inspection in the Public Reference
Room.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20112 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00053 </DOCNO>
<PARENT> FR940817-2-00041 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. RP94&hyph;356&hyph;000]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Trunkline Gas Co.; Account No. 191 Filing</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
August 11, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on August 5, 1994, Trunkline Gas Company (Trunkline), in accordance with the Commission's order
dated March 2, 1993, in Docket No. RS92&hyph;25&hyph;000, notifies the Commission that the balance in its Account
No. 191 (Purchased Gas Adjustment Deferred Account) as of May 31, 1994, is $47,889,684.87.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Trunkline also states that as of this date, it has not begun the direct billing of the amount pursuant to Section 27.1
of the General Terms and Conditions of Trunkline's FERC Gas Tariff, First Revised Volume No. 1.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Trunkline further states that since it has not begun any direct billing, it is not necessary to consider adjustments
to amounts being collected to reflect the final posting to Account No. 191 as of this time.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Trunkline requests any waiver of the Commission's Rules and Regulations which may be necessary for the acceptance
of this filing as being in compliance with the Commission's directives.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Any person desiring to be heard or to protest said filing should file a motion to intervene or protest with the Federal
Energy Regulatory Commission, 825 North Capitol Street, N.E., Washington, D.C., 20426, in accordance with Rules
211 and 214 of the Commission's Rules of Practice and Procedure (18 CFR 385.211 and 385.214). All such motions or protests
should be filed on or before August 18, 1994. Protests will be considered by the Commission in determining the appropriate
action to be taken but will not serve to make protestants parties to the proceeding. Any person wishing to become a party
must file a motion to intervene. Copies of this filing are on file with the Commission and are available for public inspection.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20113 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00054 </DOCNO>
<PARENT> FR940817-2-00042 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>ENVIRONMENTAL PROTECTION AGENCY</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[FRL&hyph;50539] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Proposed Settlement; Acid Rain Core Rules Litigation 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Environmental Protection Agency (EPA). 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of Proposed Settlement; Request for Public Comment. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 In accordance with section 113(g) of the Clean Air Act (``Act''), notice is hereby given of a proposed second partial
settlement of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=3 -->
Enviornmental Defense fund 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
v.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=3 -->
Carol M. Browner, et al
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
., No. 93&hyph;1203 (and consolidated cases) (D.C. Cir.). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The case involves challenges by several parties to the acid rain core rules published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 on January 11, 1993, at 58 FR 3590 (January 11, 1993). The proposed settlement relates primarily to the ``control''
requirement for substitution plans under section 404(b) of the Clean Air Act and &sect;72.41 of the January 11, 1993
rules. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For a period of thirty (30) days following the date of publication of this notice, the Agency will receive written comments
relating to the settlement from persons who were not named as parties to the litigation in question. EPA or the Department
of Justice may withhold or withdraw consent to the proposed settlement if the comments disclose facts or circumstances
that indicate that such consent is inappropriate, improper, inadequate, or inconsistent with the requirements
of the Act. Copies of the settlement are available from Phyllis Cochran, Air and Radiation Division (2344), Office
of General Counsel, U.S. Environmental Protection Agency, 401 Street SW., Washington, DC 20460, (202) 260&hyph;7606.
Written comments should be sent to Patricia A. Embrey at the above address and must be submitted on or before [insert
date 30 days after publication]. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: August 9, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUMMARY>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Jean C. Nelson, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
General Counsel. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20170 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6560&hyph;50&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00055 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[FRL&hyph;5027&hyph;1] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Fuels and Fuel Additives; Waiver Decision/Circuit Court Remand </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Environmental Protection Agency (EPA).
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 On July 12, 1991, under section 211(f)(4) of the Clean Air Act (Act), the Ethyl Corporation (Ethyl) requested a waiver
to permit the sale of its gasoline additive, methylcyclopentadienyl manganese tricarbonyl (MMT), an octane enhancer
commercially labeled by Ethyl as HiTEC 3000, for use in unleaded gasoline. The Administrator of EPA denied Ethyl's
application for a waiver on January 8, 1992, based primarily on concerns regarding the potential for increases in
hydrocarbon emissions resulting from MMT use. Ethyl subsequently sought judicial review of that decision in the
U.S. Court of Appeals for the District of Columbia Circuit. Based on new emissions data developed and submitted to
EPA by Ethyl, EPA requested that the Court of Appeals remand Ethyl's application to the Agency for further action.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On November 30, 1993, the Administrator of EPA found that Ethyl had met its burden to demonstrate under section 211(f)(4)
that approval of its remanded application would not cause or contribute to a failure to meet emission standards. Ethyl
agreed to resubmit its application at that time, thereby affording further time for the Agency to consider the issue
of potential health effects associated with use of MMT in unleaded gasoline. Ethyl and EPA later agreed to further
extend the deadline for final action on Ethyl's application to July 13, 1994. The Agency is today denying Ethyl's request
for a waiver for HiTEC 3000 based on unresolved concerns regarding the potential impact of manganese emissions resulting
from MMT use on public health. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Copies of the information relative to this application are available for inspection in public docket A&hyph;93&hyph;26,
A&hyph;91&hyph;46 and A&hyph;90&hyph;16 at the Air Docket (LE&hyph;131) of the EPA, Room M&hyph;1500, 401 M Street,
S.W., Washington, D.C. 20460, (202) 260&hyph;7548, between the hours of 8:30 a.m. to noon and 1:30 p.m. to 3:30 p.m.
weekdays. As provided in 40 CFR Part 2, a reasonable fee may be charged for copying services. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Joseph R. Sopata, Chemist, or James W. Caldwell, Chief, Fuels Section, Field Operations Support Division (6406J),
U.S. Environmental Protection Agency, 401 M Street, S.W., Washington, D.C. 20460, (202) 260&hyph;2635.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
Index 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
I. Background 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
II. Statutory Framework 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
A. History of Statute 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. Two Stage Process 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
C. Consideration of Potential Health Effects 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
III. Method of Review 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
A. ``Causes or Contributes'' to Emission Standard Failure 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. Discretionary Review 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
IV. Analysis of Emissions Data 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
A. Description of Previous Test Programs 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. Comments on Vehicle Emissions Issues 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
C. Available Data Meet Previously Utilized Criteria 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
D. Data on Newer-Technology Vehicles Meet More Stringent 
<!-- PJG 0012 frnewline -->
Criteria 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
E. Finding 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
V. The Onboard Diagnostics Issue 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
VI. Manganese Health Assessment 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
A. Introduction 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. Health Effects Assessment 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. Background 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Earlier Assessments 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. 1993 Revised RfC 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. Alternative Approaches to Deriving RfCs 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
a. Conventional NOAEL- or LOAEL-Based Approach 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
b. NOSTASOT Approach 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
c. Benchmark Analyses 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
d. Bayesian Analyses 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
e. Summary of RfC Estimates 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
C. Exposure Assessment 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. Background 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Additional Canadian Studies 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. The PTEAM Study 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. Estimated Mn Exposure Levels Associated with MMT 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
D. Risk Characterization 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
E. References 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
F. Comments on Health Assessment and EPA Response 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
VII. Fuel and Fuel Additive Registration and Research Needs 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
VIII. Other Issues 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
IX. Decision 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
I. Background 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 211(f)(1)(A) of the Act makes it unlawful, effective March 31, 1977, for any manufacturer of a fuel or fuel
additive to first introduce into commerce, or to increase the concentration in use of, any fuel or fuel additive for
use in light-duty motor vehicles manufactured after model year 1974 which is not substantially similar to any fuel
or fuel additive utilized in the certification of any model year 1975, or subsequent model year, vehicle or engine
under section 206 of the Act. An interpretive rule defining the term ``substantially similar'' under section 211(f)(1)(A)
was promulgated for unleaded gasoline at 46 FR 38582 (July 28, 1981), and revised at 56 FR 5352 (February 11, 1991).
Section 211(f)(1)(B) of the Act makes it unlawful, effective November 15, 1990, for any manufacturer of a fuel or fuel
additive to first introduce into commerce, or to increase the concentration in use of, any fuel or fuel additive for
use by any person in motor vehicles manufactured after model-year 1974 which is not substantially similar to any fuel
or fuel additive utilized in the certification of any model year 1975, or subsequent model year, vehicle or engine
under section 206 of the Act. Thus, section 211(f)(1)(B) expands the prohibitions of 211(f)(1)(A), which apply only
to light-duty vehicles. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00056 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 211(f)(4) of the Act provides that upon application 
<!-- PJG 0012 frnewline -->
by any fuel or fuel additive manufacturer, the Administrator of 
<!-- PJG 0012 frnewline -->
EPA may waive the prohibitions of section 211(f)(1) if the 
<!-- PJG 0012 frnewline -->
Administrator determines that the applicant has established that 
<!-- PJG 0012 frnewline -->
such fuel or fuel additive will not cause or contribute to a 
<!-- PJG 0012 frnewline -->
failure of any emission control device or system (over the useful 
<!-- PJG 0012 frnewline -->
life of any vehicle in which such device or system is used) to 
<!-- PJG 0012 frnewline -->
achieve compliance by the vehicle with the emissions standards to 
<!-- PJG 0012 frnewline -->
which it has been certified pursuant to section 206 of the Act. 
<!-- PJG 0012 frnewline -->
If the Administrator does not act to grant or deny a waiver 
<!-- PJG 0012 frnewline -->
within 180 days of receipt of the application, the statute 
<!-- PJG 0012 frnewline -->
provides that the waiver shall be treated as granted. The 
<!-- PJG 0012 frnewline -->
subject of this notice is an application by Ethyl under section 
<!-- PJG 0012 frnewline -->
211(f)(4) of the Act for a waiver for the fuel additive 
<!-- PJG 0012 frnewline -->
methylcyclopentadienyl manganese tricarbonyl (MMT), commercially 
<!-- PJG 0012 frnewline -->
labeled by Ethyl as HiTEC 3000, to be blended in unleaded 
<!-- PJG 0012 frnewline -->
gasoline resulting in a level of 0.03125 (1/32) gram per gallon 
<!-- PJG 0012 frnewline -->
manganese (gpg Mn). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
This Agency action is a reconsideration of Ethyl's fourth 
<!-- PJG 0012 frnewline -->
application for a waiver for MMT. Ethyl's first application was 
<!-- PJG 0012 frnewline -->
submitted on March 17, 1978 for concentrations of MMT resulting 
<!-- PJG 0012 frnewline -->
in 1/16 and 1/32 gpg Mn in unleaded gasoline. Ethyl's second 
<!-- PJG 0012 frnewline -->
application was submitted on May 26, 1981 for concentrations of 
<!-- PJG 0012 frnewline -->
MMT resulting in 1/64 gpg Mn in unleaded gasoline. The 
<!-- PJG 0012 frnewline -->
Administrator denied these requests for waivers due to concerns 
<!-- PJG 0012 frnewline -->
regarding increases in exhaust hydrocarbon emissions resulting 
<!-- PJG 0012 frnewline -->
from MMT use. The decisions and justifications thereof may be 
<!-- PJG 0012 frnewline -->
found in the September 18, 1978 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, 43 FR 41424, 
<!-- PJG 0012 frnewline -->
and the December 1, 1981 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, 46 FR 58630. Ethyl's 
<!-- PJG 0012 frnewline -->
third application was submitted on May 9, 1990, for 
<!-- PJG 0012 frnewline -->
concentrations of MMT resulting in a level of 0.3125 (1/32) gpg 
<!-- PJG 0012 frnewline -->
Mn in unleaded gasoline (the same levels which are requested in 
<!-- PJG 0012 frnewline -->
the application which is the subject of today's notice). Ethyl 
<!-- PJG 0012 frnewline -->
withdrew its third application on November 1, 1990, before the 
<!-- PJG 0012 frnewline -->
deadline for the Administrator to make a determination on the 
<!-- PJG 0012 frnewline -->
application. Because no determination had been made at the time 
<!-- PJG 0012 frnewline -->
Ethyl withdrew that application, EPA accepted the withdrawal and 
<!-- PJG 0012 frnewline -->
immediately terminated the proceeding without action on the 
<!-- PJG 0012 frnewline -->
application. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Ethyl's fourth application was submitted on July 12, 1991. 
<!-- PJG 0012 frnewline -->
This application was, from a practical standpoint, an extension 
<!-- PJG 0012 frnewline -->
of the third application, the entire record of which was 
<!-- PJG 0012 frnewline -->
incorporated by Ethyl into the current proceeding. On January 8, 
<!-- PJG 0012 frnewline -->
1992, the Administrator of EPA denied Ethyl's fourth application 
<!-- PJG 0012 frnewline -->
for a waiver (57 FR 2535, January 22, 1992). The application was 
<!-- PJG 0012 frnewline -->
denied based in part upon data submitted by Ford Motor Company 
<!-- PJG 0012 frnewline -->
(Ford) which indicated that, for the model groups tested by Ford 
<!-- PJG 0012 frnewline -->
and, for the conditions under which Ford tested its vehicles, the 
<!-- PJG 0012 frnewline -->
increases in hydrocarbon exhaust emissions as a result of the use 
<!-- PJG 0012 frnewline -->
of MMT were substantially greater than those observed in the 
<!-- PJG 0012 frnewline -->
Ethyl test program. The Agency stated in its decision that a 
<!-- PJG 0012 frnewline -->
likely factor which might account for the differences observed 
<!-- PJG 0012 frnewline -->
between the Ethyl and Ford test programs was the severity of the 
<!-- PJG 0012 frnewline -->
driving cycle. However, the Agency also concluded that other 
<!-- PJG 0012 frnewline -->
factors might be responsible for the observed differences. In 
<!-- PJG 0012 frnewline -->
the denial decision, the Agency stated that it had always 
<!-- PJG 0012 frnewline -->
accepted data from test programs which ``model'' the fleet in 
<!-- PJG 0012 frnewline -->
support of waiver applications, but that if an interested party 
<!-- PJG 0012 frnewline -->
were to present data indicating that a potentially significant 
<!-- PJG 0012 frnewline -->
subset of the fleet, not tested by the applicant, was especially 
<!-- PJG 0012 frnewline -->
susceptible to the negative effects of the additive, the Agency 
<!-- PJG 0012 frnewline -->
could reasonably require specific testing on representative 
<!-- PJG 0012 frnewline -->
models of that sub-fleet. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In its decision, the Agency also stated that it believes it 
<!-- PJG 0012 frnewline -->
is reasonable to consider the effect of a fuel on vehicles' 
<!-- PJG 0012 frnewline -->
ability to meet future emissions standards. (The ``Tier I'' 
<!-- PJG 0012 frnewline -->
tailpipe standards prescribed by section 202(g) of the Act began 
<!-- PJG 0012 frnewline -->
to take effect in model year 1994, which began approximately in 
<!-- PJG 0012 frnewline -->
September 1993.
<FOOTCITE>1</FOOTCITE>
) Therefore, regarding the Ford data mentioned 
<!-- PJG 0012 frnewline -->
above, the Agency stated in its decision that the concerns raised 
<!-- PJG 0012 frnewline -->
by that data related to both current and future standards. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
56 FR 25724&hyph;25790 (June 5, 1991).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Although not the basis of the 1992 denial, another important 
<!-- PJG 0012 frnewline -->
issue arose during the consideration of Ethyl's third and fourth 
<!-- PJG 0012 frnewline -->
applications. The Agency, as well as several commentors, 
<!-- PJG 0012 frnewline -->
expressed concerns regarding the possible adverse health effects 
<!-- PJG 0012 frnewline -->
of an increase in airborne manganese resulting from MMT use. 
<!-- PJG 0012 frnewline -->
These concerns were centered around: (1) The known severe 
<!-- PJG 0012 frnewline -->
neurotoxic effects of high-level exposure to manganese through 
<!-- PJG 0012 frnewline -->
inhalation, (2) the lack of data regarding the chronic effects 
<!-- PJG 0012 frnewline -->
of low-level inhalation exposure to manganese in humans, and (3) 
<!-- PJG 0012 frnewline -->
the lack of knowledge regarding potential exposures due to MMT 
<!-- PJG 0012 frnewline -->
use. It was repeatedly pointed out by commenters that neurotoxic 
<!-- PJG 0012 frnewline -->
damage could occur prior to the onset of overt symptoms. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In those proceedings, Ethyl also submitted comments 
<!-- PJG 0012 frnewline -->
regarding manganese emissions. Ethyl indicated that the 
<!-- PJG 0012 frnewline -->
manganese emissions resulting from the use of MMT in unleaded 
<!-- PJG 0012 frnewline -->
gasoline would be so small as to not materially affect human 
<!-- PJG 0012 frnewline -->
exposure to airborne manganese. In support of its view, Ethyl 
<!-- PJG 0012 frnewline -->
submitted analyses and data on exposure modeling and monitoring 
<!-- PJG 0012 frnewline -->
in both its 1990 and 1991 applications (and in subsequent 
<!-- PJG 0012 frnewline -->
submissions associated with the remand discussed below). (The 
<!-- PJG 0012 frnewline -->
issue of manganese emissions and public health is discussed in 
<!-- PJG 0012 frnewline -->
more detail in Section VI of this document.) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00057 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
During EPA's consideration of the 1990 Ethyl submission, 
<!-- PJG 0012 frnewline -->
EPA's Office of Research and Development (ORD) conducted a 
<!-- PJG 0012 frnewline -->
manganese inhalation risk assessment based on the available data 
<!-- PJG 0012 frnewline -->
which found that because of ``the considerable uncertainties and 
<!-- PJG 0012 frnewline -->
data gaps in the available information *&blank;*&blank;* it is not possible 
<!-- PJG 0012 frnewline -->
*&blank;*&blank;* to conclude definitively that the increased use of MMT as a 
<!-- PJG 0012 frnewline -->
fuel additive will (or will not) increase public health risk.''
<FOOTCITE>2</FOOTCITE>
 
<!-- PJG 0012 frnewline -->
(EPA also investigated potential hazards associated with water 
<!-- PJG 0012 frnewline -->
contamination resulting from accidental spills or leakages of 
<!-- PJG 0012 frnewline -->
pure MMT and concluded that spills or leaks, if they occurred, 
<!-- PJG 0012 frnewline -->
are likely to be contained and therefore would not pose a human 
<!-- PJG 0012 frnewline -->
health risk due to groundwater contamination. However, data 
<!-- PJG 0012 frnewline -->
available to EPA are insufficient to determine whether spills and 
<!-- PJG 0012 frnewline -->
leaks could affect exposure to benthic organisms.) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
2
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
See ``Comments on the Use of Methylcyclopentadienyl Manganese Tricarbonyl in Unleaded Gasoline'', Docket A&hyph;90&hyph;16.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Additionally, in order to obtain assistance in describing 
<!-- PJG 0012 frnewline -->
information needed to improve its manganese health risk 
<!-- PJG 0012 frnewline -->
assessment (and also to improve its environmental hazard 
<!-- PJG 0012 frnewline -->
identification of issues associated with MMT itself), EPA, in 
<!-- PJG 0012 frnewline -->
conjunction with the National Institute of Environmental Health 
<!-- PJG 0012 frnewline -->
Sciences, conducted a Manganese/MMT Symposium and Workshop on 
<!-- PJG 0012 frnewline -->
March 12&hyph;15, 1991. The conference allowed the Agency to solicit 
<!-- PJG 0012 frnewline -->
scientific information from invited extramural scientists 
<!-- PJG 0012 frnewline -->
reflecting a wide range of scientific disciplines. Invited 
<!-- PJG 0012 frnewline -->
participants included representatives of Ethyl Corporation, the 
<!-- PJG 0012 frnewline -->
Environmental Defense Fund, the Centers for Disease Control, the 
<!-- PJG 0012 frnewline -->
U.S. Food and Drug Administration and Environment Canada. A 
<!-- PJG 0012 frnewline -->
summary of the workshop discussions was provided to each 
<!-- PJG 0012 frnewline -->
participant and the information obtained from this meeting was 
<!-- PJG 0012 frnewline -->
also used by EPA to prepare a report on prioritized research 
<!-- PJG 0012 frnewline -->
needed for improving its manganese inhalation risk assessment.
<FOOTCITE>3</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
3
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Preuss, P.W. (1991) ORD Document on Information Needed to Improve the Risk Characterization of Manganese Tetraoxide
(Mn
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=2 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=2 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
) and Methylcyclopentadienyl Manganese Tricarbonyl, December 12, 1991 (memorandum to Richard Wilson). Washington,
DC: U.S. Environmental Protection Agency, Office of Research and Development; December 16, 1991. For further information
the reader is referred to Air Docket A&hyph;93&hyph;26, II&hyph;A&hyph;16.
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
EPA raised the issue of potential health effects associated 
<!-- PJG 0012 frnewline -->
with manganese exposure as a concern in its January 1992 denial, 
<!-- PJG 0012 frnewline -->
but did not base its decision on this concern because the Agency 
<!-- PJG 0012 frnewline -->
concluded that the uncertainties regarding hydrocarbon emissions 
<!-- PJG 0012 frnewline -->
increases prevented EPA from making the requisite ``cause or 
<!-- PJG 0012 frnewline -->
contribute'' determination concerning effects on regulated 
<!-- PJG 0012 frnewline -->
emissions. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
On February 13, 1992, Ethyl filed a petition for review of 
<!-- PJG 0012 frnewline -->
the January 8, 1992 waiver denial decision in the United States 
<!-- PJG 0012 frnewline -->
Court of Appeals for the District of Columbia Circuit. EPA and 
<!-- PJG 0012 frnewline -->
Ethyl subsequently entered discussions concerning a possible 
<!-- PJG 0012 frnewline -->
settlement of the court case. In the context of those 
<!-- PJG 0012 frnewline -->
discussions, Ethyl submitted to the Agency new emissions test 
<!-- PJG 0012 frnewline -->
data developed by Ethyl since the denial decision. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00058 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Based on its inspection and analysis of the new Ethyl data, EPA tentatively concluded that the data indicated that
driving cycle did not contribute significantly to MMT-induced increases in HC emissions. (EPA's preliminary analysis
was placed in docket A&hyph;92&hyph;41.) However, in addition to addressing the issue of driving cycle, the Ethyl
data appeared to confirm the finding by Ford that 1991 Escorts experienced a much higher MMT-induced HC increase than
that observed in other models tested (either in Ethyl's new program or in the original Ethyl test program). The Agency
remained concerned that these data might indicate that certain engine and emissions control system configurations
are more vulnerable to a MMT-induced emissions increase irrespective of driving cycle. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
To facilitate further settlement discussions with Ethyl, EPA decided to attempt to formulate an emission testing
program intended to address in a timely manner specific unresolved issues concerning the effect of MMT on emissions:
(1) whether other vehicles utilizing fuels containing MMT are likely to experience increases in hydrocarbon emissions
similar to those observed in 1991 Ford Escorts; and (2) whether fuels containing MMT have significant adverse effects
on emissions from vehicles utilizing the technologies most likely to be employed to meet future standards. On October
28, 1992, EPA held a public workshop to assist the Agency in its attempt to formulate such an emission testing program
(57 FR 44740, September 29, 1992). In particular, EPA hoped to obtain information and assistance from technical experts
outside of the Agency concerning the test program and, in view of the significance of any future waiver decision concerning
MMT for the auto industry and the general public, EPA was interested in obtaining comments concerning a decisional
framework designed to address and resolve these issues. A proposed emission test program developed by the Agency
and presented at the public workshop, was effectively adopted by Ethyl as its most recent vehicle emissions test program
involving the 1993 model fleet. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Although further settlement discussions between Ethyl and EPA were held subsequent to the public workshop, the parties
were not successful in reaching a settlement. However, despite the failure of the parties to reach agreement, EPA
concluded that the Administrator's denial decision should be reconsidered in light of the new emissions data generated
by Ethyl subsequent to the decision. Accordingly, EPA requested that the United States Court of Appeals for the District
of Columbia remand the denial decision to EPA for reconsideration. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
On April 6, 1993, the Court of Appeals issued a decision granting the Agency's motion and remanding the case to the Agency
to redetermine within 180 days whether to grant or deny Ethyl's application. The mandate implementing this judgement
was transmitted to the Agency on June 3, 1993. Pursuant to the court's remand decision, the Agency published a notice
indicating the commencement of a comment period (58 FR 35950, July 2, 1993). The Administrator's final decision on
remand was due within 180 days after the transmittal of the court's mandate, or by November 30, 1993. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
After the Court of Appeals granted the Agency's motion to remand the denial decision concerning Ethyl's July 12, 1991
application, Ethyl submitted to EPA a substantial amount of additional data on emission testing with fuels containing
MMT. (Specific aspects of these data are discussed below in Section IV of this document). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
During the course of the remand of Ethyl's waiver application, the EPA Office of Research and Development (ORD) reviewed
the available data concerning the health effects associated with inhalation of manganese as part of a process to revise
the reference concentration (RfC) for inhaled manganese.
<FOOTCITE>4</FOOTCITE>
 An inhalation reference concentration is defined as an estimate (with uncertainty spanning perhaps an order of magnitude)
of a continuous inhalation exposure to the human population (including sensitive subgroups) that is likely to be
without appreciable risk of deleterious non-cancer health effects during a lifetime. The methodology for establishing
an RfC accounts for uncertainties and gaps in the health data base through the assignment of uncertainty factors.
In November, 1993, ORD completed preparation and review of, and EPA released to Ethyl, a document identifying and
describing the rationale for a new inhalation RfC of 0.05 ug/m3 for manganese and manganese compounds. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
4
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
In 1990, an inhalation reference concentration (RfC) for manganese of 0.4 ug/m3 was verified and placed on IRIS. The
original RfC for manganese figured into a 1990 risk assessment of MMT prepared by the EPA Office of Research and Development
(ORD). Subsequently, in light of new information submitted by Ethyl and new results from more recently published
studies concerning manganese inhalation health effects in workers, EPA reexamined the RfC for manganese and revised
it to a value of 0.05 ug/m3 in 1993. This revised RfC for manganese was made available to Ethyl and placed on IRIS in November
1993. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Ethyl subsequently provided to EPA a detailed critique of the approach utilized to derive the revised manganese RfC.
Among other things, Ethyl argued that EPA used an inappropriate procedure to derive the RfC from a study of occupational
manganese exposures by Roels, et al. (1992). Ethyl also argued that use of MMT would not result in significant changes
in background manganese exposures, and that the favorable effects on public health resulting from changes in the
composition of gasoline when MMT is utilized would outweigh any potential for adverse health effects. (Copies of
documents describing the revised RfC and of the Ethyl comments are available in the public docket.) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
As the deadline of November 30, 1993, for final action by EPA on Ethyl's waiver application approached, EPA concluded
that the extensive data base on the emission effects of MMT assembled by Ethyl and others during the consideration
of the application was sufficient to permit a decision concerning whether Ethyl had satisfied the statutory requirement
to show that use of MMT will not cause or contribute to exceedence of emission standards. However, there had been insufficient
opportunity for public comment concerning the use of a revised manganese inhalation RfC in assessing any risks that
might be posed by granting Ethyl's application. Ethyl argued that it had not been afforded an adequate opportunity
to study the derivation of the RfC and to comment on its implications for Ethyl's application. While EPA scientists
did not necessarily agree with the specific technical arguments concerning the revised RfC and other issues pertaining
to health effects made by Ethyl, EPA concluded that it might be useful to review the revised RfC in light of further analyses
of the available data as well as the underlying data from occupational studies of inhaled manganese if such data could
be readily obtained. EPA also concluded that it would be desirable in any case to have further dialogue with Ethyl and
other interested parties on issues related to the health effects of manganese before EPA was to make a final decision
concerning Ethyl's waiver application.
<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00059 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As a result of these factors, Ethyl and EPA entered into discussions concerning a possible extension of the deadline
for a decision. Ultimately, an agreement between Ethyl and EPA concerning such an extension was implemented on November
30, 1993, and notice of the agreement was published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 on December 9, 1993 (58 FR 64761). The agreement provided for an extension of 180 days in the deadline for final action
by EPA on Ethyl's waiver application for HiTEC 3000.
<FOOTCITE>5</FOOTCITE>
 EPA was thus required to take final action either granting or denying Ethyl's resubmitted application by May 29, 1994.
For purposes of the resubmitted application, the EPA Administrator determined that Ethyl had demonstrated, as required
by section 211(f)(4), that use of HiTEC 3000 at the specified concentration will not cause or contribute to a failure
of any emission control device or system (over the useful life of any vehicle in which such device or system is used)
to achieve compliance by the vehicle with the emission standards with respect to which it has been certified.
<FOOTCITE>6</FOOTCITE>
 The Agency stated clearly in the December 9, 1993 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 notice that this determination would not preclude any subsequent regulatory action based on emission effects under
Clean Air Act section 211(c) or any other provision of the Clean Air Act in the event that the resubmitted Ethyl waiver
application were to be granted in the future. The Agency also made it clear that this determination would not apply
in the context of any other new waiver application concerning HiTEC 3000 or MMT which might be submitted in the future
if EPA were to deny Ethyl's resubmitted waiver application on other grounds. Further review of Ethyl's application
during this 180 day period focused in particular on the issues relating to the potential health effects on public health
if EPA were to permit use of MMT as a fuel additive.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
5
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
To implement this agreement, Ethyl withdrew its July 12, 1991 waiver application, as remanded by the Court of Appeals,
and immediately resubmitted the application.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
6
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
As is explained in section IV of this document, this decision was based primarily upon application of the previously
used statistical tests to the submitted emissions data. As is also explained in section IV, the Agency believes that
these tests may be outdated and is considering a formal change in its method of analysis of such data.
<!-- PJG /ITAG -->
</FOOTNOTE>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00060 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Ethyl and EPA both desired and intended to assure continuity 
<!-- PJG 0012 frnewline -->
between the proceedings concerning the July 12, 1991 waiver 
<!-- PJG 0012 frnewline -->
application, as remanded to EPA by the Court of Appeals, and 
<!-- PJG 0012 frnewline -->
Ethyl's resubmitted waiver application. The entire 
<!-- PJG 0012 frnewline -->
administrative record compiled by EPA in support of the original 
<!-- PJG 0012 frnewline -->
denial decision, as well as all submissions to the public docket 
<!-- PJG 0012 frnewline -->
concerning the remanded application, was incorporated in the 
<!-- PJG 0012 frnewline -->
record this final decision on the resubmitted application. The 
<!-- PJG 0012 frnewline -->
docket number for the resubmitted waiver application also 
<!-- PJG 0012 frnewline -->
remained the same. 
<!-- PJG 0012 frnewline -->
The additional 180 days that were provided by Ethyl's 
<!-- PJG 0012 frnewline -->
agreement to resubmit the waiver application were utilized by EPA 
<!-- PJG 0012 frnewline -->
to evaluate remaining issues that may have been relevant to 
<!-- PJG 0012 frnewline -->
today's decision. In particular, EPA continued to examine the 
<!-- PJG 0012 frnewline -->
effects on public health that might be associated with approval 
<!-- PJG 0012 frnewline -->
of Ethyl's application. EPA considered any additional underlying 
<!-- PJG 0012 frnewline -->
data concerning studies of occupational manganese exposure that 
<!-- PJG 0012 frnewline -->
were obtained by or submitted to EPA, as well as any additional 
<!-- PJG 0012 frnewline -->
data or information pertaining to the health effects of manganese 
<!-- PJG 0012 frnewline -->
submitted by Ethyl or other interested persons during the comment 
<!-- PJG 0012 frnewline -->
period. Any additional information that was submitted was also 
<!-- PJG 0012 frnewline -->
considered in exploring alternative candidate RfC estimates and 
<!-- PJG 0012 frnewline -->
their relationship to the verified revised RfC. EPA also used 
<!-- PJG 0012 frnewline -->
the additional time provided by the extension to make a decision 
<!-- PJG 0012 frnewline -->
on how the RfC should be utilized in assessing health effects 
<!-- PJG 0012 frnewline -->
that may be associated with MMT use, evaluate potential exposure 
<!-- PJG 0012 frnewline -->
to manganese compounds associated with MMT use, complete a risk 
<!-- PJG 0012 frnewline -->
assessment concerning Ethyl's application, and decide what 
<!-- PJG 0012 frnewline -->
additional data, if any, should be provided by Ethyl either 
<!-- PJG 0012 frnewline -->
before or after MMT is introduced into the market. 
<!-- PJG 0012 frnewline -->
On April 28, 1994, EPA provided Ethyl Corporation with a 
<!-- PJG 0012 frnewline -->
draft of the revised risk assessment, which updated the 1991 ORD 
<!-- PJG 0012 frnewline -->
assessment and incorporated further analyses performed during the 
<!-- PJG 0012 frnewline -->
180-day extension period. Subsequent to providing Ethyl with 
<!-- PJG 0012 frnewline -->
this draft, Ethyl provided EPA with comments on the draft and 
<!-- PJG 0012 frnewline -->
some additional new data on ambient manganese concentrations in 
<!-- PJG 0012 frnewline -->
several Canadian cities. In order to allow the Agency time to 
<!-- PJG 0012 frnewline -->
consider this new data, Ethyl requested, and the Agency agreed 
<!-- PJG 0012 frnewline -->
to, an extension of the decision deadline until July 13, 1994. 
<!-- PJG 0012 frnewline -->
An agreement implementing this extension was executed by EPA and 
<!-- PJG 0012 frnewline -->
Ethyl counsel on May 24, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Statutory Framework 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. History of Statute 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Congress first added section 211(f) to the Clean Air Act in 
<!-- PJG 0012 frnewline -->
1977 based primarily on concerns that fuels or additives might 
<!-- PJG 0012 frnewline -->
damage vehicle emission control devices. Thus, the original 
<!-- PJG 0012 frnewline -->
statute focused on vehicles designed to use unleaded gasoline, 
<!-- PJG 0012 frnewline -->
prohibiting the general use in fuels of materials not 
<!-- PJG 0012 frnewline -->
``substantially similar'' to fuels used to certify vehicles to 
<!-- PJG 0012 frnewline -->
emissions standards. Section 211(f) also provided that the 
<!-- PJG 0012 frnewline -->
Administrator of EPA ``may waive the prohibitions *&blank;*&blank;* if he 
<!-- PJG 0012 frnewline -->
determines that the applicant has established that such fuel or 
<!-- PJG 0012 frnewline -->
fuel additive *&blank;*&blank;* will not cause or contribute to a failure of any 
<!-- PJG 0012 frnewline -->
emission control device or system *&blank;*&blank;* to achieve compliance by the 
<!-- PJG 0012 frnewline -->
vehicle with the emission standards with respect to which it has been certified pursuant to section 206.''
<FOOTCITE>7</FOOTCITE>
 Additionally, the 
<!-- PJG 0012 frnewline -->
statute provides that if the Administrator does not act to grant 
<!-- PJG 0012 frnewline -->
or deny the waiver request within 180 days of receipt of the 
<!-- PJG 0012 frnewline -->
application, the waiver request shall be treated as granted. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
7
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Section 206 of the Act sets forth the certification requirements with which vehicle manufacturers must comply in
order to introduce into commerce new model year motor vehicles. Under &sect;202 of the Act, standards for hydrocarbon
(HC), carbon monoxide (CO), and oxides of nitrogen (NOx) emissions for gasoline, gaseous fuel, diesel and methanol-powered
motor vehicles have been established. For gasoline, gaseous fuel and diesel-powered motor vehicles, standards
have also been established for particulate emissions.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 211(f) was initially interpreted by the Agency as 
<!-- PJG 0012 frnewline -->
applying only to unleaded gasoline. In the 1990 Amendments, 
<!-- PJG 0012 frnewline -->
section 211(f)(1) was broadly expanded to cover all other fuels 
<!-- PJG 0012 frnewline -->
and fuel additives, including leaded gasoline, diesel fuel, and 
<!-- PJG 0012 frnewline -->
consumer additives.
<FOOTCITE>8</FOOTCITE>
 The 1990 Amendments also apply the 
<!-- PJG 0012 frnewline -->
provisions of this subsection to vehicles other than lightduty 
<!-- PJG 0012 frnewline -->
vehicles. Section 211(f)(1)(B) of the Act makes it unlawful, 
<!-- PJG 0012 frnewline -->
effective November 15, 1990, for any manufacturer of a fuel or 
<!-- PJG 0012 frnewline -->
fuel additive to first introduce into commerce, or to increase 
<!-- PJG 0012 frnewline -->
the concentration in use of, any fuel or fuel additive for use by 
<!-- PJG 0012 frnewline -->
any person in motor vehicles manufactured after model year 1974 
<!-- PJG 0012 frnewline -->
which is not substantially similar to any fuel or fuel additive 
<!-- PJG 0012 frnewline -->
utilized in the certification of any model year 1975, or 
<!-- PJG 0012 frnewline -->
subsequent model year, vehicle or engine under section 206 of the 
<!-- PJG 0012 frnewline -->
Act. Thus, section 211(f)(1)(B) expands to all motor vehicles 
<!-- PJG 0012 frnewline -->
the fuel prohibitions of the original section 211(f)(1) (now 
<!-- PJG 0012 frnewline -->
redesignated as section 211(f)(1)(A)), which apply only to light-
<!-- PJG 0012 frnewline -->
duty vehicles.
<FOOTCITE>9</FOOTCITE>
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
8
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
H.R. Rep. No. 490, Part 1, 101st Cong., 2d Sess. 313 (1990).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
9
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
An interpretive rule defining the term ``substantially similar'' under section 211(f)(1)(A) was promulgated for
unleaded gasoline at 46 FR 38582 (July 28, 1981), and revised at 56 FR 5352 (February 11, 1991). An advance notice of
proposed rulemaking (ANPRM) has been published to begin the proces of promulgating an interpretive rule to define
the term ``substantially similar'' under &sect;211(f)(1)(B) for diesel fuel and diesel fuel additives. See 56 FR
24362 (May 30, 1991).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In adding section 211, the first focus of Congress was to 
<!-- PJG 0012 frnewline -->
prevent the introduction of new additives which may prove harmful 
<!-- PJG 0012 frnewline -->
to emission control devices but to allow for the introduction of 
<!-- PJG 0012 frnewline -->
such additives if it could be demonstrated that they would not 
<!-- PJG 0012 frnewline -->
harm emission control devices. Furthermore, in framing the 
<!-- PJG 0012 frnewline -->
statute such that the Administrator was not required to grant a 
<!-- PJG 0012 frnewline -->
waiver, Congress provided authority to the Administrator to take 
<!-- PJG 0012 frnewline -->
into account other considerations associated with introduction of 
<!-- PJG 0012 frnewline -->
the new material into commerce. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Two Stage Process 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 211(f)(4) of the Act provides the legal authority 
<!-- PJG 0012 frnewline -->
for this waiver decision.
<FOOTCITE>10</FOOTCITE>
 The Agency interprets 
<!-- PJG 0012 frnewline -->
section 211(f)(4) of the Act as establishing a two stage process 
<!-- PJG 0012 frnewline -->
for the decision to grant or deny a waiver application. The 
<!-- PJG 0012 frnewline -->
first stage of the process focuses solely on whether a waiver 
<!-- PJG 0012 frnewline -->
applicant has met its burden to demonstrate that a fuel does not 
<!-- PJG 0012 frnewline -->
cause or contribute to a failure to meet emission standards. The 
<!-- PJG 0012 frnewline -->
second stage of the process reflects the discretionary authority 
<!-- PJG 0012 frnewline -->
provided to the Agency by the statute. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
10
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Section 211(f)(4) states that ``The Administrator, upon application of any manufacturer of any fuel or fuel additive,
may waive the prohibitions established under paragraph (1) or (3) of this subsection, or the limitation specified
in paragraph (2) of this subsection, if he determines that the applicant has established that such fuel or fuel additive
or a specified concentration thereof, and the emission products of such fuel or additive or specified concentration
thereof, will not cause or contribute to a failure of any emission control device or system (over the useful life of
any vehicle in which such device or system is used) to achieve compliance by the vehicle with the emission standards
with respect to which it has been certified pursuant to section 206. If the Administrator has not acted to grant or deny
an application under this paragraph within one hundred and eighty days of receipt of such application, the waiver
authorized by this paragraph shall be treated as granted.''
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00061 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In the first stage of the waiver process, the sole issue is 
<!-- PJG 0012 frnewline -->
whether a fuel ``causes or contributes'' to an emission standard 
<!-- PJG 0012 frnewline -->
failure. The waiver applicant bears the burden of demonstrating 
<!-- PJG 0012 frnewline -->
that a fuel will neither cause nor contribute to an emission 
<!-- PJG 0012 frnewline -->
standard failure for any regulated pollutant. Balancing of the 
<!-- PJG 0012 frnewline -->
emission effects of a fuel for one pollutant against those for 
<!-- PJG 0012 frnewline -->
other pollutant(s) is not permissible under the statutory 
<!-- PJG 0012 frnewline -->
language. For example, an applicant would not meet its burden of 
<!-- PJG 0012 frnewline -->
proof if its testing of a fuel shows that it causes or 
<!-- PJG 0012 frnewline -->
contributes to an emission standard failure for CO, even though 
<!-- PJG 0012 frnewline -->
testing shows decreases in emissions of HC and NOx. If an 
<!-- PJG 0012 frnewline -->
applicant does not meet its burden of demonstrating that the 
<!-- PJG 0012 frnewline -->
``cause or contribute'' test is met, the Agency cannot grant a 
<!-- PJG 0012 frnewline -->
waiver. If an applicant does meet its burden, the Agency may 
<!-- PJG 0012 frnewline -->
then exercise its discretion to grant or to deny a waiver in the 
<!-- PJG 0012 frnewline -->
second stage of the process.
<FOOTCITE>11</FOOTCITE>
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
11
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Under the statute, if the Agency does not take action to grant or deny a waiver application within 180 days of submittal,
the waiver is deemed granted.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The statute provides that the Agency ``may'' grant a waiver 
<!-- PJG 0012 frnewline -->
application if the ``cause or contribute'' test is met, but does 
<!-- PJG 0012 frnewline -->
not require such an action. The Agency may therefore choose not 
<!-- PJG 0012 frnewline -->
to grant a waiver based on other issues (e.g., public health 
<!-- PJG 0012 frnewline -->
effects) that indicate that it would not be in the public 
<!-- PJG 0012 frnewline -->
interest to do so. In this second stage of the process, the 
<!-- PJG 0012 frnewline -->
Agency has a great deal of discretion to determine which issues 
<!-- PJG 0012 frnewline -->
should be examined and to balance the potential positive and 
<!-- PJG 0012 frnewline -->
negative impacts of a waiver. Such discretionary authority is 
<!-- PJG 0012 frnewline -->
grounded not only in Congress' use of the term ``may'' rather than 
<!-- PJG 0012 frnewline -->
the term ``shall'' in section 211(f)(4), but also in the goals and 
<!-- PJG 0012 frnewline -->
purposes of section 211 when read as a whole. The Agency does 
<!-- PJG 0012 frnewline -->
not believe that Congress intended to require EPA to grant a 
<!-- PJG 0012 frnewline -->
waiver under section 211(f)(4) when available information 
<!-- PJG 0012 frnewline -->
indicates that the fuel would be potentially subject to 
<!-- PJG 0012 frnewline -->
regulatory control under section 211(c)(1) immediately upon 
<!-- PJG 0012 frnewline -->
issuance of the waiver. Similarly, EPA believes that Congress 
<!-- PJG 0012 frnewline -->
did not intend to preclude a determination of whether issuance of 
<!-- PJG 0012 frnewline -->
a waiver is consistent with other important goals of the Act once 
<!-- PJG 0012 frnewline -->
it has been demonstrated that the mandatory ``cause or contribute'' 
<!-- PJG 0012 frnewline -->
test has been met. 
<!-- PJG 0012 frnewline -->
This does not mean that the Administrator has unfettered 
<!-- PJG 0012 frnewline -->
discretion to deny a waiver application for any reason. The 
<!-- PJG 0012 frnewline -->
grounds for any denial must not be arbitrary or capricious or 
<!-- PJG 0012 frnewline -->
constitute an abuse of discretion. Thus, in using discretion to 
<!-- PJG 0012 frnewline -->
deny an application, the Administrator must identify and explain 
<!-- PJG 0012 frnewline -->
the factors on which a discretionary denial decision is based and 
<!-- PJG 0012 frnewline -->
must assure that the policy adopted is consistent for all 
<!-- PJG 0012 frnewline -->
similarly situated waiver applicants. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
C. Consideration of Potential Health Effects 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Although the basis for a discretionary denial must be 
<!-- PJG 0012 frnewline -->
rational and non-arbitrary, nothing in the statute limits the 
<!-- PJG 0012 frnewline -->
type of factors which the Administrator may consider in deciding 
<!-- PJG 0012 frnewline -->
whether to deny an application. Section 101(b)(1) states that 
<!-- PJG 0012 frnewline -->
one of the purposes of the Act is to ``protect and enhance the 
<!-- PJG 0012 frnewline -->
quality of the Nation's air resources so as to promote the public 
<!-- PJG 0012 frnewline -->
health and welfare and the productive capacity of its 
<!-- PJG 0012 frnewline -->
population.'' Given this general goal of the Act, certainly the 
<!-- PJG 0012 frnewline -->
potential effects on public health of vehicle emissions would be 
<!-- PJG 0012 frnewline -->
a factor which the Administrator may reasonably consider when 
<!-- PJG 0012 frnewline -->
utilizing the discretion which section 211(f)(4) authorizes. 
<!-- PJG 0012 frnewline -->
Furthermore, under sections 211(b)(2) and 211(e), the 
<!-- PJG 0012 frnewline -->
Administrator must require the manufacturer of a fuel or additive 
<!-- PJG 0012 frnewline -->
to produce data concerning potential health effects as a 
<!-- PJG 0012 frnewline -->
condition of, or a prerequisite to, registration of the fuel or 
<!-- PJG 0012 frnewline -->
additive.
<FOOTCITE>12</FOOTCITE>
 Under section 211(c)(1), the Administrator may, 
<!-- PJG 0012 frnewline -->
based on data collected under sections 211(b) and 211(e) or 
<!-- PJG 0012 frnewline -->
otherwise available, issue regulations controlling manufacture or 
<!-- PJG 0012 frnewline -->
sale of any fuel or fuel additive which the Administrator finds 
<!-- PJG 0012 frnewline -->
``may reasonably be anticipated to endanger the public health or 
<!-- PJG 0012 frnewline -->
welfare.'' These provisions indicate that Congress intended that 
<!-- PJG 0012 frnewline -->
the Administrator be concerned about the potential health effects 
<!-- PJG 0012 frnewline -->
of fuels and fuel additives. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
12
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Sections 211(a) and 211(b)(1) require the registration of fuels and additives designated by the Administrator as
a precondition to introduction into commerce.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The fact that the Administrator may control fuels or fuel 
<!-- PJG 0012 frnewline -->
additives which pose potential health effects under section 
<!-- PJG 0012 frnewline -->
211(c)(1) does not mean that the Administrator may not consider 
<!-- PJG 0012 frnewline -->
health effects as a factor in deciding whether to grant a waiver 
<!-- PJG 0012 frnewline -->
under section 211(f)(4). Such a construction of the statute 
<!-- PJG 0012 frnewline -->
would lead to absurd results, precluding the Administrator from 
<!-- PJG 0012 frnewline -->
denying a waiver application and leading to potential 
<!-- PJG 0012 frnewline -->
introduction of a fuel or additive into commerce, even in the 
<!-- PJG 0012 frnewline -->
specific circumstances where the Administrator has concluded that 
<!-- PJG 0012 frnewline -->
there are grounds for issuance of a proposed regulation 
<!-- PJG 0012 frnewline -->
prohibiting the fuel or additive under section 211(c). However, 
<!-- PJG 0012 frnewline -->
although this reasoning indicates that Congress could not have 
<!-- PJG 0012 frnewline -->
reasonably intended to completely preclude the consideration of 
<!-- PJG 0012 frnewline -->
health effects under section 211(f)(4), this does not mean that 
<!-- PJG 0012 frnewline -->
section 211(c) limits the circumstances in which the 
<!-- PJG 0012 frnewline -->
Administrator may consider potential health effects as part of a 
<!-- PJG 0012 frnewline -->
waiver decision. Clearly, it was the intention of Congress to 
<!-- PJG 0012 frnewline -->
treat fuels and fuel additives already registered and being sold 
<!-- PJG 0012 frnewline -->
for a particular purpose differently than those which have not 
<!-- PJG 0012 frnewline -->
already been introduced into commerce. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00062 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
III. Method of Review
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. ``Causes or Contributes'' to Emission Standard Failure
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Under section 211(f)(4) of the Act, twenty-three applications for waivers of the section 211(f)(1) prohibitions
have been received. Of these, twenty-two applications have sought a waiver for additives for unleaded gasoline.
One, the most recent, sought a waiver of the section 211(f)(1)(B) prohibitions for an additive to diesel fuel.
<FOOTCITE>13</FOOTCITE>
 Of these twenty-three applications, ten applications have been granted (some with conditions attached), ten have
been denied, and three were withdrawn by the applicant prior to the Agency's decision.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
13
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
57 FR 45790 (October 5, 1992).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 211(f)(4) clearly places upon the waiver applicant the burden of establishing that its fuel will not cause
or contribute to the failure of any vehicle to meet emission standards. Absent a sufficient showing, the Administrator
cannot make the required determination and cannot grant the waiver. If interpreted literally, however, this burden
of proof imposed by the Act would be virtually impossible for an applicant to meet, as it requires the proof of a negative
proposition: that no vehicle will fail to meet emission standards to which it has been certified. Such a literal interpretation
could be construed as requiring the testing of every vehicle. Recognizing that Congress contemplated a workable
waiver provision, EPA has previously indicated that reliable statistical sampling and fleet testing protocols
may be used to demonstrate that a fuel under consideration would not cause or contribute to a significant failure to
meet emission standards by vehicles in the national fleet.
<FOOTCITE>14</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
14
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
See Waiver Decision on Tertiary Butyl Alcohol (``TBA''), 44 FR 10530 (February 2, 1979).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
To determine whether a waiver applicant has established that the proposed fuel will not cause or contribute to vehicles
failing emission standards, EPA reviews all the material in the public docket, including the data submitted with
the application and public comments on the application, and analyzes the data to ascertain the fuel's emission effects.
The analysis concentrates on four major areas of concern_exhaust emissions, evaporative emissions, materials'
compatibility, and driveability_and evaluates the data under statistical methods appropriate to the various types
of emission effects. Emission data are analyzed according to the effects that a fuel is predicted to have on emissions
over time. If the fuel is predicted to have only an instantaneous effect on emissions (that is, the emission effects
of the fuel are immediate and remain constant throughout the life of the vehicle when operating on the waiver fuel),
then ``back-to-back'' emissions testing will suffice.
<FOOTCITE>15</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Back-to-back emission testing involves testing a vehicle on a base fuel (i.e., a gasoline which meets specifications
for certification fuel or is representative of a typically available commercial gasoline), then testing that same
vehicle on the fuel for which the waiver is requested. The difference in emission levels is attributed to the waiver
fuel.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Unlike materials traditionally allowed in unleaded gasoline, metallics, such as MMT, produce non-gaseous combustion
products, some of which may be deposited in the parts of the vehicle that come in contact with the combustion products
of the burned fuel. These areas of the vehicle include the combustion chamber, the catalyst, the oxygen sensor, and
all parts of the exhaust system.
<FOOTCITE>16</FOOTCITE>
 Since these materials build up over time,
<FOOTCITE>17</FOOTCITE>
 it has been traditionally accepted that the emissions effects of such additives occur over time as miles are accumulated,
and that the method of deposition suggests that the effects are permanent. If the fuel is predicted to have such a long-term
deteriorative effect, durability testing over the useful life of the vehicle,
<FOOTCITE>18</FOOTCITE>
 in addition to back-to-back testing, is appropriate.
<FOOTCITE>19</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
16
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Automakers and catalyst manufacturers point out that, since catalysts are designed with a honeycomb structure in
order to maximize contact between engine combustion gases and catalyst materials, if channels within the honeycomb
become blocked, the catalyst is less able to break down the exhaust gases. Furthermore, although the mechanisms associated
with manganese deposits have not been completely described, catalyst manufacturers suggest that the mere disposition
of manganese (without blockage of channels) would hinder the catalytic activity of the catalyst. Ethyl, however,
believes that the manganese deposition on the catalyst does not hinder its activity.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
17
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Reply Comments of Ethyl Corporation in Support of the HiTEC 3000 Waiver Application, August 10, 1990, 28.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
18
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The ``useful life'' of a 1993 or earlier model year light-duty vehicle (LDV) (i.e., the amount of time or mileage accumulation
through which the LDV must meet the standards to which it has been certified) is 50,000 miles or five years, whichever
occurs first (&sect;202(d)). The 1990 Amendments extended the useful life of LDVs to 100,000 miles or ten years, beginning
with 1994 model year vehicles. The amendments also tightened emissions standards for 40 percent of a vehicle manufacturer's
LDV and light-duty truck (LDT) sales in model year 1994, 80 percent in model year 1995 and for all vehicles after model
year 1995 (&sect;202(g)). The useful life for heavy-duty vehicles and engines is generally 120,000 miles or eleven
years.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
19
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Durability testing over the useful life of the vehicle has involved testing two identical sets of vehicles for 50,000
miles (in the case of pre-1994 standards for LDVs), one set using the base fuel and the other using the waiver fuel. Each
vehicle is tested for emissions at 5,000 mile intervals. This is essentially the same testing pattern which has been
required for certification of a new motor vehicle under &sect;206 of the Act. As noted above, under the 1990 Amendments,
the useful life of LDVs has been extended to 100,000 miles beginning with the 1994 model year when more stringent emissions
standards took effect (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
see 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
&sect;202 (d) and (g)).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00063 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In addition to emissions data, EPA also reviews data on fuel composition and specifications, both to fully characterize
a proposed fuel, and to determine whether that fuel would cause or contribute to a failure of vehicles to comply with
their emission standards. Such a failure often can be predicted from characterization data. For example, volatility
specifications of the fuel could demonstrate a tendency for high evaporative emissions. Similarly, data on materials
compatibility could show potential failure of fuel systems, emission related parts, and/or emission control parts
from use of the fuel. Such failures could result in greater emissions. Likewise, fuel characteristics that could
cause significant driveability problems could result in tampering with emission controls and, thus, increased
emissions.
<!-- PJG 0012 frnewline -->
One issue raised previously in the context of Ethyl's present application was whether Ethyl was required to show that
MMT will not cause or contribute to noncompliance with emission standards by vehicles certified to ``future'' emission
standards (i.e., 1994 model year standards, which were not in effect at the time of the waiver application), as well
as vehicles certified to ``current'' standards (i.e., standards in effect at the time of the waiver application).
Ethyl believes that the statute only requires it to establish that MMT will not cause or contribute to the failure of
vehicles to meet current emission standards. For the reasons outlined in the Agency's January 1992 waiver decision,
EPA disagrees with this reading of the statute and continues to believe that it is appropriate to consider the effects
of an additive on vehicles' ability to meet more stringent future standards under circumstances similar to these.
<FOOTCITE>20</FOOTCITE>
 (See 57 FR 2537&hyph;8 January 22, 1992.)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
20
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
EPA also considered effects on compliance with future standards in a previous MMT decision. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
See 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
43 FR 41424 (September 18, 1978), In Re Application for MMT Waiver.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In the past, EPA has analyzed both instantaneous emission effects and durability effects using statistical tests
to determine if the fuel additive will cause a ``significant'' number of vehicles to fail emissions tests.
<FOOTCITE>21</FOOTCITE>
 Generally speaking, these tests have focused on the portion of the fleet that will actually fail emission standards
as a result of using the fuel or additive.
<FOOTCITE>22</FOOTCITE>
 Thus, the tests used to date by the Agency primarily consider only the ``cause'' language in the statute and do not consider
the portion of the statute which requires that the applicant must also show that the fuel or additive will not ``contribute''
to the non-compliance of vehicles with emission standards.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
21
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
For a detailed description of the statistical tests which have been used in the past for instantaneous effects see
``Decision Document'', Texas Methanol Waiver Decision, U.S. EPA Air Docket Number EN&hyph;87&hyph;06, and for
those used for durability effects, see 43 FR 41426.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
22
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
In fact the primary criteria allows for the failure of some portion of the fleet as a result of use of the fuel or additive.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Agency believes that its present statistical tests and criteria do not give adequate weight to the requirement
in Section 211(f)(4) that an applicant demonstrate that a fuel will not ``contribute'' to an emission standard failure.
<FOOTCITE>23</FOOTCITE>
 This is of particular significance in light of the Clean Air Amendments of 1990, which evidence a strong Congressional
concern that more needs to be done to ensure that people are not exposed to unhealthy levels of airborne pollution.
EPA is presently reviewing alternative criteria and statistical methodologies for determining whether use of a
fuel or fuel additive will ``cause or contribute'' to emission exceedances. The Agency expects to initiate a rulemaking
in the near future which will propose more appropriate criteria and statistical methodologies for reviewing waiver
applications and will afford formal notice to future applicants of the Agency's intention to adopt revised criteria
and methodologies.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
23
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
In fact, the Agency raised questions about the appropriateness of these previously used approaches in its original
decision on Ethyl's 1991 MMT waiver application. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
See 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
57 FR 2535, 2537 and 2538 (January 22, 1992).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As explained below, the Agency has concluded that it would not be appropriate to utilize new criteria and statistical
tests concerning which Ethyl received no prior notice in evaluating Ethyl's application. However, in the event that
Ethyl reapplies in the future for a section 211(f)(4) waiver to allow the use of MMT or any other additive, that application
will be evaluated in accordance with any new fuel waiver criteria in effect at that time.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Discretionary Review
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As discussed in part II of this decision, above, the Agency believes that the use of the term ``may'' in Section 211(f)(4)
of the Act affords the Administrator broad discretion to consider other factors in deciding whether to grant a waiver,
once a waiver applicant has demonstrated that a fuel or fuel additive will not cause or contribute to an emission standard
failure. This construction of section 211(f)(4) is also consistent with the other provisions of and the general purposes
underlying the Clean Air Act. Although the Administrator has not relied on this discretionary authority to deny a
waiver in the past, certain general principles should guide the Administrator's exercise of such authority.
<!-- PJG 0012 frnewline -->
Although the discretion of the Administrator to consider other factors in making a waiver decision is broad, it is
not unfettered. To assure that any decision based on factors other than emission standard failures is not arbitrary
and is based on a proper record, the applicant and other interested persons should be afforded proper notice of any
additional factors to be considered by the Administrator and an opportunity to comment or submit information concerning
those factors. Any decision based on the discretionary authority of the Administrator to consider other factors
should include an explanation of the factors which were considered and the relation of those factors to the decision.
Moreover, any policy adopted as part of a decision to deny a waiver on a discretionary basis should be applied consistently
to all similarly situated applicants.
<!-- PJG 0012 frnewline -->
Protection of the public health is a major goal of both the Clean Air Act in general and the section 211 fuels provisions
in particular. Accordingly, the Agency believes that when a waiver is sought for a fuel or fuel additive and there are
unresolved concerns regarding the potential impact of that fuel or fuel additive on public health, potential health
effects can and should be examined as part of the waiver process. As part of this examination of the potential health
effects of a fuel or additive, the Agency should review any relevant studies or analyses of which it is aware or which
are brought to its attention by the waiver applicant or by commenters on the waiver application.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00064 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In addition to potential health effects, the Agency may 
<!-- PJG 0012 frnewline -->
consider other factors as appropriate in deciding whether it 
<!-- PJG 0012 frnewline -->
would be in the public interest to grant a waiver. In 
<!-- PJG 0012 frnewline -->
particular, the Agency may consider whether a waiver would be 
<!-- PJG 0012 frnewline -->
consistent with the objectives of the Clean Air Act. In each 
<!-- PJG 0012 frnewline -->
instance, the factors considered and relied upon should be 
<!-- PJG 0012 frnewline -->
clearly identified. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
IV. Analysis of Emissions Data 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. Description of Previous Test Programs 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In support of its request, Ethyl conducted an extensive test 
<!-- PJG 0012 frnewline -->
program to determine the effect of MMT on the ability of vehicles 
<!-- PJG 0012 frnewline -->
to comply with current and future emission standards. It also 
<!-- PJG 0012 frnewline -->
considered the impact of MMT on nonregulated vehicle emissions, 
<!-- PJG 0012 frnewline -->
urban smog or ozone, refinery emissions, and crude oil use. 
<!-- PJG 0012 frnewline -->
Ethyl claimed that its test results established that MMT would 
<!-- PJG 0012 frnewline -->
not cause or contribute to exceedences of current or future 
<!-- PJG 0012 frnewline -->
emission standards. It also claimed that MMT use would result in 
<!-- PJG 0012 frnewline -->
other benefits consistent with Clean Air Act goals. 
<!-- PJG 0012 frnewline -->
In 1988, Ethyl assembled a test fleet of 48 light-duty 
<!-- PJG 0012 frnewline -->
vehicles, composed of eight different model types (six Buick 
<!-- PJG 0012 frnewline -->
Centurys (2.5 liter), six Buick Centurys (2.8 liter), six Buick 
<!-- PJG 0012 frnewline -->
Centurys (3.8 liter), six Chevrolet Cavaliers (2.0 liter), six 
<!-- PJG 0012 frnewline -->
Ford Escorts (1.9 liter), six Ford Tauruses (3.0 liter), six Ford 
<!-- PJG 0012 frnewline -->
Crown Victorias (5.0 liter) and six Dodge Dynastys (3.0 liter)) 
<!-- PJG 0012 frnewline -->
that together represented a broad spectrum of then current (1988) 
<!-- PJG 0012 frnewline -->
technology vehicles. To accumulate mileage, Ethyl utilized the 
<!-- PJG 0012 frnewline -->
``Alternative Mileage Accumulation Cycle'' (AMA) which is a 
<!-- PJG 0012 frnewline -->
standard procedure utilized to accumulate mileage for 
<!-- PJG 0012 frnewline -->
certification purposes.
<FOOTCITE>24</FOOTCITE>
 It utilized two laboratories to 
<!-- PJG 0012 frnewline -->
measure each vehicle's exhaust emissions of the regulated 
<!-- PJG 0012 frnewline -->
pollutants (HC, oxides of nitrogen (NO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
x
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
) and carbon monoxide 
<!-- PJG 0012 frnewline -->
(CO)) at 5,000-mile intervals up to 75,000 miles in the case of 
<!-- PJG 0012 frnewline -->
most vehicles and up to 100,000 miles in the case of several.
<FOOTCITE>25</FOOTCITE>
 
<!-- PJG 0012 frnewline -->
It also tested a number of these vehicles for evaporative HC, 
<!-- PJG 0012 frnewline -->
particulate and manganese emissions, materials compatibility, 
<!-- PJG 0012 frnewline -->
driveability and catalyst durability. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
24
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
A driving cycle is a description of how to drive a vehicle to accumulate mileage, including such things as a what percentage
of driving should be done at what speed and what the overall average speed should be. The AMA cycle is described in EPA
Mobile Source Advisory Circular 37&hyph;A, (See Docket A&hyph;91&hyph;46) and is essentially prescribed for use
by manufacturers to accumulate mileage for certification of vehicles (See 40 CFR 86.092&hyph;26). A driving cycle
is used so that test vehicles accumulate mileage in a manner that is supposedly representative of in-use vehicles.
The emissions of a test vehicle that has accumulated mileage according to a driving cycle representative of in-use
vehicles are more likely to be representative of in-use vehicles' emissions. There are actually three alternative
cycles associated with the AMA; however, the average speeds of the three alternatives are very similar, ranging from
29.9 mph to 30.72 mph.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
25
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The ``useful life'' of model year 1993 and earlier light-duty vehicles (LDV's) is 50,000 miles or five years, whichever
occurs first (section 202(d)). However, the Clean Air Act Amendments of 1990 extended the useful life of LDV's to 100,000
miles or ten years, beginning with 1994 model year vehicles. For the standards that begin to take effect in model year
1994, section 207(c) provides for intermediate in-use standards for several years.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00065 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Ethyl analyzed the data collected using EPA's previously 
<!-- PJG 0012 frnewline -->
used statistical tests (43 FR 41424, September 18, 1978) and 
<!-- PJG 0012 frnewline -->
additional tests developed by its consultants to further 
<!-- PJG 0012 frnewline -->
characterize the data. Its analysis indicated that, on average, 
<!-- PJG 0012 frnewline -->
MMT at the requested concentration would result in a 0.018 gpm 
<!-- PJG 0012 frnewline -->
increase in HC emissions and decreases in NO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
x
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and CO emissions. 
<!-- PJG 0012 frnewline -->
The analyses further indicated that, when EPA's previously used 
<!-- PJG 0012 frnewline -->
tests are applied, the increase in HC emissions would not cause 
<!-- PJG 0012 frnewline -->
or contribute to vehicles' failure to meet the current HC 
<!-- PJG 0012 frnewline -->
emission standard. The results of Ethyl's testing for materials 
<!-- PJG 0012 frnewline -->
compatibility, driveability and catalyst durability also 
<!-- PJG 0012 frnewline -->
indicated that MMT would have no significant adverse effects on 
<!-- PJG 0012 frnewline -->
vehicles' ability to meet current emission standards under 
<!-- PJG 0012 frnewline -->
average driving conditions. On that basis, Ethyl claimed that it 
<!-- PJG 0012 frnewline -->
had made its statutorily required showing. 
<!-- PJG 0012 frnewline -->
Ethyl also submitted data on the catalyst efficiency of the vehicles which it tested. Ethyl performed back-pressure
tests
<FOOTCITE>26</FOOTCITE>
 on all its vehicle fleet except one model group after accumulation of 75,000 miles. Back-pressure tests were also
performed on a pair of Ford Crown Victorias, one operated on MMT-fuel and one on clear fuel, at speeds higher than those
used in Ethyl's 48-vehicle test program.
<FOOTCITE>27</FOOTCITE>
 The results of these tests indicated that back-pressure was not significantly different in the MMT vehicles when
compared to the clear fuel vehicles. Ethyl also operated two 5.7 liter Corvettes at extremely high speeds (100 mph)
for 25,000 miles, one using MMT fuel and one using clear fuel. Although similar in magnitude, the back pressure for
the MMT vehicle was slightly higher than that for the clear vehicle. Ethyl also presented catalyst efficiency
<FOOTCITE>28</FOOTCITE>
 data based on engine-out emissions of its fleet and based on ``slave engine'' testing
<FOOTCITE>29</FOOTCITE>
 for half of its fleet. Results of the slave engine testing indicated no statistically significant difference between
the catalyst efficiencies for the MMT vehicle components when compared with the clear vehicle components. Finally,
four Chevrolet Corsicas were operated to 100,000 miles, two utilizing MMT fuel and two with clear fuel. The purpose
of this testing was to investigate MMT's effect on the catalyst for a longer mileage interval than the 75,000 miles
over which most of Ethyl's fleet had been driven. Catalyst efficiencies of the MMT vehicles 
<!-- PJG 0012 frnewline -->
were not significantly different when compared to the clear fuel vehicles. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
26
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Back pressure tests are used to determine if significant plugging has occurred in a vehicle's catalyst. The total
pressure ahead of the catalyst is back pressure. This pressure is a measure of constriction in flow through the exhaust
system caused by flow of the exhaust through the emissions control system and the noise-reducing components of the
vehicle. If plugging has occurred in a vehicle, the total pressure ahead of its catalyst, the back pressure, should
be greater than expected (e.g., greater than a matching control vehicle).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
27
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
In this program the maximum speed was 65 mph for the first 25,000 miles and 80 mph for an additional 10,000 miles.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
28
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Catalyst efficiency is a measure of what fraction of the emissions entering the catalyst are actually removed (or
catalyzed) by the catalyst.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
29
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
``Slave engine'' testing is the testing of vehicle components on a single engine which is not in a vehicle. In this case,
catalyst efficiencies between control and MMT vehicles were investigated using exhaust gases from this single engine
which were routed through the removed catalysts. This would likely result in a more accurate analysis of catalyst
efficiency, since one possible confounding factor, vehicle to vehicle variability, would be eliminated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Ford presented original test data which Ford said supported 
<!-- PJG 0012 frnewline -->
its contention that actual in-use MMT-induced HC emissions 
<!-- PJG 0012 frnewline -->
increases are potentially far greater than those reported by 
<!-- PJG 0012 frnewline -->
Ethyl.
<FOOTCITE>30</FOOTCITE>
 Ford conducted testing on a more limited scale 
<!-- PJG 0012 frnewline -->
utilizing eight vehicles, representing two model groups, run for 
<!-- PJG 0012 frnewline -->
105,000 miles. Ford chose two model groups which were 
<!-- PJG 0012 frnewline -->
representative of its newest technology vehicles at the time. 
<!-- PJG 0012 frnewline -->
One (the Explorer) represented a technology that Ford believed 
<!-- PJG 0012 frnewline -->
may be especially prone to exhibit a buildup of manganese, due to 
<!-- PJG 0012 frnewline -->
significantly higher operating temperatures and loads than those 
<!-- PJG 0012 frnewline -->
of passenger cars. The other model group, the Escorts, had 
<!-- PJG 0012 frnewline -->
close-coupled catalysts, a design which is being incorporated 
<!-- PJG 0012 frnewline -->
into many new vehicles in order to meet tighter emissions 
<!-- PJG 0012 frnewline -->
standards. Like Ethyl, Ford operated part of its test fleet on 
<!-- PJG 0012 frnewline -->
clear fuel and part on fuel containing 1/32 gpg MMT. However, 
<!-- PJG 0012 frnewline -->
Ford's test program differed from Ethyl's program in several 
<!-- PJG 0012 frnewline -->
ways. When accumulating mileage, Ford utilized a commercial 
<!-- PJG 0012 frnewline -->
gasoline which contained all of the additives (detergents, etc.) 
<!-- PJG 0012 frnewline -->
typically found in such fuels. Ethyl utilized a very high 
<!-- PJG 0012 frnewline -->
quality test fuel with tight specifications and no additives. 
<!-- PJG 0012 frnewline -->
(Although used for actual emissions testing purposes, Ethyl's 
<!-- PJG 0012 frnewline -->
fuel would not be allowed for mileage accumulation when 
<!-- PJG 0012 frnewline -->
certifying vehicles since it is not representative of in-use 
<!-- PJG 0012 frnewline -->
fuel.) When accumulating mileage, Ford utilized what it called 
<!-- PJG 0012 frnewline -->
its ``durability cycle'' which it had previously developed. 
<!-- PJG 0012 frnewline -->
Compared to the AMA cycle used by Ethyl, Ford's driving cycle had 
<!-- PJG 0012 frnewline -->
a higher average speed (54 miles per hour (mph) versus 30 mph), 
<!-- PJG 0012 frnewline -->
and a higher percentage of high speed driving.
<FOOTCITE>31</FOOTCITE>
 (As 
<!-- PJG 0012 frnewline -->
previously mentioned, Ethyl utilized the AMA cycle used for 
<!-- PJG 0012 frnewline -->
certification purposes.) Additionally, in the Ford program, 
<!-- PJG 0012 frnewline -->
vehicles were tested for emissions at five mileage intervals 
<!-- PJG 0012 frnewline -->
(5,000, 20,000, 55,000, 85,000
<FOOTCITE>32</FOOTCITE>
 and 105,000 miles) and six 
<!-- PJG 0012 frnewline -->
emissions tests were done at each testing interval. Ethyl, by 
<!-- PJG 0012 frnewline -->
comparison, conducted testing every 5,000 miles to 75,000 miles 
<!-- PJG 0012 frnewline -->
(15 intervals) and utilized two emissions tests at each 
<!-- PJG 0012 frnewline -->
interval.
<FOOTCITE>33</FOOTCITE>
 Ford's test vehicles showed an elevation of HC 
<!-- PJG 0012 frnewline -->
emissions with MMT that was substantially greater than the 0.018 
<!-- PJG 0012 frnewline -->
gpm reported by Ethyl from its test program. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
30
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
EPA's emissions testing lab and Ford's lab routinely undergo correlation testing and the data indicate that correlation
is good between the labs. (See memorandum, with attached data, from Martin E. Reineman, EPA Manager of Correlation
and Engineering Services, Office of Mobile Sources, January 3, 1992, Docket A&hyph;91&hyph;46.)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
31
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Ford indicated that drivers who accumulated mileage in its test program were asked to follow posted speed limits.
Ford indicated that the cycle consisted of 5% city driving (25 to 45 mph), 5% gravel or off road driving (25 to 45 mph),
20% rural driving (45 to 55 mph), and 70% highway driving (65 mph). Posted speed limits are shown in parentheses. By
way of comparison, the AMA cycle consists of 16.1% of driving at 30 mph, 22.6 at 35 mph, 20.9 at 40 mph, 6.4 at 45 mph, 17%
at variable speed and one of the three following options: 16.7% at 50 mph or 16.5% at 55 mph or 8.6% and 7.9% at 55 mph and
70 mph, respectively.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
32
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
In fact, only two of the four Escorts were tested at 85,000 miles.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
33
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Although Ethyl conducted additional emissions tests at some mileage intervals when the initial two tests showed
high variation, these additional tests were not used in Ethyl's analysis of its data.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00066 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Toyota also submitted data on a single vehicle which was 
<!-- PJG 0012 frnewline -->
operated for 30,000 miles on MMT-containing fuel after which the 
<!-- PJG 0012 frnewline -->
oxygen sensor and catalyst were replaced with new components and 
<!-- PJG 0012 frnewline -->
then driven on fuel not containing MMT for 30,000 miles. Toyota 
<!-- PJG 0012 frnewline -->
also used a driving cycle with an average speed (41.7 mph) higher 
<!-- PJG 0012 frnewline -->
than that used by Ethyl for mileage accumulation and used fuel 
<!-- PJG 0012 frnewline -->
with what Toyota believed was a relatively high trace level of 
<!-- PJG 0012 frnewline -->
lead than that usually found in unleaded gasoline (0.0045 gpg 
<!-- PJG 0012 frnewline -->
lead) and oil with a relatively high phosphorus level (0.13 
<!-- PJG 0012 frnewline -->
weight percent). Toyota referred to this test procedure as the 
<!-- PJG 0012 frnewline -->
``Toyota 9-Laps'' and presented evidence which it said suggested 
<!-- PJG 0012 frnewline -->
that the catalyst degradation seen by vehicles using the Toyota 
<!-- PJG 0012 frnewline -->
9-Lap test was very similar to in-use catalysts tested by Toyota. 
<!-- PJG 0012 frnewline -->
Hence, Toyota suggested, these ``adjustments'' made in creating the 
<!-- PJG 0012 frnewline -->
Toyota 9-Lap make the testing of a vehicle more consistent with 
<!-- PJG 0012 frnewline -->
what would happen in actual in-use driving. Toyota's data 
<!-- PJG 0012 frnewline -->
indicated an HC level after the first 30,000 miles of vehicle use 
<!-- PJG 0012 frnewline -->
(on MMT fuel) about 0.1 gpm higher than the same vehicle after 
<!-- PJG 0012 frnewline -->
the vehicle was driven for a second 30,000 mile interval with a 
<!-- PJG 0012 frnewline -->
new catalyst and oxygen sensor. Toyota also submitted data 
<!-- PJG 0012 frnewline -->
indicating that the efficiency at which the catalyst was 
<!-- PJG 0012 frnewline -->
operating for the MMT-exposed components was less than that for 
<!-- PJG 0012 frnewline -->
the non-MMT exposed components. 
<!-- PJG 0012 frnewline -->
Some time after EPA's January 8, 1992 denial decision, EPA 
<!-- PJG 0012 frnewline -->
and Ethyl entered into discussions concerning a possible 
<!-- PJG 0012 frnewline -->
settlement of the court case which Ethyl had filed. In the 
<!-- PJG 0012 frnewline -->
context of these discussions, Ethyl submitted to the Agency new 
<!-- PJG 0012 frnewline -->
data it had developed since the denial decision. Ethyl tested 
<!-- PJG 0012 frnewline -->
six 1991 Escorts, using both the relatively high-speed driving 
<!-- PJG 0012 frnewline -->
pattern similar to that utilized by Ford in its testing of 1991 
<!-- PJG 0012 frnewline -->
Escorts (the Ford cycle) and, also, after changing emissions 
<!-- PJG 0012 frnewline -->
system components (catalyst and oxygen sensor), the driving cycle 
<!-- PJG 0012 frnewline -->
used by Ethyl in the original test program (EPA's durability 
<!-- PJG 0012 frnewline -->
certification cycle also known as the AMA). Half of the vehicles 
<!-- PJG 0012 frnewline -->
utilized MMT-containing fuel and half were run on clear fuel 
<!-- PJG 0012 frnewline -->
(fuel not containing MMT). Ethyl also performed some catalyst 
<!-- PJG 0012 frnewline -->
efficiency tests on these vehicles utilizing a ``slave engine.'' 
<!-- PJG 0012 frnewline -->
Ethyl also tested six 1988 Escorts which were used in its 
<!-- PJG 0012 frnewline -->
original test program driven on the AMA cycle. In the new 
<!-- PJG 0012 frnewline -->
program, after replacing the catalyst and oxygen sensor, Ethyl 
<!-- PJG 0012 frnewline -->
continued mileage accumulation, from 75,000 to 100,000 miles, 
<!-- PJG 0012 frnewline -->
utilizing the Ford cycle. Likewise, Ethyl tested six 1988 Buicks 
<!-- PJG 0012 frnewline -->
from its original fleet accumulating mileage (100,000 to 115,000 
<!-- PJG 0012 frnewline -->
miles) using the Ford cycle but without replacing any components. 
<!-- PJG 0012 frnewline -->
Ethyl also accumulated mileage on seven pairs of 1992 vehicles 
<!-- PJG 0012 frnewline -->
(four Crown Victorias, Six Buick Regals and four Ford Mustangs) 
<!-- PJG 0012 frnewline -->
in test programs covering from 45,000 to 100,000 miles beyond 
<!-- PJG 0012 frnewline -->
break-in with and without MMT, using the Ford cycle. 
<!-- PJG 0012 frnewline -->
Based on its inspection and analysis of the new Ethyl data, 
<!-- PJG 0012 frnewline -->
the Agency ultimately concluded that Ethyl's program had 
<!-- PJG 0012 frnewline -->
demonstrated driving cycle does not contribute significantly to 
<!-- PJG 0012 frnewline -->
MMT-induced increases in hydrocarbon emissions. However, in 
<!-- PJG 0012 frnewline -->
addition to addressing the issue of driving cycle, the Ethyl data 
<!-- PJG 0012 frnewline -->
appeared to confirm the finding by Ford that 1991 Escorts 
<!-- PJG 0012 frnewline -->
experienced a much higher MMT-induced HC increase than that 
<!-- PJG 0012 frnewline -->
observed in other models tested (either in Ethyl's 1992 fleet or 
<!-- PJG 0012 frnewline -->
in the original 1988 Ethyl fleet). The Agency was concerned that 
<!-- PJG 0012 frnewline -->
these data could indicate that certain engine and emissions 
<!-- PJG 0012 frnewline -->
control system configurations were more vulnerable to an MMT-induced emissions increase irrespective of driving
cycle. 
<!-- PJG 0012 frnewline -->
To further assist the Agency in developing a test program, 
<!-- PJG 0012 frnewline -->
EPA held a workshop in October of 1992 and presented a proposed 
<!-- PJG 0012 frnewline -->
test program which could address in a timely manner specific 
<!-- PJG 0012 frnewline -->
unresolved issues concerning the effect of MMT on emissions: 
<!-- PJG 0012 frnewline -->
(1) Whether other vehicles utilizing fuels containing MMT are 
<!-- PJG 0012 frnewline -->
likely to experience increases in hydrocarbon emissions similar 
<!-- PJG 0012 frnewline -->
to those observed in 1991 Ford Escorts; and (2) whether fuels 
<!-- PJG 0012 frnewline -->
containing MMT have significant adverse effects on emissions from 
<!-- PJG 0012 frnewline -->
vehicles utilizing the technologies most likely to be employed to 
<!-- PJG 0012 frnewline -->
meet future standards. 
<!-- PJG 0012 frnewline -->
Ultimately the court case was not settled; however, the test 
<!-- PJG 0012 frnewline -->
program presented by the Agency at the workshop was largely 
<!-- PJG 0012 frnewline -->
adopted by Ethyl and is the basis of its most recent test program 
<!-- PJG 0012 frnewline -->
involving the 1993 fleet. These vehicles (with the previously 
<!-- PJG 0012 frnewline -->
mentioned 1992 vehicles) comprise Ethyl's most recent 
<!-- PJG 0012 frnewline -->
dataset.
<FOOTCITE>34</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
34
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
On May 25, 1993, and on subsequent dates, Ethyl provided summaries of the 1992/93 test data to EPA staff and these have
been placed in public docket A&hyph;93&hyph;26.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Ethyl accumulated mileage on three 1992 model year vehicles 
<!-- PJG 0012 frnewline -->
(four Crown Victorias to 100,000 test miles,
<FOOTCITE>35</FOOTCITE>
 six Buick Regals 
<!-- PJG 0012 frnewline -->
to 65,000 test miles and four Ford Mustangs to 45,000 test miles) 
<!-- PJG 0012 frnewline -->
and six 1993 model year vehicles (six Toyota Camrys to 85,000 
<!-- PJG 0012 frnewline -->
test miles, six Oldsmobile Achievas to 65,000 test miles, six 
<!-- PJG 0012 frnewline -->
Dodge Shadows to 55,000 test miles, six TLEV Ford Escorts to 
<!-- PJG 0012 frnewline -->
85,000 test miles, six Honda Civics to 80,000 test miles and four 
<!-- PJG 0012 frnewline -->
49-state Ford Escorts to 30,000 test miles) with and without MMT. The driving cycles used for these vehicles were an
intermediate 
<!-- PJG 0012 frnewline -->
driving cycle of 45 mph on average for the 1993 model year 
<!-- PJG 0012 frnewline -->
vehicles, an average 55 mph driving cycle (i.e., the Ford Cycle) 
<!-- PJG 0012 frnewline -->
for all mileage accumulation on the 1992 Ford Mustangs and for 
<!-- PJG 0012 frnewline -->
the initial 45,000 miles of operation on the 1992 Crown Victorias 
<!-- PJG 0012 frnewline -->
and Buick Regals and an average driving cycle of 45 mph was 
<!-- PJG 0012 frnewline -->
utilized for these two models thereafter. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
35
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
As referred to here, ``test miles'' indicates mileage accumulated after break-in (break-in mileages vary among
these models) and during which some vehicles were run on fuel containing MMT while control vehicles were run on clear
fuel.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00067 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Comments on Vehicle Emissions Issues 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
EPA provided an opportunity for the public to submit written 
<!-- PJG 0012 frnewline -->
comments.
<FOOTCITE>36</FOOTCITE>
 Many comments were received from a wide variety of 
<!-- PJG 0012 frnewline -->
interests, including refiners, automakers, emission control 
<!-- PJG 0012 frnewline -->
manufacturers, states committees, environmental and public 
<!-- PJG 0012 frnewline -->
interest groups and private citizens. Taken together, the 
<!-- PJG 0012 frnewline -->
comments touched on every aspect of Ethyl's application. The 
<!-- PJG 0012 frnewline -->
following is a summary of the comments. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
36
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
As mentioned previously, the comments received concerning Ethyl's remanded waiver application are available in
public docket A&hyph;93&hyph;26.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Four automakers (Ford Motor Company (Ford), General Motors 
<!-- PJG 0012 frnewline -->
Corporation (GM), Toyota Technical Center, U.S.A., Inc. (Toyota), 
<!-- PJG 0012 frnewline -->
and Chrysler Motors Corporation (Chrysler)), the American 
<!-- PJG 0012 frnewline -->
Automobile Manufacturers Association (AAMA), and the 
<!-- PJG 0012 frnewline -->
Manufacturers of Emission Controls Association (MECA) all 
<!-- PJG 0012 frnewline -->
recommended denial of Ethyl's request and expressed several 
<!-- PJG 0012 frnewline -->
concerns with regard to the addition of MMT to unleaded gasoline. 
<!-- PJG 0012 frnewline -->
First, they noted that the use of MMT will cause an increase in 
<!-- PJG 0012 frnewline -->
HC emissions. Most indicated that the more stringent emissions 
<!-- PJG 0012 frnewline -->
standards that began taking effect in model year 1994 will make 
<!-- PJG 0012 frnewline -->
any increase in HC emissions particularly troublesome. Further, 
<!-- PJG 0012 frnewline -->
they stated that newer technology vehicles will likely be 
<!-- PJG 0012 frnewline -->
equipped with catalysts which are nearer the engine (more 
<!-- PJG 0012 frnewline -->
``closely coupled'') and that such close coupling, they stated, 
<!-- PJG 0012 frnewline -->
results in higher catalyst temperatures that may make the 
<!-- PJG 0012 frnewline -->
catalyst more prone to the deposition of manganese. These 
<!-- PJG 0012 frnewline -->
commenters indicated that deposition of manganese compounds on 
<!-- PJG 0012 frnewline -->
the surface of the catalyst would impair the catalytic breakdown 
<!-- PJG 0012 frnewline -->
of emissions from the engine, thereby decreasing catalyst 
<!-- PJG 0012 frnewline -->
effectiveness. Additionally, they were concerned that MMT, even 
<!-- PJG 0012 frnewline -->
at the 1/32 gpg Mn concentration requested, would plug catalysts 
<!-- PJG 0012 frnewline -->
and thus reduce the surface area of the catalyst available to 
<!-- PJG 0012 frnewline -->
break down emissions from the engine, especially in the case of 
<!-- PJG 0012 frnewline -->
vehicles operated under driving conditions which result in higher 
<!-- PJG 0012 frnewline -->
temperatures such as heavy load or high speed. Under such 
<!-- PJG 0012 frnewline -->
conditions, it was pointed out, the vehicle may be more prone to 
<!-- PJG 0012 frnewline -->
deposition of manganese. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Ethyl indicated that the assertions that it must 
<!-- PJG 0012 frnewline -->
``conclusively'' demonstrate the absence of negative effects is not 
<!-- PJG 0012 frnewline -->
required by the section 211(f)(4) standard. Ethyl believes that 
<!-- PJG 0012 frnewline -->
it need only demonstrate, by a preponderance of evidence, that 
<!-- PJG 0012 frnewline -->
the additive will not cause or contribute to the failure of 
<!-- PJG 0012 frnewline -->
emission control devices to comply with applicable emission 
<!-- PJG 0012 frnewline -->
standards, and, further, it believes that it has made this 
<!-- PJG 0012 frnewline -->
showing. Ethyl also stated that the EPA test program proposed at 
<!-- PJG 0012 frnewline -->
its October 1992 workshop involving the accumulation of 65,000 
<!-- PJG 0012 frnewline -->
test miles, would be sufficient for purposes of gauging the 
<!-- PJG 0012 frnewline -->
effect of MMT on emissions. Ethyl commented that it followed 
<!-- PJG 0012 frnewline -->
this proposal in the 1992/93 test fleet, although mileage 
<!-- PJG 0012 frnewline -->
accumulation has continued beyond 65,000 miles for three of the 
<!-- PJG 0012 frnewline -->
eight model year vehicles tested without new emission results 
<!-- PJG 0012 frnewline -->
different from the trends established through 65,000 miles. 
<!-- PJG 0012 frnewline -->
With respect to the automakers' concerns about effect of MMT 
<!-- PJG 0012 frnewline -->
on newer emission technology such as close-coupled catalysts, 
<!-- PJG 0012 frnewline -->
Ethyl indicated that the use of the 1993 Transitional Low 
<!-- PJG 0012 frnewline -->
Emission Vehicle (TLEV) Honda Civic in its most recent test 
<!-- PJG 0012 frnewline -->
program was intended so as to introduce a vehicle which has the 
<!-- PJG 0012 frnewline -->
most physically possible close-coupled emission technology (i.e., 
<!-- PJG 0012 frnewline -->
one connected directly to the exhaust manifold). Despite such 
<!-- PJG 0012 frnewline -->
close-coupling, Ethyl indicated that the differences in 
<!-- PJG 0012 frnewline -->
hydrocarbon emissions between clear and MMT-fueled 1993 TLEV 
<!-- PJG 0012 frnewline -->
Honda Civics was minimal. Ethyl also indicated that this concern 
<!-- PJG 0012 frnewline -->
about close-coupled catalysts completely ignores that Ethyl 
<!-- PJG 0012 frnewline -->
tested two 1988 models and three 1993 models equipped with close- 
<!-- PJG 0012 frnewline -->
coupled catalysts without showing any significant adverse effects 
<!-- PJG 0012 frnewline -->
on emissions. 
<!-- PJG 0012 frnewline -->
Toyota submitted data on catalysts and oxygen sensors from 
<!-- PJG 0012 frnewline -->
in-use customer vehicles from Canada where MMT is used as a fuel 
<!-- PJG 0012 frnewline -->
additive. Toyota believes that these catalysts and oxygen 
<!-- PJG 0012 frnewline -->
sensors indicate that exhaust emissions of hydrocarbons and 
<!-- PJG 0012 frnewline -->
carbon monoxide are higher from catalysts/oxygen systems 
<!-- PJG 0012 frnewline -->
collected in Canada than comparable catalyst/oxygen systems from 
<!-- PJG 0012 frnewline -->
U.S. vehicles. Also Toyota submitted photographs of a catalyst 
<!-- PJG 0012 frnewline -->
taken from a high mileage Canadian Hilux pickup truck which 
<!-- PJG 0012 frnewline -->
showed plugging of the catalyst passages. 
<!-- PJG 0012 frnewline -->
Ethyl's response to Toyota's catalyst/oxygen system data is 
<!-- PJG 0012 frnewline -->
that it is not clear from the description of the Toyota test 
<!-- PJG 0012 frnewline -->
results precisely what can be concluded from the test program. 
<!-- PJG 0012 frnewline -->
Ethyl stated that, without a detailed vehicle history, there is 
<!-- PJG 0012 frnewline -->
no basis to conclude that MMT had an effect on the 
<!-- PJG 0012 frnewline -->
catalyst/oxygen system data. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00068 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Chrysler submitted data on the analysis of four catalysts, which was completed by Johnson Matthey Incorporated (JMI)
at Chrysler's request, that had various degrees of manganese deposition from Canadian vehicles exposed to MMT in
the fuel. It indicated that the results of the analysis demonstrate that the washcoat of both the partially plugged
catalysts and unaffected catalysts exhibit a clear layer of ``densified'' washcoat containing large quantities
of manganese oxides. Chrysler believes that the JMI report supports its concern that manganese oxides can fill the
catalyst pores, thereby covering precious metal sites or decreasing wash coat surface area, consequently eventually
decreasing catalyst activity. Regarding the automakers' concerns about the Additive's effect on emissions system
components, such as exhaust oxygen sensors, exhaust gas recirculation valves, catalysts and oxygen sensors, Ethyl
stated that it has already provided extensive data showing that the Additive does not adversely effect any of these
emission system components.
<FOOTCITE>37</FOOTCITE>
 (Ethyl's test programs are discussed in the previous section.) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<!-- PJG ITAG l=28 g=1 f=1 -->
37Public Docket A&hyph;92&hyph;41, No. IV&hyph;D&hyph;3 (summarizing Ethyl's emission control component testing.)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Nineteen small refiners including the National Petroleum Refiners Association all recommended approval. They
concurred in Ethyl's assessment of the economic benefits and reduced refinery and vehicle emissions that would accrue
from the replacement of octane obtained through higher-severity refining with octane obtained from MMT. Several
emphasized that MMT would be especially helpful to small refiners since octane enhancement from MMT requires less
capital investment than other means of increasing octane. Many refiners also pointed out that refinery operations
at lower severity would result in decreased aromatic and benzene emissions from vehicles and increased yield for
each barrel of crude oil refined. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
C. Available Data Meet Previously Used Criteria 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The criteria and statistical tests previously used by EPA to examine durability waiver applications were used only
once by the Agency prior to Ethyl's 1990 application for the use of MMT.
<FOOTCITE>38</FOOTCITE>
 These tests include a variety of approaches to durability data designed to determine whether the additive causes
increases in regulated pollutants and, if so, whether those increases bring about failure of vehicles in the fleet
to meet the standards to which they were certified. While EPA has some concerns regarding the appropriateness of these
criteria and tests for current conditions, the Agency does not intend in this action to hold Ethyl to any new criteria
and/or tests that are not currently in place. Accordingly, the following discussion is addressed primarily to the
results of applying the most critical of the previously used EPA tests.
<FOOTCITE>39</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
38
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The test were used in EPA's examination of Ethyl's 1978 application. For a description of these tests, see EPA's decision
on the application at 43 FR 41424, September 18, 1978.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
39
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
EPA has carefully reviewed Ethyl's application of the test to these data in various combinations and has concluded
that the tests were conscientiously and accurately applied. This review focused particularly upon the application
of the ``integrated emissions test'', the ``cause or contribute'' test, and the overall sign test.
<!-- PJG 0012 frnewline -->
 </FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The earliest set of test results under consideration here (tests of 1988 vehicles submitted with Ethyl's 1990 application)
exhibit the most pronounced MMT-caused emissions increases of the data generated by the applicant (about 0.02 gm/mi
<FOOTCITE>40</FOOTCITE>
, but these increases fall substantially short of failure on the determinative ``cause or contribute'' test
<FOOTCITE>41</FOOTCITE>
 (3 of 8 vehicle models tested fail for HC and 4 of 8 models fail for CO, while 7 of the 8 models tested are required to fail
before the additive fails this overall test on either pollutant). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
40
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Determined by integration of emissions test results gathered over the full range of mileage supplied by the applicant.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
41
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Ethyl's consultant, Systems Applications, Inc., describes this test on page 19 of a report that was included as Appendix
2A in Ethyl's May 9, 1990 application for waiver. This co-called ``cause or contribute'' test, really addresses the
question of whether the additive ``causes'' a failure to meet the certified standard for a regulated pollutant for
each model group and then looks to see if enough model groups failed the test to warrant the conclusion with high confidence
that more than half of the models are caused to fail by operation on the additive.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00069 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
When the larger body of all available and appropriate
<FOOTCITE>42</FOOTCITE>
 long-term emissions data on High-Tech 3000 is evaluated using these previously used EPA tests, the conclusion is
that these increases (averaging 0.02 gm/mi for HC) bring about failure of the ``cause or contribute'' test in only
4 (for HC) or 5 (for CO) of the 19 model groups tested by the applicant and others. Failure of that test
<FOOTCITE>43</FOOTCITE>
 must occur in at least 13 of the 19 model groups examined before the additive is deemed to have failed the overall test
with 90% confidence. Fourteen of 19 must fail before the test is failed at the 95% confidence level.
<FOOTCITE>44</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
42
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Appropriate data are considered to be those collected with Federal Test Procedure (FTP) testing using an experimental
design with a control group and no obvious sources of bias. The data referred to here include the eight 1988 models tested
by Ethyl, the two 1991 models tested by Ford, and the eight 1992 and 1993 models tested by Ethyl.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
43
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
In order for a model to fail the test, emissions from the additive-fueled vehicles must be sufficiently high that then
percent of the represented fleet of that model group using the additive is predicted to exceed the standard beofre
the end of its useful life. The control vehicles must reach this failure rate at a higher mileage than the additive-fueled
vehicles.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
44
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
These ``confidence levels'' correspond, respectively, to the 0.10 and 0.05 significance levels. The significance
level is the probability that a decision to reject the null hypothesis (and find an increase) will be a result of sampling
error and thus be incorrect.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
If the newer technology 1992 and 1993 vehicles tested by the applicant are examined in isolation from the earlier test
programs, the data (with an average HC effect of 0.002 gm/mi) pass the historical tests even more easily than is the
case for the data combinations examined above. None of the nine models failed the ``cause or contribute'' test for
hydrocarbons and only one failed for carbon monoxide. Seven of nine models would have to fail for the additive to fail
the overall sign test at the 90 percent confidence level and eight would have to fail for 95 percent confidence. The
overall conclusion from the above analysis, then, is that Ethyl's additive passes the most critical of the historical
tests with a comfortable margin. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
D. Data on Newer-Technology Vehicles Meet More Stringent Criteria 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Notwithstanding the Agency's conclusion that it would not be appropriate to require Ethyl to satisfy new statistical
tests concerning which it has not been given prior notice and the Agency's decision to evaluate Ethyl's application
primarily according to the previously utilized statistical tests, the Agency nevertheless considers its existing
tests and the criteria that they implement to be obsolete under current conditions.
<FOOTCITE>45</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
45
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The tests are extremely conservative in that they place most of the burden of proof on the Agency rather than on the applicant.
The ``cause or contribute'' test is failed by an engine family only under circumstances where emissions from the family
are so high that an additive_caused increase in some pollutant pushes more than ten percent of the vehicle fleet into
violation of the standard. Moreover, the final sign test that is applied to the model-specific results is failed by
the additive only when it may be concluded with high confidence that more than half of the models in the represented
population would fail the model-specific test. In practical situations with relatively small samples, this sign
test permits a high percentage of the models in the sample to fail before the additive is declared to have failed the
test. These tests, then, may permit the granting of waivers in the face of substantively significant emissions increments
attributable to an additive_increments that would tend to offset the benefits from an increasingly stringent regulatory
program aimed at bringing the nation's most serious air quality problems under control. Agency concerns with these
tests were addressed previously in its decision on Ethyl's 1990 application (57 FR 2535, January 22, 1992) and in (58
FR 64761, December 9, 1993).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Therefore, EPA has gone beyond the historical tests to examine Ethyl's data on the use of the additive with newer technology
vehicles under more stringent criteria of the sort that seem to be warranted by current conditions. For this analysis,
EPA chose to examine the additive's performance against the most stringent of the possible criteria_a requirement
that the additive cause no statistically significant increase in emissions. If one uses a one-sided null hypothesis
that the additive causes no increase in HC emissions, one may employ various statistical tests to examine the credibility
of that hypothesis in light of the test results. One such test is the computer-intensive ``permutation test'' in a
form called an ``approximate randomization'' test.
<FOOTCITE>46</FOOTCITE>
 Application of this test to the full mileage range of HC emissions data from Ethyl's tests of 1992 and 1993 vehicles
results in a failure to discern any ``real'' emissions increase at all_that is, no increase that we may not reasonably
attribute to sampling error rather than to an additive effect on HC in the sampled vehicle population.
<FOOTCITE>47</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
46
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The permutation test is built around the idea that, if the null hypothesis is correct, the increase due to the additive
in the sample is only one member of a distribution of all possible such increases computed from assignments of vehicle
emissions to fuel groups within models. Only if the fuel-related increase from the sample is an extremely unusual
result in theis distribution of possible increases is it reasonable to reject the null hypothesis and conclude that
the additive actually brought about an increase in emissions. The way that this method works in practice is that, on
each iteration of the computer program, the computer randomly rearranges the fuel group assignments among the emission
results within each model group separately. The emission values assigned (for that iteration) to the additive fuel
group are then summed over the entire sample to form the test statistic. This process is repeated a very large number
of times (one million in this case) and the resulting test statistics are tabulated. Only if the same test statistic,
as computed from the empirical sample, exceeds a pre-determined percentage of the simulated test statistics may
we reject the ``no-difference'' hypothesis and conclude with the necessary degree of certainty that an increase
has occurred.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
47
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
This conclusion holds even when the test is performed at the 0.10 significance level used in conducting the statistical
testing on the data from Ethyl's 1978 application. It is important to note that the original Ethyl test fleet of 1988
model year vehicles that are now older than those representing the newest Ethyl data set did not fare as well and, as
mentioned previously, do demonstrate statistically significant increases in HC emissions.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
E. Finding 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Based on all of the information then available concerning the potential effect of use of MMT in unleaded gasoline on
regulated emissions, as submitted by Ethyl and others, the Administrator of EPA determined on November 30, 1994 that,
``Ethyl has satisfied its burden under Clean Air Act 211(f)(4) to establish that use of HiTEC 3000 at the specified
concentration will not cause or contribute to a failure of any emission control device or system (over the useful life
of any vehicle in which such device or system is used) to achieve compliance by the vehicle with the emission standards
with respect to which it has been certified.'' The basis for this determination was described briefly in the Administrator's
November 30, 1994 notice, and has been reviewed in detail above. 
<!-- PJG 0012 frnewline -->
The November 30, 1994 determination was specific to Ethyl's present waiver application. As the Administrator made
clear in the notice announcing the determination, it does not apply to any new application concerning either HiTEC
3000 or MMT in the event that this decision to deny Ethyl's application on the basis of concerns regarding potential
health effects is upheld in any subsequent judicial review. Although Ethyl may be able to sustain its burden under
Section 211(f)(4) in the context of any future waiver application, any such application must include satisfactory
data addressing the effect on vehicles in production at that time and will be evaluated according to the statistical
methods and criteria for evaluation of waiver applications in effect at that time. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00070 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
V. The Onboard Diagnostics Issue 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Prior to the Administrator's November 30, 1994 finding 
<!-- PJG 0012 frnewline -->
concerning emission effects, three auto manufacturers, Ford, 
<!-- PJG 0012 frnewline -->
General Motors (GM), and Chrysler, and the American Automobile 
<!-- PJG 0012 frnewline -->
Manufacturers Association (AAMA), all commented on concerns about 
<!-- PJG 0012 frnewline -->
the impact of the oxidative products of MMT on onboard diagnostic 
<!-- PJG 0012 frnewline -->
(OBD II) systems employing before-catalyst and after-catalyst 
<!-- PJG 0012 frnewline -->
oxygen sensors.
<FOOTCITE>48</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
48
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
An Onboard Diagnostic System, with the present generation commonly known as OBD&hyph;II, monitors the activity
of an automobile's emission control system, primarily the catalytic converter, and alerts the driver via a dashboard
light in the event of a malfunction. Put simply, this aspect of the OBD system functions by utilizing devices before
and after the catalyst which ``sense'' the presence of oxygen. If the catalyst is functioning properly, it will absorb
a certain amount of oxygen and a specified decrease in oxygen content in the exhaust gases can be determined by comparing
the oxygen ``sensed'' before and after the catalyst. If the catalyst is functioning improperly, oxygen storage by
the catalyst is impaired and a drop in exhaust gas oxygen after the catalyst beyond the proper range is ``sensed'' by
the OBD system. 
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
GM concerns regarding the OBD II system were two-fold. Its 
<!-- PJG 0012 frnewline -->
first concern was that since it is known that manganese oxide has 
<!-- PJG 0012 frnewline -->
the ability to store oxygen, a potential problem could occur with 
<!-- PJG 0012 frnewline -->
dual oxygen sensor systems. GM stated that, with manganese oxide 
<!-- PJG 0012 frnewline -->
covering the catalyst and the oxygen sensors, a false oxygen 
<!-- PJG 0012 frnewline -->
storage capacity of the catalyst could be indicated by the OBD II 
<!-- PJG 0012 frnewline -->
system, which could then indicate that the catalyst was still 
<!-- PJG 0012 frnewline -->
working properly while the opposite could be true. GM's second 
<!-- PJG 0012 frnewline -->
concern was that the catalyst would act as a ``filter'' and 
<!-- PJG 0012 frnewline -->
manganese oxide from MMT combustion passing through the exhaust 
<!-- PJG 0012 frnewline -->
system would coat the before-catalyst oxygen sensor and after-catalyst oxygen sensors unevenly, thus causing the
OBD II system 
<!-- PJG 0012 frnewline -->
to malfunction. GM also stated that in the 1994 model year GM 
<!-- PJG 0012 frnewline -->
planned to market two engine families equipped with OBD II 
<!-- PJG 0012 frnewline -->
systems employing before- and after-catalyst oxygen sensors. 
<!-- PJG 0012 frnewline -->
With respect to the automakers' concern that use of MMT 
<!-- PJG 0012 frnewline -->
would adversely affect operation of the OBD II system, on July 
<!-- PJG 0012 frnewline -->
15, 1993, Ethyl submitted data which it believed demonstrated 
<!-- PJG 0012 frnewline -->
that this concern has no basis.
<FOOTCITE>49</FOOTCITE>
 Ethyl stated that no 
<!-- PJG 0012 frnewline -->
production vehicles were then equipped with OBD&hyph;II systems and 
<!-- PJG 0012 frnewline -->
that the primary hardware approach being considered by the 
<!-- PJG 0012 frnewline -->
automobile manufacturers involves the use of exhaust gas oxygen 
<!-- PJG 0012 frnewline -->
(EGO) sensors before and after the catalytic converter to monitor 
<!-- PJG 0012 frnewline -->
converter efficiency. Ethyl further commented that test data 
<!-- PJG 0012 frnewline -->
generated by Ethyl showed that use of the additive would have no 
<!-- PJG 0012 frnewline -->
adverse effect on either the hardware component of these planned 
<!-- PJG 0012 frnewline -->
ODB&hyph;II systems (i.e., the oxygen sensors), or on the catalytic 
<!-- PJG 0012 frnewline -->
converter itself. Ethyl noted that, ``[s]ince these future 
<!-- PJG 0012 frnewline -->
systems are currently under development, it is impossible to 
<!-- PJG 0012 frnewline -->
consider the long term effects of MMT on these systems.'' 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
49
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
See Public Docket A&hyph;93&hyph;26, Number II&hyph;D&hyph;8, Appendix 5.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On November 4, 1994, only 26 days prior to the mandatory 
<!-- PJG 0012 frnewline -->
date for a decision on Ethyl's waiver application, Ford Motor 
<!-- PJG 0012 frnewline -->
Company submitted a report describing bench testing
<FOOTCITE>50</FOOTCITE>
 of 
<!-- PJG 0012 frnewline -->
catalysts, in which Ford measured the oxygen storage capacity of 
<!-- PJG 0012 frnewline -->
catalysts which had been deliberately degraded and then exposed 
<!-- PJG 0012 frnewline -->
to the emissions from MMT-containing fuel. Ford's conclusion 
<!-- PJG 0012 frnewline -->
based on these tests was that the exhaust gas oxygen (EGO) 
<!-- PJG 0012 frnewline -->
sensors would be affected by the deposition of manganese oxides 
<!-- PJG 0012 frnewline -->
associated with MMT use, thus sending incorrect signals to the 
<!-- PJG 0012 frnewline -->
diagnostic control system in the vehicle. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
50
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Bench testing means the testing of components during which time the components are not actually in the vehicle. The
details of this testing can be found in Document II&hyph;D&hyph;56 in Docket A&hyph;93&hyph;26. (An incomplete
preliminary report of this information was submitted to the Agency in Document II&hyph;D&hyph;38, Docket A&hyph;93&hyph;26.)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Although the Agency regarded the concerns expressed by 
<!-- PJG 0012 frnewline -->
Ford in its November 4, 1994 submission regarding the effect of 
<!-- PJG 0012 frnewline -->
MMT use on OBD systems as potentially very important, based on 
<!-- PJG 0012 frnewline -->
the very limited analysis which could be undertaken prior to the 
<!-- PJG 0012 frnewline -->
November 30, 1994 deadline for a decision concerning Ethyl's 
<!-- PJG 0012 frnewline -->
application, the Agency concluded that the limited bench testing 
<!-- PJG 0012 frnewline -->
submitted by Ford did not allow a conclusion concerning the 
<!-- PJG 0012 frnewline -->
likelihood that a significant impact would actually occur during 
<!-- PJG 0012 frnewline -->
vehicle operation. In addition, the Agency had several questions 
<!-- PJG 0012 frnewline -->
regarding the procedures involved in the Ford testing which could 
<!-- PJG 0012 frnewline -->
not be resolved within the available time. The November 30, 1994 
<!-- PJG 0012 frnewline -->
notice announcing the Administrator's determination concerning 
<!-- PJG 0012 frnewline -->
emission effects made it clear that EPA was concerned about this 
<!-- PJG 0012 frnewline -->
issue and would retain the authority to take appropriate action 
<!-- PJG 0012 frnewline -->
in the future pursuant to Clean Air Act Section 211(c). 
<!-- PJG 0012 frnewline -->
EPA met with staff of Ford in February of 1994 in order to 
<!-- PJG 0012 frnewline -->
discuss Ford's concerns raised in its November 4, 1993 
<!-- PJG 0012 frnewline -->
submission. Ford generally expressed the same concerns as had 
<!-- PJG 0012 frnewline -->
been expressed by GM (and discussed above).
<FOOTCITE>51</FOOTCITE>
 According to 
<!-- PJG 0012 frnewline -->
Ford, its testing showed that combustion of gasoline containing 
<!-- PJG 0012 frnewline -->
MMT deposits a layer of manganese oxide on top of the catalyst 
<!-- PJG 0012 frnewline -->
washcoat and that this causes the EGO Sensor to measure a lower 
<!-- PJG 0012 frnewline -->
oxygen level, thereby indicating a higher oxygen storage capacity 
<!-- PJG 0012 frnewline -->
than that which would be indicated by the catalyst without MMT. 
<!-- PJG 0012 frnewline -->
As a result, a malfunctioning catalyst might not be detected. 
<!-- PJG 0012 frnewline -->
Ford expressed particular concern because it had just introduced 
<!-- PJG 0012 frnewline -->
three 1994 model year vehicle families employing OBD&hyph;II, whereas 
<!-- PJG 0012 frnewline -->
the other automakers will not have systems out until the 1996 
<!-- PJG 0012 frnewline -->
model year. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
51
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Ford's concerns are discussed in more detail in a memo to docket A&hyph;93&hyph;26, with an attachment submitted
to the Agency entitled ``Section 211(c) Impacts of MMT''.
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Recently, on May 3, 1993, Ford submitted additional 
<!-- PJG 0012 frnewline -->
information which the Agency is currently reviewing. This new 
<!-- PJG 0012 frnewline -->
information appears to provide further evidence to substantiate 
<!-- PJG 0012 frnewline -->
the concerns expressed by Ford regarding the impact of MMT use on 
<!-- PJG 0012 frnewline -->
OBD systems. Unlike the previously submitted Ford data, the new 
<!-- PJG 0012 frnewline -->
data address an actual production vehicle fitted with a failed 
<!-- PJG 0012 frnewline -->
catalyst and the effect use of MMT had on the OBD system's 
<!-- PJG 0012 frnewline -->
ability to detect failure of the catalyst. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00071 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Agency is continuing to investigate the question of the 
<!-- PJG 0012 frnewline -->
potential impact of use of MMT in unleaded gasoline on OBD 
<!-- PJG 0012 frnewline -->
systems. If after further investigation EPA concludes that the 
<!-- PJG 0012 frnewline -->
concerns expressed by the vehicle manufacturers are warranted, 
<!-- PJG 0012 frnewline -->
EPA intends to initiate an appropriate rulemaking under Section 
<!-- PJG 0012 frnewline -->
211(c). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
VI. Manganese Health Assessment
<FOOTCITE>52</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
52
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The assessment presented here is taken from ``Reevaluation of Inhalation Health Risks Associated with Methylcyclopentadienyl
Manganese Tricarbonyl (MMT) in Gasoline'' (United States Environmental Protection Agency, 1994b) which can be
found in the docket in its entirety. 
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. Introduction 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In 1990, the EPA Office of Research and Development (ORD) assessed the potential health risks associated with the
use of 
<!-- PJG 0012 frnewline -->
methylcyclopentadienyl manganese tricarbonyl (MMT) as an additive 
<!-- PJG 0012 frnewline -->
in unleaded gasoline (U.S. Environmental Protection Agency, 
<!-- PJG 0012 frnewline -->
1990).
<FOOTCITE>53</FOOTCITE>
 Later, ORD (Preuss, 1991) reaffirmed its assessment 
<!-- PJG 0012 frnewline -->
after considering a resubmitted waiver application for MMT from 
<!-- PJG 0012 frnewline -->
Ethyl Corporation. As identified in earlier ORD evaluations 
<!-- PJG 0012 frnewline -->
(U.S. Environmental Protection Agency, 1990; Preuss, 1991), a key 
<!-- PJG 0012 frnewline -->
issue is the potential health risk associated with inhalation 
<!-- PJG 0012 frnewline -->
exposure to manganese tetroxide (Mn
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
), which is the primary by-product resulting from the combustion of MMT in gasoline. New 
<!-- PJG 0012 frnewline -->
information on manganese (Mn) health effects and exposure is 
<!-- PJG 0012 frnewline -->
incorporated in this revised risk assessment. (United States 
<!-- PJG 0012 frnewline -->
Environmental Protection Agency, 1994b) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
53
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The many references in this section of the decision dealing with manganese health effects are referred to in parentheses
and listed at the end of this section in subsection E.
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This reevaluation has four components: (1) a health effects 
<!-- PJG 0012 frnewline -->
assessment, (2) an exposure assessment, (3) a risk 
<!-- PJG 0012 frnewline -->
characterization relating the first two, and (4) a summary and 
<!-- PJG 0012 frnewline -->
conclusions. This evaluation summarizes earlier ORD assessments 
<!-- PJG 0012 frnewline -->
and incorporates information from certain other major new reports 
<!-- PJG 0012 frnewline -->
and analyses.
<FOOTCITE>54</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
54
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The reader is referred to the appendices of the full EPA/ORD reevaluation for more detailed background information.
This report, ``Reevaluation of Inhalation Health Risks Associated with Methylcyclopentadienyl Manganese Tricarbonyl
(MMT) in Gasoline'', can be found in its entirety, including the appendices, in docket A&hyph;91&hyph;46. Appendix
A presents dose-response analyses, Appendix B presents an exposure assessment, and Appendix C contains the current
verified Mn inhalation reference concentration (RfC) as it appears in the U.S. EPA Integrated Risk Information System
(IRIS, 1993).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00072 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Health Effects Assessment 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
1. Background 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The toxicity of Mn varies according to the route of 
<!-- PJG 0012 frnewline -->
exposure. By ingestion, Mn has relatively low toxicity at 
<!-- PJG 0012 frnewline -->
typical exposure levels due in part to a low rate of absorption 
<!-- PJG 0012 frnewline -->
from the gastrointestinal tract and in part to efficient 
<!-- PJG 0012 frnewline -->
regulation by homeostatic mechanisms. Manganese is considered a 
<!-- PJG 0012 frnewline -->
nutritionally essential trace element and is required for certain 
<!-- PJG 0012 frnewline -->
enzymes important for normal functioning of the central nervous 
<!-- PJG 0012 frnewline -->
system and other body organs. However, by inhalation, Mn has 
<!-- PJG 0012 frnewline -->
been known since the early 1800s to be toxic to workers. It 
<!-- PJG 0012 frnewline -->
should be noted that Mn occupational studies predominantly (and 
<!-- PJG 0012 frnewline -->
sometimes exclusively) involve men. Neurobehavioral, 
<!-- PJG 0012 frnewline -->
respiratory, and reproductive effects are the primary features of 
<!-- PJG 0012 frnewline -->
excessive occupational exposure to Mn. Manganism is 
<!-- PJG 0012 frnewline -->
characterized by various psychiatric and movement disorders, with 
<!-- PJG 0012 frnewline -->
some general resemblance to Parkinson's disease in terms of 
<!-- PJG 0012 frnewline -->
difficulties in the fine control of some movements, lack of 
<!-- PJG 0012 frnewline -->
facial expression, and involvement of underlying neuroanatomical 
<!-- PJG 0012 frnewline -->
and neurochemical factors. Neurobehavioral effects of Mn 
<!-- PJG 0012 frnewline -->
intoxication are generally more clinically prominent than 
<!-- PJG 0012 frnewline -->
respiratory or reproductive effects. However, respiratory 
<!-- PJG 0012 frnewline -->
effects (e.g., pneumonitis) and reproductive dysfunction (e.g., 
<!-- PJG 0012 frnewline -->
reduced libido) are also frequently reported features of 
<!-- PJG 0012 frnewline -->
occupational Mn intoxication. The available evidence is 
<!-- PJG 0012 frnewline -->
inadequate to determine whether or not Mn is carcinogenic; some 
<!-- PJG 0012 frnewline -->
reports suggest that it may even be protective against cancer. 
<!-- PJG 0012 frnewline -->
Based on this mixed but insufficient evidence, EPA has placed Mn 
<!-- PJG 0012 frnewline -->
in a Group D weight-of-evidence category, which signifies that it 
<!-- PJG 0012 frnewline -->
is not classifiable as to human carcinogenicity. Given these 
<!-- PJG 0012 frnewline -->
features of Mn toxicity, the health assessment focuses on the 
<!-- PJG 0012 frnewline -->
potential for chronic noncancer effects. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Various epidemiological studies of male workers exposed to 
<!-- PJG 0012 frnewline -->
Mn at average levels below the current American Conference of 
<!-- PJG 0012 frnewline -->
Governmental Industrial Hygienists Threshold Limit Value (TLV) (5 
<!-- PJG 0012 frnewline -->
mg/m
<FOOTCITE>3</FOOTCITE>

<FOOTCITE>)</FOOTCITE>

<FOOTCITE></FOOTCITE>

<FOOTCITE>55</FOOTCITE>
 have shown neurobehavioral, reproductive, and 
<!-- PJG 0012 frnewline -->
respiratory effects, both by objective testing methods and by 
<!-- PJG 0012 frnewline -->
workers' self-reported symptoms on questionnaires. 
<!-- PJG 0012 frnewline -->
Neurobehavioral effects generally have reflected disturbances in 
<!-- PJG 0012 frnewline -->
the control of hand movements (e.g., tremor, reduced hand 
<!-- PJG 0012 frnewline -->
steadiness) and/or the speed of movement (e.g., longer reaction 
<!-- PJG 0012 frnewline -->
time, slower finger-tapping speed). Reproductive effects have 
<!-- PJG 0012 frnewline -->
included a decrease in the number of children born to Mn-exposed 
<!-- PJG 0012 frnewline -->
workers (compared to matched controls) and various self-reported 
<!-- PJG 0012 frnewline -->
symptoms of sexual dysfunction. In recent studies at low to 
<!-- PJG 0012 frnewline -->
moderate occupational exposure levels, respiratory effects have 
<!-- PJG 0012 frnewline -->
been reflected primarily in self-reported symptoms of respiratory 
<!-- PJG 0012 frnewline -->
tract illnesses rather than in differences between objective 
<!-- PJG 0012 frnewline -->
pulmonary function measurements in Mn-exposed and control 
<!-- PJG 0012 frnewline -->
workers. However, the lack of studies using more sensitive 
<!-- PJG 0012 frnewline -->
investigational methods and the existence of some limited 
<!-- PJG 0012 frnewline -->
evidence from an epidemiological study of school children raise a 
<!-- PJG 0012 frnewline -->
degree of concern about pulmonary function effects in relation to 
<!-- PJG 0012 frnewline -->
lower level Mn exposure. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
55
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The American Conference of Governmental Industrial Hygienists (1992) has given notice of intent to lower the TLV
to 0.2 mg/m3.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The precise mechanisms of Mn neurotoxicity are not well 
<!-- PJG 0012 frnewline -->
understood, but it appears that Mn can affect several different 
<!-- PJG 0012 frnewline -->
aspects of central nervous system (CNS) function and structure. 
<!-- PJG 0012 frnewline -->
Some experimental evidence suggests that the mechanisms of Mn 
<!-- PJG 0012 frnewline -->
toxicity may depend on the oxidation state of Mn. However, both 
<!-- PJG 0012 frnewline -->
the trivalent form (Mn
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3+
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
) and the divalent form (Mn
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
2+
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
) have been 
<!-- PJG 0012 frnewline -->
demonstrated to be neurotoxic.
<FOOTCITE>56</FOOTCITE>
 Also, both forms of Mn can 
<!-- PJG 0012 frnewline -->
cross the blood-brain barrier, although research suggests that 
<!-- PJG 0012 frnewline -->
Mn
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3+
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 is predominantly transported bound to the protein 
<!-- PJG 0012 frnewline -->
transferrin (Aschner and Gannon, 1994), whereas Mn
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
2+
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 may enter 
<!-- PJG 0012 frnewline -->
the brain independently of such a transport mechanism (Murphy et 
<!-- PJG 0012 frnewline -->
al., 1991). Unlike ingested Mn, inhaled Mn is transported 
<!-- PJG 0012 frnewline -->
directly from the respiratory system to the vicinity of the brain 
<!-- PJG 0012 frnewline -->
before its first pass by the liver. Depending on the form of Mn 
<!-- PJG 0012 frnewline -->
inhaled, its conversion to other oxidation states (e.g., 
<!-- PJG 0012 frnewline -->
oxidation of Mn
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
2+
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 to Mn
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3+
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 or reduction of Mn
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
4+
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 to Mn
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3+
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
), and its 
<!-- PJG 0012 frnewline -->
ability to enter the brain (through a protein transport mechanism 
<!-- PJG 0012 frnewline -->
or otherwise), it is quite possible that a significant fraction 
<!-- PJG 0012 frnewline -->
of even small amounts of inhaled Mn would be able to reach target 
<!-- PJG 0012 frnewline -->
sites in the CNS. Thus, the apparently greater toxicity of 
<!-- PJG 0012 frnewline -->
inhaled versus ingested Mn may reflect important pharmacodynamic 
<!-- PJG 0012 frnewline -->
and pharmacokinetic differences of Mn that enters the body by 
<!-- PJG 0012 frnewline -->
different routes. A more definitive understanding of these 
<!-- PJG 0012 frnewline -->
issues will require more empirical information. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
56
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Various elements can exist in more than one form of charged atom, depending on the number of negatively charged and
positively charged particles contained in the atom. Manganese is one such element where, depending on the number
of charged particles associated with the atom, the atom may have a net charge of two or three ``plus'' charges resulting
in a ``divalent'' or ``trivalent'' form, respectively.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
2. Earlier Assessments 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Earlier ORD health assessments have been based on the RfC, 
<!-- PJG 0012 frnewline -->
which is defined as an estimate (with uncertainty spanning about 
<!-- PJG 0012 frnewline -->
an order of magnitude) of a continuous inhalation exposure level 
<!-- PJG 0012 frnewline -->
for the human population (including sensitive subpopulations) 
<!-- PJG 0012 frnewline -->
that is likely to be without appreciable risk of deleterious 
<!-- PJG 0012 frnewline -->
noncancer effects during a lifetime. The basic procedure for 
<!-- PJG 0012 frnewline -->
derivation of an RfC entails identifying a no-observed-adverse- 
<!-- PJG 0012 frnewline -->
effect level (NOAEL) and a lowest-observed-adverse-effect level 
<!-- PJG 0012 frnewline -->
(LOAEL) from a ``principal'' study, generally defined as the 
<!-- PJG 0012 frnewline -->
available study that best defines the highest NOAEL or lowest 
<!-- PJG 0012 frnewline -->
LOAEL for the most sensitive endpoint affected by a chemical. 
<!-- PJG 0012 frnewline -->
When an investigation of occupationally exposed humans is the 
<!-- PJG 0012 frnewline -->
principal study (as in the case of the Mn RfC), the NOAEL or 
<!-- PJG 0012 frnewline -->
LOAEL is adjusted for differences in ventilation rates and 
<!-- PJG 0012 frnewline -->
exposure durations between the occupational exposure scenario 
<!-- PJG 0012 frnewline -->
(10 m3 air breathed per 8-h workday, 5 days/week) and the 
<!-- PJG 0012 frnewline -->
``general public'' scenario (20 m3 air breathed per 24-h day, 
<!-- PJG 0012 frnewline -->
7 days/week). The adjusted NOAEL or LOAEL is then divided by 
<!-- PJG 0012 frnewline -->
uncertainty factors and a modifying factor. In the case of the 
<!-- PJG 0012 frnewline -->
original (1990) RfC for Mn, uncertainty factors of 10 each were 
<!-- PJG 0012 frnewline -->
used for extrapolating from a healthy worker population to the 
<!-- PJG 0012 frnewline -->
general population (including sensitive subpopulations) and for 
<!-- PJG 0012 frnewline -->
extrapolating from a LOAEL to a NOAEL. Also, an uncertainty 
<!-- PJG 0012 frnewline -->
factor of 3 (approximately one-half of 10 on a log scale) was 
<!-- PJG 0012 frnewline -->
used for extrapolating from subchronic to chronic exposure. A 
<!-- PJG 0012 frnewline -->
modifying factor of 3 was used because of statements by the 
<!-- PJG 0012 frnewline -->
authors of the principal study (Roels et al., 1987) that past 
<!-- PJG 0012 frnewline -->
exposure levels of workers in the subject study were probably 
<!-- PJG 0012 frnewline -->
lower than those measured at the time the study was conducted. 
<!-- PJG 0012 frnewline -->
The resulting RfC of 0.4 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
g Mn/m3 was used for the earlier ORD 
<!-- PJG 0012 frnewline -->
risk assessment (U.S. Environmental Protection Agency, 1990) and 
<!-- PJG 0012 frnewline -->
was entered on EPA's IRIS computer database of human health risk 
<!-- PJG 0012 frnewline -->
and regulatory information in December 1990. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00073 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3. 1993 Revised RfC 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The original RfC for Mn was revised, in part, because newer 
<!-- PJG 0012 frnewline -->
information supplied in conjunction with the resubmittal of the 
<!-- PJG 0012 frnewline -->
MMT waiver application by Ethyl indicated that the workers' 
<!-- PJG 0012 frnewline -->
exposure levels in the principal study had probably not increased 
<!-- PJG 0012 frnewline -->
over time, and thus the modifying factor could be ``eliminated'' 
<!-- PJG 0012 frnewline -->
(i.e., set equal to 1). Another reason for revising the original 
<!-- PJG 0012 frnewline -->
RfC was that more recent studies (Roels et al., 1992; Mergler et 
<!-- PJG 0012 frnewline -->
al., 1994) provided additional evidence of health effects in 
<!-- PJG 0012 frnewline -->
workers at relatively low airborne concentrations of Mn. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Independently of their earlier study of Mn-exposed workers (Roels et al., 1987), Roels et al. (1992) conducted a cross-sectional
study of neurobehavioral and other endpoints in another group of workers from a different factory-namely, 92 male
alkaline-battery plant workers exposed to manganese dioxide (MnO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
) dust_who were compared to a matched control group of 101 male workers without industrial Mn exposure. The geometric
mean 
<!-- PJG 0012 frnewline -->
occupational-lifetime integrated respirable dust concentration 
<!-- PJG 0012 frnewline -->
was 793 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
g Mn/m3 &times; years (range: 40 to 4,433). The equivalent 
<!-- PJG 0012 frnewline -->
value for total dust was 3,505 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
g Mn/m3 &times; years (range: 191 to 
<!-- PJG 0012 frnewline -->
27,465). The authors noted that the monitored concentrations 
<!-- PJG 0012 frnewline -->
were representative of the usual exposures of the workers because 
<!-- PJG 0012 frnewline -->
work practices had not changed during the last 15 years of the 
<!-- PJG 0012 frnewline -->
plant's operation. No data on particle size or chemical purity 
<!-- PJG 0012 frnewline -->
were provided in the report by Roels et al. (1992), but based on 
<!-- PJG 0012 frnewline -->
information provided by Roels et al. (1992) and Roels (1993), the 
<!-- PJG 0012 frnewline -->
median cut point for the respirable dust fraction was 5 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
m 
<!-- PJG 0012 frnewline -->
aerodynamic diameter. The respirable fraction is more 
<!-- PJG 0012 frnewline -->
representative of the toxicologically significant particles 
<!-- PJG 0012 frnewline -->
(i.e., the smaller particles that are inhaled and deposit 
<!-- PJG 0012 frnewline -->
predominantly in the lower respiratory tract). Total dust 
<!-- PJG 0012 frnewline -->
measurements comprised the respirable dust as well as larger 
<!-- PJG 0012 frnewline -->
particles that deposit predominantly in the nose and throat 
<!-- PJG 0012 frnewline -->
region (via nasal breathing) and would be cleared more rapidly 
<!-- PJG 0012 frnewline -->
from the respiratory tract than the smaller particles retained in 
<!-- PJG 0012 frnewline -->
the lower regions. Therefore, the respirable dust measurements 
<!-- PJG 0012 frnewline -->
were considered to be a more accurate indicator of exposure in 
<!-- PJG 0012 frnewline -->
relation to the observed health effects. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Manganese-exposed workers in the 1992 study by Roels et al. 
<!-- PJG 0012 frnewline -->
performed significantly worse than matched controls on several 
<!-- PJG 0012 frnewline -->
measures of neurobehavioral function, particularly visual 
<!-- PJG 0012 frnewline -->
reaction time, eye-hand coordination, and hand steadiness. 
<!-- PJG 0012 frnewline -->
Similar neurobehavioral impairments were also found in the 
<!-- PJG 0012 frnewline -->
earlier study by Roels et al. (1987) of a different occupational 
<!-- PJG 0012 frnewline -->
population exposed to mixed Mn oxides and salts at approximately 
<!-- PJG 0012 frnewline -->
the same levels of total dust (respirable dust was not measured). 
<!-- PJG 0012 frnewline -->
In addition, a recent study in Canada by Mergler et al. (1994) 
<!-- PJG 0012 frnewline -->
indicated that, among other effects, performance on tests of the 
<!-- PJG 0012 frnewline -->
ability to make rapid alternating hand movements, to maintain 
<!-- PJG 0012 frnewline -->
hand steadiness, and to perform other aspects of fine motor 
<!-- PJG 0012 frnewline -->
control was significantly worse, compared to matched controls, in 
<!-- PJG 0012 frnewline -->
workers who were exposed to even lower concentrations of 
<!-- PJG 0012 frnewline -->
respirable dust (35 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
g Mn/m3 at the time of the study). If 
<!-- PJG 0012 frnewline -->
Mergler et al. had included information on integrated past 
<!-- PJG 0012 frnewline -->
exposure levels (which they have since provided to ORD in a 
<!-- PJG 0012 frnewline -->
preliminary form not yet submitted for publication), their study 
<!-- PJG 0012 frnewline -->
would have provided a fivefold lower LOAEL for the derivation of 
<!-- PJG 0012 frnewline -->
the RfC. In addition, reports of a Swedish study of Mn-exposed 
<!-- PJG 0012 frnewline -->
steel workers (Iregren, 1990; Wennberg et al., 1991, 1992) 
<!-- PJG 0012 frnewline -->
provided compelling evidence of comparable neurobehavioral 
<!-- PJG 0012 frnewline -->
impairments, including slower reaction time and finger-tapping 
<!-- PJG 0012 frnewline -->
speed. The median total dust concentration in the Swedish study 
<!-- PJG 0012 frnewline -->
was 140 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
g Mn/m3, with respirable dust reported as constituting 
<!-- PJG 0012 frnewline -->
20 to 80% of individual workers' total dust exposures. Thus, the 
<!-- PJG 0012 frnewline -->
LOAEL from this study would be somewhat lower than that from 
<!-- PJG 0012 frnewline -->
Roels et al. (1992), but the less fully characterized exposure 
<!-- PJG 0012 frnewline -->
histories in the Swedish study made it more appropriate as a 
<!-- PJG 0012 frnewline -->
supporting (rather than principal) study for deriving the Mn RfC. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Taken together, the above epidemiological studies provide a 
<!-- PJG 0012 frnewline -->
consistent pattern of evidence indicating that neurotoxicity is 
<!-- PJG 0012 frnewline -->
associated with low-level occupational Mn exposure. The fact 
<!-- PJG 0012 frnewline -->
that speed and coordination of motor function are especially 
<!-- PJG 0012 frnewline -->
impaired is particularly noteworthy, given its consistency with 
<!-- PJG 0012 frnewline -->
other epidemiological, clinical, and experimental animal evidence 
<!-- PJG 0012 frnewline -->
of higher concentration Mn intoxication. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Differences among these studies in the duration of workers' 
<!-- PJG 0012 frnewline -->
exposure to Mn raise another issue of relevance to this 
<!-- PJG 0012 frnewline -->
discussion. In the Roels et al. (1992) study, the mean period of 
<!-- PJG 0012 frnewline -->
exposure was 5.3 years (range: 0.2 to 17.7 years). In the other 
<!-- PJG 0012 frnewline -->
studies, the mean durations of exposure were longer: 7.1 years 
<!-- PJG 0012 frnewline -->
in Roels et al. (1987), 9.9 years in Iregren (1990), and 16.7 
<!-- PJG 0012 frnewline -->
years in Mergler et al. (1994). The indications of lower LOAELs 
<!-- PJG 0012 frnewline -->
in the Canadian and Swedish studies suggest that neurobehavioral 
<!-- PJG 0012 frnewline -->
effects might occur at lower concentrations of Mn if the exposure 
<!-- PJG 0012 frnewline -->
periods were longer. In addition, the age of the workers may be 
<!-- PJG 0012 frnewline -->
an important factor in interpreting these findings. The oldest 
<!-- PJG 0012 frnewline -->
worker in the Roels et al. (1992) study was less than 50 years 
<!-- PJG 0012 frnewline -->
old; also, the average age in that study was only 31.3 years, 
<!-- PJG 0012 frnewline -->
versus 34.3 years in Roels et al. (1987), 43.4 years in Mergler 
<!-- PJG 0012 frnewline -->
et al. (1994), and 46.4 years in Iregren (1990). These points 
<!-- PJG 0012 frnewline -->
suggest that longer exposure and/or testing later in life might 
<!-- PJG 0012 frnewline -->
result in the detection of effects at lower concentrations than 
<!-- PJG 0012 frnewline -->
is possible after shorter periods of exposure and/or in younger 
<!-- PJG 0012 frnewline -->
workers. On the other hand, it is also evident from these 
<!-- PJG 0012 frnewline -->
studies that a much shorter period than a full lifetime of 
<!-- PJG 0012 frnewline -->
occupational Mn exposure may be sufficient to induce Mn 
<!-- PJG 0012 frnewline -->
neurotoxicity. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00074 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As Roels et al. (1992) and other investigators have noted, a threshold for the neurotoxic effects of Mn has not been
reported in the epidemiological literature. Therefore, instead of a NOAEL, a LOAEL was obtained from the study by
Roels et al. (1992) by dividing the geometric mean integrated respirable dust concentration (793 &mu;g Mn/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 &times; years) by the average period of 
<!-- PJG 0012 frnewline -->
worker exposure (5.3 years) to eliminate time (in years) from the time-weighted average, thereby yielding a LOAEL
of 150 &mu;g Mn/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. 
<!-- PJG 0012 frnewline -->
(The geometric mean concentration was used to represent the average exposure because the workers' exposure measurements
were log-normally distributed, and the arithmetic mean exposure period was used because it was the only value reported
by Roels et al. (1992).) The workplace-based LOAEL of 150 &mu;g Mn/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 was then adjusted for nonoccupational lifetime exposure by multiplying it by (1) the quotient of 10 m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
/day divided by 20 m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
/day (for worker versus nonworker ventilation rates) and (2) the quotient of 5 days divided by 7 days (for work week
versus full week). The 
<!-- PJG 0012 frnewline -->
resulting adjusted LOAEL, labeled the human equivalent concentration (HEC), was 50 &mu;g Mn/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, which was then divided by a total uncertainty factor of 1,000 to yield an RfC of 0.05 &mu;g/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. 
<!-- PJG 0012 frnewline -->
The total uncertainty factor of 1,000 incorporated the following 
<!-- PJG 0012 frnewline -->
factors: 10 to protect sensitive individuals; 10 for using a 
<!-- PJG 0012 frnewline -->
LOAEL in lieu of a NOAEL; and a composite factor of 10 for 
<!-- PJG 0012 frnewline -->
database limitations reflecting the less-than-chronic periods of 
<!-- PJG 0012 frnewline -->
exposure and the lack of reproductive and developmental toxicity 
<!-- PJG 0012 frnewline -->
data, as well as potential but unquantified differences in the 
<!-- PJG 0012 frnewline -->
toxicity of different forms of Mn. A modifying factor was not 
<!-- PJG 0012 frnewline -->
used (i.e., it was set equal to 1). 
<!-- PJG 0012 frnewline -->
Each RfC is assigned an overall rating of low, medium, or 
<!-- PJG 0012 frnewline -->
high confidence level, based on two subsidiary confidence ratings 
<!-- PJG 0012 frnewline -->
reflecting the quality of the evidence from the principal studies 
<!-- PJG 0012 frnewline -->
and the quality of the overall database for the chemical in 
<!-- PJG 0012 frnewline -->
question, respectively. The revised Mn RfC was assigned a medium 
<!-- PJG 0012 frnewline -->
level of confidence. The evidence for the neurobehavioral 
<!-- PJG 0012 frnewline -->
effects of low-level Mn exposure by inhalation was compelling and 
<!-- PJG 0012 frnewline -->
consistent across several well-conducted studies. However, the 
<!-- PJG 0012 frnewline -->
limited duration of exposure and the lack of a NOAEL for 
<!-- PJG 0012 frnewline -->
neurotoxicity in any of the principal or supporting studies 
<!-- PJG 0012 frnewline -->
prevented assigning a confidence level greater than medium. 
<!-- PJG 0012 frnewline -->
Also, the lack of definitive data on the concentration-response 
<!-- PJG 0012 frnewline -->
relationship and on the potential reproductive and developmental 
<!-- PJG 0012 frnewline -->
toxicity of inhaled Mn limited the degree of confidence in the 
<!-- PJG 0012 frnewline -->
database to a medium rating. Virtually all of the human health 
<!-- PJG 0012 frnewline -->
evidence is based on healthy, adult male workers. No known 
<!-- PJG 0012 frnewline -->
studies have investigated human female reproductive function, and 
<!-- PJG 0012 frnewline -->
even though male worker reproductive function is known to be 
<!-- PJG 0012 frnewline -->
affected by Mn exposure, it has not received adequate 
<!-- PJG 0012 frnewline -->
investigation. The limited available information concerning the 
<!-- PJG 0012 frnewline -->
developmental toxicity of inhaled Mn suggests the possibility 
<!-- PJG 0012 frnewline -->
that prenatal exposure of laboratory rodents to MnO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (via the air 
<!-- PJG 0012 frnewline -->
supplied to the pregnant mother) may depress neurobehavioral 
<!-- PJG 0012 frnewline -->
activity in neonatal rats and that continued postnatal exposure 
<!-- PJG 0012 frnewline -->
of the pups may intensify this depression. In addition, several 
<!-- PJG 0012 frnewline -->
studies have demonstrated alterations in neurochemical (dopamine) 
<!-- PJG 0012 frnewline -->
levels in young mice and rats exposed during early postnatal 
<!-- PJG 0012 frnewline -->
development to Mn via other routes. Thus, the potential for 
<!-- PJG 0012 frnewline -->
developmental toxicity due to Mn exposure exists. The 
<!-- PJG 0012 frnewline -->
concentrations and durations of exposure sufficient to induce 
<!-- PJG 0012 frnewline -->
such effects are not known. Although adequate epidemiological 
<!-- PJG 0012 frnewline -->
studies of children and the elderly have not been conducted, it 
<!-- PJG 0012 frnewline -->
is known that certain populations, such as children, pregnant 
<!-- PJG 0012 frnewline -->
women, elderly persons, iron- or calcium-deficient individuals, 
<!-- PJG 0012 frnewline -->
and individuals with liver impairment, may have an increased 
<!-- PJG 0012 frnewline -->
potential for excessive Mn body burdens due to increased 
<!-- PJG 0012 frnewline -->
absorption or altered clearance mechanisms. 
<!-- PJG 0012 frnewline -->
Another concern raised by the lack of studies involving 
<!-- PJG 0012 frnewline -->
longer periods of exposure and/or older subjects is that the 
<!-- PJG 0012 frnewline -->
compensatory or reserve capacity of certain neurological 
<!-- PJG 0012 frnewline -->
mechanisms may be stressed by Mn exposure earlier in life, with 
<!-- PJG 0012 frnewline -->
manifestations of impairments only becoming evident much later, 
<!-- PJG 0012 frnewline -->
perhaps at a geriatric stage. One reason for the latter concern 
<!-- PJG 0012 frnewline -->
is that Parkinson's disease is typically a geriatric disease in 
<!-- PJG 0012 frnewline -->
which symptoms are only seen when the loss of brain cells that 
<!-- PJG 0012 frnewline -->
produce dopamine (which is also apparently involved in Mn 
<!-- PJG 0012 frnewline -->
toxicity) reaches 80% or more. Indeed, some neurologists think 
<!-- PJG 0012 frnewline -->
that a long latency period of perhaps several decades may precede 
<!-- PJG 0012 frnewline -->
various parkinsonian syndromes. These points lead to a concern 
<!-- PJG 0012 frnewline -->
that if Mn reduces the compensatory or reserve capacity of the 
<!-- PJG 0012 frnewline -->
nervous system, parkinsonian-type effects might occur earlier in 
<!-- PJG 0012 frnewline -->
life than they would otherwise. Thus, several questions remain 
<!-- PJG 0012 frnewline -->
to be answered before higher confidence in the accuracy of the 
<!-- PJG 0012 frnewline -->
RfC can be achieved. 
<!-- PJG 0012 frnewline -->
The two studies of Roels et al. (1992, 1987) were considered coprincipal studies for the derivation of the revised
RfC, with supporting evidence in the reports of Mergler et al. (1994), Iregren (1990), and Wennberg et al. (1991, 1992).
Given the fact that these studies involved exposure to various oxides and salts of Mn, the RfC is designated as applying
to Mn and Mn compounds 
<!-- PJG 0012 frnewline -->
(including Mn
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
). The previous RfC of 0.4 &mu;g Mn/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 applied to Mn only, due to undifferentiated forms of Mn in the principal 
<!-- PJG 0012 frnewline -->
study. Given that different forms of metals may have different toxic properties (due to different oxidation states,
different solubilities, and possibly other factors), it is likely that different compounds of Mn vary in toxicity.
However, sufficient data on the comparative toxicity of various compounds of Mn are not available to judge the relative
toxicity of Mn
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 specifically. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00075 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As noted above, Mn affects multiple organ systems, including 
<!-- PJG 0012 frnewline -->
the respiratory and reproductive systems as well as the CNS. 
<!-- PJG 0012 frnewline -->
However, because the only available evidence suggests that the 
<!-- PJG 0012 frnewline -->
CNS is the most sensitive target for Mn toxicity, neurobehavioral 
<!-- PJG 0012 frnewline -->
endpoints were the focus of the RfC derivation. Although other 
<!-- PJG 0012 frnewline -->
types of effects remain a concern, it is presumed, based on the 
<!-- PJG 0012 frnewline -->
limited data now available, that protecting against neurotoxicity 
<!-- PJG 0012 frnewline -->
provides protection against these other, apparently less 
<!-- PJG 0012 frnewline -->
sensitive endpoints. 
<!-- PJG 0012 frnewline -->
In revising the RfC for Mn, a draft version was subjected to 
<!-- PJG 0012 frnewline -->
peer review by external experts (from academic and non-EPA 
<!-- PJG 0012 frnewline -->
governmental institutions) as well as internal experts. 
<!-- PJG 0012 frnewline -->
Following this peer review, a further-revised version was 
<!-- PJG 0012 frnewline -->
submitted to and verified by an EPA-wide RfD/RfC work group in 
<!-- PJG 0012 frnewline -->
September 1993. The current RfC for Mn was made available 
<!-- PJG 0012 frnewline -->
through IRIS in early November 1993 through two mechanisms. A 
<!-- PJG 0012 frnewline -->
special notice beginning November 1 in the news section of EPA's 
<!-- PJG 0012 frnewline -->
internal IRIS2 database announced the availability of a hard copy 
<!-- PJG 0012 frnewline -->
of the text to EPA requesters who contacted the Risk Information 
<!-- PJG 0012 frnewline -->
Hotline; also, the text was obtainable through the National 
<!-- PJG 0012 frnewline -->
Library of Medicine's publicly accessible on-line computer 
<!-- PJG 0012 frnewline -->
database, TOXNET, beginning November 10, 1993. It also became 
<!-- PJG 0012 frnewline -->
available on line via the EPA IRIS database beginning December 1, 
<!-- PJG 0012 frnewline -->
1993.
<FOOTCITE>57</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
57
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The complete text of the revised RfC as it exists on IRIS2 may be found in Appendix C in the docket. 
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
4. Alternative Approaches to Deriving RfCs 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
After the revised RfC for Mn became available to the public, 
<!-- PJG 0012 frnewline -->
Ethyl Corporation and other interested parties submitted comments 
<!-- PJG 0012 frnewline -->
on the RfC and issues related to it. One of the primary comments 
<!-- PJG 0012 frnewline -->
concerned the availability of various statistical techniques for 
<!-- PJG 0012 frnewline -->
deriving a NOAEL from the study by Roels et al. (1992) and/or 
<!-- PJG 0012 frnewline -->
from supplementary data for that study provided to ORD by Roels 
<!-- PJG 0012 frnewline -->
(1993). In response to Ethyl Corporation's request that EPA 
<!-- PJG 0012 frnewline -->
consider alternative approaches to analyzing these data and 
<!-- PJG 0012 frnewline -->
deriving an RfC for Mn, further analyses of the subject data were 
<!-- PJG 0012 frnewline -->
undertaken using a variety of statistical methods. These 
<!-- PJG 0012 frnewline -->
approaches may be identified as (1) conventional NOAEL- or LOAEL- 
<!-- PJG 0012 frnewline -->
based analyses, (2) ``no statistical significance of trend'' 
<!-- PJG 0012 frnewline -->
(NOSTASOT) analyses of the type described by Tukey et al. (1985), 
<!-- PJG 0012 frnewline -->
(3) benchmark dose analyses of the type described by Crump 
<!-- PJG 0012 frnewline -->
(1984), and (4) Bayesian analyses of the type described by 
<!-- PJG 0012 frnewline -->
Jarabek and Hasselblad (1991). These analyses and their 
<!-- PJG 0012 frnewline -->
results
<FOOTCITE>58</FOOTCITE>
 yield several possible RfC estimates, so designated 
<!-- PJG 0012 frnewline -->
because the current and only verified RfC for Mn is that which 
<!-- PJG 0012 frnewline -->
has been verified by the EPA-wide RfD/RfC work group and entered 
<!-- PJG 0012 frnewline -->
on IRIS. It must be emphasized that the RfC estimates developed 
<!-- PJG 0012 frnewline -->
for the purpose of this risk assessment do not represent a 
<!-- PJG 0012 frnewline -->
revision of the current verified RfC for Mn. Reexamination of 
<!-- PJG 0012 frnewline -->
the current Mn RfC, and any decision to revise or reaffirm the 
<!-- PJG 0012 frnewline -->
current RfC, will be under the purview of the EPA-wide RfD/RfC 
<!-- PJG 0012 frnewline -->
work group at some future date. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
58
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
See ``Reevaluation of Inhalation Health Risks Associated with Methycycloentadienyl Manganese Tricarbonyl (NMT)
in Gasoline'', Appendix A, Docket A&hyph;91&hyph;46.
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A fundamental issue pertaining to all of the approaches 
<!-- PJG 0012 frnewline -->
presented here is the selection of a measure of exposure. Roels 
<!-- PJG 0012 frnewline -->
et al. (1992) described two measures of respirable dust, the 
<!-- PJG 0012 frnewline -->
occupational lifetime respirable dust concentration (LIRD), 
<!-- PJG 0012 frnewline -->
expressed as &mu;g/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 x years, and the current concentration of 
<!-- PJG 0012 frnewline -->
respirable dust (CRD), expressed as &mu;g/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. The CRD concentration 
<!-- PJG 0012 frnewline -->
was measured at the time the study was conducted by Roels et al. 
<!-- PJG 0012 frnewline -->
and refers to a representative concentration measured for the 
<!-- PJG 0012 frnewline -->
type of job performed by a worker (e.g., electrician, maintenance 
<!-- PJG 0012 frnewline -->
worker). The LIRD value for each worker was a cumulative 
<!-- PJG 0012 frnewline -->
exposure measure derived by adding the CRD values over the 
<!-- PJG 0012 frnewline -->
worker's entire period of employment. If a worker changed jobs 
<!-- PJG 0012 frnewline -->
within the plant during his period of employment, the CRD for 
<!-- PJG 0012 frnewline -->
each job held was multiplied by the number of years the worker 
<!-- PJG 0012 frnewline -->
performed that job. Thus, if more than one job classification 
<!-- PJG 0012 frnewline -->
was worked, the worker's LIRD was the sum of the products of CRD 
<!-- PJG 0012 frnewline -->
multiplied by years of performance of the respective jobs. 
<!-- PJG 0012 frnewline -->
However, if a worker held only one job classification, his LIRD 
<!-- PJG 0012 frnewline -->
was simply equal to his CRD multiplied by the number of years 
<!-- PJG 0012 frnewline -->
employed. Another measure of exposure may be derived from LIRD 
<!-- PJG 0012 frnewline -->
by dividing an individual worker's LIRD value by his total number 
<!-- PJG 0012 frnewline -->
of years of employment. The latter measure, designated as the 
<!-- PJG 0012 frnewline -->
average concentration of respirable dust (ACRD), reflects a 
<!-- PJG 0012 frnewline -->
worker's time-weighted cumulative exposure level but removes 
<!-- PJG 0012 frnewline -->
years from the unit of measurement of LIRD and is expressed as 
<!-- PJG 0012 frnewline -->
&mu;g/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. Although Roels et al. (1992) did not refer to ACRD, this value could be calculated for each individual and for the entire

<!-- PJG 0012 frnewline -->
cohort by using the unpublished data provided to ORD by Roels 
<!-- PJG 0012 frnewline -->
(1993). For reasons to be discussed later, ACRD offers 
<!-- PJG 0012 frnewline -->
advantages for certain analyses and, unless otherwise noted, is 
<!-- PJG 0012 frnewline -->
the exposure measure used in the alternative RfC estimates 
<!-- PJG 0012 frnewline -->
discussed here. 
<!-- PJG 0012 frnewline -->
a. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Conventional NOAEL- or LOAEL-Based Approach
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. The conventional method, and only method used thus far by EPA, to derive an RfC has been to identify a NOAEL or LOAEL
from a study and divide that concentration by uncertainty factors, as described above for the Mn RfC. In the case of
the study by Roels et al. (1992), the geometric mean LIRD concentration of the 
<!-- PJG 0012 frnewline -->
Mn-exposed workers was used as a LOAEL. Roels et al. (1992) also 
<!-- PJG 0012 frnewline -->
performed an exposure-response analysis of their data by grouping 
<!-- PJG 0012 frnewline -->
the exposed workers into three exposure categories and comparing 
<!-- PJG 0012 frnewline -->
the prevalence of abnormal neurobehavioral scores for each of the 
<!-- PJG 0012 frnewline -->
three groups to those of controls. As indicated in the summary 
<!-- PJG 0012 frnewline -->
sheet for the Mn RfC (see Appendix C), the results of this 
<!-- PJG 0012 frnewline -->
exposure-response analysis were not used in deriving the revised 
<!-- PJG 0012 frnewline -->
Mn RfC because the reported analysis did not correct for multiple 
<!-- PJG 0012 frnewline -->
comparisons. However, ORD's analyses of additional data provided 
<!-- PJG 0012 frnewline -->
by Roels (1993) suggest a possible RfC estimate of 0.03 &mu;g/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
(versus the current RfC of 0.05 &mu;g/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
), if a one-tailed test of statistical significance is accepted (see Appendix A, 
<!-- PJG 0012 frnewline -->
``Reevaluation of Inhalation Health Risks Associated with Methyl- 
<!-- PJG 0012 frnewline -->
cyclopentadienyl Manganese Tricarbonyl (MMT) in Gasoline'' as 
<!-- PJG 0012 frnewline -->
referenced in the reference section below, hereafter referred to 
<!-- PJG 0012 frnewline -->
as Appendix A.). Because it was based on an exposure-response 
<!-- PJG 0012 frnewline -->
analysis, this RfC estimate is labeled as such in Figure 1, which could not be reproduced in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
It is available by calling the person listed in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
section of this notice. It is also available in docket A&hyph;93&hyph;26, item number II&hyph;A&hyph;17, page 12
(see 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
ADDRESS 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
section of this notice for docket location). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
b. NOSTASOT Approach
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. Another approach to analyzing dose-response data makes use of a procedure known as NOSTASOT, described by Tukey
et al. 
<!-- PJG 0012 frnewline -->
(1985). In essence, the procedure applies a trend test sequentially to determine the highest noneffective dose of
a series of doses by eliminating one dose at a time. In this manner, the dose level at which the response is not significantly
different from controls is determined to be the NOSTASOT dose, which could therefore be considered a NOAEL. Applied
to Roels' 
<!-- PJG 0012 frnewline -->
(1993) epidemiologic data by beginning with the highest individual ACRD exposure and moving downward (i.e., a ``top-down''
approach), the procedure yielded a NOSTASOT of 285 &mu;g/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for eye-hand coordination (see Table A&hyph;4, Appendix A). This approach implies that once nonsignificance is
reached, further application of trend tests to lower dose groups would also yield 
<!-- PJG 0012 frnewline -->
nonsignificance. However, this was not the case with Roels' (1993) epidemiologic data, and thus it was important
to determine not simply the highest NOAEL but the highest NOAEL below the lowest LOAEL. By this ``bottom-up'' approach,
the highest nonsignificant exposure below the lowest statistically significant exposure was 21 &mu;g/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, for visual reaction time. Using the latter value as a NOAEL and a total uncertainty factor of 100 (the same as that used
for the current Mn RfC, except omitting a factor of 10 for extrapolating from a LOAEL to a NOAEL), one would obtain a value
of 0.07 &mu;g/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for an RfC estimate (Figure 1). Disparities in the NOSTASOTs obtained for various endpoints by the top-down and bottom-up
approaches raise 
<!-- PJG 0012 frnewline -->
questions about the suitability of this technique for deriving a NOAEL from the data of Roels (1993).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00076 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
c. Benchmark Analyses.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Another approach to deriving an RfC estimate is the benchmark dose (BMD) approach, which has been described by Crump
(1984) and others (e.g., Kimmel and Gaylor, 1988; Faustman et al., 1994; Allen et al., 1994). A BMD is an estimate of
the dose (the term dose is used interchangeably here with concentration, although the latter is more appropriate
for inhalation exposure) that will produce a specified effect (e.g., a 10% increase in the prevalence of abnormal
scores on a neurobehavioral test in the case of the study by Roels et al. (1992)). The BMD is calculated by fitting a mathematical
model to the available data and obtaining a maximum likelihood estimate of the dose associated with a specified increase
in response (typically 10, 5, or 1%). A lower confidence limit is then calculated for the BMD (usually the 95th percentile),
and the result is denoted as a benchmark dose level (BMDL), which has been proposed as a substitute for a NOAEL in deriving
RfDs or RfCs (Crump, 1984; Barnes et al., 1994). Subscripts designate the effect level (10, 5, or 1%) for which the BMDL
has been calculated, as in BMDL
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
10
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, BMDL
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
5
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, or BMDL
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A large number of mathematical models could be used for deriving BMDLs, but six frequently used models have been selected
for the present exercise (as discussed in Appendix A). In applying these models to the dataset provided by Roels (1993),
it appears that the models fit the CRD and ACRD data better than the LIRD data. (As explained in Appendix A, it made little
difference whether the LIRD values were obtained from the group data provided in the report by Roels et al. (1992) or
from the individual exposure data supplied by Roels (1993), so the latter LIRD data were used here.) In principle,
LIRD is superior to CRD as a measure of long-term or cumulative exposure. One reason for the difference in goodness
of fit between LIRD and either CRD or ACRD is that two workers with low LIRD values had abnormal eye-hand coordination
responses (exceeding the 95th percentile of control scores). These two subjects appear to have had rather short exposure
durations (0.3 and 0.4 years) and moderately high CRD values (201 &mu;g/m3 each). Thus, these two data points suggest
an LIRD exposure-response relationship that is better fit by a supralinear curve with a power term &lt;1 (see Figures
A&hyph;3 and A&hyph;5 in Appendix A) than by the more nearly linear curve such as that produced by the quantal linear
or restricted Weibull model (see Figures A&hyph;1 and A&hyph;4 in Appendix A). If CRD or ACRD exposure data are used,
however, the two individuals tend to fall in line better with a linear model (see Figures A&hyph;7 to A&hyph;10 in Appendix
A). Another factor contributing to difficulty in fitting the Roels (1993) data with linear models is a tendency for
the prevalence of abnormal eye-hand coordination responses to decline slightly at the highest LIRD, CRD, and ACRD
concentrations (evident in Figures A&hyph;1 to A&hyph;6). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The supralinear exposure-response curve for abnormal eye-hand coordination scores suggests a possible corollary
to the healthy worker phenomenon; namely, the existence of newly employed, relatively sensitive workers vis-&aacute;-vis
long-term, relatively nonsensitive workers. It may be that the two above-noted workers happened to be rather susceptible
to Mn toxicity but had not been employed long enough for their greater sensitivity to become otherwise evident. There
could be a tendency for such workers to move to other types of employment, leaving a greater proportion of relatively
less sensitive individuals among the older workers. Although irregularities of the type posed by the data for these
two workers create complexities for model fitting, it is important to recognize that statistical curve fitting is
secondary to the objective of selecting the most biologically appropriate exposure variable. However, given that
the final results obtained with LIRD, CRD, and ACRD are roughly equivalent, ACRD has been selected for discussion
here because it estimates an average exposure over time and yet provides as good or better goodness of fit as CRD or LIRD
for most of the models considered. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Of the six models considered, the quantal linear model fits the data reasonably well and is the least complex (see Appendix
A). It also gives equivalent results to the restricted Weibull model for BMDL calculations (although the two models
differ slightly when used in the Bayesian analyses, to be described below). Although much more conservative results
would be obtained if the unrestricted Weibull or unrestricted log-logistic model were used, the NOAEL/LOAEL surrogates
obtained with the latter models are so small as to be practicably incalculable and extend far below the range of actual
measurements. Therefore, the following discussion is focused on the results obtained with the quantal linear model.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In addition to choosing a model, a specified rate of increase in the effect of concern must be selected in using the BMD
approach. This percentage increment is expressed in terms of the effective concentration that would yield the stated
increase. Increases of 10, 5, and 1% in the incidence of abnormal eye-hand coordination scores (as dichotomized by
Roels et al., 1992) have been considered, with the concentrations associated with these levels called ``effective
concentrations'' and designated as EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
5
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, and EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
10
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, respectively. One guide to the choice of an effect level is that the resulting BMD (before calculating the lower confidence
limit) is preferably near or within the range of observed exposure concentrations (cf. Barnes et al., 1994). Because
the BMD for EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 falls outside this range of observed concentrations, the primary focus in this discussion is devoted to the BMDL
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
5
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and the BMDL
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
10
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
It should be kept in mind that the BMDL represents the lower 95th percent confidence interval for the effective concentration
in question, and therefore the BMDL probably inherently reflects some degree of conservatism. However, the degree
of conservatism obviously varies with the effective concentration for different percentage effect levels and with
the nature of the effect (e.g., severe versus moderate impairment). For the purposes of this assessment, if one treats
the BMDL
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
10
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 derived from the dichotomized (quantal) data of Roels as if it were a minimal (less severe) LOAEL and the BMDL
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
5
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 as if it were a NOAEL, uncertainty factors of 3 and 1, respectively, would be warranted. On this basis, as shown in Figure
1 and in Table A&hyph;39 of Appendix A for the quantal linear model using ACRD, an RfC estimate of 0.09 &mu;g/m3 would
be obtained by using the quantal BMDL
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
10
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 as if it were a LOAEL and a total uncertainty factor of 300 (10 for intraspecies sensitivity, 10 for database limitations,
and 3 for a minimal severity LOAEL). Similarly, the quantal BMDL
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
5
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 would yield an RfC estimate of 0.1 &mu;g/m3, based on a total uncertainty factor of 100 (10 for intraspecies sensitivity,
10 for database limitations, and 1 for a NOAEL). As applied here, the benchmark approach yields candidate RfC estimates
of 0.09 to 0.1 &mu;g/m3.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00077 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
d. Bayesian Analyses. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Another approach to deriving a substitute for a conventional LOAEL or NOAEL, which bears some resemblance to the BMD
approach just described, is known as the Bayesian approach (see Appendix A). In essence, the Bayesian approach yields
a distribution of concentrations (rather than a point estimate) associated with a specified effect. Some features
of the BMD approach are common to the Bayesian approach: a mathematical model must be fit to the data, an effect level
must be selected, and a confidence bound on the estimated concentration associated with a given effect level must
be calculated (although the calculation procedures are different). If these choices are consistent with those for
the BMD approach, the results are quite similar. By the Bayesian analysis, for a 10% increase in abnormal eye-hand
coordination scores, the lower 90% credible set limit (roughly equivalent to the quantal BMDL 95% confidence limit
<FOOTCITE>59</FOOTCITE>
 based on the estimated median concentration obtained with the quantal linear model is 73 &mu;g/m3. Adjusting this
value to a human equivalent concentration (HEC) and treating the result (26 &mu;g/m3) as if it were a LOAEL(HEC), one
may divide by a total uncertainty factor of 300 (10 for intraspecies sensitivity, 10 for database limitations, and
3 for a minimal severity LOAEL) and obtain an RfC estimate of 0.09 &mu;g/m3. Similarly, the 5% effect level yields an
RfC estimate of 0.1 &mu;g/m3, based on a total uncertainty factor of 100. Thus, as applied here, the Bayesian approach
yields candidate RfC estimates of 0.09 to 0.1 &mu;g/m3, essentially identical to the results of the benchmark analysis
(Figure 1). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
59
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
U.S. Environmental Protection Agency. (1994a) ``Reevaluation of inhalation health risks associated with methylcyclopentadienyl
manganese tricarbonyl 9MMT) in gasoline.'' Washington, DC: Office of Research and Development; EPA report no. 600/R&hyph;94/062.
For further information see Air Docket A&hyph;93&hyph;26, II&hyph;A&hyph;12. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
One advantage of the Bayesian approach is that it lends itself well to using continuous as well as dichotomous data.
Although Roels et al. (1992) did not provide individual continuous data (i.e., actual raw scores instead of designations
of normal/abnormal) on the performance of the workers in their study, they did report mean differences and standard
deviations. With this information, it is possible to estimate the concentration at which certain effect levels would
occur based on the Bayesian posterior distribution. For example, a 10% increase in the proportion of subjects with
abnormal scores would be associated with a median concentration of 112 &mu;g/m3, which has a lower 90% credible set
limit of 90 &mu;g/m3. Adjusting the latter value as if it were a LOAEL(HEC) yields a concentration of 32 &mu;g/m3 and
an RfC estimate value of 0.1 &mu;g/m3, based on a total uncertainty factor of 300 (10 for intraspecies sensitivity,
10 for database limitations, and 3 for a minimal severity LOAEL). Note that these calculations based on continuous
data essentially approximate the quantal BMD and Bayesian calculations for a 10% effect level based on dichotomous
data (see Figure 1). Similar calculations for the actually observed difference (i.e., 13%) between the Mn-exposed
and control workers in the Roels et al. (1992) study yield an RfC estimate of 0.2 &mu;g/m3, based on a total uncertainty
factor of 300 (including a factor of 3 for a minimal severity LOAEL). Calculating the concentration associated with
the difference between the exposed and control mean values that just achieves statistical significance (a 4% difference
in this case) also results in a candidate RfC value of 0.2 &mu;g/m3, based on a total uncertainty factor of 100 (eliminating
the minimal LOAEL factor of 3). Thus, as applied here, the Bayesian analyses of continuous data yield candidate RfC
estimates of 0.1 to 0.2 &mu;g/m3. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
e. Summary of RfC Estimates.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Figure 1 displays the current, verified RfC along with over 100 possible Mn RfC estimates based on various exposure
measures, models, effects measures, and uncertainty factors. Not all of these RfC estimates are equally plausible
or worthy of consideration in assessing the potential health risks associated with Mn inhalation exposure due to
MMT usage. As discussed above, some combinations of the three exposure measures and six mathematical models fit one
another better than other combinations. Based primarily on considerations of cumulative dose toxicity, statistical
goodness-of-fit, and parsimony, ACRD and the quantal linear model appear to achieve the best results in this respect.
Given the similarities of the benchmark and Bayesian analytic results using ACRD and the quantal linear model, little
distinction can be made between the two analytic approaches in the present application. As for the results obtained
for different effect levels, using a severity uncertainty factor of 3 with a 10% effect level (for either benchmark
or Bayesian analyses) is essentially equivalent to using a severity UF of 1 with a 5% effect level. Note that the terms
LOAEL and NOAEL do not actually correspond to the results for 10% and 5% effect levels, and therefore neither is preferable
to the other in the sense that a NOAEL is preferable to a LOAEL in deriving an RfC. Therefore, benchmark and Bayesian
results for 10% and 5% effect levels (using ACRD with the quantal linear model) are regarded as equally worthy of consideration
here. These particular analyses yield Mn RfC estimates of 0.09 to 0.1 &mu;g/m3. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In general, continuous response data are preferred to dichotomized data, primarily because they provide more information
and avoid the basically arbitrary division of effect measurements into categories (e.g., normal versus abnormal).
The Bayesian analysis based on mean differences between exposed and control groups offers some of the advantages
of using continuous data, in that the reported means and standard deviations (from Roels et al., 1992) provide a basis
for estimating the distribution of continuous response measures. However, this use of continuous data is not immune
to certain common problems, such as the issue of statistical power associated with studies of limited size, for the
approaches calculating observed or just-statistically significant differences. Also, whereas the dichotomous
data analyses yield more precision in estimating the effective concentration associated with a somewhat imprecise
response variable, the continuous data analyses offer the opposite trade off (i.e., more precision in the response
variable but less in the exposure estimate). Nevertheless, the continuous data analyses appear to merit consideration
as well as the analyses based on dichotomous data. By the Bayesian analyses of continuous data, Mn RfC estimates of
approximately 0.1 to 0.2 &mu;g/m3 are obtained. 
<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00078 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Based on the available data and on decisions and 
<!-- PJG 0012 frnewline -->
assumptions involved in analyses of these data, the leading 
<!-- PJG 0012 frnewline -->
candidate estimates for an alternative Mn RfC appear to fall in a 
<!-- PJG 0012 frnewline -->
range of approximately 0.09 to 0.2 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
g/m3. (Ethyl Corporation 
<!-- PJG 0012 frnewline -->
(1994) has proposed an alternative RfC estimate based on a BMDL
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
10
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
value of 87 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
g/m3. Treating this value as essentially a NOAEL 
<!-- PJG 0012 frnewline -->
(thereby eliminating an uncertainty factor for use of a LOAEL), 
<!-- PJG 0012 frnewline -->
Ethyl Corporation divided the adjusted NOAEL(HEC) by a single 
<!-- PJG 0012 frnewline -->
uncertainty factor of 10 for sensitive subpopulations to derive a 
<!-- PJG 0012 frnewline -->
Mn RfC estimate of 3 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
g/m
<FOOTCITE>3</FOOTCITE>

<FOOTCITE>.)</FOOTCITE>

<FOOTCITE></FOOTCITE>

<FOOTCITE>60</FOOTCITE>
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
60
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The RfC listed here is not simply the BMDL
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=2 -->
10
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 of 87 &mu;g/m3 reduced by the uncertainty factor of 10 because the BMDL
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=2 -->
10
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 must first be adjusted to produce an adjusted NOAEL(HEC) (i.e., to go from an occupational exposure scenario to a scenario
for the general public) prior to reduction by the uncertainty factor.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
C. Exposure Assessment 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
1. Background 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Very limited data have been available by which to 
<!-- PJG 0012 frnewline -->
estimate potential Mn personal exposure levels likely to be 
<!-- PJG 0012 frnewline -->
associated with the use of MMT as an additive in unleaded 
<!-- PJG 0012 frnewline -->
gasoline. For example, after the completion of ORD's 1990 
<!-- PJG 0012 frnewline -->
exposure assessment for Mn (U.S. Environmental Protection Agency, 
<!-- PJG 0012 frnewline -->
1990), Ethyl Corporation provided EPA a brief report of a 
<!-- PJG 0012 frnewline -->
personal monitoring study as part of Ethyl Corporation's 
<!-- PJG 0012 frnewline -->
resubmittal of a waiver application for MMT. The study focused 
<!-- PJG 0012 frnewline -->
on 6 taxi drivers and 17 office workers in Toronto, ON, where the 
<!-- PJG 0012 frnewline -->
allowable MMT concentration in gasoline is 1/16 (0.062) g Mn/gal. 
<!-- PJG 0012 frnewline -->
(In the Toronto study, the actual concentration was reported as 
<!-- PJG 0012 frnewline -->
1/26 (0.039) g Mn/gal, which is only slightly greater than the 
<!-- PJG 0012 frnewline -->
1/32 (0.031) g Mn/gal concentration proposed for the United 
<!-- PJG 0012 frnewline -->
States. As confirmed by Kirshenblatt (1993), MMT concentrations 
<!-- PJG 0012 frnewline -->
in Canadian gasoline average well below the allowable limit 
<!-- PJG 0012 frnewline -->
there.) In comments on Ethyl's resubmittal, ORD considered the 
<!-- PJG 0012 frnewline -->
Toronto data in conjunction with results from independent field 
<!-- PJG 0012 frnewline -->
studies of personal exposures to carbon monoxide to develop a 
<!-- PJG 0012 frnewline -->
revised Mn exposure assessment (Preuss, 1991). A key element of 
<!-- PJG 0012 frnewline -->
the 1991 ORD assessment was the assumption that taxi drivers (six 
<!-- PJG 0012 frnewline -->
of whom were monitored in Toronto within a 2-week period) were 
<!-- PJG 0012 frnewline -->
members of a high-exposure cluster reflecting the upper 4% of the 
<!-- PJG 0012 frnewline -->
population in a model based on the carbon monoxide field studies. 
<!-- PJG 0012 frnewline -->
The result of the 1991 assessment was an estimate that 4% of the 
<!-- PJG 0012 frnewline -->
general public might be exposed to Mn at approximately 
<!-- PJG 0012 frnewline -->
0.09 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
g/m3, although this estimate had an undetermined amount of 
<!-- PJG 0012 frnewline -->
uncertainty due to the inadequacies of the available data. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
2. Additional Canadian Studies 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Since the 1991 ORD assessment, additional personal 
<!-- PJG 0012 frnewline -->
exposure studies have been completed in Montreal and Toronto 
<!-- PJG 0012 frnewline -->
(described in Appendix B, ``Reevaluation of Inhalation Health 
<!-- PJG 0012 frnewline -->
Risks Associated with Methyl cyclopentadienyl Manganese 
<!-- PJG 0012 frnewline -->
Tricarbonyl (MMT) in Gasoline'' as referenced in the reference 
<!-- PJG 0012 frnewline -->
section below, hereafter referred to as Appendix B.) As shown in 
<!-- PJG 0012 frnewline -->
Figure B&hyph;10 of Appendix B, the average concentrations reported in 
<!-- PJG 0012 frnewline -->
the Canadian studies vary by as much as an order of magnitude for 
<!-- PJG 0012 frnewline -->
small groups (5 to 19 persons each) of garage mechanics, taxi 
<!-- PJG 0012 frnewline -->
drivers, and office workers. The highest average Mn personal 
<!-- PJG 0012 frnewline -->
exposure level was 0.25 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
g/m3 for Montreal garage mechanics while 
<!-- PJG 0012 frnewline -->
at work; the other averages ranged from 0.002 to 0.035 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
g/m3 for 
<!-- PJG 0012 frnewline -->
various particle size fractions. Although it is impossible to 
<!-- PJG 0012 frnewline -->
extrapolate the results of these studies to the distribution of 
<!-- PJG 0012 frnewline -->
Mn exposure levels for the general population, it does appear 
<!-- PJG 0012 frnewline -->
that there is a general relationship between personal exposure 
<!-- PJG 0012 frnewline -->
levels of Mn and proximity to vehicular emissions of combusted 
<!-- PJG 0012 frnewline -->
MMT. Thus, populations living near high traffic-volume areas 
<!-- PJG 0012 frnewline -->
such as inner cities and expressways would probably tend to 
<!-- PJG 0012 frnewline -->
experience higher Mn exposure levels in relation to MMT usage. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Some of the limitations of the Canadian studies with 
<!-- PJG 0012 frnewline -->
respect to development of a quantitative exposure assessment are 
<!-- PJG 0012 frnewline -->
reviewed in detail in Appendix B and may be summarized briefly as 
<!-- PJG 0012 frnewline -->
follows. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
&bull;The studies did not have adequate sample sizes and did not 
<!-- PJG 0012 frnewline -->
sample according to a probabilistic statistical design that 
<!-- PJG 0012 frnewline -->
would help ensure the representativeness of the sampled 
<!-- PJG 0012 frnewline -->
individuals. 
<!-- PJG 0012 frnewline -->
&bull;The sampling periods were relatively short, 1 to 2 weeks at 
<!-- PJG 0012 frnewline -->
most. Meteorological and other factors that would be 
<!-- PJG 0012 frnewline -->
expected to influence ambient measurements over relatively 
<!-- PJG 0012 frnewline -->
short periods of time were not characterized. 
<!-- PJG 0012 frnewline -->
&bull;Because the studies did not use ambient monitors collocated 
<!-- PJG 0012 frnewline -->
with reference monitors (such as the dichotomous samplers 
<!-- PJG 0012 frnewline -->
used by Canadian agencies), it is difficult to relate data 
<!-- PJG 0012 frnewline -->
from the studies to larger databases from the government 
<!-- PJG 0012 frnewline -->
monitoring networks. 
<!-- PJG 0012 frnewline -->
&bull;Because the studies did not use identical monitors to 
<!-- PJG 0012 frnewline -->
measure personal exposure levels and outdoor ambient 
<!-- PJG 0012 frnewline -->
levels, it is difficult to distinguish between personal 
<!-- PJG 0012 frnewline -->
exposures and ambient levels or to relate one to the other. 
<!-- PJG 0012 frnewline -->
&bull;Quality assurance and certain other important 
<!-- PJG 0012 frnewline -->
methodological details are not fully provided in the 
<!-- PJG 0012 frnewline -->
available reports. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Because of the substantial limitations of the above 
<!-- PJG 0012 frnewline -->
exposure studies, no quantitative assessment of personal 
<!-- PJG 0012 frnewline -->
exposures to Mn in a Canadian population is possible at present. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00079 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3. The PTEAM Study 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The only published study that has used a probability-based 
<!-- PJG 0012 frnewline -->
representative sampling design for evaluating exposure levels of 
<!-- PJG 0012 frnewline -->
Mn in a general population is the Particle Total Exposure 
<!-- PJG 0012 frnewline -->
Assessment Methodology (PTEAM) study, which was conducted in 
<!-- PJG 0012 frnewline -->
Riverside, CA, over a 7-week period in the fall of 1990 
<!-- PJG 0012 frnewline -->
(Pellizzari et al., 1992). This study used personal and 
<!-- PJG 0012 frnewline -->
stationary monitors to measure Mn concentrations indoors and 
<!-- PJG 0012 frnewline -->
outdoors. The personal samplers collected PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
10
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, and the 
<!-- PJG 0012 frnewline -->
stationary samplers collected PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
2.5
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 as well as PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
10
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (see glossary 
<!-- PJG 0012 frnewline -->
of terms in Attachment B&hyph;6 to Appendix B). Of the 139,000 
<!-- PJG 0012 frnewline -->
nonsmoking residents age 10 years and older in Riverside, 178 
<!-- PJG 0012 frnewline -->
individuals were selected through a stratified sampling plan to 
<!-- PJG 0012 frnewline -->
represent the general population and were monitored over two 
<!-- PJG 0012 frnewline -->
12-hour periods (daytime and nighttime). More than 2,750 
<!-- PJG 0012 frnewline -->
particle samples were collected. Quality assurance and other 
<!-- PJG 0012 frnewline -->
procedures are summarized in Appendix B and are described 
<!-- PJG 0012 frnewline -->
extensively elsewhere (e.g., Pellizzari et al., 1992; Clayton 
<!-- PJG 0012 frnewline -->
et al., 1993; Thomas et al., 1993). The PTEAM study has been 
<!-- PJG 0012 frnewline -->
presented in various peer-reviewed publications and discussed in 
<!-- PJG 0012 frnewline -->
several scientific forums (see Attachment B&hyph;5 to Appendix B). It 
<!-- PJG 0012 frnewline -->
represents the best available information on an actual 
<!-- PJG 0012 frnewline -->
distribution of general population exposures to Mn. It also 
<!-- PJG 0012 frnewline -->
provides valuable information on potential Mn exposure associated 
<!-- PJG 0012 frnewline -->
with MMT use, because MMT was used in leaded gasoline in 
<!-- PJG 0012 frnewline -->
California prior to and during the period of the PTEAM study. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
4. Estimated Mn Exposure Levels Associated with MMT Usage 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As noted above, the substantial limitations of the 
<!-- PJG 0012 frnewline -->
available Canadian exposure studies make them unsuitable for 
<!-- PJG 0012 frnewline -->
estimating population exposure levels of Mn in relation to MMT 
<!-- PJG 0012 frnewline -->
usage. In addition, ambient monitoring data typically 
<!-- PJG 0012 frnewline -->
underestimate and may be uncorrelated with personal exposure 
<!-- PJG 0012 frnewline -->
levels of automotive-source pollutants. Therefore, of the 
<!-- PJG 0012 frnewline -->
currently existing published evidence pertaining to Mn exposure 
<!-- PJG 0012 frnewline -->
levels in relation to MMT usage, only the PTEAM Riverside study 
<!-- PJG 0012 frnewline -->
(Pellizzari et al., 1992) provides a reasonable basis for 
<!-- PJG 0012 frnewline -->
estimating potential future exposure levels in relation to a 
<!-- PJG 0012 frnewline -->
scenario where 100% of unleaded gasoline contains 1/32 g Mn/gal 
<!-- PJG 0012 frnewline -->
as proposed by Ethyl Corporation. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In the PTEAM study, measurements of personal exposure 
<!-- PJG 0012 frnewline -->
levels of PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
10
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Mn indicated that approximately half of the 
<!-- PJG 0012 frnewline -->
population in Riverside in the 1990 study period had 24-hour 
<!-- PJG 0012 frnewline -->
personal exposures to PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
10
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Mn above 0.035 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
g/m3, with the highest 
<!-- PJG 0012 frnewline -->
1% of the population having exposures above 0.223 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
g/m3 PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
10
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Mn. 
<!-- PJG 0012 frnewline -->
However, given the use of PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
5
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Mn exposure measurements in the 
<!-- PJG 0012 frnewline -->
study of Roels et al. (1992), it would be preferable to consider 
<!-- PJG 0012 frnewline -->
a population distribution of personal exposure levels of PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
5
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Mn. 
<!-- PJG 0012 frnewline -->
Due to limitations in the available data, the exposure assessment 
<!-- PJG 0012 frnewline -->
in Appendix B focuses on estimated personal exposure levels for 
<!-- PJG 0012 frnewline -->
PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Mn, not PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
5
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. Although the difference is probably small, PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
levels are an underestimate of PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
5
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 levels. The derivation of the 
<!-- PJG 0012 frnewline -->
projected exposure estimates involved several steps, which may be 
<!-- PJG 0012 frnewline -->
summarized as follows. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The automotive and nonautomotive contributions to 
<!-- PJG 0012 frnewline -->
particulate Mn exposures in the PTEAM study were estimated using 
<!-- PJG 0012 frnewline -->
data from Lyons et al. (1993), who reported particle size 
<!-- PJG 0012 frnewline -->
distributions up to PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of selected trace metals, including Mn, 
<!-- PJG 0012 frnewline -->
at two locations near Riverside in the winter and summer of 1989. 
<!-- PJG 0012 frnewline -->
They attributed most of the PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Mn to automotive sources. Based 
<!-- PJG 0012 frnewline -->
on their findings and data from other sources, it is possible to 
<!-- PJG 0012 frnewline -->
estimate that 69% of the PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
2.5
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 fraction of PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Mn they measured 
<!-- PJG 0012 frnewline -->
was derived from automotive sources (namely the combustion of MMT 
<!-- PJG 0012 frnewline -->
in motor vehicle fuel, as then allowed in leaded gasoline in 
<!-- PJG 0012 frnewline -->
California) and that 31% was derived from paved road dust (mostly 
<!-- PJG 0012 frnewline -->
earth crustal material). Next, the PTEAM Mn measurements from 
<!-- PJG 0012 frnewline -->
stationary indoor monitors (SIMs) were used to estimate personal 
<!-- PJG 0012 frnewline -->
exposure levels by adjusting the SIM PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
2.5
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Mn data to reflect the 
<!-- PJG 0012 frnewline -->
typically higher levels of all elements measured by personal 
<!-- PJG 0012 frnewline -->
exposure monitors (PEMs). This adjustment was made in two ways, 
<!-- PJG 0012 frnewline -->
either by the PEM:SIM ratio obtained for Mn or by the ratio 
<!-- PJG 0012 frnewline -->
obtained for lead (Pb), another element related to automotive 
<!-- PJG 0012 frnewline -->
fuel usage. These two methods of adjusting the SIM data to PEM 
<!-- PJG 0012 frnewline -->
values resulted in two projected distributions, as will be 
<!-- PJG 0012 frnewline -->
described below. The next step in the derivation procedure 
<!-- PJG 0012 frnewline -->
involved adjusting the PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
2.5
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 personal exposure estimates to 
<!-- PJG 0012 frnewline -->
reflect PM in the size range from 2.5 to 4 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
m (based again on 
<!-- PJG 0012 frnewline -->
data from Lyons et al., 1993). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
With these estimates of PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Mn personal exposure levels due 
<!-- PJG 0012 frnewline -->
to automotive sources, it was then possible to project from the 
<!-- PJG 0012 frnewline -->
situation in Riverside around the time of the PTEAM study (when 
<!-- PJG 0012 frnewline -->
leaded-MMT gasoline constituted about 14% of the gasoline sold 
<!-- PJG 0012 frnewline -->
and contained an average of 0.048 g Mn/gal) to a future scenario 
<!-- PJG 0012 frnewline -->
that assumes 100% of the unleaded gasoline contains MMT at 1/32 
<!-- PJG 0012 frnewline -->
(0.031) g Mn/gal. This aspect of the derivation is described in 
<!-- PJG 0012 frnewline -->
detail in Attachment B&hyph;4 to Appendix B. In essence, a factor was 
<!-- PJG 0012 frnewline -->
calculated to reflect the estimated increase in MMT usage between 
<!-- PJG 0012 frnewline -->
1990 and 1995 (i.e., the first full year in the near future). 
<!-- PJG 0012 frnewline -->
This projection factor assumed an increase of 1% per year in 
<!-- PJG 0012 frnewline -->
gasoline usage and no difference in the Mn emission rate (grams 
<!-- PJG 0012 frnewline -->
Mn emitted per gram Mn in fuel combusted) for noncatalyst 
<!-- PJG 0012 frnewline -->
vehicles using leaded-MMT gasoline in 1990 versus catalyst 
<!-- PJG 0012 frnewline -->
vehicles using unleaded-MMT gasoline in 1995. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00080 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Next, the nonautomotive contribution to PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Mn was 
<!-- PJG 0012 frnewline -->
estimated and added to the estimated automotive contribution to 
<!-- PJG 0012 frnewline -->
obtain the projected personal exposure levels of total PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Mn. 
<!-- PJG 0012 frnewline -->
Assuming the estimated PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Mn distribution has the same form as 
<!-- PJG 0012 frnewline -->
the PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
10
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Mn distribution from PTEAM (approximately lognormal with 
<!-- PJG 0012 frnewline -->
equal geometric standard deviations), the ratio of the PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
:PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
10 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
arithmetic mean personal exposure levels yields a scaling factor 
<!-- PJG 0012 frnewline -->
that can be applied to the PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
10
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 distribution to obtain the PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
distributions. Because of the alternative bases for adjusting 
<!-- PJG 0012 frnewline -->
the SIM PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
2.5
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 data for personal exposures (as noted above), two 
<!-- PJG 0012 frnewline -->
different scaling factors were multiplied by the PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
10
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
distribution, thereby producing a higher and a lower estimate of 
<!-- PJG 0012 frnewline -->
the distribution of 24-hour average PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Mn personal exposure 
<!-- PJG 0012 frnewline -->
levels. 
<!-- PJG 0012 frnewline -->
In addition, because long-term exposures are likely to have 
<!-- PJG 0012 frnewline -->
less variance than 24-hour exposures, it is appropriate to adjust 
<!-- PJG 0012 frnewline -->
the distributions of 24-hour average exposure levels to better 
<!-- PJG 0012 frnewline -->
reflect longer periods of exposure. Of various methods that may 
<!-- PJG 0012 frnewline -->
be used for this purpose (Wallace et al., 1994), two approaches 
<!-- PJG 0012 frnewline -->
were applied to adjust the geometric standard deviations of the 
<!-- PJG 0012 frnewline -->
two projected exposure distributions, based on data from either 
<!-- PJG 0012 frnewline -->
the PTEAM study or the smaller pilot study that preceded the 
<!-- PJG 0012 frnewline -->
PTEAM Riverside study. These alternative methods were applied to 
<!-- PJG 0012 frnewline -->
the two estimated distributions of 24-hour average exposures to 
<!-- PJG 0012 frnewline -->
yield the distributions of long-term average PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Mn personal 
<!-- PJG 0012 frnewline -->
exposure levels depicted as lines 1 and 2 in Figure 2 (only the 
<!-- PJG 0012 frnewline -->
highest and lowest of the four resulting estimates are shown). 
<!-- PJG 0012 frnewline -->
It must be emphasized that these two distributions do not 
<!-- PJG 0012 frnewline -->
represent upper and lower bounds, because even higher or lower 
<!-- PJG 0012 frnewline -->
estimates could be produced by alternative assumptions and 
<!-- PJG 0012 frnewline -->
adjustments of the data. Moreover, if data were available for 
<!-- PJG 0012 frnewline -->
another time of the year (e.g., spring in addition to fall), the 
<!-- PJG 0012 frnewline -->
estimates would not be season-specific and could possibly be much 
<!-- PJG 0012 frnewline -->
higher or much lower. Nevertheless, given the limited available 
<!-- PJG 0012 frnewline -->
data, lines 1 and 2 in Figure 2 represent two reasonable 
<!-- PJG 0012 frnewline -->
estimates of the projected long-term (autumnal) personal exposure 
<!-- PJG 0012 frnewline -->
levels of PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Mn in relation to MMT usage at 1/32 g Mn/gal in 
<!-- PJG 0012 frnewline -->
100% of unleaded gasoline. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00081 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
By examination of the logarithmic-probability plot of long-term personal exposure levels of Mn, it is estimated
that half of 
<!-- PJG 0012 frnewline -->
the population would be exposed to PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Mn levels of more than 
<!-- PJG 0012 frnewline -->
approximately 0.045 to 0.050 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
g/m3. Also, based on the two 
<!-- PJG 0012 frnewline -->
projection estimates, approximately 5 to 10% of the population 
<!-- PJG 0012 frnewline -->
would have personal exposure levels around 0.1 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
g/m3 PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Mn or higher. The highest 1% would be predicted to have PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Mn 
<!-- PJG 0012 frnewline -->
exposure levels above 0.15 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
g/m3. It should be noted that these 
<!-- PJG 0012 frnewline -->
projections refer specifically to Riverside, CA, with a 
<!-- PJG 0012 frnewline -->
population of more than 139,000 persons. However, in many 
<!-- PJG 0012 frnewline -->
significant respects (e.g., meteorology and traffic volume), 
<!-- PJG 0012 frnewline -->
Riverside is reasonably representative of the greater 
<!-- PJG 0012 frnewline -->
metropolitan area of Los Angeles, which has a total population of 
<!-- PJG 0012 frnewline -->
over 14.5 million persons. The exposure projection estimates for 
<!-- PJG 0012 frnewline -->
Riverside imply the possibility that hundreds of thousands of 
<!-- PJG 0012 frnewline -->
persons in the Los Angeles area alone could be exposed to PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Mn 
<!-- PJG 0012 frnewline -->
levels exceeding 0.1 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
g/m3. To the extent that any other U.S. 
<!-- PJG 0012 frnewline -->
cities (e.g., in the Southwest) share some degree of resemblance 
<!-- PJG 0012 frnewline -->
in meteorology, vehicle miles traveled (VMT), and possibly other 
<!-- PJG 0012 frnewline -->
characteristics of relevance to automotive Mn levels, the 
<!-- PJG 0012 frnewline -->
estimated exposure levels for Riverside could be pertinent, at 
<!-- PJG 0012 frnewline -->
least qualitatively, to other locales or portions of locales as 
<!-- PJG 0012 frnewline -->
well. Similarities and differences in point-source contributions 
<!-- PJG 0012 frnewline -->
to Mn exposure would also figure into comparisons with other 
<!-- PJG 0012 frnewline -->
communities. The presence of a major point source or sources of 
<!-- PJG 0012 frnewline -->
Mn in a community (which was not a factor in Riverside) would add 
<!-- PJG 0012 frnewline -->
some increment to the level of Mn exposure experienced by the 
<!-- PJG 0012 frnewline -->
persons in that community. Although these Riverside estimates 
<!-- PJG 0012 frnewline -->
cannot be applied quantitatively to any other U.S. metropolitan 
<!-- PJG 0012 frnewline -->
areas, the total population of the U.S. counties with VMT levels 
<!-- PJG 0012 frnewline -->
greater than that of Riverside (apart from the four counties Los 
<!-- PJG 0012 frnewline -->
Angeles comprises) is approximately 15 million persons. 
<!-- PJG 0012 frnewline -->
Possibly, then, several hundreds of thousands of persons could be 
<!-- PJG 0012 frnewline -->
exposed to PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Mn levels of approximately 0.1 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
g/m3 or higher if MMT were used in 100% of the unleaded gasoline in all of these 
<!-- PJG 0012 frnewline -->
areas. However, it must be emphasized that because of the 
<!-- PJG 0012 frnewline -->
limited available data, a great deal of uncertainty surrounds 
<!-- PJG 0012 frnewline -->
such estimates. The actual exposure levels could be much higher 
<!-- PJG 0012 frnewline -->
or lower.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6560&hyph;50&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0101 clearpage -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->

<!-- PJG STAG 4725 -->

<IMPORT>

<!-- PJG importformat s,d640 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->
E:GRAPHICSEN17AU94.000
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

</IMPORT>

<!-- PJG /STAG -->

<!-- PJG STAG 4703 -->

<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6560&hyph;50&hyph;C
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0101 clearpage -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00082 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=83 g=1 f=1 -->
D. Risk Characterization 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
To assess the public health risk associated with the use of 
<!-- PJG 0012 frnewline -->
MMT in gasoline in the United States, the available qualitative 
<!-- PJG 0012 frnewline -->
and quantitative health effects information on Mn must be related 
<!-- PJG 0012 frnewline -->
to the available exposure information. From the standpoint of a 
<!-- PJG 0012 frnewline -->
qualitative hazard identification, the available evidence amply 
<!-- PJG 0012 frnewline -->
demonstrates that inhaled Mn is toxic to the nervous system, the 
<!-- PJG 0012 frnewline -->
respiratory system, and the male reproductive system. The 
<!-- PJG 0012 frnewline -->
toxicity of Mn by different routes of exposure has been 
<!-- PJG 0012 frnewline -->
demonstrated by numerous medical reports and epidemiological and 
<!-- PJG 0012 frnewline -->
experimental studies. However, available data do not allow 
<!-- PJG 0012 frnewline -->
quantitative estimation of the relative toxicological potency of 
<!-- PJG 0012 frnewline -->
different Mn compounds or permit quantitative route-to-route 
<!-- PJG 0012 frnewline -->
extrapolations for predicting the effects of Mn
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The focus of the above health assessment discussion has been 
<!-- PJG 0012 frnewline -->
on the RfC and the types of risks associated with chronic Mn 
<!-- PJG 0012 frnewline -->
exposures because, for the most part, acute effect levels appear 
<!-- PJG 0012 frnewline -->
to be considerably higher than the highest projected exposure 
<!-- PJG 0012 frnewline -->
levels. However, the issue of less-than-chronic exposures does 
<!-- PJG 0012 frnewline -->
arise with respect to the potential for developmental toxicity. 
<!-- PJG 0012 frnewline -->
It is widely recognized that the human CNS develops over a period 
<!-- PJG 0012 frnewline -->
of several years, prenatally and postnatally, and can be 
<!-- PJG 0012 frnewline -->
vulnerable to long-term or irreversible effects if damage occurs 
<!-- PJG 0012 frnewline -->
during certain ``critical stages'' of development. Recent evidence 
<!-- PJG 0012 frnewline -->
from ongoing longitudinal studies of children indicates that lead 
<!-- PJG 0012 frnewline -->
(Pb) exposure (measured as blood Pb level) around 2 years of age 
<!-- PJG 0012 frnewline -->
in particular is associated with reduced cognitive performance at 
<!-- PJG 0012 frnewline -->
4 to 10 years of age. Such evidence raises the concern that 
<!-- PJG 0012 frnewline -->
exposure to another neurotoxic metal such as Mn during part of 
<!-- PJG 0012 frnewline -->
early development might also be capable of inducing permanent or 
<!-- PJG 0012 frnewline -->
irreversible damage to the developing CNS. Moreover, the 
<!-- PJG 0012 frnewline -->
ramifications of such damage might extend to other important 
<!-- PJG 0012 frnewline -->
functions, such as reproduction. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Children may also be at higher risk in terms of exposure 
<!-- PJG 0012 frnewline -->
because of biomedical and metabolic differences at a young age 
<!-- PJG 0012 frnewline -->
(greater uptake and retention) and/or because of the longer 
<!-- PJG 0012 frnewline -->
duration of their exposure over a lifetime. Over time, small 
<!-- PJG 0012 frnewline -->
impairments in neurobehavioral function may accumulate. For this 
<!-- PJG 0012 frnewline -->
reason, the elderly, whose neurobehavioral function may already 
<!-- PJG 0012 frnewline -->
be compromised by normal aging processes and possibly by other 
<!-- PJG 0012 frnewline -->
disease states (e.g., parkinsonism or preclinical parkinsonism), 
<!-- PJG 0012 frnewline -->
also represent a special population of concern. The ability of 
<!-- PJG 0012 frnewline -->
the elderly or other subpopulations to compensate for such 
<!-- PJG 0012 frnewline -->
declines in neurobehavioral function may be overwhelmed 
<!-- PJG 0012 frnewline -->
eventually by additional, albeit possibly quite small, insults 
<!-- PJG 0012 frnewline -->
due to Mn. If so, the effect could be manifested as a more 
<!-- PJG 0012 frnewline -->
severe or earlier onset of declining function in senescence, with 
<!-- PJG 0012 frnewline -->
consequent implications for increased societal health-care costs. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Special subpopulations at increased risk may be defined not 
<!-- PJG 0012 frnewline -->
only in terms of their biological susceptibility, as exemplified 
<!-- PJG 0012 frnewline -->
above by the young and the elderly, but also by their increased 
<!-- PJG 0012 frnewline -->
risk of exposure. In this respect, inner city residents and 
<!-- PJG 0012 frnewline -->
others who live near high traffic areas such as expressways 
<!-- PJG 0012 frnewline -->
(e.g., low-income and minority communities) would possibly have a 
<!-- PJG 0012 frnewline -->
disproportionate likelihood of higher Mn exposure levels due to 
<!-- PJG 0012 frnewline -->
their closer proximity to vehicular emissions. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The nature of the neurobehavioral effects observed in 
<!-- PJG 0012 frnewline -->
occupational studies such as Roels et al. (1992) should be 
<!-- PJG 0012 frnewline -->
understood as effects that probably would not be treated by, or 
<!-- PJG 0012 frnewline -->
even be readily evident to, a clinical physician. Nonetheless, 
<!-- PJG 0012 frnewline -->
they are significant from a public health standpoint when 
<!-- PJG 0012 frnewline -->
considered in terms of population effects. This concept is 
<!-- PJG 0012 frnewline -->
illustrated by the well documented findings on low-level Pb 
<!-- PJG 0012 frnewline -->
neurotoxicity in children, where changes of as little as 1 or 
<!-- PJG 0012 frnewline -->
2 points in IQ have been repeatedly demonstrated in several 
<!-- PJG 0012 frnewline -->
independent, prospective, epidemiological studies in recent 
<!-- PJG 0012 frnewline -->
years. Such changes could not be reliably demonstrated either in 
<!-- PJG 0012 frnewline -->
a clinical setting or in earlier cross-sectional epidemiological 
<!-- PJG 0012 frnewline -->
studies; yet they are now well established to be ``real'' and 
<!-- PJG 0012 frnewline -->
significant from a public health standpoint. With regard to the 
<!-- PJG 0012 frnewline -->
reductions in neurobehavioral function observed in various 
<!-- PJG 0012 frnewline -->
epidemiological studies of Mn-exposed workers, these studies 
<!-- PJG 0012 frnewline -->
independently converge on findings of impaired motor function 
<!-- PJG 0012 frnewline -->
(e.g., reductions in eye-hand coordination, slower hand or finger 
<!-- PJG 0012 frnewline -->
movements, and less control of fine movement). As recently 
<!-- PJG 0012 frnewline -->
expressed in a document prepared by the Subcommittee for Risk 
<!-- PJG 0012 frnewline -->
Assessment of the Federal Coordinating Council for Science, 
<!-- PJG 0012 frnewline -->
Engineering and Technology (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, 1993), an adverse 
<!-- PJG 0012 frnewline -->
effect can include ``both unwanted effects and any alteration from 
<!-- PJG 0012 frnewline -->
baseline that diminishes the ability to survive, reproduce or 
<!-- PJG 0012 frnewline -->
adapt to the environment.'' Thus, it can be argued that these 
<!-- PJG 0012 frnewline -->
effects in themselves warrant consideration as adverse health 
<!-- PJG 0012 frnewline -->
effects. They may also have ramifications for health and safety 
<!-- PJG 0012 frnewline -->
of an even more serious nature, if a person's ability to react 
<!-- PJG 0012 frnewline -->
quickly and accurately to a situation (e.g., traffic conditions) 
<!-- PJG 0012 frnewline -->
was impaired. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Another aspect of the findings from available occupational 
<!-- PJG 0012 frnewline -->
studies concerns the temporal relationship between exposure and 
<!-- PJG 0012 frnewline -->
effect. As noted above, the geometric mean average period of Mn 
<!-- PJG 0012 frnewline -->
exposure of the workers in the Roels et al. (1992) study was only 
<!-- PJG 0012 frnewline -->
4 years, with the longest period of Mn exposure for any one 
<!-- PJG 0012 frnewline -->
individual being less than 18 years. Also, the oldest worker in 
<!-- PJG 0012 frnewline -->
the Roels et al. (1992) study was less than 50 years old. This 
<!-- PJG 0012 frnewline -->
relatively limited period of exposure along with the absence of 
<!-- PJG 0012 frnewline -->
older subjects in the Roels study raises the question of whether 
<!-- PJG 0012 frnewline -->
sufficient time had elapsed for the full expression of the toxic 
<!-- PJG 0012 frnewline -->
effects of Mn. Some reports in the literature indicate that 
<!-- PJG 0012 frnewline -->
Mn toxicity may not be clinically evident until some years after 
<!-- PJG 0012 frnewline -->
exposure occurred or terminated (e.g., Cotzias et al., 1968; 
<!-- PJG 0012 frnewline -->
Rodier, 1955), and other reports point to a greater sensitivity 
<!-- PJG 0012 frnewline -->
of elderly persons, compared to middle-aged or young adults, for 
<!-- PJG 0012 frnewline -->
acute as well as chronic Mn toxicity (e.g., Kawamura et al., 
<!-- PJG 0012 frnewline -->
1941). An uncertainty factor for extrapolation from a subchronic 
<!-- PJG 0012 frnewline -->
exposure to chronic exposure was included in deriving the RfC 
<!-- PJG 0012 frnewline -->
estimates shown in Figure 1. However, a ``half-factor'' of 3 was 
<!-- PJG 0012 frnewline -->
used for this area of uncertainty. If the average period of Mn 
<!-- PJG 0012 frnewline -->
exposure (geometric mean: 4 years) in the Roels et al. (1992) 
<!-- PJG 0012 frnewline -->
study is compared to an assumed lifetime of 70 years, one could 
<!-- PJG 0012 frnewline -->
argue that a factor of 70/4=17.5, or at least 10, would be a 
<!-- PJG 0012 frnewline -->
more appropriate adjustment for subchronic to chronic exposures. 
<!-- PJG 0012 frnewline -->
Given the limited available data, this area of uncertainty is 
<!-- PJG 0012 frnewline -->
difficult to express in a quantitative manner, but in general 
<!-- PJG 0012 frnewline -->
practice, EPA has used an uncertainty factor of 3 for other 
<!-- PJG 0012 frnewline -->
chemicals with comparable databases. Nevertheless, this area of 
<!-- PJG 0012 frnewline -->
concern suggests that the Mn RfC estimates derived here with an 
<!-- PJG 0012 frnewline -->
uncertainty factor of 3 for subchronic to chronic exposure 
<!-- PJG 0012 frnewline -->
probably do not tend to err in the direction of being too 
<!-- PJG 0012 frnewline -->
conservative. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Another qualitative concern that should be recognized in 
<!-- PJG 0012 frnewline -->
considering the potential health effects of Mn is the possibility 
<!-- PJG 0012 frnewline -->
of certain types of effects that are suggested by clinical and 
<!-- PJG 0012 frnewline -->
other evidence but are difficult to measure quantitatively or 
<!-- PJG 0012 frnewline -->
demonstrate with currently available methods. Specifically, much 
<!-- PJG 0012 frnewline -->
of the clinical literature on manganism refers to a psychiatric 
<!-- PJG 0012 frnewline -->
component of the illness, which often involves striking emotional 
<!-- PJG 0012 frnewline -->
or mood changes that tend to appear before changes in motor 
<!-- PJG 0012 frnewline -->
function are evident. Such effects are inherently difficult to 
<!-- PJG 0012 frnewline -->
measure in a quantitative manner. However, the possibility of 
<!-- PJG 0012 frnewline -->
such effects at lower levels of exposure than those at which 
<!-- PJG 0012 frnewline -->
motor control is affected should not be discounted out of hand. 
<!-- PJG 0012 frnewline -->
Some reports in the literature (e.g., Gottschalk et al., 1991) 
<!-- PJG 0012 frnewline -->
suggest that aggressive behavior may be associated with Mn 
<!-- PJG 0012 frnewline -->
exposure (as reflected in the concentration of Mn in hair of 
<!-- PJG 0012 frnewline -->
prison inmates). Such reports require substantiation by further 
<!-- PJG 0012 frnewline -->
studies, and the validity and relevance of hair Mn levels to 
<!-- PJG 0012 frnewline -->
environmental Mn exposure remains to be established, but the 
<!-- PJG 0012 frnewline -->
suggestion that an association might exist between hair Mn and 
<!-- PJG 0012 frnewline -->
behavior cannot be totally dismissed. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00083 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Quantitative analyses of neurobehavioral data obtained from 
<!-- PJG 0012 frnewline -->
an occupational cohort provide a range of possible RfC estimates 
<!-- PJG 0012 frnewline -->
in addition to the current, verified Mn RfC value of 0.05 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
g/m3. 
<!-- PJG 0012 frnewline -->
In ORD's judgment, the leading candidates for a possible 
<!-- PJG 0012 frnewline -->
alternative RfC estimate are approximately 0.09 to 0.2 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
g/m3, 
<!-- PJG 0012 frnewline -->
based on currently available information. By definition, RfC 
<!-- PJG 0012 frnewline -->
analyses do not yield a precise concentration that defines a 
<!-- PJG 0012 frnewline -->
demarcation between safety and hazard. Rather, interpretation of 
<!-- PJG 0012 frnewline -->
a Mn RfC estimate is best made in relation to an assessment of 
<!-- PJG 0012 frnewline -->
population exposures to Mn, with the understanding that the RfC 
<!-- PJG 0012 frnewline -->
is a protective level, not a predictive value. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The exposure assessment, based largely on data from the 
<!-- PJG 0012 frnewline -->
PTEAM study, provides some reasonable but necessarily uncertain 
<!-- PJG 0012 frnewline -->
estimates of personal exposure levels of Mn that might result 
<!-- PJG 0012 frnewline -->
from the use of MMT in gasoline. These estimates indicate that 
<!-- PJG 0012 frnewline -->
if MMT (at 1/32 g Mn/gal) were used in all unleaded gasoline in 
<!-- PJG 0012 frnewline -->
Riverside, CA (or the greater Los Angeles metropolitan area), 
<!-- PJG 0012 frnewline -->
approximately 40 to 50% of the population could experience PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
Mn exposures exceeding the current RfC of 0.05 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
g/m3 (derived 
<!-- PJG 0012 frnewline -->
from PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
5
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Mn health effects data), and approximately 5 to 10% 
<!-- PJG 0012 frnewline -->
could experience PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Mn exposure levels around 0.1 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
g/m3 or 
<!-- PJG 0012 frnewline -->
higher (see Figure 2). In terms of the Los Angeles area 
<!-- PJG 0012 frnewline -->
population of 14.5 million persons, even an estimate of 5% of the 
<!-- PJG 0012 frnewline -->
population implies over 700,000 persons. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Uncertainties are inherent in any risk assessment. In this 
<!-- PJG 0012 frnewline -->
case, on the health assessment side, the numerical uncertainty 
<!-- PJG 0012 frnewline -->
factors used in the RfC analyses presented here have been 
<!-- PJG 0012 frnewline -->
explicitly described and explained in and summarized above. 
<!-- PJG 0012 frnewline -->
These factors are intended to provide a reasonable degree of 
<!-- PJG 0012 frnewline -->
public health conservatism reflecting areas of biological 
<!-- PJG 0012 frnewline -->
knowledge as well as areas of information deficit. In addition, 
<!-- PJG 0012 frnewline -->
an RfC estimate by definition reflects uncertainty spanning 
<!-- PJG 0012 frnewline -->
perhaps an order of magnitude, and thus there is no significant 
<!-- PJG 0012 frnewline -->
difference between the verified RfC of 0.05 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
g/m3 and alternative 
<!-- PJG 0012 frnewline -->
estimates of 0.09 to 0.2 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
g/m3. Other qualitative uncertainties 
<!-- PJG 0012 frnewline -->
are also discussed above. On the exposure assessment side, the 
<!-- PJG 0012 frnewline -->
primary uncertainties are related to projections from the PTEAM 
<!-- PJG 0012 frnewline -->
data, rather than the PTEAM data per se. Inferences about the 
<!-- PJG 0012 frnewline -->
relative contributions of crustal and automotive sources to PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
Mn were drawn from studies conducted in geographical and temporal 
<!-- PJG 0012 frnewline -->
proximity to the PTEAM study, but both the data from these 
<!-- PJG 0012 frnewline -->
studies and the inferences based on them introduce uncertainties. 
<!-- PJG 0012 frnewline -->
Attempts to adjust the PTEAM data in various ways, including any 
<!-- PJG 0012 frnewline -->
extrapolation from the 24-hour average distribution obtained in 
<!-- PJG 0012 frnewline -->
the fall of 1990 to a long-term average for other seasons, 
<!-- PJG 0012 frnewline -->
introduce progressively greater uncertainties at each step. Some 
<!-- PJG 0012 frnewline -->
adjustments have not even been attempted. For example, a 
<!-- PJG 0012 frnewline -->
weighting of the daytime and nighttime PTEAM exposure data to 
<!-- PJG 0012 frnewline -->
reflect a higher average ventilation rate during daytime 
<!-- PJG 0012 frnewline -->
activities and a lower ventilation rate during nighttime 
<!-- PJG 0012 frnewline -->
activities (e.g., sleeping) would have resulted in higher 
<!-- PJG 0012 frnewline -->
personal exposure estimates. Thus, given other approaches or 
<!-- PJG 0012 frnewline -->
assumptions, different projection estimates are possible. It 
<!-- PJG 0012 frnewline -->
must therefore be emphasized that the two projections of Mn 
<!-- PJG 0012 frnewline -->
exposure levels in Figure 2 should not be interpreted as upper 
<!-- PJG 0012 frnewline -->
and lower bound estimates, for even the higher projection could 
<!-- PJG 0012 frnewline -->
possibly underestimate, or the lower projection overestimate, the 
<!-- PJG 0012 frnewline -->
PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Mn exposure levels associated with MMT. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
As for the relevance of the PTEAM Riverside personal 
<!-- PJG 0012 frnewline -->
exposure estimates to other communities, the PTEAM study was, 
<!-- PJG 0012 frnewline -->
strictly speaking, only designed to statistically represent 
<!-- PJG 0012 frnewline -->
Riverside, CA. In that respect, the design and conduct of the 
<!-- PJG 0012 frnewline -->
PTEAM study provide a high degree of confidence that it does 
<!-- PJG 0012 frnewline -->
accurately represent 24-hour average Mn exposure concentrations 
<!-- PJG 0012 frnewline -->
for the Riverside population in the fall of 1990. In ORD's 
<!-- PJG 0012 frnewline -->
judgment, the PTEAM study provides a reasonable representation of 
<!-- PJG 0012 frnewline -->
the Los Angeles Basin as well, given the commonalities in 
<!-- PJG 0012 frnewline -->
geography, vehicle usage, and meteorology. However, the 
<!-- PJG 0012 frnewline -->
relevance of the Riverside data to other U.S. communities depends 
<!-- PJG 0012 frnewline -->
upon their similarities or differences in the most relevant 
<!-- PJG 0012 frnewline -->
characteristics or dimensions. For example, to the extent that 
<!-- PJG 0012 frnewline -->
several other major U.S. metropolitan areas (or subcommunities in 
<!-- PJG 0012 frnewline -->
these areas) also have a high level of vehicle usage, the 
<!-- PJG 0012 frnewline -->
Riverside projections may have greater relevance. To the extent 
<!-- PJG 0012 frnewline -->
that these same areas do not share the meteorological conditions 
<!-- PJG 0012 frnewline -->
that contribute to the Mn exposure levels measured in Riverside, 
<!-- PJG 0012 frnewline -->
the Riverside projections have lesser relevance. It is also 
<!-- PJG 0012 frnewline -->
important to consider other sources of Mn exposure apart from 
<!-- PJG 0012 frnewline -->
automotive and crustal sources. Although Riverside had no major 
<!-- PJG 0012 frnewline -->
point sources of Mn contributing to the personal exposure levels 
<!-- PJG 0012 frnewline -->
measured in the PTEAM study, other communities may have such 
<!-- PJG 0012 frnewline -->
sources, and thus the personal exposure levels of Mn from all 
<!-- PJG 0012 frnewline -->
sources might be higher in other communities than in Riverside. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00084 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The exposure estimates shown in Figure 3 are in the range of 
<!-- PJG 0012 frnewline -->
or exceed some candidate RfC estimates as well as the current 
<!-- PJG 0012 frnewline -->
RfC. Exceeding the RfC does not necessarily indicate that a 
<!-- PJG 0012 frnewline -->
public health risk will occur. At present, it is impossible to 
<!-- PJG 0012 frnewline -->
state whether projected exposures above the RfC would result in 
<!-- PJG 0012 frnewline -->
an adverse health effect for either an individual or the general 
<!-- PJG 0012 frnewline -->
population. At a sufficiently high level of exposure, adverse 
<!-- PJG 0012 frnewline -->
effects would be expected to occur, first in any sensitive 
<!-- PJG 0012 frnewline -->
subpopulations, then with greater prevalence in the general 
<!-- PJG 0012 frnewline -->
population and extending to other types of effects (e.g., 
<!-- PJG 0012 frnewline -->
reproductive and/or respiratory as well as neurobehavioral 
<!-- PJG 0012 frnewline -->
effects in the case of Mn). However, the relationship between 
<!-- PJG 0012 frnewline -->
such ``sufficiently high'' levels and the population exposure 
<!-- PJG 0012 frnewline -->
levels estimated by the projection methods employed here is 
<!-- PJG 0012 frnewline -->
unknown. Expressed differently, given the gap between observed 
<!-- PJG 0012 frnewline -->
or modeled effect levels and the RfC values obtained by applying 
<!-- PJG 0012 frnewline -->
uncertainty factors of orders of magnitude, it is impossible to 
<!-- PJG 0012 frnewline -->
state whether projected population exposures would lie above or 
<!-- PJG 0012 frnewline -->
below a presumed threshold level on the actual concentration-response curve for Mn neurotoxicity. This gap between
projected 
<!-- PJG 0012 frnewline -->
exposure levels and the lowest concentrations obtained by 
<!-- PJG 0012 frnewline -->
modeling the concentration-response relationship (at least, by 
<!-- PJG 0012 frnewline -->
the quantal linear model) makes it impossible to make any 
<!-- PJG 0012 frnewline -->
assertion regarding the likelihood of a health risk at projected 
<!-- PJG 0012 frnewline -->
exposure levels. However, this conclusion should not be 
<!-- PJG 0012 frnewline -->
interpreted to imply that, therefore, no health risk is expected 
<!-- PJG 0012 frnewline -->
to exist at exposure levels exceeding the RfC. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6560&hyph;50&hyph;P
<!-- PJG 0101 clearpage -->

<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->

<!-- PJG STAG 4725 -->

<IMPORT>

<!-- PJG importformat s,d640 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->
E:GRAPHICSEN17AU94.001
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

</IMPORT>

<!-- PJG /STAG -->

<!-- PJG STAG 4703 -->

<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6560&hyph;50&hyph;C
<!-- PJG 0101 clearpage -->

<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00085 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=74 g=1 f=1 -->
E. References 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Allen, B. C.; Kavlock, R. J.; Kimmel, C. A.; Faustman, E. M. 
<!-- PJG 0012 frnewline -->
(1994) Dose-response assessments for developmental toxicity: 
<!-- PJG 0012 frnewline -->
II. Comparison of generic benchmark dose estimates with 
<!-- PJG 0012 frnewline -->
NOAELS. Fundam. Appl. Toxicol.: in press. 
<!-- PJG 0012 frnewline -->
American Conference of Governmental Industrial Hygienists. (1992) 
<!-- PJG 0012 frnewline -->
1992&hyph;1993 threshold limit values for chemical substances and 
<!-- PJG 0012 frnewline -->
physical agents and biological exposure indices. Cincinnati, 
<!-- PJG 0012 frnewline -->
OH: American Conference of Governmental Industrial 
<!-- PJG 0012 frnewline -->
Hygienists, Technical Information Office; pp. 40&hyph;45. 
<!-- PJG 0012 frnewline -->
Aschner, M.; Gannon, M. (1994) Manganese (Mn) transport across 
<!-- PJG 0012 frnewline -->
the rat blood-brain barrier: saturable and transferrin-dependent transport mechanisms. Brain Res. Bull. 33: 345&hyph;349.

<!-- PJG 0012 frnewline -->
Barnes, D. G.; Daston, G. P.; Evans, J. S.; Jarabek, A. M.; 
<!-- PJG 0012 frnewline -->
Kavlock, R. J.; Kimmel, C. A.; Park, C.; Spitzer, H. L. 
<!-- PJG 0012 frnewline -->
(1994) Benchmark dose workshop: criteria for use of a 
<!-- PJG 0012 frnewline -->
benchmark dose to estimate a reference dose. Regul. Toxicol. 
<!-- PJG 0012 frnewline -->
Pharmacol.: submitted. 
<!-- PJG 0012 frnewline -->
Clayton, C. A.; Perritt, R. L.; Pellizzari, E. D.; Thomas, K. W.; 
<!-- PJG 0012 frnewline -->
Whitmore, R. W.; &Ouml;zkaynak, H.; Spengler, J. D.; Wallace, L. 
<!-- PJG 0012 frnewline -->
A. (1993) Particle total exposure assessment methodology 
<!-- PJG 0012 frnewline -->
(PTEAM) study: distributions of aerosol and elemental 
<!-- PJG 0012 frnewline -->
concentrations in personal, indoor, and outdoor air samples 
<!-- PJG 0012 frnewline -->
in a southern California community. J. Exposure Anal. 
<!-- PJG 0012 frnewline -->
Environ. Epidemiol. 3: 227&hyph;250. 
<!-- PJG 0012 frnewline -->
Cotzias, G. C.; Horiuchi, K.; Fuenzalida, S.; Mena, I. (1968) 
<!-- PJG 0012 frnewline -->
Chronic manganese poisoning: clearance of tissue manganese 
<!-- PJG 0012 frnewline -->
concentrations with persistence of the neurological picture. 
<!-- PJG 0012 frnewline -->
Neurology 18: 376&hyph;382. 
<!-- PJG 0012 frnewline -->
Crump, K. S. (1984) A new method for determining allowable daily 
<!-- PJG 0012 frnewline -->
intakes. Fundam. Appl. Toxicol. 4: 854&hyph;871. 
<!-- PJG 0012 frnewline -->
Ethyl Corporation. (1994) Comments of Ethyl Corporation in 
<!-- PJG 0012 frnewline -->
response to EPA's December 9, 1993 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
 notice 58 
<!-- PJG 0012 frnewline -->
Fed. Reg. 64761 (1993). Washington, DC: Ethyl Corporation, 
<!-- PJG 0012 frnewline -->
Office of the Vice President for Government Relations. 
<!-- PJG 0012 frnewline -->
Available for inspection at: U.S. Environmental Protection 
<!-- PJG 0012 frnewline -->
Agency, Central Docket Section, Washington, DC: docket no. A&hyph;93&hyph;26. 
<!-- PJG 0012 frnewline -->
Faustman, E. M.; Allen, B.C.; Kavlock, R.J.; Kimmel, C.A. (1994) 
<!-- PJG 0012 frnewline -->
Dose-response assessment for developmental toxicity: I. 
<!-- PJG 0012 frnewline -->
characterization of data base and determination of NOAELs. 
<!-- PJG 0012 frnewline -->
Fundam. Appl. Toxicol.: in press. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
. (1993) Draft report: principles of 
<!-- PJG 0012 frnewline -->
neurotoxicology risk assessment. F. R. (August 4) 
<!-- PJG 0012 frnewline -->
58: 41556&hyph;41599. 
<!-- PJG 0012 frnewline -->
Gottschalk, L. A.; Rebello, T.; Buchsbaum, M. S.; Tucker, H. G.; 
<!-- PJG 0012 frnewline -->
Hodges, E. L. (1991) Abnormalities in hair trace elements as 
<!-- PJG 0012 frnewline -->
indicators of aberrant behavior. Compr. Psychiatry 32: 229&hyph;237. 
<!-- PJG 0012 frnewline -->
Iregren, A. (1990) Psychological test performance in foundry 
<!-- PJG 0012 frnewline -->
workers exposed to low levels of manganese. Neurotoxicol. 
<!-- PJG 0012 frnewline -->
Teratol. 12: 673&hyph;675. 
<!-- PJG 0012 frnewline -->
IRIS, Integrated Risk Information System (data base). (1993) 
<!-- PJG 0012 frnewline -->
(Printout of reference concentration (RfC) for chronic 
<!-- PJG 0012 frnewline -->
manganese exposure as revised November, 1993). Cincinnati, 
<!-- PJG 0012 frnewline -->
OH: U.S. Environmental Protection Agency, Office of Health 
<!-- PJG 0012 frnewline -->
and Environmental Assessment, Environmental Criteria and 
<!-- PJG 0012 frnewline -->
Assessment Office. Available online from: TOXNET, National 
<!-- PJG 0012 frnewline -->
Library of Medicine, Rockville, MD. 
<!-- PJG 0012 frnewline -->
Jarabek, A. M.; Hasselblad, V. (1991) Inhalation reference 
<!-- PJG 0012 frnewline -->
concentration methodology: impact of dosimetric adjustments 
<!-- PJG 0012 frnewline -->
and future directions using the confidence profile method. 
<!-- PJG 0012 frnewline -->
Presented at: 84th annual meeting and exhibition; June; 
<!-- PJG 0012 frnewline -->
Vancouver, British Columbia, Canada. Pittsburgh, PA: Air and 
<!-- PJG 0012 frnewline -->
Waste Management Association; paper no. 91&hyph;173.3. 
<!-- PJG 0012 frnewline -->
Kawamura, R.; Ikuta, H.; Fukuzami, S.; Yamada, R.; Tsubaki, S.; 
<!-- PJG 0012 frnewline -->
Kodama, T. (1941) Intoxication by manganese in well water. 
<!-- PJG 0012 frnewline -->
Kitasato Arch. Exp. Med. 18: 145&hyph;169. 
<!-- PJG 0012 frnewline -->
Kimmel, C. A.; Gaylor, D. W. (1988) Issues in qualitative and 
<!-- PJG 0012 frnewline -->
quantitative risk analysis for developmental toxicology. Risk 
<!-- PJG 0012 frnewline -->
Anal. 8: 15&hyph;20. 
<!-- PJG 0012 frnewline -->
Kirshenblatt, M. (1993) (Letter to Ms. M. T. Smith, U.S. EPA, 
<!-- PJG 0012 frnewline -->
regarding the August 30, 1993, rebuttal comments from Ethyl 
<!-- PJG 0012 frnewline -->
Corporation in support of their waiver request for HITEC 3000 
<!-- PJG 0012 frnewline -->
fuel additive.) Ottawa, Ontario, Canada: Environment Canada, 
<!-- PJG 0012 frnewline -->
Transportation Systems Division, Industrial Programs Branch; 
<!-- PJG 0012 frnewline -->
September 23. 
<!-- PJG 0012 frnewline -->
Lyons, J. M.; Venkataraman, C.; Main, H. H.; Friedlander, S. K. 
<!-- PJG 0012 frnewline -->
(1993) Size distributions of trace metals in the Los Angeles 
<!-- PJG 0012 frnewline -->
atmosphere. Atmos. Environ. Part B 27B: 237&hyph;249. 
<!-- PJG 0012 frnewline -->
Mergler, D.; Huel, G.; Bowler, R.; Iregren, A.; Belanger, S.; 
<!-- PJG 0012 frnewline -->
Baldwin, M.; Tardif, R.; Smargiassi, A.; Martin, L. (1994) 
<!-- PJG 0012 frnewline -->
Nervous system dysfunction among workers with long-term 
<!-- PJG 0012 frnewline -->
exposure to manganese. Environ. Res. 64: 151&hyph;180. 
<!-- PJG 0012 frnewline -->
Murphy, V. A.; Wadhwani, K. C.; Smith, Q. R.; Rapoport, S. I. 
<!-- PJG 0012 frnewline -->
(1991) Saturable transport of manganese (II) across the rat 
<!-- PJG 0012 frnewline -->
blood-brain barrier. J. Neurochem. 57: 948&hyph;954. 
<!-- PJG 0012 frnewline -->
Pellizzari, E. D.; Thomas, K. W.; Clayton, C. A.; Whitmore, R. 
<!-- PJG 0012 frnewline -->
W.; Shores, R. C.; Zelon, H. S.; Perritt, R. L. (1992) 
<!-- PJG 0012 frnewline -->
Particle total exposure assessment methodology (PTEAM): 
<!-- PJG 0012 frnewline -->
Riverside, California pilot study, volume I (final report). 
<!-- PJG 0012 frnewline -->
Research Triangle Park, NC: U.S. Environmental Protection 
<!-- PJG 0012 frnewline -->
Agency, Atmospheric Research and Exposure Assessment 
<!-- PJG 0012 frnewline -->
Laboratory; EPA report no. EPA/600/R&hyph;93/050. Available from: 
<!-- PJG 0012 frnewline -->
NTIS, Springfield, VA; PB93&hyph;166957/XAB. 
<!-- PJG 0012 frnewline -->
Preuss, P. W. (1991) ORD's comments on Ethyl Corporation's July 
<!-- PJG 0012 frnewline -->
12, 1991 resubmittal of a waiver application for the use of 
<!-- PJG 0012 frnewline -->
methylcyclopentadienyl manganese tricarbonyl (MMT) in 
<!-- PJG 0012 frnewline -->
unleaded gasoline (memorandum to Richard Wilson). Washington, 
<!-- PJG 0012 frnewline -->
DC: U.S. Environmental Protection Agency, Office of Research 
<!-- PJG 0012 frnewline -->
and Development; December 12. 
<!-- PJG 0012 frnewline -->
Rodier, J. (1955) Manganese poisoning in Moroccan miners. Br. J. 
<!-- PJG 0012 frnewline -->
Ind. Med. 12: 21&hyph;35. 
<!-- PJG 0012 frnewline -->
Roels, H. (1993) (Letter to Dr. M. Davis, U.S. EPA, on 
<!-- PJG 0012 frnewline -->
definitions of ``respirable,'' ``total,'' and ``inhalable'' dusts). 
<!-- PJG 0012 frnewline -->
Bruxelles, Belgium: Universite Catholique de Louvain, Unite 
<!-- PJG 0012 frnewline -->
de Toxicologie Industrielle et Medecine du Travail; October 
<!-- PJG 0012 frnewline -->
19. 
<!-- PJG 0012 frnewline -->
Roels, H.; Lauwerys, R.; Genet, P.; Sarhan, M. J.; de Fays, M.; 
<!-- PJG 0012 frnewline -->
Hanotiau, I.; Buchet, J.&hyph;P. (1987) Relationship between 
<!-- PJG 0012 frnewline -->
external and internal parameters of exposure to manganese in 
<!-- PJG 0012 frnewline -->
workers from a manganese oxide and salt producing plant. Am. 
<!-- PJG 0012 frnewline -->
J. Ind. Med. 11: 297&hyph;305. 
<!-- PJG 0012 frnewline -->
Roels, H. A.; Ghyselen, P.; Buchet, J. P.; Ceulemans, E.; 
<!-- PJG 0012 frnewline -->
Lauwerys, R. R. (1992) Assessment of the permissible exposure 
<!-- PJG 0012 frnewline -->
level to manganese in workers exposed to manganese dioxide 
<!-- PJG 0012 frnewline -->
dust. Br. J. Ind. Med. 49: 25&hyph;34. 
<!-- PJG 0012 frnewline -->
Thomas, K. W.; Pellizzari, E. D.; Clayton, C. A.; Whitaker, D. 
<!-- PJG 0012 frnewline -->
A.; Shores, R. C.; Spengler, J. D.; &Ouml;zkaynak, H.; Wallace, L. 
<!-- PJG 0012 frnewline -->
A. (1993) Particle total exposure assessment methodology 
<!-- PJG 0012 frnewline -->
(PTEAM) study: method performance and data quality for 
<!-- PJG 0012 frnewline -->
personal, indoor, and outdoor aerosol monitoring at 178 homes 
<!-- PJG 0012 frnewline -->
in southern California. J. Exposure Anal. Environ. Epidemiol. 
<!-- PJG 0012 frnewline -->
3: 203&hyph;226. 
<!-- PJG 0012 frnewline -->
Tukey, J. W.; Ciminera, J. L.; Heyse, J. F. (1985) Testing the 
<!-- PJG 0012 frnewline -->
statistical certainty of a response to increasing doses of a 
<!-- PJG 0012 frnewline -->
drug. Biometrics 14: 295&hyph;301. 
<!-- PJG 0012 frnewline -->
U.S. Environmental Protection Agency. (1990) Comments on the use 
<!-- PJG 0012 frnewline -->
of methylcyclopentadienyl manganese tricarbonyl in unleaded 
<!-- PJG 0012 frnewline -->
gasoline. Washington, DC: Office of Research and Development. 
<!-- PJG 0012 frnewline -->
U.S. Environmental Protection Agency. (1991) Information needed 
<!-- PJG 0012 frnewline -->
to improve the risk characterization of manganese tetraoxide 
<!-- PJG 0012 frnewline -->
(Mn
<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=5 f=2 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=5 f=2 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
) and methylcyclopentadienyl manganese tricarbonyl 
<!-- PJG 0012 frnewline -->
(MMT). Washington, DC: Office of Research and Development; 
<!-- PJG 0012 frnewline -->
December 12. 
<!-- PJG 0012 frnewline -->
Wallace, L. A.; Duan, N.; Ziegenfus, R. (1994) Can long-term 
<!-- PJG 0012 frnewline -->
exposure distributions be predicted from short-term 
<!-- PJG 0012 frnewline -->
measurements? Risk Anal. 14: 75&hyph;85. 
<!-- PJG 0012 frnewline -->
Wennberg, A.; Iregren, A.; Struwe, G.; Cizinsky, G.; Hagman, M.; 
<!-- PJG 0012 frnewline -->
Johansson, L. (1991) Manganese exposure in steel smelters a 
<!-- PJG 0012 frnewline -->
health hazard to the nervous system. Scand. J. Work Environ. 
<!-- PJG 0012 frnewline -->
Health 17: 255&hyph;262. 
<!-- PJG 0012 frnewline -->
Wennberg, A.; Hagman, M.; Johansson, L. (1992) Preclinical 
<!-- PJG 0012 frnewline -->
neurophysiological signs of parkinsonism in occupational 
<!-- PJG 0012 frnewline -->
manganese exposure. Neurotoxicology 13: 271&hyph;274. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00086 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=83 g=1 f=1 -->
F. Comments on Health Assessment and EPA Response 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The focus of most of Ethyl's comments regarding the effects on public health and welfare resulting from the use of MMT
in unleaded gasoline deal with issues related to EPA's risk assessment and specifically to the calculation of an RfC
for manganese by the utilization of various analytical methods, to the uncertainty factors used by the Agency in determining
the RfC for manganese, and to the exposure assessment for manganese. A summary discussion of the significant issues
related to these comments follows.
<FOOTCITE>61</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
61
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
For a complete description of the EPA response to Ethyl's comments, the reader is referred to Air Docket A&hyph;93&hyph;26,
(Docket A&hyph;93&hyph;26, II&hyph;A&hyph;15) ``ORD's Response to Public Comments on the Reference Concentration
for Manganese and on the Draft ORD Risk Assessment of MMT.''
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Generally, Ethyl states that ``ORD openly concedes that after four years of efforts it is unable to conclude that a
public health risk would exist for even the most highly exposed segment of the population.'' The Agency indicated
to Ethyl in 1991 the research it could conduct to provide for a more quantitative assessment of the MMT issue. Thus,
assessment of the risks or benefits of MMT could be, or perhaps could already have been, improved if more empirical
information were provided by Ethyl to the Agency. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Ethyl commented on ORD's April 28, 1994 draft MMT Risk Assessment that, depending on the methodology used for the derivation
of the RfC for manganese, the level of manganese concentrations ``without appreciable risk'' lies somewhere within
the range of 0.1 to 3.0 &mu;g/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and that all of ORD's RfC calculations fall within this range. Contrary to Ethyl's statement, the inclusion of Ethyl's
proposed RfC estimate of 3.0 &mu;g/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 in tables and figures summarizing the RfC estimates obtained by different methods was merely an attempt by the Agency
to illustrate all of the RfC estimates. The Agency did not imply or state a conclusion that ``The majority of ORD's RfC
calculations fall in the 0.1&hyph;3.0 &mu;g/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 range.'' ORD focused on a leading candidate RfC estimate of approximately 0.1 &mu;g/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, while explicitly noting that the current official RfC of 0.05 &mu;g/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 is not meaningfully different from a possible alternative RfC estimate of 0.1 &mu;g/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
To more effectively avoid possible ambiguity that is reflected in Ethyl's comment, Figure 1 of the final MMT Risk Assessment
(U.S. Environmental Protection Agency, 1994b) shows all of the RfC estimates contained in Table A&hyph;39 of Appendix
A. Ethyl's preferred RfC estimate of 3 &mu;g/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 is now omitted from Figure 1 because it is not a value obtained by any of ORD's analyses. Moreover, it is ORD's view that
the best estimate of an alternative RfC estimate for Mn, based on the analyses and data considered to date, probably
lies in the range of 0.09 to 0.2 &mu;g/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. This judgment is based on the strengths and weaknesses of the various analytic approaches considered by ORD in the
April 28 draft assessment.
<FOOTCITE>62</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
62
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The reader is referred to Air Docket A&hyph;93&hyph;26, II&hyph;A&hyph;15, ``ORD's Response to Public Comments
on the Reference Concentration for Manganese and on the Draft ORD Risk Assessment of MMT, for further evaluation of
the various analytical approaches that were investigated by the Agency. ORD views the 10 and 5% benchmark and Bayesian
analyses of dichotomous data and the Bayesian analyses of continuous data using the quantal linear model as having
greater scientific strengths than the other analyses considered by ORD or by Ethyl.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00087 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Ethyl has stated that EPA has failed to address issues regarding both the statistical treatment of the data underlying
the RfC and EPA's decision to employ a 1000-fold factor of uncertainty in calculating the RfC. EPA disagrees. Appendix
A of the ORD Risk Assessment addresses each of these issues. The extensive analyses the Agency has conducted represent
a concerted effort to respond to the statistical issues raised by Ethyl. The fact that EPA does not adopt Ethyl's advocated
position is not a failure to address the issues. In fact, no scientific consensus or policy exists on many of these issues,
such as the selection of a specific mathematical dose-response model, the selection of an effect level, how to address
continuous data, and the appropriate magnitude of severity regarding production of uncertainty factors for the
various effect levels. As is specifically described in the ``Response to Comments'' document, ORD utilized scientific
judgment in determining the appropriateness of certain models and the inclusion of specific uncertainty factors.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Ethyl also expressed concerns that EPA had not adequately addressed alternative analyses for estimating an RfC by
utilizing different groupings of subjects in the Roels analysis. ICF Kaiser, a consultant for Ethyl, commented that
``ORD ignores alternative analyses which most closely resemble the conventional method for calculating RfCs.''
The alternative approach Ethyl employed to group the data from the study by Roels et al. (1992) has no evident rationale
other than providing a statistically nonsignificant effect level. The groupings employed by Roels et al. (1992)
and used by ORD appear to have been selected because they provided approximately equal numbers of subjects per group.
The groupings selected by Ethyl result in both smaller and more disparate numbers of subjects per group, with a consequent
reduction in statistical power to detect a significant difference between a Mn-exposed group and controls. Further,
as explained in the Response to Comments Document previously cited, ORD does not view the use of the upper boundary
of the concentration associated with a group as a scientifically appropriate or representative metric to describe
the exposure of the entire group. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Ethyl also took issue with the Agency for focusing on analyses using the average concentration of respirable dust
(ACRD). The decision to focus on ACRD was not arbitrary or designed to yield lower RfC estimates but, as explained in
Appendix A of the ORD Risk Assessment, was based on both an explicit consideration of the advantages ACRD offered for
fitting dose-response models and its ability to reflect average past exposure, thereby obviating some of the apparent
disadvantages of the two exposure measures reported by Roels et al. (1992), LIRD and CRD. Although the Agency views
ACRD as the best choice of these three available exposure measures for the analytical approaches employed in the ORD
risk assessment, Figure 1 (See Section VI&hyph;B, above.) illustrates all of the RfC estimates presented for all
three exposure measures and all analytical approaches. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Ethyl recommends that certain analyses should be omitted from consideration on the ORD risk assessment. To some extent,
the Agency believes the difference between Ethyl's and EPA's positions is related to differing interpretations
of what is reasonable versus unreasonable, biologically plausible versus implausible, or valid versus invalid.
As addressed before, the Agency's basic approach in the ORD risk assessment was to present all of the results of its
analyses and then identify a subset of the total that have a scientifically stronger basis for being considered preferentially.
<FOOTCITE>63</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
63
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
For specific discussion related to these issues the reader is referred to Air Docket A&hyph;93&hyph;26, II&hyph;A&hyph;12.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Ethyl offers several arguments directed at reducing the overall uncertainty and specifically the composite uncertainty
factor (UF) of 10 for database limitations applied in deriving estimates of an RfC for manganese. Ethyl's first argument
concerns the basic ``biological plausibility'' of the RfC, suggesting that inhaled manganese cannot be as toxic
(compared to ingested manganese) as the roughly 100-fold difference in RfC and RfD estimates would indicate.
<FOOTCITE>64</FOOTCITE>
 The Agency believes that a fundamental problem with Ethyl's comparison is that it is limited to what Ethyl estimates
is the ``systemic dose.'' The key issue is not systemic dose but delivered dose, i.e., the amount of manganese that
actually reaches and enters a critical target organ such as the brain. Furthermore, the Agency believes that, depending
on the form of manganese inhaled, and its ability to enter the brain, it is quite possible that a significant fraction
of even small amounts of inhaled manganese would be able to reach target sites in the central nervous system. Thus,
the apparently greater toxicity of inhaled versus ingested manganese may reflect important pharmacodynamic and
pharmacokinetic differences of manganese that enters the body by different routes of exposure. Ethyl's analysis
of systemic dose does not adequately address this issue.
<FOOTCITE>65</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
64
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
See Air Docket A&hyph;93&hyph;26. The Reference Dose or RfD is analogous to the RfC but for ingestion as opposed to
inhalation. Document II&hyph;A&hyph;13 (in the docket), Table 1, compares the ``systemic dose'' of manganese for
the Recommended Daily Intake (now termed ``Recommended Daily Allowance'' by FDA) of ingested manganese, the RfC
for inhaled manganese, and the RfD for manganese in drinking water. This tabular comparison does not address several
issues that the Agency has identified as factors in its assessment on inhaled manganese toxicity.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
65
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
In fact, as is indicated in ``ORD's Response to Comments on MMT'' document, many studies indicate that inhalation
exposure does result in a greater delivered dose. This evidence includes, for example, a report by Coulston and Griffin
(1977), who exposed monkeys to the whole combustion products of MMT (Mn
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=2 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=2 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
) for 23 hr/day for up to 66 weeks. According to the authors, monkeys breathed 0.86 L/min, or 119 L in a 23-hr exposure
day. AT 100 &mu;g/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
, approximately 120 &mu;g Mn would be inhaled daily, which would equate to a systemic dose of about 24 &mu;g/day (assuming
20% deposition and 100% absorption). In addition, both control and inhalation-exposed monkeys ingested about 4&hyph;5
mg Mn/day in their diet, which would equate to a systemic dose of approximately 135 &mu;g/day (assuming 3% absorption).
Even though these calculations indicate that the diet accounted for about six times more Mn entering the body of the
exposed animals, the relatively small inhalation fraction doubled the delivered dose of Mn in the brains of the inhalation-exposed
monkeys. Furthermore, the authors found blood levels of Mn to be equivalent in the exposed and control monkeys, despite
the higher brain levels in the inhalation-exposed animals. Thus, extrapolations based on estimated systemtic dose
by ingestion underpredict doses delivered to the brain by inhalation.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The more specific critique Ethyl offers regarding the composite UF of 10 for database limitations deals with three
areas of inadequate information represented by the composite factor: chronic exposure effects, reproductive/developmental
effects, and differences in toxicity of different forms of manganese. In deriving RfCs for other chemicals, any one
of these three areas of uncertainty has, in one case or another, warranted a full UF of 10.
<FOOTCITE>66</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
66
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The decision whether to utilize the full uncertainty factor of 10 is based on a judgement by the RfC workgroup on a case-by-case
basis.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Agency believes that given the possible accumulation of manganese, the effects of chronic exposure to inhaled
manganese are of concern. The maximum average exposure duration of the available occupational studies cited by both
ORD and Ethyl is 16.7 years (Mergler et al. 1994),
<FOOTCITE>67</FOOTCITE>
 which does not constitute chronic exposure. Ethyl's comments ignore the point that the RfC is in fact aimed at extrapolation
to 70 exposure years. Reproductive and developmental toxicity are widely recognized as significant public health
concerns and therefore warrant specific consideration as uncertainties in RfC derivation. The available animal
studies on reproductive and developmental effects almost exclusively involved oral dosing of manganese and are
inadequate for inhalation RfC purposes. Studies of such effects in humans are limited for males and nonexistent for
females. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
67
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Mergler D.; Huel, G.; Bowler, R.; Iregren, A.; Belanger, S.; Baldwin, M.; Tardif, R.; Smargiassi, A.; Martin, L.;
(1994) Nervous system dysfunction among workers with long-term exposure to manganese. Environ. Res. 64: 151&hyph;180.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The potential difference in toxicity potency of Mn3O4 in comparison to MnO2 or other compounds of manganese is a significant
uncertainty because no existing study has directly compared the toxicities of these compounds by inhalation exposure.
Ethyl's comparison of studies involving not only different routes of exposure but significant differences in methods,
subjects/subject populations, and other key features does not constitute an adequate quantitative assessment.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00088 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In summary, the three areas of uncertainty reflected in the 
<!-- PJG 0012 frnewline -->
composite UF of 10 used in deriving the manganese RfC estimates 
<!-- PJG 0012 frnewline -->
are appropriate because they are not adequately addressed by 
<!-- PJG 0012 frnewline -->
available studies. 
<!-- PJG 0012 frnewline -->
Ethyl stated that ORD has overlooked evidence from the 
<!-- PJG 0012 frnewline -->
Canadian exposure studies that indicate personal exposure levels 
<!-- PJG 0012 frnewline -->
of manganese are likely to be lower than indicated by the PTEAM 
<!-- PJG 0012 frnewline -->
Riverside Study. The Agency considers Ethyl's exposure 
<!-- PJG 0012 frnewline -->
assessment based on Canadian data to be deficient in several 
<!-- PJG 0012 frnewline -->
respects. Given the fundamental differences in the sampling 
<!-- PJG 0012 frnewline -->
procedures for the Canadian and Riverside studies, as well as 
<!-- PJG 0012 frnewline -->
other differences in the design and conduct of the studies in 
<!-- PJG 0012 frnewline -->
question, the Agency continues to judge the PTEAM Riverside data 
<!-- PJG 0012 frnewline -->
to be far more useful to exposure assessment purposes that the 
<!-- PJG 0012 frnewline -->
Canadian data. The ``consistency'' in the Canadian data that Ethyl 
<!-- PJG 0012 frnewline -->
emphasizes is a subjective matter that can be considered from 
<!-- PJG 0012 frnewline -->
more than one perspective.
<FOOTCITE>68</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
68
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
For specific discussion related to these issues the reader is referred to Air Docket A&hyph;93&hyph;26, II&hyph;A&hyph;15.

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Ethyl also disagrees with certain assumptions and features 
<!-- PJG 0012 frnewline -->
of ORD's draft exposure assessment. In particular, Ethyl claims 
<!-- PJG 0012 frnewline -->
that ORD's draft ``PTEAM Riverside exposure model'' overestimates 
<!-- PJG 0012 frnewline -->
manganese exposure levels for selected Canadian cities by a 
<!-- PJG 0012 frnewline -->
factor of approximately three when used with a factor for 
<!-- PJG 0012 frnewline -->
projected increases in MMT usage. Ethyl's application of the 
<!-- PJG 0012 frnewline -->
``Riverside model'' is incorrect for several reasons, including 
<!-- PJG 0012 frnewline -->
Ethyl's use of ambient monitoring data to estimate personal 
<!-- PJG 0012 frnewline -->
exposure levels (ORD used stationary indoor monitoring data 
<!-- PJG 0012 frnewline -->
collected as part of a personal exposure study). The Agency 
<!-- PJG 0012 frnewline -->
notes that qualitative differences in meteorology and the degree 
<!-- PJG 0012 frnewline -->
of automobile usage provide a more likely basis for the 
<!-- PJG 0012 frnewline -->
differences between Riverside and the Canadian cities cited by 
<!-- PJG 0012 frnewline -->
Ethyl. 
<!-- PJG 0012 frnewline -->
Ethyl also states that the manganese emission rate from 
<!-- PJG 0012 frnewline -->
catalyst vehicles should be a factor of three lower than that for 
<!-- PJG 0012 frnewline -->
noncatalyzed vehicles, which would lower ORD's projected exposure 
<!-- PJG 0012 frnewline -->
estimates by almost the same factor. After reevaluating the 
<!-- PJG 0012 frnewline -->
limited data on manganese emissions from noncatalyst and catalyst 
<!-- PJG 0012 frnewline -->
vehicles, ORD has concluded that no specific emission rate can be 
<!-- PJG 0012 frnewline -->
justified by the available data and that, consequently, an 
<!-- PJG 0012 frnewline -->
assumption of equivalent emission rates for both types of 
<!-- PJG 0012 frnewline -->
vehicles is reasonable and appropriate. 
<!-- PJG 0012 frnewline -->
Ethyl cited data pertaining to the amount of iron and 
<!-- PJG 0012 frnewline -->
manganese in soil and paved road dust (PRD) in Riverside that 
<!-- PJG 0012 frnewline -->
indicate the percentage of automotive contribution to personal 
<!-- PJG 0012 frnewline -->
exposure levels of PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 manganese should be lower than the value 
<!-- PJG 0012 frnewline -->
ORD used. ORD agrees that the iron:manganese data for Riverside 
<!-- PJG 0012 frnewline -->
PRD provide a more geographically specific basis for estimating 
<!-- PJG 0012 frnewline -->
automotive contributions, and therefore the projection estimates 
<!-- PJG 0012 frnewline -->
of personal exposure levels of manganese would be slightly lower 
<!-- PJG 0012 frnewline -->
because of this adjustment.
<FOOTCITE>69</FOOTCITE>
 This adjustment in the exposure 
<!-- PJG 0012 frnewline -->
assessment was incorporated into the final assessment as 
<!-- PJG 0012 frnewline -->
described above in section VI-C. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
69
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
This and other adjustments in the exposure assessment are incorporate in to the final ORD assessment. For further
information regarding this matter, see Air Docket A&hyph;93&hyph;26, II&hyph;A&hyph;12.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Ethyl states that Riverside is not representative of other 
<!-- PJG 0012 frnewline -->
U.S. cities, and ORD does not disagree. Nevertheless, ORD 
<!-- PJG 0012 frnewline -->
believes Riverside is reasonably representative of the greater 
<!-- PJG 0012 frnewline -->
Los Angeles metropolitan area. Consequently, the PTEAM Riverside 
<!-- PJG 0012 frnewline -->
exposure assessment can be considered representative for at least 
<!-- PJG 0012 frnewline -->
14.5 million people (the population of the greater Los Angeles 
<!-- PJG 0012 frnewline -->
area). To the extent that other U.S. cities share some degree of 
<!-- PJG 0012 frnewline -->
resemblance in meteorology, vehicles miles traveled, and possibly 
<!-- PJG 0012 frnewline -->
other characteristics of relevance to automotive manganese 
<!-- PJG 0012 frnewline -->
levels, the estimated exposure levels for Riverside may be 
<!-- PJG 0012 frnewline -->
pertinent to other locales and portions of locales as well. 
<!-- PJG 0012 frnewline -->
However, ORD can only point to qualitative similarities and is 
<!-- PJG 0012 frnewline -->
unable to make any quantitative statement on the degree of 
<!-- PJG 0012 frnewline -->
relevance of the Riverside data to other U.S. cities. 
<!-- PJG 0012 frnewline -->
In its May 27 submission,
<FOOTCITE>70</FOOTCITE>
 Ethyl has noted that a 
<!-- PJG 0012 frnewline -->
distribution of 24-hour average exposure levels is likely to have 
<!-- PJG 0012 frnewline -->
higher exposures at the upper portion of the distribution than 
<!-- PJG 0012 frnewline -->
would a longer term average for the same population. ORD agrees 
<!-- PJG 0012 frnewline -->
that this is likely, but the lack of adequate exposure data make 
<!-- PJG 0012 frnewline -->
it impossible to determine what the actual distribution would be. 
<!-- PJG 0012 frnewline -->
Although Ethyl attempts to correct the distribution of 24-hour 
<!-- PJG 0012 frnewline -->
average data to represent a longer term average, ORD notes 
<!-- PJG 0012 frnewline -->
unstated assumptions and possible errors in Ethyl's calculations 
<!-- PJG 0012 frnewline -->
and prefers alternative approaches to estimating such a 
<!-- PJG 0012 frnewline -->
correction to the distribution.
<FOOTCITE>71</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
70
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
See Air Docket A&hyph;93&hyph;26, Category II&hyph;D&hyph;98.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
71
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
For further information regarding this matter, see Air Docket A&hyph;93&hyph;26, Category II&hyph;A&hyph;15,
page 40. 
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Ethyl commented that ORD's newly released PTEAM exposure 
<!-- PJG 0012 frnewline -->
modeling shows that 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
no
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (emphasis in original) portion of the 
<!-- PJG 0012 frnewline -->
population would experience manganese exposures above the 0.1&hyph;0.3 
<!-- PJG 0012 frnewline -->
&mu;g/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 range. The Agency believes that Ethyl is mistaken in 
<!-- PJG 0012 frnewline -->
making this conclusion. Statements and graphical information in 
<!-- PJG 0012 frnewline -->
ORD's risk assessment indicate that an estimated 5&hyph;10% of the 
<!-- PJG 0012 frnewline -->
Riverside/Los Angeles population would be projected to experience 
<!-- PJG 0012 frnewline -->
personal exposure levels of PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 manganese at or above 0.1 &mu;g/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. Ethyl's statement regarding EPA's exposure assessment would be 
<!-- PJG 0012 frnewline -->
correct only if it were to replace ``0.1&hyph;0.3 &mu;g/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 range'' with 
<!-- PJG 0012 frnewline -->
``0.3 &mu;g/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 range''. 
<!-- PJG 0012 frnewline -->
Ethyl commented that the ``ORD risk assessment projects that 
<!-- PJG 0012 frnewline -->
the 99th percentile manganese exposure would be about 0.2 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
g/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 or lower, while the 90th to 95th percentiles would experience manganese exposures below even 0.1 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
g/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
.'' On the contrary, as shown in the ORD risk assessment, by 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
one
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 estimate, the 98th 
<!-- PJG 0012 frnewline -->
percentile exposure level would be approximately 0.2 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
g/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, and both estimates are above 0.1 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
g/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 at the 95th percentile. (See Figure 2, Section VI-C of this Decision.) 
<!-- PJG 0012 frnewline -->
Finally, Ethyl raises issues from comparing ORD's assessment 
<!-- PJG 0012 frnewline -->
of MMT with ORD's assessment of methyl tertiary butyl ether 
<!-- PJG 0012 frnewline -->
(MTBE). Ethyl reduces the official EPA RfC for MTBE by 
<!-- PJG 0012 frnewline -->
inappropriate uncertainty factors, compares the result to both 
<!-- PJG 0012 frnewline -->
appropriate and inappropriate exposure values for MTBE, finds an 
<!-- PJG 0012 frnewline -->
overlap of these health and exposure assessments for MTBE, and 
<!-- PJG 0012 frnewline -->
concludes that, by comparison, MMT was treated too conservatively 
<!-- PJG 0012 frnewline -->
or erroneously. Basically, because of substantial differences 
<!-- PJG 0012 frnewline -->
between the databases and characteristics of MTBE (a volatile 
<!-- PJG 0012 frnewline -->
organic compound that remains in the body for a matter of hours 
<!-- PJG 0012 frnewline -->
to days) and Mn (a metal that accumulates in the body), Ethyl's 
<!-- PJG 0012 frnewline -->
direct comparisons are not valid.
<FOOTCITE>72</FOOTCITE>
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
72
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
For further discussion regarding this matter, the reader is referred to Air Docket A&hyph;93&hyph;26, II&hyph;A&hyph;15,
Section IV.
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Comments from other interested parties regarding potential 
<!-- PJG 0012 frnewline -->
health concerns related to manganese exposure are addressed in 
<!-- PJG 0012 frnewline -->
``ORD's Response to Public Comments'' found in Docket A&hyph;93&hyph;26. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
VII. Fuels and Fuel Additives Registration and Research Needs 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
To more accurately define an RfC for manganese and to more 
<!-- PJG 0012 frnewline -->
accurately predict the distribution of expected manganese 
<!-- PJG 0012 frnewline -->
exposures associated with MMT use, additional research will have 
<!-- PJG 0012 frnewline -->
to be completed. Such research would ultimately lead to a risk 
<!-- PJG 0012 frnewline -->
assessment which could better define the risk associated with MMT 
<!-- PJG 0012 frnewline -->
use. Furthermore, regulations under sections 211(a), (b), and 
<!-- PJG 0012 frnewline -->
(e) of the Act, set forth a procedure under which required health 
<!-- PJG 0012 frnewline -->
and exposure data must be submitted prior to any new use of a 
<!-- PJG 0012 frnewline -->
fuel or additive. Given the basis for today's decision and the 
<!-- PJG 0012 frnewline -->
purpose of the testing requirements imposed by these regulations, 
<!-- PJG 0012 frnewline -->
the Agency expects that the testing required to resolve the 
<!-- PJG 0012 frnewline -->
concerns upon which today's decision is based will also be 
<!-- PJG 0012 frnewline -->
required under these regulations. The following section explains 
<!-- PJG 0012 frnewline -->
these newly promulgated requirements and how they would apply to 
<!-- PJG 0012 frnewline -->
the use of MMT in unleaded gasoline. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00089 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Under section 211 of the Clean Air Act, certain fuels and 
<!-- PJG 0012 frnewline -->
additives must be registered with EPA as a precondition to 
<!-- PJG 0012 frnewline -->
introduction into commerce. Section 211(a) of the Act authorizes 
<!-- PJG 0012 frnewline -->
EPA to designate any fuel or fuel additive for registration. 
<!-- PJG 0012 frnewline -->
Upon designation, fuels or additives may not be introduced into 
<!-- PJG 0012 frnewline -->
commerce unless they have been registered by EPA in accordance 
<!-- PJG 0012 frnewline -->
with section 211(b). In 1975, EPA issued regulations (40 CFR 
<!-- PJG 0012 frnewline -->
Part 79) implementing basic registration requirements, as 
<!-- PJG 0012 frnewline -->
stipulated by section 211(b)(1), that required applicants to 
<!-- PJG 0012 frnewline -->
submit certain information, such as commercial identifying 
<!-- PJG 0012 frnewline -->
information, range of concentration, purpose-in-use, and chemical 
<!-- PJG 0012 frnewline -->
composition, in order to register a fuel or fuel additive. 
<!-- PJG 0012 frnewline -->
The 1970 Clean Air Act also gave EPA discretionary authority 
<!-- PJG 0012 frnewline -->
to establish additional registration requirements under section 
<!-- PJG 0012 frnewline -->
211(b)(2). This section authorized EPA to require fuel and fuel 
<!-- PJG 0012 frnewline -->
additive manufacturers ``to conduct tests to determine potential 
<!-- PJG 0012 frnewline -->
public health effects of such fuel(s) or additive(s) (including 
<!-- PJG 0012 frnewline -->
but not limited to, carcinogenic, teratogenic, or mutagenic 
<!-- PJG 0012 frnewline -->
effects),'' and to further furnish other ``reasonable and 
<!-- PJG 0012 frnewline -->
necessary'' information to identify fuel and fuel additive 
<!-- PJG 0012 frnewline -->
emissions and determine their effects on vehicular emission 
<!-- PJG 0012 frnewline -->
control performance and on public health and welfare. 
<!-- PJG 0012 frnewline -->
EPA did not exercise its discretionary authority to require 
<!-- PJG 0012 frnewline -->
testing of fuels and fuel additives under section 211(b)(2) when 
<!-- PJG 0012 frnewline -->
general registration regulations were first adopted in 1975. 
<!-- PJG 0012 frnewline -->
However, in the Clean Air Act Amendments of 1977 (Public Law 95&hyph;
<!-- PJG 0012 frnewline -->
95, August 7, 1977), Congress added section 211(e), which 
<!-- PJG 0012 frnewline -->
required EPA to take certain actions to implement section 
<!-- PJG 0012 frnewline -->
211(b)(2). A final rule was signed by the Administrator of EPA on 
<!-- PJG 0012 frnewline -->
May 27, 1994 and was published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 on June 
<!-- PJG 0012 frnewline -->
27, 1994 (59 FR 33042). The final rule, ``Fuels and Fuels 
<!-- PJG 0012 frnewline -->
Additives Registration Regulations'', implemented additional 
<!-- PJG 0012 frnewline -->
registration requirements under sections 211(b)(2) and 211(e) of 
<!-- PJG 0012 frnewline -->
the Clean Air Act. The rule requires manufacturers to provide 
<!-- PJG 0012 frnewline -->
EPA with information to assist EPA in identifying and evaluating 
<!-- PJG 0012 frnewline -->
potential adverse health effects of motor vehicle fuel and fuel 
<!-- PJG 0012 frnewline -->
additive emissions, and to support and guide related regulatory 
<!-- PJG 0012 frnewline -->
actions in the future. 
<!-- PJG 0012 frnewline -->
The recently promulgated health effects testing requirements 
<!-- PJG 0012 frnewline -->
incorporate a three-tiered health effects evaluation structure. 
<!-- PJG 0012 frnewline -->
Under Tier 1, fuel and fuel additive manufacturers are required 
<!-- PJG 0012 frnewline -->
to perform a literature search on the health and welfare effects 
<!-- PJG 0012 frnewline -->
of fuel and fuel additive emissions, characterize the emissions, 
<!-- PJG 0012 frnewline -->
and provide exposure information. Tier 2 includes short-term 
<!-- PJG 0012 frnewline -->
biological testing to screen for specific health effects 
<!-- PJG 0012 frnewline -->
endpoints, involving the exposure of laboratory animals to the 
<!-- PJG 0012 frnewline -->
whole emissions of fuels or fuel/additive mixtures. 
<!-- PJG 0012 frnewline -->
Where appropriate, EPA has retained authority to modify or 
<!-- PJG 0012 frnewline -->
augment the standard Tier 2 test requirements. Under 
<!-- PJG 0012 frnewline -->
``alternative Tier 2'' procedures set forth in &sect;79.58(c), EPA may 
<!-- PJG 0012 frnewline -->
substitute alternative tests for standard Tier 2 tests or impose 
<!-- PJG 0012 frnewline -->
additional testing requirements. Alternative Tier 2 procedures 
<!-- PJG 0012 frnewline -->
may be utilized to modify standard Tier 2 requirements, but may 
<!-- PJG 0012 frnewline -->
not be utilized to entirely delete testing for any of the 
<!-- PJG 0012 frnewline -->
standard endpoints. The alternative Tier 2 provision affords the 
<!-- PJG 0012 frnewline -->
Agency flexibility when available information indicates that 
<!-- PJG 0012 frnewline -->
another testing regimen is preferable to the standard set of Tier 
<!-- PJG 0012 frnewline -->
2 tests. Instances where Alternative Tier 2 requirements may be 
<!-- PJG 0012 frnewline -->
appropriate include scenarios where previously available 
<!-- PJG 0012 frnewline -->
information may cause EPA to be concerned about potential health 
<!-- PJG 0012 frnewline -->
effects related to an endpoint not specifically addressed in Tier 
<!-- PJG 0012 frnewline -->
2, or when otherwise available information identifies a 
<!-- PJG 0012 frnewline -->
potentially significant public health risk related to a Tier 2 
<!-- PJG 0012 frnewline -->
endpoint such that more definitive testing will be required for 
<!-- PJG 0012 frnewline -->
this endpoint than is ordinarily required. In both of these 
<!-- PJG 0012 frnewline -->
scenarios, alternative Tier 2 testing can facilitate earlier and 
<!-- PJG 0012 frnewline -->
potentially more efficient acquisition of the required data. 
<!-- PJG 0012 frnewline -->
After receipt and review of a manufacturer's Tier 1 and 
<!-- PJG 0012 frnewline -->
Tier 2 submittals, EPA determines, on a case-by-case basis, if 
<!-- PJG 0012 frnewline -->
additional testing is needed under Tier 3 to evaluate the risk of 
<!-- PJG 0012 frnewline -->
a particular fuel or fuel additive (or group of fuels or fuel 
<!-- PJG 0012 frnewline -->
additives) on human health or welfare. Tier 3 testing could 
<!-- PJG 0012 frnewline -->
include any emission analysis, health effects, welfare effects, 
<!-- PJG 0012 frnewline -->
and/or exposure testing or analysis deemed necessary by EPA for 
<!-- PJG 0012 frnewline -->
this purpose. 
<!-- PJG 0012 frnewline -->
The Agency has considerable discretion to formulate and 
<!-- PJG 0012 frnewline -->
impose appropriate testing requirements under either alternative 
<!-- PJG 0012 frnewline -->
Tier 2 or Tier 3 procedures. In practice, EPA will be more 
<!-- PJG 0012 frnewline -->
likely to utilize alternative Tier 2 procedures in instances 
<!-- PJG 0012 frnewline -->
where additional data needs are apparent even prior to completion 
<!-- PJG 0012 frnewline -->
and submission of the standard Tier 2 tests, and prompt 
<!-- PJG 0012 frnewline -->
formulation of appropriate alternative testing requirements will 
<!-- PJG 0012 frnewline -->
result in a more efficient use of industry and governmental 
<!-- PJG 0012 frnewline -->
resources. Tier 3 procedures will be preferred in those 
<!-- PJG 0012 frnewline -->
instances where standard Tier 2 tests are necessary to assist EPA 
<!-- PJG 0012 frnewline -->
in identification of potential hazards and/or in design or 
<!-- PJG 0012 frnewline -->
selection of appropriate follow-up studies. 
<!-- PJG 0012 frnewline -->
For fuels and fuel additives registered as of the date of 
<!-- PJG 0012 frnewline -->
promulgation of the final rule, registrants must submit Tier 1 
<!-- PJG 0012 frnewline -->
and Tier 2 test data within six years of that date. On the other 
<!-- PJG 0012 frnewline -->
hand, manufacturers seeking to register new fuel and fuel 
<!-- PJG 0012 frnewline -->
additive products after the date of promulgation must satisfy all 
<!-- PJG 0012 frnewline -->
testing requirements before registration will be granted. 
<!-- PJG 0012 frnewline -->
In this regard, the new rule clarifies what constitutes a 
<!-- PJG 0012 frnewline -->
``new'' fuel or fuel additive, distinguishing between two types of 
<!-- PJG 0012 frnewline -->
unregistered products which a manufacturer might seek to register 
<!-- PJG 0012 frnewline -->
after the promulgation of the final rule: (1) fuel and fuel 
<!-- PJG 0012 frnewline -->
additive products similar in composition and usage to those 
<!-- PJG 0012 frnewline -->
already allowed wide commercial distribution (e.g., registered 
<!-- PJG 0012 frnewline -->
for general use by other manufacturers), and (2) fuel and fuel 
<!-- PJG 0012 frnewline -->
additive products which differ significantly in composition 
<!-- PJG 0012 frnewline -->
and/or usage from such current products. To effectuate this 
<!-- PJG 0012 frnewline -->
distinction, EPA's final rule, promulgated under sections 211(b) 
<!-- PJG 0012 frnewline -->
and (e), makes use of grouping system concepts and definitions. 
<!-- PJG 0012 frnewline -->
Specifically, a fuel additive product not registered by its 
<!-- PJG 0012 frnewline -->
manufacturer
<FOOTCITE>73</FOOTCITE>
 for a specific type of fuel as of the date of 
<!-- PJG 0012 frnewline -->
promulgation of this rule is designated as ``registrable'' if the 
<!-- PJG 0012 frnewline -->
fuel/additive mixture resulting from use of the additive in the 
<!-- PJG 0012 frnewline -->
specific fuel is in the same fuel/additive group as one or more 
<!-- PJG 0012 frnewline -->
currently registered fuels or bulk additives.
<FOOTCITE>74</FOOTCITE>
 The grouping 
<!-- PJG 0012 frnewline -->
system establishes various fuel/additive groups within each fuel 
<!-- PJG 0012 frnewline -->
family.
<FOOTCITE>75</FOOTCITE>
 Conversely, a fuel additive product not registered 
<!-- PJG 0012 frnewline -->
by its manufacturer for a specific type of fuel as of the date of 
<!-- PJG 0012 frnewline -->
promulgation is designated as ``new'' if the fuel/additive mixture 
<!-- PJG 0012 frnewline -->
resulting from use of the additive in the specific fuel cannot be 
<!-- PJG 0012 frnewline -->
grouped with one or more currently registered fuels or bulk 
<!-- PJG 0012 frnewline -->
additives. In these definitions, the term ``currently registered'' 
<!-- PJG 0012 frnewline -->
refers to the date on which the prospective applicant seeks 
<!-- PJG 0012 frnewline -->
registration for the fuel or fuel additive in question. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
73
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
For purposes of these definitions, registration is product-specific. Thus, if a particular fuel or fuel additive
product has not been registered by its manufacturer, then that manufacturer does not have the right to introduce,
market, and/or sell this product, even if a compositionally similar or identical product has been registered by another
manufacturer.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
74
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
A ``bulk additive,'' sometimes called a ``general use'' additive was defined as a product added to fuel at the refinery
as part of the original blending stream or after the fuel is transported from the refinery, but before the fuel is purchased
for introduction into the fuel tank of a motor vehicle. In contrast, an ``aftermarket additive,'' sometimes called
a consumer additive, is an additive product marketed for introduction directly into the fuel system of a motor vehicle.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
75
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
``Fuel Family'' refers to the primary categorization of fuels and fuel additives within the proposed grouping system.
A fuel family was defined as a set of F/FAs which share basic chemical and physical formulation characteristics and
can be used in the same engine or vehicle. Six such fuel families were proposed (unleaded gasoline, leaded gasoline,
diesel, methanol, ethanol, methane, and propane). EPA did not include a leaded gasoline family in the final rule because
Clean Air Act section 211(n) prohibits on-road use of leaded fuel after December 31, 1995. In the definition of ``registrable,''
the restriction ``in the same fuel family'' means that the similarity of an applicant F/FA to a bulk additive currently
registered for use in another fuel family would not suffice to make the applicant F/FA registrable. This restriction
is consistent with the general principles of the grouping system, which permits grouping of F/FAs only within defined
fuel families.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
According to these definitions, an unregistered fuel 
<!-- PJG 0012 frnewline -->
additive which meets the criteria for grouping only with a 
<!-- PJG 0012 frnewline -->
currently registered aftermarket additive (and not also with a 
<!-- PJG 0012 frnewline -->
currently registered fuel and/or bulk additive) is not 
<!-- PJG 0012 frnewline -->
registrable. This does not preclude an unregistered aftermarket 
<!-- PJG 0012 frnewline -->
additive from being registrable (since aftermarket additives can 
<!-- PJG 0012 frnewline -->
group with fuels and bulk additives), nor does it affect the 
<!-- PJG 0012 frnewline -->
registration status of currently registered aftermarket 
<!-- PJG 0012 frnewline -->
additives. 
<!-- PJG 0012 frnewline -->
For example, an unregistered detergent additive (either bulk 
<!-- PJG 0012 frnewline -->
or aftermarket) intended for use in unleaded gasoline and 
<!-- PJG 0012 frnewline -->
conforming to the ``substantially similar'' criteria for unleaded 
<!-- PJG 0012 frnewline -->
gasoline (56 FR 5352) would be registrable, since it would be 
<!-- PJG 0012 frnewline -->
able to group with currently registered baseline unleaded 
<!-- PJG 0012 frnewline -->
gasoline fuels and bulk additives.
<FOOTCITE>76</FOOTCITE>
 On the other hand, MMT is 
<!-- PJG 0012 frnewline -->
considered ``new'' rather than ``registrable'' for unleaded gasoline, 
<!-- PJG 0012 frnewline -->
because there are no currently registered manganese-containing 
<!-- PJG 0012 frnewline -->
fuels or bulk additives in the unleaded gasoline family with 
<!-- PJG 0012 frnewline -->
which a mixture of MMT and unleaded gasoline could be grouped. 
<!-- PJG 0012 frnewline -->
This is true even though products containing MMT are currently 
<!-- PJG 0012 frnewline -->
registered for bulk use in leaded gasoline and as aftermarket 
<!-- PJG 0012 frnewline -->
additives grandfathered prior to the ban on such aftermarket 
<!-- PJG 0012 frnewline -->
additives.
<FOOTCITE>77</FOOTCITE>
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
76
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The ability to join the unleaded gasoline baseline group assumes that the detergent additive does not exceed oxygen
and sulfur limits applicable to the baseline unleaded gasoline category.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
77
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Until the 1990 CAA Amendments went into effect, the statutory language of section 211(f) was interpreted as applying
only to unleaded gasoline fuels and related bulk additives. Thus, prior to November 15, 1990 (the effective date of
the CAA Amendments), aftermarket additives intended for use in unleaded gasoline and containing elements other
than carbon, hydrogen, oxygen, nitrogen, and sulfur were allowed to be registered. Under the 1990 CAA Amendments,
all types of motor vehicle fuels and fuel additives were placed under 211(f) jurisdiction. All aftermarket additives
that were not ``substantially similar'' and were introduced on or after November 15, 1990, were banned. However,
this ban does not apply to products first introduced into commerce prior to November 15, 1990 (CAA section 211(f)(1)(B)).
Thus, ``non-sub-sim'' gasoline aftermarket additives which had been registered prior to that date were allowed
to retain their registrations. These are so-called ``grandfathered'' aftermarket additives.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00090 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The recently finalized rule requires that manufacturers of 
<!-- PJG 0012 frnewline -->
new fuel and fuel additive products (i.e., fuel and fuel additive 
<!-- PJG 0012 frnewline -->
products not registered by their specific manufacturers as of the 
<!-- PJG 0012 frnewline -->
date of promulgation and not fitting the registrable criteria) 
<!-- PJG 0012 frnewline -->
submit all testing requirements prior to registration, including 
<!-- PJG 0012 frnewline -->
any alternative Tier 2 tests or Tier 3 tests prescribed by the 
<!-- PJG 0012 frnewline -->
Agency. As discussed above, under the fuel and fuel additive 
<!-- PJG 0012 frnewline -->
testing rule, MMT is designated as ``new'' for purposes of 
<!-- PJG 0012 frnewline -->
registration for use in unleaded gasoline. Accordingly, any data 
<!-- PJG 0012 frnewline -->
required to register MMT for use in unleaded gasoline must be 
<!-- PJG 0012 frnewline -->
submitted prior to registration. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
As noted above, Tier 1 requires manufacturers of designated 
<!-- PJG 0012 frnewline -->
fuels or fuel additives (or groups of manufacturers pursuant to &sect;
<!-- PJG 0012 frnewline -->
79.56) to supply to the Administrator: (1) the identity and 
<!-- PJG 0012 frnewline -->
concentration of certain emission products of such fuel and fuel 
<!-- PJG 0012 frnewline -->
additives, (2) an analysis of potential emissions exposures, and 
<!-- PJG 0012 frnewline -->
(3) any available information regarding the health and welfare 
<!-- PJG 0012 frnewline -->
effects of the whole and specified emissions. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Under the General Provision of the emission characterization 
<!-- PJG 0012 frnewline -->
requirements of Tier 1, it is stated in &sect;79.52(b)(1)(ii) that 
<!-- PJG 0012 frnewline -->
the emissions shall be generated three times (on three different 
<!-- PJG 0012 frnewline -->
days) without a functional aftertreatment device and, if 
<!-- PJG 0012 frnewline -->
applicable, three times (on three different days) with a 
<!-- PJG 0012 frnewline -->
functional aftertreatment device, and each such time shall be 
<!-- PJG 0012 frnewline -->
analyzed according to the remaining provisions in this section 
<!-- PJG 0012 frnewline -->
(b). Measurement of background emissions, under 
<!-- PJG 0012 frnewline -->
&sect;79.52(b)(1)(iii), states that it is required that 
<!-- PJG 0012 frnewline -->
ambient/dilution air be analyzed for levels of background 
<!-- PJG 0012 frnewline -->
chemical species present at the time of emission sampling (for 
<!-- PJG 0012 frnewline -->
both combustion and evaporative emissions) and that background 
<!-- PJG 0012 frnewline -->
chemical species profiles be reported with emissions speciation 
<!-- PJG 0012 frnewline -->
data. Ethyl has yet to provide the Agency with data on the 
<!-- PJG 0012 frnewline -->
characterization of emissions resulting from the use of MMT in 
<!-- PJG 0012 frnewline -->
unleaded gasoline which meets the requirements of Tier 1 under 
<!-- PJG 0012 frnewline -->
these subsections. Thus, to EPA's knowledge, data has not yet 
<!-- PJG 0012 frnewline -->
been collected which would fully satisfy Tier 1 requirements 
<!-- PJG 0012 frnewline -->
under &sect;79.52(b)(1) (ii) and (iii). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Standard Tier 2 testing includes certain specific types of 
<!-- PJG 0012 frnewline -->
short-term biological testing to screen for specific health 
<!-- PJG 0012 frnewline -->
effects endpoints, involving the exposure of laboratory animals 
<!-- PJG 0012 frnewline -->
to the whole emissions of the fuel additive (when added to a base 
<!-- PJG 0012 frnewline -->
fuel). Where appropriate, the Agency may impose an alternative 
<!-- PJG 0012 frnewline -->
Tier 2 test in lieu of a standard Tier 2 test or prescribe 
<!-- PJG 0012 frnewline -->
additional Tier 2 testing in addition to the standard Tier 2 
<!-- PJG 0012 frnewline -->
tests. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
EPA's Office of Research and Development has prepared a 
<!-- PJG 0012 frnewline -->
report that specifically identifies research which would allow a 
<!-- PJG 0012 frnewline -->
more accurate evaluation of the risk involved in utilizing MMT in 
<!-- PJG 0012 frnewline -->
unleaded gasoline.
<FOOTCITE>78</FOOTCITE>
 Some of the research described in the ORD 
<!-- PJG 0012 frnewline -->
report is intended to address toxicologic endpoints which are 
<!-- PJG 0012 frnewline -->
also addressed by standard Tier 2 tests,
<FOOTCITE>79</FOOTCITE>
 while other research 
<!-- PJG 0012 frnewline -->
described in the report is intended to address other endpoints. 
<!-- PJG 0012 frnewline -->
EPA presently has an adequate basis to conclude that there are 
<!-- PJG 0012 frnewline -->
public health concerns associated with the potential use of MMT 
<!-- PJG 0012 frnewline -->
in unleaded gasoline, and anticipates that research addressing 
<!-- PJG 0012 frnewline -->
each of the areas identified in the ORD report will be necessary 
<!-- PJG 0012 frnewline -->
to support registration of MMT for use in unleaded gasoline. It 
<!-- PJG 0012 frnewline -->
is not necessary, and would be inefficient, to wait for the 
<!-- PJG 0012 frnewline -->
completion and submission of all of the standard Tier 2 tests in 
<!-- PJG 0012 frnewline -->
order to identify the requisite test data, and use of alternative 
<!-- PJG 0012 frnewline -->
Tier 2 procedures is therefore appropriate. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
78
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
ORD originally reviewed the information needed to improve the risk characterization in: Preuss, P.W. (1991) ORD
Document on Information Needed to Improve the Risk Characterization of Manganese Tetraoxide (Mn
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=2 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=2 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
) and Methylcyclopentadienyl Manganese Tricarbonyl, December 12, 1991 [memorandum to Richard Wilson]. Washington,
DC: U.S. Environmental Protection Agency, Office of Research and Development; December 16, 1991. For further information
the reader is referred to Air Docket A&hyph;93&hyph;26, II&hyph;A&hyph;16. ORD has reevaluated these information
needs in light of new information. See Memo from Peter W. Preuss to Richard Wilson dated July 13, 1994, Docket A&hyph;93&hyph;26,
II&hyph;A&hyph;18.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
79
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
For example, it is clear that the standard Tier 2 neurotoxicity will not address adequately the potential neurotoxicity
of inhaled manganese to humans. Although the precise mechanisms of such neurotoxicity are not fully understood,
it has been shown that manganese toxicity may be associated with degeneration of certain tissues in the brain. These
brain tissues include the substantia nigra which is found only in primates and not in lower mammals. Laboratory rodents
typically employed in the standard Tier 2 neurotoxcity test do not physically possess this target for manganese toxicity
in the brain.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
If Ethyl or any other party seeks to register MMT for use in 
<!-- PJG 0012 frnewline -->
unleaded gasoline, it will need to submit the required test data 
<!-- PJG 0012 frnewline -->
in addition to obtaining the required waiver. In that case, EPA 
<!-- PJG 0012 frnewline -->
expects to identify specific alternative Tier 2 tests which must 
<!-- PJG 0012 frnewline -->
be performed prior to registration.
<FOOTCITE>80</FOOTCITE>
 In the case of endpoints 
<!-- PJG 0012 frnewline -->
addressed by the ORD report, that report will serve as the 
<!-- PJG 0012 frnewline -->
starting point for EPA in identifying appropriate alternative 
<!-- PJG 0012 frnewline -->
Tier 2 tests. In each instance where EPA does not adopt any 
<!-- PJG 0012 frnewline -->
alternative Tier 2 requirement for an endpoint which is addressed 
<!-- PJG 0012 frnewline -->
by standard Tier 2 tests, standard information or testing 
<!-- PJG 0012 frnewline -->
requirements will continue to apply. The process for 
<!-- PJG 0012 frnewline -->
establishment of alternative Tier 2 testing requirements for a 
<!-- PJG 0012 frnewline -->
product includes specific procedures for notification of the 
<!-- PJG 0012 frnewline -->
manufacturer and an opportunity for comment, and is set forth in 
<!-- PJG 0012 frnewline -->
40 C.F.R. 79.58(c). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
80
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
If there is any reason why Ethyl would prefer to complete the standard set of Tier 2 tests and submit such tests prior
to imposition of further data requirements, EPA is willing in the alternative to impose additional testing requirements
under Tier 3 procedures.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Submission of any data which is required by the registration 
<!-- PJG 0012 frnewline -->
regulations prior to registration of MMT for use in unleaded 
<!-- PJG 0012 frnewline -->
gasoline is not itself a specific legal prerequisite to the 
<!-- PJG 0012 frnewline -->
granting of a waiver under section 211(f)(4). However, in these 
<!-- PJG 0012 frnewline -->
circumstances, since the Agency is declining to grant the 
<!-- PJG 0012 frnewline -->
requested waiver based on potential health effects, the Agency 
<!-- PJG 0012 frnewline -->
considers it reasonable to require that Ethyl submit the same 
<!-- PJG 0012 frnewline -->
health effects and exposure test data which will be required 
<!-- PJG 0012 frnewline -->
prior to registration of MMT for unleaded gasoline before it will 
<!-- PJG 0012 frnewline -->
consider taking favorable action on another waiver application. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
As the health effects testing rule indicates, EPA believes 
<!-- PJG 0012 frnewline -->
that it should exercise particular caution in registering new 
<!-- PJG 0012 frnewline -->
fuel or fuel additive products that are significantly different 
<!-- PJG 0012 frnewline -->
from, or have a usage pattern which is significantly different in 
<!-- PJG 0012 frnewline -->
scope or character from, currently registered fuel or fuel 
<!-- PJG 0012 frnewline -->
additive products. EPA also believes that the same cautious 
<!-- PJG 0012 frnewline -->
approach is appropriate in evaluating waiver applications under 
<!-- PJG 0012 frnewline -->
section 211(f)(4). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00091 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In the event that Ethyl wishes to undertake the testing 
<!-- PJG 0012 frnewline -->
required to register MMT for unleaded gasoline, EPA will work 
<!-- PJG 0012 frnewline -->
with Ethyl to resolve the details of all necessary test data. 
<!-- PJG 0012 frnewline -->
Further, once the data requirements for registration have been 
<!-- PJG 0012 frnewline -->
duly established, EPA will not require submission of any 
<!-- PJG 0012 frnewline -->
additional health effects and exposure data as part of a new 
<!-- PJG 0012 frnewline -->
waiver application. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
VIII. Other Issues 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Ethyl has stated that certain other considerations and data 
<!-- PJG 0012 frnewline -->
associated with MMT use should be taken into account by the 
<!-- PJG 0012 frnewline -->
Administrator in utilizing the discretion authorized under 
<!-- PJG 0012 frnewline -->
section 211(f)(4). These issues include (1) decreased emissions 
<!-- PJG 0012 frnewline -->
of toxic air pollutants due to decreases in aromatic use when MMT 
<!-- PJG 0012 frnewline -->
is substituted as an octane enhancer; (2) decreased refinery 
<!-- PJG 0012 frnewline -->
emissions due to decreased reformer severity; (3) decreased 
<!-- PJG 0012 frnewline -->
carbon monoxide (CO) and oxides of nitrogen (NO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
X
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
) vehicle 
<!-- PJG 0012 frnewline -->
emissions, (4) increased crude oil yield and associated energy 
<!-- PJG 0012 frnewline -->
savings, and (5) decreased levels of tropospheric ozone 
<!-- PJG 0012 frnewline -->
associated with lower levels of reactive hydrocarbon emissions 
<!-- PJG 0012 frnewline -->
and NO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
X
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 emission decreases. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Regarding CO emission decreases, EPA's analysis indicates 
<!-- PJG 0012 frnewline -->
that examination of all of the available test data on the CO 
<!-- PJG 0012 frnewline -->
effects of MMT shows a small (0.07 gpm or 2% of applicable 
<!-- PJG 0012 frnewline -->
standards
<FOOTCITE>81</FOOTCITE>
) decrease attributable to the additive.
<FOOTCITE>82</FOOTCITE>
 With 
<!-- PJG 0012 frnewline -->
the exceptions of two vehicle models, the CO effects in both 
<!-- PJG 0012 frnewline -->
directions were relatively small. The most significant exception 
<!-- PJG 0012 frnewline -->
to this general pattern is the test data from the 1988 Ford Crown 
<!-- PJG 0012 frnewline -->
Victoria 5L, which showed a decrease of 0.72 gpm (or 21% of the 
<!-- PJG 0012 frnewline -->
standard). The other unusual vehicle was also a Ford Crown 
<!-- PJG 0012 frnewline -->
Victoria_a 1992 model with a 0.36 gpm decrease (11% of 
<!-- PJG 0012 frnewline -->
standard). The small average size and somewhat erratic nature of 
<!-- PJG 0012 frnewline -->
the CO decreases seen in the vehicle sample lead to questions 
<!-- PJG 0012 frnewline -->
about whether this small potential benefit is likely to actually 
<!-- PJG 0012 frnewline -->
occur in the vehicle fleet. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
81
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
This effect was calculated by integrating emissions, separately for clear and MMT fuels, over the full range of mileage
for which data were available, taking the difference between fuel groups within models to get a model-by-model effect,
and then averaging these effects over model groups.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
82
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
For a complete description the reader is referred to Air Docket A&hyph;93&hyph;26, II&hyph;A&hyph;14, ``Evidence
of CO and NO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=2 -->
X
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 Emission Decreases Attibutable to MMT in Durability Testing Data''.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
EPA also examined NO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
X
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 emissions changes demonstrated by the 
<!-- PJG 0012 frnewline -->
data which had been submitted by both Ethyl and Ford. The test 
<!-- PJG 0012 frnewline -->
data for NO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
X
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 show a more substantial and more consistent decrease 
<!-- PJG 0012 frnewline -->
for this pollutant than was the case for CO. The average across 
<!-- PJG 0012 frnewline -->
models was 0.08 gpm or 8% of the standard. The largest decreases 
<!-- PJG 0012 frnewline -->
were seen in the 1992 Ford Mustang 5.0L model and the 1988 Ford 
<!-- PJG 0012 frnewline -->
Crown Victoria 5L (each showing a 0.30 gpm decrease or 30% of the 
<!-- PJG 0012 frnewline -->
standard). Other models with substantial decreases were the 1988 
<!-- PJG 0012 frnewline -->
Ford Taurus (0.22 gpm or 22% of the standard) and the 1992 Buick 
<!-- PJG 0012 frnewline -->
Regal 3.8L (0.19 gpm or 19% of the standard). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
It is difficult to clearly determine the effects which NO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
X
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
decreases of this magnitude might have on tropospheric ozone 
<!-- PJG 0012 frnewline -->
concentrations, since such effects are influenced heavily by the 
<!-- PJG 0012 frnewline -->
mix of ozone precursors and the atmospheric chemistry of 
<!-- PJG 0012 frnewline -->
particular non-attainment areas. Modeling studies performed by 
<!-- PJG 0012 frnewline -->
EPA have shown that NO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
X
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 reductions in NO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
X
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 limited areas can 
<!-- PJG 0012 frnewline -->
significantly reduce regional ozone levels. However, although 
<!-- PJG 0012 frnewline -->
the regional ozone decreased, some urban areas showed slight 
<!-- PJG 0012 frnewline -->
increases in ozone levels. It is not possible to quantify the 
<!-- PJG 0012 frnewline -->
degree of reduction in ozone associated with the introduction of 
<!-- PJG 0012 frnewline -->
MMT in general because many factors affect ambient ozone. In 
<!-- PJG 0012 frnewline -->
order to achieve such a quantification, individual cities would 
<!-- PJG 0012 frnewline -->
need to be analyzed to determine their VOC/NO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
X
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 ratios and the 
<!-- PJG 0012 frnewline -->
mobile source contribution to those ratios. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
EPA has therefore concluded that it is likely that in 
<!-- PJG 0012 frnewline -->
certain NO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
X
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
-limited areas, ambient levels of ozone would decrease 
<!-- PJG 0012 frnewline -->
based on the expected NO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
X
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 reductions resulting from MMT use. It 
<!-- PJG 0012 frnewline -->
is impossible to quantify the exact degree of these decreases or 
<!-- PJG 0012 frnewline -->
the magnitude of the area which would be affected.
<FOOTCITE>83</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
83
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
For a complete description and response to Ethyl's comments, the reader is referred to Air Docket A&hyph;93&hyph;26,
II&hyph;A&hyph;15, ``ORD's Response to Public Comments on the Reference Concentration for Manganese and on the
Draft ORD Risk Assessment of MMT''.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Ethyl indicates that ``use of the Additive will result in as 
<!-- PJG 0012 frnewline -->
many as 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
25 fewer cancer cases
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 [emphasis in the original] 
<!-- PJG 0012 frnewline -->
attributable to automotive exhaust over the 1995&hyph;2010 span.'' 
<!-- PJG 0012 frnewline -->
Although ORD has not independently verified Ethyl's current 
<!-- PJG 0012 frnewline -->
analysis, it is nevertheless possible to evaluate their analysis 
<!-- PJG 0012 frnewline -->
by taking it at face value. Significant uncertainties are 
<!-- PJG 0012 frnewline -->
inherent in any prediction of a net change in cancer risk. For 
<!-- PJG 0012 frnewline -->
example, there are various models and assumptions underlying 
<!-- PJG 0012 frnewline -->
estimated changes in carcinogen exposures. Assumptions must be 
<!-- PJG 0012 frnewline -->
made regarding the composition of gasoline at different times in 
<!-- PJG 0012 frnewline -->
the future; projected fleet emissions must be estimated based on 
<!-- PJG 0012 frnewline -->
measurements from a few vehicles; the impact of MMT on such 
<!-- PJG 0012 frnewline -->
emissions must be estimated. In addition, the relationship of 
<!-- PJG 0012 frnewline -->
changes in emissions is assumed to be related to population 
<!-- PJG 0012 frnewline -->
exposure levels. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Cancer risk, whether characterized in terms of the number of 
<!-- PJG 0012 frnewline -->
cases in the entire U.S. population or in terms of individual 
<!-- PJG 0012 frnewline -->
unit risk estimates, also has inherent uncertainties. According 
<!-- PJG 0012 frnewline -->
to Ethyl, the predicted reduction in estimated cancer cases is 
<!-- PJG 0012 frnewline -->
0.6 to 2.0 cases per year. These represent upper bound 
<!-- PJG 0012 frnewline -->
estimates, and thus the true impact is very unlikely to be higher 
<!-- PJG 0012 frnewline -->
and may in fact be less. Ethyl also predicts that the changes in 
<!-- PJG 0012 frnewline -->
the probability of an individual contracting cancer is lowered 
<!-- PJG 0012 frnewline -->
with MMT use from about 12 cases per 100,000 to 6 cases per 
<!-- PJG 0012 frnewline -->
100,000. Again these estimates represent upper bounds, so the 
<!-- PJG 0012 frnewline -->
true risk to an individual would not be expected to be higher and 
<!-- PJG 0012 frnewline -->
could well be lower. In any case, the individual risk level 
<!-- PJG 0012 frnewline -->
remains in the 10&hyph;5 range. Relative to the uncertainties in the 
<!-- PJG 0012 frnewline -->
cancer risk estimates as well as in the emission and exposure 
<!-- PJG 0012 frnewline -->
aspects of Ethyl's analysis, the magnitude of the claimed change 
<!-- PJG 0012 frnewline -->
in risk is comparatively quite small. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The accuracy of these estimates also depends very much on 
<!-- PJG 0012 frnewline -->
the estimates of decreased aromatics use for individual refiners. 
<!-- PJG 0012 frnewline -->
Very significant changes are taking place in the refining 
<!-- PJG 0012 frnewline -->
industry to comply with various aspects of programs being 
<!-- PJG 0012 frnewline -->
implemented pursuant to the 1990 Clean Air Act amendments. 
<!-- PJG 0012 frnewline -->
Programs such as the introduction of ``reformulated gasoline'' will 
<!-- PJG 0012 frnewline -->
dramatically change the overall chemical and physical properties 
<!-- PJG 0012 frnewline -->
of gasoline. Thus, estimates of aromatics usage associated with 
<!-- PJG 0012 frnewline -->
refining are even more highly speculative over the next several 
<!-- PJG 0012 frnewline -->
years as these programs are implemented. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In any case, it is not possible to weigh these predicted 
<!-- PJG 0012 frnewline -->
changes in cancer incidence or in ozone formation against the 
<!-- PJG 0012 frnewline -->
concerns which have been explained above in relation to increased 
<!-- PJG 0012 frnewline -->
manganese emissions. Therefore, the Agency disagrees with 
<!-- PJG 0012 frnewline -->
Ethyl's claim that it can be shown scientifically that a net 
<!-- PJG 0012 frnewline -->
public health benefit results from the use of MMT in unleaded 
<!-- PJG 0012 frnewline -->
gasoline. While the Agency agrees that such risk-benefit 
<!-- PJG 0012 frnewline -->
comparisons can be important, the present data are inadequate for 
<!-- PJG 0012 frnewline -->
this purpose. With regard to the potential risks associated with 
<!-- PJG 0012 frnewline -->
inhalation exposure to manganese, the Agency's Risk Assessment as 
<!-- PJG 0012 frnewline -->
described above indicates that there are insufficient data to 
<!-- PJG 0012 frnewline -->
conclude quantitatively whether the increased use of MMT will (or 
<!-- PJG 0012 frnewline -->
will not) increase public health risk. With regard to the 
<!-- PJG 0012 frnewline -->
potential reductions in cancer incidence and tropospheric ozone 
<!-- PJG 0012 frnewline -->
levels associated with MMT use claimed by Ethyl, the above 
<!-- PJG 0012 frnewline -->
analysis indicates that, while reductions are possible, the data 
<!-- PJG 0012 frnewline -->
are too sparse to provide reasonable quantitative estimates of 
<!-- PJG 0012 frnewline -->
the magnitude of such reductions. The estimated cancer reduction 
<!-- PJG 0012 frnewline -->
is not truly discernable as a quantifiable benefit. This is 
<!-- PJG 0012 frnewline -->
because relative to the uncertainties in the cancer risk 
<!-- PJG 0012 frnewline -->
estimates as well as in the emission and exposure aspects of 
<!-- PJG 0012 frnewline -->
Ethyl's analysis, the estimated magnitude of change in risk is 
<!-- PJG 0012 frnewline -->
quite small, even when based on the ``upper bound'' cancer 
<!-- PJG 0012 frnewline -->
estimates. For ozone, it is not possible in general to quantify 
<!-- PJG 0012 frnewline -->
the degree of reduction associated with the introduction of MMT 
<!-- PJG 0012 frnewline -->
because many factors, including local volatile organic compound 
<!-- PJG 0012 frnewline -->
(VOC)/NO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
X
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 ratios affect ambient ozone levels. To achieve a 
<!-- PJG 0012 frnewline -->
quantification, all appropriate individual cities would have to 
<!-- PJG 0012 frnewline -->
be analyzed. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00092 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
IX. Decision 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As previously discussed, the Agency interprets section 
<!-- PJG 0012 frnewline -->
211(f)(4) of the Act as establishing a two-stage process for 
<!-- PJG 0012 frnewline -->
evaluating waiver applications. The first stage requires that 
<!-- PJG 0012 frnewline -->
EPA determine whether an applicant has met its burden of 
<!-- PJG 0012 frnewline -->
demonstrating that a fuel does not cause or contribute to a 
<!-- PJG 0012 frnewline -->
failure to meet regulated emission standards. Unless EPA finds 
<!-- PJG 0012 frnewline -->
that the waiver applicant has met this burden, a waiver may not 
<!-- PJG 0012 frnewline -->
be granted. The second stage of the process reflects the 
<!-- PJG 0012 frnewline -->
discretionary nature of the waiver authority provided to the EPA 
<!-- PJG 0012 frnewline -->
Administrator by the statute. In this second stage, the 
<!-- PJG 0012 frnewline -->
Administrator may consider other factors in determining whether 
<!-- PJG 0012 frnewline -->
granting a waiver is in the public interest and consistent with 
<!-- PJG 0012 frnewline -->
the objectives of the Clean Air Act. In this stage, the 
<!-- PJG 0012 frnewline -->
Administrator has broad discretion in selecting the issues to be 
<!-- PJG 0012 frnewline -->
examined and in balancing the potential positive and negative 
<!-- PJG 0012 frnewline -->
impacts of a waiver. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For purposes of the pending waiver application, as remanded 
<!-- PJG 0012 frnewline -->
to EPA by the D.C. Circuit Court of Appeals and resubmitted by 
<!-- PJG 0012 frnewline -->
Ethyl, I determined on November 30, 1993 that use of Ethyl's 
<!-- PJG 0012 frnewline -->
product HiTEC 3000 in unleaded gasoline at the specified 
<!-- PJG 0012 frnewline -->
concentration will not cause or contribute to a failure to 
<!-- PJG 0012 frnewline -->
achieve compliance with vehicle emission standards. The data and 
<!-- PJG 0012 frnewline -->
analysis upon which this determination was based are described in 
<!-- PJG 0012 frnewline -->
Section IV above. The data submitted by Ethyl in connection with 
<!-- PJG 0012 frnewline -->
this waiver application satisfy all of the quantitative criteria 
<!-- PJG 0012 frnewline -->
for determining whether an additive will ``cause or contribute'' to 
<!-- PJG 0012 frnewline -->
a failure to meet emission standards previously utilized by EPA. 
<!-- PJG 0012 frnewline -->
As noted above, EPA has serious reservations concerning the 
<!-- PJG 0012 frnewline -->
present suitability of these criteria. In light of the 
<!-- PJG 0012 frnewline -->
intractability of the nation's air pollution problems, EPA is 
<!-- PJG 0012 frnewline -->
considering adoption of new criteria which would be utilized in 
<!-- PJG 0012 frnewline -->
assessing future waiver applications. However, for purposes of 
<!-- PJG 0012 frnewline -->
Ethyl's present application, EPA concluded that it would not be 
<!-- PJG 0012 frnewline -->
appropriate to make the required determination concerning 
<!-- PJG 0012 frnewline -->
emission effects by utilizing a new methodology or new criteria 
<!-- PJG 0012 frnewline -->
concerning which Ethyl was not afforded any prior notice. My 
<!-- PJG 0012 frnewline -->
decision that Ethyl has met the requisite statutory burden for 
<!-- PJG 0012 frnewline -->
purposes of the present waiver application is also based on the 
<!-- PJG 0012 frnewline -->
Agency's assessment of the newest data provided by Ethyl on 
<!-- PJG 0012 frnewline -->
newer-technology vehicles which do not, when evaluated 
<!-- PJG 0012 frnewline -->
separately, indicate any statistically significant increase in 
<!-- PJG 0012 frnewline -->
regulated vehicle emissions. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Agency remains concerned about the possible effects of 
<!-- PJG 0012 frnewline -->
fuels containing MMT on the functioning of onboard diagnostics 
<!-- PJG 0012 frnewline -->
(OBD) equipment. At the time that EPA completed the assessment 
<!-- PJG 0012 frnewline -->
of emissions issues underlying my finding concerning emissions on 
<!-- PJG 0012 frnewline -->
November 30, 1993, the evidence to support the assertions by 
<!-- PJG 0012 frnewline -->
automakers that MMT would prevent the oxygen sensors in OBD 
<!-- PJG 0012 frnewline -->
systems from operating properly was quite limited and these 
<!-- PJG 0012 frnewline -->
assertions had not at that time been tested in any actual 
<!-- PJG 0012 frnewline -->
vehicles utilizing OBD systems. I expressed concern about the 
<!-- PJG 0012 frnewline -->
effect of MMT on OBD systems at that time, and indicated that if 
<!-- PJG 0012 frnewline -->
EPA ultimately concluded that MMT could prevent proper 
<!-- PJG 0012 frnewline -->
functioning of OBD systems, the Agency would consider appropriate 
<!-- PJG 0012 frnewline -->
action under Clean Air Act section 211(c). Since that time, the 
<!-- PJG 0012 frnewline -->
Ford Motor Company has submitted further research involving use 
<!-- PJG 0012 frnewline -->
of fuel containing MMT in an actual vehicle equipped with an OBD 
<!-- PJG 0012 frnewline -->
system, which Ford contends demonstrates that manganese oxides 
<!-- PJG 0012 frnewline -->
resulting from MMT use prevent the oxygen sensors in its OBD 
<!-- PJG 0012 frnewline -->
systems from functioning properly. EPA intends to fully 
<!-- PJG 0012 frnewline -->
investigate the significance of these findings. If further 
<!-- PJG 0012 frnewline -->
investigation supports the concerns expressed by Ford and other 
<!-- PJG 0012 frnewline -->
automakers, EPA intends to initiate an appropriate rulemaking 
<!-- PJG 0012 frnewline -->
under section 211(c). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Since I determined that Ethyl had met its burden regarding 
<!-- PJG 0012 frnewline -->
the ``cause or contribute'' finding required by the statute, the 
<!-- PJG 0012 frnewline -->
Agency has been reviewing other issues bearing on the exercise of 
<!-- PJG 0012 frnewline -->
my discretionary authority to grant or deny Ethyl the requested 
<!-- PJG 0012 frnewline -->
waiver for use in unleaded gasoline, focusing in particular on 
<!-- PJG 0012 frnewline -->
the potential effects of manganese emissions resulting from use 
<!-- PJG 0012 frnewline -->
of MMT on public health and welfare. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Agency remains concerned regarding the issue of 
<!-- PJG 0012 frnewline -->
manganese emissions from vehicles utilizing fuels containing MMT. 
<!-- PJG 0012 frnewline -->
From a hazard identification perspective, manganese can clearly 
<!-- PJG 0012 frnewline -->
be toxic to the central nervous system, the respiratory system, 
<!-- PJG 0012 frnewline -->
and the male reproductive system. The level of manganese which 
<!-- PJG 0012 frnewline -->
may safely be breathed over a lifetime is not known with 
<!-- PJG 0012 frnewline -->
precision. EPA has assessed potential health risks associated 
<!-- PJG 0012 frnewline -->
with potential exposures utilizing a Reference Concentration 
<!-- PJG 0012 frnewline -->
(RfC), which is defined as an estimate (with uncertainty spanning 
<!-- PJG 0012 frnewline -->
perhaps an order of magnitude) of a continuous inhalation 
<!-- PJG 0012 frnewline -->
exposure level for the human population (including sensitive 
<!-- PJG 0012 frnewline -->
subpopulations) that is likely to be without appreciable risk of 
<!-- PJG 0012 frnewline -->
deleterious noncancer effects during a lifetime of exposure. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Beginning with existing data on the effects of manganese 
<!-- PJG 0012 frnewline -->
exposures, the Agency utilized its standard procedure to develop 
<!-- PJG 0012 frnewline -->
a verified Reference Concentration (RfC) of 0.05 &mu;g/m3. In 
<!-- PJG 0012 frnewline -->
response to comments and criticisms by Ethyl and others, the 
<!-- PJG 0012 frnewline -->
Agency then utilized a variety of additional techniques to 
<!-- PJG 0012 frnewline -->
consider potential alternative RfC's based on additional data 
<!-- PJG 0012 frnewline -->
from the occupational exposure study on which the current RfC is 
<!-- PJG 0012 frnewline -->
based (discussed in detail in Section VI&hyph;B&hyph;4 above). The 
<!-- PJG 0012 frnewline -->
techniques judged by EPA scientists to be most appropriate 
<!-- PJG 0012 frnewline -->
produced alternative candidate RfC's ranging from 0.09 to 0.2 
<!-- PJG 0012 frnewline -->
&mu;g/m3. Since any formal revision of the present verified RfC of 
<!-- PJG 0012 frnewline -->
0.05 &mu;g/m3 based on the ORD reassessment will occur in the future 
<!-- PJG 0012 frnewline -->
and could not be completed prior to the deadline for this 
<!-- PJG 0012 frnewline -->
decision, I have evaluated the potential health effects 
<!-- PJG 0012 frnewline -->
associated with use of MMT in unleaded gasoline based on all of 
<!-- PJG 0012 frnewline -->
the likely values, focusing in particular on a potential 
<!-- PJG 0012 frnewline -->
alternative RfC of 0.1 &mu;g/m3 and the present RfC of 0.05 &mu;g/m3. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Utilizing the newest and most accurate data available on 
<!-- PJG 0012 frnewline -->
personal exposures to particulate emissions of manganese from 
<!-- PJG 0012 frnewline -->
vehicular sources, Agency scientists also prepared an exposure 
<!-- PJG 0012 frnewline -->
analysis in which they attempted to predict the range of 
<!-- PJG 0012 frnewline -->
increases in personal exposure to particulate manganese that 
<!-- PJG 0012 frnewline -->
would occur in Riverside, California urban areas if MMT were to 
<!-- PJG 0012 frnewline -->
be used in all unleaded gasoline. If MMT were utilized in 
<!-- PJG 0012 frnewline -->
unleaded gasoline at the specified concentration in urban areas 
<!-- PJG 0012 frnewline -->
similar to Riverside, California, the Agency's exposure 
<!-- PJG 0012 frnewline -->
assessment predicts that the exposures of forty to fifty percent 
<!-- PJG 0012 frnewline -->
of the population in such areas to airborne manganese levels 
<!-- PJG 0012 frnewline -->
would exceed the present verified RfC of 0.05 &mu;g/m3, and the 
<!-- PJG 0012 frnewline -->
exposures of five to ten percent would exceed manganese levels 
<!-- PJG 0012 frnewline -->
exceeding a potential alternative RfC of 0.1 &mu;g/m3. Although it 
<!-- PJG 0012 frnewline -->
is impossible to state whether a health risk would definitely 
<!-- PJG 0012 frnewline -->
exist at the projected exposure levels, neither can the 
<!-- PJG 0012 frnewline -->
possibility of such a risk be ruled out. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00093 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
It is reasonable to anticipate that persons living near 
<!-- PJG 0012 frnewline -->
major thoroughfares and in inner cities, often among the most 
<!-- PJG 0012 frnewline -->
economically disadvantaged Americans, will be disproportionately 
<!-- PJG 0012 frnewline -->
represented among persons with higher manganese exposure. 
<!-- PJG 0012 frnewline -->
Moreover, there is reason to believe certain subpopulations such 
<!-- PJG 0012 frnewline -->
as the young, the elderly, and persons with certain preexisting 
<!-- PJG 0012 frnewline -->
conditions, such as Parkinson's disease, might be more 
<!-- PJG 0012 frnewline -->
susceptible to any adverse effects of manganese exposure. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Certain occupational groups who work in proximity to 
<!-- PJG 0012 frnewline -->
vehicular emissions such as toll takers, parking garage 
<!-- PJG 0012 frnewline -->
attendants, traffic policemen, taxi dispatchers, and service 
<!-- PJG 0012 frnewline -->
station attendants, are represented in the Agency's exposure 
<!-- PJG 0012 frnewline -->
estimates only to the extent of their prevalence in the general 
<!-- PJG 0012 frnewline -->
population. These occupational groups would likely experience 
<!-- PJG 0012 frnewline -->
manganese exposures attributable to MMT use near or even 
<!-- PJG 0012 frnewline -->
exceeding the highest predicted exposures
<FOOTCITE>84</FOOTCITE>
. I realize that if 
<!-- PJG 0012 frnewline -->
Ethyl is granted the requested waiver, MMT would not be utilized 
<!-- PJG 0012 frnewline -->
immediately in all congested urban areas. Some of the urban 
<!-- PJG 0012 frnewline -->
areas with higher vehicular usage are areas which will be 
<!-- PJG 0012 frnewline -->
required to begin using a cleaner gasoline referred to as 
<!-- PJG 0012 frnewline -->
``reformulated gasoline'' beginning in 1995. If Ethyl were to 
<!-- PJG 0012 frnewline -->
obtain the waiver under section 211(f)(4) which is the subject of 
<!-- PJG 0012 frnewline -->
this decision, MMT could not be used in reformulated gasoline 
<!-- PJG 0012 frnewline -->
unless and until Ethyl obtained an additional waiver under Clean 
<!-- PJG 0012 frnewline -->
Air Act section 211(k)(2)(D). However, I am nevertheless 
<!-- PJG 0012 frnewline -->
concerned about the effects of potential MMT use in areas 
<!-- PJG 0012 frnewline -->
required to utilize reformulated gasoline, both because a waiver 
<!-- PJG 0012 frnewline -->
under section 211(f)(4) of the Act is a necessary prerequisite to 
<!-- PJG 0012 frnewline -->
the use of MMT in either conventional or reformulated gasoline 
<!-- PJG 0012 frnewline -->
and because Ethyl has made it clear that it does not seek the 
<!-- PJG 0012 frnewline -->
present waiver solely to permit use in conventional gasoline. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
84
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The Agency realizes that exposures to manganese deemed acceptable in particular industrial or occupational contexts
will often significantly exceed the levels considered by EPA to pose acceptable risks for the general population.
The establishment of appropriate limits for occupational exposures to manganese is an entirely separate process
from the establishment of an RfC for the general population. Nevertheless, I do not believe it would be appropriate
to completely disregard the likelihood of substantial incremental additions to manganese exposure for certain
categories of working Americans where such increased exposure would be attributable solely to approval of MMT use.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
I have concluded based on the assessments prepared by EPA 
<!-- PJG 0012 frnewline -->
scientists that, if I were to approve use of MMT in unleaded 
<!-- PJG 0012 frnewline -->
gasoline at the specified concentration, a significant number of 
<!-- PJG 0012 frnewline -->
persons could thereby be exposed to manganese concentrations in 
<!-- PJG 0012 frnewline -->
the ambient air which approach or exceed the current RfC or the 
<!-- PJG 0012 frnewline -->
candidate RfCs described in the risk assessment. Although all 
<!-- PJG 0012 frnewline -->
risk assessments have some degree of uncertainty, in some cases 
<!-- PJG 0012 frnewline -->
it is reasonable to conclude that the risk of adverse health 
<!-- PJG 0012 frnewline -->
effects is either very great or very small because estimated 
<!-- PJG 0012 frnewline -->
exposure levels are either far above or far below a potential 
<!-- PJG 0012 frnewline -->
health effect level. However, this is not the case with MMT. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Although it is not possible based on the present information 
<!-- PJG 0012 frnewline -->
to conclude whether specific adverse health effects will be 
<!-- PJG 0012 frnewline -->
associated with manganese exposures in the vicinity of or 
<!-- PJG 0012 frnewline -->
exceeding the RfC, neither is it possible to conclude that 
<!-- PJG 0012 frnewline -->
adverse health effects will not be associated with such 
<!-- PJG 0012 frnewline -->
exposures. Moreover, it is likely that, if adverse effects do 
<!-- PJG 0012 frnewline -->
occur as a result of MMT usage, such effects will be subtle and 
<!-- PJG 0012 frnewline -->
difficult to detect. In these circumstances, I am very reluctant 
<!-- PJG 0012 frnewline -->
to conduct a massive experiment in which the citizens of numerous 
<!-- PJG 0012 frnewline -->
American cities are subjected to the additional exposures to 
<!-- PJG 0012 frnewline -->
particulate manganese associated with MMT use. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
I am aware of the proposal by Ethyl that EPA conditionally 
<!-- PJG 0012 frnewline -->
grant its waiver application for HiTEC 3000, with conditions 
<!-- PJG 0012 frnewline -->
which would require Ethyl to develop in a specified period the 
<!-- PJG 0012 frnewline -->
additional health effects and exposure data necessary to address 
<!-- PJG 0012 frnewline -->
present uncertainties in the risk assessment, require Ethyl to 
<!-- PJG 0012 frnewline -->
conduct ambient monitoring of particulate manganese levels in 
<!-- PJG 0012 frnewline -->
certain cities where unleaded gasoline containing MMT would be 
<!-- PJG 0012 frnewline -->
sold, and provide for prompt withdrawal of HiTEC 3000 from the 
<!-- PJG 0012 frnewline -->
market in the event that ambient monitoring were to demonstrate 
<!-- PJG 0012 frnewline -->
airborne manganese levels exceeding a specified level of concern 
<!-- PJG 0012 frnewline -->
(e.g. 0.1 &mu;g/m3). However, I believe that the additional 
<!-- PJG 0012 frnewline -->
information on health effects and exposure necessary to provide 
<!-- PJG 0012 frnewline -->
greater assurance that manganese emissions from MMT use will not 
<!-- PJG 0012 frnewline -->
jeopardize public health should be provided before I decide 
<!-- PJG 0012 frnewline -->
whether to expose Americans to such emissions on even a temporary 
<!-- PJG 0012 frnewline -->
basis. Moreover, Ethyl's proposal to monitor ambient exposure 
<!-- PJG 0012 frnewline -->
levels would not assure that personal exposures exceeding the 
<!-- PJG 0012 frnewline -->
specified threshold do not occur. The EPA risk assessment makes 
<!-- PJG 0012 frnewline -->
it clear that a substantial portion of the population exposed to 
<!-- PJG 0012 frnewline -->
airborne manganese as a result of MMT use would be expected to 
<!-- PJG 0012 frnewline -->
experience personal exposures exceeding measured ambient exposure 
<!-- PJG 0012 frnewline -->
levels. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00094 </DOCNO>
<PARENT> FR940817-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
I recognize that there are some benefits that will be likely to accrue from approval of MMT use. In addition to the obvious
economic benefits associated with reductions in petroleum use and in fuel prices, there might also be some favorable
health and environmental effects. It is probable that, if MMT use were to result in reduced NO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
X
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 emissions from motor vehicles, this would be accompanied by some site-specific decreases in ozone formation. The
small decreases in cancer risks claimed by Ethyl are considerably more speculative and cannot be quantified with
existing information. In any case, it is not possible for me to weigh any modest hypothetical decrease in cancer risk
or limited site-specific ozone benefit against a risk of effects on the nervous system that could significantly decrease
the quality of life for a large number of individuals. In addition, EPA is or will be taking a number of other actions
under the Clean Air Act to reduce emissions of carcinogenic air pollutants and to limit ozone formation.
<FOOTCITE>85</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
85
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
For example, reductions in levels of carcinogenic particulates will accrue due to controls placed on diesel sulfur
(55 FR 34120, August 21, 1990). Reductions in carcinogenic toxic emissions (and NO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=2 -->
X
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 emissions after the year 2000) will accrue as a result of regulations requiring the introduction of reformulated
gasoline in 1995 promulgated under section 211(k) of the Act as amended in 1990 (59 FR 7716, February 16, 1994) and as
a result of the Agency's vehicle-based refueling emissions regulations (59 FR 16262, April 6, 1994). EPA has already
issued tighter tailpipe standard for NO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=2 -->
X
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 as required under the new amendments, and future ozone state implementation plans will address other NO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=2 -->
X
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 control strategies. In addition, the recently-promulgated enhanced emission I/M program regulations for the first
time establish a performance standard to reduce in-use NO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=2 -->
X
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 emissions in the more serious ozone nonattainment areas. Regarding stationary source control strategies, other
provisions of the Act call for a two million ton NO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=2 -->
X
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 reduction from certain utilities.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Based on the EPA analyses described in this decision and on the administrative record compiled by EPA as part of this
decision, I have concluded that there is a reasonable basis for concern about the effects on public health that could
result if EPA were to approve use of MMT in unleaded gasoline pursuant to Ethyl's application. I have also concluded
that the actual and hypothetical benefits which could accrue from MMT use are insufficient to outweigh the concerns
regarding potential adverse health effects. In circumstances where there is substantial uncertainty regarding
the nature of potential health effects which would result if a fuel additive waiver were approved, the burden of resolving
such uncertainties should fall on the waiver applicant rather than on the public. This policy is consistent with the
general policy established by the recently promulgated health effects testing rule, which requires that manufacturers
of new fuels or fuel additives complete all necessary testing prior to registration. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Therefore, for the reasons set forth above, utilizing the discretion afforded me under section 211(f)(4) of the Act,
I am today denying Ethyl's request for a waiver of the section 211(f)(1) prohibitions against the use of MMT in unleaded
gasoline. As previously stated in this decision, should Ethyl wish to undertake research intended to alleviate the
present uncertainties concerning the adverse health effects which could be associated with the use of MMT in unleaded
gasoline, the Agency will work with Ethyl to resolve the details of the needed research. If Ethyl decides to undertake
the research which is needed, and which would likely be required in any case to register MMT for unleaded gasoline under
the Agency's recently promulgated fuel and fuel additive health effects testing regulations, EPA will reconsider
granting a waiver to Ethyl at that time. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
EPA has determined that this action does not meet any of the criteria for classification as a significant regulatory
action under Executive Order 12866. Therefore, no regulatory impact analysis is required. This action is not a ``rule''
as defined in the Regulatory Flexibility Act, 5 U.S.C. 601 et seq., because EPA has not published, and is not required
to publish, a Notice of Proposed Rulemaking under the Administrative Procedure Act, 5 U.S.C. 553(b), or any other
law. Therefore, EPA has not prepared a supporting regulatory flexibility analysis addressing the impact of this
action on small entities. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
This is a final Agency action of national applicability. Jurisdiction to review this action lies exclusively in the
U.S. Court of Appeals for the District of Columbia Circuit. Under section 307(b)(1) of the Act, judicial review of
this action is available only by the filing of a petition for review in the U.S. Court of Appeals for the District of Columbia
Circuit within 60 days of August 17, 1994. Under section 307(b)(2) of the Act, today's action may not be challenged
later in a separate judicial proceeding brought by the Agency to enforce the statutory prohibitions. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: July 13, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Carol M. Browner, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Administrator. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;18941 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6560&hyph;50&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00095 </DOCNO>
<PARENT> FR940817-2-00044 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[OPP&hyph;00359A; FRL&hyph;4903&hyph;6]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Memorandum of Understanding; Amendment </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Environmental Protection Agency (EPA). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of availability.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The June 4, 1993 Memorandum of Understanding (MOU) between the Food and Drug Administration, Public Health Service,
Department of Health and Human Services and the Environmental Protection Agency regarding the regulation of liquid
chemical germicides for use on medical devices was amended on June 20, 1994. The amendment revises the disclaimer
statement required on the label of all general purpose disinfectants intended for use on devices other than critical
or semi-critical devices. This notice announces the availability of the amended MOU. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 By mail: Juanita Wills (7505C), Registration Division, Environmental Protection Agency, 401 M St., SW., Washington,
DC 20460. Office location and telephone number: Rm. 250, Crystal Mall #2, 1921 Jefferson Davis Highway, Arlington,
VA (703) 305&hyph;6661. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Electronic Availability
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
: This document, along with the amended Memorandum of Understanding, is available as an electronic file on The Federal
Bulletin Board at 9 a.m. on the date of publication in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
. By modem dial (202) 512&hyph;1387 or call (202) 512&hyph;1530 for disks or paper copies. This file is also available
in Postscript, Wordperfect, and ASCII. The Memorandum of Understanding is available in Wordperfect and ASCII.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Environmental protection.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: July 20, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Stephen L. Johnson,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Director, Registration Division, Office of Pesticide Programs. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;19776 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6560&hyph;50&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00096 </DOCNO>
<PARENT> FR940817-2-00045 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[OPP&hyph;34061; FRL 4902&hyph;1] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Notice of Receipt of Requests for Amendments to Delete Uses in Certain Pesticide Registrations </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Environmental Protection Agency (EPA). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 In accordance with section 6(f)(1) of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), as amended,
EPA is issuing a notice of receipt of request for amendment by registrants to delete uses in certain pesticide registrations.

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Unless a request is withdrawn, the Agency will approve these use deletions and the deletions will become effective
on November 15, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 By mail: James A. Hollins, Office of Pesticide Programs (7502C), Environmental Protection Agency, 401 M St., SW,
Washington, DC 20460. Office location for commercial courier delivery and telephone number: Room 216, Crystal Mall
No. 2, 1921 Jefferson Davis Highway, Arlington, VA 22202, (703) 305&hyph;5761. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
I. Introduction 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 6(f)(1) of FIFRA, provides that a registrant of a pesticide product may at any time request that any of its pesticide
registrations be amended to delete one or more uses. The Act further provides that, before acting on the request, EPA
must publish a notice of receipt of any such request in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. Thereafter, the Administrator may approve such a request. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Intent to Delete Uses 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This notice announces receipt by the Agency of applications from registrants to delete uses in the 10 pesticide registrations
listed in the following Table 1. These registrations are listed by registration number, product names and the specific
uses deleted. Users of these products who desire continued use on crops or sites being deleted should contact the applicable
registrant before November 15, 1994 to discuss withdrawal of the applications for amendment. This 90&hyph;day period
will also permit interested members of the public to intercede with registrants prior to the Agency approval of the
deletion. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->

<!-- PJG STAG 4703 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<TABLE>

<!-- PJG tableformat 3,L2,i1,14,r30,r90  -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Table
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=1 -->
 1. _ 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Registrations with Requests for Amendments to 
<!-- PJG 0012 frnewline -->
 Delete Uses in Certain Pesticide Registrations 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1EPA Reg Nos. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Product Name 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Delete From Label 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
000352&hyph;00354 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBenlate Fungicide 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMushrooms 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
000352&hyph;00470 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBladex 4L Herbicide 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSorghum 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
000352&hyph;00495 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBladex 90 DF Herbicide 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSorghum, wheat, fallow cropland 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
000352&hyph;00564 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBenlate SP Fungicide 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMushrooms 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
004581&hyph;00116 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lKryocide Insecticide 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMustard &amp; collard greens 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
010163&hyph;00041 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lProkil Cryolite 96 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l Apples, beans, cranberries, cucumbers, mustard, pears, radishes, strawberries, turnips 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
010163&hyph;00200 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrefar 4-E Herbicide 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCotton, grass seed crops, tomatoes
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
028293&hyph;00125 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPermethrin RTU Spray 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMosquito control use
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
033560&hyph;00021 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPRONONE 20G 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAquatic uses 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
033560&hyph;00041 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPRONONE Power Pellet 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAquatic uses, leeks, shallots
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->

<!-- PJG STAG 4706 -->

<!-- PJG ITAG l=11 g=1 f=4 -->
The following Table 2 includes the names and addresses of record for all registrants of the products in Table 1, in sequence
by EPA company number. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 2,L2,i1,7,r150 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Table
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=1 -->
 2. _ 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Registrants Requesting Amendments to Delete 
<!-- PJG 0012 frnewline -->
 Uses in Certain Pesticide Registrations
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Company No. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Company Name and Address 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0152 intable -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
000352 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDuPont Agricultural Products,
<!-- PJG 0012 frnewline -->
 Registration &amp; Regulatory Affairs,
<!-- PJG 0012 frnewline -->
 Walker's Mill, Barley Mill Plaza,
<!-- PJG 0012 frnewline -->
 P.O. Box 80038,
<!-- PJG 0012 frnewline -->
 Wilmington, DE 19880.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG ITAG l=01 g=1 f=4 -->
004581 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lElf Atochem North America, Inc.,
<!-- PJG 0012 frnewline -->
 Agrichemicals Division,
<!-- PJG 0012 frnewline -->
 2000 Market Street,
<!-- PJG 0012 frnewline -->
 Philadelphia, PA 19103.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG ITAG l=01 g=1 f=4 -->
010163 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lGowan Company, 
<!-- PJG 0012 frnewline -->
 P.O. Box 5569, 
<!-- PJG 0012 frnewline -->
 Yuma, AZ 85366. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG ITAG l=01 g=1 f=4 -->
028293 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lUnicorn Laboratories,
<!-- PJG 0012 frnewline -->
 1000 118th Ave., North,
<!-- PJG 0012 frnewline -->
 St. Petersburg, FL 33716.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
033560 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPro-Serve, Inc.,
<!-- PJG 0012 frnewline -->
 400 E. Brooks Road,
<!-- PJG 0012 frnewline -->
 Memphis, TN 38190.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->

<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=4 -->
III. Existing Stocks Provisions
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
The Agency has authorized registrants to sell or distribute product under the previously approved labeling for a
period of 18 months after approval of the revision, unless other restrictions have been imposed, as in special review
actions. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=84 g=1 f=4 -->
List of Subjects
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Environmental protection, Pesticides and pests, Product registrations.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Dated: July 18, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=4 -->
Daniel M. Barolo, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=4 -->
Director, Office of Pesticide Programs.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=4 -->
[FR Doc. 94&hyph;19778 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=4 -->
BILLING CODE 6560&hyph;50&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00097 </DOCNO>
<PARENT> FR940817-2-00046 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=4 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=4 -->

<RINDOCK>[OPP&hyph;34062; FRL 4902&hyph;4] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=4 -->

<DOCTITLE>Notice of Receipt of Requests for Amendments to Delete Uses in Certain Pesticide Registrations </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Environmental Protection Agency (EPA). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 In accordance with Section 6(f)(1) of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), as amended,
EPA is issuing a notice of receipt of request for amendment by registrants to delete uses in certain pesticide registrations.

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Unless a request is withdrawn, the Agency will approve these use deletions and the deletions will become effective
on November 15, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 By mail: James A. Hollins, Office of Pesticide Programs (7502C), Environmental Protection Agency, 401 M St., SW,
Washington, DC 20460. Office location for commercial courier delivery and telephone number: Room 216, Crystal Mall
No. 2, 1921 Jefferson Davis Highway, Arlington, VA 22202, (703) 305&hyph;5761. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
I. Introduction 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 6(f)(1) of FIFRA, provides that a registrant of a pesticide product may at any time request that any of its pesticide
registrations be amended to delete one or more uses. The Act further provides that, before acting on the request, EPA
must publish a notice of receipt of any such request in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. Thereafter, the Administrator may approve such a request. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Intent to Delete Uses 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This notice announces receipt by the Agency of applications from registrants to delete uses in the 14 pesticide registrations
listed in the following Table 1. These registrations are listed by registration number, product names and the specific
uses deleted. Users of these products who desire continued use on crops or sites being deleted should contact the applicable
registrant before November 15, 1994 to discuss withdrawal of the applications for amendment. This 90&hyph;day period
will also permit interested members of the public to intercede with registrants prior to the Agency approval of the
deletion. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<TABLE>

<!-- PJG tableformat 3,L2,i1,14,r60,r90 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Table
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=1 -->
 1. _ 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Registrations with Requests for Amendments to 
<!-- PJG 0012 frnewline -->
 Delete Uses in Certain Pesticide Registrations
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1EPA Reg No. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Product Name 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Delete From Label 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
000264&hyph;00472 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCHIPCO RONSTAR 50WP Herbicide 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBlue spruce 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
000802&hyph;00544 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSimazine 4G 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lNon-crop areas 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
003125&hyph;00117 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMORESTAN 25% Wettable Powder 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMacadamia nuts 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
003125&hyph;00183 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDI-SYSTON Technical 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAlfalfa, clover 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
003125&hyph;00302 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMORESTAN SOLUPAK 25% Wettable Powder 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMacadamia nuts 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
010163&hyph;00166 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lImidan 50-WP 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorn, citrus 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
010163&hyph;00169 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lImidan 50-WP 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorn, citrus 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
010163&hyph;00175 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lImidan 50-WSB 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorn, citrus 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
010163&hyph;00184 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lImidan 70-WSB 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCorn, citrus 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
041014&hyph;00002 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMarlate 50 Insecticide Wettable Powder 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCranberries, elevator 
<!-- PJG 0012 frnewline -->
 tunnels, farm buildings, 
<!-- PJG 0012 frnewline -->
 freight cars, grain 
<!-- PJG 0012 frnewline -->
 storage bins, grain 
<!-- PJG 0012 frnewline -->
 trucks, mushroom houses, 
<!-- PJG 0012 frnewline -->
 peanut warehouses, pet 
<!-- PJG 0012 frnewline -->
 bedding, ships' holds, 
<!-- PJG 0012 frnewline -->
 forage crops, field 
<!-- PJG 0012 frnewline -->
 crops, alfalfa, clover, 
<!-- PJG 0012 frnewline -->
 cowpea, forage grasses, 
<!-- PJG 0012 frnewline -->
 peanut, soybeans, all 
<!-- PJG 0012 frnewline -->
 references to acrerage &amp; 
<!-- PJG 0012 frnewline -->
 aerial uses
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
041014&hyph;00005 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMarlate Technical Grade Methoxychlor 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeaches, cranberries, 
<!-- PJG 0012 frnewline -->
 dumps, elevator tunnels, 
<!-- PJG 0012 frnewline -->
 farm buildings, freight 
<!-- PJG 0012 frnewline -->
 cars, grain storage 
<!-- PJG 0012 frnewline -->
 bins, grain trucks, 
<!-- PJG 0012 frnewline -->
 mushroom houses, non agricultural land, 
<!-- PJG 0012 frnewline -->
 peanut warehouses, pet 
<!-- PJG 0012 frnewline -->
 bedding, public parks, 
<!-- PJG 0012 frnewline -->
 ships' holds, standing 
<!-- PJG 0012 frnewline -->
 water, all references to 
<!-- PJG 0012 frnewline -->
 acrerage &amp; aerial uses 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
041014&hyph;00009 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMarlate 400 Insecticide Flowable Concentrate 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMosquito control on 
<!-- PJG 0012 frnewline -->
 beaches, dumps, non agricultural land, 
<!-- PJG 0012 frnewline -->
 public parks, standing 
<!-- PJG 0012 frnewline -->
 water, cranberries, 
<!-- PJG 0012 frnewline -->
 forage crops, field 
<!-- PJG 0012 frnewline -->
 crops, alfalfa, clover, 
<!-- PJG 0012 frnewline -->
 cowpea, forage grasses, 
<!-- PJG 0012 frnewline -->
 peanut, soybean, pet 
<!-- PJG 0012 frnewline -->
 bedding, elevator 
<!-- PJG 0012 frnewline -->
 tunnels, farm buildings, 
<!-- PJG 0012 frnewline -->
 freight cars, grain 
<!-- PJG 0012 frnewline -->
 storage bins, grain 
<!-- PJG 0012 frnewline -->
 trucks, mushroom houses, 
<!-- PJG 0012 frnewline -->
 ships' holds, all 
<!-- PJG 0012 frnewline -->
 references to acreage &amp; 
<!-- PJG 0012 frnewline -->
 aerial uses
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
041014&hyph;00011 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMarlate 300 Methoxychlor Flowable 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMosquito control on 
<!-- PJG 0012 frnewline -->
 beaches, dumps, non agricultural land, 
<!-- PJG 0012 frnewline -->
 public parks, standing 
<!-- PJG 0012 frnewline -->
 water, cranberries, 
<!-- PJG 0012 frnewline -->
 forage crops, field 
<!-- PJG 0012 frnewline -->
 crops, alfalfa, clover, 
<!-- PJG 0012 frnewline -->
 cowpea, forage grasses, 
<!-- PJG 0012 frnewline -->
 peanut, soybean, pet 
<!-- PJG 0012 frnewline -->
 bedding, elevator 
<!-- PJG 0012 frnewline -->
 tunnels, farm buildings, 
<!-- PJG 0012 frnewline -->
 freight cars, grain 
<!-- PJG 0012 frnewline -->
 storage bins, grain 
<!-- PJG 0012 frnewline -->
 trucks, mushroom houses, 
<!-- PJG 0012 frnewline -->
 ships' holds, all 
<!-- PJG 0012 frnewline -->
 references to acrerage &amp; 
<!-- PJG 0012 frnewline -->
 aerial uses
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
041014&hyph;00012 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMarlate 70% Methoxychlor Dust Base 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeaches, dumps, non agricultural land, 
<!-- PJG 0012 frnewline -->
 public parks, standing 
<!-- PJG 0012 frnewline -->
 water, cranberries, pet 
<!-- PJG 0012 frnewline -->
 bedding, elevator 
<!-- PJG 0012 frnewline -->
 tunnels, farm buildings, 
<!-- PJG 0012 frnewline -->
 freight cars, grain 
<!-- PJG 0012 frnewline -->
 storage bins, grain 
<!-- PJG 0012 frnewline -->
 trucks, mushroom houses, 
<!-- PJG 0012 frnewline -->
 ships' holds
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->

<!-- PJG STAG 4706 -->

<!-- PJG ITAG l=11 g=1 f=4 -->
The following Table 2 includes the names and addresses of record for all registrants of the products in Table 1, in sequence
by EPA company number.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<TABLE>

<!-- PJG tableformat 2,L2,i1,7,r150 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Table
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=1 -->
 2. _ 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Registrants Requesting Amendments to Delete 
<!-- PJG 0012 frnewline -->
 Uses in Certain Pesticide Registrations 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Company No. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Company Name and Address 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0152 intable -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
000264 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lRhone-Poulenc AG Company, 
<!-- PJG 0012 frnewline -->
 P.O. Box 12014, 
<!-- PJG 0012 frnewline -->
 2 T.W. Alexander Drive, 
<!-- PJG 0012 frnewline -->
 Research Triangle Park, NC 27709. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
000802 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lThe Chas. H. Lilly Co., 
<!-- PJG 0012 frnewline -->
 7737 N.E. Killingsworth, 
<!-- PJG 0012 frnewline -->
 Portland, OR 97218. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
003125 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMiles Inc., 
<!-- PJG 0012 frnewline -->
 P.O. Box 4913, 
<!-- PJG 0012 frnewline -->
 8400 Hawthorn Road, 
<!-- PJG 0012 frnewline -->
 Kansas City, MO 64120. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
010163 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lGowan Company, 
<!-- PJG 0012 frnewline -->
 P.O. Box 5569, 
<!-- PJG 0012 frnewline -->
 Yuma, AZ 85366. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
041014 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lKincade Enterprises, Inc., 
<!-- PJG 0012 frnewline -->
 P.O. Box 549, 
<!-- PJG 0012 frnewline -->
 Nitro, WV 25143. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->

<!-- PJG STAG 4703 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=84 g=1 f=4 -->
III. Existing Stocks Provisions 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
The Agency has authorized registrants to sell or distribute product under the previously approved labeling for a
period of 18 months after approval of the revision, unless other restrictions have been imposed, as in special review
actions. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=84 g=1 f=4 -->
List of Subjects
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Environmental protection, Pesticides and pests, Product registrations 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Dated: July 26, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=4 -->
Daniel M. Barolo, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=4 -->
Director, Office of Pesticide Programs.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=4 -->
[FR Doc. 94&hyph;19779 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=4 -->
BILLING CODE 6560&hyph;50&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00098 </DOCNO>
<PARENT> FR940817-2-00047 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=4 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=4 -->

<RINDOCK>[OPP&hyph;66198; FRL 4903&hyph;3]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=4 -->

<DOCTITLE>Notice of Receipt of Requests to Voluntarily Cancel Certain Pesticide Registrations </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Environmental Protection Agency (EPA). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 In accordance with Section 6(f)(1) of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), as amended,
EPA is issuing a notice of receipt of requests by registrants to voluntarily cancel certain pesticide registrations.

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Unless a request is withdrawn by November 15, 1994, orders will be issued cancelling all of these registrations. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 By mail: James A. Hollins, Office of Pesticide Programs (7502C), Environmental Protection Agency, 401 M St., SW,
Washington, DC 20460. Office location for commercial courier delivery and telephone number: 
<!-- PJG 0012 frnewline -->
Room 216, Crystal Mall No. 2, 
<!-- PJG 0012 frnewline -->
1921 Jefferson Davis Highway, 
<!-- PJG 0012 frnewline -->
Arlington, VA 22202, 
<!-- PJG 0012 frnewline -->
703&hyph;305&hyph;5761. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
I. Introduction
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 6(f)(1) of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), as amended, provides that a
pesticide registrant may, at any time, request that any of its pesticide registrations be cancelled. The Act further
provides that EPA must publish a notice of receipt of any such request in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 before acting on the request. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Intent to Cancel
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This Notice announces receipt by the Agency of requests to cancel some 147 pesticide products registered under section
3 or 24(c) of FIFRA. These registrations are listed in sequence by registration number (or company number and 24(c)
number) in the following Table 1.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<TABLE>

<!-- PJG tableformat 3,L2,i1,17,r70,r100  -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Table
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=1 -->
 1. _ 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Registrations With Pending Requests for Cancellation 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Registration No. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Product Name 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Chemical Name 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
000070&hyph;00117
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lKill-Ko New Improved Roach and Ant Killer 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
o
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Isopropoxyphenyl methylcarbamate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2,2-Dichlorovinyl dimethyl phosphate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
000303&hyph;00061
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSani-Tate Bowl Cleaner 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lHydrogen chloride 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
000352&hyph;00421
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1% Hexazinone Liquid Weed Killer 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l3-Cyclohexyl-6-(dimethylamino)-1-methyl-1,3,5-triazine
<!-- PJG 0012 frnewline -->
-2,4(1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
H
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
,3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
H
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
)-dione 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
000352&hyph;00422
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1.25% Hexazinone Liquid Weed Killer 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l3-Cyclohexyl-6-(dimethylamino)-1-methyl-1,3,5-triazine
<!-- PJG 0012 frnewline -->
-2,4(1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
H
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
,3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
H
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
)-dione 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
000432&hyph;00455
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSBP-1382 Pressurized Spray Insecticide 0.25% 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(5-Benzyl-3-furyl)methyl
<!-- PJG 0012 frnewline -->
2,2-dimethyl-3-(2-methylpropenyl)cyclopropanecarboxylate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
000432&hyph;00483
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSBP-1382 Concentrate 40 f VI 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(5-Benzyl-3-furyl)methyl
<!-- PJG 0012 frnewline -->
2,2-dimethyl-3-(2-methylpropenyl)cyclopropanecarboxylate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
000432&hyph;00495
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSBP-1382 Concentrate 5 for Manufacturing Use Only 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(5-Benzyl-3-furyl)methyl
<!-- PJG 0012 frnewline -->
2,2-dimethyl-3-(2-methylpropenyl)cyclopropanecarboxylate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
000432&hyph;00583
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSBP-1382 Insecticide Solvent Dilutable Concentrate 40 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(5-Benzyl-3-furyl)methyl
<!-- PJG 0012 frnewline -->
2,2-dimethyl-3-(2-methylpropenyl)cyclopropanecarboxylate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
000432&hyph;00608
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSBP-1382 Insecticide Aerosol 1% Formula III 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(5-Benzyl-3-furyl)methyl
<!-- PJG 0012 frnewline -->
2,2-dimethyl-3-(2-methylpropenyl)cyclopropanecarboxylate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
000432&hyph;00686
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSBP-1382/esobiothrin/p.b.o Insec. Aerosol 0.2%+ 0.3%
<!-- PJG 0012 frnewline -->
+
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2-Methyl-4-oxo-3-(2-propenyl)-2-cyclopenten-1-yl
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
d
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-trans-2,2-dimethyl- 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(Butylcarbityl)(6-propylpiperonyl) ether 80% and
<!-- PJG 0012 frnewline -->
related compounds 20% 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(5-Benzyl-3-furyl)methyl
<!-- PJG 0012 frnewline -->
2,2-dimethyl-3-(2-methylpropenyl)cyclopropanecarboxylate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
000432&hyph;00749
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSBP-1382 1% for Timed Dispenser. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(5-Benzyl-3-furyl)methyl
<!-- PJG 0012 frnewline -->
2,2-dimethyl-3-(2-methylpropenyl)cyclopropanecarboxylate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
000499&hyph;00157
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lWhitmire Pt 250 Baygon 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
o
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Isopropoxyphenyl methylcarbamate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
000499&hyph;00236
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lWhitmire Pt 252 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
o
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Isopropoxyphenyl methylcarbamate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
000499&hyph;00242
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lWhitmire Pt 253 Baygon 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
o
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Isopropoxyphenyl methylcarbamate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
000499&hyph;00335
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lP/p Baygon Insect Residual Spray with Synergized 
<!-- PJG 0012 frnewline -->
Pyrethrin
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
o
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Isopropoxyphenyl methylcarbamate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
N
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Octyl bicycloheptene dicarboximide 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(Butylcarbityl)(6-propylpiperonyl) ether 80% and
<!-- PJG 0012 frnewline -->
related compounds 20% 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrethrins 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
000572&hyph;00333
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lHormo-Root ``B'' 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lIndole-3-butyric acid 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTetramethyl thiuramdisulfide 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
000572&hyph;00334
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lHormo-Root ``C'' 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lIndole-3-butyric acid 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTetramethyl thiuramdisulfide 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
000572&hyph;00335
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lHormo-Root ``A'' 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lIndole-3-butyric acid 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTetramethyl thiuramdisulfide 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
000675&hyph;00008
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBarrage Industrial Strength Bowl Cleanse 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lHydrogen chloride 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAlkyl* dimethyl benzyl ammonium chloride *(50%C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=2 -->
14
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
, 
<!-- PJG 0012 frnewline -->
40%C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=2 -->
12
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
, 10%C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=2 -->
16
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
000777&hyph;00050
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lLysol Disinfectant Toilet Bowl Cleaner Crystals 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSodium bisulfate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
000802&hyph;00500
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMillers Wipe Out Slug &amp; Snail Bait 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l4-(Methylthio)-3,5-xylyl methylcarbamate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
000802&hyph;00566
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lLilly/miller Wipe Out Slug and Snail Bait for the Home
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l4-(Methylthio)-3,5-xylyl methylcarbamate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
000875&hyph;00088
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAccord Iodine Detergent Germicide 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lHydrogen chloride 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAlkyl* poly(oxypropylene)poly(oxyethylene) - iodine 
<!-- PJG 0012 frnewline -->
complex *(43%C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=2 -->
10
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
, 30%C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=2 -->
14
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
, 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhosphoric acid 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
000875&hyph;00112
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCrouch's Id-125 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lNonylphenoxypolyethoxyethanol - iodine complex 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhosphoric acid 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
000875&hyph;00115
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCrouch's Id=05=r 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lNonylphenoxypolyethoxyethanol - iodine complex 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhosphoric acid 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
000875&hyph;00156
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxford Ix-91 Iodophor Concentrate 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lNonylphenoxypolyethoxyethanol - iodine complex 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPotassium iodide 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhosphoric acid 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
000875&hyph;00157
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxford Bowl-Bright 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lHydrogen chloride 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhosphoric acid 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
000875&hyph;00168
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxford 919 Iodophor Concentrate 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPotassium iodide 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhosphoric acid 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
001022&hyph;00552
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChapman CCA-50 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lArsenic pentoxide 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChromic acid 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCupric oxide 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
001744&hyph;00001
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSunny Sol Bleach 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSodium hypochlorite 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
001744&hyph;00005
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSunny Sol 100 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSodium hypochlorite 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
001965&hyph;00019
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lVancide 51Z 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lZinc dimethyldithiocarbamate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2-Mercaptobenzothiazole, zinc salt 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
002344&hyph;00004
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSkoal Last Tank Sanitizer 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhosphoric acid 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDodecylbenzenesulfonic acid 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
002829&hyph;00102
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lVinyzene BP-5 DIDP 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10,10'-Oxybisphenoxarsine 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
002829&hyph;00104
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lVinyzene BP-5 Dop 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10,10'-Oxybisphenoxarsine 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
003125&hyph;00214
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBaygon 1.5 Emulsifiable Insecticide 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
o
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Isopropoxyphenyl methylcarbamate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
003282&hyph;00067
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lD-Con Four/gone Automatic Room Fogger Formula IV 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2-Methyl-4-oxo-3-(2-propenyl)-2-cyclopenten-1-yl
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
d
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-trans-2,2-dimethyl- 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(3-Phenoxyphenyl)methyl 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
d
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-cis and trans*
<!-- PJG 0012 frnewline -->
2,2-dimethyl-3-(2-methylpropenyl)cyclopro 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2,2-Dichlorovinyl dimethyl phosphate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
003282&hyph;00075
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lD-Con Four/gone Automatic Room Fogger XII 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
O,O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Diethyl 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-(3,5,6-trichloro-2-pyridyl)
<!-- PJG 0012 frnewline -->
phosphorothioate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2,2-Dichlorovinyl dimethyl phosphate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l4-Chloro-alpha-(1-methylethyl)benzeneacetic acid,
<!-- PJG 0012 frnewline -->
cyano(3-phenoxyphenyl)methyl 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
003640&hyph;00066
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMark-10 Dairy Cleaner-Sanitizer 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAlkyl* dimethyl benzyl ammonium chloride *(60%C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=2 -->
14
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
,
<!-- PJG 0012 frnewline -->
30%C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=2 -->
16
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
, 5%C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=2 -->
18
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
, 5%C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=2 -->
12
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
) 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAlkyl* dimethyl ethylbenzyl ammonium chloride
<!-- PJG 0012 frnewline -->
*(68%C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=2 -->
12
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
, 32%C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=2 -->
14
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhosphoric acid 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
004462&hyph;00009
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBeaver Iocide Detergent-Sanitizer 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lNonylphenoxypolyethoxyethanol - iodine complex 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOctylphenoxypolyethoxyethanol - iodine complex 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhosphoric acid 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
004584&hyph;00053
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrestige Spray Disinfectant 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lIsopropanol 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2-Benzyl-4-chlorophenol 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
o
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Phenylphenol 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l4-Chloro-3,5-xylenol 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
004816&hyph;00125
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBPR-Plant Spray Concentrate No. 2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(Butylcarbityl)(6-propylpiperonyl) ether 80% and 
<!-- PJG 0012 frnewline -->
related compounds 20% 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrethrins 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lRotenone 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCube Resins other than rotenone 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
004816&hyph;00323
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lNiagara Intermediate Concentrate 20&hyph;5 Insecticide 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(Butylcarbityl)(6-propylpiperonyl) ether 80% and 
<!-- PJG 0012 frnewline -->
related compounds 20% 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrethrins 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
004816&hyph;00332
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrenone House and Garden Insect Spray 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(Butylcarbityl)(6-propylpiperonyl) ether 80% and 
<!-- PJG 0012 frnewline -->
related compounds 20% 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrethrins 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
004816&hyph;00334
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lRoach &amp; Ant Spray Pressurized contains Diazinon 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
O,O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Diethyl 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-(2-isopropyl-6-methyl-4-pyrimidinyl)
<!-- PJG 0012 frnewline -->
phosphorothioate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(Butylcarbityl)(6-propylpiperonyl) ether 80% and 
<!-- PJG 0012 frnewline -->
related compounds 20% 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrethrins 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
004816&hyph;00337
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lWasp &amp; Hornet Killer No. 1 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1-Naphthyl-
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
N
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-methylcarbamate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(Butylcarbityl)(6-propylpiperonyl) ether 80% and 
<!-- PJG 0012 frnewline -->
related compounds 20% 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrethrins 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
004816&hyph;00342
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrenone Food Plant Aerosol Insecticide 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(Butylcarbityl)(6-propylpiperonyl) ether 80% and 
<!-- PJG 0012 frnewline -->
related compounds 20% 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrethrins 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
004816&hyph;00360
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrenone House and Garden Insect Spray (water Based) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(Butylcarbityl)(6-propylpiperonyl) ether 80% and 
<!-- PJG 0012 frnewline -->
related compounds 20% 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrethrins 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
004816&hyph;00362
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrenone One Shot Hi-Pressure Fogger 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(Butylcarbityl)(6-propylpiperonyl) ether 80% and 
<!-- PJG 0012 frnewline -->
related compounds 20% 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrethrins 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
004816&hyph;00371
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lRoach &amp; Ant Spray Pressurized contains Propoxur 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
o
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Isopropoxyphenyl methylcarbamate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(Butylcarbityl)(6-propylpiperonyl) ether 80% and 
<!-- PJG 0012 frnewline -->
related compounds 20% 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrethrins 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
004816&hyph;00374
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSynthrin Pressurized Spray Insecticide 0.35 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(5-Benzyl-3-furyl)methyl 
<!-- PJG 0012 frnewline -->
2,2-dimethyl-3-(2-methylpropenyl)cyclopropanecarboxylate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
004816&hyph;00384
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSynthrin Pressurized Insecticide Spray 0.25 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(5-Benzyl-3-furyl)methyl 
<!-- PJG 0012 frnewline -->
2,2-dimethyl-3-(2-methylpropenyl)cyclopropanecarboxylate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
004816&hyph;00386
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lFlea and Tick Killer for Cats and Dogs contains 
<!-- PJG 0012 frnewline -->
Allethr 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2-Methyl-4-oxo-3-(2-propenyl)-2-cyclopenten-1-yl 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
d
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-trans-2,2-dimethyl- 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lButoxypolypropylene glycol 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(Butylcarbityl)(6-propylpiperonyl) ether 80% and 
<!-- PJG 0012 frnewline -->
related compounds 20% 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
004816&hyph;00404
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSynthrin Industrial Pressurized Spray 0.50 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(5-Benzyl-3-furyl)methyl 
<!-- PJG 0012 frnewline -->
2,2-dimethyl-3-(2-methylpropenyl)cyclopropanecarboxylate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
004816&hyph;00415
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lIndustrial Pressurized Spray 2.0&hyph;0.4 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(Butylcarbityl)(6-propylpiperonyl) ether 80% and 
<!-- PJG 0012 frnewline -->
related compounds 20% 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrethrins 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
004816&hyph;00421
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lKennel &amp; Canine Insecticide 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(Butylcarbityl)(6-propylpiperonyl) ether 80% and 
<!-- PJG 0012 frnewline -->
related compounds 20% 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrethrins 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
004816&hyph;00429
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPressurized Spray Multi-Use Insecticide 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(Butylcarbityl)(6-propylpiperonyl) ether 80% and 
<!-- PJG 0012 frnewline -->
related compounds 20% 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrethrins 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
004816&hyph;00452
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrenone Special 12&hyph;1.5 Insecticide Aerosol 
<!-- PJG 0012 frnewline -->
Concentrate 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(Butylcarbityl)(6-propylpiperonyl) ether 80% and 
<!-- PJG 0012 frnewline -->
related compounds 20% 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrethrins 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
004816&hyph;00455
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lFeline Insect Spray 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(Butylcarbityl)(6-propylpiperonyl) ether 80% and 
<!-- PJG 0012 frnewline -->
related compounds 20% 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrethrins 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
004816&hyph;00458
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lEquine Fly Spray 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lButoxypolypropylene glycol 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(Butylcarbityl)(6-propylpiperonyl) ether 80% and 
<!-- PJG 0012 frnewline -->
related compounds 20% 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank; 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrethrins 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
004816&hyph;00469
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBpr W-B 1.33-0.25-1.068 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(Butylcarbityl)(6-propylpiperonyl) ether 80% and 
<!-- PJG 0012 frnewline -->
related compounds 20% 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrethrins 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lRotenone 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCube Resins other than rotenone 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
004816&hyph;00508
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTetralate General Purpose Pressurized Spray Insect 
<!-- PJG 0012 frnewline -->
Kill
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(1-Cyclohexene-1,2-dicarboximido)methyl 
<!-- PJG 0012 frnewline -->
2,2-dimethyl-3-(2-methylpropenyl)cycloprop 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(5-Benzyl-3-furyl)methyl 
<!-- PJG 0012 frnewline -->
2,2-dimethyl-3-(2-methylpropenyl)cyclopropanecarboxylate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
004816&hyph;00517
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrenone Diazinon E.C. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
O,O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Diethyl 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-(2-isopropyl-6-methyl-4-pyrimidinyl)
<!-- PJG 0012 frnewline -->
phosphorothioate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(Butylcarbityl)(6-propylpiperonyl) ether 80% and 
<!-- PJG 0012 frnewline -->
related compounds 20% 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrethrins 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
004816&hyph;00519
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrenone Dursban 0.25 Roach &amp; Ant Pressurized Spray 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
O,O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Diethyl 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-(3,5,6-trichloro-2-pyridyl)
<!-- PJG 0012 frnewline -->
phosphorothioate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(Butylcarbityl)(6-propylpiperonyl) ether 80% and 
<!-- PJG 0012 frnewline -->
related compounds 20% 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrethrins 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
004816&hyph;00533
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBPR Aerosol Concentrate 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(Butylcarbityl)(6-propylpiperonyl) ether 80% and 
<!-- PJG 0012 frnewline -->
related compounds 20% 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrethrins 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lRotenone 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCube Resins other than rotenone 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
004816&hyph;00565
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrenone Total Release 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(Butylcarbityl)(6-propylpiperonyl) ether 80% and 
<!-- PJG 0012 frnewline -->
related compounds 20% 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrethrins 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
004816&hyph;00597
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiazinon 12.5% Emulsifiable Concentrate 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
O,O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Diethyl 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-(2-isopropyl-6-methyl-4-pyrimidinyl)
<!-- PJG 0012 frnewline -->
phosphorothioate 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
004822&hyph;00054
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lJohnson Go-Getter the Working Foam Bowl Cleaner 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lHydrogen chloride 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
004822&hyph;00096
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lNew Formula Raid Liquid Ant &amp; Roach Killer 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
o
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Isopropoxyphenyl methylcarbamate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2,2-Dichlorovinyl dimethyl phosphate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
004822&hyph;00110
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lRaid Liquid Ant &amp; Roach Killer 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
o
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Isopropoxyphenyl methylcarbamate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2,2-Dichlorovinyl dimethyl phosphate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
004822&hyph;00408
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lVanish Toilet Bowl Cleaner 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSodium bisulfate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
004822&hyph;00409
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCrystal Vanish Toilet Bowl Cleaner 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSodium bisulfate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
005905&hyph;00165
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lHelena Brand Bromo-Clean 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSodium metaborate (NaBO2) 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l5-Bromo-3-sec-butyl-6-methyluracil 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSodium chlorate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
005905&hyph;00166
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lHelena Brand Veg-Clean 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSodium metaborate (NaBO2) 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l5-Bromo-3-sec-butyl-6-methyluracil 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSodium chlorate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
006836&hyph;00039
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lLonza Formulation 217 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lHydrogen chloride 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDidecyl dimethyl ammonium chloride 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOctyl decyl dimethyl ammonium chloride 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDioctyl dimethyl ammonium chloride 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
006836&hyph;00042
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lLonza Formulation 223 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lHydrogen chloride 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDidecyl dimethyl ammonium chloride 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOctyl decyl dimethyl ammonium chloride 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDioctyl dimethyl ammonium chloride 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
006931&hyph;00002
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lIodibac Formula S-30 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lNonylphenoxypolyethoxyethanol - iodine complex 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhosphoric acid 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
006931&hyph;00004
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMer-O-San Formula S-40 Acid Sanitizer 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhosphoric acid 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
007546&hyph;00005
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDe-Germ Formula No. 14 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAlkyl* dimethyl benzyl ammonium chloride *(60%C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=2 -->
14
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
, 
<!-- PJG 0012 frnewline -->
30%C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=2 -->
16
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
, 5%C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=2 -->
18
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
, 5%C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=2 -->
12
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhosphoric acid 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
007616&hyph;00065
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lKem Tek Spa Kem Liquid Bromide 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSodium bromide 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
008325&hyph;00027
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBullen Industrial Germicidal Bowl Cleaner 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lHydrogen chloride 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAlkyl* dimethyl benzyl ammonium chloride *(60%C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=2 -->
14
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
,
<!-- PJG 0012 frnewline -->
30%C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=2 -->
16
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
, 5%C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=2 -->
18
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
, 5%C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=2 -->
12
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
) 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAlkyl* dimethyl ethylbenzyl ammonium chloride 
<!-- PJG 0012 frnewline -->
*(68%C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=2 -->
12
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
, 32%C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=2 -->
14
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
008590&hyph;00570
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lLivestock Spray II 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDipropyl isocinchomeronate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
N
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Octyl bicycloheptene dicarboximide 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(Butylcarbityl)(6-propylpiperonyl) ether 80% and 
<!-- PJG 0012 frnewline -->
related compounds 20% 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrethrins 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2,2-Dichlorovinyl dimethyl phosphate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
008781&hyph;00004
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMetz Iodine Detergent Germicide 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lNonylphenoxypolyethoxyethanol - iodine complex 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhosphoric acid 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
010370&hyph;00033
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lFoam spray Products 57% Malathion 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
O,O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Dimethyl phosphorodithioate of diethyl 
<!-- PJG 0012 frnewline -->
mercaptosuccinate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
010370&hyph;00034
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lFoam spray Products Diazinon Super 12 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
O,O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Diethyl 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-(2-isopropyl-6-methyl-4-pyrimidinyl)
<!-- PJG 0012 frnewline -->
phosphorothioate 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
010370&hyph;00041
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lFord's Diazinon Plus Roach Spray 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
O,O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Diethyl 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-(2-isopropyl-6-methyl-4-pyrimidinyl)
<!-- PJG 0012 frnewline -->
phosphorothioate 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
010370&hyph;00067
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAlgaecide Concentrate NF 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPoly(oxyethylene(dimethyliminio)ethylene(dimethylimini
<!-- PJG 0012 frnewline -->
o)ethylene dichloride) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
010370&hyph;00068
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l57% Malathion 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
O,O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Dimethyl phosphorodithioate of diethyl
<!-- PJG 0012 frnewline -->
mercaptosuccinate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
010370&hyph;00070
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTerraclor 2E 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPentachloronitrobenzene 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
010370&hyph;00074
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lFord's Diazinon 45 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
O,O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Diethyl 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-(2-isopropyl-6-methyl-4-pyrimidinyl)
<!-- PJG 0012 frnewline -->
phosphorothioate 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
010370&hyph;00114
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lStaffel's 56% Malathion(premium Grade) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
O,O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Dimethyl phosphorodithioate of diethyl
<!-- PJG 0012 frnewline -->
mercaptosuccinate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
010370&hyph;00119
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lStaffel's Rats-N-Mice Killer 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l3-(alpha-Acetonylbenzyl)-4-hydroxycoumarin 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
010370&hyph;00120
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lStaffel's Rats-N-Mice Bait 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l3-(alpha-Acetonylbenzyl)-4-hydroxycoumarin 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
010370&hyph;00128
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lFords 5% Malathion Dust 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
O,O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Dimethyl phosphorodithioate of diethyl
<!-- PJG 0012 frnewline -->
mercaptosuccinate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
010370&hyph;00146
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lLiquid Edger Ready To Use 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAmmonium sulfamate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
010370&hyph;00166
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBroadleaf Spot Weeder 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDimethylamine 3,6-dichloro-
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
o
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-anisate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDimethylamine 2,4-dichlorophenoxyacetate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
010370&hyph;00170
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPCNB 10-G Soil Fungicide 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPentachloronitrobenzene 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
010370&hyph;00180
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lFord's Broadleaf Spot Weed Killer 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDimethylamine 3,6-dichloro-
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
o
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-anisate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDimethylamine 2,4-dichlorophenoxyacetate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
010370&hyph;00188
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiathrin Ant &amp; Roach Powder 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
O,O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Diethyl 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-(2-isopropyl-6-methyl-4-pyrimidinyl)
<!-- PJG 0012 frnewline -->
phosphorothioate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrethrins 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
010370&hyph;00206
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lFPC Pro Algaecide 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPoly(oxyethylene(dimethyliminio)ethylene(dimethylimini
<!-- PJG 0012 frnewline -->
o)ethylene dichloride) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
010370&hyph;00273
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lRoberts Malathion 57% Premium Grade 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
O,O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Dimethyl phosphorodithioate of diethyl
<!-- PJG 0012 frnewline -->
mercaptosuccinate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
010370&hyph;00275
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lClean Crop Diazinon 4% Garden Dust 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
O,O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Diethyl 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-(2-isopropyl-6-methyl-4-pyrimidinyl)
<!-- PJG 0012 frnewline -->
phosphorothioate 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
010370&hyph;00276
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lClean Crop Diazinon 25 Lawn &amp; Garden 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
O,O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Diethyl 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-(2-isopropyl-6-methyl-4-pyrimidinyl)
<!-- PJG 0012 frnewline -->
phosphorothioate 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
010370&hyph;00279
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lClean Crop Malathion 50 Lawn and Garden Spray 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
O,O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Dimethyl phosphorodithioate of diethyl
<!-- PJG 0012 frnewline -->
mercaptosuccinate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
010370&hyph;00287
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lClean Crop Diazinon 25 Lawn Insecticide 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
O,O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Diethyl 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-(2-isopropyl-6-methyl-4-pyrimidinyl)
<!-- PJG 0012 frnewline -->
phosphorothioate 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
010370&hyph;00292
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l25% Diazinon Garden Insect Spray 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
O,O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Diethyl 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-(2-isopropyl-6-methyl-4-pyrimidinyl)
<!-- PJG 0012 frnewline -->
phosphorothioate 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
015567&hyph;00001
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lNo. 23 Emulsion Bowl Cleaner and Disinfectant 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lHydrogen chloride 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
015567&hyph;00005
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lClout Emulsion Bowl and Porcelain Cleaner Disinfectant
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lHydrogen chloride 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
015567&hyph;00008
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l16 Bowl Cleaner Scale Solvent &amp; Disinfectant 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lHydrogen chloride 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
028293&hyph;00117
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lUnicorn Now Flea &amp; Tick Spray 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lButoxypolypropylene glycol 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(Butylcarbityl)(6-propylpiperonyl) ether 80% and 
<!-- PJG 0012 frnewline -->
related compounds 20% 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrethrins 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
033176&hyph;00002
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAirysol Brand Insect Killer 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
d
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-trans-Chrysanthemum monocarboxylic acid ester of 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
d
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-2-allyl-4-hydroxy-3- 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(Butylcarbityl)(6-propylpiperonyl) ether 80% and 
<!-- PJG 0012 frnewline -->
related compounds 20% 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
033176&hyph;00028
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAirysol Brand Professional Strength Flying &amp; Crawling 
<!-- PJG 0012 frnewline -->
I 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2-Methyl-4-oxo-3-(2-propenyl)-2-cyclopenten-1-yl 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
d
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-trans-2,2-dimethyl- 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
N
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Octyl bicycloheptene dicarboximide 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(Butylcarbityl)(6-propylpiperonyl) ether 80% and 
<!-- PJG 0012 frnewline -->
related compounds 20% 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
038664&hyph;00022
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lWah Wasp &amp; Hornet Killer 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
o
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Isopropoxyphenyl methylcarbamate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
N
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Octyl bicycloheptene dicarboximide 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(Butylcarbityl)(6-propylpiperonyl) ether 80% and 
<!-- PJG 0012 frnewline -->
related compounds 20% 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrethrins 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
039272&hyph;00002
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lWhite Emulsion Bowl Cleaner 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lHydrogen chloride 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiisobutylphenoxyethoxyethyl dimethyl benzyl ammonium
<!-- PJG 0012 frnewline -->
chloride 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
042177&hyph;00024
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOlympic Chlor-O-Rings 100 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTrichloro-
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
s
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-triazinetrione 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
042177&hyph;00036
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOlympic Clorinator Sticks 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTrichloro-
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
s
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-triazinetrione 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
042177&hyph;00057
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lYork's Roman Springs 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSodium dichloro-
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
s
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-triazinetrione 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
042177&hyph;00068
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOlympic Shock Tabs 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTrichloro-
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
s
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-triazinetrione 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
049547&hyph;00003
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAidex Pine Oil 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPine oil 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
051793&hyph;00046
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lElite Insect Spray Permethrin 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCyclopropanecarboxylic acid,
<!-- PJG 0012 frnewline -->
3-(2,2-dichloroethenyl)-2,2-dimethyl-, 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
051793&hyph;00064
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lElite Aerosol Insect Spray with Permethrin 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
N
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Octyl bicycloheptene dicarboximide 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrethrins 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCyclopropanecarboxylic acid, 
<!-- PJG 0012 frnewline -->
3-(2,2-dichloroethenyl)-2,2-dimethyl-, 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
051793&hyph;00078
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lElite Aerosol Insect Spray with Permethrin II 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCyclopropanecarboxylic acid, 
<!-- PJG 0012 frnewline -->
3-(2,2-dichloroethenyl)-2,2-dimethyl-, 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
051793&hyph;00093
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lElite Aqueous Room Fogger 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
N
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Octyl bicycloheptene dicarboximide 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrethrins 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCyclopropanecarboxylic acid, 
<!-- PJG 0012 frnewline -->
3-(2,2-dichloroethenyl)-2,2-dimethyl-, 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
051793&hyph;00104
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lElite Permethrin 13.3% EC for Plants 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCyclopropanecarboxylic acid, 
<!-- PJG 0012 frnewline -->
3-(2,2-dichloroethenyl)-2,2-dimethyl-, 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
051793&hyph;00106
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lElite Aerosol Insect Spray with Permethrin Plus 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2-Methyl-4-oxo-3-(2-propenyl)-2-cyclopenten-1-yl-
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
d
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-trans-2,2-dimethyl- 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCyclopropanecarboxylic acid, 
<!-- PJG 0012 frnewline -->
3-(2,2-dichloroethenyl)-2,2-dimethyl-, 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
051793&hyph;00129
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lElite Aerosol Insect Spray with Permethrin Plus II 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2-Methyl-4-oxo-3-(2-propenyl)-2-cyclopenten-1-yl-
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
d
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-trans-2,2-dimethyl- 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
N
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Octyl bicycloheptene dicarboximide 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCyclopropanecarboxylic acid, 
<!-- PJG 0012 frnewline -->
3-(2,2-dichloroethenyl)-2,2-dimethyl-, 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
051793&hyph;00153
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lElite Flea &amp; Tick Shampoo #9 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDipropyl isocinchomeronate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
N
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Octyl bicycloheptene dicarboximide 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(Butylcarbityl)(6-propylpiperonyl) ether 80% and 
<!-- PJG 0012 frnewline -->
related compounds 20% 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrethrins 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
051793&hyph;00155
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lElite Flea &amp; Tick Spray #9 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDipropyl isocinchomeronate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
N
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-Octyl bicycloheptene dicarboximide 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l(Butylcarbityl)(6-propylpiperonyl) ether 80% and 
<!-- PJG 0012 frnewline -->
related compounds 20% 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrethrins 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
051793&hyph;00159
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lElite Indoor Houseplant Spray 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrethrins 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCyclopropanecarboxylic acid, 
<!-- PJG 0012 frnewline -->
3-(2,2-dichloroethenyl)-2,2-dimethyl-, 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
051793&hyph;00160
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lElite Aerosol Indoor Houseplant Spray 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPyrethrins 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCyclopropanecarboxylic acid, 
<!-- PJG 0012 frnewline -->
3-(2,2-dichloroethenyl)-2,2-dimethyl-, 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
052252&hyph;00002
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSterx Cold Sterilant for Reprocessing Catheters 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lHydrogen peroxide 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPeroxyacetic acid 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
052252&hyph;00003
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lActril Cold Sterilant for Dialysis Use 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lHydrogen peroxide 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPeroxyacetic acid 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
055146&hyph;00047
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2% Liquid Gib 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lGibberellic acid 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
055146&hyph;00052
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lGibgro 4 1 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lGibberellic acid 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
055146&hyph;00058
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lGibgro K 21 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lGibberellic acid, monopotassium salt 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
055947&hyph;00039
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMarksman Herbicide 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2-Chloro-4-(ethylamino)-6-(isopropylamino)-
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
s
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-triazine 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPotassium 3,6-dichloro-
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
o
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-anisate 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
056644&hyph;00048
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSecurity Blot-Out Systemic Weed &amp; Grass Killer 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lIsopropylamine glyphosate (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
N
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
-(phosphonomethyl)glycine) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->

<!-- PJG STAG 4706 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Unless a request is withdrawn by the registrant within 90 days of publication of this notice, orders will be issued
cancelling all of these registrations. Users of these pesticides or anyone else desiring the retention of a registration
should contact the applicable registrant directly during this 90&hyph;day period. The following Table 2 includes
the names and addresses of record for all registrants of the products in Table 1, in sequence by EPA Company Number.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->

<!-- PJG STAG 4703 -->

<TABLE>

<!-- PJG tableformat 2,L2,i1,7,r150  -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Table
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=1 -->
 2. _ 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Registrants Requesting Voluntary Cancellation 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1EPA Company No. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Company Name and Address 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0152 intable -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=4 -->
000070 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lWilbur-Ellis Co., Box 16458, Fresno, CA 93755. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
000303 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lHuntington Laboratories, Inc., 968&hyph;970 E. Tipton St., 
<!-- PJG 0012 frnewline -->
Huntington, IN 46750. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
000352 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lE. I. Du Pont De Nemours &amp; Co, Inc., Barley Mill 
<!-- PJG 0012 frnewline -->
Plaza, Walker's Mill, Wilmington, DE 19880. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
000432 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lRoussel Uclaf Corp., 95 Chestnut Ridge Rd, Montvale, 
<!-- PJG 0012 frnewline -->
NJ 07645. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
000499 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lWhitmire Research Laboratories, Inc., 3568 Tree Ct 
<!-- PJG 0012 frnewline -->
Industrial Blvd, St Louis, MO 63122. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
000572 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lRockland Corp., 686 Passaic Ave., Box 809, West 
<!-- PJG 0012 frnewline -->
Caldwell, NJ 07007. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
000675 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lNational Laboratories, L &amp; F Products, 225 Summit 
<!-- PJG 0012 frnewline -->
Ave, Montvale, NJ 07645. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
000777 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lL &amp; F Products, 225 Summit Ave., Montvale, NJ 07645. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
000802 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChas H. Lilly Co., 7737 N.E. Killingsworth, Portland, 
<!-- PJG 0012 frnewline -->
OR 97218. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
000875 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiversey Corp., 12025 Tech Center Dr, Livonia, MI 
<!-- PJG 0012 frnewline -->
48150. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
001022 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lIBC Mfg. Co, c/o Sangeeta V. Khattar, 5966 Heisley 
<!-- PJG 0012 frnewline -->
Rd., Mentor, OH 44060. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
001744 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lJones Chemicals, Inc., 80 Munson Street, Leroy, NY 
<!-- PJG 0012 frnewline -->
14482. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
001965 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lR.T. Vanderbilt Co., Inc., 30 Winfield St, Norwalk, CT 
<!-- PJG 0012 frnewline -->
06856. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
002344 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lRiesen Chem Corp., 419 W. Vliet St., Milwaukee, WI 
<!-- PJG 0012 frnewline -->
53212. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
002829 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMorton International, Inc., Specialty Chemicals 
<!-- PJG 0012 frnewline -->
Group, 333 W. Wacker Drive, Chicago, IL 60606. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
003125 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMiles Inc., Agriculture Division, 8400 Hawthorn Rd., 
<!-- PJG 0012 frnewline -->
Box 4913, Kansas City, MO 64120. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
003282 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lD-Con Co. Inc., 225 Summit Ave., Montvale, NJ 07645. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
003640 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lStearns Packaging Corp., Box 3216, Madison, WI 53704. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
004462 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lU. S. Chemical, A Division of Hydrite Chemical Co, 300 N 
<!-- PJG 0012 frnewline -->
Patrick Blvd (53045), Drawer #0948, Brookfield, WI 53008. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
004584 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lE.D. Smith-Gem Inc., #1 Gem Blvd, Byhalia, MS 38611. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
004816 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lRoussel Uclaf Corp., 95 Chestnut Ridge Rd, Montvale, 
<!-- PJG 0012 frnewline -->
NJ 07645. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
004822 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lS.C. Johnson &amp; Son Inc., 1525 Howe Street, Racine, WI 
<!-- PJG 0012 frnewline -->
53403. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
005905 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lHelena Chemical Co, 6075 Poplar Ave., Suite 500, 
<!-- PJG 0012 frnewline -->
Memphis, TN 38119. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
006836 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lLonza Inc., 17&hyph;17 Rte 208, Fair Lawn, NJ 07410. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
006931 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMerit Chemical Inc., Box 513, Sharon, WI 53585. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
007546 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lU. S. Chemical, A Division of Hydrite Chemical Co, 300 N 
<!-- PJG 0012 frnewline -->
Patrick Blvd (53045), Drawer #0948, Brookfield, WI 53008. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
007616 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChem Lab Products Inc., 5160 E. Airport Dr., Ontario, 
<!-- PJG 0012 frnewline -->
CA 91761. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
008325 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMisco Products Corp., R.D. 9, Box 9155, Reading, PA 
<!-- PJG 0012 frnewline -->
19605. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
008590 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAgway Inc., c/o Universal Cooperatives Inc., Box 460, 
<!-- PJG 0012 frnewline -->
Minneapolis, MN 55440. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
008781 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMetz Sales, Inc., 522 W. First Street, Williamsburg, 
<!-- PJG 0012 frnewline -->
PA 16693. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
010370 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lRoussel Uclaf Corp., 95 Chestnut Ridge Rd, Montvale, 
<!-- PJG 0012 frnewline -->
NJ 07645. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
015567 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCreative Chemicals Inc., 3 Church Street, Palmer, MA 
<!-- PJG 0012 frnewline -->
01069. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
028293 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lUnicorn Labs &amp; Phaeton Corp., 1000 118th Ave N, St. 
<!-- PJG 0012 frnewline -->
Petersburg, FL 33716. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
033176 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAmrep, Inc., Regulatory Affairs, 990 Industrial Park 
<!-- PJG 0012 frnewline -->
Dr, Marietta, GA 30062. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
038664 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lArchem, Inc., Box 1490, Conway, AR 72032. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
039272 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lWepak Corp., Box 36803, Charlotte, NC 28236. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
042177 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lYork Chemical Corp., 3309 E. John W. Carpenter 
<!-- PJG 0012 frnewline -->
Freeway, Irving, TX 75062. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
049547 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSintesis Quimica S.A., c/o Pazianos Assoc., 1338 G 
<!-- PJG 0012 frnewline -->
St., SE, Washington, DC 20003. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
051793 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lRSR Laboratories, Inc., 501 Fifth St., Bristol, TN 
<!-- PJG 0012 frnewline -->
37620. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
052252 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMinntech Corp., Renal Systems, Div of Minntech Corp., 
<!-- PJG 0012 frnewline -->
14605 28th Ave N, Minneapolis, MN 55447. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
055146 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAgtrol Chemical Products, 7322 Southwest Freeway, 
<!-- PJG 0012 frnewline -->
Suite 1400, Houston, TX 77074. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
055947 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSandoz Agro Inc., 1300 E. Touhy Ave, Des Plaines, IL 
<!-- PJG 0012 frnewline -->
60018. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
056644 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSecurity Products Co. of Delaware, Inc., Box 59084, 
<!-- PJG 0012 frnewline -->
Minneapolis, MN 55459. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->

<!-- PJG STAG 4706 -->

<!-- PJG ITAG l=84 g=1 f=4 -->
III. Loss of Active Ingredients 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Unless these requests for cancellation, one pesticide active ingredient will no longer appear in any registered
products. Those who are concerned about the potential loss of this active ingredient for pesticidal use are encouraged
to work directly with the registrant to explore the possibility of their withdrawing the request for cancellation.
This active ingredient is listed in the following Table 3, with the EPA Company Number.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<TABLE>

<!-- PJG tableformat 3,L2,i1,10,r60,20 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Table
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=1 -->
 3. _ 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Active Ingredients Which Would Disappear as 
<!-- PJG 0012 frnewline -->
a Result of Registrants' Requests to Cancel 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Cas No. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Chemical Name 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1EPA Company No. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=4 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAlkyl *poly(oxyprophlene)poly 
<!-- PJG 0012 frnewline -->
(oxyethylene) - iodine complex * 
<!-- PJG 0012 frnewline -->
(43%C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=2 -->
10
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
, 30%C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=2 -->
14
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
, 12%C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=2 -->
12
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
, 10%C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=2 -->
16
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
, 45%C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=2 -->
18
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 007 0157 intable -->
i0000875
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->

<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
IV. Procedures for Withdrawal of Request 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Registrants who choose to withdraw a request for cancellation must submit such withdrawal in writing to James A. Hollins,
at the address given above, postmarked before November 15, 1994. This written withdrawal of the request for cancellation
will apply only to the applicable 6(f)(1) request listed in this notice. If the product(s) have been subject to a previous
cancellation action, the effective date of cancellation and all other provisions of any earlier cancellation action
are controlling. The withdrawal request must also include a commitment to pay any reregistration fees due, and to
fulfill any applicable unsatisfied data requirements. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
V. Provisions for Disposition of Existing Stocks 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The effective date of cancellation will be the date of the cancellation order. The orders effecting these requested
cancellations will generally permit a registrant to sell or distribute existing stocks for 1&hyph;year after the
date the cancellation request was received. This policy is in accordance with the Agency's statement of policy as
prescribed in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 No. 123, Vol. 56, dated June 26, 1991. Exceptions to this general rule will be made if a product poses a risk concern,
or is in noncompliance with reregistration requirements, or is subject to a data call-in. In all cases, product-specific
disposition dates will be given in the cancellation orders. Existing stocks are those stocks of registered pesticide
products which are currently in the United States and which have been packaged, labeled, and released for shipment
prior to the effective date of the cancellation action. Unless the provisions of an earlier order apply, existing
stocks already in the hands of dealers or users can be distributed, sold or used legally until they are exhausted, provided
that such further sale and use comply with the EPA-approved label and labeling of the affected product(s). Exceptions
to these general rules will be made in specific cases when more stringent restrictions on sale, distribution, or use
of the products or their ingredients have already been imposed, as in Special Review actions, or where the Agency has
identified significant potential risk concerns associated with a particular chemical. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Environmental protection, Pesticides and pests, Product registrations. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: July 26, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Daniel M. Barolo, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Director, Office of Pesticide Programs. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;19780 Filed 8&hyph;16&hyph;94; 8:45 am] 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6560&hyph;50&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00099 </DOCNO>
<PARENT> FR940817-2-00048 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[OPP&hyph;34060; FRL&hyph;4866&hyph;6]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Reregistration Eligibility Decision Documents; Completion of Comment Period</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Environmental Protection Agency (EPA).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This Notice, pursuant to section 4(g)(2) of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), concludes
the comment period for the reregistration eligibility decision documents (REDS) for several chemical cases. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Copies of these REDS are available from the National Technical Information Service (NTIS), 5285 Port Royal Road,
Springfield, VA 22161, ATTN: Order Desk; telephone no. (703)487&hyph;4650. To obtain copies you must provide the
publication number that has been assigned to the RED listed in the table below.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Technical questions on the RED documents listed below should be directed to the appropriate Chemical Review Managers:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 3,L2,p6,6/6,i1,s20,r20,r20 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Chemical Name 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Chemical Review Manager
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Telephone No.
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Barium Metaborate 
<!-- PJG 007 0104 intable -->
Brigid Lowery 
<!-- PJG 007 0104 intable -->
(703) 308&hyph;8053
<!-- PJG 0012 frnewline -->
Boric Acid 
<!-- PJG 007 0104 intable -->
Mario Fiol 
<!-- PJG 007 0104 intable -->
(703) 308&hyph;8049
<!-- PJG 0012 frnewline -->
Butylate 
<!-- PJG 007 0104 intable -->
Judy Loranger 
<!-- PJG 007 0104 intable -->
(703) 308&hyph;8056
<!-- PJG 0012 frnewline -->
Daminozide 
<!-- PJG 007 0104 intable -->
Andrew Ertman 
<!-- PJG 007 0104 intable -->
(703) 308&hyph;8063
<!-- PJG 0012 frnewline -->
Heptachlor 
<!-- PJG 007 0104 intable -->
Judy Loranger 
<!-- PJG 007 0104 intable -->
(703) 308&hyph;8056
<!-- PJG 0012 frnewline -->
Methiocarb 
<!-- PJG 007 0104 intable -->
Karen Jones 
<!-- PJG 007 0104 intable -->
(703) 308&hyph;8047
<!-- PJG 0012 frnewline -->
OBPA 
<!-- PJG 007 0104 intable -->
Venus Eagle 
<!-- PJG 007 0104 intable -->
(703) 308&hyph;8045
<!-- PJG 0012 frnewline -->
Oxytetracycline 
<!-- PJG 007 0104 intable -->
Mario Fiol 
<!-- PJG 007 0104 intable -->
(703) 308&hyph;8049
<!-- PJG 0012 frnewline -->
Sulfuryl Fluoride 
<!-- PJG 007 0104 intable -->
Robert Richards 
<!-- PJG 007 0104 intable -->
(703) 308&hyph;8057
<!-- PJG 0012 frnewline -->
Warfarin 
<!-- PJG 007 0104 intable -->
Judy Loranger 
<!-- PJG 007 0104 intable -->
(703) 308&hyph;8056
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 During fiscal years 1991, 1993 and 1994, EPA published notices in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 announcing the availability of reregistration eligibility decision documents for the listed pesticide active
ingredients. These REDs were issued as final documents, with a 60&hyph;day comment period. In these REDs, EPA provided
its regulatory position on the current registered uses of these pesticides and set forth certain requirements for
product reregistration eligibility. There were no comments for the following REDs: Barium Metaborate, Boric Acid,
Butylate, Daminozide, Methiocarb, OBPA, Oxytetracycline, Warfarin and Sulfuryl Fluoride. Comments were received
for Heptachlor but did not result in any amendments to the RED. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NTIS publication number for REDs subject to this notice are presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<TABLE>

<!-- PJG tableformat 4,L2,p6,6/6,i1,s20,r10,r15,r25 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Chemical Name 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Case Number
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1RED Date 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1RED NTIS NUMBER 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Barium Metaborate
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
0632 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
01/25/94
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
PB94&hyph;154317
<!-- PJG 0012 frnewline -->
Boric Acid 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
0024 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
02/16/94 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
PB94&hyph;160017 
<!-- PJG 0012 frnewline -->
Butylate 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
0071
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11/26/93
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
PB94&hyph;125945
<!-- PJG 0012 frnewline -->
Daminozide
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
0032
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
10/26/93
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
PB94&hyph;126083
<!-- PJG 0012 frnewline -->
Heptachlor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
0175
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
03/31/92
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
PB92&hyph;191105
<!-- PJG 0012 frnewline -->
Methiocarb
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
0577
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
03/30/94
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
PB94&hyph;166394
<!-- PJG 0012 frnewline -->
OBPA
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
0044
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
08/01/93
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
PB93&hyph;234755
<!-- PJG 0012 frnewline -->
Oxytetracycline
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
0655
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
03/30/93
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
PB93&hyph;234763
<!-- PJG 0012 frnewline -->
Sulfuryl Fluoride
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
0176
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
09/30/93
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
PB94&hyph;140134
<!-- PJG 0012 frnewline -->
Warfarin 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
0011 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
06/06/91 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
PB92&hyph;126739 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Environmental protection.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: August 5, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Louis P. True,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Director, Special Review and Reregistration Division, Office of Pesticide Programs. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;19883 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6560&hyph;50&hyph;F 
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00100 </DOCNO>
<PARENT> FR940817-2-00049 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[OPP&hyph;00383; FRL&hyph;4874&hyph;2]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Testing Guidelines for Developmental and Reproductive Toxicity </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Environmental Protection Agency (EPA).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of availability.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This Notice announces the availability of the proposed Health Effects Test Guidelines for developmental toxicity
and for reproductive and fertility effects and the start of a 60&hyph;day comment period. The documents were developed
to amend and replace specific Agency guideline documents currently used for testing pesticides and toxic substances
under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) and the Toxic Substances Control Act (TSCA),
respectively.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
: Written comments, identified by the document control number OPP&hyph;00383, must be received on or before October
17, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Copies of the proposed guidelines are available at the address listed below for the Public Response and Program Resources
Branch. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
By mail, submit three copies of written comments, identified with the docket control number ``OPP&hyph;00383''
to Public Response and Program Resources Branch, Field Operations Division (7506C), Office of Pesticide Programs,
Environmental Protection Agency, 401 M St., SW., Washington, DC 20460. In person, deliver comments to : Rm. 1132,
CM#2, 1921 Jefferson Davis Highway, Arlington, VA 22202. Information submitted as a comment concerning this document
may be claimed confidential by marking any part or all of that information as ``Confidential Business Information''
(CBI). Information so marked will not be disclosed except in accordance with procedures set forth in 40 CFR Part 2.
A copy of the comment that does not contain CBI must be submitted for inclusion in the public record. Information not
marked confidential may be disclosed publicly by EPA without prior notice. All written comments will be available
for public inspection in Rm. 1132 at the Virginia address given above, from 8 a.m. to 4 p.m., Monday through Friday,
excluding legal holidays. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Susan L. Makris, Health Effects Division (7509C), Office of Pesticide Programs, Environmental Protection Agency,
401 M St., SW, Washington, DC 20460. Office location and telephone number: Rm. 816F, CM#2, 1921 Jefferson Davis Highway,
Arlington, VA 22202. Telephone: 703&hyph;305&hyph;5222. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The OPPTS Health Effects Test Guidelines for developmental toxicity (OPPTS 870.3700) will replace the Subdivision
F Pesticide Assessment Guideline Section 83&hyph;3 (FIFRA) and 40 CFR 798.4900 (TSCA). The guideline for reproductive
and fertility effects (OPPTS 870.3800) will replace the Subdivision F Pesticide Assessment Guideline Section 83&hyph;4,
under FIFRA, and 40 CFR 798.4700, under TSCA. These revised guidelines were drafted by an inter-agency work group
comprised of experts in the areas of developmental and reproductive toxicity. The proposed testing requirements
incorporated into these developmental toxicity and reproductive and fertility effects guidelines were reviewed
at a joint meeting of the FIFRA Scientific Advisory Panel (SAP) and the Science Advisory Board (SAB) in December, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The revised guidelines will significantly improve the Agency's ability to identify and characterize potential
effects on the reproductive system and/or the developing fetus from exposure to chemicals. Availability of these
revised guidelines will enhance the ability of pesticide registrants and industrial chemical manufacturers to
plan, estimate costs of, and design studies that EPA currently requires for pesticides under 40 CFR Part 158 or may
require by test rule or consent agreement for industrial chemicals.
<!-- PJG 0012 frnewline -->
All interested parties are encouraged to submit comments on the proposed draft guidelines for developmental and
reproductive toxicity studies. Specific comments should reference the document title, section number, and paragraph
or subparagraph of the proposed guideline. Recommended technical or scientific changes/modifications should
be supported by current scientific/technical knowledge and include supporting references.
<!-- PJG 0012 frnewline -->
Comments on the proposed guidelines will be considered by the Agency and such modifications of the guidelines as are
considered to be of scientific and technical merit will be considered for inclusion before the guidelines are published
in a final form.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Environmental protection.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: August 1, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Daniel M. Barolo, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Director, Office of Pesticide Programs.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;19777 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6560&hyph;50&hyph;F 
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00101 </DOCNO>
<PARENT> FR940817-2-00050 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>FEDERAL EMERGENCY MANAGEMENT AGENCY</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Public Information Collection Requirements Submitted to OMB for Review</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Federal Emergency Management Agency (FEMA) has submitted to the Office of Management and Budget the following
public information collection requirements for review and clearance in accordance with the Paperwork Reduction
Act of 1980, 44 U.S.C. chapter 35.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Comments on this information collection must be submitted on or before October 17, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Direct comments regarding the burden estimate or any aspect of this information collection, including suggestions
for reducing this burden, to: the FEMA Information Collections clearance Officer at the address below; and to Donald
Arbuckle, Office of Management and Budget, 3235 New Executive Office Building, Washington, DC 20503, (202) 395&hyph;7340,
within 60 days of this notice.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Copies of the above information collection request and supporting documentation can be obtained by calling or writing
Muriel B. Anderson, FEMA Information Collections clearance Officer, Federal Emergency Management Agency, 500
C Street, SW., Washington, DC 20472, (202) 646&hyph;2624.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Type: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Extension of 3067&hyph;0196.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Title: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
National Flood Insurance Program Erosion Benefits.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Abstract: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
FEMA regulations 44 CFR 63, Subpart B, sets forth procedures to be followed by State authorities for certification
of structures subject to imminent collapse as a result of erosion or undermining caused by waves or current of water
exceeding anticipated cyclincal levels.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
When a claim for flood insurance benefits is filed by an insured, the State is asked to collect data at the site of the
threatened structure demonstrating that the condition of the structure meets criteria for certification that it
is subject to imminent collapse. Such a certification is necessary for insured property owners to file claims for
relocation or demolition benefits established under P.L. 100&hyph;242.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Type of Respondents: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
State or local governments.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Estimate of Total Annual Reporting and Recordkeeping
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Burden: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
360 hours.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Number of Respondents: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
60.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Estimated Average Burden Time per Response: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
6 hours.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Frequency of Response: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
One-Time.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: August 8, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Linda S. Borror,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Director, Office of Administrative Support.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20186 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6718&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00102 </DOCNO>
<PARENT> FR940817-2-00051 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[FEMA&hyph;1033&hyph;DR]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Georgia; Amendment to Notice of a Major Disaster Declaration</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Federal Emergency Management Agency (FEMA).
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This notice amends the notice of a major disaster for the State of Georgia, (FEMA&hyph;1033&hyph;DR), dated July
7, 1994, and related determinations.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
August 11, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Pauline C. Campbell, Response and Recovery Directorate, Federal Emergency Management Agency, Washington, DC 20472,
(202) 646&hyph;3606.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The notice of a major disaster for the State of Georgia dated July 7, 1994, is hereby amended to include the following
area among those areas determined to have been adversely affected by the catastrophe declared a major disaster by
the President in his declaration of July 7, 1994: Dodge County for Individual Assistance.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
(Catalog of Federal Domestic Assistance No. 83.516, Disaster Assistance)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Richard W. Krimm,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Associate Director, Response and Recovery Directorate.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20187 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6718&hyph;02&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00103 </DOCNO>
<PARENT> FR940817-2-00052 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>FEDERAL MARITIME COMMISSION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Ocean Freight Forwarder License; Applicants </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Notice is hereby given that the following applicants have filed with the Federal Maritime Commission applications
for licenses as ocean freight forwarders pursuant to section 19 of the Shipping Act of 1984 (46 U.S.C. app. 1718 and
46 CFR 510). 
<!-- PJG 0012 frnewline -->
Persons knowing of any reason why any of the following applicants should not receive a license are requested to contact
the Office of Freight Forwarders, Federal Maritime Commission, Washington, D.C. 20573. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
SCR International Freight Forwarding, Inc., 130 Minorca Avenue, Coral Gables, FL 33134, Officers: Alvaro G. Smith,
President Jose E. Smith, Treasurer 
<!-- PJG 0012 frnewline -->
New Jas International, Inc., 20,435 South Western Avenue, Torrance, CA 90501, Officers: Toru Hiraki, President;
Sakuo Kikuchi, Vice President; Fredroc A. Moede, Vice President; Etsuko Emmy Nakamura, Vice President; Makoto Niiro,
Treasurer 
<!-- PJG 0012 frnewline -->
Blue Sky, Blue Sea Company, dba International Shipping Company (USA), 169 Frelinghuysen Avenue, Newark, NJ 07114,
Officers: Asad Ferasat, President; Ali Aelaei, Vice President; Jalal Boloorchi, Treasurer
<!-- PJG 0012 frnewline -->
ITG International Transports, Inc., 140 Eastern Ave., Chelsea, MA 02150, Officers: Guenther Jocher, President;
Guido Voss, Vice President 
<!-- PJG 0012 frnewline -->
M.A.X. International, 10,518 73rd Ave., East, Puyallup, WA 98373, Janise Kae Disbrow, Sole Proprietor
<!-- PJG 0012 frnewline -->
Savino del Bene International Freight Forwarders, Incorporated, 151 Everett Ave., 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=6 f=1 -->
#
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
105, Chelsea, MA 02150, Officer: Melvin Cariofiles, President
<!-- PJG 0012 frnewline -->
Ikaros Transport Corp., 500 Ocean Ave., East Rockaway, NY 11518, Officers: Pandelis Zografakis, President; George
Zografakis, Vice President; Dean Zografakis, Treasurer
<!-- PJG 0012 frnewline -->
Steven Thomas Benefield, 2358 Roseberry Lane, Grayson, GA 30221, Sole Proprietor
<!-- PJG 0012 frnewline -->
Shippers, Inc., 10626 S.W. 148th Avenue-Drive, Miami, FL 33196, Officer: Pablo R. Vinent, President
<!-- PJG 0012 frnewline -->
Maverick Distribution Services, Inc., 100 Oceangate, Suite 620, Long Beach, CA 90802, Officers: Timothy J. Noonan,
President; Pao-Torng Liu, Vice President 
<!-- PJG 0012 frnewline -->
Ocean Trade International, Inc., 8562 NW 70th Street, Miami, FL 33166, Ana M. Blanco, Sole Proprietor 
<!-- PJG 0012 frnewline -->
Latin American Imports and Exports, Inc., dba Latimex, Inc., 39 Flamingo Street, New Orleans, LA 70124, Officers:
Victor M. Arroyo, President; Marco A. Arroyo, Vice President 
<!-- PJG 0012 frnewline -->
Welsch's International, Inc., 4872 S.W. 74th Court, Miami, FL 33155, Officer: Paul Ernest Welsch, President. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: August 11, 1994. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
By the Federal Maritime Commission. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Joseph C. Polking, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20091 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6730&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00104 </DOCNO>
<PARENT> FR940817-2-00053 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>FEDERAL RESERVE SYSTEM</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE> KeyCorp, et al.; Formations of; Acquisitions by; and Mergers of Bank Holding Companies</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The companies listed in this notice have applied for the Board's approval under section 3 of the Bank Holding Company
Act (12 U.S.C. 1842) and  225.14 of the Board's Regulation Y (12 CFR 225.14) to become a bank holding company or to acquire
a bank or bank holding company. The factors that are considered in acting on the applications are set forth in section
3(c) of the Act (12 U.S.C. 1842(c)).
<!-- PJG 0012 frnewline -->
Each application is available for immediate inspection at the Federal Reserve Bank indicated. Once the application
has been accepted for processing, it will also be available for inspection at the offices of the Board of Governors.
Interested persons may express their views in writing to the Reserve Bank or to the offices of the Board of Governors.
Any comment on an application that requests a hearing must include a statement of why a written presentation would
not suffice in lieu of a hearing, identifying specifically any questions of fact that are in dispute and summarizing
the evidence that would be presented at a hearing.
<!-- PJG 0012 frnewline -->
Unless otherwise noted, comments regarding each of these applications must be received not later than September
9, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
A. Federal Reserve Bank of Cleveland 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(John J. Wixted, Jr., Vice President) 1455 East Sixth Street, Cleveland, Ohio 44101: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
1. Keycorp
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, Cleveland, Ohio; and Key Bancshares of Maine, Inc., Portland, Maine, to acquire 100 percent of the voting shares
of Casco Northern Bank, National Association, Portland, Maine.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
2. KeyCorp
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, Cleveland, Ohio; and Key Bancshares of Maine, Inc., Portland, Maine, to acquire 100 percent of the voting shares
of BANKVERMONT Corporation, Burlington, Vermont, and thereby indirectly acquire Bank of Vermont, Burlington,
Vermont.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
B. Federal Reserve Bank of St. Louis 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(Randall C. Sumner, Vice President) 411 Locust Street, St. Louis, Missouri 63166: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
1. GAB Bancorp
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, Jasper, Indiana; to acquire 100 percent of the voting shares of First State Bank Southwest Indiana, Tell City, Indiana.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
C. Federal Reserve Bank of Kansas City 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(John E. Yorke, Senior Vice President) 925 Grand Avenue, Kansas City, Missouri 64198:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
1. Commerce Bancshares, Inc.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, Kansas City, Missouri; to acquire 100 percent of the voting shares of Twin City Corporation, which will be the surviving
corporation after a merger with CBI-Twin City Corporation, Kansas City, Kansas, a wholly owned subsidiary of Commerce
Bancshares, through the merger Commerce Bancshares, Inc., will indirectly acquire 90 percent of the voting shares
of Twin City State Bank, Kansas City, Kansas. In a second step to the transaction Twin City Corporation will merge with
another wholly owned subsidiary of Commerce Bancshares, Inc., CBI-Kansas, Inc., Kansas City, Missouri, and thereby
indirectly acquire 100 percent of the voting shares of Commerce Bank, N.A., Lenexa, Kansas, and Commerce Bank, Lawrence,
Kansas.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
2. Peoples Trust of 1987
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, Ottawa, Kansas; and its subsidiary Peoples, Inc., Ottawa, Kansas, to acquire 46.875 percent of the voting shares
of Johnson County Bank, Overland Park, Kansas.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Board of Governors of the Federal Reserve System, August 11, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Jennifer J. Johnson,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Secretary of the Board.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94-20154 Filed 8-16-94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6210-01-F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00105 </DOCNO>
<PARENT> FR940817-2-00054 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>NationsBank Corporation; Notice of Application to Engage De Novo in Nonbanking Activities</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
NationsBank Corporation, Charlotte, North Carolina (``Applicant''), has applied, pursuant to section 4(c)(8)
of the Bank Holding Company Act (12 U.S.C.  1843(c)(8)) (the ``BHC Act'') and  225.23 of the Board's Regulation Y (12
CFR 225.23), to engage 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
de novo
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 through its wholly owned subsidiaries, NationsBanc-CRT Services, Incorporated, Chicago, Illinois, and NationsBanc-CRT
Energy (U.K.) Limited, London, England (collectively, ``Companies''), in the following activities:
<!-- PJG 0012 frnewline -->
(1) providing futures commission merchant (``FCM'') execution, clearance and advisory services to affiliated
and unaffiliated customers with respect to futures and options on futures contracts on financial instruments and
financial commodities on stock and bond indexes that have been previously approved by the Board, and on exchanges
previously approved by the Board, pursuant to  225.25(b)(18) and (b)(19) of the Board's Regulation Y and SR Letter
No. 93027 (FIS) (May 21, 1993);
<!-- PJG 0012 frnewline -->
(2) providing FCM execution, clearance, and advisory services to affiliated and unaffiliated customers with respect
to futures and options on futures contracts on non-financial commodities that have been previously approved by the
Board, and on exchanges previously approved by the Board, as well as futures and options on futures contracts on certain
non-financial contracts on an exchange that the Board has not previously approved for bank holding companies, in
accordance with 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
J.P. Morgan &amp; Co., Inc.,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 80 Federal Reserve Bulletin 151 (1994), 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Caisse Nationale de Credit Agricole
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, 80 Federal Reserve Bulletin 552 (1994); and 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Bank of Montreal
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, 79 Federal Reserve Bulletin 1049 (1993); and
<!-- PJG 0012 frnewline -->
(3) providing discount and full service brokerage services and related securities credit services, and conducting
incidental activities thereto, to institutional customers, and conducting incidental activities thereto, pursuant
to  225.25(b)(15) of the Board's Regulation Y.
<!-- PJG 0012 frnewline -->
The exchange and futures and options on futures contracts with respect to which Applicant proposes to provide FCM
services, which the Board has not previously approved, include the International Petroleum Exchange, London, England,
and the following contracts traded thereon: Brent crude oil futures, Options on Brent crude oil futures, gas oil futures,
options on gas oil futures, and unleaded gasoline futures. These activities will be conducted on a worldwide basis.
<!-- PJG 0012 frnewline -->
Any comments or requests for a hearing should be submitted in writing and received by William W. Wiles, Secretary,
Board of Governors of the Federal Reserve System, Washington, DC 20551, not later than August 31, 1994. Any request
for a hearing on this application must, as required by  262.3(e) of the Board's Rules of Procedure (12 CFR 262.3(e)),
be accompanied by a statement of the reasons why a written presentation would not suffice in lieu of a hearing, identifying
specifically any questions of fact that are in dispute, summarizing the evidence that would be presented at a hearing,
and indicating how the party commenting would be aggrieved by approval of the proposal. This application may be inspected
at the offices of the Board of Governors or the Federal Reserve Bank of Richmond.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Board of Governors of the Federal Reserve System, August 11, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Jennifer J. Johnson,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Secretary of the Board.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94-20155 Filed 8-16-94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6210-01-F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00106 </DOCNO>
<PARENT> FR940817-2-00055 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>GENERAL SERVICE ADMINISTRATION</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<DOCTITLE>United States Border Station, Highgate Springs, VT; Environmental Assessment/FONSI</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This notice serves to inform the public of the availability of the Environmental Assessment (EA) and draft Finding
of No Significant Impact (FONSI) prepared by the U.S. General Services Administration for the proposed construction
of a new United States Border Station in Highgate Springs, Vermont. Comments on the proposed action may be submitted
in writing during the 30-day public comment period, which starts on August 19, 1994, and ends on September 19, 1994.
The Finding of No Significant Impact will be signed and become final after completion of the public comment period,
provided that no information leading to a contrary finding is received or comes to light during the 30-day comment
period.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For further information, please contact Mr. Peter A. Sneed, Director of Planning Staff, Public Buildings Service,
General Services Administration, 26 Federal Plaza, Room 1609, New York New York 10278. Telephone: (212) 264&hyph;3581.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued in New York, NY on August 11, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Robert W. Martin,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Regional Administrator, General Services Administration.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20173 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6820&hyph;23&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00107 </DOCNO>
<PARENT> FR940817-2-00056 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF HEALTH AND HUMAN SERVICES</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Centers for Disease Control and Prevention</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[CDC&hyph;489] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
National Institute for Occupational Safety and Health; Health and Exposure Surveillance of Siberian 
<!-- PJG 0012 frnewline -->
Asbestos Miners Cooperative Agreement 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Summary 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Centers for Disease Control and Prevention (CDC) announces the availability of fiscal year (FY) 1994 funds for
a cooperative agreement with the Finnish Institute of Occupational Health (FIOH) to evaluate workplace exposures
and conduct health assessments of workers exposed to asbestos in a large mining, milling, and production center located
in Asbest, Russia. Approximately $150,000 will be available in FY 1994 to fund the cooperative agreement. The award
will begin on or about September 30, 1994, for a 12-month budget period within a project period of up to 3 years. Funding
estimates may vary and are subject to change. Continuation award(s) within the project period will be made on the basis
of satisfactory progress and the availability of funds. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The purpose of this cooperative agreement is to assist the FIOH in further developing and strengthening epidemiologic
research, surveillance and monitoring, 
<!-- PJG 0012 frnewline -->
and training in order to promote the further understanding of the prevention of occupational respiratory disease.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The CDC will provide scientific, epidemiologic, engineering, environmental, and clinical technical assistance
to the recipient, as needed, for successful completion of this project; collaborate with the recipient on the methods
for the collection, tabulation analysis, and publication of the data related to the project; assist in the development
of the overall plan or study design for this project; assist in the design and implementation of the evaluation plan
for the project; coordinate the training of the appropriate grantee staff in technical and scientific procedures
necessary for the successful completion of the project; and assist in the development of a series of symposia to present
findings, provide training, and provide for the dissemination of information relevant to the prevention of occupational
lung disease due to asbestos exposure. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Public Health Service (PHS) is committed to achieving the health promotion and disease prevention objectives
of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Healthy People 2000
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, a PHS-led national activity to reduce morbidity and mortality and improve the quality of life. This announcement
is related to the priority area of Occupational Lung Disease. (For ordering 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Healthy People 2000,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 see the section entitled 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Where to Obtain Additional Information.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00108 </DOCNO>
<PARENT> FR940817-2-00056 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Authority 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This program is authorized under Section 22(e)(7) of the Occupational Safety and Health Act of 1970 (29 U.S.C. 671(e)(7)).

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Smoke-Free Workplace 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Public Health Service strongly encourages all grant recipients to provide a smoke-free workplace and promote
the non-use of all tobacco products. This is consistent with the PHS mission of promoting the protection and advancement
of an individual's physical and mental health. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Eligible Applicant 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Assistance will be provided only to the Finnish Institute of Occupational Health (FIOH) for conducting this evaluation.
No other applications will be solicited. The program announcement and application kit have been sent to FIOH. The
FIOH is the only appropriate and qualified institution to provide the services specified under this cooperative
agreement for the following reasons: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
There is a large asbestos mining, milling, and production activity in Asbest, Siberia, which produces in excess of
1,100,000 tons of asbestos and 300,000,000 tons of crushed stone annually. This mine supplies all of Russia's asbestos
and is one of its major exporting resources. There is an existing medical surveillance program in effect for the more
than 10,000 employees which could be reviewed for major health effects of asbestos. Russia does not have the expertise
or resources to conduct this review and analysis. However, it has expressed a desire to collaborate with others to
accomplish this effort. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Finland has an existing working relationship with Russia and has the expertise and ability to initiate and coordinate
a study of this magnitude. FIOH, NIOSH, and the Institute of Industrial Hygiene and Occupational Diseases of the Academy
of Medical Sciences, Moscow, Russia, all serve as members of the World Health Organization (WHO) Workers' Health
Program which has as one of its top priorities the prevention of occupational respiratory diseases. This shared focus
has enabled FIOH to develop a unique collaborative relationship with the Institute of Industrial Hygiene and Occupational
Diseases of the Academy of Medical Sciences, Moscow, Russia. As a result of this relationship, FIOH will be granted
access to the Asbest mining region and will be given support from the requisite Russian agencies so that they can successfully
accomplish the work required under this cooperative agreement. No one in the United States or its territories has
this unique capability. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Executive Order 12372 Review 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The applicant is not subject to review under Executive Order 12372. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Public Health System Reporting Requirements 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This program is not subject to the Public Health System Reporting Requirements. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Catalog of Federal Domestic Assistance Number 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Catalog of Federal Domestic Assistance Number for this program is 93.957. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Other Requirements 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Human Subjects 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
If the proposed project involves research on human subjects, the applicant must comply with the Department of Health
and Human Services Regulations, 45 CFR Part 46, regarding the protection of human subjects. Assurance must be provided
to demonstrate that the project will be subject to initial and continuing review by an appropriate institutional
review committee. The applicant will be responsible for providing assurance in accordance with the appropriate
guidelines and forms provided in the application kit. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Where To Obtain Additional Information 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
If you are interested in obtaining additional information regarding this project, please refer to Announcement
489 and contact Oppie M. Byrd, Grants Management Specialist, Grants Management Branch, Procurement and Grants Office,
Centers for Disease Control and Prevention (CDC), 255 East Paces Ferry Road, NE., Room 300, Mailstop E&hyph;13, Atlanta,
GA 30305, telephone (404) 842&hyph;6630. A copy of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Healthy People 2000
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (Full Report, Stock No. 017&hyph;001&hyph;00474&hyph;0) or 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Healthy People 2000
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (Summary Report, Stock No. 017&hyph;001&hyph;00473&hyph;1) referenced in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Summary
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 may be obtained through the Superintendent of Documents, Government Printing Office, Washington, DC 20402&hyph;9325,
telephone (202) 783&hyph;3238. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: August 9, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Linda Rosenstock, M.D., M.P.H., 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Director, National Institute for 
<!-- PJG 0012 frnewline -->
Occupational Safety and Healty, 
<!-- PJG 0012 frnewline -->
Centers for Disease Control and Prevention (CDC). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20139 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4163&hyph;19&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00109 </DOCNO>
<PARENT> FR940817-2-00057 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Announcement Number 494] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>State Grants To Support Development of Nutrition Intervention Programs; Amendment </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A notice announcing the availability of Fiscal Year 1994 funds for grants for 1994 State Grants to Support Development
of Nutrition Intervention Programs was published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 on July 21, 1994, [59 FR 37236]. The notice is amended as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
On page 37237, first column, under the heading ``Availability of Funds,'' the first sentence should read: ``Approximately
$1,190,000 is available in FY 1994 to fund approximately 49 awards.'' 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
On page 37237, first column, under the heading ``Availability of Funds,'' paragraph A. Nutrition Intervention Assistance:
the first two sentences should read: ``Approximately $900,000 is available to fund approximately 45 awards. It is
expected that the average award will be $20,000, ranging from $10,000 to $45,000.'' 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
All other information and requirements of the July 21, 1994, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 notice remain the same. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: August 10, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Joseph R. Carter,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Associate Director for Management and Operations, Centers for Disease Control and Prevention (CDC).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20140 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4163&hyph;18&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00110 </DOCNO>
<PARENT> FR940817-2-00058 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Food and Drug Administration</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. 94P&hyph;0091]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Asparagus Deviating From Identity Standard; Temporary Permit for Market Testing
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Food and Drug Administration, HHS.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The Food and Drug Administration (FDA) is announcing that a temporary permit has been issued to The Pillsbury Co. to
market test experimental packs of canned asparagus containing zinc chloride. The purpose of the temporary permit
is to allow the applicant to measure consumer acceptance of the food. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This permit is effective for 15 months, beginning on the date the test product is introduced or caused to be introduced
into interstate commerce, but no later than November 15, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Nannie H. Rainey, Center for Food Safety and Applied Nutrition (HFS&hyph;158), Food and Drug Administration, 200
C St. SW., Washington, DC 20204, 202&hyph;205&hyph;5099.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 In accordance with 21 CFR 130.17 concerning temporary permits to facilitate market testing of foods deviating from
the requirements of the standards of identity promulgated under section 401 of the Federal Food, Drug, and Cosmetic
Act (21 U.S.C. 341), FDA is giving notice that a temporary permit has been issued to The Pillsbury Co., Technology Center,
330 University Ave. SE., Minneapolis, MN 55414&hyph;2198. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The permit covers limited interstate marketing tests of experimental packs of canned asparagus. The test product
deviates from the U.S. standard of identity for canned asparagus (21 CFR 155.200) in that the test product will contain
added zinc chloride in an amount necessary to retain the green color of the product (at a maximum level of 75 parts per
million of zinc in the finished food). The test product meets all requirements of the standard, with the exception
of the variation. 
<!-- PJG 0012 frnewline -->
This permit provides for the temporary marketing of 10 thousand cases, each containing 12 425-gram (15-ounce) cans,
of the test product. The product will be manufactured at Green Giant Co., 711 East Main St., Dayton, WA 99328&hyph;0026.
The product will be distributed in Alabama, Florida, Georgia, Louisiana, and Mississippi.
<!-- PJG 0012 frnewline -->
For the purpose of this permit, the name of the product is ``canned asparagus.'' Each of the ingredients used in the
food must be declared on the label as required by the applicable sections of 21 CFR parts 101 and 130. This permit is effective
for 15 months, beginning on the date the test product is introduced or caused to be introduced into interstate commerce,
but no later than November 15, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: August 8, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Fred R. Shank,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Director, Center for Food Safety and Applied Nutrition.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20130 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4160&hyph;01&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00111 </DOCNO>
<PARENT> FR940817-2-00059 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. 94F&hyph;0246]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Kuraray Co.; Filing of Food Additive Petition </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Food and Drug Administration, HHS.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Food and Drug Administration (FDA) is announcing that Kuraray Co. has filed a petition proposing that the food
additive regulations be amended to provide for the safe use of ethylene-vinyl acetate-vinyl alcohol copolymers
with broadened specifications that include a decreased minimum acceptable ethylene content and an increased maximum
permitted level of migration of ethylene-vinyl acetate-vinyl alcohol oligomers. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Written comments on petitioner's environmental assessment by September 16, 1994 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Submit written comments to the Dockets Management Branch (HFA&hyph;305), Food and Drug Administration, rm. 1&hyph;23,
12420 Parklawn Dr., Rockville, MD 20857.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 </ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Diane E. Robertson, Center for Food Safety and Applied Nutrition (HFS&hyph;216), Food and Drug Administration,
200 C St. SW., Washington, DC 20204, 202&hyph;254&hyph;9511. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Under the Federal Food, Drug, and Cosmetic Act (sec. 409(b)(5) (21 U.S.C. 348(b)(5))), notice is given that a food
additive petition (FAP 4B4421) has been filed by Kuraray Co., 1001 G St., NW., suite 500 West, Washington, DC 20001.
The petition proposes to amend &sect;177.1360 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=3 -->
Ethylene-vinyl acetate-vinyl alcohol copolymers
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 (21 CFR 177.1360) of the food additive regulations to provide for the safe use of ethylene-vinyl acetate-vinyl alcohol
copolymers with broadened specifications that include a decreased minimum acceptable ethylene content and an increased
maximum permitted level of migration of ethylene-vinyl acetate-vinyl alcohol oligomers.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The potential environmental impact of this action is being reviewed. To encourage public participation consistent
with regulations promulgated under the National Environmental Policy Act, (40 CFR 1501.4 (b)), the agency is placing
the environmental assessment submitted with the petition that is the subject of this notice on public display at the
Dockets Management Branch (address above) for public review and comment. Interested persons may, on or before September
16, 1994, submit to the Dockets Management Branch (address above) written comments. Two copies of any comments are
to be submitted, except that individuals may submit one copy. Comments are to be identified with the docket number
found in brackets in the heading of this document. Received comments may be seen in the office above between 9 a.m. and
4 p.m., Monday through Friday. FDA will also place on public display any amendments to, or comments on, the petitioner's
environmental assessment without further announcement in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. If, based on its review, the agency finds that an environmental impact statement is not required and this petition
results in a regulation, the notice of availability of the agency's finding of no significant impact and the evidence
supporting that finding will be published with the regulation in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 in accordance with 21 CFR 25.40(c).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: August 5, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Fred R. Shank,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Director, Center for Food Safety and Applied Nutrition.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20131 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4160&hyph;01&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00112 </DOCNO>
<PARENT> FR940817-2-00060 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. 94G&hyph;0272]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Aplin &amp; Barrett Ltd.; Papetti's Hygrade Egg Products, Inc.; Filing of Petition for Affirmation of GRAS Status</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Food and Drug Administration, HHS.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Food and Drug Administration (FDA) is announcing that Aplin &amp; Barrett Ltd., and Papetti's Hygrade Egg Products,
Inc., as copetitioners, have filed a petition (GRASP 4G0408) proposing to affirm that nisin preparation is generally
recognized as safe (GRAS) as an antimicrobial agent in various standardized and nonstandardized liquid egg products.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Written comments by October 17, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Submit written comments to the Dockets Management Branch (HFA&hyph;305), Food and Drug Administration, rm. 1&hyph;23,
12420 Parklawn Dr., Rockville, MD 20857.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Mary E. LaVecchia, Center for Food Safety and Applied Nutrition (HFS&hyph;217), Food and Drug Administration, 200
C St. SW., Washington, DC 20204, 202&hyph;418&hyph;3072.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Under the Federal Food, Drug, and Cosmetic Act (secs. 201(s) and 409(b)(5) (21 U.S.C. 321(s) and 348(b)(5)) and the
regulations for affirmation of GRAS status in &sect;170.35 (21 CFR 170.35), notice is given that Aplin &amp; Barrett
Ltd., c/o 1001 G St. NW., suite 500 West, Washington, DC 20001; and Papetti's Hygrade Egg Products Inc., c/o 424 S. Washington
St., Alexandria, VA 22314, have filed a petition (GRASP 4G0408) proposing that nisin preparation be affirmed as GRAS
for use as an antimicrobial agent in standardized and nonstandardized liquid egg, egg whites, egg yolks, and blends
of these egg products.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The petition has been placed on display at the Dockets Management Branch (address above).
<!-- PJG 0012 frnewline -->
Any petition that meets the requirements outlined in &sect;170.30 (21 CFR 170.30) and &sect;170.35 is filed by the
agency. There is no prefiling review of the adequacy of data to support a GRAS conclusion. Thus, the filing of a petition
for GRAS affirmation should not be interpreted as a preliminary indication of suitability for GRAS affirmation.
<!-- PJG 0012 frnewline -->
The potential environmental impact of this action is being reviewed. If the agency finds that an environmental impact
statement is not required and this petition results in a regulation, the notice of availability of the agency's finding
of no significant impact and the evidence supporting that finding will be published with the regulation in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 in accordance with 21 CFR 25.40(c).
<!-- PJG 0012 frnewline -->
Interested persons may, on or before October 17,1 994, review the petition and file comments with the Dockets Management
Branch (address above). Two copies of any comments should be filed and should be identified with the docket number
found in brackets in the heading of this document. Comments should include any available information that would be
helpful in determining whether the substance is, or is not, GRAS for the proposed use. In addition, consistent with
the regulations promulgated under the National Environmental Policy Act (40 CFR 1501.4(b)), the agency encourages
public participation by review of and comment on the environmental assessment submitted with the petition that is
the subject of this notice. A copy of the petition (including the environmental assessment) and received comments
may be seen in the Dockets Management Branch between 9 a.m. and 4 p.m., Monday through Friday.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: August 8, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Fred R. Shank,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Director, Center for Food Safety and Applied Nutrition.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20132 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4160&hyph;01&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->
 
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00113 </DOCNO>
<PARENT> FR940817-2-00061 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. 94G&hyph;0267]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Fuji Oil Co., Ltd.; Filing of Petition for Affirmation of GRAS Status</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Food and Drug Administration, HHS.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Food and Drug Administration (FDA) is announcing that Fuji Oil Co., Ltd., has filed a petition (GRASP 4G0407),
proposing that a triglyceride containing behenic and oleic acids be affirmed as generally recognized as safe (GRAS)
for use as a tempering aid and as an antibloom agent in chocolate and chocolate coatings. The petitioner proposes that
bohenin be the common or usual name for this triglyceride.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Written comments by October 17, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Submit written comments to the Dockets Management Branch (HFA&hyph;305), Food and Drug Administration, rm. 1&hyph;23,
12420 Parklawn Dr., Rockville, MD 20857.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Lawrence J. Lin, Center for Food Safety and Applied Nutrition (HFS&hyph;206), Food and Drug Administration, 200
C St. SW., Washington, DC 20204, 202&hyph;418&hyph;3103.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Under the Federal Food, Drug, and Cosmetic Act (sec. 201(s) and 409(b)(5) (21 U.S.C. 321(s) and 348(b)(5)) and the
regulations for affirmation of GRAS status in &sect;170.35 (21 CFR 170.35), notice is given that Fuji Oil Co., Ltd.,
Osaka, Japan, has filed a petition (GRASP 4G0407), proposing that a triglyceride containing behenic and oleic acids
be affirmed as GRAS for use as a tempering aid and as an antibloom agent in chocolate and chocolate coatings. The petitioner
proposes that bohenin be the common or usual name for this triglyceride. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The petition has been placed on display at the Dockets Management Branch (address above).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Any petition that meets the requirements outlined in &sect;170.30 (21 CFR 170.30) and &sect;170.35 is filed by the
agency. There is no prefiling review of the adequacy of data to support a GRAS conclusion. Thus, the filing of a petition
for GRAS affirmation should not be interpreted as a preliminary indication of suitability for GRAS affirmation.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The potential environmental impact of this action is being reviewed. If the agency finds that an environmental impact
statement is not required and this petition results in a regulation, the notice of availability of the agency's finding
of no significant impact and the evidence supporting that finding will be published with the regulation in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 in accordance with 21 CFR 25.40(c).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Interested persons may, on or before October 17, 1994, review the petition and file comments with the Dockets Management
Branch (address above). Two copies of any comments should be filed and should be identified with the docket number
found in brackets in the heading of this document. Comments should include any available information that would be
helpful in determining whether the substance is, or is not, GRAS for the proposed use. In addition, consistent with
the regulations promulgated under the 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
National Environmental Policy Act (40 CFR 1501.4(b)), the agency encourages public participation by review of and
comment on the environmental assessment submitted with the petition that is the subject of this notice. A copy of the
petition (including the environmental assessment) and received comments may be seen in the Dockets Management Branch
between 9 a.m. and 4 p.m., Monday through Friday.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: August 5, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Fred R. Shank,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Director, Center for Food Safety and Applied Nutrition.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20129 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4160&hyph;01&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00114 </DOCNO>
<PARENT> FR940817-2-00062 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF THE INTERIOR</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Bureau of Land Management</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[MT&hyph;921&hyph;04&hyph;4120&hyph;03&hyph;P; NDM 83356]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
North Dakota; Coal Leases, Exploration Licenses, Etc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Bureau of Land Management, Montana State Office.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of invitation, Coal Exploration License Application NDM 83356.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Members of the public are hereby invited to participate with The Coteau Properties Company in a program for the exploration
of coal deposits owned by the United States of America in the following-described lands located in Mercer County,
North Dakota:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=26 g=1 f=1 -->
T. 145 N., R. 87 W., 5th P.M. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Sec. 2: Lot 3, SE1/4NW1/4 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
T. 146 N., R. 87 W., 5th P.M. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Sec. 30: Lots 1, 2, E1/2NW1/4
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
T. 146 N., R. 88 W., 5th P.M. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Sec. 14: S1/2SW1/4
<!-- PJG 0012 frnewline -->
Sec. 22: N1/2NE1/4, SW1/4NE1/4, W1/2, NW1/4SE1/4 
<!-- PJG 0012 frnewline -->
Sec. 26: SE1/4SE1/4
<!-- PJG 0012 frnewline -->
Sec. 34: E1/2 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
1157.06 acres.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Any party electing to participate in this exploration program shall notify, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
in writing
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, both the State Director, Bureau of Land Management, P.O. Box 36800, Billings, Montana 59107&hyph;6800; and The
Coteau Properties Company, HC 3 Box 49, Beulah, North Dakota 58523. Such written notice must refer to serial number
NDM 83356 and be received no later than 30 calendar days after publication of this Notice in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 or 10 calendar days after the last publication of this Notice in the Beulah Beacon, whichever is later. This Notice
will be published once a week for 2 consecutive weeks in the Beulah Beacon. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed exploration program is fully described and will be conducted pursuant to an exploration plan to be approved
by the Bureau of Land Management. The exploration plan, as submitted by The Coteau Properties Company, is available
for public inspection at the Bureau of Land Management, Montana State Office, Granite Tower Building, 222 North 32nd
Street, 
<!-- PJG 0012 frnewline -->
Billings, Montana, during regular business hours (9 a.m. to 4 p.m.) Monday through Friday. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: August 4, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Francis R. Cherry, Jr.,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting State Director.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20079 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4310&hyph;DN&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00115 </DOCNO>
<PARENT> FR940817-2-00063 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[ID&hyph;060&hyph;311A&hyph;02]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Idaho; Closure of Public Lands</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Bureau of Land Management, Coeur d'Alene District, Idaho.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of Restriction Order for Mica Bay Boater Park, Order No. ID060&hyph;11.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
By order, the following closures and restrictions apply to Mica Bay Boater Park, described as all public land located
in section 16, T.49N., R.4W., B.M.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(1) Entrance to the park is prohibited between the hours of 9 p.m. and 6 a.m. Persons entering prior to the designated
night closure period may remain and occupy the site for camping purposes.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) The consumption or possession of alcoholic beverages is prohibited.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) The possession of firearms is prohibited except for the portion of the above described area that is south of Loff's
Bay Road.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(4) Camping in the designated beach area is prohibited.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(5) The collection of firewood is restricted to dead and down woody vegetation. The cutting, removal or use of live
or standing dead woody vegetation is prohibited.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The authority for establishing these closures and restrictions is Title 43, Code of Federal Regulations, 8364.1.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The closures and restrictions become effective immediately and shall remain in effect until revoked and/or replaced
with supplemental rules.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The closures and restrictions do not apply to:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) Any federal, state or local official or member of an organized rescue or fire fighting force while in the performance
of an official duty.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) Any Bureau of Land Management employee, agent, contractor, cooperator or volunteer while in the performance
of an official duty.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) Public use of Loff's Bay Road.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The closures and restrictions are necessary to protect persons, property and public lands and resources. Persons
abusing alcohol and accessing the site at night cause a public disturbance and create a risk to other persons on public
lands.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Violation of this order is punishable by a fine not to exceed $1,000 and/or imprisonment not to exceed 12 months.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Jack O'Brien, Area Manager, Bureau of Land Management, 1808 North Third St., Coeur d'Alene, ID 83814.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Signed at Coeur d'Alene, Idaho this 2nd day of August 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: August 4, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Ted Graf,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting District Manager, Coeur d'Alene District, Bureau of Land Management.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20141 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4310&hyph;GG&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00116 </DOCNO>
<PARENT> FR940817-2-00064 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[CA&hyph;060&hyph;5440&hyph;10 B021]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Availability of Final Environmental Impact Report/Environmental Impact Statement for Rail-Cycle Bolo Station
Landfill, San Bernardino County</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Bureau of Land Management, Interior.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of availability.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice is hereby given that a joint final Environmental Impact Report/Impact Statement (EIR/EIS) has been prepared
by the Bureau of Land Management and the County of San Bernardino for the proposed Bolo Station Class III landfill.
The proposed Federal action comprises a land exchange involving 2.5 sections of public land, 2 rights-of-ways for
access and utilities, and a plan amendment to the California Desert Conservation Area (CDCA) Plan.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Written comments will be accepted if received on or before September 12, 1994, and comments received after that date
may not be considered in the Record of Decision. The address for written comments is given below.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Bureau of Land Management, California Desert District Office, Attn: Rail-Cycle, 6221 Box Springs Blvd., Riverside,
CA 92507.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Douglas Romoli, (909) 697&hyph;5237.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The proposed land exchange involves 2.5 sections of public land of which 1.5 sections are designated Multiple Use
Class L (Limited Use) under the CDCA Plan. The proposed use as landfill is not consistent with the guidelines for Class
L, and the proposed amendment would designate the 1.5 sections as Class M (Moderate Use). The guidelines for Class
M allow disposal of public lands for potential landfill purposes. The proposed 3 sections of private land to be acquired
contain tortoise habitat, including critical habitat, recreational value and land in the proposed East Mojave National
Park.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed landfill site is located between Amboy and Cadiz, south of Highway 66 and about 35 miles northeast of the
City of Twentynine Palms. The proposed landfill consists of 4800 acres of which 2100 acres would be used for the landfill.
Solid waste would be sorted and processed for recyclables at a Materials Recovery Facility in Southern California.
The residue would be packed into containers and transported by train to the Bolo Station site. At full operation, approximately
21,000 tons per day of solid waste would be transported, and the facility would be operated between 60-years and 100-years.
<!-- PJG 0012 frnewline -->
Besides the proposed action, two alternatives and a no-action alternative are analyzed. The EIR/EIS analyzes the
affects of the proposed action on such environmental issues as ground water, air quality, geology, visual resources
and wildlife among other resources. Copies of the Final EIR/EIS are located in the California Desert District Office,
Riverside, California and in the Needles Resource Area Office, 101 W. Spikes Rd., Needles, CA.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: August 8, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Henri R. Bisson,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
District Manager.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20212 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4310&hyph;40&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00117 </DOCNO>
<PARENT> FR940817-2-00065 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[NM&hyph;940&hyph;04&hyph;4730&hyph;12]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Filing of Plats of Survey; New Mexico</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Bureau of Land Management, Interior.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The plats of survey described below are scheduled to be officially filed in the New Mexico State Office. Bureau of Land
Management, Santa Fe, New Mexico, on September 14, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
New Mexico Principal Meridian, New Mexico
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
T. 24 N., 8 E., Accepted July 15, 1994, for Group 901 NM.
<!-- PJG 0012 frnewline -->
T. 20 N., 10 E., Accepted July 19, 1994, for Group 914 NM.
<!-- PJG 0012 frnewline -->
T. 24 N., 9 E., Accepted July 15, 1994, for Group 901 NM.
<!-- PJG 0012 frnewline -->
T. 15 N., 10 E., Accepted July 15, 1994, for Group 916 NM.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
If a protest against a survey, as shown on any of the above plats is received prior to the date of official filing, the
filing will be stayed pending consideration of the protest. A plat will not be officially filed until the day after
all protests have been dismissed and become final or appeals from the dismissal affirmed. 
<!-- PJG 0012 frnewline -->
A person or party who wishes to protest against a survey must file with the State Director, Bureau of Land Management,
a notice that they wish to protest prior to the proposed official filing date given above. 
<!-- PJG 0012 frnewline -->
A statement of reasons for a protest may be filed with the notice of protest to the State Director, or the statement of
reasons must be filed with the State Director within (30) days after the protest is filed. 
<!-- PJG 0012 frnewline -->
The above-listed plates represent dependent resurveys, survey and subdivision. 
<!-- PJG 0012 frnewline -->
These plats will be in the open files of the New Mexico State Office. Bureau of Land Management, P.O. Box 27115, Santa
Fe, New Mexico 87502&hyph;0115. Copies may be obtained from this office upon payment of $2.50 per sheet.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: August 9, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUMMARY>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
John P. Bennett,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Chief, Branch of Cadastral Survey/Geo Science.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20215 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4310&hyph;FB&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00118 </DOCNO>
<PARENT> FR940817-2-00066 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[NM&hyph;017&hyph;4210&hyph;05&hyph;RGRP]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Sale of Public Land in Bernalillo County, NM</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Bureau of Land Management, Interior.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Bureau of Land Management (BLM) announces that the following described parcels of public land have been examined
and identified as suitable for disposal by sale under section 203 of the Federal Land Policy and Management Act (FLPMA)
of 1976 (90 Stat. 2750; 43 U.S.C. 1713) at no less than the appraised fair market value shown. The parcels are isolated,
difficult and uneconomical to manage as part of the public land, and are suitable for management by another Federal
department or agency. The sale is consistent with the BLM's planning efforts, and the public interest will be served
by offering this land for sale. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Sale Method 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Parcels 1 and 7 will be offered for sale using competitive bidding procedures (43 CFR 2711.3.&hyph;1). On parcel 3,
the bidding will be modified to allow bids from designated bidders only (43 CFR 2711.3&hyph;2). Parcels 2, 4, 5, and
6 will be offered to the listed parties through Direct sale procedures not less than 60 days from publication of this
notice (43 CFR 2711.3&hyph;3). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 9,xls36,xs72,xls30,xls30,6,6,8,10,r100 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Parcel Information 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Parcel No. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Serial No. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Legal description, NMPM 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
2TWP
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
2RGE
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
2SEC
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
2Lot
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
2Acres 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Appraised value
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Method of sale 
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=4 -->
1. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
NMNM 68534
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11 N. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
5 E. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
36
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
15
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1.08
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
$4,400
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Competitive. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
NMNM 68528 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11 N.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
5 E. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
36 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
16
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1.69
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
7,800
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Direct to William J. and Mary J. Denison. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
NMNM 91330
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11 N. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
6 E. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
20 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
34
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
0.829
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1,300
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Modified. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
NMNM 91331
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11 N. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
6 E. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
33
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1.206
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
2,000
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Direct to Orvel J. and Deborah Fletcher. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
5. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
NMNM 91332
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11 N. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
6 E. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
32
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1.164
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1,900
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Direct to Perry and Dawna Anderson. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
6. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
NMNM 91333
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11 N
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
6 E. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
20
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
31
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
0.214
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
200
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Director to B.F. and Edith M. Bailey. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
7.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
NMNM 88815
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11 N
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
6 E. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
34
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
2.12
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
4,200
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Competitive. 
<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=84 g=1 f=4 -->

<!-- PJG 0012 frnewline -->
Sales Procedures 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->

<!-- PJG 0012 frnewline -->
The sale of parcels 1 and 7 will be by competitive sealed bids followed by oral bidding. However, on parcel 3 competitive
bids will only be accepted from the designated bidders named below. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=4 -->

<!-- PJG 0012 frnewline -->
Modified Competitive Sale Designated Bidders: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=4 -->

<!-- PJG 0012 frnewline -->
Parcel No. 3 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=4 -->

<!-- PJG 0012 frnewline -->
1. Gary L. McAllister and Linda M. McAllister 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
2. Gregorio Davis and Dora R. Davis 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=4 -->

<!-- PJG 0012 frnewline -->
Sealed bids will be considered only if received in the Rio Puerco Resource Area Office, 435 Montano Rd., NE., Albuquerque,
New Mexico 87107, before 10 a.m. on November 15, 1994, the day of the sale. Oral bids will be accepted commencing at 10:30
a.m., following the opening of all sealed bids, at the same place on the same sale date. Sealed bids of less than the appraised
fair market value will be rejected. The apparent highest qualified sealed bid will be publicly declared by the Authorized
Officer. The apparent highest qualified sealed bid will then become the starting point for the oral bidding. If no
apparent qualified sealed are received, the oral bidding will start at the appraised fair market value. In the absence
of oral bids, the apparent highest qualified sealed bid will establish the sale price for that parcel. In the event
that two or more sealed bids are received containing valid bids of the same amount for the same parcel, and no higher
oral bid is received for that parcel, the determination of which is to be considered the highest designated bid will
be by supplemental bidding. In such a case, the high bidders will be allowed to submit oral or sealed bids as designated
by the Authorized Officer. After oral bids, if any, are received, the highest qualifying bid, whether sealed or oral,
shall be declared by the Authorized Officer. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bidders must be 18 years of age or over and United States citizens, and corporations must be subject to the laws of any
State or of the United States. Apparent high bidders must submit proof of these requirements within 15 days after the
sale date. 
<!-- PJG /ITAG -->
</SUMMARY>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00119 </DOCNO>
<PARENT> FR940817-2-00066 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Bids must be made by the principal or his duly qualified agent. Each sealed bid must be written or typed and accompanied
by postal money order, bank draft, or cashier's check made payable to the Department of the Interior, Bureau of Land
Management, for not less than 10 percent or more than 30 percent of the amount of the bid. The sealed bid envelope containing
the bid and the required amount must be marked in the lower left-hand corner as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=77 g=1 f=4 -->
Public Sale Bid Parcel No.
<!-- PJG 0012 frnewline -->
Serial No.
<!-- PJG 0012 frnewline -->
Sale Held
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=4 -->
&blank;&blank;&blank;&blank;(Date)
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Each successful oral bidder will be required to pay not less than 20 percent of the amount of the bid immediately following
the close of the sale. Payment must be by cash, personal check, bank draft, money order, or any combination of these.
Successful bidders, whether such bid is oral or sealed, will be required to pay the remainder of the full bid price prior
to the expiration of 180 days from the date of the sale. Failure to submit the full bid price within the above specified
time limit will result in cancellation of the sale of the specific parcel and the deposit will be forfeited and disposed
of as other receipts of sale.
<!-- PJG 0012 frnewline -->
All sealed bids will be either returned, accepted, or rejected within 30 days of the sale date. Competitive and Modified
Sale Parcels not sold on the day of the sale, will be reoffered for sale every first Tuesday of each month, same time and
place, by the same procedures described above until sold or until February 10, 1995 at close of business.
<!-- PJG 0012 frnewline -->
On parcels 2, 4, 5, and 6, should any of the listed parties decline to purchase an offered parcel within the time allotted,
the unsold parcel will then be reoffered by open competitive bidding procedures described above every first Tuesday
of each month, same time and place, until sold or until February 10, 1995 at close of business.
<!-- PJG 0012 frnewline -->
In the event that the Authorized Officers rejects the highest qualified bid for any of the above parcels, or releases
the Bidder from it, the Authorized Officer shall determine whether the public land shall be withdrawn from the market
or reoffered.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=4 -->
Terms and Conditions
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
The patents, when and if issued, will contain the following reservations to the United States:
<!-- PJG 0012 frnewline -->
1. A right-of-way thereon for ditches or canals constructed by the United States pursuant to the Act of August 30, 1890
(43 U.S.C. 945).
<!-- PJG 0012 frnewline -->
2. All minerals will be reserved to the United States together with the right to prospect for, mine, and remove the minerals.
A more detailed description of this reservation, which will be incorporated in the patent document, is available
for review at this office.
<!-- PJG 0012 frnewline -->
3. All patents will be issued subject to existing rights-of-way and easements.
<!-- PJG 0012 frnewline -->
The purchaser of parcel 7 acquires the property realizing that public access to the property is lacking.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Interested parties may submit comments regarding the proposed action to the Rio Puerco Resource Area Manager by October
3, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Comments should be sent to the Bureau of Land Management, Rio Puerco Resource Area Office, 435 Montano Rd., NE., Albuquerque,
New Mexico 87107.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Additional information concerning the land, terms and conditions of sale, and bidding instructions may be obtained
from Rio Puerco Resource Area Office at the above address. Telephone calls may be directed to Joseph Maramillo at (505)
761&hyph;8779.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Comments must reference specific parcel numbers. Adverse comments received on specific parcels will not affect
the sale of any other parcel. Objections will be reviewed by the State Director who may sustain, vacate or modify this
realty action. In the absence of any objections, this realty action will become the final determination of the Department
of Interior.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Upon publication in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, the lands described above will be segregated from appropriation under the public land laws, including the mining
laws. The segregative effect of this Notice of Realty Action shall terminate upon issuance of patent or other document
of conveyance to such land, upon publication in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of a termination of the segregation or 270 days from the date of publication, whichever occurs first.
<!-- PJG 0012 frnewline -->
The BLM may accept or reject any offer to purchase or withdraw any tract from sale if the Authorized Officer determines
that consummation of the sale would not be fully consistent with FLPMA or another applicable law.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: August 9, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Sue E. Richardson,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting District Manager.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20213 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4310&hyph;FB&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00120 </DOCNO>
<PARENT> FR940817-2-00067 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Fish and Wildlife Service</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Notice of Receipt of Application for Permit </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The public is invited to comment on the following application for a permit to conduct certain activities with marine
mammals. The application was submitted to satisfy requirements of the Marine Mammal Protection Act of 1972, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
as amended 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(16 U.S.C. 1361 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
et seq.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
) and the regulations governing marine mammals (50 CFR 18). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Applicant:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Daesaeng Corporation, Seoul, Korea, PRT&hyph;792768. The U.S agent for this aquarium is: International Animal
Exchange, Ferndale, Michigan. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Type of Permit:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Take for public display 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Name and Number of Animals:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Northern sea otter (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Enhydra lutris lutris
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
), 5 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Summary of Activity to be Authorized:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The applicant requests to take (permanently remove) from the wild and export one male and four female northern sea
otters and inadvertently harass others during capture. The sea otters will be on permanent public display at Daesaeng
Corporation's 63 Aquarium where educational information will be provided to the public. As required under the 1994
amendments to the Act, the applicant has submitted professionally recognized standards on which the educational
information is based. These standards are available as part of the application for public comment. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Source of Marine Mammals for Research/Public Display:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The applicant document that currently there are no sea otters in captivity available for their acquisition; therefore,
the applicant is requesting removal of 5 sea otters from the waters surrounding Kodiak Island, Alaska. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Period of Activity:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 September through October, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Concurrent with the publication of this notice in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, the Office of Management Authority is forwarding copies of this application to the Marine Mammal Commission and
the Committee of Scientific Advisors for their review. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Written data or comments, requests for copies of the complete application, or requests for a public hearing on this
application should be sent to the U.S. Fish and Wildlife Service, Office of Management Authority, 4401 N. Fairfax
Drive, Room 420(c), Arlington, Virginia 22203, telephone 703/358&hyph;2104 or fax 703/358&hyph;2281 and must
be received within 30 days of the date of publication of this notice. Anyone requesting a hearing should give specific
reasons why a hearing would be appropriate. The holding of such hearing is at the discretion of the Director. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Documents and other information submitted with these applications are available for review, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
subject to the requirements of the Privacy Act and Freedom of Information Act,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 by any party who submits a written request for a copy of such documents within 30 days of the date of publication of this
notice at the above address. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: August 12, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Margaret Tieger, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Chief 
<!-- PJG 0012 frnewline -->
Branch of Permits, Office of Management Authority. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20166 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4310&hyph;55&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00121 </DOCNO>
<PARENT> FR940817-2-00068 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Notice of Availability of the Draft Environmental Assessment and Land Protection Plan Proposed Establishment of
Big Branch Marsh National Wildlife Refuge St. Tammany Parish, LA</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Fish and Wildlife Service, Interior.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of Availability of the Draft Environmental Assessment and Land Protection Plan for the Proposed Establishment
of Big Branch Marsh National Wildlife Refuge.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This notice advises the public that the U.S. Fish and Wildlife Service, Southeast Region, proposes to establish a
national wildlife refuge in the vicinity of St. Tammany Parish, Louisiana. The purpose of the proposed refuge is to
protect, enhance, and manage a valuable wetland area known as the Big Branch Marsh, which is threatened by urban expansion
from the city of New Orleans. A Draft Environmental Assessment and Land Protection Plan for the proposed refuge has
been developed by Service biologists in coordination with the State of Louisiana, the Northshore Coast Watch, the
Coalition to Restore Louisiana, the Lake Pontchartrain Basin Foundation, the St. Tammany Sportsmen's League, and
the St. Tammany Police Jury. The assessment considers the biological, environmental, and socioeconomic effects
of establishing the refuge. The assessment also evaluates three alternative actions and their potential impacts
on the environment. Written comments or recommendations concerning the proposal are welcomed and should be sent
to the address below.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Land acquisition planning for the project is currently underway. The draft environmental assessment and land protection
plan will be available to the public for review and comment on August 15, 1994. Written comments must be received no
later than September 13, 1994, to be considered.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Comments and requests for copies of the assessment and for further information on the project should be addressed
to Mr. Charles R. Danner, Chief, Branch of Project Development, Office of Refuges and Wildlife, U.S. Fish and Wildlife
Service, 1875 Century Boulevard, Atlanta, Georgia 30345.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The primary objectives of the proposed Big Branch Marsh National Wildlife Refuge are to provide: (1) Habitat for a
natural diversity of wildlife associated with the Big Branch Marsh, (2) wintering habitat for migratory waterfowl,
(3) nesting habitat for wood ducks, (4) habitat for non-game migratory birds, and (5) opportunities for compatible
public outdoor recreation, such as hunting, fishing, hiking, birdwatching, and environmental education and interpretation.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed refuge area is located along the north shore of Lake Pontchartrain in St. Tammany Parish, Louisiana,
just south of the town of Lacombe. It is bordered by Cane Bayou on the west, Lake Pontchartrain on the south, and the Southern
Railway trestle on the east. The northern boundary runs along several parish roads and bayous which separate the marsh
from residential development south of U.S. Highway 190, an east-west highway that runs from Slidell to Mandeville,
Louisiana.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed rufuge would consist of up to 12,000 acres of land acquired in fee title from willing sellers.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The major wildlife values are the numerous species of shorebirds, wading birds, neotropical migratory birds, and
wintering watefowl. Raptors include the osprey, northern harrier, peregrine falcon, and bald eagle. White-tailed
deer, mink, raccoon, and river otter are among the many species of mammals dependent on the area.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The entire area serves as an important nursery for fish, shrimp, and crabs and represents one of the better fish production
areas on Lake Pontchartrain. The estuaries, ponds, and bayous provide a diverse mix of brackish and freshwater habitats
for many species of saltwater and freshwater fish of both recreational and commercial importance.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: August 2, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
James W. Pulliam, Jr.,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Regional Director.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20373 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4310&hyph;55&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00122 </DOCNO>
<PARENT> FR940817-2-00069 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>National Park Service</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Draft General Management Plan/Implementation Plan Alternatives/Environmental Impact Statement for Lake Chelan
National Recreation Area, WA</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of availability.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This notice announces the availability of a draft general management plan/environmental impact statement (GMP/EIS)
and five implementation plans for Lake Chelan National Recreation Area (NRA). This notice also announces public
hearings for the purpose of receiving public comments on the draft documents.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Comments on the draft GMP/EIS should be received no later than November 1, 1994. Public hearings will be held in Seattle,
Washington on October 3, 1994, beginning at 7 p.m. in Chelan, Washington on October 5, 1994, at 7 p.m. and in Stehekin,
Washington on October 7, 1994, at 7 p.m. Further details about hearing locations will be announced in the future.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Comments on the draft GMP/EIS should be submitted to: Superintendent, North Cascades National Park Complex, National
Park Service, 2105 Highway 20, Sedro Woolley WA 98284&hyph;9314, telephone: (206) 856&hyph;5700.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Public reading copies of the draft EIS will be available for review at the following locations:
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Office of Public Affairs, National Park Service, Department of the Interior, 18th and C Streets NW., Washington,
DC 20240, telephone: (202) 208&hyph;6843.
<!-- PJG 0012 frnewline -->
Stehekin Ranger Station, Lake Chelan NRA, National Park Service, Stehekin, WA 98852, telephone: (206) 856&hyph;6055.
<!-- PJG 0012 frnewline -->
Government Publications, Suzzallo Library, University of Washington, Seattle, WA 98195, telephone: (206) 543&hyph;1937.
<!-- PJG 0012 frnewline -->
Pacific Northwest Regional Office, National Park Service, Regional Office Library, rm. 650, 909 First Ave., Seattle,
WA 98104&hyph;1060, telephone: (206) 220&hyph;4070.
<!-- PJG 0012 frnewline -->
Chelan Public Library, Chelan, WA 98816, telephone: (206) 682&hyph;5131.
<!-- PJG 0012 frnewline -->
Government Documents, Main Public Library, 1000&hyph;4th Ave., Seattle, WA 98104&hyph;1193, telephone: (206)
386&hyph;4686.
<!-- PJG 0012 frnewline -->
Reference Section, Wenatchee Public Library, 310 Douglas, Wenatchee, WA 98801, telephone: (509) 662&hyph;5021.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Documents Section, Washington State Library, 16th and Walker, Olympia, WA 98504&hyph;2478, telephone: (206) 753&hyph;4027.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A limited number of copies of the GMP/EIS are available on request from the Superintendent, North Cascades National
Park Service Complex, at the above address and telephone number.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Draft General Management Plan/Implementation Plan Alternatives/Environmental Impact Statement describes
and analyzes a proposed action and four alternatives for future management and use of Lake Chelan National Recreation
Area as required by the consent decree that was approved and entered on April 22, 1991, in the United States District
Court for the Western District of Washington (Civil Case No. C&hyph;89&hyph;1342D). Under the proposed action,
the National Park Service would not manipulate the Stehekin River or remove or manipulate woody debris except to protect
public roads and bridges. The active sand, rock, and gravel borrow pit would be maintained at less than or equal to its
current size. Fire suppression, prescribed natural fire, management-ignited prescribed fire, and selective manual
fuel reductions would be used to restore or replicate the natural role of fire. Firewood would be provided at fair market
value instead of a set permit fee and there would be no guaranteed cordage per year. The airstrip would remain open.
Land protection would emphasize high flood influence areas, wetlands, riparian areas, and high visual sensitivity
areas. Under the no-action/minimum requirements alternative, river erosion and flooding would be controlled only
to protect life, health, public roads, and bridges. Where feasible, federal lands would be treated with prescribed
fire to reduce fuels. Firewood would be obtained from harvesting 1-acre woodlots. The airstrip would remain open.
Land protection would emphasize wetlands, shoreline characteristics, high scenic quality, water quality, visitor
access, restriction of unsightly development, and development on areas with gradients greater than 20%. Under alternative
A, new river shoreline or bank protection structures would be prohibited. The mining of sand, rock, and gravel would
be prohibited within the valley. Natural ignitions would be suppressed on the valley floor for the protection of human
life and property. Woodlot cutting of firewood would stop immediately. The airstrip would be closed and restored
to natural conditions. The Stehekin Valley road between the Landing and Cottonwood Camp would be converted to a trail.
All NPS and concession housing and maintenance facilities would be substantially reduced and located at the Landing.
Land protection would involve acquisition, on a willing seller/willing buyer basis, or by eminent domain authority,
of all private lands within the recreation area. Under alternative B, riverbank protection structures would be allowed
if no adverse environmental impacts would result. Mining of sand, rock, and gravel in the valley would be prohibited.
Fire and forest fuels would be managed to restore or replicate the natural role of fire. Firewood would be provided
at fair market value instead of a set permit fee. There would be no guarantee of firewood cordage per year. The airstrip
would be closed. Land protection would emphasize high flood influence areas, wetlands, riparian areas, and high
visual sensitivity areas. Under alternative C, protection of public or private improvements threatened by river
erosion and flooding would be allowed. The size of the borrow put would remain constant. Selective manual forest fuel
reduction techniques would be used to reduce hazard forest fuel loadings. Firewood would be supplied from administrative
wood and natural selection ecoforestry selective cutting from a designated area. The airstrip would be managed by
the National Park Service for emergency use only. Land protection would emphasize high flood influence areas, wetlands,
and high visual sensitivity areas. Major impact topics assessed for the proposed action and alternatives include
natural and cultural resources and the socioeconomic environment, including the local and regional economy.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: August 9, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Charles H. Odegaard,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Regional Director, Pacific Northwest Region, National Park Service.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20093 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4310&hyph;70&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00123 </DOCNO>
<PARENT> FR940817-2-00070 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>National Register of Historic Places; Notification of Pending Nominations</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Nominations for the following properties being considered for listing in the National Register were received by
the National Park Service before August 6, 1994. Pursuant to section 60.13 of 36 CFR Part 60 written comments concerning
the significance of these properties under the National Register criteria for evaluation may be forwarded to the
National Register, National Park Service, P.O. Box 37127, Washington, DC 20013&hyph;7127. Written comments should
be submitted by September 1, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Jan Townsend,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Chief of Registration, National Register.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=75 g=1 f=1 -->
ALASKA
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
Aleutian Islands Borough-Census Area
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=3 -->
S.S. NORTHWESTERN Shipwreck Site, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Address Restricted, Unalaska vicinity, 94001065
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=75 g=1 f=1 -->
ARIZONA
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
Pima County
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=3 -->
El Montevideo Historic District,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
 3700 and 3800 blocks of streets between Broadway &amp; 5th St., Tucson, 94001070
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=75 g=1 f=1 -->
DELAWARE
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
New Castle County
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=3 -->
Hickman Blacksmith Shop and House,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
 1201 and 1203 Greenbank Rd., Marshallton, 94001078
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=75 g=1 f=1 -->
GEORGIA
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
Bartow County
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=3 -->
North Erwin Street Historic District,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
 Jct. of N. Erwin and Cherokee Sts., Cartersville, 94001071
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=75 g=1 f=1 -->
MARYLAND
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
Worcester County
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=3 -->
Chanceford,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
 209 W. Federal St., Snow Hill, 94001077
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=75 g=1 f=1 -->
MINNESOTA
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
Lake Of The Woods County
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=3 -->
Norris Camp (Federal Relief Construction in Minnesota MPS),
<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
 Off Norris_Roosevelt Forest Rd., Red Lake Wildlife Management Area, Roosevelt vicinity, 94001080
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=75 g=1 f=1 -->
MONTANA
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
Rosebud County
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=3 -->
Bookman, J.A., General Store,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
 Main St., Ingomar, 94001067
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=25 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=3 -->
Ingomar Public School,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
 Second Ave., Ingomar, 94001068
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=25 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=3 -->
Wiley, Clark &amp; Greening Bank,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
 Main St., Ingomar, 94001069
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=75 g=1 f=1 -->
NEW YORK
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
Monroe County
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=3 -->
Clarkson Corners Historic District,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
 Jct. of Ridge and Lake Rds. and E and W along Ridge and S along Lake, Clarkson Corners, 94001076
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=75 g=1 f=1 -->
NORTH CAROLINA
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
Vance County
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=3 -->
Parham, Maria, Hospital,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
 406 S. Chestnut St., Henderson, 94001066
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=75 g=1 f=1 -->
NORTH DAKOTA
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
Benson County
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=3 -->
Grace Episcopal Church (Episcopal Churches of North Dakota MPS),
<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
 210 C Ave. S., Minnewaukan, 94001072
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
Cass County
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=3 -->
Lindemann, Robert, House,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
 1.5 mi. E and 2.75 mi. N of Enderlin, Enderlin vicinity, 94001073
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
Grand Forks County
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=3 -->
House at 1648 Riverside Drive,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
 1648 Riverside Dr., Grand Forks, 94001074
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
Pembina County
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=3 -->
Grace Episcopal Church (Episcopal Churches of North Dakota MPS),
<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
 152 Ramsey St. W., Pembina, 94001075
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=75 g=1 f=1 -->
TEXAS
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
Travis County
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=3 -->
Moore_Hancock Farmstead,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
 4811 Sinclair Ave., Austin, 94001079
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=75 g=1 f=1 -->
WISCONSIN
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
La Crosse County
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=3 -->
LaCrosse Commercial Historic District,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
 Roughly bounded by Jay St., Second St. S., State St. and Fifth Ave. S., LaCrosse, 94001064
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20094 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4310&hyph;70&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00124 </DOCNO>
<PARENT> FR940817-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>UNITED STATES INTERNATIONAL TRADE COMMISSION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>Investigation No. 751&hyph;TA&hyph;16 </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Ceiling Fans From the People's Republic of China
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
United States International Trade Commission.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Institution and scheduling of a review investigation concerning the Commission's affirmative determination in
investigation No. 731&hyph;TA&hyph;473 (Final), Certain Electric Fans from the People's Republic of China (China).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Commission hereby gives notice that it has initiated an investigation pursuant to section 751(b) of the Tariff
Act of 1930 (19 U.S.C. &sect;1675(b)) (the Act) to review its determination in investigation No. 731&hyph;TA&hyph;473
(Final). The purpose of the investigation is to determine whether an industry in the United States would be materially
injured, or would be threatened with material injury, or the establishment of an industry in the United States would
be materially retarded, by reason of imports of ceiling fans from China if the antidumping order regarding such merchandise
were to be modified or revoked.
<FOOTCITE>1</FOOTCITE>
 Ceiling fans are provided for in subheading 8414.51.00 of the Harmonized Tariff Schedule of the United States.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Although the scope of Commerce's investigation included both ceiling fans and oscillating fans, the Commission
found these fans to be separate like products of separate industries and determined accordingly on the question of
injury.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
For further information concerning the conduct of this investigation, hearing procedures, and rules of general
application, consult the Commission's Rules of Practice and Procedure, part 201, subparts A through E (19 CFR part
201), and part 207, subparts A and E (19 CFR part 207).
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
August 10, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Tedford Briggs (202&hyph;205&hyph;3181), Office of Investigations, U.S. International Trade Commission, 500
E Street SW., Washington, DC 20436. Hearing-impaired persons can obtain information on this matter by contacting
the Commission's TDD terminal on 202&hyph;205&hyph;1810. Persons with mobility impairments who will need special
assistance in gaining access to the Commission should contact the Office of the Secretary at 202&hyph;205&hyph;2000.
Information can also be obtained by calling the Office of Investigations' remote bulletin board system for personal
computers at 202&hyph;205&hyph;1895 (N,8,1).
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Background._
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On October 25, 1991, the Department of Commerce determined that imports of ceiling fans from China are being sold in
the United States at less than fair value (LTFV) within the meaning of section 731 of the Act (19 U.S.C. &sect;1673)
(56 F.R. 55271, October 25, 1991) (an amendment to its determination, modifying the margins according to specific
companies, was published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 on December 9, 1991 (56 F.R. 64240)); and on December 2, 1991, the Commission determined, pursuant to section 735(b)(1)
of the Act (19 U.S.C. &sect;1673d(b)(1)), that an industry in the United States was materially injured by reason by
imports of such LTFV merchandise. Accordingly, Commerce ordered that dumping duties be imposed on such imports (December
9, 1991, 56 F.R. 64240).
<FOOTCITE>2</FOOTCITE>
 On March 2, 1994, however, Commerce published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 a revision of its original dumping determination, effectively excluding one of the Chinese producers from the order
and reducing the margin for non-specified firms (59 F.R. 9956, March 2, 1994).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
2
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Following review in the U.S. Court of International Trade, Commerce revoked the antidumping duty order applicable
to oscillating fans (58 F.R. 30026, May 25, 1993).
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On May 4, 1994, the Commission received a request to review its affirmative determination in investigation No. 731&hyph;TA&hyph;473
(Final) pursuant to section 751(b) of the Act (19 U.S.C. &sect;1675(b)). The request was filed by Encon Industries,
Inc., Fort Worth, TX. On June 10, 1994, the Commission requested written comments in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (59 F.R. 30036) as to whether the changed circumstances alleged by the petition were sufficient to warrant a review
investigation. On August 10, 1994, after reviewing comments received in response to that request, the Commission
determined that the alleged changed circumstances were sufficient to warrant a review investigation.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Participation in the investigation and public service list._
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Persons wishing to participate in the investigation as parties must file an entry of appearance with the Secretary
to the Commission, as provided in section 201.11 of the Commission's rules, not later than twenty-one (21) days after
publication of this notice in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. The Secretary will prepare a public service list containing the names and addresses of all persons, or their representatives,
who are parties to this investigation upon the expiration of the period for filing entries of appearance.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Limited disclosure of business proprietary information (BPI) under an administrative protective order (APO) and
BPI service list._
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Pursuant to section 207.7(a) of the Commission's rules, the Secretary will make BPI gathered in this investigation
available to authorized applicants under the APO issued in the investigation, provided that the application is made
not later than twenty-one (21) days after the publication of this notice in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. A separate service list will be maintained by the Secretary for those parties authorized to receive BPI under the
APO.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Staff report._
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The prehearing staff report in this investigation will be placed in the nonpublic record on October 14 1994, and a public
version will be issued thereafter, pursuant to section 207.21 of the Commission's rules.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Hearing._
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commission will hold a hearing in connection with this investigation beginning at 9:30 a.m. on October 27, 1994,
at the U.S. International Trade Commission Building. Requests to appear at the hearing should be filed in writing
with the Secretary to the Commission on or before October 20, 1994. A nonparty who has testimony that may aid the Commission's
deliberations may request permission to present a short statement at the hearing. All parties and nonparties desiring
to appear at the hearing and make oral presentations should attend a prehearing conference to be held at 9:30 a.m. on
October 24, 1994, at the U.S. International Trade Commission Building. Oral testimony and written materials to be
submitted at the public hearing are governed by sections 201.6(b)(2), 201.13(f), and 207.23(b) of the Commission's
rules. Parties are strongly encouraged to submit as early in the investigation as possible any requests to present
a portion of their hearing testimony 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
in camera.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Written submissions._
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Each party is encouraged to submit a prehearing brief to the Commission. Prehearing briefs must conform with the provisions
of section 207.22 of the Commission's rules; the deadline for filing is October 21, 1994. Parties may also file written
testimony in connection with their presentation at the hearing, as provided in section 207.23(b) of the Commission's
rules, and posthearing briefs, which must conform with the provisions of section 207.24 of the Commission's rules.
The deadline for filing posthearing briefs is November 4, 1994; witness testimony must be filed no later than three
(3) days before the hearing. In addition, any person who has not entered an appearance as a party to the investigation
may submit a written statement of information pertinent to the subject of the investigation on or before November
4, 1994. All written submissions must conform with the provisions of section 201.8 of the Commission's rules; any
submissions that contain BPI must also conform with the requirements of sections 201.6, 207.3, and 207.7 of the Commission's
rules.
<!-- PJG 0012 frnewline -->
In accordance with sections 201.16(c) and 207.3 of the rules, each document filed by a party to the investigation must
be served on all other parties to the investigation (as identified by either the public or BPI service list), and a certificate
of service must be timely filed. The Secretary will not accept a document for filing without a certificate of service.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
This investigation is being conducted under authority of the Tariff Act of 1930, title VII. This notice is published
pursuant to section 207.45 of the Commission's rules.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued: August 11, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
By order of the Commission.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Donna R. Koehnke,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20174 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 7020&hyph;02&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00125 </DOCNO>
<PARENT> FR940817-2-00072 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>Investigation No. 731&hyph;TA&hyph;659 (Final)</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Grain-Oriented Silicon Electrical Steel From Italy</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Determination
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On the basis of the record
<FOOTCITE>1</FOOTCITE>
 developed in the subject investigation, the Commission determines,
<FOOTCITE>2</FOOTCITE>
 pursuant to section 735(b) of the Tariff Act of 1930 (19 U.S.C. &sect;1673d(b)) (the Act), that an industry in the United
States is materially injured by reason of imports from Italy of grain-oriented silicon electrical steel, provided
for in subheadings 7225.10.00, 7226.10.10, and 7226.10.50 of the Harmonized Tariff Schedule of the United States,
that have been found by the Department of Commerce to be sold in the United States at less than fair value (LTFV).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The record is defined in sec. 207.2(f) of the Commission's Rules of Practice and Procedure (19 CFR &sect;207.2(f)).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
2
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Commissioner Crawford dissenting; Chairman Watson not participating and Commissioner Bragg not participating
in the determination in this investigation.
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Background
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commission instituted this investigation effective January 28, 1994, following a preliminary determination
by the Department of Commerce that imports of grain-oriented silicon electrical steel from Italy were being sold
at LTFV within the meaning of section 733(b) of the Act (19 U.S.C. &sect;1673b(b)). Notice of the institution of the
Commission's investigation and of a public hearing to be held in connection therewith was given by posting copies
of the notice in the Office of the Secretary, U.S. International Trade Commission, Washington, DC, and by publishing
the notice in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
of February 23, 1994 (59 F.R. 8658). The hearing was held in Washington, DC, on April 12, 1994, and all persons who requested
the opportunity were permitted to appear in person or by counsel.
<!-- PJG 0012 frnewline -->
The Commission transmitted its determination in this investigation to the Secretary of Commerce on August 8, 1994.
The views of the Commission are contained in USITC Publication 2800 (August 1994), entitled ``Grain-Oriented Silicon
Electrical Steel from Italy: Investigation No. 731&hyph;TA&hyph;659 (Final).''
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued: August 10, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
By order of the Commission.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20175 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 7020&hyph;02&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00126 </DOCNO>
<PARENT> FR940817-2-00073 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>Investigations Nos. 701&hyph;TA&hyph;362 and 731&hyph;TA&hyph;707&hyph;710 (Preliminary)</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Certain Seamless Carbon and Alloy Standard, Line, and Pressure Steel Pipe From Argentina, Brazil, Germany, and Italy</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Determinations
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On the basis of the record
<FOOTCITE>1</FOOTCITE>
 developed in the subject investigations, the Commission unanimously determines,
<FOOTCITE>2</FOOTCITE>
 pursuant to sections 703(a) and 733(a) of the Tariff Act of 1930, (19 U.S.C. &sect;1671b(a)) and (19 U.S.C. &sect;1673b(a)),
respectively, that there is a reasonable indication that an industry in the United States is materially injured by
reason of imports from Italy of certain seamless carbon and alloy standard, line, and pressure steel pipe
<FOOTCITE>3</FOOTCITE>
 that are alleged to be subsidized by the Government of Italy and by reason of imports from Argentina, Brazil, Italy,
and Germany of certain seamless carbon and alloy standard, line, and pressure steel pipe that are alleged to be sold
in the United States at less than fair value (LTFV).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The record is defined in sec. 207.2(f) of the Commission's Rules of Practice and Procedure (19 CFR 207.2(f)).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
2
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Due to a communications systems failure just prior to the Commission meeting on August 3, 1994, Commissioner Newquist
was not able to participate in this investigation. Had he participated, Commissioner Newquist would have made an
affirmative determination.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
3
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Imports are currently classified under Harmonized Tariff Schedule item numbers 7304.10.1020, 7304.10.5020, 7304.31.6050,
7304.39.0016, 7304.39.0020, 7304.39.0024, 7304.39.0028, 7304.39.0032, 7304.51.5005, 7304.51.5060, 7304.59.6000,
7304.59.8010, 7304.59.8015, 7304.59.8020, and 7304.59.8025.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Background
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On June 23, 1994, a petition was filed with the Commission and the Department of Commerce by the Gulf States Tube Division
of Quanex Corp., Rosenberg, TX, alleging that an industry in the United States is materially injured or threatened
with material injury by reason of imports from Italy of certain seamless carbon and alloy standard, line, and pressure
steel pipe that are alleged to be subsidized by the Government of Italy and by reason of LTFV imports from Argentina,
Brazil, Germany, and Italy of such pipe. Accordingly, effective June 23, 1994, the Commission instituted countervailing
duty investigation No. 701&hyph;TA&hyph;362 (Preliminary) and antidumping investigations Nos. 731&hyph;TA&hyph;707&hyph;710
(Preliminary).
<!-- PJG 0012 frnewline -->
Notice of the institution of the Commission's investigations and of a public conference to be held in connection therewith
was given by posting copies of the notice in the Office of the Secretary, U.S. International Trade Commission, Washington,
DC, and by publishing the notice in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
of June 30, 1994 (59 FR 33780). The conference was held in Washington, DC, on July 14, 1994, and all persons who requested
the opportunity were permitted to appear in person or by counsel.
<!-- PJG 0012 frnewline -->
The Commission transmitted its determinations in these investigations to the Secretary of Commerce on August 8,
1994. The views of the Commission are contained in USITC Publication 2801 (August 1994), entitled ``Certain Seamless
Carbon and Alloy Standard, Line, and Pressure Steel Pipe from Argentina, Brazil, Germany, and Italy: Investigations
Nos. 701&hyph;TA&hyph;362 and 731&hyph;TA&hyph;707 through 710 (Preliminary).''
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued: August 10, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
By order of the Commission.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Donna R. Koehnke,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20176 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 7020&hyph;02&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00127 </DOCNO>
<PARENT> FR940817-2-00074 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>Investigations Nos. 731&hyph;TA&hyph;671&hyph;674 (Final)</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Silicomanganese From Brazil, the People's Republic of China, Ukraine, and Venezuela</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
United States International Trade Commission.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Revised schedule for the subject investigations.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
August 5, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Douglas Corkran (202&hyph;205&hyph;3177), Office of Investigations, U.S. International Trade Commission, 500
E Street SW., Washington, DC 20436. Hearing-impaired persons can obtain information on this matter by contacting
the Commission's TDD terminal on 202&hyph;205&hyph;1810. Persons with mobility impairments who will need special
assistance in gaining access to the Commission should contact the Office of the Secretary at 202&hyph;205&hyph;2000.
Information can also be obtained by calling the Office of Investigations' remote bulletin board system for personal
computers at 202&hyph;205&hyph;1895 (N, 8, 1).
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Effective June 16, 1994, the Commission instituted the subject investigations and established a schedule for their
conduct (59 FR 36212, July 15, 1994). Subsequently, the Department of Commerce extended the date for its final determination
in the investigation of silicomanganese from the People's Republic of China to October 31, 1994 (59 FR 40008, August
5, 1994). The Commission, therefore, is revising its schedule in the silicomanganese investigations to conform
with Commerce's new schedule.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commission's new schedule for these investigations is as follows: the prehearing staff report will be placed
in the nonpublic record on October 21, 1994; requests to appear at the hearing must be filed with the Secretary to the
Commission not later than October 28; the deadline for filing prehearing briefs is also october 28; the prehearing
conference will be held at the U.S. International Trade Commission Building at 9:30 a.m. on November 2; the hearing
will be held at the U.S. International Trade Commission Building at 9:30 a.m. on November 3; and the deadline for filing
posthearing briefs is November 14.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For further information concerning these investigations see the Commission's notice of institution cited above
and the Commission's Rules of Practice and Procedure, part 201, subparts A through E (19 CFR part 201), and part 207,
subparts A and C (19 CFR part 207).
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
These investigations are being conducted under authority of the Tariff Act of 1930, title VII. This notice is published
pursuant to section 207.20 of the Commission's rules.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued: August 10, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
By order of the Commission.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Donna R. Koehnke,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20177 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 7020&hyph;02&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00128 </DOCNO>
<PARENT> FR940817-2-00075 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>INTERSTATE COMMERCE COMMISSION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Finance Docket No. 32478] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Joel T. Williams, III, Roy C. Coffee, Jr., Rafael Fernandez-MacGregor, and Bristol Investment Co., Inc._Continuance
in Control Exemption_Cen-Tex Rail Link, Ltd. and South Orient Railroad Company, Ltd. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commission, under 49 U.S.C. 10505, exempts from the prior approval requirements of 49 U.S.C. 11343, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
et seq., 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
the continuance in control by Joel T. Williams, III, Roy C. Coffee, Jr., Rafael Fernandez-MacGregor, and Bristol
Investment Co., Inc., of Cen-Tex Rail Link, Ltd. and South Orient Railroad Company, Ltd., upon Cen-Tex becoming a
carrier through its acquisition from The Atchison, Topeka and Santa Fe Railway Company of certain rail lines between
Fort Worth and Ricker TX, and between Cresson and Cleburne, TX, and certain incidental overhead trackage rights.

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Cen-Tex Rail Link, Ltd._Acquisition and Operation Exemption_Certain Lines of The Atchison, Topeka, and Santa Fe
Railway Company,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Finance Docket No. 32507 (ICC served June 10, 1994). The exemption is granted subject to standard labor protective
conditions. 
<!-- PJG 0012 frnewline -->
Any comments must be filed with the Commission and served on: Robert H. Wheeler, Oppenheimer Wolff &amp; Donnelly,
1020 19th St., NW., Suite 400, Washington, DC 20036. This exemption is effective on September 16, 1994. Petitions
to stay must be filed by August 29, 1994. Petitions to reopen must be filed by September 6, 1994. For further information,
contact Joseph H. Dettmar, (202) 927&hyph;5660. 
<!-- PJG 0012 frnewline -->
Additional information is contained in the Commission's decision. To purchase a copy of the full decision, write,
call, or pick up in person from: Dynamic Concepts, Inc., Room 2229, Interstate Commerce Commission Building, Washington,
DC 20423. Telephone: (202) 289&hyph;4357/4359. [Assistance for the hearing impaired is available through TDD service
(202) 927&hyph;5721.]
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Decided: August 5, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
By the Commission, Chairman McDonald, Vice Chairman Phillips, and Commissioners Simmons and Morgan. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Vernon A. Williams,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20164 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 7035&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00129 </DOCNO>
<PARENT> FR940817-2-00076 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF JUSTICE</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Information Collections Under Review</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Office of Management and Budget (OMB) has been sent the following collection(s) of information proposals for
review under the provisions of the Paperwork Reduction Act (44 USC Chapter 35) and the Paperwork Reduction Reauthorization
Act since the last list was published. Entries are grouped into submission categories, with each entry containing
the following information:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
(1) the title of the form/collection;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) the agency form number, if any, and the applicable component of the Department sponsoring the collection;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) how often the form must be filled out or the information is collected;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(4) who will be asked or required to respond, as well as a brief abstract;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(5) an estimate of the total number of respondents and the amount of time estimated for an average respondent to respond;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(6) an estimate of the total public burden (in hours) associated with the collection; and,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(7) an indication as to whether Section 3504(h) of Public Law 96&hyph;511 applies. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated
public burden and associated response time, should be directed to the OMB reviewer, Mr. Jeff Hill on (202) 395&hyph;7340
and to the Department of Justice's Clearance Officer, Mr. Robert B. Briggs, on (202) 514&hyph;4319. If you anticipate
commenting on a form/collection, but find that time to prepare such comments will prevent you from prompt submission,
you should notify the 20MB reviewer and the Department of Justice Clearance Officer of your intent as soon as possible.
Written comments regarding the burden estimate or any other aspect of the collection may be submitted to Office of
Information and Regulatory Affairs, Office of Management and Budget, Washington, DC 20503, and to Mr. Robert B. Briggs,
Department of Justice Clearance Officer, Systems Policy Staff/Information Resources Management/Justice Management
Division Suite 850, WCTR, Washington, DC 20530. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Extension of the expiration date of a currently approved collection without any change in the substance or in the method
of collection. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
(1) Application for Waiver of Passport 
<!-- PJG 0034 unknown -->
and/or Visa I&hyph;193.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) Form I&hyph;193. Immigration and Naturalization Service. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) On Occasion.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(4) Individuals or households. This information is needed to determine whether applicant is eligible for entry into
the U.S. under Section 211.1(B)(3)_Waiver of Visas and Section 212.1(g)_Unforeseen Emergency of the 8 CFR. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(5) 25,000 annual respondents at .166 hours per response. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(6) 4,150 annual burden hours. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(7) Not applicable under Section 3504(h) of Public Law 96&hyph;511.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Public comment on this item is encouraged. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: April 11, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Robert B. Briggs,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Department Clearance Officer, United States Department of Justice.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20089 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4410&hyph;10&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00130 </DOCNO>
<PARENT> FR940817-2-00077 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Information Collections Under Review</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Office of Management and Budget (OMB) has been sent the following collection(s) of information proposals for
review under the provisions of the Paperwork Reduction Act (44 USC Chapter 35) and the Paperwork Reduction Reauthorization
Act since the last list was published. Entries are grouped into submission categories, with each entry containing
the following information:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
(1) the title of the form/collection;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) the agency form number, if any, and the applicable component of the Department sponsoring the collection;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) how often the form must be filled out or the information is collected;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(4) who will be asked or required to respond, as well as a brief abstract;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(5) an estimate of the total number of respondents and the amount of time estimated for an average respondent to respond;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(6) an estimate of the total public burden (in hours) associated with the collection; and,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(7) an indication as to whether Section 3504(h) of Public Law 96&hyph;511 applies.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated
public burden and associated response time, should be directed to the OMB reviewer, Mr. Jeff Hill on (202) 395&hyph;7340
AND to the Department of Justice's Clearance Officer, Mr. Robert B. Briggs, on (202) 514&hyph;4319. If you anticipate
commenting on a form/collection, but find that time to prepare such comments will prevent you from prompt submission,
you should notify the OMB reviewer AND the Department of Justice Clearance Officer of your intent as soon as possible.
Written comments regarding the burden estimate or any other aspect of the collection may be submitted to Office of
Information and Regulatory Affairs, Office of Management and Budget, Washington, DC 20503, AND to Mr. Robert B. Briggs,
Department of Justice Clearance Officer, Systems Policy Staff/Information Resources Management/Justice Management
Division Suite 850, WCTR, Washington, DC 20530.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Extension of the expiration date of a currently approved collection without any change in the substance or in the method
of collection.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) Arrival Information (Form N&hyph;14A)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) Form N&hyph;14A. Immigration and Naturalization Service.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) On Occasion.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(4) Individuals or households. Used by the Immigration and Naturalization Service to identify arrival records of
aliens applying for benefits. Needed primarily to identify arrival information for arrivals prior to 1924.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(5) 1,000 annual respondents at .250 hours per response.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(6) 250 annual burden hours.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(7) Not applicable under Section 3504(h) of Public Law 96&hyph;511.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Public comment on this item is encouraged.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Dated: August 11, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=3 -->
Robert B. Briggs,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=3 -->
Department Clearance Officer, United States Department of Justice.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=3 -->
[FR Doc. 94&hyph;20090 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=3 -->
BILLING CODE 4410&hyph;10&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00131 </DOCNO>
<PARENT> FR940817-2-00078 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=3 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=3 -->

<USBUREAU>Drug Enforcement Administration</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=3 -->

<DOCTITLE>Anthony L. Cappelli, M.D.; Revocation of Registration</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
On April 25, 1994, the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration
(DEA), issued an Order to Show Cause to Anthony L. Cappelli, M.D. (Respondent), of Los Angeles, California, proposing
to revoke Respondent's DEA Certificate of Registration, BC2901230, as a practitioner. The Order to Show Cause alleged
that Respondent's registration would be inconsistent with the public interest as that term is used in 21 U.S.C. 823(f).
Specifically, the Order to Show Cause alleged that between January 1992 and February 1993, Respondent allowed an
unauthorized person to order controlled substances by permitting this person to use Respondent's DEA number; this
person also used Respondent's DEA number to issue unauthorized prescriptions during this time period in question;
this person used the controlled substances obtained in this manner to perform unlawful abortions, one of which resulted
in the death of one of the patients; and Respondent dispensed controlled substances at an unregistered location during
the time period in question.
<!-- PJG 0012 frnewline -->
The Order to Show Cause was sent to Respondent by registered mail. More than thirty days have passed since the Order
to Show Cause was received by Respondent and the DEA has received no response thereto. Pursuant to 21 CFR 1301.54(d)
and 1301.54(e), Respondent is deemed to have waived his opportunity for a hearing. Accordingly, the Deputy Administrator
now enters his final order in this matter without a hearing and based upon the investigative file. 21 CFR 1301.57.
<!-- PJG 0012 frnewline -->
In January of 1993, the Santa Ana Police Department discovered the body of a female in an alley, at or near a medical clinic,
the Clinica Femenina (clinic). Subsequent investigation revealed that the death of the female was caused by a failed
abortion attempt performed at the clinic by the owner who was not authorized to practice medicine (and thus not licensed
to perform abortions) in the State of California. An autopsy revealed that diazepam, a Schedule IV controlled substance,
was in the deceased's system.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A search warrant was served on the clinic by the Santa Ana Police Department on January 21, 1993. The search revealed
that the owner had ordered over 8,000 dosage units of controlled substances using Respondent's DEA number. The search
also revealed that the owner issued prescriptions for various controlled substances using Respondent's DEA number.
The clinic was not Respondent's DEA registered location and, in fact, did not have a DEA registration. The owner was
subsequently arrested by the Santa Ana police and charged with manslaughter and the matter is pending trial at this
time.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Shortly after the search warrant was served, Respondent was interviewed by the Santa Ana police and an investigator
of the California Medical Board. Respondent admitted to them that he allowed the clinic to use his DEA registration
number to order controlled substances to obtain drugs used in conjunction with abortions. Respondent explained
that he was hired to perform abortions on an as needed basis and was paid $80 for each abortion. He performed an abortion
about once a week or every other week. He was aware that the owner was not a licensed physician. He was not aware that the
owner had issued controlled substance prescriptions using his DEA number. Respondent also noted that there were
occasions that the owner called him to perform an abortion on short notice but that Respondent was unable to make the
appointment. When Respondent inquired of the owner how the operation had been performed, she simply explained that
the patient ``had been taken care of''. Respondent also explained that the owner had witnessed him perform abortions
on numerous occasions and that she could probably perform the operation, barring any unforeseen complications.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In evaluating whether Respondent's registration by the Drug Enforcement Administration would be inconsistent
with the public interest, the Deputy Administrator considers the factors enumerated in 21 U.S.C. 823(f). They are
as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) The recommendation of the appropriate State licensing board or professional disciplinary authority.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) The applicant's experience in dispensing, or conducting research with respect to controlled substances.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00132 </DOCNO>
<PARENT> FR940817-2-00078 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=3 -->
(3) The applicant's conviction record under Federal or State laws relating to the manufacture, distribution, or
dispensing of controlled substances. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(4) Compliance with applicable State, Federal, or local laws relating to controlled substances. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(5) Such other conduct which may threaten the public health and safety. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In determining whether a registration would be inconsistent with the public interest, the Deputy Administrator
is not required to make findings with respect to each of the factors listed above. Instead, he has the discretion to
give each factor the weight he deems appropriate, depending upon the facts and circumstances of each case. See David
E. Trawick, D.D.S., 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Docket No. 88&hyph;69, 53 FR 5326 (1988). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In this proceeding factors, two, four and five apply. Respondent allowed an unauthorized person to use his DEA number
to order controlled substances for dispensing and administering controlled substances at an unregistered location.
Respondent allowed the clinic's owner to acquire and dispense controlled substances through the use of Respondent's
DEA registration number. Under the circumstances, Respondent knew or should have known that the clinic's owner would
use his DEA number, not only for ordering, dispensing and issuing prescriptions for controlled substances, but also
for administering during unauthorized abortions. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
By allowing an unregistered and unauthorized person to use his DEA number, Respondent was responsible for any use
and misuse of that number. Moreover, such a violation is aggravated by the fact that Respondent allowed a non-practitioner
to use his DEA number at an unregistered location. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Accordingly, the Deputy Administrator of the Drug Enforcement Administration, pursuant to the authority vested
in him by 21 U.S.C. 823 and 824 and 28 CFR 0.100(b) and 0.104 (59 FR 23637), hereby orders that DEA Certificate of Registration,
BC2901230, previously issued to Anthony L. Cappelli, M.D., be, and it hereby is, revoked, and any pending applications
for the renewal of such registration, be, and they are, denied. This order is effective September 16, 1994. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: August 11, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Stephen H. Greene, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Administrator.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20178 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4410&hyph;09&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00133 </DOCNO>
<PARENT> FR940817-2-00079 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF LABOR</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Office of the Secretary</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Glass Ceiling Commission; Open Site Hearing
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Pursuant to Title II of the Civil Rights Act of 1991 (Pub. L. 102&hyph;166) and section 9 of the Federal Advisory Committee
(FACA) (Pub. L. 92&hyph;462), 5 U.S.C. app. II) a Notice of establishment of the Glass Ceiling Commission was published
the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 on March 30, 1992 (57 FR 10776). Pursuant to section 10(a) of FACA, this is to announce a public hearing of the Commission
which is to take place on Monday, September 26, 1994. The purpose of the Commission is to, among other things, focus
greater attention on the importance of eliminating artificial barriers to the advancement of minorities and women
to management and decisionmaking positions in business. The Commission has the practical task of: (a) Conducting
basic research into practices, policies, and manner in which management and decisionmaking positions in business
are filled; (b) conducting comparative research of businesses and industries in which minorities and women are promoted
or are not promoted to management and decisionmaking positions; and (c) recommending measures designed to enhance
opportunities for and the elimination or artificial barriers to the advancement of minorities and women to management
and decisionmaking positions.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
TIME AND PLACE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The hearing will be held on Monday, September 26, 1994 from 9:00 a.m. until 5:00 p.m. at the Association of The Bar of
The City Of New York, 42 West 44th Street, New York, NY 10036.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
AGENDA: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The agenda for the hearing is as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
9:00 a.m._Opening Remarks By Secretary Reich
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
9:15_Welcoming Remarks by Elected Officials
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
9:30&hyph;12:30_Testimony
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12:30&hyph;1:30_Lunch break
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1:30&hyph;5:00_Testimony
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
5:00 p.m._Hearing Adjourns
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
PUBLIC PARTICIPATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The hearing will be open to the public. Seating will be available on a first-come, first-serve basis. Seats will be
reserved for the media. Disabled individuals should contact the Commission no later than Monday, September 12, 1994,
if special accommodations are needed. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Individuals or organizations wishing to testify orally must provide written testimony in advance of the hearing.
Oral comments are limited to 10 minutes, written testimony may be longer. Send twenty-five (25) copies of testimony,
postmarked on or before Monday, September 12, 1994, to: Ms. Ren&eacute; Redwood, Executive Director, Glass Ceiling
Commission, U.S. Department of Labor, 200 Constitution Avenue, N.W., Room C&hyph;2313, Washington, D.C. 20210.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The written testimony must contain the following information:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) The name, address, and telephone number of each person to appear;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) The capacity in which the person will appear;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) The issues that will be addressed.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
This information is needed to properly develop a hearing schedule. As many people as time allows will be permitted
to testify.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
ISSUES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Testimony should highlight successful initiatives and/or recommendations for addressing the areas discussed
below. The Commission is especially interested in hearing about procedures, practices and systems that have been
put in place to make sure that goals are achieved in work force diversity.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Recruitment
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
: What systems are in place to ensure that external recruiting for decisionmaking positions will produce a pool of
applicants which includes minorities and women? Similarly, does the process for considering promotion of current
employees to decisionmaking positions ensure consideration of minorities and women?
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Developmental practices and credential building experiences
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
: How are minorities and women ensured that they will be given the kinds of experiences that will make them competitive
for decisionmaking position? Include management training, mentoring, job rotation, education, assignments to
corporate committees and task forces, special projects, relocation, etc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Compensation and appraisal systems
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
: How is the total compensation package including bonuses, stock options and other incentives evaluated for fairness
for minorities and women? Do executive management and supervisory compensation systems depend upon or reward managers'
achieving work force diversity goals, and, if so, how does that work? Is the appraisal system and or performance rating
system protected from subjective decisions which impact advancement?
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Testimony on successful initiatives may include discussion of the elements above and how other factors are combined
to create a complete initiative resulting in the advancement of minorities and women.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A videotape may be made of the hearing. A transcript of the hearing will be made.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Materials submitted at this hearing should not have been submitted at any previous Glass Ceiling Commission hearings.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Those individuals or organizations wishing to submit written statements, but not testify orally, should send twenty-five
(25) copies to Ms. Ren&eacute; Redwood, Executive Director, Glass Ceiling Commission, U.S. Department of Labor,
200 Constitution Avenue, N.W., Room C&hyph;2113, Washington, D.C. 20210. Written statements should be postmarked
on or before Monday, September 12, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Ms. Ren&eacute; Redwood, Executive Director, Glass Ceiling Commission, U.S. Department of Labor, 200 Constitution
Avenue, N.W., Room C&hyph;2113, Washington, D.C. 20210, (202) 219&hyph;7342.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Signed at Washington, D.C. this 12th day of August, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Robert B. Reich,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary of Labor.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20195 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4510&hyph;23&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00134 </DOCNO>
<PARENT> FR940817-2-00080 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Pension and Welfare Benefits Administration</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Application No. D&hyph;9240, et al.] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Proposed Exemptions; The Bank of California 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Pension and Welfare Benefits Administration, Labor.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of Proposed Exemptions. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This document contains notices of pendency before the Department of Labor (the Department) of proposed exemptions
from certain of the prohibited transaction restriction of the Employee Retirement Income Security Act of 1974 (the
Act) and/or the Internal Revenue Code of 1986 (the Code). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Written Comments and Hearing Requests 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Unless otherwise stated in the Notice of Proposed Exemption, all interested persons are invited to submit written
comments, and with respect to exemptions involving the fiduciary prohibitions of section 406(b) of the Act, requests
for hearing within 45 days from the date of publication of this 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Notice. Comments and request for a hearing should state: (1) the name, address, and telephone number of the person
making the comment or request, and (2) the nature of the person's interest in the exemption and the manner in which the
person would be adversely affected by the exemption. A request for a hearing must also state the issues to be addressed
and include a general description of the evidence to be presented at the 
<!-- PJG 0012 frnewline -->
hearing. A request for a hearing must also state the issues to be addressed and include a general description of the
evidence to be presented at the hearing. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 All written comments and request for a hearing (at least three copies) should be sent to the Pension and Welfare Benefits
Administration, Office of Exemption Determinations, Room N&hyph;5649, U.S. Department of Labor, 200 Constitution
Avenue, N.W., Washington, D.C. 20210. Attention: Application No. 
<!-- PJG 0012 frnewline -->
stated in each Notice of Proposed Exemption. The applications for exemption and the comments received will be available
for public inspection in the Public Documents Room of Pension and Welfare Benefits Administration, U.S. Department
of Labor, Room N&hyph;5507, 200 Constitution Avenue, N.W., Washington, D.C. 20210. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Notice to Interested Persons 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Notice of the proposed exemptions will be provided to all interested persons in the manner agreed upon by the applicant
and the Department within 15 days of the date of publication in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. Such notice shall include a copy of the notice of proposed exemption as published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and shall inform interested persons of their right to comment and to request a hearing (where appropriate). 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The proposed exemptions were requested in applications filed pursuant to section 408(a) of the Act and/or section
4975(c)(2) of the Code, and in accordance with procedures set forth in 29 CFR Part 2570, Subpart B (55 FR 32836, 32847,
August 10, 1990). Effective December 31, 1978, section 102 of Reorganization Plan No. 4 of 1978 (43 FR 47713, 
<!-- PJG 0012 frnewline -->
October 17, 1978) transferred the authority of the Secretary of the Treasury to issue exemptions of the type requested
to the Secretary of Labor. Therefore, these notices of proposed exemption are issued solely by the Department. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The applications contain representations with regard to the proposed exemptions which are summarized below. Interested
persons are referred to the applications on file with the Department for a complete statement of the facts and representations.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00135 </DOCNO>
<PARENT> FR940817-2-00080 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=85 g=1 f=1 -->
The Bank of California, N.A., Located in San Francisco, California; Proposed Exemption 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Application No. D&hyph;9240] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Based on the facts and representations set forth in the application, the Department is considering granting an exemption
under the authority of section 408(a) of the Act and section 4975(c)(2) of the Code and in accordance with the procedures
set forth in 29 C.F.R. Part 2570, Subpart B (55 FR 32836, 32847, August 10, 1990).
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
1 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
For purposes of this exemption reference to specific provisions of title I of the Act, unless otherwise specified,
refer also to the corresponding provisions of the Code. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=85 g=1 f=1 -->
Section I_Exemption for In-Kind Transfer of Assets 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
If the exemption is granted the restrictions of section 406(a) and section 406(b) of the Act and the sanctions resulting
from the application of section 4975 of the Code by reason of section 4975(c)(1)(A) through (F) shall not apply, effective
November 12, 1993, to the in-kind transfer to any diversified open-end investment company (the Fund or Funds) registered
under the Investment Company Act of 1940 to which the Bank of California, N.A. or any of its affiliates (collectively,
the Bank) serves as investment adviser and may provide other services of the assets of various employee benefit plans
(the Plan or Plans) that are either held in certain collective investment funds (the CIF or CIFs) maintained by the
Bank or otherwise held by the Bank as trustee, investment manager, or in any other capacity as fiduciary on behalf of
the Plans, in exchange for shares of such Funds; provided that the following conditions are met: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(a) A fiduciary (the Second Fiduciary) who is acting on behalf of each affected Plan and who is independent of and unrelated
to the Bank, as defined in paragraph (g) of section III below, receives advance written notice of the in-kind transfer
of assets of the Plans or the CIFs in exchange for shares of the Fund and the disclosures described in paragraph (g) of
section II below; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) On the basis of the information described in paragraph (g) of section II below, the Second Fiduciary authorizes
in writing the in-kind transfer of assets of the Plans in exchange for shares of the Funds, the investment of such assets
in corresponding portfolios of the Funds, and the fees received by the Bank in connection with its services to the Fund.
Such authorization by the Second Fiduciary to be consistent with the responsibilities, obligations, and duties
imposed on fiduciaries by Part 4 of Title I of the Act; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(c) No sales commissions are paid by the Plans in connection with the in-kind transfers of asset of the Plans or the CIFs
in exchange for shares of the Funds; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(d) All or a 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
pro rata 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
portion of the assets of the Plans held in the CIFs or all or a 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
pro rata 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
portion of the assets of the Plans held by the Bank in any capacities as fiduciary on behalf of such Plans are transferred
in-kind to the Funds in exchange for shares of such Funds, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(e) The Plans or the CIFs receive shares of the Funds that are equal in value to the assets of the Plans or the CIFs exchanged
for such shares; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(f) The value of the assets of the Plans or the CIFs to be transferred in-kind and the net asset value of the Funds receiving
those assets in exchange for shares is determined in a single valuation performed in the same manner and at the close
of business on the same day, in accordance with the procedures set forth in Rule 17a&hyph;7(b) (Rule 17a&hyph;7) under
the Investment Company Act of 1940, as amended from time to time or any successor rule, regulation, or similar pronouncement;

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(g) Not later than thirty (30) days after completion of each in-kind transfer of assets of the Plans or the CIFs in exchange
for shares of the Funds, the Bank sends by regular mail to the Second Fiduciary, who is acting on behalf of each affected
Plan and who is independent of and unrelated to the Bank, as defined in paragraph (g) of section III below, a written
confirmation that contains the following information: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) the identity of each of the assets that was valued for purposes of the transaction in accordance with Rule 17a&hyph;7(b)(4)
under the Investment Company Act of 1940; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00136 </DOCNO>
<PARENT> FR940817-2-00080 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(2) the price of each of the assets involved in the transaction; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) the identity of each pricing service or market maker consulted in determining the value of such assets; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(h) For all conversion transactions that occur after the date of this proposed exemption, the Bank, no later than ninety
(90) days after completion of each in-kind transfer of assets of the Plans or the CIFs in exchange for shares of the Funds,
will send by regular mail to the Second Fiduciary, who is acting on behalf of each affected Plan and who is independent
of and unrelated to the Bank, as defined in paragraph (g) of section III below, a written confirmation that contains
the following information: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) the number of CIF units held by each affected Plan immediately before the conversion (and the related per unit value
or the aggregate dollar value of the units transferred); and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) the number of shares in the Funds that are held by each affected Plan following the conversion (and the related per
share net asset value or the aggregate dollar value of the shares received). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(i) The conditions set forth in paragraphs (d), (e), (f), (o), (p), (q) and (r) of section II below are satisfied; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Section II_Exemption for Receipt of Fees From Funds 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
If the exemption is granted, effective November 12, 1993, the restrictions of section 406(a) and section 406(b) of
the Act and the sanctions resulting from the application of section 4975 of the Code, by reason of section 4975(c)(1)(D)
through (F) of the Code shall not apply to the receipt of fees by the Bank from the Funds for acting as the investment adviser,
custodian, sub-administrator, and other service provider for the Funds in connection with the investment in the
Funds by the Plans for which the Bank acts as a fiduciary provided that: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(a) No sales commissions are paid by the Plans in connection with purchases or sales of shares of the Funds and no redemption
fees are paid in connection with the sale of such shares by the Plans to the Funds; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) The price paid or received by the Plans for shares in the Funds is the net asset value per share, as defined in paragraph
(e) of section III, at the time of the transaction and is the same price which would have been paid or received for the
shares by any other investor at that time; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(c) The Bank, its affiliates, and officers or directors have not and will not purchase from or sell to any of the Plans
shares of any of the Funds; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(d) The combined total of all fees received by the Bank for the provision of services to the Plans, and in connection
with the provision of services to any of the Funds in which the Plans may invest, are not in excess of ``reasonable compensation''
within the meaning of section 408(b)(2) of the Act; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(e) The Bank does not receive any fees payable, pursuant to Rule 12b&hyph;1 under the Investment Company Act of 1940
(the 12b&hyph;1 Fees) in connection with the transactions; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(f) The Plans are not sponsored by the Bank; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(g) A Second Fiduciary who is acting on behalf of a Plan and who is independent of and unrelated to the Bank, as defined
in paragraph (g) of section III below, receives in advance of the investment by a Plan in any of the Funds a full and detailed
written disclosure of information concerning such Fund including, but not limited to: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) a current prospectus for each portfolio of each of the Funds in which such Plan is considering investing, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) a statement describing the fees for investment management, investment advisory, or other similar services,
any fees for secondary services (Secondary Services), as defined in paragraph (h) of section III below, and all other
fees to be charged to or paid by the Plan and by such Funds to the Bank, including the nature and extent of any differential
between the rates of such fees, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) the reasons why the Bank may consider such investment to be appropriate for the Plan, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(4) a statement describing whether there are any limitations applicable to the Bank with respect to which assets of
a Plan may be invested in the Funds, and, if so, the nature of such limitations; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(5) upon request of the Second Fiduciary, a copy of the proposed exemption and/or a copy of the final exemption, if granted.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(h) On the basis of the information described in paragraph (g) of this section II, the Second Fiduciary authorizes
in writing: (1) the investment of assets of the Plans in shares of the Fund, in connection with the transaction set forth
in section II; (2) the investment portfolios of the Funds in which the assets of the Plans may be invested; and (3) the
fees received by the Bank in connection with its services to the Funds; such authorization by the Second Fiduciary
to be consistent with the responsibilities obligations, and duties imposed on fiduciaries by Part 4 of Title I of the
Act; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(i) The authorization, described in paragraph (h) of this section II, is terminable at will by the Second Fiduciary
of a Plan, without penalty to such Plan. Such termination will be effected by the Bank selling the shares of the Fund
held by the affected Plan within one business day following receipt by the Bank, either by mail, hand delivery, facsimile,
or other available means at the option of the Second Fiduciary, of the termination form (the Termination Form), as
defined in paragraph (i) of section III below, or any other written notice of termination; provided that if, due to
circumstances beyond the control of the Bank, the sale cannot be executed within one business day, the Bank shall have
one additional business day to complete such sale; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00137 </DOCNO>
<PARENT> FR940817-2-00080 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(j) Plans do not pay any plan-level investment management fees, investment advisory fees, or similar fees to the Bank
with respect to any of the assets of such Plans which are invested in shares of any of the Funds. This condition does not
preclude the payment of investment advisory fees or similar fees by the Funds to the Bank under the terms of an investment
advisory agreement adopted in accordance with section 15 of the Investment Company Act of 1940 or other agreement
between the Bank and the Funds; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(k) In the event of an increase in the rate of any fees paid by the Funds to the Bank regarding any investment management
services, investment advisory services, or fees for similar services that the Bank provides to the Funds over an existing
rate for such services that had been authorized by a Second Fiduciary, in accordance with paragraph (h) of this section
II, the Bank will, at least thirty (30) days in advance of the implementation of such increase, provide a written notice
(which may take the form of a proxy statement, letter, or similar communication that is separate from the prospectus
of the Fund and which explains the nature and amount of the increase in fees) to the Second Fiduciary of each of the Plans
invested in a Fund which is increasing such fees. Such notice shall be accompanied by the Termination Form, as defined
in paragraph (i) of section III below; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(l) In the event of an addition of a Secondary Service, as defined in paragraph (h) of section III below, provided by
the Bank to the Fund for which a fee is charged or an increase in the rate of any fee paid by the Funds to the Bank for any Secondary
Service, as defined in paragraph (h) of section III below, that results either from an increase in the rate of such fee
or from the decrease in the number or kind of services performed by the Bank for such fee over an existing rate for such
Secondary Service which had been authorized by the Second Fiduciary of a Plan, in accordance with paragraph (h) of
this section II, the Bank will at least thirty (30) days in advance of the implementation of such additional service
for which a fee is charged or fee increase, provide a written notice (which may take the form of a proxy statement, letter,
or similar communication that is separate from the prospectus of the Fund and which explains the nature and amount
of the additional service for which a fee is charged or the nature and amount of the increase in fees) to the Second Fiduciary
of each of the Plans invested in a Fund which is adding a service or increasing fees. Such notice shall be accompanied
by the Termination Form, as defined in paragraph (i) of section III below. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(m) The Second Fiduciary is supplied with a Termination Form at the times specified in paragraphs (k), (l), and (n)
of this section II, which expressly provides an election to terminate the authorization, described above in paragraph
(h) of this section II, with instructions regarding the use of such Termination Form including statements that: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) the authorization is terminable at will by any of the Plans, without penalty to such Plans. Such termination will
be effected by the Bank selling the shares of the Fund held by the Plans requesting termination within one business
day following receipt by the Bank, either by mail, hand delivery, facsimile, or other available means at the option
of the Second Fiduciary, of the Termination Form or any other written notice of termination; provided that if, due
to circumstances beyond the control of the Bank, the sale of shares of such Plans cannot be executed within one business
day, the Bank shall have one additional business day to complete such sale; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) failure by the Second Fiduciary to return the Termination Form on behalf of a Plan will be deemed to be an approval
of the additional Secondary Service for which a fee is charged or increase in the rate of any fees, if such Termination
Form is supplied pursuant to paragraphs (k) and (l) of this section II, and will result in the continuation of the authorization,
as described in paragraph (h) of this section II, of the Bank to engage in the transactions on behalf of such Plan; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(n) The Second Fiduciary is supplied with a Termination Form, annually during the first quarter of each calendar year,
beginning with the first quarter of the calendar year that begins after the date the grant of this proposed exemption
is published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and continuing for each calendar year thereafter; provided that the Termination Form need not be supplied to the Second
Fiduciary, pursuant to paragraph (n) of this section II, sooner than six months after such Termination Form is supplied
pursuant to paragraphs (k) and (l) of this section II, except to the extent required by said paragraphs (k) and (l) of
this section II to disclose an additional Secondary Service for which a fee is charged or an increase in fees; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(o)(1) With respect to each of the Funds in which a Plan invests, the Bank will provide the Second Fiduciary of such Plan:

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(A) at least annually with a copy of an updated prospectus of such Fund; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(B) upon the request of such Second Fiduciary, with a report or statement (which may take the form of the most recent
financial report, the current statement of additional information, or some other written statement) which contains
a description of all fees paid by the Fund to the Bank; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) With respect to each of the Funds in which a Plan invests, in the event such Fund places brokerage transactions with
the Bank, the Bank will provide the Second Fiduciary of such Plan at least annually with a statement specifying: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(A) the total, expressed in dollars, brokerage commissions of each Fund's investment portfolio that are paid to the
Bank by such Fund; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(B) the total, expressed in dollars, of brokerage commissions of each Fund's investment portfolio that are paid by
such Fund to brokerage firms unrelated to the Bank; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(C) the average brokerage commissions per share, expressed as cents per share, paid to the Bank by each portfolio of
a Fund; and 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00138 </DOCNO>
<PARENT> FR940817-2-00080 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(D) the average brokerage commissions per share, expressed as cents per share, paid by each portfolio of a Fund to brokerage
firms unrelated to the Bank; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(p) All dealings between the Plans and any of the Funds are on a basis no less favorable to such Plans than dealings between
the Funds and other shareholders holding the same class of shares as the Plans; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(q) The Bank maintains for a period of six (6) years the records necessary to enable the persons, as described in paragraph
(r) of section II below, to determine whether the conditions of this proposed exemption have been met, except that:

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) a prohibited transaction will not be considered to have occurred if, due to circumstances beyond the control of
the Bank, the records are lost or destroyed prior to the end of the six (6) year period, and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) no party in interest, other than the Bank, shall be subject to the civil penalty that may be assessed under section
502(i) of the Act, or to the taxes imposed by section 4975 (a) and (b) of the Code, if the records are not maintained, or
are not available for examination as required by paragraph (r) of section II below; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(r)(1) Except as provided in paragraph (r)(2) of this section II and notwithstanding any provisions of subsection
(a)(2) and (b) of section 504 of the Act, the records referred to in paragraph (q) of section II above are unconditionally
available at their customary location for examination during normal business hours by_
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(i) Any duly authorized employee or representative of the Department or the Internal Revenue Service; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(ii) Any fiduciary of each of the Plans who has authority to acquire or dispose of shares of any of the Funds owned by such
a Plan, or any duly authorized employee or representative of such fiduciary; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(iii) Any participant or beneficiary of the Plans or duly authorized employee or representative of such participant
or beneficiary; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) None of the persons described in paragraph (r)(1)(ii) and (r)(1)(iii) of section II shall be authorized to examine
trade secrets of the Bank, or commercial or financial information which is privileged or confidential. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Section III_Definitions 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
For purposes of this proposed exemption, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(a) The term ``Bank'' means The Bank of California, N.A. and any affiliate of the Bank, as defined in paragraph (b) of
this section III. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) An ``affiliate'' of a person includes: 
<!-- PJG 0012 frnewline -->
(1) Any person directly or indirectly through one or more intermediaries, controlling, controlled by, or under common
control with the person; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00139 </DOCNO>
<PARENT> FR940817-2-00080 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(2) any officer, director, employee, relative, or partner in any such person; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) Any corporation or partnership of which such person is an officer, director, partner, or employee. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(c) The term ``control'' means the power to exercise a controlling influence over the management or policies of a person
other than an individual; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(d) The term ``Fund or Funds'' means any diversified open-end investment company or companies registered under the
Investment Company Act of 1940 for which the Bank serves as investment adviser, and may also provide custodial or other
services as approved by such Funds; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(e) The term, ``net asset value'' means the amount for purposes of pricing all purchases and sales calculated by dividing
the value of all securities, determined by a method as set forth in a Fund's prospectus and statement of additional
information, and other assets belonging to each of the portfolios in such Fund, less the liabilities charged to each
portfolio, by the number of outstanding shares. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(f) The term, ``relative,'' means a ``relative'' as that term is defined in section 3(15) of the Act (or a ``member of
the family'' as that term is defined in section 4975(e)(6) of the Code), or a brother, a sister, or a spouse of a brother
or a sister. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(g) The term, ``Second Fiduciary,'' means a fiduciary of a plan who is independent of and unrelated to the Bank. For
purposes of this exemption, the Second Fiduciary will not be deemed to be independent of and unrelated to the Bank if:

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) Such Second Fiduciary directly or indirectly controls, is controlled by, or is under common control with the Bank;

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) Such Second Fiduciary, or any officer, director, partner, employee, or relative of such Second Fiduciary is an
officer, director, partner, or employee of the Bank (or is a relative of such persons); 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) Such Second Fiduciary directly or indirectly receives any compensation or other consideration for his or her
own personal account in connection with any transaction described in this proposed exemption. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
If an officer, director, partner, or employee of the Bank (or a relative of such persons), is a director of such Second
Fiduciary, and if he or she abstains from participation in (i) the choice of the Plan's investment manager/advisor,
(ii) the approval of any purchase or sale by the Plan of shares of the Funds, and (iii) the approval of any change of fees
charged to or paid by the Plan, in connection with any of the transactions described in sections I and II above, then
paragraph (g)(2) of section III above, shall not apply. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(h) The term, ``Secondary Service,'' means a service, other than an investment management, investment advisory,
or similar service, which is provided by the Bank to the Funds, including but not limited to custodial, accounting,
brokerage, administrative, or any other service. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(i) The term, ``Termination Form,'' means the form supplied to the Second Fiduciary, at the times specified in paragraphs
(k), (l), and (n) of section II above, which expressly provides an election to the Second Fiduciary to terminate on
behalf of the Plans the authorization, described in paragraph (h) of section II. Such Termination Form may be used
at will by the Second Fiduciary to terminate such authorization without penalty to the Plans and to notify the Bank
in writing to effect such termination by selling the shares of the Fund held by the Plans requesting termination within
one business day following receipt by the Bank, either by mail, hand delivery, facsimile, or other available means
at the option of the Second Fiduciary, of written notice of such request for termination; provided that if, due to circumstances
beyond the control of the Bank, the sale cannot be executed within one business day, the Bank shall have one additional
business day to complete such sale. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 If the proposed exemption is granted, the exemption will be effective retroactively, as of November 12, 1993. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Summary of Facts and Representations 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. The Bank is a national banking association having its principal office at 400 California Street, San Francisco,
California. The Bank offers a wide range of banking services to its clients in California, Oregon, Washington, and
around the world. The Mitsubishi Bank Limited, a Japanese bank with principal offices in Tokyo, owns either directly
or indirectly through its wholly owned subsidiary, BanCal Tri-State Corporation, all of the outstanding stock of
the Bank. The Bank has total trust and non-trust assets of approximately $19.5 billion and $8.4 billion, respectively.
Merus Capital Management (MERUS), a division of the Bank, belongs to the Bank's Trust and Investment Management Group
which manages approximately $5.5 billion of the assets held in trust by the Bank. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</DATE>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00140 </DOCNO>
<PARENT> FR940817-2-00080 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. The Plans involved in the transactions for which the Bank requests exemptive relief are numerous Plans for which
the Bank has acted or will act as fiduciary and has exercised or will exercise investment discretion with respect to
all or a portion of the assets of such Plans.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 For this reason, certain specific information relating to each individual involved Plan does not appear in the application.
However, it is anticipated that the Plans include or will include various employee benefit plans, as defined by section
3(3) of the Act, and certain plans or trusts, as described in section 4975(e)(1) of the Code. These Plans are sponsored
or maintained by parties unrelated to the Bank.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Such Plans include, among others: (1) pension, profit sharing, stock bonus, and other retirement plans which are
qualified for tax purposes under section 401(a) of the Code, (2) voluntary employees' beneficiary associations
and other welfare benefit plans, and (3) individual retirement accounts and simplified employee pension plans,
as described in section 408 of the Code. The Bank serves as fiduciary to these Plans through the management of the CIFs
in which the Plans invest or through providing individual management or advice to the Plans. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
2
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The Department herein is not proposing relief for transactions afforded relief by Section 404(c) of the Act. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
3
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The Department, herein, is not proposing relief for transactions involving any plan sponsored by the Bank or its affiliates.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
It is represented that the Bank, as of October 23, 1992, had under management approximately $760 million in assets
from approximately 400 Plans. The Bank receives compensation for serving as fiduciary with respect to these Plans
in accordance with standard published fee schedules or as otherwise agreed upon by the Bank and the sponsors of such
Plans.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
4 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
4
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The Department expresses no opinion as to whether the provision of services by the Bank or its affiliates to the Plans
satisfies the requirements for statutory exemption, as set forth in section 408(b)(2) of the Act and 29 CFR 2550.408(b)(2)
of the Department's regulation. To the extent that such provision of services to the Plan by the Bank or its affiliates
does not satisfy the requirements of section 408(b)(2) of the Act, the Department, herein, is offering no relief.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
3. The Bank or its affiliates also provide services to numerous Funds. The Funds are open-end investment companies
registered under the Investment Company Act of 1940. Because the Bank would like the exemption to apply prospectively
to any Fund to which the Bank or any of its affiliates may provide services, the Bank represents that it cannot supply
detailed information on each such future Fund. However, the Bank has provided a detailed description with respect
to a certain Fund, the HighMark Group (HighMark), which is currently operating and to which it provides services.
The Bank represents that all future Funds will assume similar structures and Plan investments therein will be subject
to the terms and conditions of this exemption. The structure of HighMark is summarized in paragraph 4 below. To the
extent Plans for which the Bank serves as fiduciary are currently invested in HighMark, the Bank represents that such
investments were made in compliance with Prohibited Transaction Class Exemption 77&hyph;4 (PTCE 77&hyph;4).
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
5 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
5
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
PTCE 77&hyph;4 was granted April 8, 1977, at 42 FR 732 and was proposed November 16, 1976, at 41 FR 50516. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
4. HighMark, a Massachusetts business trust organized on March 10, 1987, is registered under the Investment Company
Act of 1940 as a diversified, open-end, management investment company. HighMark is governed by a board of trustees
(the HighMark Trustees), all of whom are independent of the Bank. MERUS, a division of the Bank, acts as investment
adviser to HighMark. In the context of registered investment companies, the term ``investment adviser'' generally
refers to the entity that has investment management authority with respect to the assets of the investment company.
In this regard, subject to the general supervision of the HighMark Trustees, MERUS manages each of the separate investment
portfolios within HighMark in accordance with the investment objectives, and policies of each portfolio, makes
decisions with respect to and places orders for all purchases and sales of securities, and maintains records with
respect thereto. In addition, the Bank serves as custodian, sub-administrator, sub-transfer agent, and sub-accountant
to HighMark. It is represented that the Bank may in the future seek to serve in additional capacities for and to provide
additional services to HighMark. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
HighMark consists of separate investment portfolios with combined total net assets of approximately $1 billion.
It is represented that currently there are eight (8) portfolios in HighMark. Three of these portfolios are invested
in money market instruments (the Money Market Portfolios), and three are invested primarily in non-money market
debt or equity securities (the Non-Money Market Portfolios). The remaining two portfolios of HighMark are the California
Tax-Free Fund, and the Tax-Free Fund.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
6 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In addition to these portfolios, HighMark is in the process of establishing two additional portfolios, the Balanced
Fund and the Growth Fund, and may establish other portfolios. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
6
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
It is represented that the Tax-Free Fund has been the subject of an inquiry by the Securities and Exchange Commission
(SEC) concerning a municipal bond backed by Mutual Benefit Life Insurance Company held in the Tax-Free Fund. In July
1991, when Mutual Benefit Life Insurance Company was seized by its regulator, the Bank was serving as accountant for
the Tax-Free Fund. It is represented that due to a clerical data entry error and the failure of an employee to follow
established procedures, the impact of the seizure on the value of the bond was not brought to the attention of the management
of the Bank until August 1991. At that time, the Bank represents that it informed the SEC, purchased the bond from the
Tax-Free Fund at par plus accrued interest, and informed shareholders by mailing to them a special prospectus, dated
September 5, 1991. As the situation was corrected promptly, the Bank believes that this should not affect the merits
of the application or the availability of the Tax-Free Fund for investment by the Plan, if deemed appropriate under
the circumstances as authorized by the Second 
<!-- PJG 0012 frnewline -->
Fibuciary, and if based on criteria set forth in section 404 of the Act.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In the future HighMark may modify, reorganize, or terminate any or all of its portfolios. All existing portfolios
and any portfolios established or modified in the future will be available for investment by the Plans, if deemed appropriate
under the circumstances, as authorized by the Second Fiduciary, and if based on criteria set forth in section 404 of
the Act. However, it is represented that the Bank does not expect the Plans ordinarily to be invested in tax-free funds.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00141 </DOCNO>
<PARENT> FR940817-2-00080 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Winsbury Company (Winsbury), located in Columbus, Ohio, serves as the general manager, administrator, and principal
underwriter of HighMark. For these administrative services, Winsbury receives fees computed daily at .20% of the
average net assets of each portfolio of HighMark. Winsbury also receives fees from HighMark for serving as the distributor
of shares in HighMark. Pursuant to a plan of distribution implemented only with respect to the Class A shares for the
Money Market Portfolios, HighMark pays out of the assets attributable to such shares monthly fees to Winsbury in accordance
with Rule 12b&hyph;1 of the Investment Company Act of 1940 (the 12b&hyph;1 Fees) equal to .25% of the average daily
net assets attributable to such shares.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
7
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 An affiliate of Winsbury, the Winsbury Service Corporation (Winsbury Service), is the transfer agent, accountant,
and shareholder servicing agent of HighMark. Winsbury and Winsbury Service are unrelated to the Bank. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
7
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
It is represented that the Plans currently are invested only in shares of HighMark that are not subject to 12b&hyph;1
Fees and that there is no present intention to change this arrangement. The Department notes that proposed relief
is limited to the transactions described herein, and no relief has been provided in connection with the payment of
distribution expenses, pursuant to Rule 12b&hyph;1 under the Investment Company Act. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
5. Because the Bank recognizes that (1) in-kind transfers to Funds that the Bank services or advises of all or a 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
pro rata 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
portion of Plan assets in the CIFs or all or a 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
pro rata 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
portion of Plan assets that the Bank otherwise manages, and (2) the approval process for additional services for which
a fee is charged and fee increases by the Bank for these services may be outside the scope of PTCE 77&hyph;4, the Bank
has requested relief for the transactions described in section I and II. Each of these transactions is discussed more
fully in paragraphs 6, 7, 8, and 9 below. The exemption for each of the transactions involving HighMark is conditioned
on the satisfaction of certain requirements and compliance with various general conditions which are also discussed
below. It is the Bank's expressed intention that the description of these transactions and the conditions of the requested
exemption with respect to such transactions were and will be applicable uniformly to HighMark and to any of the other
Funds for which the Bank serves as the investment advisor and in which the Plans invest. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
In-Kind Transfers to Funds 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00142 </DOCNO>
<PARENT> FR940817-2-00080 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
6. It is represented that the Bank has maintained CIFs in which the Plans have invested in accordance with Regulation
9 promulgated by the Comptroller of the Currency and the Internal Revenue Service. The Bank has decided to terminate
certain CIFs and to offer to the Plans participating in such CIFs appropriate interests in certain Funds as alternative
investments. Because interests in CIFs generally must be liquidated or withdrawn to effect distributions, the Bank
believes that the interests of the Plans invested in CIFs would be better served by investment in shares of the Funds
which can be distributed in-kind. Also, the Bank believes that the Funds offer the Plans numerous advantages as pooled
investment vehicles. In this regard, the Plans, as shareholders of a Fund, have the opportunity to exercise voting
and other shareholder rights. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Plans, as shareholders of the Funds, as mandated by the SEC, periodically receive certain disclosures concerning
the Funds: (1) a copy of the prospectus which is updated annually; (2) an annual report containing audited financial
statements of the Funds and information regarding such Funds performance (unless such performance information
is included in the prospectus of such Funds); (3) a semi-annual report containing unaudited financial statements;
and (4) at the option of the Funds other pertinent information. With respect to the Plans, the Bank reports all transactions
in shares of the Funds in periodic account statements provided the Second Fiduciary of each of the Plans. Further,
the Bank maintains that the investment performance of the portfolios of the Funds can be monitored daily from information
available in newspapers of general circulation.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In order to avoid the potentially large brokerage expenses that would otherwise be incurred, the Bank proposes that
from time to time assets of the CIFs be transferred in-kind to corresponding portfolios of the Funds in exchange for
shares of such Funds. In this regard, some Funds may, as in the case of HighMark, be in existence and operating at the
time of the in-kind transfer of such assets. Some Funds may be created to assume the assets of the terminating CIF. Similarly,
the Bank proposes that from time to time it may be appropriate for an individual Plan for which the Bank serves as fiduciary
to transfer all or a 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
pro rata
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 share of its assets in-kind to any of the Funds in exchange for shares of such Funds. In this regard, for example, in the
case of an in-kind exchange between an individual Plan whose portfolio consists of common stock, money market securities,
and real estate, and a Fund that, under its investment policy, invests only in common stock and money market securities,
the exchange would involve all or a 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
pro rata
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 share of the common stock and money market securities held by the Plan, if such stock and securities are eligible for
purchase by the Fund,
<FOOTCITE>8</FOOTCITE>
 and would not involve the transfer or exchange of the real estate holdings of such Plan. No brokerage commission or
other fees or expenses (other than customary transfer charges paid to parties other than the Bank or its affiliates)
have been or will be charged to the Plans or the CIFs in connection with the in-kind transfers of assets into the Funds
and the acquisition of shares of the Funds by the Plans or the CIFs. Thus, in addition to retroactive relief, the Bank
has requested prospective relief for transactions which would involve: (1) the in-kind transfer by the CIFs of all
or a 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
pro rata
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 portion of the assets of any of the Plans held in such CIFs to the Funds in exchange for shares of the Fund which subsequently
are distributed to the Plans; or (2) the in-kind transfer of all or a 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
pro rata
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 portion of the assets of any of the Plans held by the Bank in any capacity as fiduciary on behalf of such Plans to the Funds
in exchange for shares of such Funds; provided that conditions described in section I above are satisfied. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
8
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
It is represented that a Fund's eligible investments are described under ``Investment Policies and Fund Portfolio''
of its prospectus. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Bank maintains that the transfers in-kind of assets in exchange for shares of the Funds are ministerial transactions
performed in accordance with pre-established objective procedures which are approved by the board of trustees of
each Fund. Such procedures require that assets transferred to a Fund: (1) are consistent with the investment objectives,
policies, and restrictions of the corresponding portfolios of such Fund, (2) satisfy the applicable requirements
of the Investment Company Act of 1940 and the Code, (3) have a readily ascertainable market, (4) are liquid, and (5)
are not subject to restrictions on resale. It is represented that assets which do not meet these requirements will
be sold in the open market through an unaffiliated brokerage firm prior to any transfer in-kind. Further, as described
in section I, prior to entering into an in-kind transfer each affected Plan receives certain disclosures from the
Bank and approves such transaction in writing. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Bank represents that valuation of assets transferred in-kind to the Funds will be established by reference to
independent sources. In this regard, for purposes of the transaction, it is represented that all assets transferred
in-kind are valued in accordance with the valuation procedures described in Rule 17a-7(b) under the Investment Company
Act of 1940, as amended from time to time or any successor rule, regulation, or similar pronouncement. Further, the
Bank represents that within thirty (30) days of the completion of a transfer in-kind, it will provide to Plans written
confirmation of the identity of each security valued under Rule 17a-7(b)(4), the price of each security, and the identity
of each pricing service or market maker consulted in determining the value of the assets transferred. The securities
subject to valuation under Rule 17(a)-7(b)(4) include all securities other than ``reported securities,'' as the
term is defined in Rule 11Aa3&hyph;1 under the Securities Exchange Act of 1934 (the 1934 Act), or those quoted on the
NASDAQ system or for which the principal market is an exchange. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
It is represented that the value of the assets transferred in-kind will be equal to the aggregate value of the corresponding
portfolios shares of the Fund at the close of business on the date of the transaction. In this regard, it is represented
that for all conversion transactions that occur after the date of this proposed exemption, the Bank, no later than
ninety (90) days after completion of each in-kind transfer of assets of the Plans or the CIFs in exchange for shares
of the Funds, will mail to the Second Fiduciary a written confirmation of the number of CIF units held by each affected
Plan immediately before the conversion (and the related per unit value or the aggregate dollar value of the units transferred),
and the number of shares in the Funds that are held by each affected Plan following the conversion (and the related per
share net asset value or the aggregate dollar value of the shares received). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00143 </DOCNO>
<PARENT> FR940817-2-00080 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
7. The Bank has requested retroactive relief, for the in-kind transfer to HighMark that occurred over the weekend
of November 12, 1993. It is represented that on the weekend of November 12, 1993, all of the assets of five CIFs
<FOOTCITE>9</FOOTCITE>
, which were maintained by the Bank and in which the Plans held interests, were transferred to HighMark in exchange
for an appropriate number of shares of certain portfolios of HighMark which have investment objectives and policies
substantially identical to those of the CIFs. At the same time, the five CIFs were terminated and the assets of each,
then consisting of shares in portfolios of HighMark, were distributed in-kind to the Plans participating in such
CIFs based on each Plan's 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
pro rata
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 share of the assets of the CIFs on the date of the transaction. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
9
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
It is represented that the CIFs maintained by the Bank which engaged in the transfer in-kind on November 12, 1993, were
the Balanced Fund, the Flexible Bond Fund A, the Government Fund, the Income and Growth Equity Fund, and the Income
Equity Fund A. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Bank provided to the Second Fiduciary for each affected Plan disclosures that announced the termination of the
CIFs, summarized the transaction, and otherwise complied with provisions of Section I. It is represented that based
on these disclosures, the Second Fiduciary from each affected Plan approved in writing the transfer of the CIFs assets
to the corresponding portfolios of HighMark, the investment of the assets of the Plans in shares of HighMark, and the
receipt by the Bank of fees for services to HighMark and to the Plans. It is represented that the assets of Plans that
did not approve investment in HighMark were withdrawn from the CIFs and held or invested in appropriate alternative
investments in accordance with the terms of such Plans. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Prior to the transaction, the assets of the five CIFs were reviewed to confirm that such were appropriate investments
for the corresponding portfolios of HighMark into which such assets were transferred. If any of the assets of the five
CIFs were not appropriate for HighMark, it is represented that the Bank sold such assets in the open market through
an unaffiliated brokerage firm prior to the transfer. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
It is represented that the assets transferred by the five CIFs to HighMark consisted entirely of cash and marketable
securities. For purposes of the transfer in-kind, the value of the securities in each of the five CIFs were determined
based on market values as of the close of business on November 12, 1993, the last business date prior to the transfer.
It is represented that the values were determined in a single valuation using the valuation procedures described
in Rule 17a&hyph;7 under the Investment Company Act of 1940. In this regard, it is represented that the ``current market
price'' for specific types of CIF securities involved in the transaction was determined as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) If the security was a ``reported security'' as the term is defined in Rule 11Aa3&hyph;1 under the 1934 Act, the last
sale price with respect to such security reported in the consolidated transaction reporting system (the Consolidated
System) for November 12, 1993; or if there were no reported transactions in the Consolidated System that day, the average
of the highest independent bid and the lowest independent offer for such security (reported pursuant to Rule 11Ac1&hyph;1
under the 1934 Act), as of the close of business on November 12, 1993; or 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) If the security was not a reported security, and the principal market for such security was an exchange, then the
last sale on such exchange on November 12, 1993; or if there were no reported transactions on such exchange that day,
the average of the highest independent bid and lowest independent offer on such exchange as of the close of business
on November 12, 1993; or 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) If the security was not a reported security and was quoted in the NASDAQ system, then the average of the highest independent
bid and lowest independent offer reported on Level 1 of NASDAQ as of the close of business on November 12, 1993; or 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(4) For all other securities, the average of the highest independent bid and lowest independent offer as of the close
of business on November 12, 1993, determined on the basis of reasonable inquiry. For securities in this category,
the Bank represents that it obtained quotations from at least three sources that were either broker-dealers or pricing
services independent of and unrelated to the Bank and, where more than one valid quotation was available, used the
average of the quotations to value the securities, in conformance with interpretations by the SEC and practice under
Rule 17a&hyph;7. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
It is represented that the securities received by the corresponding portfolio of HighMark were valued by such portfolio
for purposes of the transfer in the same manner and on the same day as such securities were valued by the CIFs. The per
share 
<!-- PJG 0012 frnewline -->
value of the shares of each portfolio of HighMark issued to the CIFs were based on the corresponding portfolio's then
current net asset value. It is represented that the aggregate value of the shares of the corresponding portfolio of
HighMark issued to the CIFs were equal to the value of the assets (cash and marketable securities) transferred to such
portfolio as of the close of business on November 12, 1993. It is also represented that the value of a Plan's investment
in shares of a corresponding portfolio of HighMark as of the opening of business on the first business day after the
transaction (November 15, 1993) was equal to the value of such Plan's investment in the CIF as of the close of business
on the last business day prior to the transaction (November 12, 1993). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
It is represented that not later than thirty (30) days after completion of the transaction (December 15, 1993), the
Bank sent by regular mail a written confirmation of the transaction to each affected Plan. Such confirmation contained:
(1) the identity of each security that was valued in accordance with Rule 17a7(b)(4), as described in the paragraph
7(4) above; (2) the price of each such security for purposes of the transaction; and (3) the identity of each pricing
service or market maker consulted in determining the value of such securities. To reiterate the above discussion,
and in accordance with the conditions under section I, similar procedures will occur upon any future in-kind exchanges
between CIFs maintained by the Bank, Plans, and the Funds. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Receipt of Fees From Funds 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
8. It is represented that the Bank currently invests assets of the Plans it manages in shares of the Funds in accordance
with the conditions set forth in PTCE 77&hyph;4. Under certain conditions, PTCE 77&hyph;4 permits the Bank to receive
fees from the Funds under either of two circumstances: (a) where a Plan does not pay any investment management, investment
advisory, or similar fees with respect to the assets of such Plan invested in shares of a Fund for the entire period of
such investment; or (b) where a Plan pays investment management, investment advisory, or similar fees to the Bank
based on the total assets of such Plan from which a credit has been subtracted representing such Plan's 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
pro rata
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 share of such investment advisory fees paid to the Bank by the Fund. As such, it is represented that there are two levels
of fees_those fees which the Bank charges to the Plans for serving as trustee with investment discretion or as investment
manager (the Plan-level fees); and those fees the Bank charges to the Funds (the Fund-level fees) for serving as investment
advisor, custodian, or service provider. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00144 </DOCNO>
<PARENT> FR940817-2-00080 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
It is represented that at present the vast majority of Plans for which the Bank acts as a fiduciary do not pay any separate
Plan-level investment management, investment advisory, or similar fees with respect to the assets of such Plans
invested in shares of the Funds. A few Plans, however, continue to pay Plan-level investment management, investment
advisory, and similar fees and receive credits which represent each of the Plans 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
pro rata 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
share of investment advisory fees paid to the Bank by the Funds. The Bank represents that Plan-level fees currently
charged are paid monthly and are calculated as a percentage of the market value of the assets of a Plan with respect to
which the Bank provides services. It is represented that Plan-level investment management, investment advisory
or similar fees for all of the services provided by the Bank, including services in connection with the automated cash
``sweep'' arrangement, are charged in the form of a single asset-based fee. It is represented that Plan-level fees
are subject to annual minimums for administration and management expressed as flat dollar amounts and are subject
to the application of certain ``break points.'' In addition to the Plan-level fees for investment management, investment
advisory, or similar services, a one-time fee (also a flat dollar amount) may be charged in connection with the establishment
of an account for a Plan, and separate transaction fees may be charged for various administrative transactions, such
as for example, a participant loan. It is represented that depending on the terms of the governing documents of the
Plan, Plan-level fees are paid to the Bank either by the sponsor of the Plan or from the assets of the Plan. 
<!-- PJG 0012 frnewline -->
As mentioned above, the Bank also receives Fund-level fees. Such Fund-level fees can be divided into: (1) fees paid
to the Bank by a Fund for investment management, investment advisory, or similar services provided to such Fund, and
(2) fees paid to the Bank for administrative, custodial, transfer, accounting, and other Secondary Services provided
either to such Fund or to the distributor of shares of such Funds and its affiliates. For example, with respect to investment
management/advisory services and Secondary Services, the current fee arrangements between the Bank and HighMark
provide for: (1) MERUS, a division of the Bank, to receive fees from HighMark for acting as investment advisor, (2)
the Bank to receive custodian fees from HighMark, (3) the Bank to receive fees from Winsbury for serving as sub-administrator
to HighMark, and (4) the Bank to receive fees from Winsbury Services for services as sub-accountant and sub-transfer
agent provided to HighMark. It is represented that this compensation paid to the Bank for investment advisory services
and Secondary Services is in accordance with various agreements between Winsbury, Winsbury Service, HighMark,
and the Bank. In this regard, it is represented that the HighMark Trustees and the shareholders of HighMark approve
the compensation that the Bank receives from HighMark. Also, the HighMark Trustees approve any changes in the compensation
paid to the Bank for services rendered to HighMark. 
<!-- PJG 0012 frnewline -->
It is represented that the Fund-level fees from HighMark are computed daily and billed monthly. The Bank represents
that at the end of each month and promptly upon receipt of the Fund-level fees from HighMark, for those Plans which pay
to the Bank Plan-level investment management, investment advisory, or similar fees, the Bank currently credits
to each Plan its 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
pro rata
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 share of all investment management, investment advisory, or similar fees charged by the Bank to HighMark. 
<!-- PJG 0012 frnewline -->
9. Under the fee structure proposed in this exemption, it is represented that the arrangement for Plan-level fees
where assets of the Plans managed by the Bank are invested in the Funds is different in several respects from that described
in paragraph 8 above. In this regard, a separate Plan-level fee will be charged to the Plans for basic administrative
services not including investment management.
<FOOTCITE>10</FOOTCITE>
 Such administrative services would include, among others, the Bank's acting as custodian of the assets of a Plan,
maintaining the records of a Plan, preparing periodic reports concerning the status of the Plan and its assets, and
accounting for contributions, benefit distributions, and other receipts and disbursements. It is represented
that these functions performed by the Bank on the Plan-level are separate and distinct from those performed on the
Fund-level by the Bank, by Winsbury, and by Winsbury Services. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
10
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The fact that certain transactions and fee arrangements are the subject of an administrative exemption does not relieve
the fiduciaries of the Plans from the general fiduciary responsibility provisions of section 404 of the Act. Thus,
the Department cautions the fiduciaries of the Plans investing in the Funds that they have an ongoing duty under section
404 of the Act to monitor the services provided to the Plans to assure that the fees paid by the Plans for such services
are reasonable in relation to the value of the services provided. Such responsibilities would include determinations
that the services provided are not duplicative and that the fees are reasonable in light of the level of services provided.

<!-- PJG 0012 frnewline -->
In addition, the Department notes that the combined total of all fees received by the Bank directly or indirectly from
the Plan for the provision of services to the Plan and/or to the Fund should not be in excess of ``reasonable compensation''
within the meaning of section 408(b)(2) of the Act. 
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
It is represented that the Bank will continue to receive compensation from the Plans for investment management services
provided with respect to assets of the Plans 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
not 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
invested in shares of any of the Funds. However, under the proposed fee structure, the Bank will no longer credit to
any of the Plans their 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
pro rata 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
share of the investment advisory fees, as described in paragraph 8 above, because the Plans will no longer pay Plan-level
fees to the Bank for investment advisory services with respect to any of the assets of the Plans invested in shares of
any of the Funds. Instead, the compensation received by the Bank for investment advisory services will be that which
is paid by the Funds to the Bank for such services rendered to such Funds. In addition, the Bank will continue to retain
fees for providing Secondary Services to the Funds. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00145 </DOCNO>
<PARENT> FR940817-2-00080 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The applicant maintains that this proposed fee arrangement complies with PTCE 77&hyph;4. However, there is one difference
from PTCE 77&hyph;4 requested by the Bank for which an exemption is required. In this regard, one of the requirements
of PTCE 77&hyph;4 has been that any change in any of the rates of fees would require prior written approval by the Second
Fiduciary of the Plans participating in the Funds. The applicant maintains that where many Plans participate in a
Fund, the addition of a service or any good faith increase in fees could not be implemented until written approval of
such change is obtained from every Second Fiduciary. The applicant proposes an alternative which the Bank maintains
provides the basic safeguards for the Plans and is more efficient, cost effective, and administratively feasible
than those contained in PTCE 77&hyph;4. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
It is represented that in the event of an increase in the rate of any investment management fees, investment advisory
fees, or similar fees, the addition of a Secondary Service for which a fee is charged, or an increase in the fees for Secondary
Services paid by the Funds to the Bank over an existing rate that had been authorized by the Second Fiduciary, the Bank
will provide, at least thirty (30) days in advance of the implementation of such additional service or fee increase,
to the Second Fiduciary of all the Plans invested in such Fund a written notice of such additional service or fee increase,
(which may take the form of a proxy statement, letter, or similar communication that is separate from the prospectus
of the Fund and which explains the nature and amount of the additional service or the nature and amount of the increase
in fees). In this regard, such increase in fees for Secondary Services can result either from an increase in the rate
of such fee or from the decrease in the number or kind of services performed by the Bank for such fee over that which had
been authorized by the Second Fiduciary of a Plan. It is represented that providing notice in this way will give the
Second Fiduciary of each of the Plans adequate opportunity to decide whether or not to continue the authorization
of a Plan's investment in any of the portfolios of the Funds in light of the increase in investment management fees,
investment advisory fees, or similar fees, the additional Secondary Service for which a fee is charged, or the increase
in fees for any Secondary Services. In addition, the Bank represents that such fee increase will be disclosed to the
Secondary Fiduciaries in a supplement to the Fund's prospectus in the case of an increase in fees for investment management,
investment advisory, or similar services and in the Fund's Statement of Additional Information in the case of an additional
Secondary Service for which a fee is charged or an increase in the fees for Secondary Services. 
<!-- PJG 0012 frnewline -->
10. It is represented that the written notice of an additional service for which a fee is charged or a fee increase, as
described in paragraph 9 above, will be accompanied by a Termination Form, as defined in paragraph (i) of section III,
and by instructions on the use of such form, as described in paragraph (m) of section II, which expressly provide an
election to the Second Fiduciaries to terminate at will any prior authorizations without penalty to the Plans. In
addition, it is represented that the Second Fiduciary will be supplied with a Termination Form annually during the
first quarter of each calendar year, beginning with the first quarter of the calendar year that begins after the date
the grant of this proposed exemption is published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and continuing for each calendar year thereafter, regardless of whether there have been any changes in the fees payable
to the Bank or changes in other matters in connection with services rendered to the Funds. However, if the Termination
Form has been provided to the Second Fiduciary in the event of an increase in the rate of any investment management fees,
investment advisory fees, or similar fees, an addition of a Secondary Service for which a fee is charged, or an increase
in any fees for Secondary Services paid by the Fund to the Bank, then such Termination Form need not be provided again
to the Second Fiduciary until at least six months have elapsed, unless such Termination Form is required to be sent
sooner as a result of another increase in any investment management fees, investment advisory fees, or similar fees,
the addition of a Secondary Service for which a fee is charged, or an increase in any fees for Secondary Services. 
<!-- PJG 0012 frnewline -->
The Termination Form will contain instructions regarding its use which will state expressly that the authorization
is terminable at will by a Second Fiduciary, without penalty to any Plan, and that failure to return the form will be
deemed to be an approval of the additional Secondary Service or the increase in the rate of any fees and will result in
the continuation of all authorizations previously given by such Second Fiduciary. It is represented that termination
by any Plan of authorization to invest in the Funds will be effected by the Bank selling the shares of the Fund held by
the affected Plan within one business day following receipt by the Bank, either by mail, hand delivery, facsimile,
or other available means at the option of the Second Fiduciary, of the Termination Form or any other written notice
of termination. If, due to circumstances beyond the control of the Bank, the sale cannot be executed within one business
day, the Bank shall have one additional business day to complete such sale. 
<!-- PJG 0012 frnewline -->
11. It is represented that the rates paid by each of the portfolios of the Funds to the Bank for services rendered may
differ depending on the fee schedule for each portfolio and on the daily net assets in each portfolio. The investment
advisory fees paid to the Bank by the Funds will be based on the different fee rates of each of the portfolios into which
the assets of the Plans are allocated. For example, for services provided to the Money Market Portfolios, the California
Tax Free Fund, and the Tax Free Fund, the Bank receives the following fees from HighMark based on each portfolio's average
daily net assets: (a) .40% of the first $500 million; (b) .35% of the next $500 million; and (c) .30% of the remaining
average daily net assets. For services provided to the Non-Money Market Portfolios, the Bank receives the following
fees from HighMark based on each portfolio's average daily net assets: (a) 1.00% of the first $40 million; and (b) .60%
on the remaining average daily net assets. It is represented that the Bank currently allocates investments by the
Plans among the portfolios offered by HighMark, and proposes to continue to allocate the assets of the Plans among
the portfolios of HighMark and/or any of the Funds under the terms of this proposed exemption. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00146 </DOCNO>
<PARENT> FR940817-2-00080 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
It is represented that the impact of the change in fee structures, described in paragraph 9 above, on aggregate fees
received by the Bank is difficult to determine, because various factors and variables are unique to each Plan. These
factors include the size of the Plan, the extent to which Plan assets are invested in the Funds, and the application
of certain ``break points'' in the schedule of Plan-level fees. Further, Fund size and the application of certain
``break points'' in the rate schedule of Fund-level fees, the identity of the particular investment portfolio of
the Fund into which the Plan assets are allocated, and voluntary waivers by the Bank of Fund-level fees are likely to
be different in each situation and may affect the aggregate amount of fees received by the Bank. In this regard, it is
represented that the combined total of all Plan-level and Fund-level fees received by the Bank for the provision of
services to the Plans and to the Funds, respectively, are not in excess of ``reasonable compensation'' within the
meaning of section 408(b)(2) of the Act. 
<!-- PJG 0012 frnewline -->
12. The exemption is subject to satisfaction of certain general conditions. Chief among such conditions is the requirement
that the proposed transactions are subject to the prior authorization of a Second Fiduciary, acting on behalf of each
of the Plans, who has been provided with full written disclosure by the Bank. It is represented that the Second Fiduciary
will generally be the administrator, sponsor, or a committee appointed by the sponsor to act as a named fiduciary for
a Plan. 
<!-- PJG 0012 frnewline -->
With respect to disclosure, the Second Fiduciary of such Plan will receive in writing in advance of the investment
by a Plan in any of the Funds: (1) a current prospectus for each portfolio of each of the Funds in which such Plan may invest,
(2) a statement describing the investment management fees, investment advisory fees, or similar fees, any fees for
Secondary Services, and all other fees to be charged to or paid by the Plan and by such Funds to the Bank, including the
nature and extent of any differential between the rates of such fees, (3) the reasons why the Bank may consider such
investment(s) to be appropriate for the Plan, (4) a statement describing whether there are any limitations applicable
to the Bank with respect to which assets of a Plan may be invested in the Funds, and, if so, the nature of such limitations,
and (5) upon request of the Second Fiduciary a copy of the proposed exemption and/or the final exemption, if granted.

<!-- PJG 0012 frnewline -->
In addition to the disclosures provided to the Plan prior to investment in any of the Funds, the Bank represents that
it will routinely provide at least annually to the Second Fiduciary updated prospectuses of the Funds in accordance
with the requirements of the Investment Company Act of 1940 and the SEC rules promulgated thereunder. Further, the
Second Fiduciary will be supplied, upon request, with a report or statement (which may take the form of the most recent
financial report of such Funds, the current statement of additional information, or some other written statement)
which contains a description of all fees paid by the Fund. 
<!-- PJG 0012 frnewline -->
It is represented that the Bank does not now execute nor in the future intend to execute securities brokerage transactions
for the investment portfolios of any of the Funds, except as and to the extent permitted by the Investment Company Act
of 1940 and applicable rules of the Securities and Exchange Commission. In the event the Bank ever performs brokerage
services for which a fee is paid to the Bank by the investment portfolio of any of the Funds, the Bank represents that
it will at least thirty (30) days in advance of the implementation of such additional service provide a written notice
which explains the nature of such additional brokerage service and the amount of the fees. Further, the Bank represents
that it will provide at least annually to the Second fiduciary of any Plan that invests in such Funds with a written disclosure
indicating (a) the total, expressed in dollars, of brokerage commissions of each Fund's investment portfolio that
are paid to the Bank by such Fund; (b) the total, expressed in dollars, of brokerage commissions of each Fund's investment
portfolio that are paid by such Fund to brokerage firms unrelated to the Bank; (c) the average brokerage commissions
per share, expressed as cents per share, paid to the Bank by each portfolio of a Fund; and (d) the average brokerage commissions
per share, expressed as cents per share, paid by each portfolio of a Fund to brokerage firms unrelated to the Bank. 
<!-- PJG 0012 frnewline -->
On the basis of the information disclosed, it is represented that the Second Fiduciary will authorize in writing (i)
the investment of assets of the Plans in shares of the Fund in connection with the transactions set forth herein; (ii)
the investment portfolios of the Funds in which the assets of the Plans may be invested; and (iii) the compensation
received by the Bank in connection with its services to the Funds. It is represented that written authorization will
extend to only those investment portfolios of the Funds with respect to which the Second Fiduciary has received the
written disclosures referred to above and which are specifically mentioned in such authorization. Having obtained
the authorization of the Second Fiduciary, the Bank will be permitted to invest the assets of a Plan among the portfolios
and in the manner covered by the authorization, subject to satisfaction of the other terms and conditions of this proposed
exemption. However, the Bank will not be permitted to invest assets of a Plan in any portfolio not specifically mentioned
in the written authorization. For example, if the written authorization of the Second Fiduciary covered only three
of six portfolios then existing, the Bank could only invest the assets of such Plans in those three portfolios specifically
authorized. Further, if a new portfolio were established under any of the Funds, the Bank could invest assets of a Plan
in such new portfolio only after providing the required disclosures and obtaining from the Second Fiduciary a separate
written authorization which specifically mentions the new portfolio. 
<!-- PJG 0012 frnewline -->
13. The receipt of fees, as described above, are generated in connection with the investment in the Funds by the Plans.
These investments are the result of purchases of shares in the Funds and exchanges of assets of the Plans, including
those in CIFs, for shares in the Funds. 
<!-- PJG 0012 frnewline -->
It is represented: (1) that Plans and other investors will purchases or sell shares in the Funds in accordance with
standard procedures described in the prospectus for each portfolio of the Funds; (2) that the Plans will pay no sales
commissions or redemption fees in connection with purchase or sales of shares in the Funds by the Plans; (3) that the
Bank will not purchase from or sell to any of the Plans shares of any of the Funds; and (4) the price paid or received by
the Plans for shares of the Funds will be the net asset value per share at the time of such purchase or sale and will be the
same price as any other investor would have paid or received at that time.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
11 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
11
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
In this regard, it is represented that the value of HighMark's shares and the value of each of HighMark's portfolios
are determined on a daily basis. In the case of the Non-Money Market Portfolios, assets are valued at fair or market
value, as required by Rule 2a-4 under the Investment Company Act. In the case of the Money Market Portfolios, the assets
are valued based on the amortized cost method authorized by SEC Rule 2a-7, in order to maintain net asset value at $1.00
per share. Both the Money Market Portfolios and the Non-Money Market Portfolios determine the net asset value per
share for purposes of pricing purchases and sales by dividing the value of all securities, determined by a method as
set forth in the prospectus for each HighMark portfolio, and other assets belonging to each of the portfolios, less
the liabilities charged to each portfolio, by the number of each portfolio's outstanding shares. 
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
14. Purchases and sales of shares in any of the Funds by the Plans may also occur in connection with daily automated cash
``sweep'' arrangements. However, agreement to such arrangement is not a condition for the Plan otherwise choosing
to invest in shares of the Fund, nor will the reverse be required. 
<!-- PJG 0012 frnewline -->
It is represented that at the time the application was filed, all of the Plans served by the Bank had elected to participate
in automated cash ``sweep'' arrangements with HighMark. Further, it is represented that the ``sweep'' procedures,
as described below with respect to HighMark, will remain in effect under the proposed exemption for any of the Funds.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00147 </DOCNO>
<PARENT> FR940817-2-00080 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Under the automated cash ``sweep'' arrangement, a Plan may participate in the ``sweep'' program only with the initial
written approval of the Second Fiduciary and only after certain disclosures have been provided by the Bank. If such
approval is given, cash balances of the Plan held from time to time thereafter pending other investment or distribution
are invested automatically in shares of one or more of HighMark's Money Market Portfolios selected by the Second Fiduciary
on behalf of a Plan at the time of the initial authorization. It is represented that the automated cash ``sweep'' arrangement
would not involve shares of HighMark's Non-Money Market Portfolios. 
<!-- PJG 0012 frnewline -->
After the Money Market Portfolios have been selected by the Second Fiduciary on behalf of the Plan, otherwise uninvested
cash down to the last $1.00 balance of the Plans may be invested automatically on a nightly basis. It is represented
that the Bank has no discretion with respect to the timing of the ``sweep'' either into or out of HighMark. Under the
automated cash ``sweep'' arrangement, the Bank's computerized cash management system automatically scans the
accounts of the Plans, as of the end of each business day to determine whether such accounts have positive or negative
net cash balances. Based on this information the system automatically invests the cash of the Plans having positive
balances in shares of the selected Money Market Portfolios. In the case of a Plan having a negative cash balance, the
system automatically liquidates HighMark shares as necessary to eliminate such negative balance. 
<!-- PJG 0012 frnewline -->
It is represented that Plans may terminate their participation in the automated cash ``sweep'' arrangement and withdraw
at any time by notifying the Bank. Such termination will be affected by the Bank selling the shares of HighMark held
by the Plan requesting termination within one business day following receipt by the Bank, either by mail, hand delivery,
facsimile, or other available means at the option of the Second Fiduciary, of the Termination Form or any other written
notice of termination. However, if due to circumstances beyond the control of the Bank, the sale of shares of such Plan
cannot be executed within one business day, the Bank shall have one additional business day to complete such sale.

<!-- PJG 0012 frnewline -->
It is represented that no fee, charge, or penalty of any kind is charged in connections with a termination by a Plan of
participation in the automated cash ``sweep arrangement'' in HighMark or in any of the Funds. It is further represented
that the Bank does not charge separate or additional fees to Plans in order to participate in the daily automated cash
``sweep'' arrangement, nor is such additional compensation contemplated by the proposed exemption.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
12 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
12
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The Department in a letter, dated August 1, 1986, to Robert S. Plotkin, Assistant Director, Division of Banking Supervision
and Regulation, Board of Governors of the Federal Reserve System, addressed the application of section 408(b)(2)
of the Act to arrangements involving ``sweep services.'' In that letter the Department set forth several examples
to illustrate various circumstances under which violations of section 406(b) of the Act would arise with respect
to such arrangements. Conversely, the letter provided that, if a bank provides ``sweep'' services without the receipt
of additional compensation or other consideration (other than reimbursement of direct expenses properly and actually
incurred in the performance of such services), then the provision of ``sweep'' services by the bank would not, in itself,
constitute a violation of section 406(b) of the Act. Moreover, including ``sweep'' services under a single fee arrangement
for investment management services which is calculated as a percentage of the market value of the total assets under
management would not, in itself, constitute an act described in section 406(b)(1), because the bank would not be exercising
its fiduciary authority or control to cause a plan to pay an additional fee. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In addition, the letter also discusses the applicability of the statutory exemptions under section 408(b)(6) fees
for ``ancillary services'' and under section 408(b)(8) for collective trust funds maintained by such bank of the
Act to such ``sweep'' service arrangements. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
15. In summary, the Bank represents that the proposed transactions meet the statutory criteria of section 408(a)
of the Act because: 
<!-- PJG 0012 frnewline -->
(a) Neither the Plans nor the CIFs have paid or will pay sales commissions or redemption fees in connection with the
in-kind transfer of assets to the Funds in exchange for shares of the Funds or in connection with purchases or sales
by the Plans of shares of the Funds, including purchases and sales handled through daily automated cash ``sweep''
arrangements; 
<!-- PJG 0012 frnewline -->
(b) The Plans or the CIFs have received and will receive shares of the Funds that are equal in value to the assets of the
Plans or the CIFs exchanged for such shares, as determined in a single valuation performed in the same manner and at
the close of business on the same day in accordance with the procedures set forth in Rule 17a&hyph;7 under the Investment
Company Act of 1940, as amended from time to time or any successor rule, regulation, or similar pronouncement; 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00148 </DOCNO>
<PARENT> FR940817-2-00080 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(c) Not later than thirty (30) days after completion of each in-kind transfer of assets in exchange for share of the
Funds, the Second Fiduciaries for affected Plans have received and will receive written confirmation of the assets
involved in the exchange, the price of such assets, and the identity of the pricing service or market maker consulted;

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(d) For all conversion transactions that occur after the date of this proposed exemption, the Bank, no later than ninety
(90) days after completion of each in-kind transfer of assets of the Plans or the CIFs in exchange for shares of the Funds,
will mail to the Second Fiduciary a written confirmation of the number of CIF units held by each affected Plan immediately
before the conversion (and the related per unit value or the aggregate dollar value of the units transferred), and
the number of shares in the Funds that are held by each affected Plan following the conversion (and the related per share
net asset value or the aggregate dollar value of the shares received); 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(e) The price that has been or will be paid or received by the Plans for shares in the Funds is the net asset value per share
at the time of the transaction and is the same price for the shares which would have been paid or received by any other
investor at that time; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(f) The Bank, its affiliates, and officers or directors have not and will not purchase from or sell to any of the Plans
shares of any of the Funds; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(g) The combined total of all fees received by the Bank for the provision of services to the Plans, and in connection
with the provision of services to any of the Funds in which the Plans may invest, has not been and will not be in excess
of ``reasonable compensation'' within the meaning of section 408(b)(2) of the Act; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(h) The Bank has not and will not receive any 12b-1 Fees in connection with the transactions; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(i) Prior to investment by a Plan in any of the Funds, in connection with transactions, the Second Fiduciary has received
and will receive a full and detailed written disclosure of information concerning such Fund; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(j) subsequent to the investment by a Plan in any of the Funds, the Bank will provide the Second Fiduciary of such Plan,
among other information, at least annually with an updated copy of the prospectus for each of the Funds in which the
Plan invests; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(k) in the event such Fund places brokerage transactions with the Bank, the Bank will provide the Second Fiduciary
of such Plan at least annually with a statement specifying the total, expressed in dollars, of brokerage commissions
of each Fund's investment portfolio that are paid by such Fund to the Bank and to unrelated brokerage firms and the average
brokerage commissions per share, expressed as cents per share, by each portfolio of a Fund paid to the Bank and to brokerage
firms unrelated to the Bank; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 (l) On the basis of the disclosures, the Second Fiduciary has authorized and will authorize the transactions; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(m) The authorization by the Second Fiduciary has been and will be terminable at will without penalty to such Plans,
and has been and will be effected within one business day following receipt by the Bank, either by mail, hand delivery,
facsimile, or other available means at the option of the Second Fiduciary, of the Termination Form or any other written
notice of termination, unless circumstances beyond the control of the Bank delay execution for no more than one additional
business day; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(n) The Plans do not pay any investment management, investment advisory, or similar fees to the Bank with respect to
any of the assets of such Plans which are invested in shares of any of the Funds; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(o) the Second Fiduciary has received and will receive a written notice accompanied by a Termination Form with instructions
regarding the use of such form, at least thirty (30) days in advance of the implementation of any increase in the rate
of any fees for investment management, investment advisory, or similar fees, any additional Secondary Service for
which a fee is charged, or any increase in fees for Secondary Services that the Bank provides to the Funds; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(p) All dealings between the Plans and any of the Funds have been and will on a basis no less favorable to such Plans than
dealings between the Funds and other shareholders holding the same class of shares as the Plans. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00149 </DOCNO>
<PARENT> FR940817-2-00080 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Notice to Interested Persons 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Those persons who may be interested in the pendency of the requested exemption include the fiduciaries of Plans which
have invested, as of the effective date of this exemption, in HighMark and/or in any of the Funds, where the Bank served
as investment adviser to such Funds and also served in any capacity as fiduciary for such Plans. In addition, it is represented
that many other Plans for which the Bank serves in any capacity as a fiduciary may from time to time invest in HighMark
and/or in any of the Funds to which the Bank may serve as investment adviser in the future. For this reason, the Bank does
not know the number of Plans which may therefore be affected by this proposed exemption. Accordingly, the Department
has determined that the only practical form of providing notice to interested persons is the distribution by the Bank
by first class mail of a copy of the notice of pendency of this proposed exemption (the Notice) within thirty (30) days
of the date of the publication of such Notice in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 to the fiduciaries of any of the Plans which are invested, on the date of the publication of the Notice in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, in HighMark and/or any the Funds to which the Bank serves as investment adviser. Such distribution to interested
persons shall include a copy of the Notice, as published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, plus a copy of the supplemental statement, as required, pursuant to 29 CFR 2570.43(b)(2), which shall inform such
interested persons of their right to comment and to request a hearing. The Bank also represents that it will provide
a copy of the proposed exemption and/or a copy of the final exemption, if granted, to any Second Fiduciary of a Plan upon
request.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Angelena C. Le Blanc of the Department, telephone (202) 219&hyph;8883 (this is not a toll-free number.) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00150 </DOCNO>
<PARENT> FR940817-2-00080 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=85 g=1 f=1 -->
Marshall &amp; Ilsley Trust Company Located in Milwaukee, Wisconsin; Proposed Exemption
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Application No. D&hyph;9257] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Department is considering granting an exemption under the authority of section 408(a) of the Act and section 4975(c)(2)
of the Code and in accordance with the procedures set forth in 29 CFR Part 2570, Subpart B (55 FR 32836, 32847, August
10, 1990). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Section I_Exemption for In-Kind Transfer of CIF Assets
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
If the exemption is granted, the restrictions of section 406(a) and 406(b) of the Act and the sanctions resulting from
the application of section 4975 of the Code, by reason of section 4975(c)(1)(A) through (F) of the Code, shall not apply,
as of November 20, 1992, to the in-kind transfer of assets of plans for which Marshall &amp; Ilsley Trust Company or
an affiliate (collectively, M&amp;I) serves as a fiduciary (the Client Plans), other than plans established and
maintained by M&amp;I, that are held in certain collective investment funds maintained by M&amp;I (the CIFs), in
exchange for shares of the Marshall Funds, Inc. (the Funds), an open-end investment company registered under the
Investment Company Act of 1940 (the 1940 Act), for which M&amp;I acts as investment adviser, custodian, and/or shareholder
servicing agent, in connection with the termination of such CIFs, provided that the following conditions and the
general conditions of Section III below are met: 
<!-- PJG 0012 frnewline -->
(a) No sales commissions or other fees are paid by the Client Plans in connection with the purchase of Fund shares through
the in-kind transfer of CIF assets and no redemption fees are paid in connection with the sale of such shares by the Client
Plans to the Funds. 
<!-- PJG 0012 frnewline -->
(b) Each Client Plan receives shares of a Fund which have a total net asset value that is equal to the value of the Client
Plan's pro rata share of the assets of the CIF on the date of the transfer, based on the current market value of the CIF's
assets, as determined in a single valuation performed in the same manner at the close of the same business day, using
independent sources in accordance with Rule 17a-7(b) of the Securities and Exchange Commission under the 1940 Act
and the procedures established by the Funds for the valuation of such assets. Such procedures must require that all
securities for which a current market price cannot be obtained by reference to the last sale price for transactions
reported on a recognized securities exchange or NASDAQ be valued based on an average of the highest current independent
bid and lowest current independent offer, as of the close of business on the Friday preceding the weekend of the CIF
transfers, determined on the basis of reasonable inquiry from at least three sources that are broker-dealers or pricing
services independent of M&amp;I. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00151 </DOCNO>
<PARENT> FR940817-2-00080 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(c) A second fiduciary who is independent of and unrelated to M&amp;I (the Second Fiduciary) receives advance written
notice of the in-kind transfer of assets of the CIFs and full written disclosure of information concerning the Funds
(including a current prospectus for each of the Funds and a statement describing the fee structure) and, on the basis
of such information, authorizes in writing the in-kind transfer of the Client Plan's CIF assets to a corresponding
Fund in exchange for shares of the Fund. 
<!-- PJG 0012 frnewline -->
(d) For all subsequent transfers of CIF assets to a Fund following the publication of this proposed exemption in the

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, M&amp;I sends by regular mail to each affected Client Plan a written confirmation, not later than 30 days after completion
of the transaction, containing the following information: 
<!-- PJG 0012 frnewline -->
(1) The identity of each security that was valued for purposes of the transaction in accordance with Rule 17a-7(b)(4);

<!-- PJG 0012 frnewline -->
(2) The price of each such security involved in the transaction; and 
<!-- PJG 0012 frnewline -->
(3) The identity of each pricing service or market maker consulted in determining the value of such securities. 
<!-- PJG 0012 frnewline -->
(e) For all subsequent transfers of CIF assets to a Fund following the publication of this proposed exemption in the

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, M&amp;I sends by regular mail to the Second Fiduciary no later than 90 days after completion of each transfer a written
confirmation that contains the following information: 
<!-- PJG 0012 frnewline -->
(1) The number of CIF units held by the Client Plan immediately before the transfer, the related per unit value, and
the total dollar amount of such CIF units; and 
<!-- PJG 0012 frnewline -->
(2) The number of shares in the Funds that are held by the Client Plan following the transfer, the related per share net
asset value, and the total dollar amount of such shares. 
<!-- PJG 0012 frnewline -->
(f) The conditions set forth in paragraphs (e), (f) and (l) of Section II below are satisfied. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Section II_Exemption for Receipt of Fees
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
If the exemption is granted, the restrictions of sections 406(a) and 406(b) of the Act and the sanctions resulting
from the application of section 4975 of the Code, by reason of section 4975(c)(1) (A) through (F) of the Code, shall
not apply as of November 20, 1992, to: (1) The receipt of fees by M&amp;I from the Funds for acting as an investment adviser
to the Funds in connection with the investment by the Client Plans in shares of the Funds; and (2) the receipt and proposed
retention of fees by M&amp;I from the Funds for acting as custodian and shareholder servicing agent to the Funds as
well as for any other services to the Funds which are not investment advisory services (i.e. ``secondary services'')
in connection with the investment by the Client Plans in shares of the Funds, provided that the following conditions
and the general conditions of Section III are met: 
<!-- PJG 0012 frnewline -->
(a) No sales commissions are paid by the Client Plans in connection with the purchase or sale of shares of the Funds and
no redemption fees are paid in connection with the sale of shares by the Client Plans to the Funds. 
<!-- PJG 0012 frnewline -->
(b) The price paid or received by a Client Plan for shares in a Fund is the net asset value per share at the time of the transaction,
as defined in Section IV(e), and is the same price which would have been paid or received for the shares by any other investor
at that time. 
<!-- PJG 0012 frnewline -->
(c) Neither M&amp;I nor an affiliate, including any officer or director of M&amp;I, purchases or sells shares of the
Funds to any Client Plan. 
<!-- PJG 0012 frnewline -->
(d) Each Client Plan receives a credit, either through cash or the purchase of additional shares of the Funds pursuant
to an annual election made by the Client Plan, of such Plan's proportionate share of all fees charged to the Funds by
M&amp;I for investment advisory services, within no more than one business day of the receipt of such fees by M&amp;I.

<!-- PJG 0012 frnewline -->
(e) The combined total of all fees received by M&amp;I for the provision of services to a Client Plan, and in connection
with the provision of services to the Funds in which the Client Plan may invest, are not in excess of ``reasonable compensation''
within the meaning of section 408(b)(2) of the Act. 
<!-- PJG 0012 frnewline -->
(f) M&amp;I does not receive any fees payable pursuant to Rule 12b-1 under the 1940 Act in connection with the transactions.

<!-- PJG 0012 frnewline -->
(g) The Client Plans are not employee benefit plans sponsored or maintained by M&amp;I. 
<!-- PJG 0012 frnewline -->
(h) The Second Fiduciary receives full and detailed written disclosure of information concerning the Funds (including
a current prospectus for each of the Funds and statement describing the fee structure) in advance of any investment
by the Client Plan in a Fund. 
<!-- PJG 0012 frnewline -->
(i) On the basis of the information described above in paragraph (h), the Second Fiduciary authorizes in writing the
investment of assets of the Client Plan in each particular Fund, the fees to be paid by such Funds to M&amp;I, and the
purchase of additional shares of a Fund by the Client Plan with the fees credited to the Client Plan by M&amp;I. 
<!-- PJG 0012 frnewline -->
(j) All authorizations made by a Second Fiduciary regarding investments in a Fund and the fees paid to M&amp;I are subject
to an annual reauthorization wherein any such prior authorization referred to in paragraph (i) shall be terminable
at will by the Client Plan, without penalty to the Client Plan, upon receipt by M&amp;I of written notice of termination.
A form expressly providing an election to terminate the authorization described in paragraph (i) above (the Termination
Form) with instructions on the use of the form must be supplied to the Second Fiduciary no less than annually. The instructions
for the Termination Form must include the following information: 
<!-- PJG 0012 frnewline -->
(1) The authorization is terminable at will by the Client Plan, without penalty to the Client Plan, upon receipt by
M&amp;I of written notice from the Second Fiduciary; and 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00152 </DOCNO>
<PARENT> FR940817-2-00080 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(2) Failure to return the Termination Form will result in continued authorization of M&amp;I to engage in the transactions
described in paragraph (i) on behalf of the Client Plan. 
<!-- PJG 0012 frnewline -->
(k) The Second Fiduciary of each Client Plan invested in a particular Fund receives full written disclosure, in a statement
separate from the Fund prospectus, of any proposed increases in the rates of fees charged by M&amp;I to the Funds for
secondary services (as defined in Section IV(h) below) at least 30 days prior to the effective date of such increase,
accompanied by a copy of the Termination Form, and receives full written disclosure in a Fund prospectus or otherwise
of any increases in the rates of fees charged by M&amp;I to the Funds for investment advisory services even though such
fees will be credited as required by paragraph (d) above. 
<!-- PJG 0012 frnewline -->
(l) All dealings between the Client Plans and the Funds are on a basis no less favorable to the Client Plans than dealings
with other shareholders of the Funds. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Section III_General Conditions 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(a) M&amp;I maintains for a period of six years the records necessary to enable the persons described below in paragraph
(b) to determine whether the conditions of this exemption have been met, except that: (1) a prohibited transaction
will not be considered to have occurred if, due to circumstances beyond the control of M&amp;I, the records are lost
or destroyed prior to the end of the six-year period, and (2) no party in interest other than M&amp;I shall be subject
to the civil penalty that may be assessed under section 502(i) of the Act or to the taxes imposed by section 4975 (a) and
(b) of the Code if the records are not maintained or are not available for examination as required by paragraph (b) below.

<!-- PJG 0012 frnewline -->
(b) (1) Except as provided in paragraph (b)(2) and notwithstanding any provisions of section 504 (a)(2) and (b) of
the Act, the records referred to in paragraph (a) are unconditionally available at their customary location for examination
during normal business hours by_
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(i) Any duly authorized employee or representative of the Department or the Internal Revenue Service, 
<!-- PJG 0012 frnewline -->
(ii) Any fiduciary of the Client Plans who has authority to acquire or dispose of shares of the Funds owned by the Client
Plans, or any duly authorized employee or representative of such fiduciary, and 
<!-- PJG 0012 frnewline -->
(iii) Any participant or beneficiary of the Client Plans or duly authorized employee or representative of such participant
or beneficiary; 
<!-- PJG 0012 frnewline -->
(2) None of the persons described in paragraph (b)(1)(ii) and (iii) shall be authorized to examine trade secrets of
M&amp;I, or commercial or financial information which is privileged or confidential. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Section IV_Definitions 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
For purposes of this proposed exemption: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00153 </DOCNO>
<PARENT> FR940817-2-00080 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(a) The term ``M&amp;I'' means the Marshall &amp; Ilsley Trust Company and any affiliate thereof as defined below
in paragraph (b) of this section. 
<!-- PJG 0012 frnewline -->
(b) An ``affiliate'' of a person includes: 
<!-- PJG 0012 frnewline -->
(1) Any person directly or indirectly through one or more intermediaries, controlling, controlled by, or under common
control with the person; 
<!-- PJG 0012 frnewline -->
(2) Any officer, director, employee, relative, or partner in any such person; and 
<!-- PJG 0012 frnewline -->
(3) Any corporation or partnership of which such person is an officer, director, partner, or employee. 
<!-- PJG 0012 frnewline -->
(c) The term ``control'' means the power to exercise a controlling influence over the management or policies of a person
other than an individual. 
<!-- PJG 0012 frnewline -->
(d) The term ``Fund'' or ``Funds'' shall include the Marshall Funds, Inc., or any other diversified open-end investment
company or companies registered under the 1940 Act for which M&amp;I serves as an investment adviser and may also serve
as a custodian, shareholder servicing agent, transfer agent or provide some other ``secondary service'' (as defined
below in paragraph (h) of this Section) which has been approved by such Funds. 
<!-- PJG 0012 frnewline -->
(e) The term ``net asset value'' means the amount for purposes of pricing all purchases and sales calculated by dividing
the value of all securities, determined by a method as set forth in the Fund's prospectus and statement of additional
information, and other assets belonging to the Fund or portfolio of the Fund, less the liabilities charged to each
such portfolio or Fund, by the number of outstanding shares. 
<!-- PJG 0012 frnewline -->
(f) The term ``relative'' means a ``relative'' as that term is defined in section 3(15) of the Act (or a ``member of the
family'' as that term is defined in section 4975(e)(6) of the Code), or a brother, a sister, or a spouse of a brother or
a sister. 
<!-- PJG 0012 frnewline -->
(g) The term ``Second Fiduciary'' means a fiduciary of a Client Plan who is independent of and unrelated to M&amp;I.
For purposes of this exemption, the Second Fiduciary will not be deemed to be independent of and unrelated to M&amp;I
if: 
<!-- PJG 0012 frnewline -->
(1) Such fiduciary directly or indirectly controls, is controlled by, or is under common control with M&amp;I; 
<!-- PJG 0012 frnewline -->
(2) Such fiduciary, or any officer, director, partner, employee, or relative of the fiduciary is an officer, director,
partner or employee of M&amp;I (or is a relative of such persons); 
<!-- PJG 0012 frnewline -->
(3) Such fiduciary directly or indirectly receives any compensation or other consideration for his or her own personal
account in connection with any transaction described in this exemption. 
<!-- PJG 0012 frnewline -->
If an officer, director, partner or employee of M&amp;I (or relative of such persons), is a director of such Second
Fiduciary, and if her or she abstains from participation in: (i) The choice of the Client Plan's investment adviser,
(ii) the approval of any such purchase or sale between the Client Plan and the Funds, and (iii) the approval of any change
in fees charged to or paid by the Client Plan in connection with any of the transactions described in Sections I and II
above, then paragraph (g)(2) of this section shall not apply. 
<!-- PJG 0012 frnewline -->
(h) The term ``secondary service'' means a service other than an investment management, investment advisory, or
similar service, which is provided by M&amp;I to the Funds. However, for purposes of this exemption, the term ``secondary
service'' will not include any brokerage services provided to the Funds by M&amp;I for the execution of securities
transactions engaged in by the Funds. 
<!-- PJG 0012 frnewline -->
(i) The term ``Termination Form'' means the form supplied to the Second Fiduciary which expressly provides an election
to the Second Fiduciary to terminate on behalf of a Client Plan the authorization described in paragraph (j) of Section
II. Such Termination Form may be used at will by the Second Fiduciary to terminate an authorization without penalty
to the Client Plan and to notify M&amp;I in writing to effect a termination by selling the shares of the Funds held by
the Client Plan requesting such termination within one business day following receipt by M&amp;I of the form; provided
that if, due to circumstances beyond the control of M&amp;I, the sale cannot be executed within one business day, M&amp;I
shall have one additional business day to complete such sale.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 If the proposed exemption is granted, the exemption will be effective November 20, 1992. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Summary of Facts and Representations 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</DATE>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00154 </DOCNO>
<PARENT> FR940817-2-00080 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. Marshall &amp; Ilsley Trust Company (M&amp;I Trust) is a Wisconsin corporation with its principal offices located
at 770 North Water Street, Milwaukee, Wisconsin, and is a subsidiary of Marshall &amp; Ilsley Corporation (M&amp;I
Corp.), a bank holding company. M&amp;I Corp. and various affiliates (referred to herein as ``M&amp;I''), serve
as trustee, directed trustee, investment manager, or custodian for approximately 1,163 employee benefit plans.
As of September 30, 1992, M&amp;I had total assets of approximately $25.3 million and total assets under management
of approximately $4.86 billion.
<!-- PJG 0012 frnewline -->
M&amp;I represents that its status as a fiduciary with investment discretion for a Client Plan arises out of its relationship
as a trustee or investment manager for such Plan, but does not result from the rendering of any investment advice to
a Plan fiduciary that has investment discretion for the Client Plan. As a custodian or directed trustee of a Client
Plan, M&amp;I has custody of Plan assets, collects all income, performs bookkeeping and accounting services, generates
periodic statements of account activity and other reports, and makes payments or distributions from the account
as directed. However, M&amp;I has no duty as custodian or directed trustee to review investments or make recommendations,
acting only as directed by an authorized Second Fiduciary.
<!-- PJG 0012 frnewline -->
The Client Plans include various pension, profit sharing, and stock bonus plans as well as voluntary employees' beneficiary
associations, supplemental unemployment benefit plans, simplified employee benefit plans, retirement plans
for self-employed individuals (i.e., Keogh plans), and individual retirement accounts (IRAs).
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
13
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 M&amp;I, in its capacity as a fiduciary of the Client Plans, may exercise investment discretion for all or a portion
of he assets of such Client Plans.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
13
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
M&amp;I states that only pension, profit sharing and Keogh plans were invested in the CIFs at the time of the transfers
of assets from the CIFs to the Funds.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. M&amp;I requests an exemption for investments in a Fund which occur through an in-kind transfer of a Client Plan's
pro rata share of assets from a terminating CIF to a corresponding Fund in exchange for shares of such Fund.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
14
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 M&amp;I also requests an exemption for the receipt of fees from the Funds in connection with the investment of assets
of a Client Plan (including any assets of a Client Plan which were held in a terminating CIF) for which it acts as a trustee,
directed trustee, investment manager, or custodian, in shares of the Funds in instances where M&amp;I is an investment
adviser, custodian, and shareholder servicing agent for the Funds. The exemption would include Client Plans for
which M&amp;I exercises investment discretion as well as Client Plans where investment decisions are directed by
a Second Fiduciary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
14
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
M&amp;I is not requesting an exemption for any investment in the Funds by the M&amp;I Plans. M&amp;I represents that
the M&amp;I Plans may acquire or sell shares of the Funds pursuant to Prohibited Transaction Exemption 77&hyph;3
(PTE 77&hyph;3, 42 FR 18734, April 8, 1977). PTE 77&hyph;3 permits the acquisition or sale of shares of a registered,
open-end investment company by an employee benefit plan covering only employees of such investment company, employees
of the investment adviser or principal underwriter for such investment company, or employees of any affiliated person
(as defined therein) of such investment adviser or principal underwriter, provided certain conditions are met.
The Department is expressing no opinion in this proposed exemption regarding whether any transactions with the Funds
by the M&amp;I Plans would be covered by PTE 77&hyph;3.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Client Plans' pro rata share of fees paid by the Funds to M&amp;I for investment advisory services are credited
to the Client Plans, in accordance with the conditions of the proposed exemption (as discussed in Item 7 below), with
respect to the assets of the Client Plans involved in Fund investments. Any amounts received by M&amp;I for serving
as a custodian and shareholder servicing agent of the Funds are also currently credited to the Client Plans to the extent
that such amounts exceed M&amp;I's direct expenses for providing the service to the Funds. However, M&amp;I proposes
to retain such fees in the future. All investments in the Funds are made by M&amp;I pursuant to an initial written authorization
and an annual reauthorization of the investment by the Second Fiduciary. M&amp;I invests assets of a Client Plan in
any of the Funds for which it has received prior written authorization for such investment from the Second Fiduciary
during the period that the authorization is effective.
<!-- PJG 0012 frnewline -->
3. The Funds are a Wisconsin corporation organized as an open-end investment company registered under the 1940 Act.
The Funds currently consist of five Funds or ``portfolios'', each having a separate prospectus and representing
a distinct investment vehicle. The shares of each Fund represent a proportionate interest in the assets of that Fund.
The existing Funds include the Marshall Money Market Fund, the Marshall Government Income Fund, the Marshall Intermediate
Bond Fund, the Marshall Short-Term Income Fund, and the Marshall Stock Fund. M&amp;I states that additional Funds
may be established in the future. Shares of the Funds are offered and sold to eligible investors. Certain shares, identified
by each prospectus as Trust Shares, are offered to trust accounts of M&amp;I as a means of acquiring an interest in a
diversified porfolio of investments. M&amp;I states that the Trust Shares are offered to M&amp;I's trust customers,
including the Client Plans, under terms and conditions which are at least as favorable to such customers as the terms
and conditions involved in any other class of Fund shares. If the proposed exemption is granted, the exemption would
cover only investments by Client Plans in Trust Shares. Thus, all references herein to the transactions involving
the Client Plans refer only to the Trust Shares described by the prospectus for each Fund.
<!-- PJG 0012 frnewline -->
Investments of Client Plan assets in the Funds occur either through a transfer of assets from a terminating CIF, the
direct purchase of shares of the Funds for a Client Plan by M&amp;I, the transfer by M&amp;I of Client Plan assets from
one Fund to another Fund, or a daily automated sweep of uninvested cash of a Client Plan by M&amp;I into one or more Funds
previously designated by the Client Plan for sweeping such cash.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
15
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 All such investments for the Client Plans are made pursuant to the Second Fiduciary's prior written authorization
and annual reauthorization to M&amp;I (as described in Item 8 below).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
15
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
M&amp;I states that an automated sweep of uninvested cash is currently available as a means of investment by the Client
Plans into either the Marshall Money Market Fund, the Marshall Government Income Fund, and the Marshall Short-Term
Income Fund.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00155 </DOCNO>
<PARENT> FR940817-2-00080 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
4. Federated Securities Corporation (FSC) is the principal distributor for all shares of the Funds including Trust
Shares which are sold to the Client Plans.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
16
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 There are no fees for distribution expenses, pursuant to Rule 12b&hyph;1 under the 1940 Act, paid to FSC with respect
to the Trust Shares. In addition, M&amp;I does not and will not receive fees payable pursuant to Rule 12b&hyph;1 in
connection with transactions involving any shares of the Funds. The Trust Shares are charged for certain administrative
expenses of the Funds. FSC is a subsidiary of Federated Investors (Federated) which, through other subsidiaries,
acts as the transfer and dividend disbursing agent for the Funds and provides certain personnel and administrative
services for the Funds. Federated and its subsidiaries are unrelated to M&amp;I. However, M&amp;I Trust is the custodian
for the securities and cash of the Funds and Marshall Funds Investor Services (MFIS), another affiliate of M&amp;I
Corp., is the shareholder servicing agent for the Funds.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
16
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
According to the Fund prospectuses, investors may purchase shares of the Funds through M&amp;I Brokerage Services,
Inc. (M&amp;I Brokerage Services), an affiliate of M&amp;I Corp. However, the involvement of M&amp;I Brokerage
Services in selling Fund shares is limited to transactions through M&amp;I ``retail'' accounts_i.e., accounts
other than those accounts handled by M&amp;I Trust or other M&amp;I affiliated trust companies. M&amp;I represents
that purchases and sales of Fund shares for all M&amp;I trust accounts, including the Client Plans, are handled by
M&amp;I trust officers dealing directly with Federated, the Funds' distributor.
<!-- PJG 0012 frnewline -->
In addition, M&amp;I Brokerage Services does not provide portfolio execution services for the Funds. M&amp;I states
that securities transactions for a Fund's portfolio are executed by broker-dealers unrelated to M&amp;I and do not
generate commissions or other fees to M&amp;I Brokerage Services or any affiliate. The Department notes that for
purposes of this exemption the term ``secondary service'' does not include any brokerage services provided to the
Funds by M&amp;I for the execution of securities transactions engaged in by the Funds (see Section IV(h) above).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
5. M&amp;I Investment Management Corp. (M&amp;I Management), a wholly-owned subsidiary of M&amp;I Corp., serves
as the investment adviser for the Funds pursuant to investment advisory agreements with the Funds (the Agreements)
which allow M&amp;I Management to receive monthly investment advisory fees based on a percentage of the average daily
net assets of each of the Funds. The Agreements and the fees received by M&amp;I Management are approved by the Board
of Directors of the Funds (the Funds' Directors), in accordance with the applicable provisions of the 1940 Act. Any
changes in the fees are approved by the Funds' Directors. All of the Funds' Directors are independent of M&amp;I.
<!-- PJG 0012 frnewline -->
6. Prior to November 20, 1992, M&amp;I generally invested assets of Client Plans for which it acted as a trustee with
investment discretion in a series of CIFs. In addition, certain Client Plans where investment decisions are directed
by a Second Fiduciary generally used an M&amp;I CIF as an investment option for individual accounts in the Client Plans.
However, on Friday, November 20, 1992, M&amp;I terminated three of its CIFs_the M&amp;I Employee Benefit Money Market
Fund, the M&amp;I Employee Benefit Bond Fund, and the M&amp;I Employee Benefit Stock Fund. The assets in these CIFs
were transferred to the Marshall Money Market Fund, the Marshall Intermediate Bond Fund, and the Marshall Stock Fund,
respectively. Each CIF transferred its assets to the corresponding Fund in exchange for Trust Shares of that Fund
at the then current market value of the CIF assets, in accordance with Rule 17a&hyph;7 under the 1940 Act (as discussed
below).
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
17
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The CIFs were liquidated and the Trust Shares were distributed to the Client Plans, subject to the prior written consent
of the Second Fiduciary for the Client Plan. Any Client Plan that had not provided prior written approval for the transfer
of its CIF assets to the Funds, by the deadline set for such approvals, received a cash distribution of its pro rata share
of the CIF assets no later than Friday, November 20, 1992, preceding the transfers.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
17
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Rule 17a&hyph;7 permits transactions between investment funds that use the same investment adviser, subject to
certain conditions. Rule 17a&hyph;7 requires, among other things, that such transactions be effected at the ``independent
current market price'' for each security, involve only securities for which market quotations are readily available,
involve no brokerage commissions or other remuneration, and comply with valuation procedures adopted by the board
of directors of the investment company to ensure that all requirements of the Rule are satisfied.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The assets of the CIFs were reviewed by M&amp;I Management as investment adviser to the Funds, in coordination with
Federated Administrative Services (FAS), the Funds' third party administrator, to determine that the assets were
appropriate investments for the corresponding Funds. FAS created a portfolio accounting system to track the securities
to be acquired by the Funds. Prior to the transfer of CIF assets to the Funds, the Funds did not hold any securities or
other assets except cash or, as in the case of the Marshall Money Market Fund, U.S. Treasury Bills.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00156 </DOCNO>
<PARENT> FR940817-2-00080 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The transfer transactions occurred using market values as of the close of business on Friday, November 20, 1992. The
securities transferred from the CIFs were the same as the securities received by the Funds. The applicant states that
the value of the securities was determined in a single valuation by M&amp;I as investment adviser for the Funds, in
accordance with the requirement of Rule 17a-7(b) that transactions be effected at the ``independent current market
price'' of the securities. The valuation of the securities was performed in the same manner for both the CIF and the
corresponding Fund at the close of the same business day. Specifically, as required by the Rule, securities listed
on exchanges were valued at their closing prices on Friday, November 20, and unlisted securities were valued based
on the average of bid and ask quotations at the close of the market on Friday, November 20, obtained from three brokers
independent of M&amp;I. Any fees charged by the independent brokers for the bid and ask prices were paid by M&amp;I.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Each Client Plan that approved the CIF asset transfers to the Funds received account statements describing the asset
transfers either in mid-December 1992, if such Plans were on a monthly account statement schedule, or mid-January
1993, if such Plans were on a quarterly account statement schedule. The statements showed the disposition of the CIF
units from the Client Plan account and the acquisition by the account of Fund shares, both posted as of Monday, November
23, 1992.
<FOOTCITE>18</FOOTCITE>
 This information provided the affected Client Plans with written confirmation of the number of CIF units held by the
Client Plan immediately before the transfer, the related per unit value and the total dollar amount of such CIF units
as well as the number of shares of the Funds held by the Client Plan following the transfer, the related per share net
asset value, and the total dollar amount of such shares. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
18
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The applicant has provided the following example: Assume a Client Plan held 12,506 units of the M&amp;I Employee Benefit
Stock Fund prior to the asset transfers. The account statement showed a disposition of 12,506 units of M&amp;I Employee
Benefit Stock Fund, at a value of $72.08 per unit, on November 23, 1992, with total proceeds of $901,432.18. The statement
also showed a purchase on that same date of 90,143.218 shares of the Marshall Stock Fund, the Fund corresponding to
the M&amp;I Employee Benefit Stock Fund, at $10 per share, at a total cost of $901,432.18, the same amount as the proceeds
of the disposition from the M&amp;I Employee Benefit Stock Fund. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Thus, the applicant represents that as of November 23, 1992, Client Plans that were formerly invested in the terminated
CIFs held Trust Shares of the corresponding Funds which were of the same value, based on the Client Plans' pro rata share
of the underlying market value of the securities transferred to the Funds, as their assets in the CIF as of the close
of business on Friday, November 20, 1992. M&amp;I represents that the other CIFs may be terminated in the future and
that all such terminations and subsequent transfers of CIF assets for Trust Shares of the Funds will comply with Rule
17a-7 as described above and the conditions of this proposed exemption.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
19 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
19
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
On Friday, October 1, 1993, M&amp;I terminated the M&amp;I Dividend Fund and transferred its assets upon written
approval from the investors to a new Marshall Fund, the Marshall Equity Income Fund. The transfer of assets occurred
in the same manner as the asset transfers which occurred on November 20, 1992. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
M&amp;I states that for all subsequent transfers of CIF assets to a Fund following the publication of this proposed
exemption in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, M&amp;I will send by regular mail to each affected Client Plan a written confirmation, not later than 30 days after
completion of the transaction, containing the following information: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) The identity of each security that was valued for purposes of the transaction in accordance with Rule 17a-7(b)(4);

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) The price of each such security involved in the transaction; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) The identity of each pricing service or market maker consulted in determining the value of such securities. 
<!-- PJG 0012 frnewline -->
Securities which are valued in accordance with Rule 17a-7(b)(4) are securities for which the current market price
cannot be obtained by reference to the last sale price for transactions reported on a recognized securities exchange
or the NASDAQ system. M&amp;I states that such securities are valued based on an average of the highest current independent
bid and lowest current independent offer, as of the close of business on the Friday preceding the weekend of the CIF
transfers, determined on the basis of reasonable inquiry from at least three sources that are broker-dealers or pricing
services independent of M&amp;I. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In addition, for all in-kind transfers of CIF assets to a Fund that occur after the date this proposed exemption is published
in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, M&amp;I will send by regular mail to the Second Fiduciary no later than 90 days after completion of each transfer a
written confirmation that contains the following information: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) The number of CIF units held by the Client Plan immediately before the transfer, the related per unit value, and
the total dollar amount of such CIF units; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) The number of shares in the Funds that are held by the Client Plan following the transfer, the related per share net
asset value, and the total dollar amount of such shares. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
M&amp;I believes that the interests of the Client Plans are better served by the collective investment of assets of
the Client Plans in the Funds rather than in the CIFs. The Funds are valued on a daily basis, whereas the majority of the
CIFs are valued monthly. The daily valuation permits: (i) Immediate investment of Client Plan contributions in various
types of investments; (ii) greater flexibility in transferring assets from one type of investment to another; and
(iii) daily redemption of investments for purposes of making distributions. In addition, information concerning
the investment performance of the Funds will be available in newspapers of general circulation which will allow Client
Plan fiduciaries to monitor the performance of investments on a daily basis and make more informed investment decisions.

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00157 </DOCNO>
<PARENT> FR940817-2-00080 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
7. For investments in the Funds on behalf of Client Plans subsequent to the transfer of the CIF assets to the Funds where
the assets involved were not previously invested in any CIFs, M&amp;I currently offsets its investment management
or advisory fees for assets invested in the Funds in accordance with one of the methods for offsetting double investment
advisory fees described in Prohibited Transaction Exemption 77&hyph;4 (PTE 77&hyph;4, 42 FR 18732, April 8, 1977).
<FOOTCITE>20</FOOTCITE>
 Consequently, the applicant represents that the fee structure for these investments complies with the fee structure
under PTE 77&hyph;4, and that the other conditions of PTE 77&hyph;4 are met.
<FOOTCITE>21</FOOTCITE>
 However, for Client Plan investments in the Funds with respect to assets that were previously held in the CIFs prior
to the investment of such assets in the Funds, M&amp;I uses the fee structure (the Fee Structure) described below.
M&amp;I anticipates using the Fee Structure for future Client Plan investments in the Funds where the assets involved
were not previously invested in the CIFs if the Second Fiduciary for the Client Plan elects to use the Fee Structure
in lieu of the offset or credit methods prescribed by PTE 77&hyph;4. M&amp;I states that the Fee Structure preserves
a Client Plan's existing fee rates for investment management services by M&amp;I when such Plan invests in the Funds
or when such Plan's assets are transferred from the CIFs to the Funds. The Fee Structure is described as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
20
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
PTE 77&hyph;4, in pertinent part, permits the purchase and sale by an employee benefit plan of shares of a registered,
open-end investment company when a fiduciary with respect to the plan is also the investment adviser for the investment
company, provided that, among other things, the plan does not pay an investment management, investment advisory
or similar fee with respect to the plan assets invested in such shares for the entire period of such investment. Section
II(c) of PTE 77&hyph;4 states that this condition does not preclude the payment of investment advisory fees by the
investment company under the terms of an investment advisory agreement adopted in accordance with section 15 of the
Investment Company Act of 1940. Section II(c) states further that this condition does not preclude payment of an investment
advisory fee by the plan based on total plan assets from which a credit has been subtracted representing the plan's
pro rata share of investment advisory fees paid by the investment company. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
21
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The Department is expressing no opinion in this proposed exemption regarding whether any transactions with the Funds
under the circumstances described herein would be covered by PTE 77&hyph;4. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(a) M&amp;I charges its standard fees to all the Client Plans for serving as a trustee, directed trustee, investment
manager, or custodian for the Client Plans.
<FOOTCITE>22</FOOTCITE>
 All fees are billed on a quarterly basis. The annual charges for a Client Plan account are based on fee schedules negotiated
with M&amp;I. For example, if the fee is unbundled, the standard charge by M&amp;I to a Client Plan for serving as a trustee
with solely custodial responsibilities varies from 17.5 basis points for account assets under $5 million to 5 basis
points for account assets over $75 million, subject to a base annual charge of $1,500 and additional charges for specific
services. Where M&amp;I serves as investment manager to a Client Plan account, depending on the type of portfolio,
the charge may vary from 30 basis points up to 80 basis points. This charge is separate from, and would be in addition
to, the fee for custodial services described above. M&amp;I provides services to the Client Plans for which it acts
as a trustee with investment discretion, including sweep services for uninvested cash balances in such Plans, under
a bundled or single fee arrangement which is calculated as a percentage of the market value of the Plan assets under
management. Thus, in such instances, there are no separate charges for the provision of particular services to the
Client Plans. However, for Client Plans where investment decisions are directed by a Second Fiduciary, a separate
charge is assessed for particular services, including sweep services, where the Second Fiduciary specifically
agrees to have M&amp;I provide such services to the Client Plan.
<FOOTCITE>23</FOOTCITE>
 M&amp;I states that in many cases fees charged by M&amp;I to a Client Plan are paid by the Client Plan sponsor rather
than by the Client Plan. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
22
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The applicant represents that all fees paid by Client Plans directly to M&amp;I for services performed by M&amp;I
are exempt from the prohibited transaction provisions of the Act by reason of section 408(b)(2) of the Act and the regulations
thereunder (see 29 CFR 2550.408b&hyph;2). The Department notes that to the extent there are prohibited transactions
under the Act as a result of services provided by M&amp;I directly to the Client Plans which are not covered by section
408(b)(2), no relief is being proposed herein for such transactions. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
23
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
See DOL Letter dated August 1, 1986 to Robert S. Plotkin, Assistant Director, Division of Banking Supervision and
Regulation, Board of Governors of the Federal Reserve System, stating the Department's views regarding the application
of the prohibited transaction provisions of the Act to sweep services provided to plans by fiduciary banks and the
potential applicability of certain statutory exemptions as described therein. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(b) M&amp;I Management charges the Funds for its services to the Funds as investment adviser, in accordance with the
Agreements between M&amp;I and the Funds. Under the Agreements, M&amp;I Management charges fees at a different rate
for each Fund, computed based on the average daily net assets for the respective Fund. The fee differentials among
the Funds result from the particular level of services rendered by M&amp;I Management to the Funds. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00158 </DOCNO>
<PARENT> FR940817-2-00080 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(c) The investment advisory and other fees paid by each of the existing Funds are accrued on a daily basis and billed
by M&amp;I Management to the Funds at the beginning of the month following the month in which the fees accrued. The applicant
states that any additional Funds will follow the same monthly billing arrangement. 
<!-- PJG 0012 frnewline -->
(d) At the beginning of each month (pursuant to the terms of the applicable Agreements) and essentially simultaneously
with the billing described in (c) above, but in no event more than one business day following the receipt of such fees
by M&amp;I Management, M&amp;I credits to each Client Plan directly with cash such Plan's pro rata share of all investment
advisory fees charged by M&amp;I Management to the Funds (the Credit Program). In addition, M&amp;I currently credits
to each Client Plan any amounts it is paid for providing custody and shareholder services to the Funds in the same manner
as the investment advisory fees but only to the extent that these amounts exceed M&amp;I's direct expenses for providing
such services. However, M&amp;I proposes in the future to retain any fees received by M&amp;I from the Funds for custody
and shareholder services or other secondary services.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
24 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
24
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
M&amp;I states that such secondary services are distinct from the services provided by M&amp;I as trustee to a Client
Plan. Trustee services rendered at the Plan-level include maintaining custody of the assets of the Client Plan (including
the Fund shares, but not the assets underlying the Fund shares), processing benefit payments, maintaining participant
accounts, valuing plan assets, conducting non-discrimination testing, preparing Forms 5500 and other required
filings, and producing statements and reports regarding overall plan and individual participant holdings. These
trustee services are necessary regardless of whether the Client Plan's assets are invested in the Funds. Thus, M&amp;I
represents that its proposed receipt of fees for both secondary services at the Fund-level and trustee services at
the Plan-level would not involve the receipt of ``double fees'' for duplicative services to the Client Plans because
a Fund is charged for custody and other services relative to the individual securities owned by the Fund, while a Client
Plan is charged for the maintenance of Plan accounts reflecting ownership of the Fund shares and other assets. 
<!-- PJG 0012 frnewline -->
In this regard, the Department notes that the combined total of all fees received by M&amp;I directly and indirectly
from the Client Plans for the provision of services to the Plans and/or to the Funds should not be in excess of ``reasonable
compensation'' within the meaning of section 408(b)(2) of the Act. 
<!-- PJG 0012 frnewline -->
In addition, the fact that certain transactions and fee arrangements are the subject of an administrative exemption
does not relieve a Client Plan fiduciary from the general fiduciary responsibility provisions of section 404 of the
Act. Thus, the Department cautions the fiduciaries of the Client Plans investing in the Funds that they have an ongoing
duty under section 404 of the Act to monitor the services provided to the Client Plans to assure that the fees paid by
the Client Plans for such services are reasonable in relation to the value of the services provided. Such responsibilities
would include determinations that the services provided are not duplicative and that the fees are reasonable in light
of the level of services provided. 
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
M&amp;I represents that the credited fees are currently paid to the Client Plan only in cash, but that the credits may
be effectuated in the future through the purchase of additional shares of the Funds pursuant to an annual election
made by the Second Fiduciary for the Client Plan. The purchase of the shares will occur in lieu of a cash credit on the
same day that such credit would have been paid to the Client Plan. M&amp;I states that the fee credits were initially
made in cash to the Client Plans so that no authorizations for crediting fees in the form of additional shares of the
Funds would be involved at the time of the transfers of the CIF assets to the Funds. All decisions regarding the use of
the credited fees to purchase additional shares of the Funds, including annual reauthorizations for such credits,
will be made by a Second Fiduciary for the Client Plan. 
<!-- PJG 0012 frnewline -->
The Credit Program ensures that M&amp;I does not receive any additional investment management, advisory or similar
fees from the Funds as a result of investments in the Funds by the Client Plans. Thus, M&amp;I represents that the Fee
Structure is at least as advantageous to the Client Plans as an arrangement pursuant to the conditions of PTE 77&hyph;4
whereby investment advisory fees paid by the Funds to M&amp;I Management would be offset or credited against investment
management fees charged directly by M&amp;I to the Client Plans. In this regard, M&amp;I states that the Credit Program
essentially has the same effect in offsetting M&amp;I Management's investment advisory fees as an arrangement under
PTE 77&hyph;4, section II(c), allowing for a credit by subtracting the amount of such fees from the investment management
fees charged directly by M&amp;I to the Client Plans (the Subtraction Method). M&amp;I states further that in many
instances the Credit Program is more advantageous to a Client Plan than an arrangement using the Subtraction Method
because under the Credit Program a Client Plan receives a credit in either cash or shares on the same day (or within one
business day after) the fees are received by M&amp;I Management from the Funds. However, under the Subtraction Method,
a Client Plan would not receive a credit on the same day (or within one business day after) the fees are paid to M&amp;I
Management from the Funds if the billing period for services to the Funds is different than the billing period for M&amp;I's
fiduciary services to the Client Plan. The Fee Structure with the Credit Program allows M&amp;I to maintain a fixed
fiduciary fee schedule for services to the Client Plans without any adjustments in billing for such services, as required
under the Subtraction Method. M&amp;I notes that the Fee Structure also allows the Client Plan sponsor the option
to pay the Client Plan's fees to M&amp;I for serving as a trustee, directed trustee, investment manager, or custodian
and have the Client Plan receive a credit of the Plan's pro rata share of the investment advisory fees paid to M&amp;I.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
25 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
25
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
To the extent that the Department of the Treasury determines that this arrangement should be deemed a contribution
by an employer to a Client Plan of the credited fees, the transaction must be examined under the applicable provisions
of the Internal Revenue Code, including sections 401(a)(4), 404 and 415. 
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
M&amp;I is responsible for establishing and maintaining a system of internal accounting controls for the Credit
Program. In addition, M&amp;I has retained the services of Arthur Anderson &amp; Co. of Milwaukee, Wisconsin (the
Auditor), an independent accounting firm, to audit annually the crediting of fees to the Client Plans under the Credit
Program. M&amp;I states that such audits provide independent verification of the proper crediting to the Client
Plans of fees charged by M&amp;I to the Funds. M&amp;I states further that information obtained from the audits is
used in the preparation of required financial disclosure reports to the Client Plans' fiduciaries. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00159 </DOCNO>
<PARENT> FR940817-2-00080 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
By letter dated November 6, 1992, the Auditor describes the procedures that are used in the annual audit of the Credit
Program. The Auditor obtains: (i) A calculation of the daily actual balances for all the Funds and for the total Client
Plan shareholders of such Funds; (ii) a detailed list of the expenses charged to the Funds' shareholders by type of
expense; and (iii) calculations of the total expenses charged by M&amp;I to each Fund which are reimbursable to the
Client Plans. On the basis of such information, the Auditor: (i) Reviews and tests compliance with the Credit Program's
operational controls and procedures established by M&amp;I; (ii) verifies the daily credit factors transmitted
to M&amp;I from the Funds, including the proper assignment of identification numbers to all Client Plan shareholders;
and (iii) verifies the credits paid in total to the sum of all credits paid to each Client Plan. The Auditor recomputes,
in total, the cash received in connection with the credit of each Client Plan's expenses to ensure that the proper amount
of cash was issued to the Client Plan. Finally, the Auditor recomputes on a test basis the amount of credits received
by selected Client Plan shareholders of the Funds to verify that such credits were properly made. In this regard, the
Auditor obtains a listing of the credits paid to each Client Plan regarding its shares in each of the Funds to determine
that the total credit paid to the Client Plan by M&amp;I equals the total amount that was required to be credited. At
such time as M&amp;I offers Client Plans the option to have the fees credited as additional Fund shares, the Auditor
will also recompute the number of Fund shares issued to the Client Plans to ensure that each Client Plan received the
proper number of shares. 
<!-- PJG 0012 frnewline -->
In the event either the internal audit by M&amp;I or the independent audit by the Auditor identifies that an error has
been made in the crediting of fees to the Client Plans, M&amp;I will correct the error. With respect to any shortfall
in credited fees to a Client Plan involving cash credits, M&amp;I will make a cash payment to the Client Plan equal to
the amount of the error plus interest paid at money market rates offered by M&amp;I for the period involved. With respect
to a shortfall in credited fees involving a Client Plan where the Second Fiduciary's election is to have credited fees
invested in shares of a particular Fund, M&amp;I will make a cash payment equal to at least the amount of the error plus
interest based on the greater of either: (i) The money market rates offered by M&amp;I for the period involved, or (ii)
the total rate of return for shares of the Fund that would have been acquired during such period. Any excess credits
made to a Client Plan will be corrected by an appropriate deduction and reallocation of cash during the next payment
period to reflect accurately the amount of total credits due to the Client Plan for the period involved. 
<!-- PJG 0012 frnewline -->
8. With respect to any transfer of a Client Plan's CIF assets to a Fund, M&amp;I states that a Second Fiduciary for the
Client Plan receives advance written notice of the in-kind transfer of assets of the CIFs and full written disclosure
of information concerning the Fund. On the basis of such information, the Second Fiduciary authorizes in writing
the in-kind transfer of the Client Plan's CIF assets to a Fund in exchange for shares of the Fund. With respect to the
receipt of fees by M&amp;I from a Fund in connection with any Client Plan's investment in the Fund, M&amp;I states that
a Second Fiduciary receives full and detailed written disclosure of information concerning the Fund in advance of
any investment by the Client Plan in the Fund. On the basis of such information, the Second Fiduciary authorizes in
writing the investment of assets of the Client Plan in the Fund and the fees to be paid by the Fund to M&amp;I. Such authorization
will include in the future an election for the Second Fiduciary to purchase additional shares of the Fund with the fees
credited to the Client Plan by M&amp;I. In addition, M&amp;I represents that the Second Fiduciary of each Client Plan
invested in a particular Fund will receive full written disclosure, in a statement separate from the Fund prospectus,
of any proposed increases in the rates of fees charged by M&amp;I to the Funds for secondary services which are above
the rate reflected in the prospectus for the Fund, at least 30 days prior to the effective date of such increase. The
Second Fiduciary will also receive full written disclosure in a Fund prospectus or otherwise of any increases in the
rate of fees charged by M&amp;I to the Funds for investment advisory services even though such fees will be credited,
as required by Section II(d) above. 
<!-- PJG 0012 frnewline -->
Any authorizations by a Second Fiduciary regarding the investment of a Client Plan's assets in a Fund and the fees to
be paid to M&amp;I, including any future increases in rates of fees for secondary services, are or will be terminable
at will by the Second Fiduciary, without penalty to the Client Plan, upon receipt by M&amp;I of written notice of termination.
A Termination Form expressly providing an election to terminate the authorization with instructions on the use of
the form is supplied to the Second Fiduciary no less than annually. The instructions for the Termination Form include
the following information: 
<!-- PJG 0012 frnewline -->
(a) The authorization is terminable at will by the Client Plan, without penalty to the Client Plan, upon receipt by
M&amp;I of written notice from the Second Fiduciary; and 
<!-- PJG 0012 frnewline -->
(b) Failure to return the form will result in continued authorization of M&amp;I to engage in the subject transactions
on behalf of the Client Plan. 
<!-- PJG 0012 frnewline -->
M&amp;I states that the Termination Form may be used at will by the Second Fiduciary to terminate an authorization
without penalty to the Client Plan and to notify M&amp;I in writing to effect a termination by selling the shares of
the Funds held by the Client Plan requesting such termination within one business day following receipt by M&amp;I
of the form; provided that if, due to circumstances beyond the control of M&amp;I, the sale cannot be executed within
one business day, M&amp;I shall have one additional business day to complete such sale. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00160 </DOCNO>
<PARENT> FR940817-2-00080 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Any disclosure of information regarding a proposed increase in the rate of any fees for secondary services will be
accompanied by an additional Termination Form with instructions on the use of the form as described above. Therefore,
the Second Fiduciary will have prior notice of the proposed increase and an opportunity to withdraw from the Funds
in advance of the date the increase becomes effective. Although the Second Fiduciary will also have notice of any increase
in the rates of fees charged by M&amp;I to the Funds for investment advisory services, through an updated prospectus
or otherwise, such notice will not be accompanied by an additional Termination Form since all increases in investment
advisory fees will be credited by M&amp;I to the Client Plans and will be subject to an annual reauthorization as described
above. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
M&amp;I states that the Second Fiduciary always receives a current prospectus for each Fund and a written statement
giving full disclosure of the Fee Structure prior to any investment in the Funds. The disclosure statement explains
why M&amp;I believes that the investment of assets of the Client Plan in the Funds is appropriate. The disclosure statement
also describes whether there are any limitations on M&amp;I with respect to which Client Plan assets may be invested
in shares of the Funds and, if so, the nature of such limitations.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
26 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
26
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
See section II(d) of PTE 77&hyph;4 which requires, in pertinent part, that an independent plan fiduciary receive
a current prospectus issued by the investment company and a full and detailed written disclosure of the investment
advisory and other fees charged to or paid by the plan and the investment company, including a discussion of whether
there are any limitations on the fiduciary/investment adviser with respect to which plan assets may be invested in
shares of the investment company and, if so, the nature of such limitations. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
M&amp;I states further that the Second Fiduciary receives an updated prospectus for each Fund at least annually and
either annual or semi-annual reports for each Fund. M&amp;I provides monthly reports to the Second Fiduciary of all
transactions engaged in by the Client Plan, including purchases and sales of Fund shares. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
9. No sales commissions are paid by the Client Plans in connection with the purchase or sale of shares of the Funds. In
addition, no redemption fees are paid in connection with the sale of shares by the Client Plans to the Funds. The applicant
states that all other dealings between the Client Plans and the Funds, M&amp;I Management or any affiliate, are on
a basis no less favorable to the Client Plans than such dealings are with the other shareholders of the Funds. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
10. In summary, M&amp;I represents that the transactions described herein satisfy the statutory criteria of section
408(a) of the Act because: (a) The Funds provide the Client Plans with a more effective investment vehicle than the
CIFs maintained by M&amp;I without any increase in investment management, advisory or similar fees paid to M&amp;I;
(b) with respect to the transfer of a Client Plan's CIF assets into a Fund in exchange for Fund shares, a Second Fiduciary
authorizes in writing such transfer prior to the transaction only after full written disclosure of information concerning
the Fund; (c) each Client Plan receives shares of a Fund in connection with the transfer of assets of a terminating CIF
which have a net asset value that is equal to the value of the Client Plan's pro rata share of the CIF assets on the date
of the transfer, based on the current market value of such assets as determined in a single valuation at the close of
the same business day using independent sources in accordance with procedures established by the Fund which comply
with Rule 17a-7 of the 1940 Act; (d) with respect to any investments in a Fund by the Client Plans and the payment of any
fees by the Fund to M&amp;I, a Second Fiduciary receives full written disclosure of information concerning the Fund,
including a current prospectus and a statement describing the Fee Structure, and authorizes in writing the investment
of the Client Plan's assets in the particular Fund and the fees paid by such Fund to M&amp;I; (e) any authorizations
made by a Client Plan regarding investments in a Fund and fees paid to M&amp;I, or any increases in the rates of fees for
secondary services which are retained by M&amp;I, are or will be terminable at will by the Client Plan, without penalty
to the Client Plan, upon receipt by M&amp;I of written notice of termination from the Second Fiduciary; (f) M&amp;I
requires annual audits by an independent accounting firm to verify the proper crediting to the Client Plans of fees
charged by M&amp;I to the Funds; (g) no commissions or redemption fees are paid by the Client Plan in connection with
either the acquisition of Fund shares, through either a direct purchase of the shares or a transfer of CIF assets in
exchange for the shares, or the sale of Fund shares; and (h) all dealings between the Client Plans, the Funds and M&amp;I,
are on a basis which is at least as favorable to the Client Plans as such dealings are with other shareholders of the Funds.

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Notice to Interested Persons
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Notice of the proposed exemption shall be given to all Second Fiduciaries of Client Plans described herein that had
investments in a terminating CIF and from whom approval was sought, or will be sought prior to the granting of this proposed
exemption, for a transfer of a Client Plan's CIF assets to a Fund. In addition, interested persons shall include the
Second Fiduciaries of all Client Plans which have invested in the Funds, from the effective date of the proposed exemption
(November 20, 1992) until the date the notice of the proposed exemption is published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, where M&amp;I has provided services to the Funds and received fees which would be covered by the exemption, if granted.
Notice to interested persons shall be provided by first class mail within fifteen (15) days following the publication
of the proposed exemption in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. Such notice shall include a copy of the notice of proposed exemption as published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and a supplemental statement (see 29 CFR 2570.43(b)(2)) which informs all interested persons of their right to comment
on and/or request a hearing with respect to the proposed exemption. Comments and requests for a public hearing are
due within forty-five (45) days following the publication of the proposed exemption in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Mr. E. F. Williams of the Department, telephone (202) 219&hyph;8194. (This is not a toll-free number.) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00161 </DOCNO>
<PARENT> FR940817-2-00080 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=85 g=1 f=1 -->
New Standard Corporation Pension Plan (the Plan) Located in Mt. Joy, Pennsylvania; Proposed Exemption
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Application No. D&hyph;9698] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Department is considering granting an exemption under the authority of section 408(a) of the Act and section 4975(c)(2)
of the Code and in accordance with the procedures set forth in 29 CFR Part 2570, Subpart B (55 FR 32836, 32847, August
10, 1990). If the exemption is granted, the restrictions of sections 406(a) and 406(b) (1) and (2) of the Act and the
sanctions resulting from the application of section 4975 of the Code, by reason of section 4975(c)(1) (A) through
(E) of the Code, shall not apply to the sale of a certain parcel of real property (the Property) from the Plan to New Standard
Corporation (the Employer), a party in interest with respect to the Plan, provided that the following conditions
are met: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. The fair market value of the Property is established by a real estate appraiser independent of the Plan and the Employer;

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. The Employer pays the greater of $115,000 or the current fair market value of the Property (excluding site improvements)
with the enhancement value for an adjoining owner as of the date of sale; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. The sale is a one-time transaction for cash; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. The Plan pays no fees or commissions in regard to the sale; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
5. The Employer pays any applicable excise taxes to the Internal Revenue Service under section 4975(a) of the Code
resulting from its use of the Property since October 1993. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Summary of Facts and Representations
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. The Employer is a metal stampings manufacturing concern with offices in Mt. Joy and Hellam Township, Pennsylvania.
The Plan is a defined benefit plan which had approximately 66 participants and total assets of approximately $1,083,139
as of the time of filing of the exemption application. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. The Plan purchased the Property in April 1978 from unrelated parties for a purchase price of $22,689 in cash. The
Property is a vacant lot of about 2.51 acres located in Hellam Township adjacent to property of the Employer. The adjacent
property includes a one-story manufacturing and warehouse complex utilized by the Employer. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The total cost to the Plan of acquiring and holding the Property since the time of purchase has been only the original
purchase price. All taxes and other costs related to the holding of the Property by the Plan have been paid by the Employer.
A small portion of the lot was recently paved at the expense of the Employer to provide an additional parking opportunity
to the Employer, and certain other improvements to the Property (including storm sewer installation and driveway
access) have been financed by the Employer. The Employer has expended a total of $72,260, including taxes, on the Property
since the time it was acquired by the Plan. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. The applicant obtained an appraisal on the Property dated April 14, 1994, from B. Daniel Wagner, MAI (Wagner) of
Associated Appraisers in York, Pennsylvania. The applicant represents that Wagner is independent of the Plan and
the Employer. Wagner states that he is aware that the Employer is the owner of contiguous property and is the prospective
buyer of the Property. In Wagner's opinion, the fair market value of the Property (excluding site improvements which
were constructed at the expense of the Employer) to an adjoining owner and including the enhancement value for such
adjoining owner was $115,000 as of the date of the appraisal. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. The Plan now proposes to sell the Property to the Employer. The Employer will pay the greater of the current fair market
value of the Property (excluding site improvements) for an adjoining owner, based on an updated independent appraisal,
or the total amount the Plan has expended on the Property as of the date of sale. The sale of the Property will be entirely
for cash, and the Plan will pay no fees or commissions in regard to the transaction. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The applicant represents that portion of the Property which was paved for parking has been utilized by employees of
the Employer. This parking area contains 48 spaces and was completed in October 1993. A supplement to the above described
appraisal, prepared by Wagner on June 20, 1994, estimates the total fair market rental for such usage to be approximately
$350 per month. The Employer will compensate the Plan in that amount for the period of time the Employer has utilized
the parking area from October 1993 to the date of sale of the Property.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
27 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
27
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The applicant recognizes that the use of a portion of the Property for parking purposes of the Employer may have constituted
prohibited transactions under section 406 of the Act and section 4975 of the Code. Accordingly, the Employer will
pay the Internal Revenue Service any excise taxes that are applicable under section 4975(a) of the Code within 90 days
of the publication in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 of the grant of this proposed exemption. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
5. In summary, the applicant represents that the proposed transaction will satisfy the statutory criteria of section
408(a) of the Act because: (1) The fair market value of the Property will be established by a real estate appraiser independent
of the Plan and the Employer; (2) the Employer will pay the greater of the current fair market value of the Property (excluding
site improvements) for an adjoining owner or the total amount the Plan has expended on the Property; (3) the Plan will
pay no fees or commissions in connection with the sale; and (4) the sale of the Property will be an all cash transaction.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Paul Kelty of the 
<!-- PJG 0012 frnewline -->
Department, telephone (202) 219&hyph;8883. (This is not a toll-free number.) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00162 </DOCNO>
<PARENT> FR940817-2-00080 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
General Information
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The attention of interested persons is directed to the following:
<!-- PJG 0012 frnewline -->
(1) The fact that a transaction is the subject of an exemption under section 408(a) of the Act and/or section 4975(c)(2)
of the Code does not relieve a fiduciary or other party in interest of disqualified person from certain other provisions
of the Act and/or the Code, including any prohibited transaction provisions to which the exemption does not apply
and the general fiduciary responsibility provisions of section 404 of the Act, which among other things require a
fiduciary to discharge his duties respecting the plan solely in the interest of the participants and beneficiaries
of the plan and in a prudent fashion in accordance with section 404(a)(1)(b) of the act; nor does it affect the requirement
of section 401(a) of the Code that the plan must operate for the exclusive benefit of the employees of the employer maintaining
the plan and their beneficiaries; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) Before an exemption may be granted under section 408(a) of the Act and/or section 4975(c)(2) of the Code, the Department
must find that the exemption is administratively feasible, in the interests of the plan and of its participants and
beneficiaries and protective of the rights of participants and beneficiaries of the plan; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) The proposed exemptions, if granted, will be supplemental to, and not in derogation of, any other provisions of
the Act and/or the Code, including statutory or administrative exemptions and transitional rules. Furthermore,
the fact that a transaction is subject to an administrative or statutory exemption is not dispositive of whether the
transaction is in fact a prohibited transaction; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(4) The proposed exemptions, if granted, will be subject to the express condition that the material facts and representations
contained in each application are true and complete and accurately describe all material terms of the transaction
which is the subject of the exemption. In the case of continuing exemption transactions, if any of the material facts
or representations described in the application change after the exemption is granted, the exemption will cease
to apply as of the date of such change. In the event of any such change, application for a new exemption may be made to the
Department.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Signed at Washington, DC, this 11th day of August, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Ivan Strasfeld, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Director of Exemption Determinations, Pension and Welfare Benefits Administration, U.S. Department of Labor.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20010 Filed 8&hyph;16&hyph;94; 8:45 am] 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4510&hyph;29&hyph;P 
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00163 </DOCNO>
<PARENT> FR940817-2-00081 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Prohibited Transaction Exemption 94&hyph;61; </RINDOCK>
<!-- PJG 0012 frnewline -->
Exemption Application No. D&hyph;9230, et al.] 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Grant of Individual Exemptions; Batterymarch Financial Management, et al. </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Pension and Welfare Benefits Administration, Labor.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Grant of Individual Exemptions.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This document contains exemptions issued by the Department of Labor (the Department) from certain of the prohibited
transaction restrictions of the Employee Retirement Income Security Act of 1974 (the Act) and/or the Internal Revenue
Code of 1986 (the Code). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Notices were published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of the pendency before the Department of proposals to grant such exemptions. The notices set forth a summary of facts
and representations contained in each application for exemption and referred interested persons to the respective
applications for a complete statement of the facts and representations. The applications have been available for
public inspection at the Department in Washington, D.C. The notices also invited interested persons to submit comments
on the requested exemptions to the Department. In addition the notices stated that any interested person might submit
a written request that a public 
<!-- PJG 0012 frnewline -->
hearing be held (where appropriate). The applicants have represented that they have complied with the requirements
of the notification to interested persons. No public comments and no requests for a hearing, unless otherwise stated,
were received by the Department. 
<!-- PJG 0012 frnewline -->
The notices of proposed exemption were issued and the exemptions are being granted solely by the Department because,
effective December 31, 1978, section 102 of Reorganization Plan No. 4 of 1978 (43 FR 47713, October 17, 1978) transferred
the authority of the Secretary of the Treasury to issue exemptions of the type proposed to the Secretary of Labor. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Statutory Findings 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In accordance with section 408(a) of the Act and/or section 4975(c)(2) of the Code and the procedures set forth in 29
CFR Part 2570, Subpart B (55 FR 32836, 32847, August 10, 1990) and based upon the entire record, the Department makes
the following findings: 
<!-- PJG 0012 frnewline -->
(a) The exemptions are administratively feasible; 
<!-- PJG 0012 frnewline -->
(b) They are in the interests of the plans and 
<!-- PJG 0012 frnewline -->
their participants and beneficiaries; and 
<!-- PJG 0012 frnewline -->
(c) They are protective of the rights of the 
<!-- PJG 0012 frnewline -->
participants and beneficiaries of the plans. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUMMARY>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00164 </DOCNO>
<PARENT> FR940817-2-00081 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Batterymarch Financial Management (BFM) 
<!-- PJG 0012 frnewline -->
Located in Boston, Massachusetts; Exemption
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Prohibited Transaction Exemption 94&hyph;61; 
<!-- PJG 0012 frnewline -->
Application No. D&hyph;9230] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The restrictions of section 406(b)(2) of the Act shall not apply to the proposed cross-trading of equity securities
between various accounts managed by BFM (the Accounts) where at least one Account involved in any cross-trade is an
employee benefit plan account (Plan Account) for which BFM acts as a fiduciary. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Conditions and Definitions 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This exemption is subject to the following conditions: 
<!-- PJG 0012 frnewline -->
1. (a) Each Plan Account's participation in the cross-trade program is subject to BFM's receipt of a written authorization
executed in advance by a qualified Plan fiduciary, which is independent of BFM and its Affiliates (the Independent
Fiduciary). 
<!-- PJG 0012 frnewline -->
(b) The authorization referred to in paragraph (a) is terminable at will, without penalty to the Plan Account, upon
receipt by BFM of written notice of termination. 
<!-- PJG 0012 frnewline -->
(c) Before an authorization is made for any Account, an independent account representative, which must be an Independent
Fiduciary in the case of a Plan Account (collectively, an Independent Account Representative) must be furnished
with any reasonable available information necessary for the Independent Account Representative to determine whether
the authorization should be made, including (but not limited to) a copy of the proposed and final exemption issued
by the Department, an explanation of how the authorization may be terminated, a description of BFM's cross-trade
practices, and any other information requested by the Independent Account Representative. 
<!-- PJG 0012 frnewline -->
2. Each cross-trade transaction must satisfy the following: 
<!-- PJG 0012 frnewline -->
(a) The cross-trade opportunity must be triggered as a result of an Account participating in the program experiencing
a need to sell equity securities arising from one of the following three circumstances: 
<!-- PJG 0012 frnewline -->
(i) the Independent Account Representative specifically directs that all of the assets in the Account be liquidated;

<!-- PJG 0012 frnewline -->
(ii) the Independent Account Representative specifically directs that a portion of the Account be liquidated and
the selection of the particular equity securities to be sold is made either by the Independent Account Representative
or by an optimization program used by BFM (the Optimization Program) which operates, pursuant to certain prescribed
objective criteria, to automatically generate an optimal portfolio for such Accounts; or 
<!-- PJG 0012 frnewline -->
(iii) the application of the Optimization Program to the specific investment objectives and restrictions established
by the Independent Account Representative requires the sale of a security which is otherwise ranked by BFM as a buy
or a hold for all relevant Accounts under the Stock Evaluation Process. 
<!-- PJG 0012 frnewline -->
(b) With respect to each cross-trade opportunity triggered under paragraph 2(a), the Optimization Program used
by BFM must determine, in the ordinary course of its considering all available equity securities in the applicable
universe, that another Account or Accounts participating in the program should purchase some or all of the available
equity securities. 
<!-- PJG 0012 frnewline -->
(c) The cross-trade transaction must take place within three business days of the ``triggering event'' giving rise
to the cross-trade opportunity described in paragraph 2(a) above. 
<!-- PJG 0012 frnewline -->
(d) The cross-trade transaction must be effected through a broker which is unaffiliated with BFM and its Affiliates.

<!-- PJG 0012 frnewline -->
(e) The Independent Account Representative of each Account engaging in a cross-trade transaction must be provided
with a written confirmation of the cross-trade transaction within 10 days after the completion of the transaction.
The confirmation must set forth: 
<!-- PJG 0012 frnewline -->
(i) the particular equity securities involved; 
<!-- PJG 0012 frnewline -->
(ii) the number of shares involved; 
<!-- PJG 0012 frnewline -->
(iii) the price at which the transaction was executed; and 
<!-- PJG 0012 frnewline -->
(iv) the specific triggering event, identified above in paragraph 2(a), which caused the cross-trade transaction
to occur. 
<!-- PJG 0012 frnewline -->
3. (a) Each cross-trade must be effected at the closing price for the equity securities involved on the date of the transaction,
as quoted by the exchange on which such securities are principally traded or by the NASDAQ National Market System (NASDAQ).
In the case of domestic equity securities traded over-the-counter, other than those traded on NASDAQ, the price must
be the mean between the closing daily ``bid'' and ``asked'' prices on the date of the transactions, obtained from recognized
independent sources, unless such securities have actually traded within 24 hours of the cross-trade transaction
in which case the price must be the last sale price for the securities. If more than one source is used by BFM to price a
particular domestic equity security traded over-the-counter, then the price must be equal to the average of the highest
current independent bid and lowest current independent offer obtained from such sources. No foreign equity securities,
other than those traded on a recognized foreign securities exchange for which market quotations are readily available,
shall be cross-traded by the Accounts. 
<!-- PJG 0012 frnewline -->
(b) The equity securities involved in the cross-trade are those for which there is a generally recognized market with
adequate pricing information to enable BFM to use the Optimization Program for the Accounts in the transaction. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00165 </DOCNO>
<PARENT> FR940817-2-00081 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(c) The cross-trade must involve less than 5 percent of the aggregate average daily trading volume of the equity securities
which are the subject of the transaction for the week immediately preceding the completion of the transaction. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. For any cross-trade opportunity where equity securities available for sale from a Selling Account may be sold to
more than one Buying Account, each cross-trade opportunity shall be allocated first to the Buying Account which is
ranked by the Optimization Program as being furthest from optimality, measured on a numerical basis at the time of
the transaction, until such Account is brought up to par with the Account which is next furthest from optimality. Such
Accounts shall then be allocated cross-trade opportunities on a pro rata basis until the Accounts are brought up to
the level of the next Account which is furthest from optimality. This allocation process shall continue until all
cross-trade opportunities involving the equity securities in question are exhausted. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
5. (a) BFM furnishes the Independent Fiduciary for each Plan Account participating in the cross-trade program at
least once every three months, and not later than 45 days following the period to which it related, a report disclosing:

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(i) a list of all cross-trade transactions engaged in on behalf of the Plan Account during the period; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(ii) with respect to each cross-trade transaction, the actual price used to effect the transaction and the identity
of the pricing source, as well as the highest and lowest reported prices at which the equity securities involved in
the transaction were traded on the date of such transaction. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) The authorizing Independent Fiduciary for each Plan Account participating in the program is furnished with a
summary report at least once per year. The summary must be furnished within 45 days after the end of the period to which
it relates, and must contain the following: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(i) a description of the total amount of the Plan Account's assets, by type of equity security, involved in cross-trade
transactions during the period; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(ii) a description of BFM's cross-trade practices, if such practices have changed materially during the period covered
by the summary; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(iii) a statement that the Independent Fiduciary's authorization of cross-trade transactions may be terminated
upon receipt by BFM of the Independent Fiduciary's written notice to that effect; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(iv) a statement that the Independent Fiduciary's authorization of the Plan Account's participation in the cross-trade
program will continue in effect unless it is terminated. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
6. The cross-trade transaction does not involve assets of any employee benefit plan established or maintained by
BFM or any of its Affiliates (Batterymarch Plan). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
7. Each employee benefit plan comprising a Plan Account that participates in the cross-trading program must have
total assets equal to at least $25 million. In the case of multiple employee benefit plans maintained by a single employer
or controlled group of employers, the $25 million requirement may be met by aggregating the assets of such plans if
the assets are commingled for investment purposes in a single master trust. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
8. BFM receives no fee or other compensation (other than its agreed investment management fee) with respect to any
cross-trade transaction. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
9. BFM is a discretionary investment manager with respect to Plan Accounts participating in the cross-trade program
and does not cause any Plan Account to purchase or sell equity securities with another Account in order to merely track
or replicate the portfolio of an independently maintained third party index. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
10. For purposes of this exemption: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(a) ``Account'' means a Plan Account or a Non-Plan Account; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) ``Affiliate'' means any person directly or indirectly through one or more intermediaries, controlling, controlled
by, or under common control with Batterymarch; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(c) ``Buying Account'' means the Account which seeks to purchase equity securities in a cross-trade transaction;

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(d) ``Cross-trade transaction'' means a purchase and sale of equity securities between Accounts for which BFM or
an Affiliate is acting as a trustee or investment manager; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(e) ``Plan Account'' means an Account managed by BFM consisting of assets of one or more employee benefit plans which
are subject to the Act; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(f) ``Independent Account Representative'' means the authorized representative of the Account. In the case of a
Plan Account, the Independent Account Representative must be an Independent Fiduciary authorized to act for the
Plan Account; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(g) ``Non-Plan Account'' means an Account managed by BFM consisting of assets of clients which are not employee benefit
plans subject to the Act; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(h) ``Selling Account'' means the Account which seeks to sell its equity securities in a cross-trade transaction;
and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(i) The ``Optimization Program'' means a computer program developed by a third party, independent of BFM and its Affiliates,
which BFM uses pursuant to a license agreement and which utilizes objective mathematical formulas to construct ``optimal''
portfolios for each Account. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For a more complete statement of the facts and representations supporting the Department's decision to grant this
exemption, refer to the notice of proposed exemption published on May 25, 1994 at 59 FR 27042. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00166 </DOCNO>
<PARENT> FR940817-2-00081 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
For Further Information Contact: Mr. E.F. Williams of the 
<!-- PJG 0012 frnewline -->
Department, telephone (202) 219&hyph;8194. (This is not a toll-free number.)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Prohibited Transaction Exemption 94&hyph;62; Exemption Application No. D&hyph;9613] Abbott Pension Plan (the
Plan) 
<!-- PJG 0012 frnewline -->
Located in Lynn, MA; Exemption 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The restrictions of sections 406(a), 406 (b)(1) and (b)(2) of the Act and the sanctions resulting from the application
of section 4975 of the Code, by reason of section 4975(c)(1) (A) through (E) of the Code, shall not apply to the proposed

<!-- PJG 0012 frnewline -->
transfer by the Plan, of certain limited partnership interests (the Interests) to Abbott House Nursing Home, Inc.
(Abbott); Winthrop Nursing Home, Inc. (which does business as the Bay View Nursing Home and is referred to herein as
Winthrop/Bay View); Devereux House Nursing Home, Inc. (Devereux); and the Greenview House Nursing Home, Inc. (Greenview),
in satisfaction of certain cash advances made to the Plan by these entities. (Abbott, Winthrop/Bay View, Devereux
and Greenview, which are parties in interest with respect to the Plan, are collectively referred to herein as the Nursing
Facilities.) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
This exemption is conditioned upon the following requirements: (1) the transfer represents a one-time transaction
and satisfies certain cash advances made by the Nursing Facilities to the Plan; (2) the Interests are transferred
for the greater of their historical cost to the Plan, their fair market value or the total amount of cash advanced to
the Plan; (3) for purposes of the transfer, the fair market value the Interests has been established by a qualified,
independent appraiser; and (4) the Plan does not pay any fees or commissions in connection with the transfer. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For a more complete statement of the facts and representations supporting the Department's decision to grant this
exemption, refer to the notice of proposed exemption published on June 21, 1994 at 59 FR 32017. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For Further Information Contact: Ms. Jan D. Broady of the Department, telephone (202) 219&hyph;8881. (This is not
a toll-free number.) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00167 </DOCNO>
<PARENT> FR940817-2-00081 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=85 g=1 f=1 -->
AT&amp;T Management Pension Plan and 
<!-- PJG 0012 frnewline -->
AT&amp;T Pension Plan (the AT&amp;T Plans), and 
<!-- PJG 0012 frnewline -->
BellSouth Management Pension Plan and 
<!-- PJG 0012 frnewline -->
BellSouth Pension Plan (the BellSouth Plans; 
<!-- PJG 0012 frnewline -->
Collectively, the Plans) 
<!-- PJG 0012 frnewline -->
Located in Morristown, New Jersey; Exemption 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
[Prohibited Transaction Exemption 94&hyph;63; 
<!-- PJG 0012 frnewline -->
Exemption Application Nos. D&hyph;9607, D&hyph;9608, D&hyph;9609, D&hyph;9610] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The restrictions of sections 406(a), 406(b)(1) and (b)(2) of the Act and the sanctions resulting from the application
of section 4975 of the Code, by reason of section 4975(c)(1) (A) through (E) of the Code, shall not apply, effective
June 3, 1993, to the past and proposed lease (the Lease) by the Plans, through the Telephone Real Estate Equity Trust
(TREET), of office space in Southpark C, a commercial office building in Austin, Texas, to American Telephone and
Telegraph Co. (AT&amp;T), one of the sponsors of the Plans; provided that the following conditions are satisfied:

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(A) The interests of TREET for all purposes under the Lease are represented by Hill Partners, which is independent
of and unrelated to AT&amp;T, serving as a fiduciary under the Act; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(B) At all times under the Lease, AT&amp;T pays TREET rent of no less than the fair market rental value of the Property;
and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(C) All terms and conditions of the Lease are at least as favorable to TREET as those which TREET could obtain in arm's-length
transactions with unrelated parties. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For a more complete statement of the facts and representations supporting the Department's decision to grant this
exemption, refer to the notice of proposed exemption published on June 21, 1994 at 59 FR 32018. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Effective Date: This exemption is effective as of June 3, 1993. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Written Comments: The Department received one written comment and no requests for a hearing. The comment was submitted
on behalf of AT&amp;T (the Applicant) in supplementation of the Summary of Facts and Representations (the Summary)
in the notice of proposed exemption. The points addressed by the Applicant in the comment are summarized as follows:

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(A) Paragraph (1) of the Summary indicates that the BellSouth Master Trust hold assets of the BellSouth Plans, which
are sponsored by BellSouth. The Applicant states that it has become aware that one additional plan participates in
the BellSouth Master Trust: the Retirement Plan of Stevens Graphics, Inc., sponsored by Stevens Graphics, Inc.,
an affiliate of BellSouth Corporation. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(B) In paragraph (6) of the Summary, it is stated that with the addition of the Southpark assets, Karsten commenced
to hold under management over 20 percent of the assets of TREET. The Applicant represents that this statement does
not accurately describe Karsten's position with respect to management of TREET assets. The Applicant represents
that with the addition of the Southpark assets, the TREET assets under management by Karsten constituted over twenty
percent of all assets managed by Karsten on behalf of all its clients. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
After consideration of the entire record, including the comment, the Department has determined to grant the exemption.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For Further Information Contact: Ronald Willett of the Department, telephone (202) 219&hyph;8881. (This is not
a toll-free number.) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00168 </DOCNO>
<PARENT> FR940817-2-00081 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=85 g=1 f=1 -->
NatWest Securities Corporation, Inc. (NatWest) 
<!-- PJG 0012 frnewline -->
Located in New York, New York; Exemption 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Prohibited Transaction Exemption 94&hyph;64; 
<!-- PJG 0012 frnewline -->
Exemption Application No. D&hyph;9681] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
I. Transactions 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A. Effective December 22, 1993, the restrictions of 
<!-- PJG 0012 frnewline -->
sections 406(a) and 407(a) of the Act and the taxes imposed by section 4975 (a) and (b) of the Code by reason of section
4975(c)(1) (A) through (D) of the Code shall not apply to the following transactions involving trusts and certificates
evidencing interests therein: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) The direct or indirect sale, exchange or transfer of certificates in the initial issuance of certificates between
the sponsor or underwriter and an employee benefit plan when the sponsor, servicer, trustee or insurer of a trust,
the underwriter of the certificates representing an interest in the trust, or an obligor is a party in interest with
respect to such plan; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) The direct or indirect acquisition or disposition 
<!-- PJG 0012 frnewline -->
of certificates by a plan in the secondary market for such certificates; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) The continued holding of certificates acquired by a plan pursuant to subsection I.A. (1) or (2). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Notwithstanding the foregoing, section I.A. does not provide an exemption from the restrictions of sections 406(a)(1)(E),
406(a)(2) and 407 for the acquisition or holding of a certificate on behalf of an Excluded Plan by any person who has
discretionary authority or renders investment advice with respect to the assets of that Excluded Plan.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Section I.A. provides no relief from sections 406(a)(1)(E), 406(a)(2) and 407 for any person rendering investment
advice to an Excluded Plan within the meaning of section 3(21)(A)(ii) and regulation 29 CFR 2510.3&hyph;21(c). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
B. Effective December 22, 1993, the restrictions of sections 406(b)(1) and 406(b)(2) of the Act and the taxes imposed
by section 4975 (a) and (b) of the Code by reason of section 4975(c)(1)(E) of the Code shall not apply to: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) The direct or indirect sale, exchange or 
<!-- PJG 0012 frnewline -->
transfer of certificates in the initial issuance of certificates between the sponsor or underwriter and a plan when
the person who has discretionary authority or renders investment advice with respect to the investment of plan assets
in the certificates is (a) an obligor with respect to 5 percent or less of the fair market value of obligations or receivables
contained in the trust, or (b) an affiliate of a person described in (a); if: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(i) The plan is not an Excluded Plan; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(ii) solely in the case of an acquisition of certificates in connection with the initial issuance of the certificates,
at least 50 percent of each class of certificates in which plans have invested is acquired by persons independent of
the members of the Restricted Group and at least 50 percent of the aggregate interest in the trust is acquired by persons
independent of the Restricted Group; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(iii) a plan's investment in each class of certificates does not exceed 25 percent of all of the certificates of that
class outstanding at the time of the acquisition; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(iv) immediately after the acquisition of the 
<!-- PJG 0012 frnewline -->
certificates, no more than 25 percent of the assets of a plan with respect to which the person has discretionary authority
or 
<!-- PJG 0012 frnewline -->
renders investment advice are invested in certificates 
<!-- PJG 0012 frnewline -->
representing an interest in a trust containing assets sold or 
<!-- PJG 0012 frnewline -->
serviced by the same entity.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 For purposes of this paragraph B.(1)(iv) only, an entity will not be considered to service assets contained in a trust
if it is merely a subservicer of that trust; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
2
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
For purposes of this exemption, each plan participating in a commingled fund (such as a bank collective trust fund
or insurance company pooled separate account) shall be considered to own the same proportionate undivided interest
in each asset of the commingled fund as its proportionate interest in the total assets of the commingled fund as calculated
on the most recent preceding valuation date of the fund. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(2) The direct or indirect acquisition or disposition of certificates by a plan in the secondary market for such certificates,
provided that the conditions set forth in paragraphs B.(1) (i), (iii), and (iv) are met; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00169 </DOCNO>
<PARENT> FR940817-2-00081 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(3) The continued holding of certificates acquired by a plan pursuant to subsection I.B. (1) or (2). 
<!-- PJG 0012 frnewline -->
C. Effective December 22, 1993, the restrictions of sections 406(a), 406(b) and 407(a) of the Act, and the taxes imposed
by section 4975 (a) and (b) of the Code by reason of section 4975(c) of the Code, shall not apply to transactions in connection
with the servicing, management and operation of a trust; provided: 
<!-- PJG 0012 frnewline -->
(1) such transactions are carried out in accordance 
<!-- PJG 0012 frnewline -->
with the terms of a binding pooling and servicing arrangement; and 
<!-- PJG 0012 frnewline -->
(2) the pooling and servicing agreement is provided 
<!-- PJG 0012 frnewline -->
to, or described in all material respects in the prospectus or private placement memorandum provided to, investing
plans before they purchase certificates issued by the trust.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
3
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
In the case of a private placement memorandum, such memorandum must contain substantially the same information that
would be disclosed in a prospectus if the offering of the certificates were made in a registered public offering under
the Securities Act of 1933. In the Department's view, the private placement memorandum must contain sufficient information
to permit plan fiduciaries to make informed investment decisions. 
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Notwithstanding the foregoing, section I.C. does not provide an exemption from the restrictions of section 406(b)
of the Act or from the taxes imposed by reason of section 4975(c) of the Code for the receipt of a fee by a servicer of the
trust from a person other than the trustee or sponsor, unless such fee constitutes a ``qualified administrative fee''
as defined in section III.S. 
<!-- PJG 0012 frnewline -->
D. Effective December 22, 1993, the restrictions of sections 406(a) and 407(a) of the Act, and the taxes imposed by
sections 4975 (a) and (b) of the Code by reason of sections 4975(c)(1) (A) through (D) of the Code, shall not apply to
any transactions to which those restrictions or taxes would otherwise apply merely because a person is deemed to be
a party in interest or disqualified person (including a fiduciary) with respect to a plan by virtue of providing services
to the plan (or by virtue of having a relationship to such service provider described in section 3(14) (F), (G), (H),
or (I) of the Act or section 4975(e)(2) (F), (G), (H), or (I) of the Code), solely because of the plan's ownership of certificates.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
II. General Conditions 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A. The relief provided under Part I is available only if the following conditions are met: 
<!-- PJG 0012 frnewline -->
(1) The acquisition of certificates by a plan is on terms (including the certificate price) that are at least as favorable
to the plan as they would be in an arm's length transaction with an unrelated party; 
<!-- PJG 0012 frnewline -->
(2) The rights and interests evidenced by the 
<!-- PJG 0012 frnewline -->
certificates are not subordinated to the rights and interests evidenced by other certificates of the same trust;

<!-- PJG 0012 frnewline -->
(3) The certificates acquired by the plan have received a rating at the time of such acquisition that is in one of the
three highest generic rating categories from either Standard &amp; Poor's Corporation (S&amp;P's), Moody's Investors
Service, Inc. (Moody's), Duff &amp; Phelps Inc. (D&amp;P) or Fitch Investors Service, Inc. (Fitch); 
<!-- PJG 0012 frnewline -->
(4) The trustee is not an affiliate of any member of the Restricted Group. However, the trustee shall not be considered
to be an affiliate of a servicer solely because the trustee has succeeded to the rights and responsibilities of the
servicer pursuant to the terms of a pooling and servicing agreement providing for such succession upon the occurrence
of one or more events of default by the servicer; 
<!-- PJG 0012 frnewline -->
(5) The sum of all payments made to and retained by the underwriters in connection with the distribution or placement
of certificates represents not more than reasonable compensation for underwriting or placing the certificates;
the sum of all payments made to and retained by the sponsor pursuant to the assignment of obligations (or interests
therein) to the trust represents not more than the fair market value of such 
<!-- PJG 0012 frnewline -->
obligations (or interests); and the sum of all payments made to and retained by the servicer represents not more than
reasonable compensation for the servicer's services under the pooling and servicing agreement and reimbursement
of the servicer's reasonable expenses in connection therewith; and 
<!-- PJG 0012 frnewline -->
(6) The plan investing in such certificates is 
<!-- PJG 0012 frnewline -->
an ``accredited investor'' as defined in Rule 501(a)(1) of 
<!-- PJG 0012 frnewline -->
Regulation D of the Securities and Exchange Commission under the Securities Act of 1933. 
<!-- PJG 0012 frnewline -->
B. Neither any underwriter, placement agent, sponsor, trustee, servicer, insurer, or any obligor, unless it or any
of its affiliates has discretionary authority or renders investment advice with respect to the plan assets used by
a plan to acquire certificates, shall be denied the relief provided under Part I, if the provision of subsection II.A.(6)
above is not satisfied with respect to acquisition or holding by a plan of such certificates, provided that (1) such
condition is disclosed in the prospectus or private placement memorandum; and (2) in the case of a private placement
of certificates, the trustee obtains a representation from each initial purchaser which is a plan that it is in compliance
with such condition, and obtains a covenant from each initial purchaser to the effect that, so long as such initial
purchaser (or any transferee of such initial purchaser's certificates) is required to obtain from its transferee
a representation regarding compliance with the Securities Act of 1933, any such transferees will be required to make
a written representation regarding compliance with the condition set forth in subsection II.A.(6) above.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
III. Definitions 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
For purposes of this exemption: 
<!-- PJG 0012 frnewline -->
A. ``Certificate'' means: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00170 </DOCNO>
<PARENT> FR940817-2-00081 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(1) a certificate 
<!-- PJG 0012 frnewline -->
(a) that represents a beneficial ownership 
<!-- PJG 0012 frnewline -->
interest in the assets of a trust; and 
<!-- PJG 0012 frnewline -->
(b) that entitles the holder to pass-through 
<!-- PJG 0012 frnewline -->
payments of principal, interest, and/or other payments made with respect to the assets of such trust; or 
<!-- PJG 0012 frnewline -->
(2) a certificate denominated as a debt instrument_ 
<!-- PJG 0012 frnewline -->
(a) that represents an interest in a Real Estate Mortgage Investment Conduit (REMIC) within the meaning of section
860D(a) of the Internal Revenue Code of 1986; and 
<!-- PJG 0012 frnewline -->
(b) that is issued by and is an obligation of a trust; with respect to certificates defined in (1) and (2) for which NatWest
or any of its affiliates which is subject to the jurisdiction of the United States courts is either (i) the sole underwriter
or the manager or co-manager of the underwriting syndicate, or (ii) a selling or placement agent. 
<!-- PJG 0012 frnewline -->
For purposes of this exemption, references to ``certificates representing an interest in a trust'' include certificates
denominated as debt which are issued by a trust. 
<!-- PJG 0012 frnewline -->
B. ``Trust'' means an investment pool, the corpus of which is held in trust in the United States and consists solely
of: 
<!-- PJG 0012 frnewline -->
(1) either 
<!-- PJG 0012 frnewline -->
(a) secured consumer receivables that bear 
<!-- PJG 0012 frnewline -->
interest or are purchased at a discount (including, but not 
<!-- PJG 0012 frnewline -->
limited to, home equity loans and obligations secured by shares issued by a cooperative housing association); 
<!-- PJG 0012 frnewline -->
(b) secured credit instruments that bear interest 
<!-- PJG 0012 frnewline -->
or are purchased at a discount in transactions by or between business entities (including, but not limited to, qualified
equipment notes secured by leases, as defined in section III.T); 
<!-- PJG 0012 frnewline -->
(c) obligations that bear interest or are 
<!-- PJG 0012 frnewline -->
purchased at a discount and which are secured by single-family residential, multi-family residential and commercial
real property, (including obligations secured by leasehold interests on commercial real property); 
<!-- PJG 0012 frnewline -->
(d) obligations that bear interest or are 
<!-- PJG 0012 frnewline -->
purchased at a discount and which are secured by motor vehicles or equipment, or qualified motor vehicle leases (as
defined in section III.U); 
<!-- PJG 0012 frnewline -->
(e) ``guaranteed governmental mortgage pool 
<!-- PJG 0012 frnewline -->
certificates,'' as defined in 29 CFR section 2510.3&hyph;101(i)(2); 
<!-- PJG 0012 frnewline -->
(f) fractional undivided interests in any of the 
<!-- PJG 0012 frnewline -->
obligations described in clauses (a)&hyph;(e) of this section B.(1); 
<!-- PJG 0012 frnewline -->
(2) property which had secured any of the obligations 
<!-- PJG 0012 frnewline -->
described in subsection B.(1); 
<!-- PJG 0012 frnewline -->
(3) undistributed cash or temporary investments made 
<!-- PJG 0012 frnewline -->
therewith maturing no later than the next date on which distributions are to be made to certificateholders; and 
<!-- PJG 0012 frnewline -->
(4) rights of the trustee under the pooling and 
<!-- PJG 0012 frnewline -->
servicing agreement, and rights under any insurance policies, third-party guarantees, contracts of suretyship
and other credit support arrangements with respect to any obligations described in subsection B.(1). 
<!-- PJG 0012 frnewline -->
Notwithstanding the foregoing, the term ``trust'' does not include any investment pool unless: (i) the investment
pool consists only of assets of the type which have been included in other investment pools, (ii) certificates evidencing
interests in such other investment pools have been rated in one of the three highest generic rating categories by S&amp;P's,
Moody's, D&amp;P, or Fitch for at least one year prior to the plan's acquisition of certificates pursuant to this exemption,
and (iii) certificates evidencing interests in such other investment pools have been purchased by investors other
than plans for at least one year prior to the plan's acquisition of certificates pursuant to this exemption. 
<!-- PJG 0012 frnewline -->
C. ``Underwriter'' means: 
<!-- PJG 0012 frnewline -->
(1) NatWest; 
<!-- PJG 0012 frnewline -->
(2) any person directly or indirectly, through one or 
<!-- PJG 0012 frnewline -->
more intermediaries, controlling, controlled by or under common control with NatWest; or 
<!-- PJG 0012 frnewline -->
(3) any member of an underwriting syndicate or selling 
<!-- PJG 0012 frnewline -->
group of which NatWest or a person described in (2) is a manager or co-manager with respect to the certificates. 
<!-- PJG 0012 frnewline -->
D. ``Sponsor'' means the entity that organizes a trust by depositing obligations therein in exchange for certificates.

<!-- PJG 0012 frnewline -->
E. ``Master Servicer'' means the entity that is a party to the pooling and servicing agreement relating to trust assets
and is fully responsible for servicing, directly or through subservicers, the assets of the trust. 
<!-- PJG 0012 frnewline -->
F. ``Subservicer'' means an entity which, under the supervision of and on behalf of the master servicer, services
receivables contained in the trust, but is not a party to the pooling and servicing agreement. 
<!-- PJG 0012 frnewline -->
G. ``Servicer'' means any entity which services receivables contained in the trust, including the master servicer
and any subservicer. 
<!-- PJG 0012 frnewline -->
H. ``Trustee'' means the trustee of the trust, and in the case of certificates which are denominated as debt instruments,
also means the trustee of the indenture trust. 
<!-- PJG 0012 frnewline -->
I. ``Insurer'' means the insurer or guarantor of, or 
<!-- PJG 0012 frnewline -->
provider of other credit support for, a trust. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00171 </DOCNO>
<PARENT> FR940817-2-00081 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Notwithstanding the foregoing, a person is not an insurer solely because it holds securities representing an interest
in a trust which are of a class subordinated to certificates representing 
<!-- PJG 0012 frnewline -->
an interest in the same trust. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
J. ``Obligor'' means any person, other than the insurer, that is obligated to make payments with respect to any obligation
or receivable included in the trust. Where a trust contains qualified motor vehicle leases or qualified equipment
notes secured by leases, ``obligor'' shall also include any owner of property subject to any lease included in the
trust, or subject to any lease securing an obligation included in the trust. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
K. ``Excluded Plan'' means any plan with respect to which any member of the Restricted Group is a ``plan sponsor'' within
the meaning of section 3(16)(B) of the Act. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
L. ``Restricted Group'' with respect to a class of certificates means: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) each underwriter; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) each insurer; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) the sponsor; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(4) the trustee; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(5) each servicer; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(6) any obligor with respect to obligations or receivables included in the trust constituting more than 5 percent
of the aggregate unamortized principal balance of the assets in the trust, determined on the date of the initial issuance
of certificates by the trust; or 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(7) any affiliate of a person described in (1)&hyph;(6) 
<!-- PJG 0012 frnewline -->
above. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
M. ``Affiliate'' of another person includes: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) Any person directly or indirectly, through one 
<!-- PJG 0012 frnewline -->
or more intermediaries, controlling, controlled by, or under common control with such other person; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) Any officer, director, partner, employee, 
<!-- PJG 0012 frnewline -->
relative (as defined in section 3(15) of the Act), a brother, a 
<!-- PJG 0012 frnewline -->
sister, or a spouse of a brother or sister of such other person; 
<!-- PJG 0012 frnewline -->
and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) Any corporation or partnership of which such 
<!-- PJG 0012 frnewline -->
other person is an officer, director or partner. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
N. ``Control'' means the power to exercise a controlling 
<!-- PJG 0012 frnewline -->
influence over the management or policies of a person other than 
<!-- PJG 0012 frnewline -->
an individual. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
O. A person will be ``independent'' of another person 
<!-- PJG 0012 frnewline -->
only if: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) such person is not an affiliate of that other 
<!-- PJG 0012 frnewline -->
person; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00172 </DOCNO>
<PARENT> FR940817-2-00081 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(2) the other person, or an affiliate thereof, is not a fiduciary who has investment management authority or renders

<!-- PJG 0012 frnewline -->
investment advice with respect to any assets of such person. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
P. ``Sale'' includes the entrance into a forward delivery 
<!-- PJG 0012 frnewline -->
commitment (as defined in section Q below), provided: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) The terms of the forward delivery commitment 
<!-- PJG 0012 frnewline -->
(including any fee paid to the investing plan) are no less favorable to the plan than they would be in an arm's length
transaction with an unrelated party; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) The prospectus or private placement memorandum is provided to an investing plan prior to the time the plan enters

<!-- PJG 0012 frnewline -->
into the forward delivery commitment; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) At the time of the delivery, all conditions of 
<!-- PJG 0012 frnewline -->
this exemption applicable to sales are met. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Q. ``Forward delivery commitment'' means a contract for the 
<!-- PJG 0012 frnewline -->
purchase or sale of one or more certificates to be delivered at an agreed future settlement date. The term includes
both mandatory contracts (which contemplate obligatory delivery and acceptance of the certificates) and optional
contracts (which give one party the right but not the obligation to deliver certificates to, or demand delivery of
certificates from, the other party). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
R. ``Reasonable compensation'' has the same meaning as that 
<!-- PJG 0012 frnewline -->
term is defined in 29 CFR section 2550.408c-2. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
S. ``Qualified Administrative Fee'' means a fee which meets 
<!-- PJG 0012 frnewline -->
the following criteria: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) the fee is triggered by an act or failure to act 
<!-- PJG 0012 frnewline -->
by the obligor other than the normal timely payment of amounts 
<!-- PJG 0012 frnewline -->
owing in respect of the obligations; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) the servicer may not charge the fee absent the act 
<!-- PJG 0012 frnewline -->
or failure to act referred to in (1); 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) the ability to charge the fee, the circumstances 
<!-- PJG 0012 frnewline -->
in which the fee may be charged, and an explanation of how the fee is calculated are set forth in the pooling and servicing
agreement; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(4) the amount paid to investors in the trust will 
<!-- PJG 0012 frnewline -->
not be reduced by the amount of any such fee waived by the servicer. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
T. ``Qualified Equipment Note Secured By A Lease'' means an 
<!-- PJG 0012 frnewline -->
equipment note: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(a) which is secured by equipment which is leased; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) which is secured by the obligation of the lessee 
<!-- PJG 0012 frnewline -->
to pay rent under the equipment lease; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(c) with respect to which the trust's security 
<!-- PJG 0012 frnewline -->
interest in the equipment is at least as protective of the rights of the trust as the trust would have if the equipment
note were secured only by the equipment and not the lease. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
U. ``Qualified Motor Vehicle Lease'' means a lease of a motor vehicle where: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(a) the trust holds a security interest in the lease; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) the trust holds a security interest in the leased 
<!-- PJG 0012 frnewline -->
motor vehicle; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(c) the trust's security interest in the leased motor 
<!-- PJG 0012 frnewline -->
vehicle is at least as protective of the trust's rights as the trust would receive under a motor vehicle installment
loan contract. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
V. ``Pooling and Servicing Agreement'' means the agreement or agreements among a sponsor, a servicer and the trustee
establishing a trust. In the case of certificates which are denominated as debt instruments, ``Pooling and Servicing
Agreement'' also includes the indenture entered into by the trustee of the trust issuing such certificates and the
indenture trustee. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For a more complete statement of the facts and representations supporting the Department's decision to grant this
exemption, refer to the notice of proposed exemption published on June 10, 1994, at 59 FR 30049. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Effective Date: This exemption is effective for transactions occurring on or after December 22, 1993. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For Further Information Contact: Gary H. Lefkowitz of the Department, telephone (202) 219&hyph;8881. (This is not
a toll-free number.) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00173 </DOCNO>
<PARENT> FR940817-2-00081 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
General Information 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The attention of interested persons is directed to the following: 
<!-- PJG 0012 frnewline -->
(1) The fact that a transaction is the subject of an exemption under section 408(a) of the Act and/or section 4975(c)(2)
of the Code does not relieve a fiduciary or other party in interest or disqualified person from certain other provisions
to which the exemptions does not apply and the general fiduciary responsibility provisions of section 404 of the Act,
which among other things require a fiduciary to discharge his duties respecting the plan solely in the interest of
the participants and beneficiaries of the plan and in a prudent fashion in accordance with section 404(a)(1)(B) of
the Act; nor does it affect the requirement of section 401(a) of the Code that the plan must operate for the exclusive
benefit of the employees of the employer maintaining the plan and their beneficiaries; 
<!-- PJG 0012 frnewline -->
(2) These exemptions are supplemental to and not in derogation of, any other provisions of the Act and/or the Code,
including statutory or administrative exemptions and transactional rules. Furthermore, the fact that a transaction
is subject to an administrative or statutory exemption is not dispositive of whether the transaction is in fact a prohibited
transaction; and 
<!-- PJG 0012 frnewline -->
(3) The availability of these exemptions is subject to the express condition that the material facts and representations
contained in each application are true and complete and accurately describe all material terms of the transaction
which is the subject of the exemption. In the case of continuing exemption transactions, if any of the material facts
or representations described in the application change after the exemption is granted, the exemption will cease
to apply as of the date of such change. In the event of any such change, application for a new exemption may be made to the
Department. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Signed at Washington, D.C., this 11th day of August 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Ivan Strasfeld, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Director of Exemption Determinations, 
<!-- PJG 0012 frnewline -->
Pension and Welfare Benefits 
<!-- PJG 0012 frnewline -->
Administration, 
<!-- PJG 0012 frnewline -->
U.S. Department of Labor. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20009 Filed 8&hyph;16&hyph;94; 8:45 am] 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4510&hyph;29&hyph;P 
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00174 </DOCNO>
<PARENT> FR940817-2-00082 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>NATIONAL LABOR RELATIONS BOARD</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Privacy Act of 1974; System of Records</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
National Labor Relations Board (NLRB).
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of amended routine uses for NLRB system of records NLRB&hyph;19, Telephone Call Detail Records.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This notice amends the language of three routine uses in the NLRB Privacy Act system of records NLRB&hyph;19, Telephone
Call Detail Records. The three amended routine uses narrow the existing routine uses to specify more exactly the information
that may be disclosed.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The amended routine uses will become effective without further notice 30 days from the date of this publication (September
16, 1994), unless comments are received on or before that date which result in a contrary determination.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Written comments on the amended routine uses may be submitted to the Executive Secretary, National Labor Relations
Board, 1099 Fourteenth Street, NW., Washington, DC 20570&hyph;0001. Copies of all comments received will be available
for inspection between 8:30 and 5 pm in room 11600.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
John C. Truesdale, Executive Secretary, National Labor Relations Board, room 11600, 1099 Fourteenth Street NW.,
Washington, DC 20570&hyph;0001.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Pursuant to subsection (e)(11) of the Privacy Act of 1974, 5 U.S.C. 552a, the National Labor Relations Board is publishing
a notice revising existing routine uses Nos. 1, 3, and 8 in its system of records NLRB&hyph;19, Telephone Call Detail
Records. The system notice of NLRB&hyph;19 was last published in its entirety in 58 FR 50957 on September 29, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As amended, routine use No. 1 will specify that on disclosure to an inquiring congressional office, the subject individual
must be the constituent about whom the records are maintained. The other two amended routine uses Nos. 3 and 8 respectively
will narrow the existing routine uses to specify more exactly the information that may be disclosed to a court or an
adjudicative body in the course of presenting evidence or argument, including disclosure to opposing counsel or
witnesses in the course of civil discovery, and to an inquiring Federal authority for hiring or retention of an employee.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A report of this notice to amend the three routine uses in NLRB&hyph;19, Telephone Call Detail Records was filed pursuant
to 5 U.S.C. 552a(r) with the Office of Management and Budget and with Congress. The specific changes to the notice being
amended (58 FR 50957, September 29, 1993) are set forth below. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
By direction of the Board.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: Washington, DC, August 11, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
John C. Truesdale,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Executive Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
NLRB&hyph;19
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
System name:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Telephone Call Detail Records.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Routine uses of records maintained in the system, including categories of users and the purposes of such uses:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. A Member of Congress or to a Congressional staff member in response to an inquiry of the Congressional office made
at the written request of the constituent about whom the record is maintained. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
3. A court, a magistrate, administrative tribunal, or other adjudicatory body in the course of presenting evidence
or argument, including disclosure to opposing counsel or witnesses in the course of civil discovery, litigation,
or settlement negotiations, or in connection with criminal law proceedings, when: (a) The NLRB or any component thereof;
or (b) any employee of the NLRB in his or her official capacity; or (c) any employee of the NLRB in his or her individual
capacity where the NLRB has agreed to represent the employee; or (d) the United States Government, is a party to litigation
or has interest in such litigation, and determines that such disclosure is relevant and necessary to the litigation
and that the use of such records is therefore deemed by the NLRB to be for a purpose that is compatible with the purpose
for which the records were collected. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
8. A Federal authority, in response to its request, that this system of records contains information relevant to the
hiring or retention of an employee, the issuance or retention of a security clearance, the letting of a contract, or
the issuance or retention of a license, grant, or other benefit. The other agency or licensing organization, however,
may then make a request supported by the written consent of the individual for the entire record if it so chooses. No
disclosure will be made unless the information has been determined to be sufficiently reliable to support a referral
to another office within the NLRB or to another Federal agency for criminal, civil, administrative, personnel, or
regulatory action. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20217 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 7545&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00175 </DOCNO>
<PARENT> FR940817-2-00083 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>NUCLEAR REGULATORY COMMISSION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Advisory Committee on Reactor Safeguards Subcommittee Meeting on Containment Systems; Meeting</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The ACRS Subcommittee on Containment Systems will hold a meeting on September 7, 1994, Room T&hyph;2B3, 11545 Rockville
Pike, Rockville, Maryland.
<!-- PJG 0012 frnewline -->
The entire meeting will be open to public attendance.
<!-- PJG 0012 frnewline -->
The agenda for the subject meeting shall be as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Wednesday, September 7, 1994_8:30 a.m. Until the Conclusion of Business
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Subcommittee will review proposed changes to Appendix J to 10 CFR Part 50, ``Primary Reactor Containment Leakage
Testing for Water-Cooled Power Reactors''. The purpose of this meeting is to gather information, analyze relevant
issues and facts, and to formulate proposed positions and actions, as appropriate, for deliberation by the full Committee.

<!-- PJG 0012 frnewline -->
Oral statements may be presented by members of the public with the concurrence of the Subcommittee Chairman; written
statements will be accepted and made available to the Committee. Electronic recordings will be permitted only during
those portions of the meeting that are open to the public, and questions may be asked only by members of the Subcommittee,
its consultants, and staff. Persons desiring to make oral statements should notify the cognizant ACRS staff engineer
named below five days prior to the meeting, if possible, so that appropriate arrangements can be made. 
<!-- PJG 0012 frnewline -->
During the initial portion of the meeting, the Subcommittee, along with any of its consultants who may be present,
may exchange preliminary views regarding matters to be considered during the balance of the meeting. 
<!-- PJG 0012 frnewline -->
The Subcommittee will then hear presentations by and hold discussions with representatives of the NRC staff, nuclear
industry, their consultants, and other interested persons regarding this review. 
<!-- PJG 0012 frnewline -->
Further information regarding topics to be discussed, the scheduling of sessions open to the public, whether the
meeting has been cancelled or rescheduled, the Chairman's ruling on requests for the opportunity to present oral
statements and the time allotted therefor can be obtained by contacting the cognizant ACRS staff engineer, Mr. M.
Dean Houston, (telephone 301/415&hyph;6899) between 7:30 a.m. and 4:15 p.m. (EST). Persons planning to attend this
meeting are urged to contact the above named individual five days before the scheduled meeting to be advised of any
changes in schedule, etc., that may have occurred.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: August 10, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Sam Duraiswamy, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Chief, Nuclear Reactors Branch. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20137 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 7590&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00176 </DOCNO>
<PARENT> FR940817-2-00084 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Advisory Committee on Reactor Safeguards Subcommittee Meeting on Planning and Procedures; Meeting</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The ACRS Subcommittee on Planning and Procedures will hold a meeting on September 7, 1994, Room T&hyph;2E13, 11545
Rockville Pike, Rockville, Maryland.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The entire meeting will be open to public attendance, with the exception of a portion that may be closed pursuant to
5 U.S.C. 552b(c) (2) and (6) to discuss organizational and personnel matters that relate solely to internal personnel
rules and practices of ACRS, and matters the release of which would represent a clearly unwarranted invasion of personal
privacy.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The agenda for the subject meeting shall be as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Wednesday, September 7, 1994_2:00 p.m. Until the Conclusion of Business
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Subcommittee will discuss proposed ACRS activities and related matters. Also, it will discuss qualifications
of candidates nominated for appointment to the ACRS. The purpose of this meeting is to gather information, analyze
relevant issues and facts, and to formulate proposed positions and actions, as appropriate, for deliberation by
the full Committee.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Oral statements may be presented by members of the public with the concurrence of the Subcommittee Chairman; written
statements will be accepted and made available to the Committee. Electronic recordings will be permitted only during
those portions of the meeting that are open to the public, and questions may be asked only by members of the Subcommittee,
its consultants, and staff. Persons desiring to make oral statements should notify the cognizant ACRS staff person
named below five days prior to the meeting, if possible, so that appropriate arrangements can be made.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Further information regarding topics to be discussed, the scheduling of sessions open to the public, whether the
meeting has been cancelled or rescheduled, the Chairman's ruling on requests for the opportunity to present oral
statements, and the time allotted therefor can be obtained by contacting the cognizant ACRS staff person, Dr. John
T. Larkins (telephone: 301/415&hyph;7360) between 7:30 a.m. and 4:15 p.m. (EST). Persons planning to attend this
meeting are urged to contact the above named individual five days before the scheduled meeting to be advised of any
changes in schedule, etc., that may have occurred.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: August 11, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Sam Duraiswamy,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Chief, Nuclear Reactors Branch.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20136 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 7590&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00177 </DOCNO>
<PARENT> FR940817-2-00085 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>SECURITIES AND EXCHANGE COMMISSION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Self-Regulatory Organizations; Applications for Unlisted Trading Privileges; Notice and Opportunity for Hearing;
Boston Stock Exchange, Incorporated</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
August 11, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The above named national securities exchange has filed applications with the Securities and Exchange Commission
(``Commission'') pursuant to Section 12(f)(1)(B) of the Securities Exchange Act of 1934 and Rule 12f&hyph;1 thereunder
for unlisted trading privileges in the following securities:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Carmike Cinemas, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Class A Common Stock, $.03 Par Value (File No. 7&hyph;12799)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Collins &amp; Aikman Corp. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, $.01 Par Value (File No. 7&hyph;12800)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Oasis Residential, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, $.01 Par Value (File No. 7&hyph;12801)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Paul Revere Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, $1.00 Par Value (File No. 7&hyph;12802)
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
These securities are listed and registered on one or more other national securities exchanges and are reported in
the consolidated transaction reporting system.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Interested persons are invited to submit on or before September 1, 1994, written data, views and arguments concerning
the above-referenced application. Persons desiring to make written comments should file three copies thereof with
the Secretary of the Securities and Exchange Commission, 450 5th Street NW., Washington, DC 20549. Following this
opportunity for hearing, the Commission will approve the application if it finds, based upon all the information
available to it, that the extensions of unlisted trading privileges pursuant to such applications are consistent
with the maintenance of fair and orderly markets and the protection of investors.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
For the Commission, by the Division of Market Regulation, pursuant to delegated authority.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Jonathan G. Katz,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20117 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 8010&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00178 </DOCNO>
<PARENT> FR940817-2-00086 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Self-Regulatory Organizations; Applications for Unlisted Trading Privileges; Notice and Opportunity for Hearing;
Chicago Stock Exchange, Incorporated</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
August 11, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The above named national securities exchange has filed applications with the Securities and Exchange Commission
(``Commission'') pursuant to Section 12(f)(1)(B) of the Securities Exchange Act of 1934 and Rule 12f&hyph;1 thereunder
for unlisted trading privileges in the following securities:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Embotelladora Andina S.A.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
American Depository Shares (each Rep. 6 Shrs. of Common Stock) No Par Value (File No. 7&hyph;12782)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Banpais S.A. Institucion De Banca Multiple Grupo Financiero Asemex Banpais
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(Rep 6 Series L Limited Voting Shares) $1.00 Par Value (File No. 7&hyph;12783)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Collins &amp; Aikman Corporation
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock $.01 Par Value (File No. 7&hyph;12784)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Instituto Nazionale Delle Assicurazioni SPA
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
American Depository Shares (rep 10 ord Shrs LIT) $1.00 Par Value (File No. 7&hyph;12785)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Morgan Stanley Pacific Asia Fund, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock $.01 Par Value (File No. 7&hyph;12786)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Apartment Investment and Management Company
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock $.01 Par Value (File No. 7&hyph;12787)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Desc S.A. De C.V.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
American Depository Shares, No Par Value (File No. 7&hyph;12788)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Greenbrier Companies, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock $.01 Par Value (File No. 7&hyph;12789)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Grupo Industrial Durango SA De C.V.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
American Depository Shares (each Rep 2 Ord Participation Cert.) No Par Value (File No. 7&hyph;12790)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Paragon Group, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock $.01 Par Value (File No. 7&hyph;12791)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Taiwan Equity Fund, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock $.01 Par Value (File No. 7&hyph;12792)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
WCI Steel, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock No Par Value (File No. 7&hyph;12793)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
WHX-Corporation (Holding Company)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock No Par Value (File No. 7&hyph;12794)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Empresa Nacional De Electricidad S.A. Chile
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
American Depository Shares (Rep 30 shrs of Common Stock) No Par Value (File No. 7&hyph;12795)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Home Properties of New York
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock $.01 Par Value (File No. 7&hyph;12796)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Partial National Corporation
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock No Par Value (File No. 7&hyph;12797)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Freeport McMoran Copper and Gold
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Dep Shrs. (each rep. approx. 2.941 Shrs of a 7% Conv. Exch. Special Pref. Stock) No Par Value (File No. 7&hyph;12798)
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
These securities are listed and registered on one or more other national securities exchanges and are reported in
the consolidated transaction reporting system.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Interested persons are invited to submit on or before September 1, 1994, written data, views and arguments concerning
the above-referred application. Persons desiring to make written comments should file three copies thereof with
the Secretary of the Securities and Exchange Commission, 450 Fifth Street, N.W., Washington, D.C. 20549. Following
this opportunity for hearing, the Commission will approve the application if it finds, based upon all the information
available to it, that the extensions of unlisted trading privileges pursuant to such application is consistent with
the maintenance of fair and orderly markets and the protection of investors.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
For the Commission, by the Division of Market Regulation, pursuant to delegated authority.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Jonathan G. Katz,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20116 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 8010&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00179 </DOCNO>
<PARENT> FR940817-2-00087 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Release No. 34&hyph;34516; File No. SR&hyph;CHX&hyph;94&hyph;12]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Self-Regulatory Organizations; Chicago Stock Exchange, Inc.; Order Approving Proposed Rule Change Relating To
Disclosure of Pending Formal Exchange Disciplinary Proceedings to the Central Registration Depository</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
August 10, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
I. Introduction
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On May 6, 1994, the Chicago Stock Exchange, Inc. (``CHX'' or ``Exchange'') submitted to the Securities and Exchange
Commission (``Commission'' or ``SEC''), pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934 (``Act''),
<FOOTCITE>1</FOOTCITE>
 and Rule 19b&hyph;4 thereunder,
<FOOTCITE>2</FOOTCITE>
 a proposed rule change to authorize the Exchange to provide information to the Central Registration Depository (``CDR'')
concerning pending formal, Exchange disciplinary proceedings for disclosure to the public.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 78s(b)(1) (1988).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
2
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
17 CFR 240.19b&hyph;4 (1994).
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed rule change was noticed in Securities Exchange Act Release No. 34268 (June 28, 1994), 59 FR 34459 (July
5, 1994). No comments were received on the proposal. This order approves the proposed rule change.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Description of the Proposal
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The CHX is adopting Rule 9 to Article XII of the Exchange's Rules to authorize the CHX to provide information to the CRD
<FOOTCITE>3</FOOTCITE>
 concerning pending formal Exchange disciplinary proceedings for disclosure to the public. According to the Exchange,
a formal disciplinary proceeding is considered to be pending from the time charges are issued
<FOOTCITE>4</FOOTCITE>
 until the proceeding is completed.
<FOOTCITE>5</FOOTCITE>
 Currently, the Exchange discloses information only on final Exchange disciplinary actions to the CRD.
<FOOTCITE>6</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
3
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The CRD is an automated industry database containing employment and disciplinary history of members and associated
persons registered with self-regulatory organizations (``SROs'') and state securities agencies. The CRD is operated
by the National Association of Securities Dealers, Inc. (``NASD'') with input on policy and other matters from federal
and state agencies and other SROs, including the Exchange.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
4
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
CHX Article XII, Rule 1(b) provides, in part, that if in the judgment of the President it shall appear that an accused
has committed a default or other offense in violation of the Constitution or Rules of the Exchange the President shall,
except as hereinafter provided, direct the staff to prefer written charges against the accused. A copy of such charges
shall be served upon the accused. The accused shall also be served with written notice of when and where the charges
will be heard.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
5
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
See CHX Article XII, Rule 7.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
6
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Information concerning final disciplinary actions taken by the Exchange, the NASD and other self-regulatory and
regulatory organizations, as well as information concerning certain criminal convictions contained in the CRD,
has been disclosed to the public pursuant to the NASD's 800 number service since October 1991. The Commission subsequently
approved the NASD's procedures for operating its 800 number service in Securities Exchange Act Release No. 30629
(April 23, 1992), 57 FR 18535 (April 30, 1992) (File No. SR&hyph;NASD&hyph;91&hyph;39) (``800 Number Service Plan
Approved Order''). On July 1, 1993, the SEC approved an NASD rule change to make more information available to the general
public regarding pending disciplinary proceedings or actions taken by federal or state securities agencies and
SROs that relate to securities or commodities transactions, and regarding criminal indictments and information.

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
See
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 Securities Exchange Act Release No. 32568 (July 1, 1993), 58 FR 36723 (July 8, 1993) (File No. SR&hyph;NASD&hyph;93&hyph;26)
(``Pending Event Disclosure Approval Order'').
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Information on pending formal SRO disciplinary proceedings, among other events, is currently in the CRD, but only
to the extent that reports are made by members, member organizations and associated persons pursuant to their reporting
obligations on the Uniform Application for Securities Industry Registration or Transfer (Form U&hyph;4) and Form
BD, the uniform application form for broker-dealer registration. The proposal would expand the information available
on pending disciplinary actions by requiring the Exchange to report such cases to the CRD.
<FOOTCITE>7</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
7
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
On March 31, 1994, the Commission approved a similar proposal by the New York Stock Exchange, Inc. (``NYSE'') which
authorized the NYSE to provide information to the CRD concerning pending formal NYSE disciplinary proceedings,
for disclosure to the public. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
See
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 Securities Exchange Act Release No. 33844 (March 31, 1994), 59 FR 16669 (April 7, 1994) (order approving File No. SR&hyph;NYSE&hyph;94&hyph;11).
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Exchange believes that the proposed rule change is consistent with Section 6(b)(5) of the Act in that it is designed
to promote just and equitable principles of trade, to remove impediments and to perfect the mechanisms of a free and
open market and a national market system, and in general, to protect investors and the public interest.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
III. Discussion
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commission finds that the proposed rule change is consistent with the requirements of the Act and the rules and
regulations thereunder applicable to a national securities exchange, and, in particular, with the requirements
of Section 6(b).
<FOOTCITE>8</FOOTCITE>
 In particular, the Commission believes the proposal is consistent with the Section 6(b)(5)
<FOOTCITE>9</FOOTCITE>
 requirements that the rules of an exchange be designed to promote just and equitable principles of trade, to prevent
fraudulent and manipulative acts and, in general, to protect investors and the public interest.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
8
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 78f (1988).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
9
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
25 U.S.C. 78f(b)(5) (1988).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00180 </DOCNO>
<PARENT> FR940817-2-00087 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In the Securities Enforcement Remedies and Penny Stock Reform Act of 1990 (``Penny Stock Reform Act''), Congress
mandated that the NASD establish a toll-free telephone number (`800 number service'') for the purpose of receiving
and responding to inquiries from the public regarding the background of NASD members and their associated persons.
The NASD began operating its 800 number service on October 1, 1991. Upon the request of a caller, the NASD may disclose,
in the form of a written report, the following information contained in the CRD: 
<FOOTCITE>10</FOOTCITE>
 past and present employment history of NASD members and their associated persons; all final disciplinary actions,
<FOOTCITE>11</FOOTCITE>
 taken by federal and state regulatory agencies and SROs, that relate to securities or commodities transactions;
and all criminal convictions reported on Form BD or Form U&hyph;4.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
10
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Under NASD procedures, the 800 number service operator does not provide any information over the telephone. Instead,
a written copy of the information requested is sent to the caller and to the NASD member and/or associated person who
is the subject of the inquiry. The identity of the caller remains confidential. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
See
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 800 Number Service Plan Approval Order, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
supra,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 note 6.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
11
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The NASD's 800 number service plan does not define the term ``disciplinary action.'' According to the NASD, however,
the term includes, but is not limited to, information provided in response to question 7 on Form BD and question 22 on
Form U&hyph;4. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
See
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 Pending Event Disclosure Approval Order, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
supra,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 note 6.
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In 1993, the Commission approved a rule change by the NASD to expand the scope of information that is reportable through
its 800 number service.
<FOOTCITE>12</FOOTCITE>
 Thus, in addition to the information set forth above, the NASD may disclose to the public such events as pending formal
disciplinary actions initiated by federal and state regulatory agencies and SROs; criminal indictments or informations;
civil judgments; and certain arbitration awards in securities and commodities disputes involving public customers.
Currently, the NASD relies on members and associated persons to report these events to the CRD on Form BD or Form U&hyph;4,
respectively. Because this represents the only means by which the NASD can obtain data about pending disciplinary
actions (other than its own), the quality of the CRD database, and thus of the 800 number service, depends on complete
and timely reporting by members and associated persons.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
12
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
See
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 Pending Event Disclosure Approval Order, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
supra,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 note 6. The Commission notes that, in 1992, Congress requested that the General Accounting Office (``GAO'') conduct
a review of various aspects of the Penny Stock Reform Act, including the NASD's 800 number service. Among other things,
the GAO recommended that information about final arbitration awards be reported. Accordingly, the NASD submitted,
and the Commission approved, a rule change authorizing the NASD to disclose certain arbitration awards, as well as
pending formal disciplinary actions, through its 800 number service. In this context, the Commission notes that
it has requested all SROs to coordinate with the NASD the transfer of information about awards rendered in each exchange's
arbitration program.
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In the Commission's opinion, Rule 9 to Article XII should help fill a potential gap in the NASD's 800 number service,
by authorizing the Exchange to report the initiation of a formal CHX disciplinary proceeding
<FOOTCITE>13</FOOTCITE>
 involving an Exchange member, member organization or associated person, and significant changes in the status thereof,
<FOOTCITE>14</FOOTCITE>
 directly to the CRD. As a result, that information will be available to the public whether or not it is voluntarily reported
by the member or associated person. The Commission therefore finds that the proposed rule change should enhance the
fairness and accuracy of the CRD database and, accordingly, of information released to the public through the 800
number service.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
13
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
For purposes of reporting to the CRD, the CHX considers a formal disciplinary proceeding to be pending from the time
charges are issued until completion of the proceeding. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
See supra,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 notes 4 and 5.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
14
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
CHX Rule 9 provides the following examples of significant changes in the status of a pending formal disciplinary proceeding
which would require disclosure: the issuance of a decision by the President; and the filing of an appeal to and/or the
issuance of a decision by, a Judiciary Committee, the Exchange's Executive Committee or Board of Governors.
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commission has long believed that investors need access to reliable information in order to protect themselves
against potential fraud and abuse. In this respect, Rule 9 to Article XII should help customers make an informed decision
about whether they should conduct or continue to conduct business with particular securities professionals. In
sum, the Commission has concluded that the rule change should increase the flow of information to the public and thus
should ultimately strengthen investor protection.
<!-- PJG 0012 frnewline -->
It is therefore ordered, pursuant to Section 19(b)(2)
<FOOTCITE>15</FOOTCITE>
 that the proposed rule change (SR&hyph;CHX&hyph;94&hyph;12) is hereby approved.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 78s(b)(2) (1988).
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
For the Commission, by the Division of Market Regulation, pursuant to delegated authority.
<FOOTCITE>16</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
16
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
17 CFR 200.30&hyph;3(a)(12) (1994).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Margaret H. McFarland,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20122 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 8010&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00181 </DOCNO>
<PARENT> FR940817-2-00088 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Self-Regulatory Organizations; Applications for Unlisted Trading Privileges; Notice and Opportunity for Hearing;
Cincinnati Stock Exchange, Incorporated</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
August 11, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The above named national securities exchange has filed applications with the Securities and Exchange Commission
(``Commission'') pursuant to Section 12(f)(1)(B) of the Securities Exchange Act of 1934 and Rule 12f&hyph;1 thereunder
for unlisted trading privileges in the following securities:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Amway Japan Ltd.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
American Depositary Shares (rep. 1/2 sh. Com. stk. without Par Value (File No. 7&hyph;12823)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Capstone Capital Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, $.001 Par Value (File No. 7&hyph;12824)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Case Equipment Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, $.01 Par Value (File No. 7&hyph;12825)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Cole National Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Class A Common Stock, $.01 Par Value (File No. 7&hyph;12826)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Collins &amp; Aikman Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, $.01 Par Value (File No. 7&hyph;12827)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Ferrellgas Partners
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Units, (rep. L.P. Units), No Par Value (File No. 7&hyph;12828)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
First Industrial Realty Trust, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, $.01 Par Value (File No. 7&hyph;12829)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Franchise Finance Corp. of America
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, $.01 Par Value (File No. 7&hyph;12830)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Franklin Electronic Publishers, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, No Par Value (File No. 7&hyph;12831)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
HS Resources, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, $.001 Par Value (File No. 7&hyph;12832)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Kaydon Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Shares, $.10 Par Value (File No. 7&hyph;12833)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
MFS Intermediate Income Trust
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Shares of Beneficial Interest, No Par Value (File No. 7&hyph;12834)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Nations Balanced Target Maturity Fund, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, $.001 Par Value (File No. 7&hyph;12835)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Smith (Charles E.) Residential Realty, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, $.01 Par Value (File No. 7&hyph;12836)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Texaco Capital LLC
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Cm. Adj. Rate ``MIPS'' Ser. B (File No. 7&hyph;12837)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
United Wisconsin Services, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, No Par Value (File No. 7&hyph;12838)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Viking Star Shipping, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, No Par Value (File No. 7&hyph;12839)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
WCI Steel, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, No Par Value (File No. 7&hyph;12840)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Cira Pharmaceuticals, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, $.01 Par Value (File No. 7&hyph;12841)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Interdigital Communications
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, $.01 Par Value (File No. 7&hyph;12842)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Intermagnetics General Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, $.10 Par Value (File No. 7&hyph;12843)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Rotonics Manufacturing
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, No Par Value (File No. 7&hyph;12844)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Texas Meridian Resources Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, $.01 Par Value (File No. 7&hyph;12845)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Top Source Technologies, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, $.001 Par Value (File No. 7&hyph;12846)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Voyageur Minnesota Municipal Income III
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, $.01 Par Value (File No. 7&hyph;12847)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
XCL, Ltd.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, $.01 Par Value (File No. 7&hyph;12848)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
CKE Restaurants, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, $.01 Par Value (File No. 7&hyph;12849)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Dominion Resources Black Warrior Trust
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Trust Units (File No. 7&hyph;12850)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
These securities are listed and registered on one or more other national securities exchanges and are reported in
the consolidated transaction reporting system.
<!-- PJG 0012 frnewline -->
Interested persons are invited to submit on or before September 1, 1994, written data, views and arguments concerning
the above-referenced applications. Persons desiring to make written comments should file three copies thereof
with the Secretary of the Securities and Exchange Commission, 450 Fifth Street, NW Washington, DC 20549. Following
this opportunity for hearing, the Commission will approve the applications if it finds, based upon all the information
available to it, that the extensions of unlisted trading privileges pursuant to such applications are consistent
with the maintenance of fair and orderly markets and the protection of investors.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
For the Commission, by the Division of Market Regulation, pursuant to delegated authority.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Jonathan G. Katz,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20119 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 8010&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00182 </DOCNO>
<PARENT> FR940817-2-00089 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Release No. 34&hyph;34511; File No. SR&hyph;GSCC&hyph;94&hyph;06]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Self-Regulatory Organizations; Government Securities Clearing Corporation; Notice of Filing of Proposed Rule
Change Modifying the Trade Reporting Requirements for Category 2 Inter-Dealer Broker Netting Members</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
August 10, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934 (``Act''),
<FOOTCITE>1</FOOTCITE>
 notice is hereby given that on July 5, 1994, the Government Securities Clearing Corporation (``GSCC'') filed with
the Securities and exchange Commission (``Commission'') the proposed rule change (File No. SR&hyph;GSCC&hyph;94&hyph;06)
as described in Items I, II, and III below, which Items have been prepared primarily by the self-regulatory organization.
The Commission is publishing this notice to solicit comments on the proposed rule change from interested persons.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 78s(b)(1) (1988).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=85 g=1 f=1 -->
I. Self-Regulatory Organization's Statement of the Terms of Substance of the Proposed Rule Change
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed rule change will modify GSCC's rules concerning the trade reporting requirements for category 2 inter-dealer
broker netting members (``IDBs'').
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=85 g=1 f=1 -->
II. Self-Regulatory Organization's Statement of the Purpose of, and Statutory Basis for, the Proposed Rule Change
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In its filing with the Commission, the self-regulatory organization included statements concerning the purpose
of and basis for the proposed rule change and discussed any comments it received on the proposed rule change. The text
of these statements may be examined at the places specified in Item IV below. The self-regulatory organization has
prepared summaries, set forth in sections A, B, and C below, of the most significant aspects of such statements.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. Self-Regulatory Organization's Statement of the Purpose of, and the Statutory Basis for, the Proposed Rule Change
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The classification of category 2 IDBs was established by GSCC in 1993 in order to permit qualifying IDBs to engage in
up to ten percent of their trading activity in eligible securities with non-netting members.
<FOOTCITE>2</FOOTCITE>
 Each category 2 IDB must act exclusively as a broker and at least ninety percent of its business, measured based on the
overall dollar volume of next day and forward settlement activity in eligible netting securities over the most recent
twenty day period, must be with netting members.
<FOOTCITE>3</FOOTCITE>
 In addition, Category 2 IDBs have clearing fund and margin requirements essentially the same as those of a category
1 dealer netting members.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
2
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The Commission approved category 2 IDBs in Securities Exchange Act Release No. 32722 (August 12, 1993), 58 FR 42993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
3
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
For a temporary period established by GSCC's Board of Directors, the term netting members is defined to include certain
specifically designated grandfathered non-netting members firms that currently have IDB screen access. This will
temporarily allow category 2 IDBs to trade with nonmember dealers that historically have had access to the IDBs' screens.
An IDB's trading activity with grandfathered dealers will not be included for purposes of determining when an IDB
meets the ten percent scope of business limitation.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In order to monitor compliance with their scope of business requirements, each category 2 IDB is obligated to provide
GSCC in writing with a list of all of the legal entities that it acts on behalf of and must promptly inform GSCC of any change
to such list. Each IDB also is required to submit daily to GSCC all of its next day and forward settling trades in eligible
netting securities, including trades with non-grandfathered non-members and must indicate the buy and sell side
of each transaction.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
GSCC's rule do not, however, expressly require that a category 2 IDB provide to GSCC for every trade done involving
an eligible netting security the identity of each buy side and sell side counterparty. This information is significant
to GSCC for risk monitoring and surveillance purposes. In particular, it is important for GSCC to understand and to
be able to assess the volume of and degree of concentration of trading done by a category 2 IDB with one or more specific
non-members.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed rule change, therefore, will expressly require each category 2 IDB to disclose to GSCC for every trade
done involving an eligible netting security, including trades done with non-members, the identity of each buy side
and sell side counterparty.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
GSCC believes that because the proposed rule change allows GSCC to ensure that it can appropriately monitory its existing
netting members, it is consistent with Section 17A of the Act
<FOOTCITE>4</FOOTCITE>
 and the rules and regulations thereunder applicable to GSCC.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
4
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 78q&hyph;1 (1988).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00183 </DOCNO>
<PARENT> FR940817-2-00089 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Self-Regulatory Organization's Statement on Burden on Competition
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
GSCC does not believe that the proposed rule change will impose any burden on competition.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
C. Self-Regulatory Organization's Statement on Comments on the Proposed Rule Change Received from Members, Participants,
or Others
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Comments on the proposed rule change have not yet been solicited or received. GSCC members will be notified of the rule
filing and comments will be solicited by a GSCC Important Notice. GSCC will then notify the Commission of any written
comments received by GSCC regarding the proposed rule change.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=85 g=1 f=1 -->
III. Date of Effectiveness of the Proposed Rule Change and Timing for Commission Action
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Within thirty-five days of the date of publication of this notice in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
or within such longer period (i) as the Commission may designate up to ninety days of such date if it finds such longer
period to be appropriate and publishes its reasons for so finding or (ii) as to which the self-regulatory organization
consents, the Commission will:
<!-- PJG 0012 frnewline -->
(A) by order approve such proposed rule change or
<!-- PJG 0012 frnewline -->
(B) institute proceedings to determine whether the proposed rule change should be disapproved.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
IV. Solicitation of Comments
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Interested persons are invited to submit written data, views, and arguments concerning the foregoing. Persons making
written submissions should file six copies thereof with the Secretary, Securities and Exchange Commission, 450
Fifth Street, NW., Washington, DC 20549. Copies of the submission, all subsequent amendments, all written statements
with respect to the proposed rule change that are filed with the Commission, and all written communications relating
to the proposed rule change between the Commission and any person, other than those that may be withheld from the public
in accordance with the provisions of 5 U.S.C. &sect;552, will be available for inspection and copying in the Commission's
Public Reference Section, 450 Fifth Street, NW., Washington, DC 20549. Copies of such filing will also be available
for inspection and copying at the principal office of GSCC. All submissions should refer to file number SR&hyph;GSCC&hyph;94&hyph;06
and should be submitted by September 7, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
For the Commission, by the Division of Market Regulation, pursuant to delegated authority.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Margaret H. McFarland,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20120 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 8010&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00184 </DOCNO>
<PARENT> FR940817-2-00090 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Release No. 3434512; File No. SR&hyph;MBSCC&hyph;94&hyph;3]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Self-Regulatory Organizations; MBS Clearing Corporation; Notice of Amendments and Order Granting Accelerated
Approval of Proposed Rule Change Relating to Corporate Governance Changes</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
August 10, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On June 21, 1994, MBS Clearing Corporation (``MBSCC'') filed with the Securities and Exchange Commission (``Commission'')
a proposed rule change pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934 (``Act'').
<FOOTCITE>1</FOOTCITE>
 The Commission published notice of the proposed rule change in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 on July 18, 1994.
<FOOTCITE>2</FOOTCITE>
 On July 15, July 22, August 4, and August 9, 1994, MBSCC filed amendments to the proposed rule change.
<FOOTCITE>3</FOOTCITE>
 No comments have been received on the filing. As discussed below, the Commission is approving the proposed rule change,
including the amendemnts, on an accelerated basis.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 78s(b)(1) (1988).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
2
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Securities Exchange Act Release No. 34337 (July 8, 1994), 59 FR 36457.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<!-- PJG ITAG l=28 g=1 f=1 -->
3&blank;Amendment No. 1 corrected a typographical error in the filing. Letter from David T. Rusoff, Foley &amp; Lardner,
to Jerry Carpenter, Division of Market Regulation (``Division''), Commission (July 14, 1994). Amendment No. 2 clarified
certain provisions of the Shareholders Agreement. Letter from Daniel B. Silver, Cleary, Gottlieb, Steen &amp; Hamilton
to Jerry Carpenter, Division, Commission (July 21, 1994). Amendment No. 3 clarified the procedure for shareholders
to terminate the Shareholders Agreement. Letter from David T. Rusoff, Foley &amp; Lardner, to Jerry Carpenter, Division,
Commission (August 3, 1994). Amendment No. 4 provided for a limitation on the voting entitlements of bank holding
companies. Letter from David T. Rusoff, Foley &amp; Lardner, to Jerry Carpenter, Division, Commission (August 9,
1994).
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
I. Description
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
MBSCC is currently a wholly owned subsidiary of the Chicago Stock Exchange, Incorporated (``CHX''). CHX has agreed
to sell all of CHX's ownership interest in MBSCC to MBSCC participants and the National Securities Clearing Corporation
(``NSCC'').
<FOOTCITE>4</FOOTCITE>
 After the transaction is completed, participants of MBSCC will own 100% of Class A common shares of MBSCC, and NSCC
will own 100% of Class B common shares of MBSCC.
<FOOTCITE>5</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
4
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
CHX will sell all of its shares to a corporation formed for the sole purpose of acquiring MBSCC stock (``MBSCC Acquisition
Corporation''). MBSCC participants will own 90% of MBSCC Acquisition Corporation, and NSCC will own 10% of MBSCC
Acquisition Corporation. After the sale of MBSCC stock to MBSCC Acquisition Corporation, MBSCC Acquisition Corporation
will be merged into MBSCC with MBSCC being the surviving corporation.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
5
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
All MBSCC participants will have the opportunity to purchase shares in MBSCC in proposition to their usage of MBSCC.
After the initial sale to participants, participants who are not shareholders will be entitled to purchase one share
of Class A common stock. All shareholders will be required to sign the Shareholders Agreement described below.
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed rule change adopts corporate governance changes for MBSCC consistent with the transaction described
above. The proposed rule change amends Article FOURTH of MBSCC's Certificate of Incorporation, amends various provisions
of MBSCC's By-Laws and Rules, and authorizes MBSCC to enter into a Shareholders Agreement.
<!-- PJG 0012 frnewline -->
Article FOURTH of MBSCC's Certificate of Incorporation is amended to increase the number of shares of stock that MBSCC
is authorized to issue and to divide the common stock into Class A and Class B shares. The increased number of authorized
shares permits MBSCC participants to hold MBSCC shares in proportion to their usage of MBSCC without creating fractional
shares. The division of the common stock into Class A and Class B shares provides a mechanism whereby NSCC, which will
purchase 100% of Class B shares, is assured one seat on the board of directors of MBSCC.
<!-- PJG 0012 frnewline -->
The amendments to the By-Laws and the Shareholders Agreement set forth, among other things, the number of directors,
their eligibility, and the manner in which directors will be elected. Specifically, the amendment to Article 3, Section
3.1 of the By-Laws increases the size of the MBSCC board to thirteen from its present size of eleven directors.
<FOOTCITE>6</FOOTCITE>
 In addition, Article 3, Section 3.1 of the By-Laws and Section 2 of the Shareholders Agreement require that each director,
other than the NSCC director and one director that represents the management of MBSCC, must be an officer or general
partner of or hold a similar management position with a participant of MBSCC (``Participant Director'') and that
no more than one officer, partner, director, or employee of a participant may serve as director at any given time.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
6
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Pursuant to Article 3, Section 3.2 of the By-Laws and pursuant to the proposed Shareholders Agreement, one of the newly
created slots on the MBSCC board is for NSCC's delegate to the board, and one slot is for an additional representative
of participants. NSCC will elect one director of the Class III directors for so long as NSCC owns Class B shares. Section
3.1 of the By-Laws provides for a staggered board of directors with each of the three classes elected once every three
years.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00185 </DOCNO>
<PARENT> FR940817-2-00090 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed rule change also amends provisions of the By-Laws to lower the number of votes required to call a special
meeting from 75% to 25% of the outstanding voting power (Article 2, Section 2.3), to provide for waiver of notice of
a stockholders' meeting (Article 2, Section 2.4), and to authorize the board of directors to establish the salaries
of MBSCC's officers (Article 5, Section 5.2).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Section 2 of the Shareholders Agreement specifies how Participant Directors and members of the nominating committee
<FOOTCITE>7</FOOTCITE>
 are elected. As is currently the practice, the nominating committee will nominate candidates for Participant Directors
and members of the following year's nominating committee.
<FOOTCITE>8</FOOTCITE>
 Participants are given the opportunity to petition for additional candidates.
<FOOTCITE>9</FOOTCITE>
 If no petitions are filed, the participant shareholders must elect the candidates nominated by the nominating committee.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
7
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Under Section 2(A)(ii) of the Shareholders Agreement, no person who is a current member of the board or who was a member
of the board or nominating committee for the prior year may be elected to the nominating committee. Members of the nominating
committee must be officers or general partners of or hold similar management positions with MBSCC participants.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
8
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The nominating committee must submit its list of nominees to the Secretary of MBSCC no later than sixty days before
the annual meeting.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
9
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The petition must be signed by a least five participants and filed with the Secretary of MBSCC at least thirty days prior
to the annual meeting.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
If there are competing candidates due to a petition or petitions being filed, ballots will be mailed to all participants.
Pursuant to Section 2(A)(iii) of the Shareholders Agreement, each participant of MBSCC is entitled to the number
of votes determined by multiplying the number of persons to be elected Participant Directors at the annual meeting
by one vote for each $1,000 of average monthly volume-related fees (rounded down to the nearest one thousand dollars)
payable or paid by the participant to MBSCC during the preceding year (``Voting Entitlement'').
<FOOTCITE>10</FOOTCITE>
 Every participant shall have at least one vote. Each participant may cast all of its votes for a single nominee or distribute
its votes among several nominees. Participants Owners of Class A stock must vote their shares as determined by the
vote of all of the participants whether or not the voting participants are shareholders. In the event of a tie vote,
the nominating committee selects the person who is to be elected director.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
10
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The Shareholders Agreement contains special provisions for participants that are bank holding companies (``BHC'')
(as such term is defined under the Bank Holding Company Act of 1956) and their affiliates. The voting entitlement of
a BHC participant and its affiliates is limited to 4.9% of the total voting entitlements. The voting entitlement of
all BHC participants and their affiliates is limited to 24.9% of the total voting entitlements. Should the sum of the
voting entitlements of all BHC participants exceed 24.9%, each BHC participant's voting entitlement will be reduced
pro rata to comply with the 24.9% limitation. The 4.9% limitation will not apply to a BHC participant if that BHC participant
provides confirmation from the appropriate bank regulatory agency that the limitation is not applicable to that
BHC participant. The 24.9% limitation will not apply to BHC participants if any BHC participant provides confirmation
from the appropriate bank regulatory agency that the total voting entitlements of all BHC participants can exceed
24.9% of the total voting entitlements.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00186 </DOCNO>
<PARENT> FR940817-2-00090 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Shareholders Agreement also contains provisions relating to shareholder votes for other than the election of
directors.
<FOOTCITE>11</FOOTCITE>
 In addition, the Shareholders Agreement contains provisions relating to required transfers of MBSCC's stock
<FOOTCITE>12</FOOTCITE>
 and permitted transfers of MBSCC's Class A and Class B stock.
<FOOTCITE>13</FOOTCITE>
 The Shareholders Agreement also provides that the provisions governing the voting of shares shall continue in force
for ten years and shall be automatically renewed for a subsequent ten year period.
<FOOTCITE>14</FOOTCITE>
 Finally, MBSCC is amending Article V, Rule 6, Section 3 of its Rules to delete references to the CHX.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
11
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Participant shareholders may not remove a director of MBSCC, with or without cause but must remove a director for cause
if directed to do so by a majority of the directors. A 2/3 affirmative vote of the MBSCC shares is required to amend the
Certificate of Incorporation or the By-Laws of MBSCC, for MBSCC to repurchase or issue any of its securities, or for
MBSCC to purchase securities not incident to MBSCC's normal business. In addition, the shareholders must vote as
directed by the board of directors for amendments to the Certificate of Incorporation relating to (1) Greater than
majority requirements of quorum and voting at board meetings; (2) cumulative voting for the election of directors;
(3) classification of directors; (4) shareholder rights to fix consideration for shares, to determine the stated
capital and surplus upon issuance, and to authorize a reduction in capital in respect of such shares; (5) shareholder
rights to fix compensation of directors; and (6) shareholder rights to elect and remove directors. In addition, the
board also has the authority to direct shareholder voting for the amendment of any By-Laws except any By-Law which
the board is prohibited from amending by the provisions of the By-Laws.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
12
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Upon the insolvency of a participant shareholder, all MBSCC shares held by it will be transferred automatically to
all other participant shareholders pro rata.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
13
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
A participant may sell its Class A shares only to another participant but only after giving notice to MBSCC of the proposed
sale. NSCC, the sole owner of Class B stock, may sell its Class B shares only to another participant (which shares will
immediately convert into Class A shares) or to a registered clearing agency but only after giving notice to MBSCC of
the proposed sale. MBSCC has the option to purchase the Class A or Class B shares for the lower of $100 per share or the
offering price.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
14
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The provisions in the Shareholders Agreement governing voting include: (1) The obligation of the shareholders to
elect directors selected by all participants; (2) the prohibition against shareholders removing directors with
or without cause; (3) 2/3 majority voting requirements; and (4) requirements that the shareholders vote as directed
by the board for certain matters (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
see supra 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
footnote 10). All other provisions of the Shareholders Agreement remain in effect unless the agreement is terminated
or amended by the consent of all of the parties to the agreement. If at the end of any calendar year there is no agreement
governing the voting of the shares in effect, the shares of MBSCC will be redistributed in proportion to each participant's
usage of MBSCC.
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Discussion
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commission believes the proposed rule change is consistent with Section 17A of the Act and, therefore, is approving
the proposal. Specifically, the Commission believes the proposal is consistent with Section 17A(b)(3)(C)
<FOOTCITE>15</FOOTCITE>
 of the Act in that it assures the fair representation of its shareholders and participants in the selection of its directors
and administration of its affairs.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 78q&hyph;1(b)(3)(C) (1988).
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Act does not define fair representation or set up particular standards of representation. Instead it provides
that the Commission must determine whether the rules of the clearing agency assure adequate representation of participants
and shareholders in the selection of the board of directors and the administration of the clearing agency's affairs.
In its release setting forth the standards for registration of clearing agencies (``Standards Release''), the Commission
stated that rather than prescribing a single method for providing fair representation, the Commission would evaluate
each clearing agency's procedures on a case-by-case basis.
<FOOTCITE>16</FOOTCITE>
 With respect to providing participants with a meaningful opportunity to be represented in the selection of the board
of directors and the administration of the clearing agency's affairs, the Standards Release suggests a number of
methods can be used to comply with the fair representation standard. Among others, these include the allocation of
voting stock to all participants based on their usage of the clearing agency or the selection by participants of a slate
of nominees for which the stockholders of the clearing agency will be required to vote their shares.
<FOOTCITE>17</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
16
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Securities Exchange Act Release No. 16900 (July 1, 1980), 45 FR 41920.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
17
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The other suggestions in the Standards Release are: (1) Solicitation of board of director nominations from all participants;
(2) selection of candidates for election to the board of directors by a nominating committee which would be composed
of and selected by the participants or representatives chosen by participants; or (3) a number of directors chosen
by and from the participants.
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
MBSCC's proposal initially allows all participants to purchase voting stock based on their usage of MBSCC. Rather
than reallocating the voting shares each year in proportion to participants' usage of MBSCC, the Shareholders Agreement
requires the participant shareholders to elect directors selected by all participants. If the voting provisions
of the Shareholders Agreement expire, the participants' voting stock will be reallocated each year in accordance
with each participant's usage of MBSCC. Both methods of electing directors appear to be consistent with the methods
outlined in the Standards Release.
<!-- PJG 0012 frnewline -->
The Shareholders Agreement should ensure that the candidates for the board and the nominating committee represent
the entire MBSCC participant base. The nominating committee is directed to select candidates with a view toward providing
fair representation for the interests of a cross section of the participants. Other candidates may be nominated if
the nominating committee is petitioned by participants.
<!-- PJG 0012 frnewline -->
Other aspects to the proposed rule change serve to enhance the ability of small participants to have a voice in the administration
of MBSCC's affairs. By limiting each participant's representation on the board to only one director, MBSCC's board
should represent a cross-section of MBSCC's participant base and should not be dominated by one or two large participants.
To counter the potential for a few large participants to determine the outcome of a shareholder vote, certain provisions
of the Shareholders Agreement limit the shareholders' authority in favor of board power. For example, the shareholders
must vote as directed by the board regarding removal of directors and the amendment of certain provisions of the Certificate
of Incorporation. In addition, by requiring a 2/3 vote to amend the Certificate of Incorporation or the By-Laws, a
greater consensus among shareholders must be obtained before making substantial changes to MBSCC's administration.
The Commission believes that the provisions enhancing the authority of the board of directors, who represent all
the participants, are consistent with a clearing agency's obligations of fair representation.
<!-- PJG 0012 frnewline -->
The Commission also believes that the limitation on the voting entitlement of BHC participants is permissible under
the fair representation requirements. During 1993, the BHCs' usage of MBSCC was less than 20% of the total usage of
MBSCC, and therefore, no reduction in the BHCs' voting entitlement would have been required. MBSCC has agreed to notify
the Commission if the BHCs' usage of MBSCC exceeds 24%. However, the Commission believes that even if a reduction of
the BHCs' voting entitlement occurs, the fair representation requirements are not violated because the provision
was adopted at the request of the BHCs, whose voting entitlements are being reduced, because of the Bank Holding Company
Act of 1956.
<!-- PJG 0012 frnewline -->
MBSCC has requested that the Commission find good cause for approving the proposed rule change prior to the thirtieth
day after the date of publication of the notice of filing. The parties to the merger have agreed to close the transaction
during the first two weeks of August 1994. To permit an efficient transfer of ownership from the CHX to MBSCC participants,
it is necessary that the appropriate governance changes are in place. Therefore, the Commission finds sufficient
cause to accelerate approval of this proposal.
<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00187 </DOCNO>
<PARENT> FR940817-2-00090 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Interested persons are invited to submit written data, views, and arguments concerning the amendments to the proposed
rule change. Persons making written submissions should file six copies thereof with the Secretary, Securities and
Exchange Commission, 450 Fifth Street, NW., Washington, DC 20549. Copies of the submission, all subsequent amendments,
all written statements with respect to the proposed rule change that are filed with the Commission, and all written
communications relating to these amendments between the Commission and any person, other than those that may be withheld
from the public in accordance with the provisions of 5 U.S.C. 552, will be available for inspection and copying in the
Commission's Public Reference Section, 450 Fifth Street, NW., Washington, DC, 20549. Copies of such filing also
will be available for inspection and copying at the principal office of the above-mentioned self-regulatory organization.
All submissions should refer to File No. SR&hyph;MBSCC&hyph;CC&hyph;94&hyph;3 and should be submitted by September
7, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
III. Conclusion
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
For the reasons stated above, the Commission finds that the proposed rule change is consistent with Section 17A of
the Act.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
It is therefore ordered, pursuant to Section 19(b)(2) of the Act, that the proposed rule change (File No. SR&hyph;MBSCC&hyph;94&hyph;03)
be, and hereby is, approved.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
For the Commission by the Division of Market Regulation, pursuant to delegated authority.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Margaret H. McFarland,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20121 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 8010&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00188 </DOCNO>
<PARENT> FR940817-2-00091 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Self-Regulatory Organizations; Applications for Unlisted Trading Privileges; Notice and Opportunity for Hearing;
Pacific Stock Exchange, Incorporated</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
August 11, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The above named national securities exchange has filed applications with the Securities and Exchange Commission
(``Commission'') pursuant to Section 12(f)(1)(B) of the Securities Exchange Act of 1934 and Rule 12f&hyph;1 thereunder
for unlisted trading privileges in the following securities:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Amphenol Corporation,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Class A Common Stock, $.001 Par Value (File No. 7&hyph;12803).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Coram Healthcare Corporation,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, $.001 Par Value (File No. 7&hyph;12804).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Potash Corp. of Saskatchewan,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, No Par Value (File No. 7&hyph;12805).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
United Asset Management Corp.,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, $.01 Par Value (File No. 7&hyph;12806).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Whx Corporation,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, $.01 Par Value (File No. 7&hyph;12807).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Whx Corporation,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Warrents expiring January 3, 1996 (File No. 7&hyph;12808).
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
These securities are listed and registered on one or more other national securities exchange and are reported in the
consolidated transaction reporting system.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Interested persons are invited to submit on or before September 1, 1994, written data, views and arguments concerning
the above-referenced application. Persons desiring to make written comments should file three copies thereof with
the Secretary of the Securities and Exchange Commission, 450 5th Street, NW., Washington, DC 20549. Following this
opportunity for hearing, the Commission will approve the application if it finds, based upon all the information
available to it, that the extensions of unlisted trading privileges pursuant to such applications are consistent
with the maintenance of fair and orderly markets and the protection of investors.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
For the Commission, by the Division of Market Regulation, pursuant to delegated authority.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Jonathan G. Katz,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20118 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 8010&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00189 </DOCNO>
<PARENT> FR940817-2-00092 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Self-Regulatory Organizations; Applications for Unlisted Trading Privileges; Notice and Opportunity for Hearing;
Philadelphia Stock Exchange, Incorporated</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
August 11, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The above named national securities exchange has filed applications with the Securities and Exchange Commission
(``Commission'') pursuant to Section 12(f)(1)(B) of the Securities Exchange Act of 1934 and Rule 12f&hyph;1 thereunder
for unlisted trading privileges in the following securities:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Desc S.A. De C.V.,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
American Depository Shares (each representing 4 series C Shares, No Par Value (File No. 7&hyph;12809).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Emotelladora Andina S.A.,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
American Depository Shares, (each representing 6 Shares of Common Stock, No Par Value (File No. 7&hyph;12810).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Banpais S.A. Institucion de Banca Multiple Grupo Financiero Asemex Banpais,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
American Depository Shares, (each representing 6 Shares L Limited Voting Shares NPS 1.00, Par Value (File No. 7&hyph;12811).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Collin &amp; Aikman Corporation,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, $.01 Par Value (File No. 7&hyph;12812).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Coram Healthcare Corporation,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, $.001 Par Value (File No. 7&hyph;12813).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Morgan Stanley Asia Pacific Fund, Inc.,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, $.01 Par Value (File No. 7&hyph;12814).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Freeport McMoran Copper &amp; Gold, Inc., 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Depository Shares, (File No. 7&hyph;12815).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Apartment Investment and Management Company,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, $.01 Par Value (File No. 7&hyph;12816).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Empresa Nacional de Electricidad S.A. Chile,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, No Par Value (File No. 7&hyph;12817).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Home Properties of New York, Inc.,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, $.01 Par Value (File No. 7&hyph;12818).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Silverado Foods, Inc.,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, $.01 Par Value (File No. 7&hyph;12819).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Watsco, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, $.50 Par Value (File No. 7&hyph;12820).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Rightchoice Managed Care, Inc.,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, $.01 Par Value (File No. 7&hyph;12821).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
DIMAC Corporation,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Common Stock, $.01 Par Value (File No. 7&hyph;12822).
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
These securities are listed and registered on one or more other national securities exchanges and are reported in
the consolidated transaction reporting system.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Interested persons are invited to submit on or before September 1, 1994, written data, views and arguments concerning
the above-referenced application. Persons desiring to make written comments should file three copies thereof with
the Secretary of the Securities and Exchange Commission, 450 5th Street, NW., Washington, DC 20549. Following this
opportunity for hearing, the Commission will approve the application if it finds, based upon all the information
available to it, that the extensions of unlisted trading privileges pursuant to such applications are consistent
with the maintenance of fair and orderly markets and the protection of investors.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
For the Commission, by the Division of Market Regulation, pursuant to delegated authority.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Jonathan G. Katz,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20115 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 8010&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00190 </DOCNO>
<PARENT> FR940817-2-00093 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF STATE</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Public Notice No. 2047; Delegation of Authority of Authority No. 213]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Designation of Administrator Delegation of Authority
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Pursuant to the powers vested in me as Acting Secretary of State, including by Section 1(a) of the Department of State
Basic Authorities Act, as amended by Section 161(a) of the Foreign Relations Authorization Act, Fiscal Years 1994&hyph;1995,
Public Law 103&hyph;236 (April 30, 1994) (``the Act'') and by Section 104(b) of the Immigration and Nationality Act
of 1952, 66 Stat. 163, as amended by Section 162(h) of the Act, I hereby designate the Assistant Secretary of State for
Consular Affairs as Administrator.
<!-- PJG 0012 frnewline -->
I hereby further provide that all delegations that conferred authorities of the Secretary of State upon the Assistant
Secretary of State for Consular Affairs as of July 28, 1994, shall continue in force and effect as delegations to the
Assistant Secretary of State for Consular Affairs and Administrator. Such delegations shall include, but not be
limited to, Delegation of Authority Number 74, Public Notice 132 (November 27, 1953), and all subsequent amendments
thereto.
<!-- PJG 0012 frnewline -->
This designation and delegation shall be published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: July 29, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Secretary of State.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Strobe Talbott,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20084 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4710&hyph;10&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00191 </DOCNO>
<PARENT> FR940817-2-00094 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF TRANSPORTATION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Federal Aviation Administration</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Aviation Rulemaking Advisory Committee (ARAC); Engine Harmonization Working Group
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Federal Aviation Administration (FAA), DOT.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of new task assignments for the Aviation Rulemaking Advisory Committee.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice is given of new task assignments for the Engine Harmonization Working Group of the Aviation Rulemaking Advisory
Committee (ARAC). This notice informs the public of the activities of the ARAC.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Mr. Michael Borfitz, Assistant Executive Director for Transport Airplane and Engine Issues, Aviation Rulemaking
Advisory Committee, FAA Engine &amp; Propeller Directorate, 12 New England Executive Park, Burlington, Massachusetts
01803; telephone (617) 238&hyph;7110, fax (617) 238&hyph;7199.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
On January 22, 1991 (56 FR 2190), the Federal Aviation Administration (FAA) established the Aviation Rulemaking
Advisory Committee (ARAC). The committee provides advice and recommendations to the FAA Administrator, through
the Associate Administrator for Regulation and Certification, on the full range of the FAA's rulemaking activities
with respect to aviation-related issues.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In order to develop such advice and recommendations, the ARAC may choose to establish working groups to which specific
tasks are assigned. Such working groups are comprised of experts from those organizations having an interest in the
assigned tasks. A working group member need not be a representative of a member of the full committee. One of the working
groups established by the ARAC is the Engine Harmonization Working Group.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The FAA announced at the Joint Aviation Authorities (JAA)_Federal Aviation Administration (FAA) Harmonization
Conference in Toronto, Canada, (June 2&hyph;5, 1992), that it would consolidate within the ARAC structure an ongoing
objective to ``harmonize'' the Joint Aviation Requirements (JAR) and the Federal Aviation Regulations (FAR).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Tasks
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Engine Harmonization Working Group new tasks are as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Task 1, Fire Pervention_
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Review FAR and JAR requirements and create one set of common requirements (FAR 33.17; JAR&hyph;E&hyph;530).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Task 2, FAR 35_
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Conduct a comparison of FAR Park 35 and JAR&hyph;P requirements and advisory material and identify significant differences.
This comparison should clarify and redefine existing requirements to include new standards to reflect recent advancements
in design and construction of composite material propellers, propeller control systems (such as dual acting control
systems) and electronic controls.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Reports
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
For each task listed, the Engine Harmonization Working Group should develop and present to the ARAC:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. A recommended work plan for completion of the tasks, including the rationale supporting such as a plan, for consideration
at the meeting of the ARAC to consider transport airplane and engine issues held following publication of this notice;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. A detailed conceptual presentation on the proposed recommendation(s), prior to proceeding with the work stated
in item 3. below;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. A draft Notice of Proposed Rulemaking, with supporting economic and other required analyses, and/or any other
related guidance material or collateral documents the working group determines to be appropriate; or, if new or revised
requirements or compliance methods are not recommended, a draft report stating the rationale for not making such
recommendations; and
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. A status report at each meeting of the ARAC held to consider transport airplane and engine issues.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Participation in Working Group Task
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
An individual who has expertise in the subject matter and wishes to become a member of the working group should write
to the person listed under the caption 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
expressing that desire, describing his or her interest in the task(s), and stating the expertise he or she would bring
to the working group. The request will be reviewed with the assistant chair and working group chair, and the individual
will be advised whether or not the request can be accommodated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Secretary of Transportation has determined that the formation and use of the Aviation Rulemaking Advisory Committee
are necessary in the public interest in connection with the performance of duties imposed on the FAA by law.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Meetings of the Aviation Rulemaking Advisory Committee will be open to the public, except as authorized by section
10(d) of the Federal Advisory Committee Act. Meetings of the working group will not be open to the public, except to
the extent that individuals with an interest and expertise are selected to participate. No public announcement of
working group meetings will be made.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued in Washington, DC, on August 10, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Chris A. Christie,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Executive Director, Aviation Rulemaking Advisory Committee.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20151 Filed 8&hyph;6&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;13&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00192 </DOCNO>
<PARENT> FR940817-2-00095 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Intent To Rule on Application To Impose and Use the Revenue From a Passenger Facility Charge (PFC) at Quad City Airport,
Moline, IL</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Federal Aviation Administration (FAA), DOT.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of Intent to Rule on Application.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The FAA proposes to rule and invites public comment on the application to impose and use the revenue from a PFC at Quad
City Airport under the provisions of the Aviation Safety and Capacity Expansion Act of 1990 (Title IX of the Omnibus
Budget Reconciliation Act of 1990) (Public Law 101&hyph;508) and Part 158 of the Federal Aviation Regulations (14
CFR Part 158).
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Comments must be received on or before September 16, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Comments on this application may be mailed or delivered in triplicate to the FAA at the following address: Federal
Aviation Administration, Chicago Airports District Office, 2300 East Devon Avenue, Room 258, Des Plaines, IL 60018.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In addition, on copy of any comments submitted to the FAA must be mailed or delivered to Mr. Kent G. George, Director
of Aviation of the Metropolitan Airport Authority of Rock Island County, Illinois at the following address: P.O.
Box 9009, Moline, IL 61265.
<!-- PJG 0012 frnewline -->
Air carriers and foreign air carriers may submit copies of written comments previously provided to the Metropolitan
Airport Authority or Rock Island County, Illinois under section 158.23 of Part 158.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Mr. Louis H. Yates, Manager, Chicago Airports District Office, 2300 East Devon Avenue, Room 258, Des Plaines, IL 60018,
(708) 294&hyph;7335. This application may be reviewed in person at this same location.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The FAA proposes to rule and invites public comment on the application to impose and use the revenue from a PFC at Quad
City Airport under the provisions of the Aviation Safety and Capacity Expansion Act of 1990 (Title IX of the Omnibus
Budget Reconciliation Act of 1990) (Public Law 101&hyph;508) and Part 158 of the Federal Aviation Regulations (14
CFR Part 158).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On July 15, 1994, the FAA determined that the application to impose and use the revenue from a PFC submitted by Metropolitan
Airport Authority of Rock Island County, Illinois was substantially complete within the requirements of section
158.25 of Part 158. The FAA will approve or disapprove the application, in whole or in part, no later than October 18,
1994.
<!-- PJG 0012 frnewline -->
The following is a brief overview of the application.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Level of the proposed PFC: $3.00 
<!-- PJG 0012 frnewline -->
Proposed charge effective date: November 1, 1994
<!-- PJG 0012 frnewline -->
Proposed charge expiration date: November 1, 2010
<!-- PJG 0012 frnewline -->
Total estimated PFC revenue: $13,355,830
<!-- PJG 0012 frnewline -->
Brief description of proposed project(s): Extension of Runway 13/31, Environmental Study for Runway 9/27, Reimbursement
of Land Acquisition for Noise Abatement and Obstruction Removal, GA Itinerant Ramp Replacement, Extension of Runway
9/27, Expansion of Airfield Maintenance Building, ARFF Equipment Rehab and Purchase, Demolition of Old Terminal
Bldg and T-hangars, Concourse ``A'' Ramp Replacement, Anti-Skid Treatment of Runway 9/27, Extension of Taxiway
Bravo, Snow Removal Equipment Purchase, North Ramp Replacement Phase V, and Taxiways D, E, &amp; K Improvements.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Class or classes of air carriers which the public agency has requested not be required to collect PFCs: Air Taxi/Commercial
Operators.
<!-- PJG 0012 frnewline -->
Any person may inspect the application in person at the FAA office listed above under 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
In addition, any person may, upon request, inspect the application, notice and other documents germane to the application
in person at the Metropolitan Airport Authority of Rock Island County, Illinois.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued in Des Plaines, Illinois on August 10, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Benito DeLeon,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Manager, Planning/Programming Branch Airports Division, Great Lakes Region.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20150 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;13&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00193 </DOCNO>
<PARENT> FR940817-2-00096 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Research, Engineering and Development Advisory Committee; Subcommittee on Aircraft Safety</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Pursuant to Section 10(A)(2) of the Federal Advisory Committee Act (Public Law 92&hyph;362; 5 U.S.C. App. I), notice
is hereby given of a meeting of the Subcommittee on Aircraft Safety of the Federal Aviation Administration (FAA) Research,
Engineering and Development Advisory Committee. The meeting will take place on Tuesday, August 30, 1994, at 10:00
a.m. The meeting will take place at McDonnell Douglas, 1735 Jefferson-Davis Highway, Suite 12, Spirit Room, Crystal
City, VA.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The agenda for this meeting will include a review and finalization of the subcommittee report on the FAA's Aircraft
Safety Research and Development Program.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Attendance is open to the interested public but limited to space available. With the approval of the committee chairman,
members of the public may present oral statements at the meeting. Persons wishing to present oral statements, obtain
information, or access the building to attend the meeting should contact the Designated Federal Official, Mr. Dan
Salvano, Aircraft Certification Service, AIR&hyph;3, 800 Independence Avenue, S.W., Washington, DC 20591, 202&hyph;267&hyph;9554.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Members of the public may present a written statement to the subcommittee at any time.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issue in Washington, DC on August 11, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Martin T. Pozesky,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Executive Director, Research, Engineering and Development Advisory Committee.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20165 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;13&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00194 </DOCNO>
<PARENT> FR940817-2-00097 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Federal Highway Administration</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Environmental Impact Statement: Sacramento County, CA</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Federal Highway Administration (FHWA), DOT.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of Intent.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The FHWA is issuing this notice to advise the public that an environmental impact statement will be prepared for a proposed
highway project in Sacramento County, California.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Dennis A. Scovill, Chief, District Operations_C, Federal Highway Administration, 980 Ninth Street, Suite 400,
Sacramento, California, 95814, Telephone (916) 551&hyph;1307.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The FHWA, in cooperation with the California Department of Transportation and with the City of Sacramento, will prepare
an environmental impact statement (EIS) on a proposal to construct a 4-lane connector roadway between Garden Highway
and Arden Way which includes construction of a bridge over the Natomas East Main Drainage Canal (NEMDC). The connector
and bridge are needed to meet existing and projected traffic demands. The length of the connector roadway is approximately
1.3 miles including the bridge.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Alternatives to be considered may include (1) Taking no action; (2) widening West El Camino Boulevard; and (3) different
alignment crossings of the Natomas East Main Drainage Canal. Variations of grade and alignment may be studied for
the various build alternatives.
<!-- PJG 0012 frnewline -->
Letters describing the proposed action and soliciting comments will be sent to appropriate Federal, State, and local
agencies, and to private organizations and citizens who have previously expressed or are known to have interest in
this proposal. Public and agency scoping meetings will be held as required. A public meeting will be held upon completion
of the draft EIS. Public notice will be given of the time and place of the meeting. The draft EIS will be available for
public and agency review and comment prior to the public meeting.
<!-- PJG 0012 frnewline -->
To ensure that the full range of issues related to this proposal are addressed and all significant issues identified,
comments and suggestions are invited from all interested parties. Comments or questions concerning this proposed
action and the EIS should be directed to the FHWA Chief of District Operations at the address indicated above.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
(Catalog of Federal Domestic Assistance Program Number 20.205, Highway Research Planning and Construction. The
regulations implementing Executive Order 12372 regarding intergovernmental consultation on Federal programs
and activities apply to this program.)
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued on: August 3, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Jeffery S. Lewis,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Chief, District Operations_C.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20087 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;22&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00195 </DOCNO>
<PARENT> FR940817-2-00098 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>DEPARTMENT OF TRANSPORTATION</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Maritime Administration</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
DEPARTMENT OF COMMERCE
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>National Oceanic and Atmospheric Administration</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
DEPARTMENT OF THE TREASURY
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Internal Revenue Service</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Applicable Rate of Interest on Nonqualified Withdrawals From a Capital Construction Fund
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Under the authority in Section 607(h)(4)(B) of the Merchant Marine Act, 1936, as amended (46 U.S.C. 1177(h)(4)(B)),
we hereby determine and announce that the applicable rate of interest on the amount of additional tax attributable
to any nonqualified withdrawals from a Capital Construction Fund established under Section 607 of the Act shall be
5.62 percent, with respect to nonqualified withdrawals made in the taxable year beginning in 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The determination of the applicable rate of interest with respect to nonqualified withdrawals was computed, according
to the joint regulations issued under the Act (46 CFR 391.7(e)(2)(ii)), by multiplying eight percent by the ratio
which (a) the average yield on 5-year Treasury securities for the calendar year immediately preceding the beginning
of such taxable year bears to (b) the average yield on 5-year Treasury securities for the calendar year 1970. The applicable
rate so determined was computed to the nearest one-hundredth of one percent.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
SO ORDERED BY:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Maritime Administrator, Maritime Administration.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Administrator, National Oceanic, and Atmopsheric Administration.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Assistant Secretary for Tax Policy, Department of the Treasury.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: August 11, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
A.J. Herberger, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Maritime Administrator.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Douglas K. Hall,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Undersecretary for Oceans and Atmosphere.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Leslie Samuels,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Assistant Secretary for Tax Policy.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20069 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;81&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00196 </DOCNO>
<PARENT> FR940817-2-00099 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF TRANSPORTATION</USDEPT>

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>National Highway Traffic Safety Administration</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. 93&hyph;79; Notice 5]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Child Seating Systems Manufactured by Fisher-Price, Inc.; Cancellation of Public Meeting and Termination of Proceeding
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 National Highway Traffic Safety Administration (NHTSA).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Cancellation of public meeting and termination of proceeding.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 By notice published on August 1, 1994, NHTSA scheduled a public meeting for August 17, 1994 regarding an appeal by Fisher-Price,
Inc., of NHTSA's denial of its petition for an exemption from the recall requirements of the National Traffic and Motor
Vehicle Safety Act. Fisher-Price recently advised the agency that it is now taking the position that it has not determined
that its child safety seats failed to comply with the flammability requirements of Federal Motor Vehicle Safety Standard
No. 213. Under the agency's regulations, a manufacturer may not seek an exemption from the recall requirements in
the absence of such a determination. Therefore, this proceeding is hereby terminated, and the public meeting is hereby
cancelled.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Chris Flanigan, Office of Rulemaking, NHTSA (202&hyph;366&hyph;4918).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 On March 11, 1993, a contractor for NHTSA's Office of Vehicle Safety Compliance (OVSC) tested certain child safety
seats manufactured by Fisher-Price to ascertain whether those seats complied with the requirements of Federal Motor
Vehicle Safety Standard (FMVSS) No. 213, ``Child Restraint Systems.'' The results of those tests indicated that
the seats failed the flammability requirements of that standard, which are incorporated by reference from FMVSS
No. 302, ``Flammability of Interior Materials,'' in that the shoulder belt webbing of the seats burned at a rate above
the limit established by the standard. Upon receipt of the test results, OVSC opened a noncompliance investigation,
NCI 3270.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Although Fisher-Price initially resisted OVSC's suggestion that the company should make a formal determination
that the seats failed to comply, on September 16, 1993, Fisher-Price, submitted a letter, pursuant to 49 CFR Part 573,
``Defect and Noncompliance Reports,'' notifying the agency that it had ``become aware of information suggesting
that the molded shoulder belt webbing on its Model AO9191, DO9101, 9103, 9149, 9173, 9179, and 9180 car seats may not
comply with the requirements of FMVSS 302.''
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Concurrently, Fisher-Price filed a petition asking NHTSA for ``an exemption from the notification and remedy requirements
*&blank;*&blank;* based on an inconsequential noncompliance with the requirements *&blank;*&blank;* as related
to motor vehicle safety.'' This petition was filed pursuant to former section 157 of the Act (now 49 U.S.C. 30118(d)
and 30120(h)) and 49 CFR Part 556, ``Exemption for Inconsequential Defect or Noncompliance.''
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Pursuant to 49 CFR 556.4(a), inconsequentiality petitions may only be filed by a manufacturer following a determination
that a vehicle or item of equipment produced by the manufacturer contains a defect or fails to comply with an applicable
FMVSS. In its September 16, 1993 letter, Fisher-Price stated that ``[i]n order to comply with the requirements of
49 CFR 556.4(b)(6) [sic] that a report in accordance with 49 CFR Part 573 be submitted with its Petition for exemption,''
it was providing the information required by Part 573.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Under the circumstances, including the fact that the results of the compliance tests conducted both by OVSC and by
Fisher-Price clearly indicated that the seats in question did not satisfy the flammability requirements of the standard,
NHTSA interpreted Fisher-Price's statement as a notification of the company's noncompliance determination. Therefore,
the agency accepted the inconsequentiality petition for processing. It published a notice that the petition had
been filed on November 9, 1993 (58 FR 59511), and denied the petition on March 22, 1994. Notice of the denial was published
on May 5, 1994 (59 FR 23253). On May 6, Fisher-Price appealed the denial and asked for a public meeting. Notice of the
appeal was published on June 16, 1994 (59 FR 30957), and the public meeting requested by the company was scheduled for
August 17, 1994 (59 FR 39015).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Upon reviewing the documents that Fisher-Price submitted with its appeal, NHTSA noted that Fisher-Price seemed
to be taking the position that its child safety seats did not fail to comply with FMVSS No. 213. Therefore, the agency
requested Fisher-Price to clarify whether it had in fact made a noncompliance determination. On August 10, 1994,
Fisher-Price advised NHTSA that it would not concede that its seats failed to comply with the standard and that its
September 16, 1993 letter should not be construed as a determination of noncompliance.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Because 49 CFR 556.4(a) precludes consideration of Fisher-Price's petition for an inconsequentiality exemption
in the absence of such a determination, NHTSA is terminating this proceeding (Docket 93-79) and is cancelling the
public meeting scheduled for August 17, 1994. The agency plans to take further action with respect to the noncompliance
investigation in the near future.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 49 U.S.C. 30118, 30120; delegations of authority at 49 CFR 1.50(a) and 49 CFR 501.8.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued on: August 12, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Barry Felrice,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Associate Administrator for Rulemaking.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20231 Filed 8&hyph;12&hyph;94; 4:59 pm]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;59&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00197 </DOCNO>
<PARENT> FR940817-2-00100 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Research and Special Programs Administration</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Office of Hazardous Materials Safety; Applications for Exemptions</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Research and Special Programs Administration, DOT.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
List of Applicants for Exemptions.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
In accordance with the procedures governing the application for, and the processing of, exemptions from the Department
of Transportation's Hazardous Materials Regulations (49 CFR Part 107, Subpart B), notice is hereby given that the
Office of Hazardous Materials Safety has received the applications described herein. Each mode of transportation
for which a particular exemption is requested is indicated by a number in the ``Nature of Application'' portion of
the table below as follows: 1_Motor vehicle, 2_Rail freight, 3_Cargo vessel 4_Cargo aircraft only, 5_Passenger-carrying
aircraft.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Comments must be received on or before September 16, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESS COMMENTS TO: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Docket Unit, Research and Special Programs Administration, U.S. Department of Transportation, Washington, DC
20590.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Comments should refer to the application number and be submitted in triplicate. If confirmation of receipt of comments
is desired, include a self-addressed stamped postcard showing the exemption application number.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Copies of the applications are available for inspection in the Dockets Unit, Room 8426, Nassif Building, 400 7th Street,
SW. Washington, DC.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00198 </DOCNO>
<PARENT> FR940817-2-00100 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<TABLE>

<!-- PJG tableformat 4,L2,i1,xls35,r100,r100,r200 -->

<!-- PJG ITAG l=95 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
New Exemptions
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Application No. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Applicant
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Regulation(s) affected
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Nature of exemption thereof
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=4 -->
11294&hyph;N
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Northeast Environmental Services of America, Inc., Canastota, NY
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
49 CFR 177.848
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To load, transport and store combustible materials classed as Division 4.2; poison materials classed as Division
6.1 in Packing Group 1, Zone A packed in ``lab-pack'' drums on the same transport vehicle carrying packages containing
various classes of hazardous materials. (mode 1)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
11297&hyph;N
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Reebok International Ltd., Stoughton, MA
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
49 CFR (Parts 171&hyph;177) of Subtitle B, 175.10, subchapter C
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
This exemption authorizes the transportation of Reebok ``instapump'' inflators equipped with CO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=2 -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 cartridges, classed in division 2.2, which are presently forbidden either in the passenger cabin of the aircraft,
or the cargo compartment. (mode 5)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
11299&hyph;N
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Minnesota Valley, Engineering, Inc., Bloomington, MN
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
49 CFR 178.57&hyph;10(a)(1), 178.57&hyph;21(a)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Authorize the manufacture, marking and sale of non-DOT specification cylinders of ASTM A240 Type 201LN stainless
steel for use in transporting non-flammable gases, Division 2.2. (modes 1, 2, 3, 4)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
11301&hyph;N
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
ICI Explosives USA Inc., Dallas, TX
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
49 CFR 173.51, 173.54, 173.57, 173.62, 177.801
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To authorize the transportation of unclassified explosive material consisting of articles and solid substances
classed in Division 1.1, waste substances (or articles); explosives, n.o.s. overpacked in packaging group II containers
transported by EPA licensed hazardous waste haulers. (mode 1)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
11302&hyph;N
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Stolt Tank Containers Limited, Hull, North Humberside, EN
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
49 CFR 178.245&hyph;1(b)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To authorize the manufacture, marking and sale of non-DOT specification cargo tanks built to DOT&hyph;51 specification
equipped with modified outlets on the bottom side for use in transporting various hazardous materials classed in
Division 2.1, 2.2, 2.3, and Class 3. (modes 1, 2, 3)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
11304&hyph;N
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
AT&amp;T, Basking Ridge, NJ
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
49 CFR 173.28(b)(2)(iii)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
To be exempt from retesting criteria for up to 5 gallons capacity DOT Specification containers containing gasoline,
Class 3, for use in fueling service vehicles. (mode 1)
<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This notice of receipt of applications for new exemptions is published in accordance with Part 107 of the Hazardous
Materials Transportation Act (49 U.S.C. 1806; 49 CFR 1.53(e)).
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued in Washington, DC, on August 10, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
J. Suzanne Hedgepeth,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Chief, Exemption Programs, Office of Hazardous Materials Exemptions and Approvals.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20153 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;60&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00199 </DOCNO>
<PARENT> FR940817-2-00101 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Office of Hazardous Materials Safety; Applications for Modification of Exemptions or Applications to Become a Party
to an Exemption</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Research and Special Program Administration, DOT.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
List of Applications for Modification of Exemptions or Applications to Become a Party to an Exemption.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
In accordance with the procedures governing the application for, and the processing of, exemptions from the Department
of Transportation's Hazardous Materials Regulations (49 CFR Part 107, Subpart B), notice is hereby given that the
Office of Hazardous Materials Safety has received the applications described herein. This notice is abbreviated
to expedite docketing and public notice. Because the sections affected, modes of transportation, and the nature
of application have been shown in earlier Federal Register publications, they are not repeated here. Requests for
modifications of exemptions (e.g. to provide for additional hazardous materials, packing design changes, additional
mode of transportation, etc.) are described in footnotes to the application number. Application numbers with the
suffix ``X'' denote a modification request. Application numbers with the suffix ``P'' denote a party to request.
These applications have been separated from the new applications for exemptions to facilitate processing.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Comments must be received on or before September 1, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESS COMMENTS TO: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Dockets Unit, Research and Special Program Administration, U.S. Department of Transportation, Washington, DC
20590.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Comments should refer to the application number and be submitted in triplicate. If confirmation of receipt of comments
is desired, include a self-addressed stamped postcard showing the exemption number.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Copies of the applications are available for inspection in the Dockets Unit, Room 8426, Nassif Building, 400 7th Street
SW, Washington, DC. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00200 </DOCNO>
<PARENT> FR940817-2-00101 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<TABLE>

<!-- PJG tableformat 3,L2,tp0,i1,xls35,r50,8 -->

<!-- PJG ITAG l=95 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Application No.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Applicant
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Renewal of exemption
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
5022&hyph;X
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
United Technologies Chemical Corp., San Jose, CA (See Footnote 1)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
5022
<!-- PJG 0012 frnewline -->
8249&hyph;X
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
LPS Industries, Inc., Newark, NJ (See Footnote 2)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
8249
<!-- PJG 0012 frnewline -->
8489&hyph;X
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
FMC Corporation, Carteret, NJ (See Footnote 3)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
8489
<!-- PJG 0012 frnewline -->
8627&hyph;X
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Petrolite Corporation, Saint Louis, MO (See Footnote 4)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
8627
<!-- PJG 0012 frnewline -->
9894&hyph;X
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
International Safety Instruments, Inc., Lawrenceville, GA (See Footnote 5)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
9894
<!-- PJG 0012 frnewline -->
10256&hyph;X
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Comdyne I, Inc., West Liberty, OH (See Footnote 6)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
10256
<!-- PJG 0012 frnewline -->
10380&hyph;X
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Reeled Tubing, Inc., Harvey, LA (See Footnote 7)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
10380
<!-- PJG 0012 frnewline -->
10380&hyph;X
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Reeled Tubing, Inc., Harvey, LA (See Footnote 7)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
10380
<!-- PJG 0012 frnewline -->
10705&hyph;X
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Baker Performance Chemicals, Inc., Houston, TX (See Footnote 8)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
10705
<!-- PJG 0012 frnewline -->
11215&hyph;X
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Orbital Sciences Corporation (OSC) Dulles, VA (See Footnote 9)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11215
<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00201 </DOCNO>
<PARENT> FR940817-2-00101 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
(1) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
To modify the exemption to provide for a single 300 gallon diesel fuel tank instead of two 110-gallon tanks on Titan
IV rocket motors, Division 1.3C explosives.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
(2) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
To modify exemption to provide for zipper reclosable barrier bags as inside container for use in transporting limited
quantities of various hazardous materials.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
(3) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
To modify exemption to provide for the transportation of hazardous waste solid, n.o.s., Class 9, as an additional
commodity to be transported in bulk bags.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
(4) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
To modify exemption to provide for a 2
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; piping, rearrangement of the ``manifold'' design to two levels, enlargement of the skid frame to 10
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; in height for shipment of various hazardous materials classed as Class 3.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
(5) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
To modify this exemption to authorize non-DOT specification cylinders to be used for underwater breathing purposes
for transporting various non-flammable compressed gases, Division 2.2.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
(6) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
To modify exemption to provide for additional sizes FRP&hyph;1 type, non-DOT specification cylinders for use in
transporting Division 2.1 material.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
(7) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
To modify exemption authorizing the manufacture, marking and sale of non-DOT specification cryogenic portable
tanks to be reissued to the owner and shipper of the portable tanks.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
(8) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
To modify exemption to authorize the transportation of acrolein, inhibited, PIH, Zone C material, Division 6.1,
in non-insulated portable tanks manufactured to DOT Specification 51.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
(9) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
To modify the exemption to provide for an additional Pegasus three stage winged solid fuel rocket launch vehicle.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00202 </DOCNO>
<PARENT> FR940817-2-00101 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<TABLE>

<!-- PJG tableformat 3,L2,tp0,i1,xls35,r50,8 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Application No.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Application
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Parties to exemption
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
3004&hyph;P 
<!-- PJG 007 0104 intable -->
BOC Gases, Murray Hill, NJ 
<!-- PJG 007 0104 intable -->
3004
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3302&hyph;P 
<!-- PJG 007 0104 intable -->
BOC Gases, Murray Hill, NJ 
<!-- PJG 007 0104 intable -->
3302
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4453&hyph;P 
<!-- PJG 007 0104 intable -->
W.H. Burt Explosives, Inc., Moab, UT 
<!-- PJG 007 0104 intable -->
4453
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4453&hyph;P 
<!-- PJG 007 0104 intable -->
Florex Explosives, Inc., Cuddy, PA 
<!-- PJG 007 0104 intable -->
4453
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4884&hyph;P 
<!-- PJG 007 0104 intable -->
Balchem Corporation, Slate Hill, NY 
<!-- PJG 007 0104 intable -->
4884
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4884&hyph;P 
<!-- PJG 007 0104 intable -->
MG Industry, Morrisville, PA 
<!-- PJG 007 0104 intable -->
4884
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
5604&hyph;P 
<!-- PJG 007 0104 intable -->
BOC Gases, Murray Hill, NJ 
<!-- PJG 007 0104 intable -->
4604
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
5704&hyph;P 
<!-- PJG 007 0104 intable -->
Chemical Waste Management, Inc., OAK Brook, IL 
<!-- PJG 007 0104 intable -->
5704
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
6309&hyph;P 
<!-- PJG 007 0104 intable -->
Carpenter Co., Richmond, VA 
<!-- PJG 007 0104 intable -->
6309
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
6349&hyph;P 
<!-- PJG 007 0104 intable -->
BOC Gases, Murray Hill, NJ 
<!-- PJG 007 0104 intable -->
6349
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
6530&hyph;P 
<!-- PJG 007 0104 intable -->
BOC Gases, Murray Hill, NJ 
<!-- PJG 007 0104 intable -->
6530
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
6765&hyph;P 
<!-- PJG 007 0104 intable -->
BOC Gases, Murray Hill, NJ 
<!-- PJG 007 0104 intable -->
6765
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
7835&hyph;P 
<!-- PJG 007 0104 intable -->
American Welding Supply, San Jose, CA 
<!-- PJG 007 0104 intable -->
7835
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
8074&hyph;P 
<!-- PJG 007 0104 intable -->
AGL Welding Supply Co., Inc., Clifton, NJ 
<!-- PJG 007 0104 intable -->
8074
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
8445&hyph;P 
<!-- PJG 007 0104 intable -->
Albermarle Corporation, Baton Rouge, LA 
<!-- PJG 007 0104 intable -->
8445
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
8554&hyph;P 
<!-- PJG 007 0104 intable -->
W.H. Burt Explosives, Inc., Moab, UT 
<!-- PJG 007 0104 intable -->
8554
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
8723&hyph;P 
<!-- PJG 007 0104 intable -->
Florex Explosives, Inc., Cuddy, PA 
<!-- PJG 007 0104 intable -->
8723
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
9248&hyph;P 
<!-- PJG 007 0104 intable -->
AB&amp;C Group, Inc., Ranson, WV 
<!-- PJG 007 0104 intable -->
9248
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
9275&hyph;P 
<!-- PJG 007 0104 intable -->
Stern Fragrances, Inc., Orange, CT 
<!-- PJG 007 0104 intable -->
9275
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
9346&hyph;P 
<!-- PJG 007 0104 intable -->
Consumers Power Co., Essexville, MI 
<!-- PJG 007 0104 intable -->
9346
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
10094&hyph;P 
<!-- PJG 007 0104 intable -->
Dyno Nobel, Inc., Salt Lake City, UT 
<!-- PJG 007 0104 intable -->
10094
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
10441&hyph;P 
<!-- PJG 007 0104 intable -->
Frank's Vacuum Truck Service, Inc., Niagara Falls, NY 
<!-- PJG 007 0104 intable -->
10441
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
10441&hyph;P 
<!-- PJG 007 0104 intable -->
Franklin Environmental Services, Inc., Wrentham, MA 
<!-- PJG 007 0104 intable -->
10441
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
10575&hyph;P 
<!-- PJG 007 0104 intable -->
BOC Gases, Murray Hill, NJ 
<!-- PJG 007 0104 intable -->
10575
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
10692&hyph;P 
<!-- PJG 007 0104 intable -->
Miller-Leaman, Inc., Port Orange, FL 
<!-- PJG 007 0104 intable -->
10692
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
10933&hyph;P 
<!-- PJG 007 0104 intable -->
All Chemical Disposal, Inc., San Jose, CA 
<!-- PJG 007 0104 intable -->
10933
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
11043&hyph;P 
<!-- PJG 007 0104 intable -->
Frank's Vacuum Truck Services, Inc., Niagara Falls, NY 
<!-- PJG 007 0104 intable -->
11043
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
11136&hyph;P 
<!-- PJG 007 0104 intable -->
Rodney Clark, Anchorage, AK 
<!-- PJG 007 0104 intable -->
11136
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
11136&hyph;P 
<!-- PJG 007 0104 intable -->
Lynn C. Johnson, Anchorage, AK 
<!-- PJG 007 0104 intable -->
11136
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
11136&hyph;P 
<!-- PJG 007 0104 intable -->
Alfred R. Lupton, Anchorage, AK 
<!-- PJG 007 0104 intable -->
11136
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
11136&hyph;P 
<!-- PJG 007 0104 intable -->
Mark O. Holt, Kodiak, AK 
<!-- PJG 007 0104 intable -->
11136
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
11136&hyph;P 
<!-- PJG 007 0104 intable -->
FireArt by Griz, Anchorage, AK 
<!-- PJG 007 0104 intable -->
11136
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
11156&hyph;P 
<!-- PJG 007 0104 intable -->
ICI Explosives USA, Inc., Dallas, TX 
<!-- PJG 007 0104 intable -->
11156
<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This notice of receipt of applications for modification of exemptions and for party to an exemption is published in
accordance with Part 107 of the Hazardous Materials Transportations Act (49 U.S.C. 1806; 49 CFR 1.53(e)).
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued in Washington, DC, on August 11, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
J. Suzanne Hedgepeth,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Chief, Exemption Programs, Office of Hazardous Materials Exemptions and Approvals.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20152 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;60&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00203 </DOCNO>
<PARENT> FR940817-2-00102 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF THE TREASURY</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Public Information Collection Requirements Submitted to OMB for </DOCTITLE>
<!-- PJG 0012 frnewline -->
Review
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
August 11, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Department of Treasury has submitted the following public information collection requirement(s) to OMB for
review and clearance under the Paperwork Reduction Act of 1980, Public Law 96&hyph;511. Copies of the submission(s)
may be obtained by calling the Treasury Bureau Clearance Officer listed. Comments regarding this information collection
should be addressed to the OMB reviewer listed and to the Treasury Department Clearance Officer, Department of the
Treasury, Room 2110, 1425 New York Avenue, NW., Washington, DC 20220. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Bureau of the Public Debt (BPD) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=3 -->
OMB Number: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
1535&hyph;0063 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=3 -->
Form Number: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
PD F 4239 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=3 -->
Type of Review: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Extension 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=3 -->
Title: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Request by Owner or Person Entitled to Payment or Reissue of United States Savings Bonds/Notes Deposited in Safekeeping
When Original Custody Receipts Are Not Available 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=3 -->
Description: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
PD F 4239 is used by owner or persons entitled to request reissue or payment of United States Savings Bonds/Notes deposited
in safekeeping when original custody receipts are not available. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=3 -->
Respondents: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Individuals or households 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=3 -->
Estimated Number of Respondents: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
500 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=3 -->
Estimated Burden Hours Per Response: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
10 minutes 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=3 -->
Frequency of Response: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
On occasion 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=3 -->
Estimated Total Reporting Burden: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
84 hours 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=3 -->
Clearance Officer: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Vicki S. Ott (304) 480&hyph;6553, Bureau of the Public Debt, 200 Third Street, Parkersburg, West VA 26106&hyph;1328.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=3 -->
OMB Reviewer: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Milo Sunderhauf (202) 395&hyph;7340, Office of Management and Budget, Room 10226, New Executive Office Building,
Washington, DC 20503. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Dale A. Morgan,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Departmental Reports, Management Officer. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20146 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE: 4810&hyph;40&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00204 </DOCNO>
<PARENT> FR940817-2-00103 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Public Information Collection Requirements Submitted to OMB for Review</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=14 g=1 f=1 -->
August 10, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Department of Treasury has submitted the following public information collection requirement(s) to OMB for
review and clearance under the Paperwork Reduction Act of 1980, Public Law 96&hyph;511. Copies of the submission(s)
may be obtained by calling the Treasury Bureau Clearance Officer listed. Comments regarding this information collection
should be addressed to the OMB reviewer listed and to the Treasury Department Clearance Officer, Department of the
Treasury, Room 2110, 1425 New York Avenue, NW., Washington, DC 20220.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Bureau of the Public Debt (BPD)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=3 -->
OMB Number
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
: 1535&hyph;0102
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=3 -->
Form Number
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
: PD F 1071
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=3 -->
Type of Review
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
: Extension
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=3 -->
Title
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
: Certificate of Ownership of United States Bearer Securities
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=3 -->
Description
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
: Person or their legal representative that claims to be the owner of U.S. Bearer Securities. It may also be completed
by the official representative of an organization owning U.S. Bearer Securities.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=3 -->
Respondents
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
: Individuals or households, State or local governments, Businesses or other for-profit, Non-profit institutions,
Small businesses or organizations
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=3 -->
Estimated Number of Respondents
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
: 1,000
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=3 -->
Estimated Burden Hours Per Response
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
: 30 minutes
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=3 -->
Frequency of Response
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
: On occasion
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=3 -->
Estimated Total Reporting Burden
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
: 500 hours
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Clearance Officer: Vicki S. Ott (304) 480&hyph;6553, Bureau of the Public Debt, 200 Third Street, Parkersburg, West
VA 26106&hyph;1328.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
OMB Reviewer: Milo Sunderhauf (202) 395&hyph;7340, Office of Management and Budget, Room 10226, New Executive Office
Building, Washington, DC 20503.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Dale A. Morgan,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Departmental Reports Management Officer.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20145 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4810&hyph;40&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00205 </DOCNO>
<PARENT> FR940817-2-00104 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->

<DOCTITLE>Public Information Collection Requirements Submitted to OMB for </DOCTITLE>
<!-- PJG 0012 frnewline -->
Review 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
August 10, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Department of Treasury has submitted the following public information collection requirement(s) to OMB for
review and clearance under the Paperwork Reduction Act of 1980, Public Law 96&hyph;511. Copies of the submission(s)
may be obtained by calling the Treasury Bureau Clearance Officer listed. Comments regarding this information collection
should be addressed to the OMB reviewer listed and to the Treasury Department Clearance Officer, Department of the
Treasury, Room 2110, 1425 New York Avenue, NW., Washington, DC 20220. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Bureau of the Public Debt (BPD) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
OMB Number:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 1535&hyph;0012. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Form Number:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 PD F 1455. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
 
<!-- PJG 0012 frnewline -->
Type of Review:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Extension. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
 
<!-- PJG 0012 frnewline -->
Title:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Request by Fiduciary for Reissue of United States Savings Bonds/Notes. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
 
<!-- PJG 0012 frnewline -->
Description:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 PD F 1455 is used by fiduciary to request distribution of United States Savings Bonds/Notes to the person(s) entitled.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Respondents:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Individuals or households. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
 
<!-- PJG 0012 frnewline -->
Estimated Number of Respondents:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 72,000. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
 
<!-- PJG 0012 frnewline -->
Estimated Burden Hours Per Response:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 30 minutes. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
 
<!-- PJG 0012 frnewline -->
Frequency of Response:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 On occasion. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
 
<!-- PJG 0012 frnewline -->
Estimated Total Reporting Burden:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 36,000 hours. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Clearance Officer: Vicki S. Ott (304) 480&hyph;6553, 
<!-- PJG 0012 frnewline -->
 Bureau of the Public Debt, 
<!-- PJG 0012 frnewline -->
 200 Third Street, 
<!-- PJG 0012 frnewline -->
 Parkersburg, West VA 26106&hyph;1328 
<!-- PJG 0012 frnewline -->
OMB Reviewer: Milo Sunderhauf (202) 395&hyph;7340, 
<!-- PJG 0012 frnewline -->
 Office of Management and Budget, 
<!-- PJG 0012 frnewline -->
 Room 10226, New Executive Office Building, 
<!-- PJG 0012 frnewline -->
 Washington, DC 20503 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Dale A. Morgan, 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Departmental Reports, 
<!-- PJG 0012 frnewline -->
 Management Officer. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20144 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4810&hyph;40&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00206 </DOCNO>
<PARENT> FR940817-2-00105 </PARENT>
<TEXT>
 
<!-- PJG FTAG 4718 -->

<!-- PJG STAG 4718 -->

<!-- PJG ITAG l=90 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=1 -->
&blank;/&blank;Vol. 59, No. 158&blank;/&blank;Wednesday, August 17, 1994&blank;/&blank;Sunshine Act Meetings
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Vol. 59, No. 158
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
Wednesday, August 17, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=2 -->
COMMODITY FUTURES TRADING COMMISSION
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
TIME AND DATE:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 11 a.m., Friday September 2, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
PLACE:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 2033 K St., NW., Washington, DC, 8th Floor Hearing Room.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
STATUS:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Closed.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
MATTERS TO BE CONSIDERED:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Surveillance Matters.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
CONTACT PERSON FOR MORE INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Jean A. Webb, 254&hyph;6314.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</DATE>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Jean A. Webb,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary of the Commission.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20367 Filed 8&hyph;15&hyph;94; 3:58 pm]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6351&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->

<!-- PJG /FTAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00207 </DOCNO>
<PARENT> FR940817-2-00106 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=2 -->
COMMODITY FUTURES TRADING COMMISSION 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
TIME AND PLACE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
11:00 a.m., Friday, September 9, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
PLACE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
2033 K St., N.W., Washington, D.C., 8th Floor Hearing Room. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
STATUS: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Closed. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
MATTERS TO BE CONSIDERED: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Surveillance Matters. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
CONTACT PERSON FOR MORE INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Jean A. Webb, 254&hyph;6314. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</DATE>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Jean A. Webb, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary of the Commission. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20368 Filed 8&hyph;15&hyph;94; 3:58 pm] 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6351&hyph;01&hyph;M 
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00208 </DOCNO>
<PARENT> FR940817-2-00107 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=2 -->
COMMODITY FUTURES TRADING COMMISSION 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
TIME AND DATE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
11:00 a.m., Friday, September 16, 1994. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
PLACE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
2033 K St., N.W., Washington, D.C., 8th Floor Hearing Room. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
STATUS: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Closed. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
MATTERS TO BE CONSIDERED: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Surveillance Matters. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
CONTACT PERSON FOR MORE INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Jean A. Webb, 254&hyph;6314. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</DATE>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Jean A. Webb, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary of the Commission. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20369 Filed 8&hyph;15&hyph;94; 3:58 pm]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6351&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00209 </DOCNO>
<PARENT> FR940817-2-00108 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->
6351&hyph;01
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=2 -->
COMMODITY FUTURES TRADING COMMISSION
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
TIME AND DATE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
11:00 a.m., Friday, September 23, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
PLACE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
2033 K St., N.W., Washington, D.C., 8th Floor Hearing Room.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
STATUS: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Closed.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
MATTERS TO BE CONSIDERED: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Surveillance Matters.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
CONTACT PERSON FOR MORE INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Jean A. Webb, 254&hyph;6314.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</DATE>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Jean A. Webb,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary of the Commission.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20370 Filed 8&hyph;15&hyph;94; 3:58 pm]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6351&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00210 </DOCNO>
<PARENT> FR940817-2-00109 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=2 -->
COMMODITY FUTURES TRADING COMMISSION
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
TIME AND DATE:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 11 a.m., Friday, September 30, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
PLACE:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 2033 K St., NW., Washington, DC, 8th Floor Hearing Room.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
STATUS:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Closed.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
MATTERS TO BE CONSIDERED:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Surveillance Matters.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
CONTACT PERSON FOR MORE INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Jean A. Webb, 254&hyph;6314.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</DATE>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Jean A. Webb,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary of the Commission.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20371 Filed 8&hyph;15&hyph;94; 3:58 pm]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6351&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00211 </DOCNO>
<PARENT> FR940817-2-00110 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=2 -->
BOARD OF GOVERNORS OF THE FEDERAL RESERVE SYSTEM
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
TIME AND DATE:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 11 a.m., Monday, August 22, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
PLACE:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Marriner S. Eccles Federal Reserve Board Building, C Street entrance between 20th and 2lst Streets, NW., Washington,
DC 20551.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
STATUS:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Closed.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
MATTERS TO BE CONSIDERED:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
1. Proposed end-user computing strategy within the Federal Reserve System.
<!-- PJG 0012 frnewline -->
2. Personnel actions (appointments, promotions, assignments, reassignments, and salary actions) involving individual
Federal Reserve System employees.
<!-- PJG 0012 frnewline -->
3. Any items carried forward from a previously announced meeting.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
CONTACT PERSON FOR MORE INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Mr. Joseph R. Coyne, Assistant to the Board; (202) 452&hyph;3204. You may call (202) 452&hyph;3207, beginning at
approximately 5 p.m. two business days before this meeting, for a recorded announcement of bank and bank holding company
applications scheduled for the meeting.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: August 12, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</DATE>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Jennifer J. Johnson,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Secretary of the Board.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20251 Filed 8&hyph;15&hyph;94; 9:18 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6210&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00212 </DOCNO>
<PARENT> FR940817-2-00111 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=2 -->
UNITED STATES POSTAL SERVICE BOARD OF GOVERNORS
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=2 -->
Notice of a Meeting
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
The Board of Governors of the United States Postal Service, pursuant to its Bylaws (39 CFR Section 7.5) and the Government
in the Sunshine Act (5 U.S.C. Section 552b), hereby gives notice that it intends to hold a meeting at 10:30 a.m. on Monday,
August 29, 1994, and at 9 a.m. on Tuesday, August 30, 1994, in St. Louis, Missouri. The August 29 meeting, at which the
Board will have an informational briefing on funding for Multiline Optical Character Readers (MLOCR) is closed to
the public [See 59 FR 40415, August 8, 1994].
<!-- PJG 0012 frnewline -->
The August 30 meeting is open to the public and will be held at the Ritz-Carlton Hotel, 100 Carondelet Plaza, St. Louis,
in Salon II of the Ballroom. The Board expects to discuss the matters stated in the agenda which is set forth below. Requests
for information about the meeting should be addressed to the Secretary for the Board, David F. Harris, at (202) 268&hyph;4800.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=2 -->
Agenda
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=2 -->
Monday Session
<!-- PJG 0012 frnewline -->
August 29_10:30 a.m. (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=3 -->
Closed
<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
1. Informational Briefing on MLOCR Funding. (William J. Dowling, Vice President, Engineering.)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Tuesday Session
<!-- PJG 0012 frnewline -->
August 30_9 a.m. (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=3 -->
Open
<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
1. Minutes of the Previous Meeting, August 1&hyph;2, 1994.
<!-- PJG 0012 frnewline -->
2. Remarks of the Postmaster General/Chief Executive Officer. (Marvin Runyon.)
<!-- PJG 0012 frnewline -->
3. Postal Rate Commission FY 1995 Budget. (Chairman Sam Winters.)
<!-- PJG 0012 frnewline -->
4. Fiscal Year 1995 Financing Plan. (Michael J. Riley, Chief Financial Officer, Senior Vice President.)
<!-- PJG 0012 frnewline -->
5. Tentative FY 1996 Appropriation Request. (Mr. Riley.)
<!-- PJG 0012 frnewline -->
6. Status Report on Chicago, New York City and Washington, DC, Mail Service. (William J. Good, John F. Kelly, and Henry
A. Pankey, Area Vice Presidents.)
<!-- PJG 0012 frnewline -->
7. Report on the Mid-West Area (William J. Brown, Vice President, Mid-West Area Operations.)
<!-- PJG 0012 frnewline -->
8. Tentative Agenda for the October 3&hyph;4, 1994, meeting in Seattle, Washington.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
David F. Harris,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20323 Filed 8&hyph;15&hyph;94; 2:47 pm]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 7710&hyph;12&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00213 </DOCNO>
<PARENT> FR940817-2-00112 </PARENT>
<TEXT>
 
<!-- PJG FTAG 4717 -->

<!-- PJG STAG 4717 -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Wednesday
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
August 17, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=1 -->
Part II
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=04 g=1 f=1 -->
Nuclear Regulatory Commission
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=05 g=1 f=1 -->
Operating Licenses, Amendments; No Significant Hazards Considerations; Biweekly Notices
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->

<!-- PJG /FTAG -->

<!-- PJG FTAG 4701 -->

<!-- PJG STAG 4701 -->

<!-- PJG ITAG l=90 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=1 -->
&blank;/&blank;Vol. 59, No. 158&blank;/&blank;Wednesday, 
<!-- PJG 0012 frnewline -->
August 17, 1994&blank;/&blank;Notices 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<USDEPT>UNITED STATES NUCLEAR REGULATORY COMMISSION</USDEPT>

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Biweekly Notice
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Applications and Amendments to Facility Operating Licenses
<!-- PJG 0012 frnewline -->
Involving No Significant Hazards Considerations
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
I. Background
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Pursuant to Public Law 97-415, the U.S. Nuclear Regulatory Commission (the Commission or NRC staff) is publishing
this regular biweekly notice. Public Law 97-415 revised section 189 of the Atomic Energy Act of 1954, as amended (the
Act), to require the Commission to publish notice of any amendments issued, or proposed to be issued, under a new provision
of section 189 of the Act. This provision grants the Commission the authority to issue and make immediately effective
any amendment to an operating license upon a determination by the Commission that such amendment involves no significant
hazards consideration, notwithstanding the pendency before the Commission of a request for a hearing from any person.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
This biweekly notice includes all notices of amendments issued, or proposed to be issued from July 25, 1994, through
August 5, 1994. The last biweekly notice was published on August 3, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Notice Of Consideration Of Issuance Of Amendments To Facility Operating Licenses, Proposed No Significant Hazards
Consideration Determination, And Opportunity For A Hearing
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commission has made a proposed determination that the following amendment requests involve no significant hazards
consideration. Under the Commission's regulations in 10 CFR 50.92, this means that operation of the facility in accordance
with the proposed amendment would not (1) involve a significant increase in the probability or consequences of an
accident previously evaluated; or (2) create the possibility of a new or different kind of accident from any accident
previously evaluated; or (3) involve a significant reduction in a margin of safety. The basis for this proposed determination
for each amendment request is shown below. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Commission is seeking public comments on this proposed determination. Any comments received within 30 days after
the date of publication of this notice will be considered in making any final determination. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Normally, the Commission will not issue the amendment until the expiration of the 30-day notice period. However,
should circumstances change during the notice period such that failure to act in a timely way would result, for example,
in derating or shutdown of the facility, the Commission may issue the license amendment before the expiration of the
30-day notice period, provided that its final determination is that the amendment involves no significant hazards
consideration. The final determination will consider all public and State comments received before action is taken.
Should the Commission take this action, it will publish in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
a notice of issuance and provide for opportunity for a hearing after issuance. The Commission expects that the need
to take this action will occur very infrequently. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Written comments may be submitted by mail to the Rules Review and Directives Branch, Division of Freedom of Information
and Publications Services, Office of Administration, U.S. Nuclear Regulatory Commission, Washington, DC 20555,
and should cite the publication date and page number of this 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
notice. Written comments may also be delivered to Room 6D22, Two White Flint North, 11545 Rockville Pike, Rockville,
Maryland from 7:30 a.m. to 4:15 p.m. Federal workdays. Copies of written comments received may be examined at the NRC
Public Document Room, the Gelman Building, 2120 L Street, NW., Washington, DC 20555. The filing of requests for a hearing
and petitions for leave to intervene is discussed below.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
By September 16, 1994, the licensee may file a request for a hearing with respect to issuance of the amendment to the
subject facility operating license and any person whose interest may be affected by this proceeding and who wishes
to participate as a party in the proceeding must file a written request for a hearing and a petition for leave to intervene.
Requests for a hearing and a petition for leave to intervene shall be filed in accordance with the Commission's ``Rules
of Practice for Domestic Licensing Proceedings'' in 10 CFR Part 2. Interested persons should consult a current copy
of 10 CFR 2.714 which is available at the Commission's Public Document Room, the Gelman Building, 2120 L Street, NW.,
Washington, DC 20555 and at the local public document room for the particular facility involved. If a request for a
hearing or petition for leave to intervene is filed by the above date, the Commission or an Atomic Safety and Licensing
Board, designated by the Commission or by the Chairman of the Atomic Safety and Licensing Board Panel, will rule on
the request and/or petition; and the Secretary or the designated Atomic Safety and Licensing Board will issue a notice
of a hearing or an appropriate order. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
As required by 10 CFR 2.714, a petition for leave to intervene shall set forth with particularity the interest of the
petitioner in the proceeding, and how that interest may be affected by the results of the proceeding. The petition
should specifically explain the reasons why intervention should be permitted with particular reference to the following
factors: (1) the nature of the petitioner's right under the Act to be made a party to the proceeding; (2) the nature and
extent of the petitioner's property, financial, or other interest in the proceeding; and (3) the possible effect
of any order which may be entered in the proceeding on the petitioner's interest. The petition should also identify
the specific aspect(s) of the subject matter of the proceeding as to which petitioner wishes to intervene. Any person
who has filed a petition for leave to intervene or who has been admitted as a party may amend the petition without requesting
leave of the Board up to 15 days prior to the first prehearing conference scheduled in the proceeding, but such an amended
petition must satisfy the specificity requirements described above.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Not later than 15 days prior to the first prehearing conference scheduled in the proceeding, a petitioner shall file
a supplement to the petition to intervene which must include a list of the contentions which are sought to be litigated
in the matter. Each contention must consist of a specific statement of the issue of law or fact to be raised or controverted.
In addition, the petitioner shall provide a brief explanation of the bases of the contention and a concise statement
of the alleged facts or expert opinion which support the contention and on which the petitioner intends to rely in proving
the contention at the hearing. The petitioner must also provide references to those specific sources and documents
of which the petitioner is aware and on which the petitioner intends to rely to establish those facts or expert opinion.
Petitioner must provide sufficient information to show that a genuine dispute exists with the applicant on a material
issue of law or fact. Contentions shall be limited to matters within the scope of the amendment under consideration.
The contention must be one which, if proven, would entitle the petitioner to relief. A petitioner who fails to file
such a supplement which satisfies these requirements with respect to at least one contention will not be permitted
to participate as a party. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Those permitted to intervene become parties to the proceeding, subject to any limitations in the order granting leave
to intervene, and have the opportunity to participate fully in the conduct of the hearing, including the opportunity
to present evidence and cross-examine witnesses. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
If a hearing is requested, the Commission will make a final determination on the issue of no significant hazards consideration.
The final determination will serve to decide when the hearing is held. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
If the final determination is that the amendment request involves no significant hazards consideration, the Commission
may issue the amendment and make it immediately effective, notwithstanding the request for a hearing. Any hearing
held would take place after issuance of the amendment. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
If the final determination is that the amendment request involves a significant hazards consideration, any hearing
held would take place before the issuance of any amendment. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A request for a hearing or a petition for leave to intervene must be filed with the Secretary of the Commission, U.S.
Nuclear Regulatory Commission, Washington, DC 20555, Attention: Docketing and Services Branch, or may be delivered
to the Commission's Public Document Room, the Gelman Building, 2120 L Street, NW., Washington DC 20555, by the above
date. Where petitions are filed during the last 10 days of the notice period, it is requested that the petitioner promptly
so inform the Commission by a toll-free telephone call to Western Union at 1-(800) 248-5100 (in Missouri 1-(800) 342-6700).
The Western Union operator should be given Datagram Identification Number N1023 and the following message addressed
to 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
(Project Director)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
: petitioner's name and telephone number, date petition was mailed, plant name, and publication date and page number
of this 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
notice. A copy of the petition should also be sent to the Office of the General Counsel, U.S. Nuclear Regulatory Commission,
Washington, DC 20555, and to the attorney for the licensee. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Nontimely filings of petitions for leave to intervene, amended petitions, supplemental petitions and/or requests
for a hearing will not be entertained absent a determination by the Commission, the presiding officer or the Atomic
Safety and Licensing Board that the petition and/or request should be granted based upon a balancing of factors specified
in 10 CFR 2.714(a)(1)(i)-(v) and 2.714(d). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For further details with respect to this action, see the application for amendment which is available for public inspection
at the Commission's Public Document Room, the Gelman Building, 2120 L Street, NW., Washington, DC 20555, and at the
local public document room for the particular facility involved. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Arizona Public Service Company, et al., Docket Nos. STN 50-528, STN 50-529, and STN 50-530, Palo Verde Nuclear Generating
Station, Unit Nos. 1, 2, 
<!-- PJG 0012 frnewline -->
and 3, Maricopa County, Arizona
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment requests: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
May 4, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment requests: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
These amendment requests would revise Limiting Condition for Operation (LCO) 3.4.8.3 and Surveillance Requirement
4.4.8.3.1, ``Overpressure Protection Systems.'' Specifically, the LCO and surveillance requirements are revised
to clarify that both shutdown cooling system (SCS) suction line relief valves shall be OPERABLE and aligned to provide
overpressure protection not only during reactor (RCS) cooldown or heatup evolutions, but also during any steady
state temperature periods maintained in the course of RCS cooldown or heatup evolutions.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensees have provided their analysis about the issue of no significant hazards
consideration, which is presented below: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Standard 1 -- Involve a significant increase in the probability or consequence of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed amendments provide further clarification of the Technical Specifications and represent an additional
operating limitation. Incorporating the noted clarification will not change the bases or assumptions contained
in the safety analysis for this system. The most limiting low-temperature overpressure protection (LTOP) transients,
the starting of an idle reactor coolant pump (RCP) and the inadvertent actuation of two high pressure safety injection
(HPSI) pumps into a solid RCS, are not affected by the proposed clarification. Therefore, the proposed amendments
do not involve a significant increase in the probability or consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Standard 2 -- Create the possibility of a new or different kind of accident from any accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Clarifying the applicability of the LCO's and surveillance for steady state periods achieved and maintained during
either a heatup or cooldown evolution does not modify the design or operation of plant equipment. No new or different
failure modes will be introduced by incorporating this clarification into the LCO and surveillance requirement.
Therefore, the proposed amendments will not create the possibility of a new or different kind of accident from any
accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Standard 3 -- Involve a significant reduction in a margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The clarification will enhance LCO 3.4.8.3 and Surveillance Requirement 4.4.8.3.1 for heatup and cooldown evolutions
by ensuring operators are aware of this applicability during periods of steady state conditions. This clarification
does not involve a change to safety limits, setpoints, or design margins. As such, the proposed amendments will not
involve a significant reduction in a margin of safety at PVNGS.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensees' analysis and, based on that review, it appears that the three standards of
50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment requests involve no significant
hazards consideration.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Phoenix Public Library, 12 East McDowell Road, Phoenix, Arizona 85004
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensees: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Nancy C. Loftin, Esq., Corporate Secretary and Counsel, Arizona Public Service Company, P.O. Box 53999, Mail Station
9068, Phoenix, Arizona 85072-3999 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Theodore R. Quay
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Arizona Public Service Company, et al., Docket Nos. STN 50-528, STN 50-529, and STN 50-530, Palo Verde Nuclear Generating
Station, Unit Nos. 1, 2, 
<!-- PJG 0012 frnewline -->
and 3, Maricopa County, Arizona
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment requests: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
June 17, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment requests: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed amendments would increase the minimum nitrogen accumulator pressure for the atmospheric dump valves
(ADVs), as stated in the surveillance requirements of Technical Specification (TS) 3/4.7.1.6. The change to the
Bases increases the minimum time the ADV accumulators must be operable.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensees have provided their analysis about the issue of no significant hazards
consideration, which is presented below: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Standard 1 -- Involve a significant increase in the probability or consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed Technical Specification change in the nitrogen accumulator supply minimum pressure will not increase
the probability or consequences of any accident previously analyzed. The nitrogen accumulator pressure is normally
maintained between 650-680 psig. Nitrogen pressure from the accumulator is reduced to 105 psig prior to use in the
operation of the ADVs. The pressure reduction will remain the same with the higher minimum accumulator pressure.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Standard 2 -- Create the possibility of a new or different kind of accident from any accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Increasing the nitrogen accumulator minimum pressure does not create any new or different accidents than those previously
evaluated. The normal air supply (the Instrument Air System) to the ADV is maintained between 105 to 125 psig. Currently,
nitrogen from the accumulator is reduced to 105 psig prior to use in the ADV. The increased minimum pressure in the accumulator
will still be reduced to 105 psig prior to use in the ADV.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Standard 3 -- Involve a significant reduction in a margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The limitation on maintaining the nitrogen accumulator at a certain pressure is to ensure that a sufficient volume
of nitrogen is in the accumulator to operate the associated ADV. Maintaining a higher minimum pressure ensures that
sufficient nitrogen will be available to maintain the unit at HOT STANDBY for four hours and an additional 9.3 hours
to reach COLD SHUTDOWN under natural circulation conditions in the event of failure of the normal control air system.
Therefore, the proposed change does not involve a reduction in a margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensees' analysis and, based on that review, it appears that the three standards of
50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment requests involve no significant
hazards consideration.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Phoenix Public Library, 12 East McDowell Road, Phoenix, Arizona 85004
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensees: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Nancy C. Loftin, Esq., Corporate Secretary and Counsel, Arizona Public Service Company, P.O. Box 53999, Mail Station
9068, Phoenix, Arizona 85072-3999 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Theodore R. Quay
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Arizona Public Service Company, et al., Docket Nos. STN 50-528, STN 50-529, and STN 50-530, Palo Verde Nuclear Generating
Station, Unit Nos. 1, 2, 
<!-- PJG 0012 frnewline -->
and 3, Maricopa County, Arizona
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment requests: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 12, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment requests: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed amendment would enhance the PVNGS Technical Specifications (TS) by adding a limiting condition for
operation (LCO) action statement to Entry VIII B of Table 3.3-3, ``Engineered Safety Features Actuation System Instrumentation.''
The proposed action statement would enhance safe plant operation by requiring timely plant shutdown if more than
one of the new solid state degraded voltage relays in either train of 4.16kV are inoperable or not energized.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensees have provided their analysis about the issue of no significant hazards
consideration, which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Standard 1--Involve a significant increase in the probability or consequence of an accident previously evaluated:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed amendment will add an action statement to TS Table 3.3-3 entry VIII B which would allow eight hours to effect
repairs. This action statement would be entered if more than one of the required four degraded voltage relays on either
4.16 kv bus is inoperable or not energized. If the eight hour allowed outage time is not met, the unit is placed in Hot
Standby within six hours and in Cold Shutdown within the next thirty hours. Technical Specification 3.8.3.1 currently
allows eight hours to restore a 4.16 kv bus in the event of a loss of power to that bus. The loss of degraded voltage relays
on that bus does not impact plant nuclear safety any more than the loss of the bus itself. Furthermore, even with the
loss of all four degraded voltage relays monitoring one 4.16 kv bus (for example, due to a blown 125 vdc circuit fuse),
the loss-of-voltage relays on that bus, and the degraded voltage relays, as well as the loss-of-voltage relays monitoring
the other bus would be unaffected. None of the UFSAR chapter 15 accident analyses are affected by this proposed amendment.
The existing TS requirements and those components to which they apply are not altered by this TS amendment. There are
no changes to the maintenance, surveillance, and/or qualification of any component/function in Table 3.3-3. Therefore,
the addition of this proposed eight hour action statement to Table 3.3-3 entry VIII B does not increase the probability
of occurrence or the consequences of any previously evaluated accident.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Standard 2--Create the possibility of a new or different kind of accident from any accident previously evaluated:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The TS requirements and the components to which they apply are not altered by this amendment. The new solid state degraded
voltage relays in each 4.16 kv bus were installed under the 10 CFR 50.59 change process. APS [Arizona Public Service
Company] determined that the installation created no unreviewed safety question. This amendment has no impact on
plant maintenance, testing, shutdown equipment, or component qualification. Plant operational safety is enhanced
by this amendment. Therefore, the possibility of a new or different kind of accident is not created by this amendment.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Standard 3--Involve a significant reduction in a margin of safety:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The TS does not alter existing TS requirements or those components to which they apply. More specifically, there is
no impact on safe plant shutdown, maintenance, containment isolation capability, containment leakage rate, or
the operability of safety related valves. Therefore, the addition of the proposed action statement to the TS will
not involve reduction in a margin of safety for fission product release to the atmosphere. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensees' analysis and, based on that review, it appears that the three standards of
50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment requests involve no significant
hazards consideration.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Phoenix Public Library, 12 East McDowell Road, Phoenix, Arizona 85004
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG 0012 frnewline -->
Attorney for licensees: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Nancy C. Loftin, Esq., Corporate Secretary and Counsel, Arizona Public Service Company, P.O. Box 53999, Mail Station
9068, Phoenix, Arizona 85072-3999 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Theodore R. Quay
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Baltimore Gas and Electric Company, Docket Nos. 50-317 and 50-318, Calvert Cliffs Nuclear Power Plant, Unit Nos.
1 and 2, Calvert County, Maryland
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendments request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
June 8, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendments request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed amendment would revise the Calvert Cliffs Nuclear Power Plant (CCNPP) Units 1 and 2 Technical Specification
(TS) Section 4.7.1.2.c to extend the interval for three Auxiliary Feedwater (AFW) surveillance requirements from
18 to 24 months. Specifically, TS Section 4.7.2.c.1 requires the verification of each automatic valve in the flowpath
actuate to its correct position and each AFW pump automatically start upon receipt of each AFW actuation system test
signal; TS Section 4.7.2.c.2 requires verification that the AFW system is capable of providing a minimum 300 gallons
per minute nominal flow to each leg. This request is one of a series of proposed license amendments that would eliminate
the need for mid-cycle surveillance outages by extending 18-month frequency surveillances to every refueling outage
(nominally each 24 months). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
1. Would not involve a significant increase in the probability or consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Auxiliary Feedwater (AFW) System provides a safety-related source of feedwater to the steam generators to mitigate
design basis accidents involving loss of Main Feedwater. Failure of the AFW System is not an initiator for any previously
analyzed accident. Therefore, the proposed change does not involve an increase in the probability of an accident
previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A historical review of surveillance test results and system performance indicates that the AFW System is very reliable.
In addition, monthly surveillances of the AFW System will continue to verify proper pump and valve operation. The
AFW System reliability and monthly surveillances provide assurance that undetected system degradation will not
occur between 24-month surveillances. Therefore, the AFW System will continue to perform its safety function and
there will be no significant increase in the consequences of accidents. Therefore, the proposed Technical Specification
changes do not increase the probability or consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Would not create the possibility of a new or different type of accident from any accident previously evaluated?
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
This requested revision to increase the interval for some AFW surveillances from 18 to 24 months does not involve a
significant change in the design or operation of the plant. No hardware is being added to the plant as part of the proposed
change. The proposed change will not introduce any new accident initiators. Therefore, this change would not create
the possibility of a new or different type of accident from any accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. Does operation of the facility in accordance with the proposed amendment involve a significant reduction in a margin
of safety?
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The AFW System provides a margin of safety by providing a safety-related alternate supply of feedwater to the steam
generator for removal of decay heat and cooldown of the Reactor Coolant System. The proposed changes do not affect
the operation or design of the AFW System. Monthly surveillances and historical data provide assurance that the reduction
in surveillance frequency will not adversely affect our ability to detect degradation in the system. Therefore,
the proposed change does not involve a significant reduction in a margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
50.92(c) are satisfied.
<!-- PJG 0012 frnewline -->
Therefore, the NRC staff proposes to determine that the amendments request involves no significant hazards consideration.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Calvert County Library, Prince Frederick, Maryland 20678. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Jay E. Silbert, Esquire, Shaw, Pittman, Potts and Trowbridge, 2300 N Street, NW., Washington, DC 20037.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Michael L. Boyle
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Consolidated Edison Company of New York, Docket No. 50-247, Indian Point Nuclear Generating Unit No. 2, Westchester
County, New York
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
April 29, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This amendment is an additional followup to the amendment request of May 29, 1992, published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
on July 8, 1992 (57FR30242), which changed the Technical Specifications Section 1.0, Definitions, to accommodate
a 24-month fuel cycle and which proposed the extension of the test intervals for specific surveillance tests. This
amendment proposes extending the surveillance intervals to 24 months for the following additional surveillance
tests:
<!-- PJG 0012 frnewline -->
(1) Calibrate and test channels for Auxiliary Feedwater (AFW) initiation on steam generator water level (low-low).
<!-- PJG 0012 frnewline -->
(2) Test channels for Auxiliary Feedwater initiation on trip of main feedwater pumps.
<!-- PJG 0012 frnewline -->
The licensee's amendment proposal of November 25, 1992, requested approval for extending the surveillance interval
of the Auxiliary Feedwater System to accommodate a 24-month fuel cycle and the approved change was issued in License
Amendment No. 166. Subsequently, the licensee determined that two additional surveillances associated with this
system had not been identified in the November 25, 1992, request. This amendment proposal requests approval of the
additional surveillances. The changes requested by the licensee are in accordance with Generic Letter 91-04, ``Changes
in Technical Specification Surveillance Intervals to Accommodate a 24-Month Fuel Cycle.''
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below:
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
The proposed change does not involve a significant hazards consideration since:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. There is no significant increase in the probability or consequences of an accident.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The test results over the last four refuelings confirmed system operability with only one failure. This failure would
not have impaired the ability of the auxiliary feedwater system to perform its intended safety function. The auxiliary
feedwater system is redundant and diverse. The failure in the turbine driven pump did not impact the motor driven pumps.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Based on the historical test data, it is concluded that no significant increase in the probability or consequences
of an accident would be incurred by extending the operating cycle due to an increased surveillance interval.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. The possibility of a new or different kind of accident from any previously analyzed has not been created.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The failure noted from the past test data appears random in nature and would not have defeated the redundancy in design
that exists in the AFW system. The AFW system would have been capable of performing its intended safety function and
therefore a new or different kind of accident would not have been created.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. There has been no reduction in the margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Past historical data demonstrates that the AFW systems would perform their safety function for an extended operating
cycle should the surveillance period be extended by several months.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves no significant
hazards consideration. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
White Plains Public Library, 100 Martine Avenue, White Plains, New York 10610.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Brent L. Brandenburg, Esq., 4 Irving Place, New York, New York 10003.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Pao Tsin Kuo
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Consolidated Edison Company of New York, Docket No. 50-247, Indian Point Nuclear Generating Unit No. 2, Westchester
County, New York
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
June 16, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed amendment would revise License Condition 2.K of the license issued August 24, 1981, to provide for compliance
with the NRC-approved fire protection program as described in the Updated Final Safety Analysis Report and for making
changes to the 
<!-- PJG 0012 frnewline -->
NRC-approved fire protection program; would delete fire protection Technical Specification (TS) Sections 3.13
and 4.14 which contain limiting conditions for operation and surveillance requirements, respectively, for the
high-pressure water fire protection system, fire protection spray systems, penetration fire barriers, fire detection
systems, fire hose stations and hydrants, and the cable spreading room halon system; would delete Section 6.2.2.f
which contains fire brigade staffing requirements; would delete Section 6.4.2 which contains fire brigade training
requirements; would add Section 6.5.1.6.1 to add fire protection program responsibilities to the Station Nuclear
Committee; would add Section 6.8.1.e to require written procedures and administrative policies for the fire protection
program; would delete Section 6.9.2.b which requires a Special Report for inoperable fire protection and detection
equipment; and would make corresponding changes to the Table of Contents and List of Tables.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Generic Letter (GL) 86-10, dated April 24, 1986, and GL 88-12, dated August 2, 1988, from the NRC provided guidance
to licensees to request removal of the fire protection TS. The licensee's proposed amendment is in response to these
GLs.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
The Commission has provided guidance concerning the application of the standards for determining whether a ``Significant
Hazards Consideration'' exists by providing certain examples in 51 FR 7744 (dated March 6, 1986). Example (vii) of
those involving no significant hazards considerations relates to ``a change to conform a license to changes in the
regulations, where the license change results in very minor changes to facility operations clearly in keeping with
the regulations.''
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In this case, NRC Generic Letters 86-10 and 88-12, although not regulations, provide pertinent guidance relative
to the above described proposed changes and implementation of the NRC fire protection regulations of 10 CFR 50.48(a).
Specifically, the generic letters allow licensees to delete fire protection related technical specifications,
provided that administrative requirements are added to technical specifications and a license condition is provided
that requires the implementation and maintenance in effect of the approved fire protection program. Further, the
generic letters provide for inclusion of the fire protection program into the UFSAR [Updated Final Safety Analysis
Report] and permits future changes to the fire protection program without prior NRC approval, all as provided by the
license condition and in accordance with the provisions of 10 CFR 50.59. Therefore, since the actions required by
the generic letters have been taken and conform the license to the current interpretation of NRC fire protection regulations
as described in Generic Letters 86-10 and 88-12, with no changes to facility operations, these proposed changes are
in accordance with Example (vii) above.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In accordance with the requirements of 10 CFR 50.92, the proposed changes to the Technical Specifications are deemed
not to involve any ``Significant Hazards Considerations'' because operation of Indian Point Unit No. 2 in accordance
with these changes would not:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) Involve a significant increase in the probability or consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The fire protection program requirements are not affected in that the function, operation or surveillance requirements
for any fire protection system or component are not being altered. The proposed changes simply relocate these requirements
from the Technical Specifications to the UFSAR, are administrative in nature, and do not affect any other current
plant equipment or practices. Therefore, the conclusions of current accident analyses are not affected. Further,
as permitted by the proposed License Condition 2.K, changes in the NRC-approved fire protection program will require
an evaluation per the criteria of 10 CFR 50.59 to determine that the proposed change will not involve an unreviewed
safety question. Therefore, future changes to the fire protection program will be evaluated in accordance with appropriate
criteria.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) Create the possibility for a new or different kind of accident from any previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed changes introduce no new mode of plant operation, do not involve physical modification to any structure,
system or component, do not affect the function, operation or surveillance requirements for any equipment necessary
for safe operation or shutdown of the plant or of fire protection equipment which protects such equipment, and do not
involve any changes to setpoints or operating parameters. The changes are administrative only and all existing fire
protection requirements are maintained. Therefore, the changes can not result in an unanalyzed accident. Further,
as permitted by the proposed License Condition 2.K, changes in the NRC-approved fire protection program will require
an evaluation per the criteria of 10 CFR 50.59 to determine that the proposed change will not involve an unreviewed
safety question. Therefore, future changes to the fire protection program will be evaluated in accordance with appropriate
criteria.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) Involve a significant reduction in the margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The existing fire protection program operability and surveillance requirements are retained as they are contained
in the FPPP [Fire Protection Program Plan], and compliance will continue through proposed License Condition 2.K.
Therefore, no margins of safety established by design or verified by testing to ensure operability of fire protection
systems or components are affected. Further, as permitted by the proposed License Condition 2.K, changes in the NRC-approved
fire protection program will require an evaluation per the criteria of 10 CFR 50.59 to determine that the proposed
change will not involve an unreviewed safety question. Therefore, future changes to the fire protection program
will be evaluated in accordance with appropriate criteria.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Based on the above discussion, since these proposed changes to the Indian Point Unit No. 2 Technical Specifications
satisfy the criteria specified in 10 CFR 50.92, are similar to an example provided by the Commission of a change which
involves ``No Significant Hazards Considerations'', and are not similar to any examples that involve a ``Significant
Hazards Consideration'', Con Edison has determined that this amendment application does not involve any ``Significant
Hazards Considerations.''
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed Technical Specification changes have been reviewed by the Station Nuclear Safety Committee and the
Con Edison Nuclear Facilities Safety Committee. Both committees concur that these proposed changes do not represent
any ``Significant Hazards Considerations.''
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves no significant
hazards consideration. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
White Plains Public Library, 100 Martine Avenue, White Plains, New York 10610. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Brent L. Brandenburg, Esq., 4 Irving Place, New York, New York 10003.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Michael L. Boyle
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Consolidated Edison Company of New York, Docket No. 50-247, Indian Point Nuclear Generating Unit No. 2, Westchester
County, New York
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 8, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed amendment would revise Technical Specification Section 3.7, Auxiliary Electrical Systems to clarify
offsite power availability requirements and to revise emergency diesel generator fuel oil availability requirements.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Consistent with the requirements of 10 CFR 50.92, the enclosed application involves no significant hazards based
on the following information:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1) Does the proposed license amendment involve a significant increase in the probability or consequences of an accident
previously evaluated?
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Response:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Neither the probability nor the consequence of an accident previously analyzed is increased due to the proposed changes.
There are no changes on the existing offsite power supply configuration or on the existing diesel fuel oil supply system
or inventory requirements. This proposed amendment will allow for three diesel operation when a fuel oil storage
tank or transfer pump is unavailable. In the event of an accident at this time, the three diesel operation would allow
for more than minimum safeguards to be available, with maximum safeguards available for the first part of the event.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2) Does the proposed license amendment create the possibility of a new or different kind of accident from any previously
evaluated?
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Response:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The existing 138 kV and 13.8 kV offsite power reliability is maintained with this change. There is no impact on availability
of the alternate AC system, the three gas turbines, with this change. This change is consistent with the original licensing
basis that the AEC accepted for the diesel fuel oil supply system.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3) Does the proposed amendment involve a significant reduction in the margin of safety?
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Response:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed amendment does not involve a significant reduction in the margin of safety. The proposed amendment maintains
the reliability of the preferred 138 kV and 13.8 kV offsite power and is consistent with the original licensing basis
for diesel fuel oil inventory.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves no significant
hazards consideration. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
White Plains Public Library, 100 Martine Avenue, White Plains, New York 10610.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Brent L. Brandenburg, Esq., 4 Irving Place, New York, New York 10003.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Robert A. Capra
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Duquesne Light Company, et al., Docket No. 50-334, Beaver Valley Power Station, Unit No. 1, Shippingport, Pennsylvania
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 29, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed amendment would revise Technical Specifications (TSs) 3/4.4.5 and 3/4.4.6.2 and associated bases
to allow the implementation of interim steam generator tube plugging criteria for the tube support elevations during
cycle 11. The allowed primary-to-secondary operational leakage from any one steam generator is proposed to be reduced
from 500 gallons per day (gpd) to 150 gpd. The total allowed primary-to-secondary operational leakage from all steam
generators would be reduced from one gallon per minute (1440 gpd) to 
<!-- PJG 0012 frnewline -->
450 gpd.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
1. Does the change involve a significant increase in the probability or consequences of an accident previously evaluated?
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Testing of model boiler specimens for free span tubing (no tube support plate [TSP] restraint) at room temperature
conditions show[s] burst pressures in excess of 5000 psi for indications of outer diameter stress corrosion cracking
with voltage measurement as high as 19 volts. Burst testing performed on intersections pulled from BVPS [Beaver Valley
Power Station] with up to a 2.7 volt indication shows measured burst pressure in excess of 6600 psi at room temperature.
Burst testing performed on pulled tubes from other plants with up to 7.5 volt indications show[s] burst pressures
in excess of 6300 psi at room temperatures. Correcting for the effects of temperature on material properties and minimum
strength levels (as the burst testing was done at room temperature), tube burst capability significantly exceeds
the safety factor requirements of RG [Regulatory Guide] 1.121. As stated earlier, tube burst criteria are inherently
satisfied during normal operating conditions due to the proximity of the TSP. Test data indicates that tube burst
cannot occur within the TSP, even for tubes which have 100 percent through wall electric discharge machining (EDM)
notches, 0.75 inch long, provided that the TSP is adjacent to the notched area. Since tube to TSP proximity precludes
tube burst during normal operating conditions, use of the criteria must retain tube integrity characteristics which
maintain a margin of safety of 1.43 times the bounding faulted condition steam line break (SLB) pressure differential.
As previously stated, the RG 1.121 criterion requiring maintenance of a safety factor of 1.43 times the SLB pressure
differential on tube burst is satisfied by 7/8 inch diameter tubing with bobbin coil indications with signal amplitudes
less than 8.82 volts regardless of the indicated depth measurement. The plugging criteria (resulting in a projected
end-of-cycle [EOC] voltage) compares favorably with the 8.82 volt structural limit considering the extremely slow
apparent voltage growth rate of indications at BVPS. Using the established methodology of RG 1.121, the structural
limit is reduced by allowances for uncertainty and growth to develop a beginning-of-cycle (BOC) repair limit which
should preclude indications at EOC conditions which exceed the structural limit. The non-destructive examination
(NDE) uncertainty component is 20.5 percent and is based on the EPRI [Electric Power Research Institute] Alternate
Repair Criteria (ARC). A bounding growth allowance of 40 percent will be applied. This value is conservative for BVPS
Unit 1. The BOC maximum allowable repair limit should not permit the existence of EOC indications (when the 40 percent
growth and 20.5 percent uncertainty allowances are applied) which exceed the 8.82 volt structural limit. By adding
NDE uncertainty allowances and an allowance for crack growth to the repair limit, the structural limit can be validated.
Therefore, the maximum allowable BOC repair limit (RL) based on the structural limit of 8.82 volts can be represented
by the expression:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
RL + (0.205 X RL) + (0.40 x RL) = 8.82 volts, or the maximum allowable BOC repair limit can be expressed as:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
RL = 8.82 volt structural limit/1.605 = 5.5 volts.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
It is reasonable that this repair limit (5.5 volts) could be applied for IPC [interim plugging criterion] implementation
to repair bobbin indications greater than 1.0 or 2.0 volts independent of RPC [rotating pancake coil] confirmation
of the indication. The analyses were performed based on a 1.0 or 2.0 volt repair limit. Duquesne Light Company has chosen
to use a steam generator tube repair limit of 1.0 volt. Conservatively, an upper limit of 3.6 volts will be used to assess
tube integrity for those bobbin indications which are above 1.0 volt but do not have confirming RPC calls. This 3.6
volt upper limit for non-confirmed RPC calls is consistent with other recently approved IPC programs for the two other
plants with 7/8 inch tubing that currently implement IPCs. Since the upper bound for repair of non-confirmed RPC is
limited to a value far less than the limit associated with a full alternate criteria, the establishment of the repair
limits are [is] judged to be independent of the pulled tube data base used.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The conservatism of the growth allowance used to develop the repair limit is shown by the most recent BVPS eddy current
data. The average voltage growth for all indications was 16 percent while the average voltage growth for indications
greater than 0.75 volts at BOC was 6 percent. The largest overall voltage growth in a particular steam generator was
found in the ``A'' steam generator, which had an overall average growth of 25 percent. Only two tubes had an absolute
voltage growth which exceeded 1.0 volt for Cycle 9. The maximum absolute voltage growth in the 1993 inspection was
recorded to be 1.18 volts. Each of the last three inspections, which included 100 percent of all hot leg tubes, showed
decreasing voltage growth trends in each successive inspection for all categories; overall voltage growth, growth
of BOC indications less than 0.75 volts, and growth of indications greater than 0.75 volts. The decreasing voltage
growth rate trend data indicates that DLC has good control of the ODSCC [outer diameter stress corrosion cracking]
occurring in the BVPS Unit 1 steam generators and also implies that atypical voltage growth of a few indications is
unlikely.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Relative to the expected leakage during accident condition loadings, it has been previously established that a postulated
main SLB [steam line break] outside of containment but upstream of the main steam isolation valve (MSIV) represents
the most limiting radiological condition relative to the IPC. In support of implementation of the interim plugging
criteria, it will be determined whether the distribution of cracking indications at the TSP intersections at the
end of Cycle 11 are [is] projected to be such that primary-to-secondary leakage would result in site boundary doses
within a small fraction of the 10 CFR 100 guidelines. A separate calculation has determined this allowable SLB leakage
limit to be 6.6 gpm in the faulted loop. This limit was calculated using the Technical Specification RCS [reactor coolant
system] Iodine-131 activity level of 1.0 micro Curies per gram dose equivalent Iodine-131 and the recommended Iodine-131
transient spiking values consistent with NUREG-0800. The projected SLB leakage rate calculation methodology prescribed
in Section 3.3 of draft NUREG-1477 will be used to calculate EOC leakage. The log-logistic probability of leakage
correlation will be used to establish the SLB leak rate used for comparison with the 6.6 gpm faulted loop allowable
limit. Due to the relatively low voltage levels of indications at BVPS and low voltage growth rates, it is expected
that the actual calculated leakage values will be far less than this limit. Additionally, the current Iodine-131
levels as of May 1994 at BVPS are about 1000 times less than the Technical Specification limit of 1.0.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Application of the criteria requires the projection of postulated SLB leakage, based on the projected EOC voltage
distribution for the upcoming cycle. Projected EOC voltage distribution is developed using the most recent EOC eddy
current results and a voltage measurement uncertainty. Data indicate that a threshold voltage of 2.8 volts would
result in through wall cracks long enough to leak at steam line break conditions. Draft NUREG-1477 requires that all
indications to which the IPC are applied must be included in the leakage projection. Tube pull results from another
plant with 7/8 inch tubing with a substantial voltage growth data base have shown that tube wall degradation of greater
than 40 percent through wall was readily detectable either by the bobbin or RPC probe. The tube with maximum through
wall penetration of 56 percent (42 percent average) had a voltage of 2.02 volts. This indication also was the largest
recorded bobbin voltage from the EOC eddy current data. Based on the BVPS pulled tube and industry pulled tube data
supporting a lower threshold for SLB leakage of 2.8 volts, inclusion of all IPC intersections in the leakage model
is quite conservative. The ODSCC occurring at BVPS has historically resulted in relatively low voltage levels and
has exhibited decreasing voltage growth trends over the last three inspections. BVPS has not identified ODSCC as
a contributor to operational leakage. The current leakage levels at BVPS are negligible (less than 1 gpd). In order
to satisfy the requirements of draft NUREG-1477, EOC 10 eddy current data will be used to calculate the projected SLB
leakage according to draft NUREG-1477 methodology. Leakage calculated using the recommended EPRI leakage correlation
will also be provided. Duquesne Light Company is requesting that the NRC review and approve the EPRI SLB leakage calculation
methodology. Sufficient justification is included to establish acceptability of the EPRI leakage correlation
based on criteria provided by the NRC in the February 8, 1994, Industry/NRC working meeting on the voltage based criteria.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In order to assess the sensitivity of application of the voltage based criteria upon SLB leakage, the EOC 9 eddy current
results were used to calculate postulated EOC 10 leakage using both the NUREG-1477 methodology and EPRI correlation
assuming that a 1.0 or 2.0 volt plugging limit were implemented at the BOC 10. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Results indicate SLB leakage of 0.46 gpm and 0.044 gpm using the NUREG and EPRI methodologies with an assumed probability
of detection (POD) of 0.6 for a 2.0 volt repair limit. Since Duquesne Light Company has chosen to limit the voltage based
plugging limit at 1.0 volt, EOC 11 SLB leakage is analyzed to be approximately 5 percent lower than the calculated SLB
leakage with a 2.0 volt repair limit.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Therefore, implementation of the interim plugging criteria does not adversely affect steam generator tube integrity
and implementation will be shown to result in acceptable dose consequences, therefore, the proposed amendment does
not result in any increase in the probability or consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Does the change create the possibility of a new or different kind of accident from any accident previously evaluated?
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Implementation of the proposed steam generator tube interim TSP plugging criteria does not introduce any significant
changes to the plant design basis. Use of the criteria does not provide a mechanism which could result in an accident
outside of the region of the TSP elevations; no ODSCC that has been identified at the TSP has been detected outside the
thickness of the TSPs. Neither a single or multiple tube rupture event would be expected in a steam generator in which
the plugging criteria has been applied (during all plant conditions).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Specifically, Duquesne Light Company will implement a maximum leakage rate limit of 150 gpd per steam generator to
help preclude the potential for excessive leakage during all plant conditions. The technical specification limits
on primary-to-secondary leakage at operating conditions are to be a maximum of 450 gpd for all steam generators, or,
a maximum of 150 gpd for any one steam generator. The RG 1.121 criterion for establishing operational leakage rate
limits that require plant shutdown are based upon leak-before-break considerations to detect a free span crack before
potential tube rupture during faulted plant conditions. The 150 gpd limit should provide for leakage detection and
plant shutdown in the event of the occurrence of an unexpected single crack resulting in leakage that is associated
with the longest permissible crack length. RG 1.121 acceptance criteria for establishing operating leakage limits
are based on leak-before-break considerations such that plant shutdown is initiated if the leakage associated with
the longest permissible crack is exceeded.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The single through wall crack lengths that result in tube burst at 1.43 times the steam line break pressure differential
and SLB pressure differential alone are approximately 0.57 inch and 0.84 inch, respectively. A leak rate of 150 gpd
will provide for detection of 0.41 inch long cracks at nominal leak rates and 0.62 inch long cracks at the lower 95 percent
confidence level leak rates. Since tube burst is precluded during normal operation due to the proximity of the TSP
to the tube and the potential exists for the crevice to become uncovered during SLB conditions, the leakage from the
maximum permissible crack must preclude tube burst at SLB conditions. Thus, the 150 gpd limit provides for plant shutdown
prior to reaching critical crack lengths for SLB conditions using the lower 95 percent leakage data. Additionally,
this leak-before-break evaluation assumes that the entire crevice area is uncovered during blowdown. Partial uncovery
will provide benefit to the burst capacity of the intersection. Analyses have shown that only a small percentage of
the TSPs are deflected greater than the TSP thickness during a postulated SLB.
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Steam generator tube integrity continues to be maintained through inservice inspection and primary-to-secondary
leakage monitoring, therefore, the possibility of a new or different kind of accident from any accident previously
developed is not created.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. Does the change involve a significant reduction in a margin of safety?
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The use of the voltage based bobbin probe interim TSP elevation plugging criteria is demonstrated to maintain steam
generator tube integrity commensurate with the requirements of RG 1.121. RG 1.121 describes a method acceptable
to the NRC staff for meeting GDCs 14, 15, 31, and 32 by reducing the probability or the consequences of steam generator
tube rupture. This is accomplished by determining the limiting conditions of degradation of steam generator tubing,
as established by inservice inspection, for which tubes with unacceptable cracking should be removed from service.
Upon implementation of the criteria, even under the worst case conditions, the occurrence of ODSCC at the TSP elevations
is not expected to lead to a steam generator tube rupture event during normal or faulted plant conditions. The EOC distribution
of crack indications at the TSP elevations will be confirmed to result in acceptable primary-to-secondary leakage
during all plant conditions and that radiological consequences are not adversely impacted.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In addressing the combined effects of loss of coolant accident (LOCA) and safe shutdown earthquake (SSE) on the steam
generator component (as required by GDC 2), it has been determined that tube collapse may occur in the steam generators
at some plants. This is the case as the TSP may become deformed as a result oflateral loads at the wedge supports at the
periphery of the plate due to the combined effects of the LOCA rarefaction wave and SSE loadings. Then, the resulting
pressure differential on the deformed tubes may cause some of the tubes to collapse.
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
There are two issues associated with steam generator tube collapse. First, the collapse of steam generator tubing
reduces the RCS flow area through the tubes. The reduction in flow area increases the resistance to flow of steam from
the core during a LOCA which, in turn, may potentially increase peak clad temperature (PCT). Second, there is a potential
that partial through wall cracks in tubes could progress to through wall cracks during tube deformation or collapse.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Consequently, since the leak-before-break methodology is applicable to the BVPS reactor coolant loop piping, the
probability of breaks in the primary loop piping is sufficiently low that they need not be considered in the structural
design of the plant. The limiting LOCA event becomes either the accumulator line break or the pressurizer surge line
break. LOCA loads for the primary pipe breaks were used to bound the conditions at BVPS for smaller breaks. The results
of the analysis using the larger break inputs show that the LOCA loads were found to be of insufficient magnitude to
result in steam generator tube collapse or significant deformation. The LOCA and SSE tube collapse evaluation performed
for another plant with Series 51 steam generators using bounding input conditions (large break loadings) is considered
applicable to BVPS.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Addressing RG 1.83 considerations, implementation of the bobbin probe voltage based interim tube plugging criteria
is supplemented by: enhanced eddy current inspection guidelines to provide consistency in voltage normalization,
a 100 percent eddy current inspection sample size at the TSP elevations, and RPC inspection requirements for the larger
indications left inservice to characterize the principal degradation as ODSCC.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
As noted previously, implementation of the TSP elevation plugging criteria will decrease the number of tubes which
must be repaired. The installation of steam generator tube plugs reduces the RCS flow margin. Thus, the implementation
of the alternate plugging criteria will maintain the margin of flow that would otherwise be reduced in the event of
increased tube plugging.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Based on the above, it is concluded that the proposed license amendment request does not result in a significant reduction
in margin with respect to plant safety as defined in the Final Safety Analysis Report or any Bases of the Technical Specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
10 CFR 50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves
no significant hazards consideration.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 B. F. Jones Memorial Library, 663 Franklin Avenue, Aliquippa, Pennsylvania 15001.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Gerald Charnoff, Esquire, Jay E. Silberg, Esquire, Shaw, Pittman, Potts &amp; Trowbridge, 2300 N Street, NW., Washington,
DC 20037.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Walter R. Butler, Director
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Entergy Operations, Inc., Docket Nos. 50-313, Arkansas Nuclear One, 
<!-- PJG 0012 frnewline -->
Unit 1, Pope County, Arkansas
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
June 22, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed amendment revises technical specifications (TSs) related to the emergency feedwater system (EFW).
The proposed changes extend the allowable outage time when one EFW train is inoperable from 36 hours to 72 hours and
adapt other EFW sections from the ``Restructured Standard Technical Specifications for B&amp;W Plants'' to the
Arkansas Nuclear One, Unit 1 (ANO-1) format. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Criterion 1 - Does Not Involve a Significant Increase in the Probability or Consequences of an Accident Previously
Evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Emergency Feedwater (EFW) system mitigates the consequences of any event with a loss of normal feedwater. This
system is not the initiator of any previously analyzed accident, and therefore, changes to the specifications applicable
to the EFW system present no significant increase in the probability of any previously evaluated accident.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The changes that revise the required Actions and Allowable Outage Times associated with the EFW system have been evaluated
for their effect on the Core Damage Frequency (CDF) previously calculated in the ANO-1 Probabilistic Risk Assessment
(PRA). The new ANO-1 CDF values, incorporating the proposed AOT extension, are 4.73E-05 (for the turbine-driven
EFW pump) and 4.70E-05 (for the motor-driven pump). These values do not exceed the NRC Safety Goal of 1.0E-04 per reactor
year, as stated in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Federal Register 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
50FR32138. The delta CDF associated with these changes (6.16E-07 for the turbine-driven EFW pump and 3.04E-07 for
the motor-driven EFW pump) have been evaluated with respect to criteria contained in SECY-91-270, dated August 27,
1991, and NUMARC 91-04, dated January 1992, and fall within the category of events of low risk significance requiring
no compensatory measures. This evaluation has shown the risk associated with the proposed changes to pose no undue
risk to public health and safety, to be categorized as having low risk significance, and involve no significant increase
in the consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The changes revising the Limiting Conditions for Operation result in more restrictive controls on the operability
of the motor-driven EFW pump. The previous specification required operability of both EFW pumps when the reactor
was heated above 280
<!-- PJG 0017 degreeslatlong -->
&cir;F. The proposed change requires the operability of the motor-driven EFW pump whenever the unit is above the cold
shutdown condition and any steam generator is relied upon for heat removal. With this change, the motor-driven EFW
pump is now required to be operable in a condition not previously specified, constituting an additional requirement
not previously specified. This change does not involve a significant increase in the consequences of an accident
previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The changes revising the Limiting Conditions for Operation also incorporate an Allowable Outage Time for the turbine-driven
EFW pump steam supply valves which was not previously specified. The 7 day AOT is reasonable based on:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. The redundant steam supply (from the opposite steam generator) to the turbine-driven EFW pump is operable,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. The motor-driven EFW pump is operable, and
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. The probability of an event occurring that would require the inoperable steam supply valve to actuate is relatively
low.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The changes to the surveillance specifications clarify the proper conditions required for the operability test
of the turbine-driven EFW pump, and revise the requirement for the verification of proper EFW flow path valve alignment.
The change clarifying the test conditions is required to ensure a sufficient steam supply to the turbine-driven EFW
pump to perform the test. During plant startup, from an RCS temperature of 280
<!-- PJG 0017 degreeslatlong -->
&cir;F to an RCS temperature of approximately 525
<!-- PJG 0017 degreeslatlong -->
&cir;F (corresponding to a steam generator pressure of approximately 830 psig) the turbine-driven EFW pump is classified
as available until operability is proven by successful completion of the surveillance 
<!-- PJG 0012 frnewline -->
requirement. The proposed changes state that the EFW pumps and their associated flow paths shall be operable when
the RCS is above the cold shutdown condition with any steam generator relied upon for heat removal (motor-driven EFW
pump) and when RCS temperature is greater than or equal to 280
<!-- PJG 0017 degreeslatlong -->
&cir;F (turbine-driven EFW pump). This specification requires that the flow paths be properly aligned to maintain
operability and is as restrictive as the current TS 4.8.1.c. The revised specification incorporates a new requirement
to verify operator flexibility in determining the method of verification. Some methods that could be considered
as fulfilling this requirement would include valve alignment checks, or a flow test verifying a level decrease in
the `Q' condensate storage tank with a corresponding level increase in both steam generators. These changes result
in no significant increase in the consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The other proposed changes included in this submittal, including the Bases changes, are considered to be administrative
in nature and have no effect on the consequences of an accident previously evaluated. Relocation of the Emergency
Feedwater Initiation and Control (EFIC) requirements from Section 3.4 to Section 3.5 places the requirements for
this instrumentation system with the requirements for other instrumentation systems, resulting in greater consistency
throughout the ANO-1 TS. Information in the Bases associated with the EFIC system has been corrected to reflect the
actual plant condition and resolve a conflict with the ANO-1 Safety Analysis Report. The Bases changes add clarifying
information to aid the operator in determining the applicability of the various EFW specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Therefore, this change does not involve a significant increase in the probability or consequences of any accident
previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Criterion 2 - Does Not Create the Possibility of a New or Different Kind of Accident from any Previously Evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed changes introduce no new mode of plant operation. The EFW system is not an event initiator. It functions
to mitigate the consequences of any event with a loss of normal feedwater.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Therefore, this change does not create the possibility of a new or different kind of accident from any previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Criterion 3 - Does Not Involve a Significant Reduction in the Margin of Safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The changes proposed to the Limiting Conditions for Operation associated with the EFW system are more conservative
than the current specification, thus resulting in an increase in the margin of safety. The proposed changes to the
actions required when both of the EFW trains are inoperable and the auxiliary feedwater pump is unavailable no longer
require an immediate plant runback, that is currently required, which could introduce a plant transient, thus resulting
in an increase in the margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The changes revising the Limiting Conditions for Operations also incorporate and Allowable Outage Time for the turbine-driven
EFW pump steam supply valves which was not previously specified. The 7 day AOT is reasonable based on:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. The redundant steam supply (from the opposite steam generator) to the turbine-driven EFW pump is operable,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. The motor-driven EFW pump is operable, and
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. The probability of an event occurring that would require the inoperable steam supply valve to actuate is relatively
low.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The changes to the surveillance specifications clarify the proper conditions required for the operability test
of the turbine-driven EFW pump, and revise the requirement for the verification of proper EFW flow path valve alignment.
The change clarifying the test conditions is required to ensure a sufficient steam supply to the turbine-driven EFW
pump to perform the test. During plant startup, from an RCS temperature of 280
<!-- PJG 0017 degreeslatlong -->
&cir;F to an RCS temperature of approximately 525
<!-- PJG 0017 degreeslatlong -->
&cir;F (corresponding to a steam generator pressure of approximately 830 psig) the turbine-driven EFW pump is classified
as available until operability is proven by successful completion of the surveillance requirement. The proposed
changes state that the EFW pumps and their associated flow paths shall be operable when the RCS is above the cold shutdown
condition with any steam generator relied upon for heat removal (motor-driven EFW pump) and when RCS temperature
is greater than or equal to 280
<!-- PJG 0017 degreeslatlong -->
&cir;F (turbine-driven EFW pump). This specification requires that the flow paths be properly aligned to maintain
operability and is as restrictive as the current TS 4.8.1.c. The revised specification incorporates a new requirement
to verify proper alignment prior to relying upon any steam generator for heat removal. This allows the operator flexibility
in determining the method of verification. Some methods that could be considered as fulfilling this requirement
would include manual valve alignment checks, or a flow test verifying a level decrease in the `Q' condensate storage
tank with a corresponding level increase in both steam generators.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
This change does involve an incremental reduction in the margin of safety since the extension of the EFW Allowable
Outage Time from 36 hours to 72 hours does result in a slight increase in the Core Damage Frequency (CDF) as calculated
in the ANO-1 Probabilistic Risk Assessment. The new ANO-1 CDF values, incorporating the proposed AOT extension,
are 4.73E-05 (for the turbine-driven EFW pump) and 4.70E-05 (for the motor-driven EFW pump). These values do not exceed
the NRC Safety Goal of 1.0E-04 per reactor year, as stated in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Federal Register 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
50FR32138. The CDF associated with these changes (6.16E-07 for the turbine-driven EFW pump and 3.04E-07 for the motor-driven
EFW pump) have been evaluated with respect to criteria contained in SECY-91-270, dated August 27, 1991, and NUMARC
91-04, dated 
<!-- PJG 0012 frnewline -->
January 1992, and fall within the category of events of low risk significance requiring no compensatory measures.
This reduction is not considered significant in that the increase in CDF has been evaluated as posing no undue risk
to the public health and safety and is categorized as having low risk significance.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The other proposed changes included in this submittal, including the Bases changes, are considered to be administrative
in nature. Relocation of the Emergency Feedwater Initiation and Control (EFIC) requirements from Section 3.4 to
Section 3.5 places the requirements for this instrumentation system with the requirements for other instrumentation
systems, resulting in greater consistency throughout the ANO-1 TS. Information in the Bases associated with the
EFIC system has been corrected to reflect the actual plant condition and resolve a conflict with the ANO-1 Safety Analysis
Report. The Bases changes add clarifying information to aid the operator in determining the applicability of the
various EFW specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Therefore, this change does not involve a significant reduction in the 
<!-- PJG 0012 frnewline -->
margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
10 CFR 50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves
no significant hazards consideration.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Tomlinson Library, Arkansas Tech University, Russellville, Arkansas 72801
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Nicholas S. Reynolds, Esquire, Winston and Strawn, 1400 L Street, N.W., Washington, D.C. 20005-3502
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
William D. Beckner
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Entergy Operations, Inc., Docket Nos. 50-313 and 50-368, Arkansas
<!-- PJG 0012 frnewline -->
Nuclear One, Unit Nos. 1 and 2 (ANO-1&amp;2), Pope County, Arkansas
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
June 20, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed amendments revise the administrative and control sections of the technical specifications (TSs) for
Arkansas Nuclear One, Units 1 and 2. The proposed changes relocate controls associated with the ``Review and Audit''
functions from the TSs to the Quality Assurance Program and relocate requirements for the audit of emergency and security
plans and implementing procedures from the TSs to the respective emergency and security plans.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Criterion 1 - Does Not Involve a Significant Increase in the Probability or Consequences of an Accident Previously
Evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed changes do not affect reactor operations or accident analyses, have no radiological consequences,
and are considered to be purely administrative in nature. All requirements relocated from the TSs have been evaluated
with respect to the four criteria of the NRC "Final Policy Statement On Technical Specifications Improvements''
as presented in SECY-93-067, and found to meet none of the criteria for inclusion in the TS.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Therefore, this change does not involve a significant increase in the probability or consequences of any accident
previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Criterion 2 - Does Not Create the Possibility of a New or Different Kind of Accident from any Previously Evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed changes introduce no new mode of plant operation and do not affect the operability of safety-related
equipment. All requirements relocated or deleted from the TSs have been evaluated with respect to the four criteria
of the NRC ``Final Policy Statement On Technical Specifications Improvements'' as presented in SECY-93-067, and
found to meet none of the criteria for inclusion in the TS.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Therefore, this change does not create the possibility of a new or different kind of accident from any previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Criterion 3 - Does Not Involve a Significant Reduction in the Margin of Safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Existing TS operability and surveillance requirements are not reduced by the proposed change, thus no margins of
safety are reduced. All requirements relocated or deleted from the TSs have been evaluated with respect to the four
criteria of the NRC ``Final Policy Statement On Technical Specifications Improvements'' as presented in SECY-93-067,
and found to meet none of the criteria for inclusion in the TS.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Therefore, this change does not involve a significant reduction in the margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
10 CFR 50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves
no significant hazards consideration. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Tomlinson Library, Arkansas Tech University, Russellville, Arkansas 72801
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Nicholas S. Reynolds, Esquire, Winston and Strawn, 1400 L Street, N.W., Washington, D.C. 20005-3502
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
William D. Beckner
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Entergy Operations Inc., Docket No. 50-382, Waterford Steam Electric
<!-- PJG 0012 frnewline -->
Station, Unit 3, St. Charles Parish, Louisiana
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
February 9, 1993 as supplemented by letter dated July 22, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed amendment would revise Section 3.0 and 4.0 of the Technical Specifications (TSs) consistent with the
provision and intent of Generic Letter (GL) 87-09 dated June 4, 1987.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
TS 3.0.4 prevents entry into an operational mode or other specified condition unless Limiting Conditions for Operations
(LCOs) are met without reliance on Action Requirements. The intent of this TS is to ensure that a higher mode of operation
is not entered when equipment is inoperable or when parameters exceed their specified limits.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change clarifies TS 3.0.4 such that LCOs with Action Statements that permit continued operation for
an unlimited period of time are exempt from the restrictions of TS 3.0.4. This provision is modified to require an additional
plant safety review prior to implementing additional exceptions to 3.0.4 other than those currently stated in the
individual specifications. This proposed change is consistent with existing NRC regulatory requirements for LCOs.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change to TS 4.0.3 incorporates a 24-hour delay in implementing the Action Statements due to a missed
surveillance requirement when the Action Statements provide a restoration time that is less than 24 hours. As reflected
in GL 87-09, this change is justified in that it is overly conservative to assume that systems or components are immediately
inoperable when a surveillance requirement has not been performed. The NRC concludes in Generic Letter 87-09 that
a 24-hour time limit balances the risks associated with an allowance for completing the surveillance within this
period against the risks associated with the potential for a plant upset and challenge to safety systems when the alternative
is a shutdown to comply with Action Statements before the surveillance can be completed. The NRC further states that
the potential for a plant upset and challenge to safety systems is increased if surveillances are performed during
actions to initiate a shutdown to comply with Action Requirements.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
TS 4.0.4 has been modified to note that its provisions shall not prevent passage through or to operational modes as
required to comply with Action Requirements. This change is consistent with the intent of the existing TS and represents
a clarification.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
No previously analyzed accident scenario is changed by the proposed TS changes described above. Initiating conditions
and assumptions remain as previously analyzed.
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Therefore, the proposed changes will not involve a significant increase in the probability or consequences of any
accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change to TS 3.0.4 is administrative in nature. Entry into an operational mode or other specified condition
will be allowed for those specifications not currently stating an exception to 3.0.4 when 1) the applicable LCOs Action
Requirement permits continued operation for an unlimited period of time and 2) the PORC [plant operations review
committee] has reviewed and approved the exception.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change to TS 4.0.3 will allow continued operation for an additional 24-hours after discovery of a missed
surveillance. As reflected in GL 87-09, missing a surveillance does not mean that a component or system is inoperable.
In most cases, surveillances provide positive verification of operability.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change to TS 4.0.4 will alleviate conflict within the TS. The change is necessary to allow the plant to
proceed through or to required operational modes to comply with Action Statements even if applicable Surveillance
Requirements may not have been performed.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
These changes do not affect the operation of the plant or the manner in which it is operated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Therefore, the proposed changes will not create the possibility of a new or different kind of accident from any accident
previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change to TS 3.0.4 is administrative in nature and will have no impact on any margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change to TS 4.0.3 will allow up to 24-hours to perform a missed surveillance. In some cases this will eliminate
the need for a plant shutdown. As reflected in GL 87-09, the overall effect is an increase in plant safety by avoiding
unnecessary shutdowns and associated system transients due to missed surveillances.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change to TS 4.0.4 will eliminate an internal conflict within the TS and allow the plant to proceed through
or to required operational modes to comply with Action Statements even if applicable Surveillance Requirements
for that mode may not have been performed.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The NRC staff has previously evaluated these change in Generic Letter 87-09 and determined that the TS modifications
will result in improved TS.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Therefore, the proposed change will not involve a significant reduction in a margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
10 CFR 50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves
no significant hazards consideration.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
University of New Orleans Library, Louisiana Collection, Lakefront, New Orleans, Louisiana 70122
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
N.S. Reynolds, Esq., Winston &amp; Strawn 1400 L Street N.W., Washington, D.C. 20005-3502
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
William D. Beckner
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Florida Power and Light Company, et al., Docket No. 50-335, St. Lucie Plant, Unit No. 1, St. Lucie County, Florida
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 28, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendment will revise Technical Specifications (TS) 3/4.4.13 to incorporate Low Temperature Overpressure
Protection (LTOP) requirements similar to those recommended by the NRC staff via Generic Letter 90-06. The proposed
changes are in accordance with the resolution of Generic Issue 94 for St. Lucie Units 1 and 2.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Pursuant to 10 CFR 50.92, a determination may be made that a proposed license amendment involves no significant hazards
consideration if operation of the facility in accordance with the proposed amendment would not: (1) involve a significant
increase in the probability or consequences of an accident previously evaluated; or (2) create the possibility of
a new or different kind of accident from any accident previously evaluated; or (3) involve a significant reduction
in a margin of safety. Each standard is discussed as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1)Operation of the facility in accordance with the proposed amendment would not involve a signifiant increase in
the probability or consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The changes proposed for St. Lucie Unit 1 Technical Specifications (TS) 3/4.4.13 are similar to those recommended
by the NRC staff via Generic Letter 90-06 for Low Temperature Overpressure Protection (LTOP) systems. On the basis
of technical studies performed for Generic Issue 94, the staff concluded that LTOP system unavailability is a contributor
to the risk associated with overpressure transients during the shutdown modes of plant operation. Revisions to the
actions required and the time for completion of such actions, in the event that one or more Power Operated Relief Valves
(PORV) become inoperable, provide more rigor than the existing specifications and are designed to increase LTOP
system availability. The administrative restrictions do not change the results of existing analyses performed
to evaluate postulated accidents but will improve the availability of systems designed to mitigate pressure transients
that could occur within the LTOP range. Therefore, operation of the facility in accordance with the proposed amendment
will not involve a significant increase in the probability or consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2)Operation of the facility in accordance with the proposed amendment would not create the possibility of a new or
different kind of accident from any accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed amendment will not change the physical plant or the modes of operation defined in the facility license.
The changes do not involve the addition of new equipment or the modification of existing equipment, nor do they alter
the design of St. Lucie plant systems. Therefore, operation of the facility in accordance with the proposed amendment
would not create the possibility of a new or different kind of accident from any accident previously evaluated.
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3)Operation of the facility in accordance with the proposed amendment would not involve a significant reduction
in a margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed amendment provides additional administrative restrictions for the operation of LTOP equipment. The
applicability of Limiting Conditions of Operation (LCO) involving the PORVs will be extended to include Operational
MODE 6 when the head is on the reactor vessel, and the rigor of required actions and action compleiton times in the event
that one or more PORVs become inoperable will be increased. Consequently, the risk of low temperature operations
will be reduced and safety during the shutdown modes of operation will be enhanced. Therefore, operation of the facility
in accordance with the proposed amendment would not involve a significant reduction in a margin of safety. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Based on the discussion presented above and on the supporting Evaluation of Proposed TS Changes, FPL has concluded
that this proposed license amendment involves no significant hazards consideration.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves no significant
hazards consideration.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Indian River Junior College Library, 3209 Virginia Avenue, Fort Pierce, Florida 34954-9003
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Harold F. Reis, Esquire, Newman and Holtzinger, 1615 L Street, NW., Washington, DC 20036
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Victor M. McCree (Acting)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Northeast Nuclear Energy Company, et al., Docket No. 50-336, Millstone Nuclear Power Station, Unit No. 2, New London
County, Connecticut
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 1, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed amendment to the Technical Specification (TS) would:
<!-- PJG 0012 frnewline -->
1. Modify the facility by providing an auctioneered power supply for the engineered safety feature actuation system
(ESFAS) sensor cabinets;
<!-- PJG 0012 frnewline -->
2 Reinstate the 2-out-of-4 sump recirculation system (SRAS) logic;
<!-- PJG 0012 frnewline -->
3. Change Table 3.3 of the (Safety Feature Actuation System Instrumentation) by adding Manual main steam isolation
(MSI) (Trip Buttons); by removing note (f) which describes the SRAS logic as a modified 2-out-of-4 logic; and by replacing
Action Statement 4 with an Action Statement that allows operation with a second inoperable channel, provided both
channels are placed in the bypassed condition. 
<!-- PJG 0012 frnewline -->
4. Add to the TS new limiting conditions for operation and new surveillance requirements together with BASES (TS 3.3.2.2
and 4.3.2.2.1 and 4.3.2.2.2) for the ESFAS sensor cabinet power supply drawers. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
...The proposed changes do not involve an SHC [significant hazards consideration] because the changes would not:

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. Involve a significant increase in the probability or consequences of an accident previously analyzed. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
SRAS Logic Modification
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Implementation of the auctioneered power supply for the sensor cabinets will permit the reinstatement of the original
2-out-of-4 (six possible combinations) logic for SRAS initiation. The current logic only has four possible combinations.
Changing the minimum number of SRAS channels required to be operable from four to three does not significantly reduce
the available actuation combinations. Operation with one channel inoperable will still provide a 2-out-of-3 logic
(three possible trip combinations). With the current SRAS logic, operation with one channel in bypass does not meet
the single failure criterion for proper SRAS operation. Amendment No. 168 prevents that condition. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Allowing continued operation with three operable channels is consistent with the original Millstone Unit No. 2 Technical
Specifications (prior to Amendment No. 168).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Note (f), which describes the current logic, will no longer apply after the auctioneering circuit is installed. This
note is for information only and has no associated action or surveillance requirements. Therefore, removal of note
(f) cannot affect either the probability or consequences of a postulated accident. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In addition to the change in the minimum number of channels required to be operable, Action statement 4 will be revised
to allow a limited period of two hours when a second channel may be placed in bypass for performance of surveillance
testing. This is acceptable due to the installation of the auctioneering circuit and restoration of the full SRAS
logic. Prior to the implementation of the short term modifications and Amendment No. 168, Action Statement 2 also
applied to the SRAS. That Action Statement allows two hours of operation with two channels out of service. However,
Action Statement 2 requires one of the two channels to be placed in the tripped position.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Postulating a LOCA [loss-of-coolant accident] and an additional failure, while in an action statement that specifies
a maximum allowed outage time, is beyond the design basis of Millstone Unit No. 2. However, with one SRAS channel in
bypass and one in the tripped position, an additional failure (such as the loss of a DC vital bus) following the onset
of a LOCA could result in a false SRAS signal.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
From an overall safety perspective, the potential consequences from a false SRAS at the onset of a LOCA are more severe
than those from the failure to automatically generate an actuation signal. Proposed Action Statement 4 would require
actuation of the remaining channel (following a LOCA and a loss of DC bus as a second failure) to initiate the SRAS. The
existing operation procedures instruct the operator to ensure that the SRAS actuation occurs when the refueling
water storage tank level decreases to a predetermined value. In the unlikely event that a LOCA occurred while a Action
Statement 4 and no SRAS was generated at the appropriate time due to an additional failure which prevents one channel
from tripping, the SRAS would be manually initiated by the operator. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The amount of time that Millstone Unit No. 2 would operate under Action Statement 4 (with two SRAS channels in bypass)
is approximately 6 hours per month. This is based on the requirement to conduct monthly channel functional tests for
the three operable channels. The probability of a LOCA occurring during these surveillance, while in Action Statement
4, with a subsequent failure of the remaining 2-out-of-2 SRAS logic, is very low.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sensor Cabinet Auctioneering
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed new Technical Specification 3.3.2.2, which establishes the requirements for the ESFAS sensor cabinets
power supply drawers, permits 48 hours to restore an inoperable sensor cabinet power supply drawer to operable status.
A power supply drawer renders it inoperable, or if either its normal or backup power is not available.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Existing Technical Specification 3.8.2.1 contains an 8-hour action statement for restoring the power sources (VA-10,
20, 30, and 40) if they become inoperable. The proposed 48-hour action statement for the power supply drawers is appropriate
since the sensor cabinet would remain functional if either normal or alternate power was not available. However,
a LOCA and an additional failure while in the action statement could result in a false SRAS, since two channels would
supplied from a single DC power supply. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Prior to Amendment No. 168, operation with an inoperable power supply drawer could continue indefinitely, provided
the provisions of Technical Specification 3/4.3.2 were followed. Operation with a power supply inoperable for an
indefinite period of time places all the signals associated with that sensor cabinet in the tripped condition. This
creates a 1-out-of-4 tripped condition for SRAS. In this condition, the single failure required to be postulated
could result in a false SRAS actuation.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
This 48-hour action statement is consistent with other action statements for ESFAS such as Action Statement 1 of Table
3.3-3. Also, this is consistent with the current wording of Action Statement 4 which allows 48 hours to restore an inoperable
channel to operable while operating with the modified 2-out-of-4 logic. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
MSI Trip Button Addition
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The manual trip buttons provide a mechanism for the control room operator to initiate an MSI trip. The proposed Technical
Specification change will require that a plant shutdown be initiated if either channel is out of service for more than
48 hours, and establishes a requirement for surveillance testing every refueling outage. Including the trip buttons
in the Technical Specifications and establishing operation and surveillance requirements ensures their operability
commensurate with their safety significance. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Based on the above, the changes to Technical Specification 3/4.3 do not increase the probability or consequence of
an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Create the possibility of a new or different kind of accident from any previously analyzed.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
SRAS Logic Modification
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Changing the number of channels required to be operable from four to three is acceptable since the original 2-out-of-4
logic will be restored. This change only affects the number and combinations of actuation channels necessary to initiate
a SRAS. There is no change to the source or types of initiators, nor is there a change to the automatic response resulting
from a SRAS.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Note (f), which described the modified logic, will no longer apply after the auctioneering circuit is installed.
This note is for information only and has no associated action or surveillance requirements. Therefore, removal
of note (f) cannot create a new or different kind of accident.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
New Action Statement 4 restores the ability to operate for an indefinite period of time with one channel in bypass and
for a limited period of time while two channels are out of service. The change from the original action statement to
require that both channels be in bypass will prevent a false SRAS in the unlikely (and beyond design basis) event of
a LOCA with an additional failure of a DC bus while in an LCO [limiting condition for operation].
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sensor Cabinet Auctioneering
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The addition of a Technical Specification for the sensor cabinet power supply drawers does not create a potential
for a new or different kind of accident. This new specification implements more restrictive operating requirements
for the sensor cabinets. These are necessary to ensure that the sensor cabinets are energized from their primary power
supply. The new specification does not affect the initiation of a SRAS signal nor the type of signal produced. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The auctioneering modification does bring two vital AC facilities together via isolation devices. This introduces
a potential for a new type of failure mechanism. As described in Attachment 1, adequate isolation ensures that a failure
on one side of an isolation transformer does not adversely degrade the other side.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
MSI Trip Button Addition
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The manual trip buttons provide a mechanism for the control room operation to initiate an MSI trip. The Technical Specification
change will require that a plant shutdown be initiated if either manual trip channel is out of service for more than
48 hours, and establishes a requirement for surveillance testing every refueling outage. The trip buttons were installed
during the 1992 outage. Establishing operability requirements and surveillance frequency cannot create a new or
different kind of accident.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Therefore, the proposed changes do not create the possibility of a new or different kind of accident from any previously
analyzed. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. Involve a significant reduction in the margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The net effect of the proposed modifications is to improve the reliability of the ESFAS and restore the design 2-out-of-4
logic for the SRAS. The proposed modifications improve the availability of the ESFAS, and do not affect the vital AC
instrument panels.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Technical Specification changes establish controls for the used of the SRAS with the restored logic configuration.
The combination of the auctioneering of the power supplies, the restoration of the 2-out-of-4 logic, and the revised
Technical Specifications restores the margin of safety and operational flexibility originally designed for the
sensor cabinets. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Based on the above, there is no reduction in the margin of safety. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
10 CFR 50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves
no significant hazards consideration.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Learning Resource Center, Three Rivers Community-Technical College, Thames Valley Campus, 574 New London Turnpike,
Norwich, Connecticut 06360.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Gerald Garfield, Esquire, Day, Berry &amp; Howard, City Place, Hartford, Connecticut 06103-3499.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
John F. Stolz
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
PECO Energy Company, Docket No. 50-353, Limerick Generating Station, Unit 2, Montgomery County, Pennsylvania
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
June 30, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This amendment would remove certain remote shutdown system control valves and primary containment isolation valves
from Technical Specifications Tables 3.3.7.4-1 and 3.6.3-1 respectively, as a result of eliminating the steam condensing
mode of the Residual Heat Removal system.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
1. The proposed Technical Specifications (TS) changes do not involve a significant increase in the probability or
consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
These proposed changes will result in abandoning in place certain remote shutdown system control valves and removing
from service and abandoning in place certain Primary Containment Isolation Valves (PCIVs) associated with the Residual
Heat Removal (RHR) system steam condensing mode, and will remove the interface between the High Pressure Coolant
Injection (HPCI) and RHR systems, therefore changing the primary containment pressure boundary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The RHR system steam condensing mode is a non-safety related function of the RHR system; however, the pressure and
structural integrity of the associated piping and valves are safety-related. These proposed changes will not affect
any components required to perform the safety-related function of the RHR or HPCI systems.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The ability of the RHR or HPCI systems to respond to an accident will not be degraded. Only valves specifically dedicated
for use for the RHR system steam condensing mode will be abandoned in-place, or removed from the plant. The valves'
handswitches which are part of the remote shutdown panel (RSP) controls, will be physically removed from the RSP,
since they will not perform any function (i.e., the associated valves will have the electrical power removed). The
flanges and penetration caps that will become part of the primary containment boundary will be periodically tested
for leakage as required by TS and 10CFR50, Appendix J. All piping and components that will remain operable will meet
the original design requirements. The other modes of operation of the RHR system (e.g., Low Pressure Coolant Injection
(LPCI), Shutdown [C]ooling (SDC)) will not be affected by these changes. Therefore, the proposed TS changes do not
involve an increase in the probability or consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. The proposed TS changes do not create the possibility of a new or different kind of accident from any accident previously
evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
No new failure modes of RHR or HPCI systems are created by the proposed TS changes. The proposed changes will have no
impact on the existing High Energy Line Break (HELB) analysis for Limerick Generating Station (LGS). All valves or
piping removed and/or abandoned in place, are dedicated specifically for the RHR system steam condensing mode, and
will not affect the operation of any components or piping required for other modes of operation of the RHR or HPCI systems.
Therefore, the proposed TS changes do not create the possibility of a new or different kind of accident from any previously
evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. The proposed TS changes do not involve a significant reduction in a margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The steam condensing mode is a non-safety related function of the RHR system and, therefore, is not addressed in the
TS. This mode will be physically separated from the other modes of operation of RHR and HPCI systems, and consequently,
will not preclude them from performing their safety-related functions. The remote shutdown system control valves
to be abandoned in place are not being used presently, and the proposed changes will not impact the safety operation
of LGS Unit 2. The primary containment penetration caps, safety-related pipe caps and the flanges replacing the removed
PCIVs will be designed, fabricated and installed in accordance with the original design requirements, i.e., American
Society of Mechanical Engineers (ASME) Boiler and Pressure Vessel (B&amp;PV) Code, Section III, 1971 Edition with
Addenda through Winter 1971. The added penetration caps and flanges will be capable of maintaining the primary containment
pressure boundary and isolation capabilities that were required of the PCIVs and will be tested for leakage periodically,
as required by TS and 10 CFR 50, Appendix J. Additionally, all piping and components that will remain operable will
meet original design requirements. Therefore, the proposed TS changes do not involve a reduction in a margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
10 CFR 50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves
no significant hazards consideration. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Pottstown Public Library, 500 High Street, Pottstown, Pennsylvania 19464.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
J. W. Durham, Sr., Esquire, Sr. V. P. and General Counsel, PECO Energy Company, 2301 Market Street, Philadelphia,
Pennsylvania 19101
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Charles L. Miller
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Pennsylvania Power and Light Company, Docket Nos. 50-387 and 50-388 Susquehanna Steam Electric Station, Units 1
and 2, Luzerne County, Pennsylvania
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment requests: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 19, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This amendment will change the Technical Specification 3.1.5 for each unit for the standby liquid control system
(SLCS) to remove the operability requirement for the SLCS while in Operational Condition 5 (refueling) with any control
rod withdrawn, and to delete the 18-month system surveillance requirement (Surveillance Requirement 4.1.5.d.3).

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
1. This proposal does not involve a significant increase in the probability or consequences of an accident previously
evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed Technical Specification change to delete the operability requirement for the SLC System in OPCON 5*
(OPERATIONAL CONDITION 5 with any control rod withdrawn) does not affect the probability or consequences of an accident
previously evaluated. Design basis accident mitigation scenarios for SSES in OPCON 5 do not depend on, or require,
SLC operability; therefore, the proposed change to delete SLC operability in OPCON 5* does not affect the probability
or consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed Technical Specification change to delete Surveillance Requirement 4.1.5.d.3, 18 month SLC heater
operability check, does not affect the probability or consequences of an accident previously evaluated. Regarding
the SLC heater function, the operability of the SLC system depends on maintaining the temperature of the sodium pentaborate
solution above 70
<!-- PJG 0017 degreeslatlong -->
&cir;F to prevent the boric acid from precipitating out of solution. SLC heater 'A' is used to maintain tank temperature
between 85
<!-- PJG 0017 degreeslatlong -->
&cir; F and 95
<!-- PJG 0017 degreeslatlong -->
&cir;F, thus ensuring that the boric acid remains in solution. The operability of the heater 'A' is verified through
the daily performance of Technical Specification Surveillance Requirement 4.1.5.a.1, which checks SLC solution
temperature, and a control room alarm. Heater 'B' functions to raise SLC solution temperature prior to the mixing
of SLC chemicals - the mixing of sodium pentaborate and water is an endothermic (heat consuming) reaction. The operability
of heater 'B' is verified at the time when chemicals are added to the SLC tank, since a precondition for adding the chemicals
is using heater 'B' to increase tank temperature to 100
<!-- PJG 0017 degreeslatlong -->
&cir;F. Heater 'B' does not function to maintain tank temperature during normal operation. Therefore, the proposed
change does not impact Susquehanna's ability to maintain SLC solution temperature and thus does not increase the
probability or consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. This proposal does not create the possibility of a new or different kind of accident or [sic] from any accident previously
evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed Technical Specification change to delete the operability requirement for the SLC System in OPCON 5*
does not create the possibility of a new or different kind of accident or [sic] from any accident previously evaluated.
The purpose of the SLC System is to provide backup capability for bringing the reactor from full power to a cold, Xenon-free
shutdown, assuming that none of the withdrawn control rods can be inserted. This bases is consistent with the required
operability of the SLC System in OPCONs 1 &amp; 2. The proposed change does not affect the ability of SLC to meet its design
basis. No credit is taken for SLC in OPCON 5 to mitigate the effects of reactivity transients, and the SLC system is not
designed to terminate an inadvertent criticality event during core alterations (OPCON 5) with vessel water level
at least 22 feet above top of vessel flange. Therefore, no new or different accident scenarios are created by the proposed
change.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed Technical Specification change to delete Surveillance Requirement 4.1.5.d.3, 18 month SLC heater
operability check, does not create the possibility of a new or different kind of accident or [sic] from any accident
previously evaluated. The proposed change does not affect systems, structures, or components (SSCs) or the operation
of these [SSCs]. The heating and heater control subsystems of the SLC system will continue to function as they were
designed. The proposed change does not alter the heating limits or the method for maintaining SLC solution temperature.
Therefore, the proposed change does not create the possibility of a new or different kind of accident or [sic] from
any accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. This change does not involve a significant reduction in a margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed Technical Specification change to delete the operability requirement for the SLC System in OPCON 5*
does not involve a significant reduction in a margin of safety. The potential for a decrease in the margin of safety,
under this proposed change, would be associated with periods during OPCON 5* when the SLC system was not operable.
Allowing the SLC system to be inoperable during OPCON 5* with the vessel level at least 22 feet above top of vessel flange,
represents no reduction in the margin of safety since the SLC System is not designed to terminate an inadvertent criticality
event with a greater volume of water in the reactor. Having the SLC system inoperable in OPCON 5* with reactor water
levels at normal operating volumes, does not significantly reduce the margin of safety because of the number of other
design and operating features which act to prevent inadvertent criticality events. Adequate shutdown margin is
maintained through design and administrative controls; including, Shutdown Margin Demonstration, Technical
Specification 3.1.1, defueling and refueling procedures, and refueling interlocks. In addition, the Reactor Protection
System monitors for recriticality and actuates the Control Rod Scram function if a significant reactivity addition
is sensed.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed Technical Specification change to delete Surveillance Requirement 4.1.5.d.3, 18 month SLC heater
operability check, does not involve a significant reduction in a margin of safety. Adequate controls are in place,
independent of the 18 month heater operability check, to ensure that the temperature of the sodium pentaborate solution
is maintained above 70
<!-- PJG 0017 degreeslatlong -->
&cir; F. These controls include Surveillance Requirement 4.1.5.a.1, which checks SLC solution temperature daily,
a control room alarm on low and high temperature, and the ambient temperature conditions in the SLC area which prevent
rapid changes in SLC solution temperature. Operability of the 'B' heater is not needed to maintain SLC solution temperature,
and the operability of this heater is verified at the time when chemicals are added to the SLC tank.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
10 CFR 50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves
no significant hazards consideration. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Osterhout Free Library, Reference Department, 71 South Franklin Street, Wilkes-Barre, Pennsylvania 18701 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Jay Silberg, Esquire, Shaw, Pittman, Potts and Trowbridge, 2300 N Street NW., Washington, DC 20037
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Charles L. Miller
<!-- PJG 0012 frnewline -->
Power Authority of the State of New York, Docket No. 50-333, James A. FitzPatrick Nuclear Power Plant, Oswego County,
New York
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
June 13, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed amendment would modify the Facility Operating License by removing License Condition 2.E. This condition
applies to the construction cleanup, restoration, and maintenance of transmission lines. It incorporated into
the Facility Operating License the requirements of U.S. Department of Interior publication ``Environmental Criteria
for Electric Transmission Systems'' - 1970. The proposed amendment was requested to eliminate duplication of regulatory
authority by government agencies of the same activity.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Operation of the FitzPatrick plant in accordance with the proposed Amendment would not involve a significant hazards
consideration as defined in 10 CFR 50.92, since it would not:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. involve a significant increase in the probability or consequences of an accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change will remove a license condition unrelated to nuclear safety. License condition 2.E incorporated
into the Operating License the requirements of U.S. Department of Interior publication ``Environmental Criteria
for Electric Transmission Systems'' - 1970. The goal of this standard is to ``safeguard aesthetic and environmental
values within the constraints imposed by the current state of high-voltage transmission technology.'' License
condition 2.E addresses the preservation of the environment and natural resources. Removing this condition from
the Facility Operating License has no bearing on plant safety or the health and safety of the public considering its
non-nuclear safety nature. The transmission line right-of-ways maintained by the Authority are subject to regulation
by other State and Federal agencies. Removal of this license condition will not affect operation of safety related
structures, systems or components nor affect the quality assurance program at the FitzPatrick plant. Therefore,
the proposed change does not involve a significant increase in the probability or consequences of an accident previously
evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. create the possibility of a new or different kind of accident from any accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
License condition 2.E of the James A. FitzPatrick Plant Operating License applies to the construction cleanup, restoration,
and maintenance of transmission lines. The Authority's transmission lines are managed under guidelines based on
the ``Generic Transmission Line Right-of-Way Management'' plan requirements. The requirements imposed by the
plan on the FitzPatrick transmission line right-of-ways exceed those of the U.S. Department of Interior publication
referenced in license condition 2.E in both scope and details. Therefore, implementing the proposed change will
not create the possibility of a new or different kind of accident from any accident previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. involve a significant reduction in a margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
License condition 2.E of the James A. FitzPatrick Operating License applies to the construction cleanup, restoration,
and maintenance of transmission lines. The requirements imposed by this license condition are unrelated to nuclear
safety. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Continued operation of the plant without Condition 2.E does not involve a significant reduction in any margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves no significant
hazards consideration. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Reference and Documents Department, Penfield Library, State University of New York, Oswego, New York 13126.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Mr. Charles M. Pratt, 1633 Broadway, New York, New York 10019. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Michael L. Boyle
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Power Authority of the State of New York, Docket No. 50-333, James A. FitzPatrick Nuclear Power Plant, Oswego County,
New York
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 21, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed changes would modify paragraph 2.C.(3) of the Facility Operating License and relocate fire protection
requirements from the Technical Specifications to an administrative procedure. These changes are based on the guidance
contained in NRC Generic Letter 86-10, ``Implementation of Fire Protection Requirements,'' and Generic Letter
88-12, ``Removal of Fire Protection Requirements from Technical Specifications.'' 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Operation of the FitzPatrick plant in accordance with the proposed Amendment will not involve a significant hazards
consideration as defined in 10 CFR 50.92, because:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) This change does not involve a significant increase in the probability or consequences of an accident previously
evaluated because no modifications, no changes to operating procedure requirements, no reduction in administrative
controls and no reduction in equipment reliability are being made as a result of these changes. This proposed amendment
relocates the fire protection LCOs [Limiting Conditions for Operation] and Surveillance Requirements from the
Technical Specifications to an Administrative Procedure. No significant changes in content are being made to the
Technical Specification requirements that are being relocated. Operating limitations will continue to be in effect,
and required surveillances will continue to be performed in accordance with written procedures and instructions
auditable by the NRC.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Although future proposed changes to the fire protection program elements previously located in the Technical Specifications
will no longer be controlled by 10 CFR 50.36, proposed changes to the Fire Protection requirements will be controlled
by the License Condition and plant procedures. Programmatic controls will continue to assure that fire protection
program changes do not reduce the effectiveness of the program to achieve and maintain safe shutdown in the event of
a fire.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) The possibility of an accident or malfunction of a different type than evaluated previously in the safety analysis
report is not created because no reduction to the fire protection requirements, no modifications, no changes to operating
procedure requirements, no reduction in administrative controls and no reduction in equipment reliability are
being made as a result of these changes. Programmatic controls will continue to assure that fire protection program
changes do not reduce the effectiveness of the program to achieve and maintain safe shutdown in the event of a fire.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) This proposed amendment does not involve a reduction to the approved fire protection program or Fire Protection
Technical Specification requirements because the Technical Specification fire protection requirements are being
relocated, with no significant change in content, to an administrative procedure. Since there is no reduction in
the requirements, no modifications, no changes to operating procedure requirements, no reduction in administrative
controls and no reduction in equipment reliability are being made as a result of these changes, there is no reduction
in the margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves no significant
hazards consideration. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Reference and Documents Department, Penfield Library, State University of New York, Oswego, New York 13126.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Mr. Charles M. Pratt, 1633 Broadway, New York, New York 10019. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Pao Tsin Kuo
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Power Authority of The State of New York, Docket No. 50-286, Indian Point
<!-- PJG 0012 frnewline -->
Nuclear Generating Unit No. 3, Westchester County, New York 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 25, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The licensee has requested an amendment to the Technical Specifications (TS) to revise Table 3.6-1 (Non-Automatic
Containment Isolation Valves Open Continuously or Intermittently for Plant Operation) and Table 4.4-1 (Containment
Isolation Valves) to delete valves SI-1833A(B) and add valves SI-MOV-1835A(B). The valves being deleted no longer
perform a containment isolation function as a result of a modification which removed the boron injection tank. The
valves being added are needed for testing the safety injection pumps.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Consistent with the criteria of 10 CFR 50.92, the enclosed application is judged to involve no significant hazards
based on the following information:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) Does the proposed license amendment involve a significant increase in the probability or consequences of any
accident previously evaluated?
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Response:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed license amendment does not involve a significant increase in the probability or consequences of any
accident previously evaluated. The change permits the removal of the two containment isolation valves on the Boron
Injection Tank (BIT) bypass line. A previous amendment [Amendment No. 139, issued on October 15, 1993] to the Operating
License removed the functional requirement for the BIT. Consequently, the function of the BIT bypass line to provide
a Safety Injection [SI] pump test flow path has been rendered obsolete, permitting removal of the bypass line and associated
valves. The bypass line will be cut and capped to assure containment integrity, therefore eliminating the need for
containment isolation valves SI-1833A and SI-1833B. Opening the BIT outlet valve [SI-MOV-1835A or B] permits operability
testing of the SI pumps, and is consistent with the current provision permitting opening of the BIT bypass valves.
The changes do not impact the current operability and surveillance requirements for the Safety Injection System.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) Does the proposed license amendment create the possibility of a new or different kind of accident from any previously
evaluated?
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Response:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed license amendment does not create the possibility of a new or different kind of accident from any previously
evaluated. The change proposes to eliminate two containment isolation valves on the BIT bypass line whose function
has been rendered obsolete by a previous amendment to the Operating License. The bypass line will be cut and capped
to assure containment integrity, therefore eliminating the need for these containment isolation valves. Intermittent
opening of the BIT outlet valve is consistent with the current provision permitting opening of the BIT bypass valves,
thereby allowing operability testing of the SI pumps. The changes do not impact the operability or surveillance requirements
for the Safety Injection System.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) Does the proposed amendment involve a significant reduction in a margin of safety?
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Response:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed license amendment does not involve a significant reduction in a margin of safety for the following reasons.
Currently, an orientation deficiency with the inboard BIT bypass isolation valve exposes its stem packing to the
non-isolable side of the valve. The modification corrects this problem by removing both isolation valves and capping
the pipes to assure integrity of the Containment and Safety Injection System. Additionally, removal of the isolation
valves removes the potential for containment leakage resulting from valve degradation. Finally, removal of the
BIT bypass line and its associated isolation valves does not inhibit the ability to test the SI pumps since a previous
modification approved in an Amendment to the Operating License removed the functional requirement for the BIT. Consequently,
the SI pumps may be flow tested with the BIT inservice, rendering obsolete the function of the BIT bypass line. Intermittent
opening the BIT outlet valve is consistent with the current provision permitting opening of the BIT bypass valves,
thereby allowing operability testing of the SI pumps.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves no significant
hazards consideration. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
White Plains Public Library, 100 Martine Avenue, White Plains, New York 10601.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Mr. Charles M. Pratt, 10 Columbus Circle, New York, New York 10019.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Pao Tsin Kuo 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Public Service Electric &amp; Gas Company, Docket Nos. 50-272 and 50-311, Salem Nuclear Generating Station, Unit
Nos. 1 and 2, Salem County, New Jersey 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
June 29, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
These proposed amendments would revise the Technical Specifications to increase the minimum volume of oil contained
in the Diesel Fuel Oil Storage Tanks (DFOSTs) at the Salem Generating Station (SGS). It would also revise the Updated
Final Safety Analysis Report (UFSAR) description of the fuel oil storage system capability.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
(1) [This proposal does] not involve a significant increase in the probability or consequences of an accident previously
evaluated. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Emergency Diesel Generator (EDG) fuel oil is used to support mitigation of design basis events involving loss of the
preferred (offsite) source of A.C. power. Fuel oil storage capacity has no effect on the probability of any accident
previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Onsite fuel oil storage capability is designed to provide assurance of long term diesel operation to mitigate the
consequences of a design basis accident. The proposed change would increase the minimum required volume in the Seismic
Class I Diesel Fuel Oil Storage Tanks (DFOSTs), and would revise the Updated Final Safety Analysis Report (UFSAR),
as part of an effort to reconstitute the basis for SGS fuel oil storage capacity. The DFOST inventory at the proposed
minimum Technical Specification (TS) limit, combined with the emergency fill connection and Seismic Class III Fuel
Oil Storage Tank and transfer capability, would continue to provide a long term onsite fuel oil supply to the EDGs.
Operations and Emergency Preparedness procedures would facilitate the transfer of fuel oil, and procurement from
offsite sources as a contingency measure. Therefore, the ability to provide a long term supply of fuel oil to the EDG's
is maintained, and the proposed change would not result in any significant increase in consequences of an accident
previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) [This proposal does] not create the possibility of a new or different kind of accident from any accident previously
evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change would increase the minimum DFOST level required by TS, and redefines the fuel oil storage and transfer
systems' capability based on plant specific fuel oil consumption rate and EDG load profiles. These changes would
not result in operation in any configuration prohibited by the present TS, and do not introduce the possibility of
any new type of accident.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) [This change does] not involve a significant reduction in a margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The EDG fuel oil storage and transfer capability would continue to support reliable, long term EDG operation, thereby
maintaining an acceptable margin of safety relative to the ability of onsite A.C. power to support operation of equipment
important to safety. The proposed changes do not involve a significant reduction in margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
10 CFR 50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves
no significant hazards consideration. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Salem Free Public library, 112 West Broadway, Salem, New Jersey 08079
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Mark J. Wetterhahn, Esquire, Winston and Strawn, 1400 L Street, NW., Washington, DC 20005-3502
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Charles L. Miller
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Tennessee Valley Authority, Docket Nos. 50-259 and 50-296, Browns Ferry Nuclear Plant, Units 1 and 3, Limestone County,
Alabama 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
March 31, 1994 (TS 319)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed amendment revises the setpoints for instrumentation used to isolate high energy line breaks in the high
pressure coolant injection (HPCI) and reactor core isolation cooling (RCIC) systems. The proposed amendment also
defines specific areas where steam line space temperatures are monitored.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
1. The proposed amendment does not involve a significant increase in the probability or consequences of an accident
previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed changes to the HPCI and RCIC steam line space isolation setpoints do not affect any precursor for any design
basis events or operational transients analyzed in the Browns Ferry Final Safety Analysis Report. Therefore, the
probability of an accident previously evaluated is not increased.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The HPCI and RCIC steam line space high temperature isolations are provided to ensure automatic closure of each system's
primary containment isolation valves for a HPCI or RCIC steam line break. The isolation occurs when a very small leak
has occurred. If the small leak is allowed to continue without isolation, offsite dose limits may be reached. As a result
of the environmental qualification program, the environmental responses of the reactor building to high energy
line breaks were analyzed. TVA used computer modeling techniques to predict the temperature response of various
reactor building zones to high energy line breaks. The results indicate that the setpoints for the HPCI and RCIC temperatures
switches should be lowered. The lower setpoints assure the timely initiation of a closure signal to the primary containment
isolation valves. Therefore, assuring the maximum allowable temperatures are not exceeded.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change to the HPCI and RCIC steam line space isolation setpoints are in the conservative direction and
provides the same or earlier detection and isolation of HPCI and RCIC steam line breaks.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed trip level settings are high enough to ensure that spurious trips do not occur from normal or transient
system operation and low enough to ensure that line breaks are detected and isolated before design conditions are
exceeded. Therefore, the proposed changes will not significantly increase the consequences of an accident previously
evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. The proposed amendment does not create the possibility of a new or different kind of accident from any accident previously
evaluated. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change to the HPCI/RCIC steam line space high temperature isolations does not involve any modification
to plant equipment or changes in operating procedures. No new failure modes are introduced. There is no effect on the
function or operation of any other plant system. No new system interactions have been introduced by the change. The
results of a break in the HPCI or RCIC steam lines remain as before. The HPCI or RCIC steam line area temperature switches
will still detect a break due to an increase in area temperature and provide an initiation signal to close the system
primary containment isolation valves to prevent reactor coolant loss. The proposed change will conservatively
serve to detect and mitigate HPCI and RCIC line breaks more expeditiously. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Therefore, the proposed changes do not create the possibility of a new or different kind of accident.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. The proposed amendment does not involve a significant reduction in a margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change will not reduce the margin of safety. The proposed change ensure that HPCI and RCIC steam line breaks
are isolated at the same or lower steam line area temperatures. Computer modeling techniques were utilized to predict
the temperature response in various areas through which the HPCI and RCIC steam lines pass. The revised setpoints
are established above the maximum expected normal room temperatures to avoid spurious actions due to ambient conditions
and below the analytical limits to ensure timely pipe break detection and isolation. Substantial margin exist between
the maximum temperature expected in each area and the minimum actuation temperature determined for each temperature
switch. With the substantial margin between maximum temperatures for the areas and the minimum actuation temperature
of the switches, the maximum temperatures cannot result in actuation of the switches. The design and function of the
affected components has not been changed. Therefore, the proposed change does not involve a significant reduction
in a margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC has reviewed the licensee's analysis and, based on this review, it appears that the three standards of 10 CFR
50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves no significant
hazards consideration.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Athens Public Library, South Street, Athens, Alabama 35611
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
General Counsel, Tennessee Valley Authority, 400 West Summit Hill Drive, ET 11H, Knoxville, Tennessee 37902
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Mr. Frederick J. Hebdon
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Tennessee Valley Authority, Docket No. 50-260, Browns Ferry Nuclear Plant, Unit 2, Limestone County, Alabama 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
May 11, 1994 (TS 347T)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed amendment extends the allowed outage time for the Browns Ferry Nuclear Plant (BFN) Unit 2 
<!-- PJG 0012 frnewline -->
250 volt DC (direct current) control power supplies from 5 to 45 days. The amendment is a temporary revision to the BFN
Unit 2 Technical Specifications (TS) to permit replacement of batteries and other hardware.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration,
which is presented below: 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
1. The proposed amendment does not involve a significant increase in the probability or consequences of an accident
previously evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change involves temporarily (one-year period) extending the 5-day AOT [allowed outage time] for the
250-volt shutdown board control power supplies to 45 days. As such, this change does not increase the probability
of any accident previously analyzed. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The 250-volt DC Power System is required to function to mitigate the consequences of design basis accidents. The loss
of a single 250-volt DC shutdown board control power supply will result in a loss of control power for the 480-volt and
the 4160-volt shutdown board that it serves. Loss of control power results in loss of only those engineered safeguards
supplied by its respective shutdown boards. Redundant safe shutdown equipment exists to mitigate the consequences
of design basis accidents. As discussed in Final Safety Analysis Report (FSAR) subsection 8.6.4.3, a single failure
of a shutdown board control power supply is acceptable.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Loss of a single 250-volt plant DC power supply will not prevent Unit 2 safe shutdown. The 250-volt plant DC power supply
system is designed so that any two out of the three power supplies carry the entire load needed for safe shutdown. As
discussed in FSAR subsection 8.6.4.2 a single failure of a 250-volt plant DC power supply is acceptable.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
At no time will control power be unavailable to the shutdown boards during the system upgrades. The proposed change
will only increase the time allowed to operate the plant while a 250-volt DC shutdown board control power supply is
out of service.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed TS change allows an additional 40 days to perform system upgrades and results in a small increase in risk.
This small increase in risk is associated with the probability and consequences of a 250-volt plant DC power supply
malfunction while it is supplying shutdown board control power. The increase in risk associated with extending the
AOT was analyzed in a Probabilistic Safety Assessment (PSA) and determined to be approximately 0.3 percent. This
small increase in risk is determined to be insignificant and well within the uncertainty bounds of the PSA.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed TS change does not change the function of any plant structure, system or component. The proposed change
allows for improvements to the 250-volt DC shutdown board control power supply system. The improvements will increase
the capability and reliability of the system. Qualified backup power will be utilized at all times during system modifications.
Only one power supply will be out of service at a time during the modifications.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The small increase in risk is more than offset by the increased capability, capacity, and reliability of the new power
supplies. Therefore, the power supply modifications will result in a net overall safety benefit.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
[The licensee has also committed to implement compensatory measures while performing the power supply modifications.
These measures provide additional confidence that potential accident consequences are not increased.]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. The proposed amendment does not create the possibility of a new or different kind of accident from any accident previously
evaluated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Extending the 5-day AOT for the 250-volt shutdown board control power supplies to 45 days does not create the possibility
of a new or different kind of accident, nor does it increase the probability that an accident will occur. The AOT extension
does not involve plant modifications that could create the possibility of a new or different kind of accident from
any of those discussed in the FSAR.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The 250-volt DC shutdown board control power supply modifications involve replacement of the existing components
with more reliable, increased capacity equipment having the same functions as before.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. The proposed amendment does not involve a significant reduction in a margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed TS change involves a risk increase of approximately 0.3 percent. TVA [the Tennessee Valley Authority,
the licensee] considers this small increase to be insignificant. TVA also considers that the small increase in risk
is offset by the benefits associated with replacing the control power supplies with new, upgraded equipment. Therefore,
the proposed TS change does not involve a significant reduction in a margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
[The licensee has also committed to implement compensatory measures while performing the power supply modifications.
These measures provide additional capability to mitigate an accident, minimizing any effect on safety margin.]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC has reviewed the licensee's analysis and, based on this review, it appears that the three standards of 10 CFR
50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the 
<!-- PJG 0012 frnewline -->
amendment request involves no significant hazards consideration.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Athens Public Library, South Street, Athens, Alabama 35611
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
General Counsel, Tennessee Valley Authority, 400 West Summit Hill Drive, ET 11H, Knoxville, Tennessee 37902
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Mr. Frederick J. Hebdon
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Wisconsin Electric Power Company, Docket Nos. 50-266 and 50-301, Point Beach Nuclear Plant, Unit Nos. 1 and 2, Town
of Two Creeks, Manitowoc County, Wisconsin
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 18, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed amendment would modify Point Beach Nuclear Plant Technical Specification (TS) 15.3.7, ``Auxiliary
Electrical Systems,'' by including an allowed outage time for one of the four connected station battery chargers
and subsequent shutdown requirements. The basis for Section 15.3.7 would also be revised to support the above changes.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Basis for proposed no significant hazards consideration determination: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As required by 10 CFR 50.91(a), the licensee has provided its analysis of the issue of no significant hazards consideration
which is presented below:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
In accordance with the requirements of 10 CFR 50.91(a), Wisconsin Electric Power Company (Licensee) has evaluated
the proposed changes against the standards of 10 CFR 50.92 and has determined that the operation of Point Beach Nuclear
Plant, Units 1 and 2, in accordance with the proposed amendments, does not present a significant hazards consideration.
A proposed facility operating license amendment does not present a significant hazards consideration if operation
of the facility in accordance with the proposed amendment will not:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. Create a significant increase in the probability or consequences of an accident previously evaluated; or
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Create the possibility of a new or different kind of accident from any accident previously evaluated; or
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. Will not create a significant reduction in a margin of safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed amendment allows operation for up to two hours with one out of the four connected station battery chargers
out of service. The 2-hour outage time is based on Regulatory Guide 1.93 and reflects a reasonable time to assess plant
status and either connect an operable battery charger to the affected DC bus or prepare to effect an orderly and safe
shutdown of the operating unit(s). Since the batteries, chargers, and their associated vital instrument buses provide
sufficient redundancy to assure the initiation of proper protective actions during degraded system conditions,
operation of PBNP in accordance with these proposed amendments cannot create an increase in the probability or consequences
of an accident previously evaluated, create a new or different kind of accident, or result in a significant reduction
in a margin of safety. Therefore, the proposed changes do not present a significant hazards consideration.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NRC staff has reviewed the licensee's analysis and, based on this review, it appears that the three standards of
10 CFR 50.92(c) are satisfied. Therefore, the NRC staff proposes to determine that the amendment request involves
no significant hazards consideration.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Joseph P. Mann Library, 1516 Sixteenth Street, Two Rivers, Wisconsin 54241. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Gerald Charnoff, Esq., Shaw, Pittman, Potts, and Trowbridge, 2300 N Street, NW., Washington, DC 20037.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
John N. Hannon
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Previously Published Notices Of consideration Of Issuance Of Amendments To Facility Operating Licenses, Proposed
No Significant Hazards Consideration Determination, And Opportunity For A Hearing
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The following notices were previously published as separate individual notices. The notice content was the same
as above. They were published as individual notices either because time did not allow the Commission to wait for this
biweekly notice or because the action involved exigent circumstances. They are repeated here because the biweekly
notice lists all amendments issued or proposed to be issued involving no significant hazards consideration.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For details, see the individual notice in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
on the day and page cited. This notice does not extend the notice period of the original notice.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Georgia Power Company, Docket No. 50-366, Edwin I. Hatch Nuclear Plant, Unit 2, Appling County, Georgia
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 19, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed amendment would revise Technical Specification 3.3.6.6 to permit the traversing incore probe (TIP)
system to be considered operable with less than four operable TIP units.
<!-- PJG 0012 frnewline -->
Date of publication of individual notice in Federal Register: July 22, 1994 (59 FR 37516) Expiration date of individual
notice: Comment Period expires August 8, 1994; Notice period expires August 22, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Appling County Public Library, 301 City Hall Drive, Baxley, Georgia 31513
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Notice Of Issuance Of Amendments To Facility Operating Licenses
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
During the period since publication of the last biweekly notice, the Commission has issued the following amendments.
The Commission has determined for each of these amendments that the application complies with the standards and requirements
of the Atomic Energy Act of 1954, as amended (the Act), and the Commission's rules and regulations. The Commission
has made appropriate findings as required by the Act and the Commission's rules and regulations in 10 CFR Chapter I,
which are set forth in the license amendment. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Notice of Consideration of Issuance of Amendment to Facility Operating License, Proposed No Significant Hazards
Consideration Determination, and Opportunity for A Hearing in connection with these actions was published in the

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
as indicated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Unless otherwise indicated, the Commission has determined that these amendments satisfy the criteria for categorical
exclusion in accordance with 10 CFR 51.22. Therefore, pursuant to 10 CFR 51.22(b), no environmental impact statement
or environmental assessment need be prepared for these amendments. If the Commission has prepared an environmental
assessment under the special circumstances provision in 10 CFR 51.12(b) and has made a determination based on that
assessment, it is so indicated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For further details with respect to the action see (1) the applications for amendment, (2) the amendment, and (3) the
Commission's related letter, Safety Evaluation and/or Environmental Assessment as indicated. All of these items
are available for public inspection at the Commission's Public Document Room, the Gelman Building, 2120 L Street,
NW., Washington, DC 20555, and at the local public document rooms for the particular facilities involved.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Carolina Power &amp; Light Company, Docket No. 50-261, H. B. Robinson Steam
<!-- PJG 0012 frnewline -->
Electric Plant, Unit No. 2, Darlington County, South Carolina
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
September 15, 1993
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendment revises the pressure-temperature limits from 15 to 24 effective full power years. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 29, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 July 29, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
149
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
DPR-23. Amendment revises the Technical Specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
October 13, 1993 (58 FR 52980) The Commission's related evaluation of the amendment is contained in a Safety Evaluation
dated July 29, 1994.
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Hartsville Memorial Library, Home and Fifth Avenues, Hartsville, South Carolina 29550 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Carolina Power &amp; Light Company, et al., Docket No. 50-400, Shearon Harris Nuclear Power Plant, Unit 1, Wake and
Chatham Counties, North Carolina
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
February 4, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendment revises the Action Statement of TS 3.6.5, Vacuum Relief System, to require in Modes 1-4 with one vacuum
relief system inoperable that the system be restored to the operable status within seventy-two hours or be in at least
hot standby within the next six hours.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 27, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 27, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
49
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
NPF-63. Amendment revises the Technical Specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
March 30, 1994 (59 FR 14886) The Commission's related evaluation of the amendment is contained in a Safety Evaluation
dated July 27, 1994.
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Cameron Village Regional Library, 1930 Clark Avenue, Raleigh, North Carolina 27605. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Carolina Power &amp; Light Company, et al., Docket No. 50-400, Shearon Harris Nuclear Power Plant, Unit 1, Wake and
Chatham Counties, North Carolina
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
May 11, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendment revises TS 3/4.2.3 to establish limits on reactor power level as a function of total reactor coolant
system (RCS) flow rate up to 5 percent below the current specified flow rate.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 27, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 27, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
50
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
NPF-63. Amendment revises the Technical Specifications. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
May 25, 1994 (59 FR 27079) The Commission's related evaluation of the amendment is contained in a Safety Evaluation
dated July 27, 1994.
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Cameron Village Regional Library, 1930 Clark Avenue, Raleigh, North Carolina 27605.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Commonwealth Edison Company, Docket Nos. STN 50-456 and STN 50-457, Braidwood Station, Unit Nos. 1 and 2, Will County,
Illinois
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendments: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
March 30, 1994, as supplemented by letters dated June 13, June 14, July 11, July 21 and July 28, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendments: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendment revises the Technical Specifications (TSs) by changing the Unit 1 heatup and cooldown pressure-temperature
(P-T) curves (i.e., Figures 3.4-2a and 3.4-3a) to incorporate a newly determined reactor pressure vessel (RPV) reference
nil-ductility temperature, RT
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
NDT
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. This new value of RT
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
NDT
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 was determined from the licensee's analysis of the first irradiation sample removed from Unit 1. The setpoint curve
contained in Figure 3.4-4a for the Unit 1 Low Temperature Overpressure Protection System (LTOPS) is also revised
to reflect the changes in the P-T curves and to provide a margin for uncertainties in measuring the reactor pressure.
Additionally, the amendment updates the removal schedule of RPV surveillance capsules for both units in accordance
with the American Society for Testing Materials (ASTM) Standard ASTM E185-82. Finally, the amendment incorporates
an editorial change for Unit 2 in which some clarifying text was added in the Table of Contents to indicate the lifetime
applicability of Figure 3.4-4b for Unit 2.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 29, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 29, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment Nos.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
53 and 53
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License Nos. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
NPF-72 and NPF-77. The amendments revised the Technical Specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
May 12, 1994 (59 FR 24747) The Commission's related evaluation of the amendments is contained in a Safety Evaluation
dated July 29, 1994. 
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Wilmington Township Public Library, 201 S. Kankakee Street, Wilmington, Illinois 60481.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Commonwealth Edison Company, Docket Nos. 50-373 and 50-374, LaSalle County Station, Units 1 and 2, LaSalle County,
Illinois
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendments: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
September 10, 1993 as supplemented November 17, 1993
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendments: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendments revise the LaSalle County Station, Units 1 and 2 Updated Final Safety Analysis Report Section 11.5.2.1.4
to specify that operator action is required to trip the mechanical vacuum pump upon receipt of a main steam line high
radiation alarm, rather than the action of an automatic trip, which is currently described in the UFSAR. NRC approval
was required because the required operator action, an existing condition, is contrary to that described in the UFSAR
and the NRC's Safety Evaluation Report related to the operation of LaSalle County station (NUREG-0519), and involved
an unreviewed safety question. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 26, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 26, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment Nos.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
101 and 85
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License Nos. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
NPF-11 and NPF-18. The amendments revised the UFSAR.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
December 1, 1993 (58 FR 63403) The Commission's related evaluation of the amendments is contained in a Safety Evaluation
dated July 26, 1994. 
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Public Library of Illinois Valley Community College, Rural Route No. 1, Oglesby, Illinois 61348.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Commonwealth Edison Company, Docket Nos. 50-295 and 50-304, Zion Nuclear Power Station, Units 1 and 2, Lake County,
Illinois
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendments: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
June 16, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendments: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendments change specification 3/4.10.1 to recognize the exemption of a single valve on each unit from Type C
testing until the next refueling outage on each unit.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
August 1, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
August 1, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment Nos.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
155 and 143
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License Nos. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
DPR-39 and DPR-48. The amendments revised the Technical Specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
June 30, 1994 (59 FR 33798) Public comments requested as to proposed no significant hazards consideration: yes. The
notice provided an opportunity to submit comments on the Commission's proposed no significant hazards consideration
determination. No comments have been received. The notice also provided an opportunity to request a hearing by August
1, 1994, but indicated that if the Commission makes a final no significant hazards consideration determination,
any such hearing would take place after issuance of the amendment. The Commission's related evaluation of the amendment
and final significant hazards consideration determination is contained in a Safety Evaluation dated August 1, 1994.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Waukegan Public Library, 128 N. County Street, Waukegan, Illinois 60085.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Consolidated Edison Company of New York, Docket No. 50-003 and Docket No. 50-247, Indian Point Nuclear Generating
Unit Nos. 1 and 2, Westchester County, New York
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendments: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
September 29, 1993
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendments: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendments revise the Technical Specifications (TSs) to change the submittal frequency of the Radioactive Effluent
Release Report from semiannually to annually, and change the reporting date.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 21, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As of the date of issuance to be implemented within 30 days.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment Nos.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
44 and 172
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License Nos. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
DPR-5 and DPR-26: Amendments revised the Technical Specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
November 24, 1993 (58 FR 62153) The Commission's related evaluation of the amendments is contained in a Safety Evaluation
dated July 21, 1994. 
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
White Plains Public Library, 100 Martine Avenue, White Plains, New York 10610.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Consolidated Edison Company of New York, Docket No. 50-247, Indian Point
<!-- PJG 0012 frnewline -->
Nuclear Generating Unit No. 2, Westchester County, New York
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
September 29, 1993, as supplemented by letter dated April 1, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendment revises the Technical Specifications to remove the cycle-specific parameter limits and to reference
a Core Operating Limits Report containing these limits. These changes are in accordance with the guidance provided
in Generic Letter 88-16, ``Removal of Cycle-Specific Parameter Limits from Technical Specifications.''
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 26, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This license amendment is effective as of the date of issuance of the COLR by the licensee to be implemented no later
than the return to operation following the 1995 refueling outage.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment No.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
173
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
DPR-26: Amendment revised the Technical Specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
November 24, 1993 (58 FR 62154) The April 1, 1994, provided additional information that did not change the initial
determination. The Commission's related evaluation of the amendment is contained in a Safety Evaluation dated July
26, 1994.
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
White Plains Public Library, 100 Martine Avenue, White Plains, New York 10610.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Consolidated Edison Company of New York, Docket No. 50-247, Indian Point
<!-- PJG 0012 frnewline -->
Nuclear Generating Unit No. 2, Westchester County, New York
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 28, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendment revises the TSs to change the containment isolation valve testing frequency and the acceptance criteria
for the combined containment leakage rate to accommodate operation on a 24-month fuel cycle. These changes follow
the guidance provided in Generic Letter 91-04, ``Changes in Technical Specification Surveillance Intervals to
Accommodate a 24-Month Fuel Cycle.''
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 29, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As of the date of issuance to be implemented within 30 days.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment No.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
174
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
DPR-26: Amendment revised the Technical Specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
April 13, 1994 (59 FR 17596) The Commission's related evaluation of the amendment is contained in a Safety Evaluation
dated July 29, 1994.
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
White Plains Public Library, 100 Martine Avenue, White Plains, New York 10610.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Consumers Power Company, Docket No. 50-155, Big Rock Point Plant, Charlevoix County, Michigan
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
April 22, 1994, as supplemented July 6, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendment revised the reactor vessel pressure-temperature limits in the Technical Specifications. The change
insures that the vessel fracture toughness requirements of Section V of 10 CFR Part 50, Appendix G, are satisfied through
end of life. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 25, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 25, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment No.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
113
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
DPR-6. Amendment revised the Technical Specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
May 12, 1994 (59 FR 24749). The July 6, 1994, letter provided clarifying information within the scope of the initial
notice and did not affect the staff's proposed no significant hazards consideration findings. The Commission's
related evaluation of the amendment is contained in a Safety Evaluation dated July 25, 1994.
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
North Central Michigan College, 1515 Howard Street, Petoskey, Michigan 49770.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Detroit Edison Company, Docket No. 50-341, Fermi-2, Monroe County, Michigan 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
May 10, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendment revises the Fermi-2 Technical Specifications (TS) to remove Table 3.6.3-1, the list of primary containment
isolation valves and Table 3.8.4.3-1, the list of safety systems' motor-operated valve thermal overload protection
from the TS to administrative procedures in accordance with the guidance contained in Generic Letter 91-08. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
August 1, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
August 1, 1994, with full implementation within 45 days. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment No.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
102
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
NPF-43. Amendment revises the Technical Specifications
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
June 8, 1994 (59 FR 29626) The Commission's related evaluation of the amendment is contained in a Safety Evaluation
dated August 1, 1994.
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Monroe County Library System, 3700 South Custer Road, Monroe, Michigan 48161.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Duke Power Company, Docket Nos. 50-369 and 50-370, McGuire Nuclear Station, Units 1 and 2, Mecklenburg County, North
Carolina
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendments: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
November 11, 1993, as supplemented on June 13, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendments: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendments revise the Technical Specification surveillance requirements for the emergency core cooling system
subsystems.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 29, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 29, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment Nos.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
145 and 127
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License Nos. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
NPF-9 and NPF-17: Amendments revised the Technical Specifications. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
April 13, 1994 (59 FR 17579) The June 13, 1994, letter provided clarifying and additional information that did not
change the scope of the November 11, 1993, application and the initial proposed no significant hazards consideration
determination. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Commission's related evaluation of the amendments is contained in a Safety Evaluation dated July 29, 1994. 
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Atkins Library, University of North Carolina, Charlotte (UNCC Station), North Carolina 28223 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Duke Power Company, Docket Nos. 50-369 and 50-370, McGuire Nuclear Station, Units 1 and 2, Mecklenburg County, North
Carolina
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendments: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
May 5, 1994, as supplemented June 13, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendments: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendments revise the Technical Specifications to increase Main Steam and Pressurizer Code Safety Valve Setpoint
Tolerances.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
August 2, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
August 2, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment Nos.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
146 and 128
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License Nos. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
NPF-9 and NPF-17: Amendments revised the Technical Specifications. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
June 21, 1994 (59 FR 32029) The Commission's related evaluation of the amendments is contained in a Safety Evaluation
dated August 2, 1994.
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Atkins Library, University of North Carolina, Charlotte (UNCC Station), North Carolina 28223 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Entergy Operations, Inc., Docket No. 50-382, Waterford Steam Electric
<!-- PJG 0012 frnewline -->
Station, Unit 3, St. Charles Parish, Louisiana
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
December 14, 1993
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendment revised the Technical Specifications to revise the azimuthal power tilt limit from less than or equal
to 0.10 (10%) to less than or equal to 0.03 (3%) and revises the action statement for control element assembly misalignment
to allow 24 hours to restore the tilt to less than 3%.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
August 3, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
August 3, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment No.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
97
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
NPF-38. Amendment revised the Technical Specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 19, 1994 (59 FR 2866) The Commission's related evaluation of the amendment is contained in a Safety Evaluation
dated August 3, 1994.
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
University of New Orleans Library, Louisiana Collection, Lakefront, New Orleans, Louisiana 70122.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
GPU Nuclear Corporation, et al., Docket No. 50-219, Oyster Creek Nuclear Generating Station, Ocean County, New Jersey
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
April 6, 1994, as supplemented June 21, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendment eliminates the scram and main steam line isolation valve (MSIV) closure requirements associated with
the main steam line radiation monitors (MSLRM). The amendment also eliminates the following related automatic isolation
functions that are associated with the MSLRM scram and MSIV isolation: a) Main Steam Line Condenser Drain Valves,
b) Emergency Condenser Drain Valves, c) Reactor Recirculation Loop Sample Valve, d) Instrumental Air Valves, and
e) Condenser Pump Isolation.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 29, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As of the date of issuance to be implemented at the restart from refueling outage 15R. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment No.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
169
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
DPR-16. Amendment revised the Technical Specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
April 28, 1994 (59 FR 22008). The June 21, 1994, letter provided clarifying information that did not change the initial
proposed no significant hazards consideration determination. The Commission's related evaluation of this amendment
is contained in a Safety Evaluation dated July 29, 1994.
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Ocean County Library, Reference Department, 101 Washington Street, Toms River, New Jersey 08753.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
GPU Nuclear Corporation, et al., Docket No. 50-289, Three Mile Island Nuclear Station, Unit No. 1, Dauphin County,
Pennsylvania
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 15, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendment revises the plant Technical Specifications (TSs) on the Reactor Coolant Inventory Trending System
(RCITS). The change is consistent with NUREG-1430 entitled ``Standard Technical Specifications for Babcock and
Wilcox Plants.'' The RCITS information will be available to the operator to enhance the operator's ability to understand
and manage transients and events when needed.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
August 1, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As of its date of issuance, to be implemented within 30 days of issuance.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment No.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
191
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
DPR-50. Amendment revised the Technical Specifications. 
<!-- PJG 0012 frnewline -->
I11
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
June 8, 1994 (59 FR 29626) The Commission's related evaluation of the amendment is contained in a Safety Evaluation
dated August 1, 1994. 
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Government Publications Section, State Library of Pennsylvania, Walnut Street and Commonwealth Avenue, Box 1601,
Harrisburg, Pennsylvania 17105.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
GPU Nuclear Corporation, et al., Docket No. 50-289, Three Mile Island Nuclear Station, Unit No. 1, Dauphin County,
Pennsylvania
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
February 10, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendment revises the TMI-1 Technical Specifications (TS) to revise specification 3.7.2.c, ``Unit Electric
Power System,'' to provide an option to testing an emergency diesel generator (EDG) when the redundant EDG is inoperable.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 25, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As of the date of issuance to be implemented within 30 days. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment No.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
188
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
DPR-50. Amendment revised the Technical Specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
June 22, 1994 (59 FR 32230) The Commission's related evaluation of this amendment is contained in a Safety Evaluation
dated July 25, 1994.
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Government Publications Section, State Library of Pennsylvania, Walnut Street and Commonwealth Avenue, Box 1601,
Harrisburg, Pennsylvania 17105.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
GPU Nuclear Corporation, et al., Docket No. 50-289, Three Mile Island Nuclear Station, Unit No. 1, Dauphin County,
Pennsylvania
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
March 2, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendment revises the plant Technical Specifications to modify Operational Safety Instrumentation requirements
to specify completion time which allows for performance of maintenance or surveillance within a reasonable time
and to be consistent with the allowable outage time for other safety-related equipment when only one train is affected.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 25, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As of the date of issuance to be implemented within 30 days after issuance.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment No.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
189
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
DPR-50. Amendment revised the Technical Specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
April 13, 1994 (59 FR 17600). The Commission's related evaluation of the amendment is contained in a Safety Evaluation
dated July 25, 1994.
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Government Publications Section, State Library of Pennsylvania, Walnut Street and Commonwealth Avenue, Box 1601,
Harrisburg, Pennsylvania 17105.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
GPU Nuclear Corporation, et al., Docket No. 50-289, Three Mile Island Nuclear Station, Unit No. 1, Dauphin County,
Pennsylvania 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
March 11, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendment revises the plant Technical Specifications to specify an allowable outage time for the Emergency Feedwater
Pumps during surveillance activities. It also changes the requirement to test redundant components for operability
to a requirement to ensure operability based on verification of completion of appropriate surveillance activities.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 25, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As of the date of issuance to be implemented within 30 days of issuance.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment No.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
190
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
DPR-50. Amendment revised the Technical Specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
April 13, 1994 (59 FR 17601).
<!-- PJG 0012 frnewline -->
The Commission's related evaluation of the amendment is contained in a Safety Evaluation dated July 25, 1994.
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Government Publications Section, State Library of Pennsylvania, Walnut Street and Commonwealth Avenue, Box 1601,
Harrisburg, Pennsylvania 17105.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Gulf States Utilities Company, Cajun Electric Power Cooperative, and Entergy Operations, Inc., Docket No. 50-458,
River Bend Station, Unit 1, West Feliciana Parish, Louisiana
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 14, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendment revised TS Sections 3/4.3, ``Instrumentation,'' 3/4.4.2, ``Safety/Relief Valves,'' and associated
Bases to increase the surveillance test intervals and allowable out-of-service times for various instruments.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
August 2, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
August 2, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment No.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
74
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
NPF-47. The amendment revised the Technical Specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
April 26, 1994 (59 FR 21787) The additional information contained in the supplemental letter dated July 15, 1994,
was clarifying in nature and thus, within the scope of the initial notice and did not affect the staff's proposed no
significant hazards consideration determination.
<!-- PJG 0012 frnewline -->
The Commission's related evaluation of the amendment is contained in a Safety Evaluation dated August 2, 1994.
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received. No.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Government Documents Department, Louisiana State University, Baton Rouge, Louisiana 70803
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Houston Lighting &amp; Power Company, City Public Service Board of San Antonio, Central Power and Light Company,
City of Austin, Texas, Docket Nos. 50-498 and 50-499, South Texas Project, Units 1 and 2, Matagorda County, Texas
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
March 16, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendments: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendments modified Figure 3.4-4, ``Nominal Maximum Allowable PORV Setpoint for the Cold Overpressure System,''
for the cold overpressure mitigation system with a revised setpoint curve. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 August 3, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
August 3, 1994, to be implemented within 31 days of issuance
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment Nos.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Unit 1 - Amendment No. 63; Unit 2 - Amendment No. 52
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License Nos. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
NPF-76 and NPF-80. The amendments revised the Technical Specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
April 13, 1994 (59 FR 17601) The Commission's related evaluation of the amendments is contained in a Safety Evaluation
dated August 3, 1994.
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Wharton County Junior College, J. M. Hodges Learning Center, 911 Boling Highway, Wharton, Texas 77488
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Northeast Nuclear Energy Company, Docket No. 50-245, Millstone
<!-- PJG 0012 frnewline -->
Nuclear Power Station, Unit 1, New London County, Connecticut
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
April 29, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendment changes the requirement for reactor operators in Table 6.2-1 from 2 to 3 for the RUN, STARTUP/HOT STANDBY
and HOT SHUTDOWN conditions. In addition, two typographical corrections were made to page 6-4.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
August 2, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As of the date of issuance to be implemented within 60 days. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment No.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
75
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
DPR-21. Amendment revised the Technical Specifications. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
June 22, 1994 (59 FR 32231) The Commission's related evaluation of the amendment is contained in a Safety Evaluation
dated August 2, 1994. 
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Learning Resource Center, Three Rivers Community-Technical College, Thames Valley Campus, 574 New London Turnpike,
Norwich, Connecticut 06360.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Pacific Gas and Electric Company, Docket No. 50-133, Humboldt Bay Power Plant, Unit 3, Humboldt County, California
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 October 8, 1993 (Reference HBL-93-058)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This amendment modified the Technical Specifications (TS) incorporated in 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
DPR-7 as Appendix A by incorporating a title change into Section VII, Administrative Controls. This change reflects
a plant organizational name change. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 26, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This license amendment is effective as of the date of its issuance and must be fully implemented no later than 30 days
from the date of issuance. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment No.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
27
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
DPR-7: The amendment revised the TS.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 5, 1994 (59 FR 624) The Commission's related evaluation of the amendment is contained in a Safety Evaluation
dated July 26, 1994
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Humboldt County Library, 636 F Street, Eureka, California 95501
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Philadelphia Electric Company, Public Service Electric and Gas Company
<!-- PJG 0012 frnewline -->
Delmarva Power and Light Company, and Atlantic City Electric Company,
<!-- PJG 0012 frnewline -->
Docket Nos. 50-277 and 50-278, Peach Bottom Atomic Power Station,
<!-- PJG 0012 frnewline -->
Unit Nos. 2 and 3, York County, Pennsylvania
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendments: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
October 27, 1993, as supplemented by letters dated April 29, 1994, and June 27, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendments: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
These amendments revise the Unit 2 and Unit 3 Technical Specifications to allow one of the required on-shift senior
reactor operators (SRO) to be combined with the required shift technical advisor (STA) position (i.e., dual-role
SRO/STA position) as long as a minimum of three qualified individuals fill the SRO and STA positions.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
August 2, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
August 2, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendments Nos.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
191 and 196
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License Nos. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
DPR-44 and DPR-56: Amendments revised the Technical Specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
December 8, 1993 (58 FR 64613)
<!-- PJG 0012 frnewline -->
The Commission's related evaluation of the amendments is contained in a Safety Evaluation dated August 2, 1994.
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Government Publications Section, State Library of Pennsylvania, (REGIONAL DEPOSITORY) Education Building, Walnut
Street and Commonwealth Avenue, Box 1601, Harrisburg, Pennsylvania 17105.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Power Authority of The State of New York, Docket No. 50-286, Indian Point Nuclear Generating Unit No. 3, Westchester
County, New York 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
May 10, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Technical Specifications amendment revised Section 3.1.C.3 and Table 4.1-1 of Appendix A of the Operating License.
These changes require that the reactor coolant average temperature (T
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
avg
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
) be no lower than 540
<!-- PJG 0017 degreeslatlong -->
&cir;F during critical operation. Critical operation at T
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
avg
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 less than 540
<!-- PJG 0017 degreeslatlong -->
&cir;F requires operator response to restore T
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
avg
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 to greater than or equal to 540
<!-- PJG 0017 degreeslatlong -->
&cir;F within 15 minutes or be in hot shutdown within the following 15 minutes. Additionally, the change in Table 4.1-1
entitled, ``Minimum Frequencies for Checks, Calibrations and Tests,'' adds the requirement for T
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
avg
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 instrument check frequency to be reduced to 30 minutes when the T
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
avg
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 banks are above zero steps. Furthermore, the revision to the Bases indicates that the minimum temperature for criticality
provides assurance that the reactor is operated within the bounds of the safety analyses. Also included is an administrative
change to correct some typographical errors on page 3.1-25 of the Technical Specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 25, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As of the date of issuance to be implemented within 30 days.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment No.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
149
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
DPR-64: Amendment revised the Technical Specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
June 8, 1994 (59 FR 29630) The Commission's related evaluation of the amendment is contained in a Safety Evaluation
dated July 25, 1994. 
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
White Plains Public Library, 100 Martine Avenue, White Plains, New York 10610.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Public Service Electric &amp; Gas Company, Docket Nos. 50-272 and 50-311, Salem Nuclear Generating Station, Unit
Nos. 1 and 2, Salem County, New Jersey 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendments: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
May 3, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendments: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendments revised the Technical Specification (TS) for Combustible Gas Control (3/4.6.4.1) by changing the
surveillance frequency for performing the channel functional test to once-per-quarter and the channel calibration
to once-per-refueling. Also, the TS for the Auxiliary Feedwater System (3/4.7.1.2) were changed to reduce the surveillance
frequency for performing pump operability tests to once-per-quarter on a staggered test basis. These changes are
consistent with the provisions of Generic Letter 93-05, ``Line-Item Technical Specifications Improvements to
Reduce Surveillance Requirements For Testing During Power Operations.''
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 27, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 27, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment Nos. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
153 and 134
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License Nos. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
DPR-70 and DPR-75. These amendments revised the Technical Specifications. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
June 8, 1994 (59 FR 29634) The Commission's related evaluation of the amendments is contained in a Safety Evaluation
dated July 27, 1994.
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Salem Free Public Library, 112 West Broadway, Salem, New Jersey 08079
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
South Carolina Electric &amp; Gas Company, South Carolina Public Service
<!-- PJG 0012 frnewline -->
Authority, Docket No. 50-395, Virgil C. Summer Nuclear Station, Unit No. 1, Fairfield County, South Carolina
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
March 11, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendment changes the Technical Specifications to delete TS Surveillance Requirement 4.8.4.1.a.3 that requires
periodic retest of containment penetration overcurrent protection fuses and to remove references to containment
penetration fuse testing from the TS Bases. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 29, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 29, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment No.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
115
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
NPF-12. Amendment revises the Technical Specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
May 12, 1994 (59 FR 24752) The Commission's related evaluation of the amendment is contained in a Safety Evaluation
dated July 29, 1994.
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Fairfield County Library, Garden and Washington Streets, Winnsboro, South Carolina 29180.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Southern Nuclear Operating Company, Inc., Docket No. 50-348, Joseph M. Farley Nuclear Plant, Unit 1, Houston County,
Alabama.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
June 17, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendment changes the Technical Specifications to revise the nuclear enthalpy rise hot channel factor (F delta
H) from equal to or less than 1.65 [1 plus 0.3(1-P)] to equal to or less than l.70 [1 plus 0.3(1-P)] where P is a fraction
of rated power. The amendment also revises the action statement to reflect guidance contained in the improved standard
technical specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 22, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 22, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment No.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
109
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
NPF-2. Amendment revises the Technical Specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
June 22, 1994 (59 FR 32249) The Commission's related evaluation of the amendment is contained in a Safety Evaluation
dated July 22, 1994.
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Houston-Love Memorial Library, 212 W. Burdeshaw Street, Post Office Box 1369, Dothan, Alabama 36302 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Tennessee Valley Authority, Docket Nos. 50-259, 50-260 and 50-296, Browns Ferry Nuclear Plant, Units 1, 2 and 3, Limestone
County, Alabama
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendments: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
August 25, 1992 (TS 321)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendments: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendments delete reference to recirculation equalizer valves from the technical specifications. These components
have been removed from Browns Ferry Unit 3, and are not used in Browns Ferry Units 1 and 2.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
August 4, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
August 4, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment Nos.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
211, 226 and 184
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License Nos. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
DPR-33, DPR-52 and DPR-68: Amendments revised the Technical Specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
October 28, 1992 (57 FR 48829) The Commission's related evaluation of the amendment is contained in a Safety Evaluation
dated August 4, 1994.
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: None
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Athens Public Library, South Street, Athens, Alabama 35611
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Tennessee Valley Authority, Docket Nos. 50-327 and 50-328, Sequoyah Nuclear Plant, Units 1 and 2, Hamilton County,
Tennessee
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendments: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
June 17, 1993 (TS 93-08)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendments: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendments revise the allowable values for the intermediate and source range neutron flux reactor trip setpoints.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 26, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 26, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment Nos.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
185 and 177 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License Nos. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
DPR-77 and DPR-79: Amendments revise the technical specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
August 4, 1993 (58 FR 41514) The Commission's related evaluation of the amendments are contained in a Safety Evaluation
dated July 26, 1994.
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: None 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Chattanooga-Hamilton County Library, 1101 Broad Street, Chattanooga, Tennessee 37402
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Toledo Edison Company, Centerior Service Company, and The Cleveland Electric Illuminating Company, Docket No.
50-346, Davis-Besse Nuclear Power Station, Unit No. 1, Ottawa County, Ohio
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
February 17, 1993 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This amendment increases the TS trip setpoint and its associated allowable value for containment high-radiation
specified in TS Table 3.3-4 from ``&lt;2 x Background at RATED THERMAL POWER'' to ``&lt;4 x Background at RATED THERMAL
POWER.''
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 27, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As of the date of issuance to be implemented within 90 days.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->

<!-- PJG 0012 frnewline -->
Amendment No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
190
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
NPF-3. Amendment revised the Technical Specifications. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
June 23, 1993 (58 FR 34096) The Commission's related evaluation of the amendment is contained in a Safety Evaluation
dated July 27, 1994. 
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
University of Toledo Library, Documents Department, 2801 Bancroft Avenue, Toledo, Ohio 43606.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
TU Electric Company, Docket Nos. 50-445 and 50-446, Comanche Peak Steam Electric Station, Unit Nos. 1 and 2, Somervell
County, Texas
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of amendment request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
February 14, 1994, as supplemented by letter dated April 29, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendments: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendments increase the boron concentration limits for the Unit 2 refueling water storage tank and emergency
core cooling system, and delete a footnote concerning refueling canal boron concentration during initial fuel load
for both units.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
August 2, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
August 2, 1994, to be implemented prior to startup for Cycle 2 for Comanche Peak Steam Electric Station, Unit 2.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment Nos.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Unit 1 - Amendment No. 26; Unit 2 - Amendment No. 12 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License Nos. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
NPF-87 and NPF-89. The amendments revised the Technical Specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
April 28, 1994 (59 FR 22015) The information contained in the April 29, 1994, letter was editorial in nature and thus,
within the scope of the initial notice and did not affect the staff's proposed no significant hazards consideration
determination. The Commission's related evaluation of the amendments is contained in a Safety Evaluation dated
August 2, 1994.
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
University of Texas at Arlington Library, Government Publications/Maps, 701 South Cooper, P.O. Box 19497, Arlington,
Texas 76019.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Union Electric Company, Docket No. 50-483, Callaway Plant, Unit 1, Callaway County, Missouri
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
February 17, 1994, supplemented by letter dated May 18, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendment revises the Technical Specification 3/4.5.1 and associated Bases Section 3/4.5.1. A new Action Statement
a. provides a 72-hour allowed outage time (AOT) for one accummulator inoperable due to boron concentration. The Action
Statement b. AOT was changed to 24 hours. Surveillance Requirements 4.5.1.1.a.1 and 4.5.1.1.b were revised and 4.5.1.2
was deleted from the TS.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
August 5, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
August 5, 1994 to be implemented within 30 days 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment No.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
91
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
NPF-30. Amendment revised the Technical Specifications 3/4.5.1 and associated Bases Section 3/4.5.1. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
March 30, 1994 (59 FR 14898) The additional information contained in the May 18, 1994, letter provided additional
supplemental information that did not change the initial proposed no significant hazards consideration. 
<!-- PJG 0012 frnewline -->
The Commission's related evaluation of the amendment is contained in a Safety Evaluation dated August 5, 1994.
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Callaway County Public Library, 710 Court Street, Fulton, Missouri 65251.
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Virginia Electric and Power Company, et al., Docket Nos. 50-338 and 50-339, North Anna Power Station, Units No. 1 and
No. 2, Louisa County, Virginia
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendments: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
April 19, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendments: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendments revise the NA-1&amp;2 Technical Specifications surveillance frequency requirements for control
rod motion testing from once per 31 days to once per 92 days.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 28, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 28, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment Nos.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
185 and 166
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License Nos. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
NPF-4 and NPF-7: Amendments revised the Technical Specifications. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
May 25, 1994 (59 FR 27070) The Commission's related evaluation of the amendments is contained in a Safety Evaluation
dated July 28, 1994.
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Alderman Library, Special Collections Department, University of Virginia, Charlottesville, Virginia 22903-2498.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Virginia Electric and Power Company, Docket Nos. 50-280 and 50-281, Surry Power Station, Unit Nos. 1 and 2, Surry County,
Virginia.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendments: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
April 19, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendments: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
These amendments modify the surveillance frequency of the control rod motion testing from monthly to quarterly
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
August 2, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
August 2, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment Nos. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
192 and 192
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License Nos. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
DPR-32 and DPR-37: Amendments revised the Technical Specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
May 25, 1994 (59 FR 27070) The Commission's related evaluation of the amendment is contained in a Safety Evaluation
dated August 2, 1994
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Swem Library, College of William and Mary, Williamsburg, Virginia 23185
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Washington Public Power Supply System, Docket No. 50-397, Nuclear Project No. 2, Benton County, Washington
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
April 1, 1993
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendment modifies the Technical Specifications to add inservice inspection requirements for reactor coolant
system piping in accordance with Generic Letter 88-01, ``NRC Position on Intergranular Stress Corrosion Cracking
(IGSCC) in BWR Austenitic Stainless Steel Piping.'' In addition, the amendment corrects an administrative error
in a TS that references a table listing high/low pressure interface valve leakage pressure monitors.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
July 28, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
30 days after the date of issuance.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment No.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
130
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
NPF-21: The amendment revised the Technical Specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
May 12, 1993 (58 FR 28065) The Commission's related evaluation of the amendment is contained in a Safety Evaluation
dated July 28, 1994.
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Richland Public Library, 955 Northgate Street, Richland, Washington 99352
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Washington Public Power Supply System, Docket No. 50-397, Nuclear Project No. 2, Benton County, Washington
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
February 17, 1994, supplemented by letter dated May 13, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendment changes the Technical Specifications (TS) 10-year hydrostatic testing requirements. The changes
(1) add a special test exception for inservice leak testing and hydrostatic testing, (2) add a new minimum reactor
vessel metal pressure-temperature curve for less than or equal to eight effective full power years, and (3) delete
Table B 3/4.4.6-1, ``Reactor Vessel Toughness,'' from the TS bases.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
May 27, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
May 27, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment No.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
122
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
NPF-21: The amendment revised the Technical Specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
March 30, 1994 (59 FR 14902) The Commission's related evaluation of the amendment is contained in a Safety Evaluation
dated May 27, 1994.
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Richland Public Library, 955 Northgate Street, Richland, Washington 99352 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Wisconsin Public Service Corporation, Docket No. 50-305, Kewaunee Nuclear
<!-- PJG 0012 frnewline -->
Power Plant, Kewaunee County, Wisconsin
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
December 1, 1993
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendment revises the Kewaunee Nuclear Power Plant (KNPP) Technical Specifications (TS) by incorporating technical
and administrative changes to TS 3.10, Control Rod and Power Distribution Limits. The changes eliminate specifications
for fuel designs no longer used at Kewaunee, specify required actions to be taken upon exceeding control bank insertion
limits, and revise the limits for Departure from Nucleate Boiling (DNB) related parameters to assure operation within
the assumptions of the Updated Safety Analysis Report (USAR) analyses.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
August 3, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As of the date of issuance to be implemented within 30 days. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment No.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
110
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License No. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
DPR-43. Amendment revised the Technical Specifications.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of initial notice in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
February 2, 1994 (59 FR 4949) The Commission's related evaluation of the amendment is contained in a Safety Evaluation
dated August 3, 1994. 
<!-- PJG 0012 frnewline -->
No significant hazards consideration comments received: No.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
University of Wisconsin Library Learning Center, 2420 Nicolet Drive, Green Bay, Wisconsin 54301.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Notice Of Issuance Of Amendments To Facility Operating Licenses And Final Determination Of No Significant Hazards
Consideration And Opportunity For A Hearing (Exigent Public Announcement Or Emergency Circumstances)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
During the period since publication of the last biweekly notice, the Commission has issued the following amendments.
The Commission has determined for each of these amendments that the application for the amendment complies with the
standards and requirements of the Atomic Energy Act of 1954, as amended (the Act), and the Commission's rules and regulations.
The Commission has made appropriate findings as required by the Act and the Commission's rules and regulations in
10 CFR Chapter I, which are set forth in the license amendment. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Because of exigent or emergency circumstances associated with the date the amendment was needed, there was not time
for the Commission to publish, for public comment before issuance, its usual 30-day Notice of Consideration of Issuance
of Amendment, Proposed No Significant Hazards Consideration Determination, and Opportunity for a Hearing. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For exigent circumstances, the Commission has either issued a 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
notice providing opportunity for public comment or has used local media to provide notice to the public in the area
surrounding a licensee's facility of the licensee's application and of the Commission's proposed determination
of no significant hazards consideration. The Commission has provided a reasonable opportunity for the public to
comment, using its best efforts to make available to the public means of communication for the public to respond quickly,
and in the case of telephone comments, the comments have been recorded or transcribed as appropriate and the licensee
has been informed of the public comments.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In circumstances where failure to act in a timely way would have resulted, for example, in derating or shutdown of a
nuclear power plant or in prevention of either resumption of operation or of increase in power output up to the plant's
licensed power level, the Commission may not have had an opportunity to provide for public comment on its no significant
hazards consideration determination. In such case, the license amendment has been issued without opportunity for
comment. If there has been some time for public comment but less than 30 days, the Commission may provide an opportunity
for public comment. If comments have been requested, it is so stated. In either event, the State has been consulted
by telephone whenever possible.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Under its regulations, the Commission may issue and make an amendment immediately effective, notwithstanding the
pendency before it of a request for a hearing from any person, in advance of the holding and completion of any required
hearing, where it has determined that no significant hazards consideration is involved. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Commission has applied the standards of 10 CFR 50.92 and has made a final determination that the amendment involves
no significant hazards consideration. The basis for this determination is contained in the documents related to
this action. Accordingly, the amendments have been issued and made effective as indicated. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Unless otherwise indicated, the Commission has determined that these amendments satisfy the criteria for categorical
exclusion in accordance with 10 CFR 51.22. Therefore, pursuant to 10 CFR 51.22(b), no environmental impact statement
or environmental assessment need be prepared for these amendments. If the Commission has prepared an environmental
assessment under the special circumstances provision in 10 CFR 51.12(b) and has made a determination based on that
assessment, it is so indicated.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For further details with respect to the action see (1) the application for amendment, (2) the amendment to Facility
Operating License, and (3) the Commission's related letter, Safety Evaluation and/or Environmental Assessment,
as indicated. All of these items are available for public inspection at the Commission's Public Document Room, the
Gelman Building, 2120 L Street, NW., Washington, DC 20555, and at the local public document room for the particular
facility involved. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Commission is also offering an opportunity for a hearing with respect to the issuance of the amendment. By September
16, 1994, the licensee may file a request for a hearing with respect to issuance of the amendment to the subject facility
operating license and any person whose interest may be affected by this proceeding and who wishes to participate as
a party in the proceeding must file a written request for a hearing and a petition for leave to intervene. Requests for
a hearing and a petition for leave to intervene shall be filed in accordance with the Commission's ``Rules of Practice
for Domestic Licensing Proceedings'' in 10 CFR Part 2. Interested persons should consult a current copy of 10 CFR 2.714
which is available at the Commission's Public Document Room, the Gelman Building, 2120 L Street, NW., Washington,
DC 20555 and at the local public document room for the particular facility involved. If a request for a hearing or petition
for leave to intervene is filed by the above date, the Commission or an Atomic Safety and Licensing Board, designated
by the Commission or by the Chairman of the Atomic Safety and Licensing Board Panel, will rule on the request and/or
petition; and the Secretary or the designated Atomic Safety and Licensing Board will issue a notice of a hearing or
an appropriate order. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
As required by 10 CFR 2.714, a petition for leave to intervene shall set forth with particularity the interest of the
petitioner in the proceeding, and how that interest may be affected by the results of the proceeding. The petition
should specifically explain the reasons why intervention should be permitted with particular reference to the following
factors: (1) the nature of the petitioner's right under the Act to be made a party to the proceeding; (2) the nature and
extent of the petitioner's property, financial, or other interest in the proceeding; and (3) the possible effect
of any order which may be entered in the proceeding on the petitioner's interest. The petition should also identify
the specific aspect(s) of the subject matter of the proceeding as to which petitioner wishes to intervene. Any person
who has filed a petition for leave to intervene or who has been admitted as a party may amend the petition without requesting
leave of the Board up to 15 days prior to the first prehearing conference scheduled in the proceeding, but such an amended
petition must satisfy the specificity requirements described above.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Not later than 15 days prior to the first prehearing conference scheduled in the proceeding, a petitioner shall file
a supplement to the petition to intervene which must include a list of the contentions which are sought to be litigated
in the matter. Each contention must consist of a specific statement of the issue of law or fact to be raised or controverted.
In addition, the petitioner shall provide a brief explanation of the bases of the contention and a concise statement
of the alleged facts or expert opinion which support the contention and on which the petitioner intends to rely in proving
the contention at the hearing. The petitioner must also provide references to those specific sources and documents
of which the petitioner is aware and on which the petitioner intends to rely to establish those facts or expert opinion.
Petitioner must provide sufficient information to show that a genuine dispute exists with the applicant on a material
issue of law or fact. Contentions shall be limited to matters within the scope of the amendment under consideration.
The contention must be one which, if proven, would entitle the petitioner to relief. A petitioner who fails to file
such a supplement which satisfies these requirements with respect to at least one contention will not be permitted
to participate as a party. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Those permitted to intervene become parties to the proceeding, subject to any limitations in the order granting leave
to intervene, and have the opportunity to participate fully in the conduct of the hearing, including the opportunity
to present evidence and cross-examine witnesses. Since the Commission has made a final determination that the amendment
involves no significant hazards consideration, if a hearing is requested, it will not stay the effectiveness of the
amendment. Any hearing held would take place while the amendment is in effect. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A request for a hearing or a petition for leave to intervene must be filed with the Secretary of the Commission, U.S.
Nuclear Regulatory Commission, Washington, DC 20555, Attention: Docketing and Services Branch, or may be delivered
to the Commission's Public Document Room, the Gelman Building, 2120 L Street, NW., Washington, DC 20555, by the above
date. Where petitions are filed during the last 10 days of the notice period, it is requested that the petitioner promptly
so inform the Commission by a toll-free telephone call to Western Union at 1-(800) 248-5100 (in Missouri 1-(800) 342-6700).
The Western Union operator should be given Datagram Identification Number N1023 and the following message addressed
to 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
(Project Director)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
: petitioner's name and telephone number, date petition was mailed, plant name, and publication date and page number
of this 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
notice. A copy of the petition should also be sent to the Office of the General Counsel, U.S. Nuclear Regulatory Commission,
Washington, DC 20555, and to the attorney for the licensee. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Nontimely filings of petitions for leave to intervene, amended petitions, supplemental petitions and/or requests
for a hearing will not be entertained absent a determination by the Commission, the presiding officer or the Atomic
Safety and Licensing Board that the petition and/or request should be granted based upon a balancing of the factors
specified in 10 CFR 2.714(a)(1)(i)-(v) and 2.714(d).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Commonwealth Edison Company, Docket Nos. STN 50-454 and STN 50-455, Byron Station, Unit Nos. 1 and 2, Ogle County,
Illinois
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of application for amendments: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
August 2, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brief description of amendments: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendments revise the Technical Specifications by adding a footnote that recognizes that through the end of cycle
6, the Unit 1, loop B wide range hot leg indication at the remote shutdown panel is inoperable.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of issuance: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
August 5, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
August 5, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amendment Nos.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
63 and 63
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Facility Operating License Nos. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
NPF-37 and NPF-66. The amendments revised the Technical Specifications.
<!-- PJG 0012 frnewline -->
Public comments requested as to proposed no siginificant hazards consideration: No. 
<!-- PJG 0012 frnewline -->
The Commission's related evaluation of the amendments, finding of emergency circumstances, and final determination
of no significant hazards consideration are contained in a Safety Evaluation dated August 5, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Attorney for licensee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Michael I. Miller, Esquire; Sidley and Austin, One First National Plaza, Chicago, Illinois 60690
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Local Public Document Room location: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Byron Public Library, 109 N. Franklin, P.O. Box 434, Byron, Illinois 61010.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
NRC Project Director: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Robert A. Capra 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated at Rockville, Maryland, this 10th day of August 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For The Nuclear Regulatory Commission 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Steven A. Varga, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Director, Division of Reactor Projects - I/II 
<!-- PJG 0012 frnewline -->
Office of Nuclear Reactor Regulation
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[Doc. 94&hyph;20006 Filed 8-16-94 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 7590&hyph;01&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /STAG -->

<!-- PJG /FTAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00214 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG FTAG 4717 -->

<!-- PJG STAG 4717 -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Wednesday
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
August 17, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=1 -->
Part III
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=04 g=1 f=1 -->
Environmental Protection Agency
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=05 g=1 f=1 -->
Final Report: Principles of Neurotoxicity Risk Assessment; Notice
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->

<!-- PJG /FTAG -->

<!-- PJG FTAG 4701 -->

<!-- PJG STAG 4701 -->

<!-- PJG ITAG l=90 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=1 -->
&blank;/&blank;Vol. 59, No. 158&blank;/&blank;Wednesday, August 17, 1994&blank;/&blank;Notices 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<USDEPT>ENVIRONMENTAL PROTECTION AGENCY </USDEPT>

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[FRL&hyph;5050&hyph;9] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Final Report: Principles of Neurotoxicity Risk Assessment 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 U.S. Environmental Protection Agency.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Final Document.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The U.S. Environmental Protection Agency is publishing a document entitled 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=3 -->
Final Report: Principles of Neurotoxicity Risk Assessment
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
, which was prepared by the Working Party on Neurotoxicology under the auspices of the Subcommittee on Risk Assessment
of the Federal Coordinating Council for Science, Engineering, and Technology (FCCSET). The purpose of this report
is to articulate a view of neurotoxicology that scientists generally hold in common today and to draw on this understanding
to generate a series of general principles that can be used to establish guidelines for assessing neurotoxicity risk.
It is not the intent of this report to provide specific directives for how neurotoxicity risk assessment should be
performed. The intent of this document is to provide the scientific basis for the development of a cogent strategy
for neurotoxicity risk assessment. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This document is the result of the combined efforts of senior scientists of 13 Federal agencies comprising the ad hoc
Interagency Committee on Neurotoxicology, including the Agency for Toxic Substances and Disease Registry, Center
for Food Safety and Applied Nutrition, Center for Biologics Evaluation and Research, Center for Drug Evaluation
and Research, Consumer Product Safety Commission, Department of Agriculture, Department of Defense, Environmental
Protection Agency, National Center for Toxicological Research, National Institutes of Health, National Institute
for Occupational Safety and Health, and National Toxicology Program. Discussions were held under the auspices of
the Working Party on Neurotoxicology of the Subcommittee on Risk Assessment of the Federal Coordinating Council
for Science, Engineering, and Technology. The draft report, a product of the Working Party on Neurotoxicology, contains
six chapters: an introduction, an overview of the discipline of neurotoxicology, a review of methods for assessing
human neurotoxicity, a review of methods for assessing animal neurotoxicity, an overview of principles of neurotoxicity
risk assessment, and a general summary. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The draft report was prepared in view of the decision-making processes currently used by many regulatory agencies
relating to neurotoxicity risk assessment. It is intended that the principles reviewed in this document will serve
as the basis for consistent regulatory neurotoxicity guidelines to be used by Federal agencies to meet their respective
legislative mandates. This document is not meant to be used to perform risk assessment nor does it recommend one approach
or strategy. The document reviews the science of neurotoxicology and attempts to formulate general assumptions
and principles that could lead to such approaches or strategies. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The draft report has undergone interagency review under the auspices of the Subcommittee on Risk Assessment of FCCSET.
Public comments received were used in the preparation of the final report by the Working Party on Neurotoxicology.

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: August 9, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Ken Sexton, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Director, Office of Health Research. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<!-- PJG /STAG -->

<!-- PJG /FTAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00215 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Final Report: Principles of Neurotoxicology Risk Assessment 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
Contents 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
1. Introduction 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
1.1. Background 
<!-- PJG 0012 frnewline -->
1.2. Purpose of This Report 
<!-- PJG 0012 frnewline -->
1.3. Context of This Report 
<!-- PJG 0012 frnewline -->
1.4. Content of This Report 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
2. Overview of Neurotoxicology 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
2.1. Scope of the Problem 
<!-- PJG 0012 frnewline -->
2.1.1. Introduction 
<!-- PJG 0012 frnewline -->
2.1.2. Examples of Neurotoxicity and Incidents of Exposure 
<!-- PJG 0012 frnewline -->
2.1.3. Federal Response 
<!-- PJG 0012 frnewline -->
2.1.3.1. Food and Drug Administration 
<!-- PJG 0012 frnewline -->
2.1.3.2. Occupational Safety and Health Administration 
<!-- PJG 0012 frnewline -->
2.1.3.3. National Institute for Occupational Safety and Health 
<!-- PJG 0012 frnewline -->
2.1.3.4. Environmental Protection Agency 
<!-- PJG 0012 frnewline -->
2.1.3.5. Consumer Product Safety Commission 
<!-- PJG 0012 frnewline -->
2.1.3.6. Agency for Toxic Substances and Disease Registry 
<!-- PJG 0012 frnewline -->
2.2. Basic Toxicological Considerations for Neurotoxicity 
<!-- PJG 0012 frnewline -->
2.2.1. Basic Toxicological Principles 
<!-- PJG 0012 frnewline -->
2.2.2. Basic Neurotoxicological Principles 
<!-- PJG 0012 frnewline -->
2.3. Basic Neurobiological Principles 
<!-- PJG 0012 frnewline -->
2.3.1. Structure of the Nervous System 
<!-- PJG 0012 frnewline -->
2.3.2. Transport Processes 
<!-- PJG 0012 frnewline -->
2.3.3. Ionic Balance 
<!-- PJG 0012 frnewline -->
2.3.4. Neurotransmission 
<!-- PJG 0012 frnewline -->
2.4. Types of Effects on the Nervous System 
<!-- PJG 0012 frnewline -->
2.5. Special Considerations 
<!-- PJG 0012 frnewline -->
2.5.1. Susceptible Populations 
<!-- PJG 0012 frnewline -->
2.5.2. Blood-Brain and Blood-Nerve Barriers 
<!-- PJG 0012 frnewline -->
2.5.3. Metabolism 
<!-- PJG 0012 frnewline -->
2.5.4. Limited Regenerative Ability 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
3. Methods for Assessing Human Neurotoxicity 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
3.1. Introduction 
<!-- PJG 0012 frnewline -->
3.2. Clinical Evaluation 
<!-- PJG 0012 frnewline -->
3.2.1. Neurologic Evaluation 
<!-- PJG 0012 frnewline -->
3.2.2. Neuropsychological Testing 
<!-- PJG 0012 frnewline -->
3.2.3 Applicability of Clinical Methods to Neurotoxicology Risk Assessment 
<!-- PJG 0012 frnewline -->
3.3. Current Neurotoxicity Testing Methods 
<!-- PJG 0012 frnewline -->
3.3.1. Neurobehavioral Methods 
<!-- PJG 0012 frnewline -->
3.3.1.1. Test Batteries 
<!-- PJG 0012 frnewline -->
3.3.1.2. Investigator-Administered Test Batteries 
<!-- PJG 0012 frnewline -->
3.3.1.3. Computerized Test Batteries 
<!-- PJG 0012 frnewline -->
3.3.2. Neurophysiologic Methods 
<!-- PJG 0012 frnewline -->
3.3.3. Neurochemical Methods 
<!-- PJG 0012 frnewline -->
3.3.4. Imaging Techniques 
<!-- PJG 0012 frnewline -->
3.3.5. Neuropathologic Methods 
<!-- PJG 0012 frnewline -->
3.3.6. Self-Report Assessment Methods 
<!-- PJG 0012 frnewline -->
3.3.6.1. Mood Scales 
<!-- PJG 0012 frnewline -->
3.3.6.2. Personality Scales 
<!-- PJG 0012 frnewline -->
3.4. Approaches to Neurotoxicity Assessment 
<!-- PJG 0012 frnewline -->
3.4.1. Epidemiologic Studies 
<!-- PJG 0012 frnewline -->
3.4.1.1. Case Reports 
<!-- PJG 0012 frnewline -->
3.4.1.2. Cross-Sectional Studies 
<!-- PJG 0012 frnewline -->
3.4.1.3. Case-Control (Retrospective) Studies 
<!-- PJG 0012 frnewline -->
3.4.1.4. Prospective (Cohort, Followup) Studies 
<!-- PJG 0012 frnewline -->
3.4.2. Human Laboratory Exposure Studies 
<!-- PJG 0012 frnewline -->
3.4.2.1. Methodologic Aspects 
<!-- PJG 0012 frnewline -->
3.4.2.2. Human Subject Selection Factors 
<!-- PJG 0012 frnewline -->
3.4.2.3. Exposure Conditions and Chemical Classes 
<!-- PJG 0012 frnewline -->
3.4.2.4. Test Methods 
<!-- PJG 0012 frnewline -->
3.4.2.5. Controls 
<!-- PJG 0012 frnewline -->
3.4.2.6. Ethical Issues 
<!-- PJG 0012 frnewline -->
3.5. Assessment of Developmental Neurotoxicity 
<!-- PJG 0012 frnewline -->
3.5.1. Developmental Deficits 
<!-- PJG 0012 frnewline -->
3.5.2. Methodologic Considerations 
<!-- PJG 0012 frnewline -->
3.6. Issues in Human Neurotoxicology Test Methods 
<!-- PJG 0012 frnewline -->
3.6.1. Risk Assessment Criteria for Neurobehavioral Test Methods 
<!-- PJG 0012 frnewline -->
3.6.1.1. Sensitivity 
<!-- PJG 0012 frnewline -->
3.6.1.2. Specificity 
<!-- PJG 0012 frnewline -->
3.6.1.3. Reliability and Validity 
<!-- PJG 0012 frnewline -->
3.6.1.4. Dose Response 
<!-- PJG 0012 frnewline -->
3.6.1.5. Structure-Activity 
<!-- PJG 0012 frnewline -->
3.6.2. Other Considerations in Risk Assessment 
<!-- PJG 0012 frnewline -->
3.6.2.1. Mechanisms of Action 
<!-- PJG 0012 frnewline -->
3.6.2.2. Exposure Duration 
<!-- PJG 0012 frnewline -->
3.6.2.3. Time-Dependent Effects 
<!-- PJG 0012 frnewline -->
3.6.2.4. Multiple Exposures 
<!-- PJG 0012 frnewline -->
3.6.2.5. Generalizability and Individual Differences 
<!-- PJG 0012 frnewline -->
3.6.2.6. Veracity of Neurobehavioral Test Results 
<!-- PJG 0012 frnewline -->
3.6.3. Cross-Species Extrapolation 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
4. Methods to Assess Animal Neurotoxicity 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
4.1. Introduction 
<!-- PJG 0012 frnewline -->
4.1.1. Role of Animal Models 
<!-- PJG 0012 frnewline -->
4.1.2. Validity of Animal Models 
<!-- PJG 0012 frnewline -->
4.1.3. Special Considerations in Animal Models 
<!-- PJG 0012 frnewline -->
4.1.3.1. Susceptible Populations 
<!-- PJG 0012 frnewline -->
4.1.3.2. Dosing Scenario 
<!-- PJG 0012 frnewline -->
4.1.3.3. Other Factors 
<!-- PJG 0012 frnewline -->
4.1.3.4. Statistical Considerations 
<!-- PJG 0012 frnewline -->
4.2. Tiered Testing in Neurotoxicology 
<!-- PJG 0012 frnewline -->
4.2.1. Type of Test 
<!-- PJG 0012 frnewline -->
4.2.2. Dosing Regimen 
<!-- PJG 0012 frnewline -->
4.3. Endpoints of Neurotoxicity 
<!-- PJG 0012 frnewline -->
4.3.1. Introduction 
<!-- PJG 0012 frnewline -->
4.3.2. Behavioral Endpoints 
<!-- PJG 0012 frnewline -->
4.3.2.1. Functional Observational Batteries 
<!-- PJG 0012 frnewline -->
4.3.2.2. Motor Activity 
<!-- PJG 0012 frnewline -->
4.3.2.3. Neuromotor Function 
<!-- PJG 0012 frnewline -->
4.3.2.4. Sensory Function 
<!-- PJG 0012 frnewline -->
4.3.2.5. Learning and Memory 
<!-- PJG 0012 frnewline -->
4.3.2.6. Schedule-Controlled Behavior 
<!-- PJG 0012 frnewline -->
4.3.3. Neurophysiological Endpoints of Neurotoxicity 
<!-- PJG 0012 frnewline -->
4.3.3.1. Nerve Conduction Studies 
<!-- PJG 0012 frnewline -->
4.3.3.2. Sensory Evoked Potentials 
<!-- PJG 0012 frnewline -->
4.3.3.3. Convulsions 
<!-- PJG 0012 frnewline -->
4.3.3.4. Electroencephalography 
<!-- PJG 0012 frnewline -->
4.3.3.5. Electromyography 
<!-- PJG 0012 frnewline -->
4.3.3.6. Spinal Reflex Excitability 
<!-- PJG 0012 frnewline -->
4.3.4. Neurochemical Endpoints of Neurotoxicity 
<!-- PJG 0012 frnewline -->
4.3.5. Structural Endpoints of Neurotoxicity 
<!-- PJG 0012 frnewline -->
4.3.6. Developmental Neurotoxicity 
<!-- PJG 0012 frnewline -->
4.3.7. Physiological and Neuroendocrine Endpoints 
<!-- PJG 0012 frnewline -->
4.3.8. Other Considerations 
<!-- PJG 0012 frnewline -->
4.3.8.1. Structure-Activity Relationship 
<!-- PJG 0012 frnewline -->
4.3.8.2. In Vitro Methods 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
5. Neurotoxicology Risk Assessment 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
5.1. Introduction 
<!-- PJG 0012 frnewline -->
5.2. The Risk Assessment Process 
<!-- PJG 0012 frnewline -->
5.2.1. Hazard Identification 
<!-- PJG 0012 frnewline -->
5.2.1.1. Human Studies 
<!-- PJG 0012 frnewline -->
5.2.1.2. Animal Studies 
<!-- PJG 0012 frnewline -->
5.2.1.3. Special Issues 
<!-- PJG 0012 frnewline -->
5.2.2. Dose-Response Assessment 
<!-- PJG 0012 frnewline -->
5.2.3. Exposure Assessment 
<!-- PJG 0012 frnewline -->
5.2.4. Risk Characterization 
<!-- PJG 0012 frnewline -->
5.3. Generic Assumptions and Uncertainty Reduction 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
6. General Summary 
<!-- PJG 0012 frnewline -->
7. References
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
Tables 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
1&hyph;1. Major Regulatory Agencies 
<!-- PJG 0012 frnewline -->
1&hyph;2. Authorities for Toxicity Testing 
<!-- PJG 0012 frnewline -->
2&hyph;1. Human Neurotoxic Exposures 
<!-- PJG 0012 frnewline -->
3&hyph;1. Neurobehavioral Methods 
<!-- PJG 0012 frnewline -->
4&hyph;1. Examples of Potential Endpoints of Neurotoxicity 
<!-- PJG 0012 frnewline -->
4&hyph;2. Examples of Specialized Tests to Measure Neurotoxicity 
<!-- PJG 0012 frnewline -->
4&hyph;3. Summary of Measures in the Functional Observational Battery and the Type of Data Produced by Each 
<!-- PJG 0012 frnewline -->
4&hyph;4. Neurotoxicants With Known Neurochemical Mechanisms 
<!-- PJG 0012 frnewline -->
4&hyph;5. Examples of Known Neuropathic Agents 
<!-- PJG 0012 frnewline -->
4&hyph;6. Partial List of Agents Believed to Have Developmental Neurotoxicity 
<!-- PJG 0012 frnewline -->
5&hyph;1. General Assumptions That Underlie Traditional Risk Assessments 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00216 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
1. Introduction
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
1.1. Background 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Over the years, agencies and programs have been established to deal with hazardous 
<!-- PJG 0012 frnewline -->
substances, with a focus on deleterious long-term effects, including noncancer endpoints such 
<!-- PJG 0012 frnewline -->
as neurotoxicity (Reiter, 1987). Recent evidence indicates that exposure to neurotoxic agents 
<!-- PJG 0012 frnewline -->
may constitute a significant health problem (WHO, 1986; OTA, 1990; chapter 2). Table 1&hyph;1 
<!-- PJG 0012 frnewline -->
lists the four Federal regulatory agencies with authority to regulate either exposure to or use 
<!-- PJG 0012 frnewline -->
of chemicals and that require data reporting on assessment of hazards. Regulatory bodies 
<!-- PJG 0012 frnewline -->
vary greatly in their mandate to require approval of chemicals prior to entering the 
<!-- PJG 0012 frnewline -->
marketplace and to regulate subsequent exposure (Fisher, 1980) (Table 1&hyph;2). The 
<!-- PJG 0012 frnewline -->
Occupational Safety and Health Administration (OSHA) cannot require chemical testing by 
<!-- PJG 0012 frnewline -->
the manufacturer whereas all other agencies can. Only the Food and Drug Administration 
<!-- PJG 0012 frnewline -->
(FDA) and the Environmental Protection Agency (EPA) have authority for premarketing 
<!-- PJG 0012 frnewline -->
testing of chemicals (i.e., FDA for drugs and food additives and EPA for pesticides). EPA 
<!-- PJG 0012 frnewline -->
can, under some circumstances, require premarket testing of industrial and agricultural 
<!-- PJG 0012 frnewline -->
chemicals. The Consumer Product Safety Commission (CPSC) regulates a number of 
<!-- PJG 0012 frnewline -->
consumer products including household chemicals and fabric treatments. Laws administered 
<!-- PJG 0012 frnewline -->
by CPSC require cautionary labeling on all hazardous household products whether the hazard 
<!-- PJG 0012 frnewline -->
is based on acute or chronic effects. These laws also provide the authority to ban hazardous 
<!-- PJG 0012 frnewline -->
products and to ask for data in support of product labeling.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 2,L2,i1,s100,r100 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Table 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=1 -->
1&hyph;1._
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Major Regulatory Agencies 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Agency 
<!-- PJG 007 0150 intable -->
1Statute and sources covered
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=4 -->
Food and Drug Administration (FDA) 
<!-- PJG 007 0104 intable -->
Food, Drug, and Cosmetics Act for food 
<!-- PJG 0012 frnewline -->
additives; color in cosmetics; medical devices; 
<!-- PJG 0012 frnewline -->
animal drugs of medical and feed additives.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A unit of the Department of Health and 
<!-- PJG 0012 frnewline -->
Human Services with authority over the 
<!-- PJG 0012 frnewline -->
regulation of medical and veterinary drugs; 
<!-- PJG 0012 frnewline -->
foods and food additives; cosmetics 
<!-- PJG 007 0104 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Occupational Safety and Health Administration 
<!-- PJG 0012 frnewline -->
(OSHA) 
<!-- PJG 007 0104 intable -->
Occupational Safety and Health Act covers 
<!-- PJG 0012 frnewline -->
toxic chemicals in the workplace. 
<!-- PJG 0012 frnewline -->
A unit of the Department of Labor that 
<!-- PJG 0012 frnewline -->
regulates workplace conditions 
<!-- PJG 007 0104 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Environmental Protection Agency (EPA)
<!-- PJG 0012 frnewline -->
Independent agency (i.e., not part of a Cabinet 
<!-- PJG 0012 frnewline -->
department); administers a number of diverse 
<!-- PJG 0012 frnewline -->
laws concerned with human health and the 
<!-- PJG 0012 frnewline -->
environment
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Toxic Substances Control Act requires 
<!-- PJG 0012 frnewline -->
premanufacture evaluation of all new 
<!-- PJG 0012 frnewline -->
chemicals (other than foods, food additives, 
<!-- PJG 0012 frnewline -->
drugs, pesticides, alcohol, tobacco); allows 
<!-- PJG 0012 frnewline -->
EPA to regulate existing chemical hazards not 
<!-- PJG 0012 frnewline -->
sufficiently controlled under other laws. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=4 -->
&blank; 
<!-- PJG 007 0104 intable -->
Clean Air Act requires regulation of hazardous 
<!-- PJG 0012 frnewline -->
air pollutants. 
<!-- PJG 0012 frnewline -->
&blank; 
<!-- PJG 007 0104 intable -->
Federal Water Pollution Control Act 
<!-- PJG 0012 frnewline -->
governs toxic water pollutants.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&blank; 
<!-- PJG 007 0104 intable -->
Safe Drinking Water Act covers drinking 
<!-- PJG 0012 frnewline -->
water contaminants. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&blank; 
<!-- PJG 007 0104 intable -->
Federal Insecticide, Fungicide, and 
<!-- PJG 0012 frnewline -->
Rodenticide Act covers pesticides.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&blank; 
<!-- PJG 007 0104 intable -->
Resource Conservation and Recovery Act 
<!-- PJG 0012 frnewline -->
covers hazardous wastes.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&blank; 
<!-- PJG 007 0104 intable -->
Marine Protection Research and Sanctuaries 
<!-- PJG 0012 frnewline -->
Act covers ocean dumping.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=4 -->
Consumer Product Safety Commission (CPSC) 
<!-- PJG 0012 frnewline -->
Regulates a variety of consumer products 
<!-- PJG 0012 frnewline -->
including household chemicals and fabric 
<!-- PJG 0012 frnewline -->
treatments 
<!-- PJG 007 0104 intable -->
Federal Hazardous Substances Act covers 
<!-- PJG 0012 frnewline -->
``toxic'' household products.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0120 intable -->
Consumer Product Safety Act covers 
<!-- PJG 0012 frnewline -->
 dangerous consumer products.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=4 -->
&blank; 
<!-- PJG 007 0104 intable -->
Poison Prevention Packaging Act covers 
<!-- PJG 0012 frnewline -->
packaging of dangerous children's products. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&blank; 
<!-- PJG 007 0104 intable -->
Lead-Based Paint Poison Prevention 
<!-- PJG 0012 frnewline -->
Act covers use of lead paint in federally 
<!-- PJG 0012 frnewline -->
assisted housing.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00217 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<TABLE>

<!-- PJG tableformat 6,L2,i1,s30,r50,r30,xls60C,xls60C,xls60C -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Table 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=1 -->
1&hyph;2._
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Authorities for Toxicity Testing 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Agency 
<!-- PJG 007 0150 intable -->
1Law 
<!-- PJG 007 0150 intable -->
1Coverage 
<!-- PJG 007 0150 intable -->
1Authorities 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
2Premarketing approval 
<!-- PJG 007 0150 intable -->
2Testing by manufacturer 
<!-- PJG 007 0150 intable -->
2Reporting of data
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=4 -->
FDA 
<!-- PJG 007 0104 intable -->
Food, Drug, and Cosmetics Act 
<!-- PJG 007 0104 intable -->
Drugs and foods 
<!-- PJG 007 0104 intable -->
x 
<!-- PJG 007 0104 intable -->
x 
<!-- PJG 007 0104 intable -->
x
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=4 -->
&blank; 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l 
<!-- PJG 007 0104 intable -->
Food additives and cosmetics 
<!-- PJG 007 0104 intable -->
x 
<!-- PJG 007 0104 intable -->
x 
<!-- PJG 007 0104 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=4 -->
EPA 
<!-- PJG 007 0104 intable -->
Federal Insecticide, Fungicide, and Rodenticide Act 
<!-- PJG 007 0104 intable -->
Pesticides 
<!-- PJG 007 0104 intable -->
x 
<!-- PJG 007 0104 intable -->
x 
<!-- PJG 007 0104 intable -->
x
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=4 -->
&blank; 
<!-- PJG 007 0104 intable -->
Toxic Substances Control Act 
<!-- PJG 007 0104 intable -->
Industrial chemicals 
<!-- PJG 007 0104 intable -->
1x 
<!-- PJG 007 0104 intable -->
x 
<!-- PJG 007 0104 intable -->
x
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&blank; 
<!-- PJG 007 0104 intable -->
Clean Air Act 
<!-- PJG 007 0104 intable -->
Air pollutants 
<!-- PJG 007 0104 intable -->
 
<!-- PJG 007 0104 intable -->
 
<!-- PJG 007 0104 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&blank; 
<!-- PJG 007 0104 intable -->
Resource Conservation and Recovery Act 
<!-- PJG 007 0104 intable -->
Industrial waste 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
x 
<!-- PJG 007 0104 intable -->
x
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=4 -->
OSHA 
<!-- PJG 007 0104 intable -->
Occupational Safety and Health Act 
<!-- PJG 007 0104 intable -->
Occupational exposure 
<!-- PJG 007 0104 intable -->
 
<!-- PJG 007 0104 intable -->
 
<!-- PJG 007 0104 intable -->
x
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
CPSC 
<!-- PJG 007 0104 intable -->
Federal Hazardous Substances Act 
<!-- PJG 007 0104 intable -->
Consumer products 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
x 
<!-- PJG 007 0104 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=4 -->
&blank; 
<!-- PJG 007 0104 intable -->
Consumer Product Safety Act 
<!-- PJG 007 0104 intable -->
Consumer products 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
x
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->
1Can require testing based on available data.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00218 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=83 g=1 f=4 -->
1.2. Purpose of This Report 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
The purpose of this document is to: (1) articulate a view of neurotoxicity that 
<!-- PJG 0012 frnewline -->
scientists generally hold in common today and (2) draw upon this understanding to compose, 
<!-- PJG 0012 frnewline -->
as was done here by senior scientists from a number of Federal agencies, a series of general 
<!-- PJG 0012 frnewline -->
principles that can be used to establish general guidelines for assessing neurotoxicity risk. It 
<!-- PJG 0012 frnewline -->
is not the intent of this report to provide specific directives to agencies with respect to their 
<!-- PJG 0012 frnewline -->
own approach for neurotoxicity risk assessment. This document is intended to provide the 
<!-- PJG 0012 frnewline -->
scientific basis for the development of a cogent strategy for neurotoxicology risk assessment 
<!-- PJG 0012 frnewline -->
as needed by each agency. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Because of present gaps in understanding, the principles contained in this document 
<!-- PJG 0012 frnewline -->
are based on the best judgment of those involved in writing this document, as well as 
<!-- PJG 0012 frnewline -->
statements of what is generally accepted as fact. There has been, however, an attempt to 
<!-- PJG 0012 frnewline -->
distinguish where possible between the different types of information presented. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The principles contained in this document can serve as the basis for consistent 
<!-- PJG 0012 frnewline -->
regulatory neurotoxicology guidelines that the Federal agencies can tailor to meet the 
<!-- PJG 0012 frnewline -->
requirements of the legislative acts they are charged to implement. This document should be 
<!-- PJG 0012 frnewline -->
viewed broadly as part of an ongoing process within the Federal Government to periodically 
<!-- PJG 0012 frnewline -->
update and review the current scientific understanding and regulatory utility of neurotoxicity 
<!-- PJG 0012 frnewline -->
risk assessment. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
This document is the result of the combined efforts of senior scientists from the 
<!-- PJG 0012 frnewline -->
following Federal health-related units, operating under the direction of the Office of Science 
<!-- PJG 0012 frnewline -->
and Technology Policy (OSTP): 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=4 -->
Agency for Toxic Substances and Disease Registry (ATSDR) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Center for Biologics Evaluation and Research (CBER), FDA 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Center for Drug Evaluation and Research (CDER), FDA 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Center for Food Safety and Applied Nutrition (CFSAN), FDA 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Consumer Product Safety Commission 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Department of Agriculture (USDA) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Department of Defense (DoD) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Environmental Protection Agency 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
National Center for Toxicological Research (NCTR), FDA 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
National Institutes of Health (NIH) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
National Institute for Occupational Safety and Health 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
National Toxicology Program (NTP) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=4 -->
1.3. Context of This Report 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
This document was prepared in light of a decision-making process used by many 
<!-- PJG 0012 frnewline -->
regulatory agencies pertaining to the assessment of neurotoxicity risks posed by chemical 
<!-- PJG 0012 frnewline -->
agents. The scientific basis for such assessment can be best understood by examining the 
<!-- PJG 0012 frnewline -->
decision-making process in some detail. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Risk can be thought of as being composed of two aspects, each of which can be 
<!-- PJG 0012 frnewline -->
addressed by science, i.e., hazard and exposure assessment. Although other definitions have 
<!-- PJG 0012 frnewline -->
been used historically, this document conforms to present usage. Hazard generally refers to 
<!-- PJG 0012 frnewline -->
the toxicity of a substance and is deduced from a wide array of data, including those from 
<!-- PJG 0012 frnewline -->
epidemiological studies or controlled clinical trials in humans, short- and long-term 
<!-- PJG 0012 frnewline -->
toxicological studies in animals, and studies of mechanistic information and structure-activity 
<!-- PJG 0012 frnewline -->
relationships. Exposure generally refers to the amount of a substance with which people 
<!-- PJG 0012 frnewline -->
come in contact. The risk in a quantitative risk assessment is estimated by considering the 
<!-- PJG 0012 frnewline -->
results of the exposure and hazard assessments. As either the hazard or exposure approaches 
<!-- PJG 0012 frnewline -->
zero, the risk also approaches zero. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
As a first step in assessing the neurotoxic risk associated with the use of a particular 
<!-- PJG 0012 frnewline -->
chemical substance, the qualitative evidence that a given chemical substance is likely to be a 
<!-- PJG 0012 frnewline -->
human neurotoxicant must be evaluated. In this step, as in the whole process, a number of 
<!-- PJG 0012 frnewline -->
assumptions and approximations must be made in order to deal with inherent limitations 
<!-- PJG 0012 frnewline -->
found in the existing data bases. Then, estimates of human exposure and distribution of 
<!-- PJG 0012 frnewline -->
exposures likely to be encountered in the population are made. In the absence of dose-
<!-- PJG 0012 frnewline -->
response relationships in humans, one or more methods for estimating the dose-response 
<!-- PJG 0012 frnewline -->
relationship including doses below those generally used experimentally must also be 
<!-- PJG 0012 frnewline -->
evaluated. Finally, the exposure assessment is combined with the dose-response relationship 
<!-- PJG 0012 frnewline -->
to generate an estimate of risk. The various ways in which these steps are conducted and 
<!-- PJG 0012 frnewline -->
combined and their attendant uncertainties constitute what is generally referred to as 
<!-- PJG 0012 frnewline -->
``neurotoxicity risk assessment.'' 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Some legislation calls for action in the presence of any risk. Other forms of 
<!-- PJG 0012 frnewline -->
legislation use the concept of unreasonable risk, defined in some acts as a condition in which 
<!-- PJG 0012 frnewline -->
the risks outweigh the benefits. A spectrum of regulatory responses, from simply informing 
<!-- PJG 0012 frnewline -->
the public of a risk through restricted use to a complete ban, may be available to bring the 
<!-- PJG 0012 frnewline -->
risks and benefits into appropriate balance. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
This document does not perform a risk assessment nor does it suggest that one 
<!-- PJG 0012 frnewline -->
method of neurotoxicology risk assessment is better than another. Rather, it attempts to 
<!-- PJG 0012 frnewline -->
review the science of chemical neurotoxicology and develops from this review a set of 
<!-- PJG 0012 frnewline -->
general principles. It is not a comprehensive review nor a document written for the lay 
<!-- PJG 0012 frnewline -->
public; this document is a semitechnical review that evaluates the impact of scientific findings 
<!-- PJG 0012 frnewline -->
of the last decade on general assumptions or principles important to risk assessment. This is 
<!-- PJG 0012 frnewline -->
based on the belief that elucidation of the basic mechanisms underlying neurotoxicity and the 
<!-- PJG 0012 frnewline -->
identification of neurotoxic agents and conditions, when coupled to research aimed at 
<!-- PJG 0012 frnewline -->
identifying and characterizing the problems caused by such agents, should provide the best 
<!-- PJG 0012 frnewline -->
scientific bases for making sound and reasonable judgments. These overlapping approaches 
<!-- PJG 0012 frnewline -->
to evaluating the problems of neurotoxicology should form a strong foundation for decision-making. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=4 -->
1.4. Content of This Report 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Including the Introduction (chapter 1), this document contains six chapters. Chapter 2 
<!-- PJG 0012 frnewline -->
provides an overview of the discipline of neurotoxicology. It is important to understand the 
<!-- PJG 0012 frnewline -->
scope of the problem as it relates to neurotoxicology, including: (1) Definitions of 
<!-- PJG 0012 frnewline -->
neurotoxicity and adverse effect, (2) examples of neurotoxicity and incidents of exposure, 
<!-- PJG 0012 frnewline -->
and (3) Federal response to neurotoxicology. Chapter 2 also discusses the basic principles of 
<!-- PJG 0012 frnewline -->
toxicology that apply generally to the evaluation of neurotoxicity. Issues such as dose, 
<!-- PJG 0012 frnewline -->
exposure, target site, and the intended use of the chemical are discussed, as are principles of 
<!-- PJG 0012 frnewline -->
pharmacodynamics, chemical interactions, and the concept of threshold. Chapter 2 also lays 
<!-- PJG 0012 frnewline -->
the neurobiological basis for understanding how and where chemicals can affect the nervous 
<!-- PJG 0012 frnewline -->
system and provides examples of such chemical types. Finally, chapter 2 discusses special 
<!-- PJG 0012 frnewline -->
considerations for neurotoxicology including the issue of susceptible populations, the blood 
<!-- PJG 0012 frnewline -->
brain barrier, and the limited capability of the nervous system to repair following chemical 
<!-- PJG 0012 frnewline -->
insult. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Chapter 3 examines methods for assessing human neurotoxicity. Neurologic 
<!-- PJG 0012 frnewline -->
evaluations, neuropsychological testing, and applicability of methods used in clinical 
<!-- PJG 0012 frnewline -->
evaluations and case studies are discussed in this chapter. Epidemiologic study designs, 
<!-- PJG 0012 frnewline -->
endpoints, and methods are also discussed, as well as problems of causal inference and 
<!-- PJG 0012 frnewline -->
applications and limitations of epidemiologic and field study methods for risk assessment. 
<!-- PJG 0012 frnewline -->
Chapter 3 also describes human laboratory exposure studies, including methods for assessing 
<!-- PJG 0012 frnewline -->
neurobehavioral function, self-report methods for assessing subjective states, and a number of 
<!-- PJG 0012 frnewline -->
other methodological issues. This chapter also discusses the comparability of human and 
<!-- PJG 0012 frnewline -->
animal laboratory methods and special considerations in human neurotoxicity assessments. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Chapter 4 assesses methods for evaluating animal neurotoxicity. Discussed in this 
<!-- PJG 0012 frnewline -->
chapter is the role that animal models play in the assessment of chemicals for neurotoxicity, 
<!-- PJG 0012 frnewline -->
the validity of animal models, and experimental design considerations in animal 
<!-- PJG 0012 frnewline -->
neurotoxicological studies. Also included in this chapter is a discussion of tier-testing 
<!-- PJG 0012 frnewline -->
approaches in chemical evaluations. Specific endpoints used in animal neurotoxicological 
<!-- PJG 0012 frnewline -->
studies are also discussed, including methods for neurobehavioral, neurophysiological, 
<!-- PJG 0012 frnewline -->
neuroanatomical, and neurochemical assessments. Developmental neurotoxicology and in 
<!-- PJG 0012 frnewline -->
vitro neurotoxicology are also described in this chapter. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Chapter 5 of this document discusses principles of neurotoxicity risk assessment. 
<!-- PJG 0012 frnewline -->
This chapter evaluates the generic assumptions in neurotoxicity risk assessment, ending with 
<!-- PJG 0012 frnewline -->
a discussion of uncertainty reduction and identification of knowledge gaps. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Chapter 6 is a general summary of the material presented in the first five chapters.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00219 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=4 -->
2. Overview of Neurotoxicology 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=4 -->
2.1. Scope of the Problem 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=4 -->
2.1.1. Introduction 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Chemicals are an integral part of our lives, with the capacity to both improve as well 
<!-- PJG 0012 frnewline -->
as endanger our health. The general population is exposed to chemicals with neurotoxic 
<!-- PJG 0012 frnewline -->
properties in air, water, foods, cosmetics, household products, and drugs used therapeutically 
<!-- PJG 0012 frnewline -->
or illicitly. Naturally occurring neurotoxins, such as fish and plant toxins, present other 
<!-- PJG 0012 frnewline -->
hazards. During the daily life of an ordinary person, there is a multitude of exposures, both 
<!-- PJG 0012 frnewline -->
voluntary and unintentional, to neuroactive substances. Under conditions of multiple 
<!-- PJG 0012 frnewline -->
exposures, identifying the substance responsible for an adverse response may be difficult. 
<!-- PJG 0012 frnewline -->
The EPA's inventory of toxic chemicals is greater than 65,000 and increasing yearly. 
<!-- PJG 0012 frnewline -->
Concerns have been raised about the toxicological data available for many compounds used 
<!-- PJG 0012 frnewline -->
commercially (NRC, 1984). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
It is not known how many chemicals are neurotoxic to humans. However, estimates 
<!-- PJG 0012 frnewline -->
have been made for subsets of substances. A large percentage of the more than 500 
<!-- PJG 0012 frnewline -->
registered active pesticide ingredients are neurotoxic to varying degrees. Of 588 chemicals 
<!-- PJG 0012 frnewline -->
listed by the American Conference of Government and Industrial Hygienists (ACGIH), 167 
<!-- PJG 0012 frnewline -->
affected the nervous system or behavior (Anger, 1984; CDC, 1986). Using a generally 
<!-- PJG 0012 frnewline -->
broad definition of neurotoxicity, Anger (1990a) estimated that of the approximately 200 
<!-- PJG 0012 frnewline -->
chemicals to which 1 million or more American workers are exposed, more than one-third 
<!-- PJG 0012 frnewline -->
may have adverse effects on the nervous system at some level of exposure. Anger (1984) 
<!-- PJG 0012 frnewline -->
also recognized neurotoxic effects as one of the ten leading workplace disorders. In addition, 
<!-- PJG 0012 frnewline -->
a number of therapeutic substances, including some anticancer and antiviral agents and 
<!-- PJG 0012 frnewline -->
abused drugs, can cause adverse or neurotoxicological side effects (OTA, 1990). It has been 
<!-- PJG 0012 frnewline -->
estimated that there is inadequate toxicological information available for more than three-
<!-- PJG 0012 frnewline -->
fourths of the 12,860 chemicals with a production volume of 1 million pounds or more 
<!-- PJG 0012 frnewline -->
(NRC, 1984). It should be noted, however, that estimates concerning the number of 
<!-- PJG 0012 frnewline -->
neurotoxicants vary widely. O'Donoghue (1989), for example, reported that of 488 
<!-- PJG 0012 frnewline -->
compounds assessed in his chemical evaluation process, only 2.7% had effects on the 
<!-- PJG 0012 frnewline -->
nervous sytem. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=4 -->
2.1.2. Examples of Neurotoxicity and Incidents of Exposure 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
There is a long-standing history associating certain neurological and psychiatric 
<!-- PJG 0012 frnewline -->
disorders to exposure to a toxin or chemical of an environmental origin (OTA, 1990) (Table 
<!-- PJG 0012 frnewline -->
2&hyph;1). Lead is one of the earliest examples of a neurotoxic chemical with widespread 
<!-- PJG 0012 frnewline -->
exposure. This metal is widely distributed with major sources of inorganic lead including 
<!-- PJG 0012 frnewline -->
industrial emissions, lead-based paints, food, beverages, and the burning of leaded gasolines. 
<!-- PJG 0012 frnewline -->
Organic lead compounds such as tetraethyl lead have been reported to produce a toxic 
<!-- PJG 0012 frnewline -->
psychosis (Cassells and Dodds, 1946). If exposure occurs at relatively low levels during 
<!-- PJG 0012 frnewline -->
development, lead can cause a variety of neurobehavioral problems, learning disorders, and 
<!-- PJG 0012 frnewline -->
altered mental development (Bellinger et al., 1987; Needleman, 1990). Over the years, 
<!-- PJG 0012 frnewline -->
Federal Government regulations have been developed to decrease human exposure to lead, 
<!-- PJG 0012 frnewline -->
and as a goal an intervention level of 10 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
g/dcl whole blood has been recommended (CDC, 
<!-- PJG 0012 frnewline -->
1991). Lead exposure in the United States has decreased significantly during the last several years.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00220 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<TABLE>

<!-- PJG tableformat 4,L2,i1,s20,r35,r35,r100  -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Table 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=1 -->
2&hyph;1._
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Human Neurotoxic Exposures 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Year(s) 
<!-- PJG 007 0150 intable -->
1Location 
<!-- PJG 007 0150 intable -->
1Substance 
<!-- PJG 007 0150 intable -->
1Comments 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0152 intable -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=4 -->
370 B.C. 
<!-- PJG 007 0104 intable -->
Greece 
<!-- PJG 007 0104 intable -->
Lead 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Lead toxicity recognized in mining industry. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1st century A.D 
<!-- PJG 007 0104 intable -->
Rome 
<!-- PJG 007 0104 intable -->
Lead 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Vapors recognized as toxic. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1837 
<!-- PJG 007 0104 intable -->
Scotland 
<!-- PJG 007 0104 intable -->
Manganese 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Chronic manganese poisoning described. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1924 
<!-- PJG 007 0104 intable -->
United States (New Jersey) 
<!-- PJG 007 0104 intable -->
Tetraethyl lead 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Workers suffer neurologic symptoms. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1930 
<!-- PJG 007 0104 intable -->
United States (Southeast) 
<!-- PJG 007 0104 intable -->
Tri-o-cresylphosphate (TOCP) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Chemical contaminant added to Ginger Jake, an alcoholic beverage substitute; more than 5,000 paralyzed, 20,000
to 100,000 affected. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1930's 
<!-- PJG 007 0104 intable -->
Europe 
<!-- PJG 007 0104 intable -->
Apiol 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Drug containing TOCP causes 60 cases of neuropathy. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1932 
<!-- PJG 007 0104 intable -->
United States (California) 
<!-- PJG 007 0104 intable -->
Thallium 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Contaminated barley laced with thallium sulfate poisons family, causing neurologic symptoms. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1937 
<!-- PJG 007 0104 intable -->
South Africa 
<!-- PJG 007 0104 intable -->
TOCP 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Paralysis develops after use of contaminated cooking oil. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1946 
<!-- PJG 007 0104 intable -->
England 
<!-- PJG 007 0104 intable -->
Tetraethyl lead 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Neurologic effects observed in people cleaning gasoline tanks. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1950's 
<!-- PJG 007 0104 intable -->
Japan (Mina- 
<!-- PJG 007 0120 intable -->
&blank;mata) 
<!-- PJG 007 0104 intable -->
Methylmercury 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Fish and shellfish contaminated with mercury are ingested, causing neurotoxicity. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1950's 
<!-- PJG 007 0104 intable -->
France 
<!-- PJG 007 0104 intable -->
Organotin 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Medication (Stalinon) containing diethyltin diiodide results in poisoning. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1950's 
<!-- PJG 007 0104 intable -->
Morocco 
<!-- PJG 007 0104 intable -->
Manganese 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Miners suffer chronic manganese intoxication. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1950's 
<!-- PJG 007 0104 intable -->
Guam 
<!-- PJG 007 0104 intable -->
Cycad 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Ingestion of plants associated with amyortrophic lateral sclerosis and Parkinson-like syndrome. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1956 
<!-- PJG 007 0104 intable -->
Turkey 
<!-- PJG 007 0104 intable -->
Hexachlorobenzene 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Hexachlorobenzene causes poisoning. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1956 
<!-- PJG 007 0104 intable -->
Japan 
<!-- PJG 007 0104 intable -->
Clioquinol 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Drug causes neuropathy. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1959 
<!-- PJG 007 0104 intable -->
Morocco 
<!-- PJG 007 0104 intable -->
TOCP 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Cooking oil contaminated with lubricating oil causes poisoning. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1960 
<!-- PJG 007 0104 intable -->
Iraq 
<!-- PJG 007 0104 intable -->
Methylmercury 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Mercury-treated seed grain causes neurotoxicity. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1964 
<!-- PJG 007 0104 intable -->
Japan 
<!-- PJG 007 0104 intable -->
Methylmercury 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Methylmercury neurotoxicity. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1968 
<!-- PJG 007 0104 intable -->
Japan 
<!-- PJG 007 0104 intable -->
PCBs 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Polychlorinated biphenyls are leaked into rice oil, causing neurotoxicity. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1969 
<!-- PJG 007 0104 intable -->
Japan 
<!-- PJG 007 0104 intable -->
n-Hexane 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Neuropathy due to n-hexane exposure. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1969 
<!-- PJG 007 0104 intable -->
United States (New Mexico) 
<!-- PJG 007 0104 intable -->
Methylmercury 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Fungicide-treated grain results in alkyl mercury poisoning. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1971 
<!-- PJG 007 0104 intable -->
United States 
<!-- PJG 007 0104 intable -->
Hexachlorophene 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Hexachlorophene-containing disinfectant is found to be toxic to nervous system. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1971 
<!-- PJG 007 0104 intable -->
Iraq 
<!-- PJG 007 0104 intable -->
Methylmercury 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Methylmercury used as fungicide to treat seed grain causes poisoning. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1972 
<!-- PJG 007 0104 intable -->
France 
<!-- PJG 007 0104 intable -->
Hexachlorophene 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Hexachlorophene poisoning of children. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1973 
<!-- PJG 007 0104 intable -->
United States (Ohio) 
<!-- PJG 007 0104 intable -->
Methyl n-butylketone 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Fabric production plant employees exposed to MnBK solvent suffer polyneuropathy. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1974&hyph;1975 
<!-- PJG 007 0104 intable -->
United States (Virginia) 
<!-- PJG 007 0104 intable -->
Chlordecone (Keptone) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Chemical plant employees exposed to insecticide suffer severe neurologic problems. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1976 
<!-- PJG 007 0104 intable -->
United States (Texas) 
<!-- PJG 007 0104 intable -->
Leptophos (Phosvel) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
At least nine employees suffer serious neurologic problems after exposure to insecticide. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1977 
<!-- PJG 007 0104 intable -->
United States (California) 
<!-- PJG 007 0104 intable -->
Dichloropropene (Telone II) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
People hospitalized after exposure to pesticide. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1979&hyph;1980 
<!-- PJG 007 0104 intable -->
United States (Texas) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
2-t-Butylazo-2-hydroxy-5-methylhexane (BHMH) (Lucel-7) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Employees of manufacturing plant experience serious neurologic problems. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1980's 
<!-- PJG 007 0104 intable -->
United States 
<!-- PJG 007 0104 intable -->
Methylphenyltetrahydropyridine (MPTP) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Impurity in synthesis of illicit drug causes Parkinson's disease-like effects. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1981 
<!-- PJG 007 0104 intable -->
Spain 
<!-- PJG 007 0104 intable -->
Toxic oil 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
People ingesting toxic substance in oil suffer severe neuropathy. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1983&hyph;84 
<!-- PJG 007 0104 intable -->
United States 
<!-- PJG 007 0104 intable -->
Vitamin B
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=2 -->
6
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Excessive intake, causes sensory neuropathy, numbness, parathesia, and motor dysfunction. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1985 
<!-- PJG 007 0104 intable -->
United States and Canada 
<!-- PJG 007 0104 intable -->
Aldicarb 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
People experience neuromuscular deficits after ingestion of contaminated melons. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1987 
<!-- PJG 007 0104 intable -->
Canada 
<!-- PJG 007 0104 intable -->
Domoic acid 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Ingestion of mussels contaminated with domoic acid causes illnesses. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1988 
<!-- PJG 007 0104 intable -->
India 
<!-- PJG 007 0104 intable -->
TOCP 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Ingestion of adulterated rapeseed oil cause polyneuritis. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1989 
<!-- PJG 007 0104 intable -->
United States 
<!-- PJG 007 0104 intable -->
L-tryptophan-containing products 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Ingestion of a chemical contaminant associated with the manufacture of L-tryptophan results in eosinophilia-myalgia
syndrome. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1991 
<!-- PJG 007 0104 intable -->
Nigeria 
<!-- PJG 007 0104 intable -->
Scopoletin 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Natural component of gari caused neuropathy associated with optic atrophy and ataxia. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00221 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Mercury compounds are potent neurotoxic substances and have caused a number of 
<!-- PJG 0012 frnewline -->
human poisonings, with symptoms of vision, speech, and coordination impairments (Chang, 
<!-- PJG 0012 frnewline -->
1980). Erethism, a syndrome with such neurologic features as tremor and behavioral 
<!-- PJG 0012 frnewline -->
symptoms as anxiety, irritability, and pathologic shyness, is seen in people exposed to 
<!-- PJG 0012 frnewline -->
elemental mercury (Bidstrup, 1964). One major incidence of human exposure occurred in 
<!-- PJG 0012 frnewline -->
the mid-1950's when a chemical plant near Minamata Bay, Japan, discharged mercury as 
<!-- PJG 0012 frnewline -->
part of waste sludge. An epidemic of mercury poisoning developed when the local 
<!-- PJG 0012 frnewline -->
inhabitants consumed contaminated fish and shellfish. Congenitally affected children 
<!-- PJG 0012 frnewline -->
displayed a progressive neurological disturbance resembling cerebral palsy and manifested 
<!-- PJG 0012 frnewline -->
other neurological problems as well. In 1971, an epidemic occurred in Iraq from 
<!-- PJG 0012 frnewline -->
methylmercury used as a fungicide to treat grain (OTA, 1990). 
<!-- PJG 0012 frnewline -->
Manganese is used in metal alloys and has been proposed to replace lead in gasoline. 
<!-- PJG 0012 frnewline -->
It is an essential dietary substance for normal body functioning yet parenteral exposure to 
<!-- PJG 0012 frnewline -->
manganese can be neurotoxic, producing a dyskinetic motor syndrome similar to Parkinson's 
<!-- PJG 0012 frnewline -->
disease (Cook et al., 1974). Exposed miners in several countries have suffered from 
<!-- PJG 0012 frnewline -->
``manganese madness'' characterized by hallucinations, emotional instability, and numerous 
<!-- PJG 0012 frnewline -->
neurological problems. Long-term manganese toxicity produces muscle rigidity and 
<!-- PJG 0012 frnewline -->
staggering gait similar to that seen in patients with Parkinson's disease (Politis et al., 1980). 
<!-- PJG 0012 frnewline -->
A Parkinsonian-like syndrome was also observed in people who accidentally ingested 
<!-- PJG 0012 frnewline -->
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) (Langston et al., 1983). MPTP was a 
<!-- PJG 0012 frnewline -->
byproduct of a meperidine derivative sold illicitly as ``synthetic heroin.'' 
<!-- PJG 0012 frnewline -->
Organic solvents are encountered frequently in occupational settings. Most solvents 
<!-- PJG 0012 frnewline -->
are volatile, i.e., they can be converted from a liquid to a gaseous state and readily inhaled 
<!-- PJG 0012 frnewline -->
by the worker. They are also lipid soluble and readily accumulate in the fat deposits of the 
<!-- PJG 0012 frnewline -->
exposed organism. An example of a solvent exposure in humans is carbon disulfide. 
<!-- PJG 0012 frnewline -->
Workers exposed to high levels of this solvent were found to have an increased frequency of 
<!-- PJG 0012 frnewline -->
depression and suicide (Seppalainen and Haltia, 1980). Furthermore, repeated exposure to 
<!-- PJG 0012 frnewline -->
organic solvents is suspected of producing chronic encephalopathy. Workers exposed to 
<!-- PJG 0012 frnewline -->
methyl-n-butyl ketone, a dye solvent and cleaning agent, displayed peripheral nervous system 
<!-- PJG 0012 frnewline -->
neuropathy involving degeneration of nerve fibers (Spencer and Schaumburg, 1980). 
<!-- PJG 0012 frnewline -->
Solvents including ether, ketones, alcohols, and various combinations are commonly used in 
<!-- PJG 0012 frnewline -->
glues, cements, and paints and when inhaled can be neurotoxic. Repeated abuse of such 
<!-- PJG 0012 frnewline -->
solvents can lead to permanent neurological effects due to severe and permanent loss of nerve 
<!-- PJG 0012 frnewline -->
cells (OTA, 1990). 
<!-- PJG 0012 frnewline -->
Pesticides are one of the most commonly encountered classes of neurotoxic 
<!-- PJG 0012 frnewline -->
substances. These can include insecticides (used to control insects), fungicides (for blight 
<!-- PJG 0012 frnewline -->
and mildew), rodenticides (for rodents such as rats, mice, and gophers), and herbicides (to 
<!-- PJG 0012 frnewline -->
control weeds). Active ingredients are combined with so-called inert substances to make 
<!-- PJG 0012 frnewline -->
thousands of different pesticide formulations. Workers who are overexposed to pesticides 
<!-- PJG 0012 frnewline -->
may display obvious signs of poisoning, including tremors, weakness, ataxia, visual 
<!-- PJG 0012 frnewline -->
disturbances, and short-term memory loss (Ecobichon and Joy, 1982). Chlordecone exposure 
<!-- PJG 0012 frnewline -->
results in nervousness and tremors (Cannon et al., 1978). The organophosphorous 
<!-- PJG 0012 frnewline -->
insecticides have neurotoxic properties and account for approximately 40 percent of 
<!-- PJG 0012 frnewline -->
registered pesticides. A delayed neurotoxicity can be seen as a result of exposure to certain 
<!-- PJG 0012 frnewline -->
organophosphate pesticides, producing irreversible loss of motor function and an associated 
<!-- PJG 0012 frnewline -->
neuropathology (Ecobichon and Joy, 1982). Organophosphate and carbamate insecticides are 
<!-- PJG 0012 frnewline -->
known to interfere with a specific enzyme, acetylcholinesterase (AChE) (Davis and 
<!-- PJG 0012 frnewline -->
Richardson, 1980). Paralysis has also been reported following consumption of nonpesticide 
<!-- PJG 0012 frnewline -->
organophosphate products such as tri-o-cresylphosphate (TOCP). 
<!-- PJG 0012 frnewline -->
Neurotoxicities in humans, domestic livestock, and poultry associated with fungal 
<!-- PJG 0012 frnewline -->
toxins (mycotoxins) have been well documented (Kurata, 1990; Aibara, 1986; Wyllie and 
<!-- PJG 0012 frnewline -->
Morehouse, 1978). Mycotoxins not only have a negative economic effect on animal 
<!-- PJG 0012 frnewline -->
production, but they also represent a definite threat to human health. Mycotoxins occur in 
<!-- PJG 0012 frnewline -->
forages, field crops, and grains used for livestock; they also are incorporated into cereals, 
<!-- PJG 0012 frnewline -->
grains, and grain-based products used for human consumption. Therefore, human exposure 
<!-- PJG 0012 frnewline -->
may occur either through direct consumption of these products or secondarily through 
<!-- PJG 0012 frnewline -->
consumption of meat, milk, or eggs. An example of human exposure to fungal toxins is 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Claviceps purpurea
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
- or 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
C. paspali
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
-infected wheat, barley, and oats used for bread and as a 
<!-- PJG 0012 frnewline -->
dietary supplement for livestock. These fungal toxins are notorious for producing the 
<!-- PJG 0012 frnewline -->
gangrenous and convulsive forms of the disease known as ``ergotism'' (Bove, 1970). These 
<!-- PJG 0012 frnewline -->
fungi are in the family 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Clavicipitaceae
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and produce a group of compounds known as ergot 
<!-- PJG 0012 frnewline -->
alkaloids, which have neurotropic, uterotonic, and vasoconstrictive activities. They may act 
<!-- PJG 0012 frnewline -->
as dopamine agonists or serotonin antagonists, and also block alpha-adrenergic receptors. 
<!-- PJG 0012 frnewline -->
Since there are numerous naturally occurring ergot alkaloids, this represents only part of 
<!-- PJG 0012 frnewline -->
their pharmacopoeia (Berde and Schield, 1978). These alkaloids are highly toxic and cause 
<!-- PJG 0012 frnewline -->
both acute and chronic poisonings. Although guidelines now limit the amount of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Claviceps
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
-contaminated, or ``ergot''-contaminated, grains, these compounds may enter human food 
<!-- PJG 0012 frnewline -->
sources through secondary mechanisms. Other fungi associated with ergot-like syndromes in 
<!-- PJG 0012 frnewline -->
livestock include 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Acremonium lolii 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(Gallagher et al., 1984) and 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
A. coenophialum 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(Thompson 
<!-- PJG 0012 frnewline -->
and Porter, 1990). 
<!-- PJG 0012 frnewline -->
Cyclopiazonic acid (CPA) is an indole tetramic acid produced by 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Aspergillus flavus, 
<!-- PJG 0012 frnewline -->
A. oryzae, Penicillium cyclopium
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, and 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
P. camemberti. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This mycotoxin is suspected of 
<!-- PJG 0012 frnewline -->
causing ``kodua poisoning'' in humans who consumed kodo millet seed in India (Rao and 
<!-- PJG 0012 frnewline -->
Husain, 1985). 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Fusarium moniliforme
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 is a common fungal infection in corn (Bacon et al., 
<!-- PJG 0012 frnewline -->
1992) and directly related to neurotoxic syndrome in horses known as equine 
<!-- PJG 0012 frnewline -->
leukoencephalomalaisia (ELEM). 
<!-- PJG 0012 frnewline -->
Natural plant toxins also represent a health risk to both livestock and humans. 
<!-- PJG 0012 frnewline -->
Movement toward limited uses of herbicides, fungicides, and no-till agricultural practices 
<!-- PJG 0012 frnewline -->
increases the possibility of noxious weeds and weed seeds being incorporated into food 
<!-- PJG 0012 frnewline -->
products. Ergot alkaloids also are produced by morning glories 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
(Ipomea violacea)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and may 
<!-- PJG 0012 frnewline -->
be incorporated into soybeans, corn, peas, etc., during harvest. Export regulations limit 
<!-- PJG 0012 frnewline -->
morning glory-contaminated soybeans because of the hallucinogenic and other effects 
<!-- PJG 0012 frnewline -->
produced by ergot alkaloids. Jimson weed 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
(Datura stramonium)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, another weed incorporated 
<!-- PJG 0012 frnewline -->
into agricultural commodities, produced scopolamine, hyocyamine, and stropine, all of which 
<!-- PJG 0012 frnewline -->
have parasympatholytic (anticholinergic) activities. 
<!-- PJG 0012 frnewline -->
Recently, an outbreak of toxic encephalopathy caused by eating mussels contaminated 
<!-- PJG 0012 frnewline -->
with domoic acid, an excitotoxin, was reported (Perl et al., 1990). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00222 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=81 g=1 f=1 -->
2.1.3. Federal Response 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In the United States, several agencies, including EPA, FDA, OSHA, CPSC, NIOSH, 
<!-- PJG 0012 frnewline -->
and ATSDR, have been given the mandate to regulate or evaluate public exposure to toxic 
<!-- PJG 0012 frnewline -->
chemicals (Tilson, 1989). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
2.1.3.1. Food and Drug Administration. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The FDA has the authority to regulate the use of 
<!-- PJG 0012 frnewline -->
food and color additives as well as to determine whether or not various foods are unsafe for 
<!-- PJG 0012 frnewline -->
human consumption because of adulteration by environmental contaminants. The 
<!-- PJG 0012 frnewline -->
manufacturer must supply adequate data to establish the safety of the food additives. Before 
<!-- PJG 0012 frnewline -->
marketing approval, the potential toxicity of proposed food and color additives is established 
<!-- PJG 0012 frnewline -->
in a battery of animal toxicity studies. During all of these studies, clinical signs of toxicity, 
<!-- PJG 0012 frnewline -->
including abnormal behavior, are monitored and abnormalities recorded. At the termination 
<!-- PJG 0012 frnewline -->
of these studies, tissues from all organs, including the brain, are sectioned and evaluated for 
<!-- PJG 0012 frnewline -->
both gross and histopathological changes, in addition to being evaluated for their clinical 
<!-- PJG 0012 frnewline -->
chemistry and hematology. None of the routinely required tests is specifically designed to 
<!-- PJG 0012 frnewline -->
assess neurotoxicity. If neurotoxic effects are detected during any of the standard toxicity 
<!-- PJG 0012 frnewline -->
tests, however, they must be reported. Specific neurotoxicity testing may then be required. 
<!-- PJG 0012 frnewline -->
The FDA is currently revising its guidelines for the safety assessment of direct food and 
<!-- PJG 0012 frnewline -->
color additives to include neurotoxicity as a routine element in toxicological testing. 
<!-- PJG 0012 frnewline -->
The FDA is also authorized to regulate substances in food considered to be poisonous 
<!-- PJG 0012 frnewline -->
or deleterious. Unavoidable environmental contaminants in food fall into this category. The 
<!-- PJG 0012 frnewline -->
FDA determines a level at which the risks from realistically possible intakes are negligible or 
<!-- PJG 0012 frnewline -->
acceptable. Based on this risk assessment, an action level or tolerance is established. Once 
<!-- PJG 0012 frnewline -->
the action level or tolerance is formally established, the FDA may take appropriate action to 
<!-- PJG 0012 frnewline -->
restrict adulterated food from the market if these standards are exceeded. 
<!-- PJG 0012 frnewline -->
The FDA is responsible for assessing the toxicity of human therapeutic products. 
<!-- PJG 0012 frnewline -->
Many products have been shown to produce adverse effects on the nervous system at 
<!-- PJG 0012 frnewline -->
standard therapeutic doses as well as at higher doses. Before marketing approval is given, 
<!-- PJG 0012 frnewline -->
the toxicity of potential new products is assessed. A battery of animal toxicity study 
<!-- PJG 0012 frnewline -->
parameters relevant to the nervous system, including gross behavioral observation and gross 
<!-- PJG 0012 frnewline -->
and histopathological examination of the nervous tissue, are evaluated. This information is 
<!-- PJG 0012 frnewline -->
used to help guide the surveillance of human subjects for adverse effects that are assessed 
<!-- PJG 0012 frnewline -->
during clinical trials. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
2.1.3.2. Occupational Safety and Health Administration. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
OSHA has been given the 
<!-- PJG 0012 frnewline -->
responsibility to ensure that the working environment is a safe and healthy place of 
<!-- PJG 0012 frnewline -->
employment. In the early 1970's, OSHA adopted the existing Federal standards, most of 
<!-- PJG 0012 frnewline -->
which were developed under the Walsh-Healy Act (including the 1968 ACGIH Threshold 
<!-- PJG 0012 frnewline -->
Limit Values), and approximately 20 consensus standards of the American National 
<!-- PJG 0012 frnewline -->
Standards Institute (ANSI) as Permissible Exposure Limits (PELs). Of the 393 remaining 
<!-- PJG 0012 frnewline -->
original PELs, 145 were set in part to protect the individual from neurotoxic effects. 
<!-- PJG 0012 frnewline -->
Since the adoption of the initial standards, OSHA has issued new or revised health 
<!-- PJG 0012 frnewline -->
standards or work practices for 23 substances. Of these, the one concerning lead was based 
<!-- PJG 0012 frnewline -->
in part on nervous system effects. Four other compounds, inorganic arsenic, acrylonitrile, 
<!-- PJG 0012 frnewline -->
ethylene oxide, and 1,2-dibromo-3-chloropropane, were cited as causing various disturbances 
<!-- PJG 0012 frnewline -->
in the nervous system, but the standards for these were based primarily on carcinogenic 
<!-- PJG 0012 frnewline -->
effects. 
<!-- PJG 0012 frnewline -->
In 1989, OSHA updated 428 exposure limits for air contaminants. Of these, 25 
<!-- PJG 0012 frnewline -->
substances were categorized by OSHA as ``substances for which limits are based on 
<!-- PJG 0012 frnewline -->
avoidance of neuropathic effects.'' In addition, 24 substances were included in the category 
<!-- PJG 0012 frnewline -->
``substances for which limits are based on avoidance of narcosis.'' However, OSHA stated 
<!-- PJG 0012 frnewline -->
that the categorization was intended as a tool to manage the large number of substances being 
<!-- PJG 0012 frnewline -->
regulated and not to imply that the category selected identified the most sensitive or the 
<!-- PJG 0012 frnewline -->
exclusive adverse health effects of that substance. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
2.1.3.3. National Institute for Occupational Safety and Health. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Occupational Safety 
<!-- PJG 0012 frnewline -->
and Health Act established NIOSH as a Public Health Service (PHS) agency to develop and 
<!-- PJG 0012 frnewline -->
recommend criteria for prevention of disease and hazardous conditions in the workplace. 
<!-- PJG 0012 frnewline -->
NIOSH also performs research on occupational health issues and conducts worksite 
<!-- PJG 0012 frnewline -->
evaluations of suspected hazards. OSHA and the Mine Safety and Health Administration 
<!-- PJG 0012 frnewline -->
(MSHA) use NIOSH recommendations in the promulgation of new or revised health and 
<!-- PJG 0012 frnewline -->
safety standards. 
<!-- PJG 0012 frnewline -->
In establishing recommended exposure limits (RELs) for chemicals, NIOSH examines 
<!-- PJG 0012 frnewline -->
all relevant scientific information about a given compound and attempts to identify exposure 
<!-- PJG 0012 frnewline -->
limits that will protect all workers from adverse effects. NIOSH has recommended standards 
<!-- PJG 0012 frnewline -->
for approximately 644 chemicals or classes of chemicals. For 214 (33 percent) of these, 
<!-- PJG 0012 frnewline -->
neurotoxicity was cited as a health effect considered when formulating the REL (NIOSH, 
<!-- PJG 0012 frnewline -->
1992). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
2.1.3.4. Environmental Protection Agency. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Toxic Substances Control Act (TSCA) and 
<!-- PJG 0012 frnewline -->
the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) provide the legislative 
<!-- PJG 0012 frnewline -->
authority for EPA to require data collection for premarket approval of chemicals. Under 
<!-- PJG 0012 frnewline -->
section 5 of TSCA, after a manufacturer has notified EPA of its plans to produce a ``new'' 
<!-- PJG 0012 frnewline -->
chemical that has not yet been listed on the inventory, EPA has the responsibility to assess 
<!-- PJG 0012 frnewline -->
possible health hazards. Potential neurotoxicity is included in the health hazards assessment. 
<!-- PJG 0012 frnewline -->
If there are reasons to suspect neurotoxicologic effects (e.g., from structure-activity analysis, 
<!-- PJG 0012 frnewline -->
information in the literature, or data submitted by the manufacturer), EPA can issue a test 
<!-- PJG 0012 frnewline -->
rule requiring the manufacturer to develop data directed toward these effects. At the same 
<!-- PJG 0012 frnewline -->
time, EPA can restrict the chemical or prohibit it entirely from entering commerce until the 
<!-- PJG 0012 frnewline -->
required data are submitted and reviewed. In addition, for ``old'' chemicals (under section 4 
<!-- PJG 0012 frnewline -->
of TSCA), if EPA suspects neurotoxicity, a test rule would be the mechanism used for 
<!-- PJG 0012 frnewline -->
obtaining the data. Many other statutes provide authority to regulate chemicals through the 
<!-- PJG 0012 frnewline -->
setting of standards, including the Clean Air Act, Clean Water Act, and Safe Drinking Water 
<!-- PJG 0012 frnewline -->
Act. 
<!-- PJG 0012 frnewline -->
Neurotoxicity is recognized as a health effect of concern under FIFRA, and there are 
<!-- PJG 0012 frnewline -->
neurotoxicity testing requirements for premarketing submission of data to EPA for 
<!-- PJG 0012 frnewline -->
registration of a pesticide under FIFRA. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00223 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=81 g=1 f=1 -->
2.1.3.5. Consumer Product Safety Commission.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The CPSC is an independent Federal 
<!-- PJG 0012 frnewline -->
regulatory agency with jurisdiction over most consumer products. Most chemical hazards are 
<!-- PJG 0012 frnewline -->
regulated under the Federal Hazardous Substances Act (FHSA) administered by CPSC. The 
<!-- PJG 0012 frnewline -->
FHSA requires appropriate cautionary labeling on all hazardous household products (hazards 
<!-- PJG 0012 frnewline -->
include chronic toxicity such as neurotoxicity). While the FHSA does not require premarket 
<!-- PJG 0012 frnewline -->
registration, a manufacturer is required to assess the hazards of a product prior to marketing 
<!-- PJG 0012 frnewline -->
and assure that it is labeled with all necessary cautionary information. The FHSA also bans 
<!-- PJG 0012 frnewline -->
children's products that are hazardous and provides the CPSC with the authority to ban other 
<!-- PJG 0012 frnewline -->
hazardous products. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
2.1.3.6. Agency for Toxic Substances and Disease Registry.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
ATSDR has a mission to 
<!-- PJG 0012 frnewline -->
prevent or mitigate adverse effects to both human health and the quality of life resulting from 
<!-- PJG 0012 frnewline -->
exposure to hazardous substances in the environment. The ATSDR publishes a National 
<!-- PJG 0012 frnewline -->
Priority List (NPL) of hazardous substances that are found at National Priority Waste Sites. 
<!-- PJG 0012 frnewline -->
The order of priority is based on an algorithm, taking into consideration frequency with 
<!-- PJG 0012 frnewline -->
which substances are found at NPL sites, toxicity, and potential for human exposure; this list 
<!-- PJG 0012 frnewline -->
is reranked on a yearly basis. So far, 129 toxicological profiles have been developed for the 
<!-- PJG 0012 frnewline -->
priority hazardous substances, and 92 substances have a profile with a neurological health 
<!-- PJG 0012 frnewline -->
effect endpoint (HAZDAT, 1992). Neurotoxicity has been selected by the ATSDR to be one 
<!-- PJG 0012 frnewline -->
of the seven high-priority health conditions resulting from exposure to environmental 
<!-- PJG 0012 frnewline -->
toxicants. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
2.2. Basic Toxicological Considerations for Neurotoxicity 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
2.2.1. Basic Toxicological Principles 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A chemical must enter the body, reach the tissue target site(s), and be maintained at a 
<!-- PJG 0012 frnewline -->
sufficient concentration for a period of time in order for an adverse effect to occur. Not all 
<!-- PJG 0012 frnewline -->
chemicals have the same level of toxicity; some may be very toxic in small amounts while 
<!-- PJG 0012 frnewline -->
others may have little effect even at extremely high amounts. Thus, the dose-response 
<!-- PJG 0012 frnewline -->
relationship is a major concept in determining the toxicity of a specific substance. Other 
<!-- PJG 0012 frnewline -->
factors in determining toxicity include the physical and chemical properties of the substance, 
<!-- PJG 0012 frnewline -->
the route and level of exposure, the susceptibility of the target tissue, and the health, gender, 
<!-- PJG 0012 frnewline -->
and age of the exposed individual. 
<!-- PJG 0012 frnewline -->
Once the toxic substance has entered the body, usually through the lungs (inhalation), 
<!-- PJG 0012 frnewline -->
the skin (absorption), or the gastrointestinal tract (ingestion), it is partitioned into various 
<!-- PJG 0012 frnewline -->
body tissues where it can act on its target sites. The substance is eliminated from the 
<!-- PJG 0012 frnewline -->
bloodstream by the process of accumulation into the various sites in the body, with the liver 
<!-- PJG 0012 frnewline -->
and kidney being major sites of accumulation of toxic substances. This is thought to be 
<!-- PJG 0012 frnewline -->
associated with these organs' large blood capacity and major role in elimination of substances 
<!-- PJG 0012 frnewline -->
from the body. Lipophilic chemicals accumulate in lipid-rich areas of the body and present a 
<!-- PJG 0012 frnewline -->
significant potential problem for the nervous system. The nervous system is unique in its 
<!-- PJG 0012 frnewline -->
high percentage content of lipid (50 percent of dry weight) and may be particularly 
<!-- PJG 0012 frnewline -->
vulnerable to such chemicals. The site or sites of accumulation for a specific toxic substance 
<!-- PJG 0012 frnewline -->
may or may not be the primary sites of action. Examples include two known neurotoxicants, 
<!-- PJG 0012 frnewline -->
carbon monoxide in the red blood cells and lead in the bone. It must be noted that some 
<!-- PJG 0012 frnewline -->
substances are not distributed throughout the body, partially as a function of their 
<!-- PJG 0012 frnewline -->
insolubility, polarity, or molecular weight. 
<!-- PJG 0012 frnewline -->
The effect that a substance has will generally depend on the body burden or level in 
<!-- PJG 0012 frnewline -->
the tissue and duration of exposure. The time course of the levels is determined by several 
<!-- PJG 0012 frnewline -->
factors, including the amount at time of exposure, duration of exposure, and metabolic fate 
<!-- PJG 0012 frnewline -->
of the chemical. The study of such metabolic processes, pharmacokinetics, has demonstrated 
<!-- PJG 0012 frnewline -->
complex patterns in the absorption, distribution, possible biotransformation, and elimination 
<!-- PJG 0012 frnewline -->
of various substances (Klaassen, 1980). 
<!-- PJG 0012 frnewline -->
Many substances are removed by the kidney and excreted through the urine. The 
<!-- PJG 0012 frnewline -->
liver can detoxify substances like organic lead, which are excreted from the liver into the bile 
<!-- PJG 0012 frnewline -->
and then the small intestines, bypassing the blood and kidney. Lipophilic toxic substances 
<!-- PJG 0012 frnewline -->
are primarily removed from the body through feces and bile, and water-soluble metabolites 
<!-- PJG 0012 frnewline -->
are removed in the urine, through the skin, and through expiration into the air. 
<!-- PJG 0012 frnewline -->
Biotransformation is a biochemical process that converts a substance into a different chemical 
<!-- PJG 0012 frnewline -->
compound, allowing it to be excreted more easily. Substances are more easily removed if 
<!-- PJG 0012 frnewline -->
they are biotransformed into a more hydrophilic compound. Biotransformation can either aid 
<!-- PJG 0012 frnewline -->
in the detoxification of a substance or produce a more toxic metabolite. Therefore, the 
<!-- PJG 0012 frnewline -->
original substance may not be the substance that is producing the toxicity on the nervous 
<!-- PJG 0012 frnewline -->
system or any other system. Thus, several factors must be taken into consideration when 
<!-- PJG 0012 frnewline -->
evaluating the potential neurotoxicity of a chemical. They include the pharmacokinetics of 
<!-- PJG 0012 frnewline -->
the parent compound, the target tissue concentrations of the parent chemical or its 
<!-- PJG 0012 frnewline -->
bioactivated proximate toxicant, the uptake kinetics of the parent chemical or metabolite into 
<!-- PJG 0012 frnewline -->
the cell and/or membrane interactions, and the interaction of the chemical or metabolite with 
<!-- PJG 0012 frnewline -->
presumed receptor sites. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
2.2.2. Basic Neurotoxicological Principles 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Neurotoxicity can be manifest as a structural or functional adverse response of the 
<!-- PJG 0012 frnewline -->
nervous system to a chemical, biological, or physical agent (Tilson, 1990b). It is a function 
<!-- PJG 0012 frnewline -->
of both the property of the agent and a property of the nervous system itself. Neurotoxicity 
<!-- PJG 0012 frnewline -->
refers broadly to the adverse neural responses following exposure to chemical or physical 
<!-- PJG 0012 frnewline -->
agents (e.g., radiation) (Tilson, 1990b). Adverse effects include any change that diminishes 
<!-- PJG 0012 frnewline -->
the ability to survive, reproduce, or adapt to the environment. Neuroactive substances may 
<!-- PJG 0012 frnewline -->
also impair health indirectly by altering behavior in such a way that safety is decreased in the 
<!-- PJG 0012 frnewline -->
performance of numerous activities. Toxicity can occur at any time in the life cycle, from 
<!-- PJG 0012 frnewline -->
conception through senescence, and its manifestations can change with age. The range of 
<!-- PJG 0012 frnewline -->
responses can vary from temporary responses following acute exposures to delayed responses 
<!-- PJG 0012 frnewline -->
following acute or chronic exposure to persistent responses. Neurotoxicity may or may not 
<!-- PJG 0012 frnewline -->
be reversible following cessation of exposure. The responses may be graded from transient 
<!-- PJG 0012 frnewline -->
to fatal and there may be different responses to the same neurotoxicant at different dose 
<!-- PJG 0012 frnewline -->
levels but similar responses to exposure to different agents. Displays of a neurotoxic 
<!-- PJG 0012 frnewline -->
response may be progressive in nature, with small deficits occurring early in exposure and 
<!-- PJG 0012 frnewline -->
developing to become more severe over time. Expression of neurotoxicity can encompass 
<!-- PJG 0012 frnewline -->
multiple levels of organization and complexity including structural, biochemical, 
<!-- PJG 0012 frnewline -->
physiological, and behavioral measurements. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00224 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Caution must be exercised in labeling a substance neurotoxic. The intended use and 
<!-- PJG 0012 frnewline -->
effect of the chemical, the dose, exposure scenario and whether or not the chemical acts 
<!-- PJG 0012 frnewline -->
directly or indirectly on the nervous system, must be taken into consideration. A substance 
<!-- PJG 0012 frnewline -->
that may be neurotoxic at a high concentration may be safe and beneficial at a lower 
<!-- PJG 0012 frnewline -->
concentration. For example, vitamin A, vitamin B6, are required in the diet in trace 
<!-- PJG 0012 frnewline -->
amounts, yet all result in neurotoxicity when consumed in large quantities. Pharmaceutical 
<!-- PJG 0012 frnewline -->
agents may also have adverse effects at high dose levels or where the beneficial effects 
<!-- PJG 0012 frnewline -->
outweigh the adverse side effects. For example, antipsychotic drugs have allowed many 
<!-- PJG 0012 frnewline -->
people suffering from schizophrenia to lead relatively normal lives; however, chronic 
<!-- PJG 0012 frnewline -->
prescribed use of some of these drugs may result in severe tardive dyskinesia characterized 
<!-- PJG 0012 frnewline -->
by involuntary movements of the face, tongue, and limbs. Other examples include toxic 
<!-- PJG 0012 frnewline -->
neuropathies induced by chemotherapeutic agents like cis-platinum, toxic anticholinergic 
<!-- PJG 0012 frnewline -->
effects of high doses of tricyclic antidepressants, disabling movement disorders in patients 
<!-- PJG 0012 frnewline -->
treated with anti-Parkinsonian agents and major tranquilizers, and hearing loss and balance 
<!-- PJG 0012 frnewline -->
disruption triggered by certain antibacterials (Sterman and Schaumburg, 1980). Drugs of 
<!-- PJG 0012 frnewline -->
abuse such as ethanol also have neurotoxic potential. Opiates such as heroin may lead to 
<!-- PJG 0012 frnewline -->
dependence, which is considered to be a long-term adverse alteration of nervous system 
<!-- PJG 0012 frnewline -->
functioning. Simultaneous exposure to drugs or toxic agents may produce toxic interactions 
<!-- PJG 0012 frnewline -->
either in the environment or occupational settings. For example, exposure to noise and 
<!-- PJG 0012 frnewline -->
certain antibiotics can exacerbate the loss of hearing function (Boettcher et al., 1987; Lim, 
<!-- PJG 0012 frnewline -->
1986; Bhattacharyya and Dayal, 1984). 
<!-- PJG 0012 frnewline -->
The nervous system is a highly complex and integrated organ. It is possible that 
<!-- PJG 0012 frnewline -->
nonlinear dose-response relationships or a threshold effect could exist for some agents. It 
<!-- PJG 0012 frnewline -->
has been hypothesized that the nervous system has a reserve capacity that masks subtle 
<!-- PJG 0012 frnewline -->
damage and any exposure that does not overcome this reserve capacity may not reach the 
<!-- PJG 0012 frnewline -->
threshold and no observable impairment will be evident (Tilson and Mitchell, 1983). 
<!-- PJG 0012 frnewline -->
However, the functional reserve may be depleted over time and the manifestations of toxicity 
<!-- PJG 0012 frnewline -->
may be delayed in relationship to the exposure. The reserve may be depleted by a number of 
<!-- PJG 0012 frnewline -->
factors including aging, stress, or chronic exposure to an environmental insult, in which case 
<!-- PJG 0012 frnewline -->
functioning will eventually be impaired and toxicity will become apparent. If a number of 
<!-- PJG 0012 frnewline -->
events occur simultaneously, the response is progressive in nature, or there is a long latency 
<!-- PJG 0012 frnewline -->
between exposure and manifestation of toxicity, the identification of a single cause of the 
<!-- PJG 0012 frnewline -->
functional impairment may not be possible. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
2.3. Basic Neurobiological Principles 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
2.3.1. Structure of the Nervous System 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The nervous system is composed of two parts: the central nervous system (CNS) and 
<!-- PJG 0012 frnewline -->
the peripheral nervous system (PNS) (Spencer and Schaumburg, 1980). Within the nervous 
<!-- PJG 0012 frnewline -->
system, there exist predominantly two general types of cells_nerve cells (neurons) and glial 
<!-- PJG 0012 frnewline -->
cells. Neurons have many of the same structures found in every cell of the body; they are 
<!-- PJG 0012 frnewline -->
unique, however, in that they have axons and dendrites, extensions of the neuron along 
<!-- PJG 0012 frnewline -->
which nerve impulses travel. The structure of the neuron consists of a cell body, 10 to 100 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
m in diameter, containing a nucleus and organelles for the synthesis of various components 
<!-- PJG 0012 frnewline -->
necessary for the cell's functioning, e.g., proteins and lipids. There are numerous branch 
<!-- PJG 0012 frnewline -->
patterns of elongated processes, the dendrites, that emanate from the cell body and increase 
<!-- PJG 0012 frnewline -->
the neuronal surface area available to receive inputs from other sources. Neurons 
<!-- PJG 0012 frnewline -->
communicate with each other by releasing chemical signals onto specific surface regions, 
<!-- PJG 0012 frnewline -->
receptors, of the other neuron. The axon is a process specialized for the conduction of nerve 
<!-- PJG 0012 frnewline -->
impulses away from the cell toward the terminal synapses and eventually toward other cells 
<!-- PJG 0012 frnewline -->
(neurons, muscle cells, or gland cells). 
<!-- PJG 0012 frnewline -->
Neurons are responsible for the reception, integration, transmission, and storage of 
<!-- PJG 0012 frnewline -->
information (Raine, 1989). Certain nerve cells are specialized to respond to particular 
<!-- PJG 0012 frnewline -->
stimuli. For example, chemoreceptors in the mouth and nose send information about taste 
<!-- PJG 0012 frnewline -->
and smell to the brain. Cutaneous receptors in the skin are involved in the sensation of 
<!-- PJG 0012 frnewline -->
pressure, pain, heat, cold, and touch. In the retina, the rods and cones sense light. In 
<!-- PJG 0012 frnewline -->
general, the length of the axon is tens to thousands of times greater than the cell body 
<!-- PJG 0012 frnewline -->
diameter. For example, the cell body whose processes innervate the muscles in the human 
<!-- PJG 0012 frnewline -->
foot is found in the spinal cord at the level of the middle back. The axons of these cells are 
<!-- PJG 0012 frnewline -->
more than a meter in length. Many, but not all, axons are surrounded by the layers of 
<!-- PJG 0012 frnewline -->
membrane from the cytoplasmic process of glial cells. These layers are called myelin 
<!-- PJG 0012 frnewline -->
sheaths and are composed mostly of lipid. In the PNS, the myelin sheaths are formed by 
<!-- PJG 0012 frnewline -->
Schwann cells, while in the CNS the sheaths are formed by the oligodendroglia. The myelin 
<!-- PJG 0012 frnewline -->
sheath formed by one glial cell covers only a short length of the axon. The entire length of 
<!-- PJG 0012 frnewline -->
the axon is ensheathed in myelin by numerous glial cells. Between adjacent glial sheaths, a 
<!-- PJG 0012 frnewline -->
very short length of bare axon exists called the node of Ranvier. In unmyelinated axons, a 
<!-- PJG 0012 frnewline -->
nerve impulse must travel in a continuous fashion down the entire length of the nerve. The 
<!-- PJG 0012 frnewline -->
presence of myelin accelerates the nerve impulse by up to 100 times by allowing the impulse 
<!-- PJG 0012 frnewline -->
to jump from one node to the next in a process called ``saltatory conduction.'' 
<!-- PJG 0012 frnewline -->
The nerve cells of the PNS are generally found in aggregates called ganglia. The 
<!-- PJG 0012 frnewline -->
brain and spinal cord make up the CNS and the neurons are segregated into functionally 
<!-- PJG 0012 frnewline -->
related aggregates called nuclei. They synthesize and secrete neurotransmitters, which are 
<!-- PJG 0012 frnewline -->
specialized chemical messengers that interact with receptors of other neurons in the 
<!-- PJG 0012 frnewline -->
communication process. Various nuclei together with the interconnecting bundles of axonal 
<!-- PJG 0012 frnewline -->
fibers are functionally related to one another to form higher levels of organization called 
<!-- PJG 0012 frnewline -->
systems. For example, there is the motor system, the visual system, and the limbic system. 
<!-- PJG 0012 frnewline -->
At the base of the brain, several small nuclei in the hypothalamus form the neuroendocrine 
<!-- PJG 0012 frnewline -->
system, which plays a critical role in the control of the body's endocrine (hormone-secreting) 
<!-- PJG 0012 frnewline -->
glands. Nerve cells in the hypothalamus secrete chemical messengers into a short loop of 
<!-- PJG 0012 frnewline -->
blood vessels that carries the messengers to the pituitary gland which, in turn, releases 
<!-- PJG 0012 frnewline -->
chemical messengers into the general circulation. These pituitary messengers regulate other 
<!-- PJG 0012 frnewline -->
glands (e.g., the thymus and the gonads). The entire system maintains a state of optimal 
<!-- PJG 0012 frnewline -->
physiological function for all of the body's organ systems. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00225 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=81 g=1 f=1 -->
2.3.2. Transport Processes 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
All types of cells must transport proteins and other molecular components from their site of production near the nucleus
to the other sites in the cell (Hammerschlag and Brady, 1989). Neurons are unique in that the neuronal cell body must
maintain not only the functions normally associated with its own support, but it must also provide support to its various
processes. This support may require transport of material over relatively vast distances. Delivery of necessary
substances by intracellular transport down the axon (axonal transport) represents a supply line that is highly vulnerable
to interruption by toxic chemicals. In addition, the integrity of the function of the neuronal cell body is often dependent
on a supply of trophic factors from the cells that it innervates. These factors are continually supplied to the neural
cells by the process of retrograde axonal transport, often as a process of normal exchange between two or more cells.
They play a significant factor in the normal growth and maintenance of the neural cells, and a continual supply of certain
trophic factors is necessary for cell functioning. 
<!-- PJG 0012 frnewline -->
The majority of axonal transport occurs along longitudinally arranged fiber tracks called neurofilaments. This
movement along neurofilaments requires energy in the form of oxidative metabolism. Toxicants that interfere with
this metabolism or that disrupt the spatial arrangement or production of neurofilaments may block axonal transport
and can produce neuropathy (Lowndes and Baker, 1980). This can be seen following exposure to many substances, such
as n-hexane and methyl n-butyl ketone as well as the drugs vincristine, vinblastine, and taxol. Acrylamide produces
a dying-back axonopathy but by an alternative mechanism involving altered axonal transport. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
2.3.3. Ionic Balance 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The axonal membrane is semipermeable to positively and negatively charged ions (mostly potassium, sodium, and chloride)
within and outside of the axon. There are several enzyme systems that maintain an ionic balance that changes following
depolarization of the membrane (Davies, 1968). This is maintained only by the continual active transport of ions
across the membrane, which requires an expenditure of energy. The nerve impulse is a traveling wave of depolarization
normally originating from the cell body; however, in sensory neurons it originates at the terminal receptive end
of specialized axons (Davies, 1968). The wave is continued by openings in the membrane that allow ions to rush into
the axon. This sudden change in the charge across the axon's membrane is the nerve impulse. It is an amplified depolarization
that reaches the threshold value and spreads down the axon from one length to another until the next length of membrane
reaches the threshold value. It continues in this fashion until it reaches the synaptic terminal regions. There are
a number of varieties of membrane channels (e.g., calcium) that rapidly open and close during impulse generation;
the common ones are the sodium and potassium channels. They are very small and allow only ions of a certain size to pass.
Several classes of drugs (e.g., local anesthetics) and natural toxins (e.g., tetrodotoxin) inhibit nerve impulse
conduction by blocking these channels. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
2.3.4. Neurotransmission 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The terminal branches of the axon end in small enlargements called synaptic ``boutons.'' It is from these boutons
that chemical messengers will be released in order to communicate with the target cell at the point of interaction,
the synapse (Hammerschlag and Brady, 1989). When the nerve impulse reaches the terminal branches of the axon, it depolarizes
the synaptic boutons. This depolarization causes the release of the chemical messengers (neurotransmitters and
neuromodulators) stored in vesicles in the axon terminal (Willis and Grossman, 1973). Classical neurotransmitters
include serotonin, dopamine, acetylcholine, and norepinephrine and are typically secreted by one neuron into the
synaptic cleft where they are on the postsynaptic membrane. Neuropeptides, however, may travel long distances through
the bloodstream to receptors on distant nerve cells or in other tissues. Following depolarization, the amount of
secretion is dependent on the number of nerve impulses that reach the synaptic bouton, i.e., the degree of depolarization.
The chemical messengers diffuse across the synaptic cleft or into the intraneuronal space and bind to receptors on
adjacent nerve cells or effector organs, thus triggering biochemical events that lead to electrical excitation
or inhibition. 
<!-- PJG 0012 frnewline -->
When information is transmitted from nerves to muscle fibers, the point of interaction is called the neuromuscular
junction and the interaction leads to contraction or relaxation of the muscle. When the target is a gland cell, the
interaction leads to secretion. Synaptic transmission between neurons is slightly more complicated, but still
dependent on the opening and closing of ion channels in the membrane. The binding of the messenger to the receptor of
the receiving cell can lead to either the excitation or inhibition of the target cell. At an excitatory synapse, the
neurotransmitter-receptor interaction leads to an opening in certain ion-specific channels. The charged ions
that move through these opened chambers carry a current that serves to depolarize the cell membranes. At inhibitory
synapses, the interaction leads to an opening in a different type of ion-specific channel that produces an increase
in the level of polarization (hyperpolarization). The sum of all the depolarizing and hyperpolarizing currents
determines the transmembrane potential and when a threshold level of depolarization is reached at the axon's initial
segment, a nerve impulse is generated and begins to travel down the axon. 
<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00226 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The duration of neurotransmitter action is primarily a function of the length of time it remains in the synaptic cleft.
This duration is very short due to specialized enzymes that quickly remove the transmitter either by degrading it
or by reuptake systems that transport it back into the synaptic bouton. A toxic substance may disrupt this process
in several different ways. It is important that the duration of the effect of synaptically released chemical messengers
be limited. Some neurotoxicants, e.g., cholinesterase-inhibiting organophosphorous pesticides, inhibit the
enzyme (AChE), which serves to terminate the effect of the neurotransmitter (acetylcholine) on its target. The result
is an overstimulation of the target cell. Other substances, particularly biological toxins, are able to interact
with the receptor molecule and mimic the action of the neurotransmitter. Some toxic substances, like neuroactive
pharmaceuticals, may interfere with the synthesis of a particular neurotransmitter, while others may block the
neurotransmitter's access to its receptor molecule. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
2.4. Types of Effects on the Nervous System 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The normal activity of the nervous system can be altered by many toxic substances. A variety of adverse health effects
can be seen ranging from impairment of muscular movement to disruption of vision and hearing to memory loss and hallucinations
(WHO, 1986; Anger, 1984, 1990). Toxic substances can alter both the structure and the function of cells in the nervous
system. Structural alterations include changes in the morphology of the cell and its subcellular structures. In
some cases, agents produce neuropathic conditions that resemble naturally occurring neurodegenerative disorders
in humans (Calne et al., 1986). Cellular alterations can include the accumulation, proliferation, or rearrangement
of structural elements (e.g., intermediate filaments, microtubules) or organelles (mitochondria) as well as the
breakdown of cells. By affecting the biochemistry and/or physiology of a cell, a toxic substance can alter the internal
environment of any neural cell. Intracellular changes can result from oxygen deprivation (anoxia) because neurons
require relatively large quantities of oxygen due to their high metabolic rate. 
<!-- PJG 0012 frnewline -->
Many times the response of the nervous system to a toxic substance can be a slow degeneration of the nerve cell body or
axon that may result in permanent neuronal damage. Substances can act as a cytotoxicant after having been transported
into the nerve terminal. A complete loss of nerve cells can occur following exposure to a number of toxic substances.
Sensory nerve cells may be lost following treatment with megavitamin doses of vitamin B6; hippocampal neurons undergo
degeneration with trimethyltin and trimethyl lead poisoning; motor nerve cells are affected in cycad toxicity,
which has been loosely linked to Guam-ALS-Parkinsonism dementia. Acute carbon monoxide poisoning can produce a
delayed, progressive deterioration over a period of weeks of portions of the nervous system that may lead to psychosis
and death. Substances such as mercury and lead can cause central nervous system dysfunction. In children, mercury
intoxication can cause degeneration of neurons in the cerebellum and can lead to tremors, difficulty in walking,
visual impairment, and even blindness. Lead affects the cortex of the immature brain, resulting in mental retardation.

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00227 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
At the cellular level, a substance might interfere with cellular processes like protein 
<!-- PJG 0012 frnewline -->
synthesis, leading to a reduced production of neurotransmitters and brain dysfunction (Bondy, 
<!-- PJG 0012 frnewline -->
1985). Nicotine and some insecticides mimic the effects of the neurotransmitter 
<!-- PJG 0012 frnewline -->
acetylcholine. Organophosphorous compounds, carbamate insecticides, and nerve gases act 
<!-- PJG 0012 frnewline -->
by inhibiting AChE, the enzyme that inactivates the neurotransmitter acetylcholine. This 
<!-- PJG 0012 frnewline -->
results in a buildup of acetylcholine and can lead to loss of appetite, anxiety, muscle 
<!-- PJG 0012 frnewline -->
twitching, and paralysis. Amphetamines stimulate the nervous system by releasing and 
<!-- PJG 0012 frnewline -->
blocking reuptake of the neurotransmitters norepinephrine and dopamine from nerve cells. 
<!-- PJG 0012 frnewline -->
Cocaine affects the release and reuptake of norepinephrine, dopamine, and serotonin. Both 
<!-- PJG 0012 frnewline -->
drugs can cause paranoia, hyperactivity, aggression, high blood pressure, and abnormal heart 
<!-- PJG 0012 frnewline -->
rhythms. Opium-related drugs such as morphine and heroin act at specific opioid receptors 
<!-- PJG 0012 frnewline -->
in the brain, producing sedation, euphoria, and analgesia. They also tend to slow the heart 
<!-- PJG 0012 frnewline -->
rate and cause nausea, convulsions, and slow breathing patterns. Other substances can alter 
<!-- PJG 0012 frnewline -->
the synthesis and release of specific neurotransmitters and activate their receptors in specific 
<!-- PJG 0012 frnewline -->
neuronal pathways. They may perturb the system by overstimulating receptors, blocking 
<!-- PJG 0012 frnewline -->
transmitter release and/or inhibiting transmitter degradation, or blocking reuptake of 
<!-- PJG 0012 frnewline -->
neurotransmitter precursors. 
<!-- PJG 0012 frnewline -->
Also at the cellular level, the flow of ions such as calcium, sodium, and potassium 
<!-- PJG 0012 frnewline -->
across the cell membrane may be changed and the transmission of information between nerve 
<!-- PJG 0012 frnewline -->
cells altered. A substance may interfere with the ionic balance of a neuron. 
<!-- PJG 0012 frnewline -->
Organophosphate and carbamate insecticides produce autonomic dysfunction and 
<!-- PJG 0012 frnewline -->
organochlorine insecticides increase sensorimotor sensitivity, produce tremors and in some 
<!-- PJG 0012 frnewline -->
cases cause seizures and convulsions (Ecobichon and Joy, 1982). Lindane, DDT, 
<!-- PJG 0012 frnewline -->
pyrethroids, and trimethyltin also produce convulsions. Conversely, solvents act to raise the 
<!-- PJG 0012 frnewline -->
threshold for eliciting seizures or act to reduce the severity or duration of the elicited 
<!-- PJG 0012 frnewline -->
convulsions. 
<!-- PJG 0012 frnewline -->
The role of excitatory amino acid (EAA)-mediated synaptic activation is critical for 
<!-- PJG 0012 frnewline -->
normal function of the CNS. Because endogenous EAA-mediated synaptic transmission is a 
<!-- PJG 0012 frnewline -->
widespread excitatory system in the brain and is involved in the process of learning and 
<!-- PJG 0012 frnewline -->
memory, the issue of the effects of endogenous and exogenous EAA-related toxicity has 
<!-- PJG 0012 frnewline -->
broad implications for both CNS morbidity and mortality in humans. Much of the injury and 
<!-- PJG 0012 frnewline -->
neuronal death associated with toxicity is mediated by receptors for excitatory amino acids, 
<!-- PJG 0012 frnewline -->
especially glutamic acid. When applied in sufficient excess from either endogenous or 
<!-- PJG 0012 frnewline -->
exogenous sources, EAAs have profound neurotoxic effects that can result in the destruction 
<!-- PJG 0012 frnewline -->
of neurons and, as a consequence, lead to acute phase confusion, seizures, and generalized 
<!-- PJG 0012 frnewline -->
weakness or to persistent impairments such as memory loss (Choi, 1988). 
<!-- PJG 0012 frnewline -->
A final common path in the activation of these receptor classes is an increase in free 
<!-- PJG 0012 frnewline -->
cytosolic Ca
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->

<!-- PJG 20052070 minuteslatlong -->
&rsquo;
<!-- PJG 20052070 minuteslatlong -->
&rsquo;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 that can result in the release and activation of intracellular enzymes (which 
<!-- PJG 0012 frnewline -->
break down the cytoskeleton) and in further release of glutamate, both of which can be 
<!-- PJG 0012 frnewline -->
cytotoxic (Choi, 1988). Critical to an understanding of the etiopathology associated with at 
<!-- PJG 0012 frnewline -->
least some of the neurotoxic degeneration may be the link that impaired energy metabolism 
<!-- PJG 0012 frnewline -->
could have with excitotoxic neuronal death. It is likely that reduced oxidative metabolism 
<!-- PJG 0012 frnewline -->
results in the partial depolarization of resting membrane potential, the activation of ionotropic 
<!-- PJG 0012 frnewline -->
membrane receptor/channels, and the influx of Ca
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->

<!-- PJG 20052070 minuteslatlong -->
&rsquo;
<!-- PJG 20052070 minuteslatlong -->
&rsquo;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 or its release from intracellular stores. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00228 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The nervous system is dependent on an extensive system of blood vessels and 
<!-- PJG 0012 frnewline -->
capillaries to deliver large quantities of oxygen and nutrients as well as to remove toxic waste 
<!-- PJG 0012 frnewline -->
products. Damage to the capillaries in the brain can lead to the swelling characteristic of 
<!-- PJG 0012 frnewline -->
encephalopathy. This can be seen following exposure to higher concentrations of lead. 
<!-- PJG 0012 frnewline -->
Other metals (e.g., cadmium, thallium, and mercury) and organotin (e.g., trimethyltin) cause 
<!-- PJG 0012 frnewline -->
rupturing of vessels that can also result in encephalopathy. 
<!-- PJG 0012 frnewline -->
One large aspect of function that may be affected by neurotoxicants is behavior, 
<!-- PJG 0012 frnewline -->
which is the product of various sensory, motor, and associative functions of the nervous 
<!-- PJG 0012 frnewline -->
system. Neurotoxic substances can adversely affect sensory or motor functions, disrupt 
<!-- PJG 0012 frnewline -->
learning and memory processes, or cause detrimental behavioral effects; however, the 
<!-- PJG 0012 frnewline -->
underlying mechanisms for these effects have yet to be determined. Although changes may 
<!-- PJG 0012 frnewline -->
be subtle, the assessment of behavior may serve as a robust means of monitoring the well-being of the organism (Tilson
and Cabe, 1978). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
2.5. Special Considerations 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
2.5.1. Susceptible Populations 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Everyone is at a certain level of risk of being adversely affected by neurotoxic 
<!-- PJG 0012 frnewline -->
substances. Individuals of certain age groups, health states, and occupations, however, may 
<!-- PJG 0012 frnewline -->
be at a greater level of risk. Fetuses, children, the elderly, workers in occupations involving 
<!-- PJG 0012 frnewline -->
exposure to relatively high levels of toxic chemicals, and persons who abuse drugs are 
<!-- PJG 0012 frnewline -->
among those in high-risk groups. Neurotoxic substances may exacerbate existing 
<!-- PJG 0012 frnewline -->
neurological or psychiatric disorders in a population. Although controversial (Waddell, 
<!-- PJG 0012 frnewline -->
1993), recent evidence suggests that there may be a subpopulation of people who have 
<!-- PJG 0012 frnewline -->
become sensitive to chemicals and experience adverse reactions to low-level exposures to 
<!-- PJG 0012 frnewline -->
environmental chemicals (Bell, et al., 1992). Confounded in all of these groups is the role 
<!-- PJG 0012 frnewline -->
that nutrition plays in the response of the organism to exposure. Both general nutritional 
<!-- PJG 0012 frnewline -->
status and specific nutritional deficiencies (for example, protein, iron, and calcium) can 
<!-- PJG 0012 frnewline -->
significantly influence the response to a toxic substance. 
<!-- PJG 0012 frnewline -->
It is widely accepted that during development adverse effects can result from exposure 
<!-- PJG 0012 frnewline -->
to some chemicals at lower levels than would be necessary for the average adult (Suzuki, 
<!-- PJG 0012 frnewline -->
1980). The developing nervous system appears to be differentially sensitive to some kinds of 
<!-- PJG 0012 frnewline -->
damage (Cushner, 1981; Pearson and Dietrich, 1985; Annau and Eccles, 1986; Hill and 
<!-- PJG 0012 frnewline -->
Tennyson, 1986; Silbergeld, 1986). During the developmental period, the nervous system is 
<!-- PJG 0012 frnewline -->
actively growing and establishing intricate cellular networks. Both the blood-brain and 
<!-- PJG 0012 frnewline -->
blood-nerve barriers that will eventually protect much of the adult brain, spinal cord, and 
<!-- PJG 0012 frnewline -->
peripheral nerves are incomplete. The protective mechanisms by which the organism deals 
<!-- PJG 0012 frnewline -->
with toxic substances, such as the detoxification systems, are not fully developed. Exposure 
<!-- PJG 0012 frnewline -->
to chemicals during development can result in a range of effects. At the highest exposure, 
<!-- PJG 0012 frnewline -->
effects include death, gross structural abnormalities, or altered growth. Larger populations 
<!-- PJG 0012 frnewline -->
are generally exposed to more moderate levels resulting in more subtle functional 
<!-- PJG 0012 frnewline -->
impairments. The qualitative nature of some injuries during development may differ from 
<!-- PJG 0012 frnewline -->
those seen in the adult, such as changes in tissue volume, misplaced or misoriented neurons, 
<!-- PJG 0012 frnewline -->
or delays or acceleration of the appearance of functional or structural endpoints (Rodier, 
<!-- PJG 0012 frnewline -->
1986). In many cases, the results of early injuries may become evident only as the nervous 
<!-- PJG 0012 frnewline -->
system matures and ages (Rodier, 1990). There are several instances in which functional 
<!-- PJG 0012 frnewline -->
alterations have resulted from exposure during the period between conception and sexual 
<!-- PJG 0012 frnewline -->
maturity (Riley and Vorhees, 1986; Vorhees, 1987). 
<!-- PJG 0012 frnewline -->
Early exposure to relatively low levels of lead can result in reduced scores on tests of 
<!-- PJG 0012 frnewline -->
mental development (Bellinger et al., 1987; Needleman, 1990). Early gestational exposure 
<!-- PJG 0012 frnewline -->
to neurotoxicants such as cocaine can produce long-term neurobehavioral abnormalities 
<!-- PJG 0012 frnewline -->
(Anderson-Brown et al., 1990; Hutchings et al., 1989); heavy alcohol exposure produces 
<!-- PJG 0012 frnewline -->
craniofacial abnormalities and mental retardation (Jones and Smith, 1973), while moderate 
<!-- PJG 0012 frnewline -->
levels of alcohol consumption during gestation can delay motor development (Little et al., 
<!-- PJG 0012 frnewline -->
1989). 
<!-- PJG 0012 frnewline -->
With aging, the level of risk for a number of health-related factors increases; it has 
<!-- PJG 0012 frnewline -->
been hypothesized that the risk for toxic perturbations to the nervous system also increases 
<!-- PJG 0012 frnewline -->
with age (Weiss, 1990). It is generally believed that with increasing age comes a decreased 
<!-- PJG 0012 frnewline -->
ability of the nervous system to respond to adverse events or to compensate for either 
<!-- PJG 0012 frnewline -->
biological, physical, or toxic effects. At the tissue and cellular level, the aging process can 
<!-- PJG 0012 frnewline -->
result in nerve cell loss, formation of neurofibrillary tangles (abnormal accumulation of 
<!-- PJG 0012 frnewline -->
certain filamentous proteins) and neuritic plaques (abnormal clusters of proteins and other 
<!-- PJG 0012 frnewline -->
substances near synapses). As cells die, the complex neuronal circuitry of the brain becomes 
<!-- PJG 0012 frnewline -->
impaired. Neurotransmitter concentrations and the enzymes involved in their synthesis may 
<!-- PJG 0012 frnewline -->
be altered. Some axons can gradually lose their myelin sheath, resulting in a slowed 
<!-- PJG 0012 frnewline -->
conduction of nerve impulses along the axon. It has been postulated that with age, not only 
<!-- PJG 0012 frnewline -->
might the nervous system become more susceptible to new insults, but the effects of previous 
<!-- PJG 0012 frnewline -->
exposures also may become evident, with a diminished capacity for compensation (Weiss, 
<!-- PJG 0012 frnewline -->
1990). The increased incidence of multiple drug-taking in the elderly population might also 
<!-- PJG 0012 frnewline -->
lead to interactions, either drug/drug or drug/chemical, which can adversely affect the 
<!-- PJG 0012 frnewline -->
nervous system. Nutritionally, the aged experience increased incidences of both general 
<!-- PJG 0012 frnewline -->
undernutrition and deficits of specific nutrients such as iron or calcium, which might 
<!-- PJG 0012 frnewline -->
influence the response to toxic substances. 
<!-- PJG 0012 frnewline -->
In the geriatric population, the clinical manifestation of neurodegenerative disorders 
<!-- PJG 0012 frnewline -->
may have a contributing component of past exposures to environmental chemical agents. 
<!-- PJG 0012 frnewline -->
Calne et al. (1986) hypothesized that various agents contribute to Alzheimer's disease, 
<!-- PJG 0012 frnewline -->
Parkinson's disease, or amyotrophic lateral sclerosis (ALS, motoneurone disease, or Lou 
<!-- PJG 0012 frnewline -->
Gehrig's disease) by depleting neuronal reserves to an extent that perturbations become 
<!-- PJG 0012 frnewline -->
observable in the context of the natural aging process. B-N-methylamino-L-alanine, from the 
<!-- PJG 0012 frnewline -->
seed of the false sago palm (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Cycas circinalis 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
L.), has been reported to induce a form of 
<!-- PJG 0012 frnewline -->
amyotrophic lateral sclerosis (Spencer et al., 1987). Alzheimer-type syndromes have been 
<!-- PJG 0012 frnewline -->
reported in individuals occupationally exposed to organic solvents or metal vapors (Freed and 
<!-- PJG 0012 frnewline -->
Kandel, 1988). Severe cognitive dysfunction has been noted in Alzheimer's disease and 
<!-- PJG 0012 frnewline -->
aluminum intoxication (Yokel et al., 1988). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00229 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
At any age, preexisting physical as well as mental disorders of the individual may play a significant role in the manifestation
of a toxic response following exposure to a potentially toxic substance. Both types of disorders compromise the system
in some way so that either the defense mechanisms of the organism are not able to deal with the toxic substance or are
not able to repair themselves quickly. In addition to the basic altered biology, for individuals with a physical or
mental disorder who are under some form of medical intervention, the combination of therapeutic drugs and toxic substances
may have an interactive effect on the nervous system. For example, due to the delicate electrochemical balance of
the nervous system, mental disorders may be exacerbated by exposure to a toxic substance. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
2.5.2. Blood-Brain and Blood-Nerve Barriers 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The bioavailability of a specific chemical to the nervous system is a function of both the target tissue and the chemical.
The brain, spinal cord, and peripheral nerves are surrounded by a series of semipermeable tissues referred to as the
blood-brain and blood-nerve barriers (Katzman, 1976; Peters et al., 1991). In the central nervous system, the blood-brain
barrier is composed of tight junctions formed by endothelial cells and astrocytes. These tight junctions and cellular
interactions forming the barrier restrict the free passage of most bloodborne substances. By doing this, they create
a finely controlled extracellular environment for the nerve cells. Certain regions of the brain and nerves are directly
exposed to chemicals in the blood because the barrier is not present in some areas of the nervous system. For example,
it is absent in the circumventricular area, around the dorsal root ganglion in the peripheral nervous system, and
around the olfactory nerve, which may allow chemicals to penetrate directly from the nasal region to the frontal cortex.

<!-- PJG 0012 frnewline -->
The existence of these blood-brain and blood-nerve barriers suggests that proper functioning of the nervous system
is dependent on control of the substances to which nerve cells are exposed. The term ``barrier,'' however, is somewhat
of a misnomer. Although water-soluble and polar compounds enter the brain poorly, lipophilic substances readily
cross the barrier. In addition, a series of specific transport mechanisms exist through which required nutrients
(hormones, amino acids, peptides, proteins, fatty acids, etc.) reach the brain (Pardridge, 1988). If toxicants
are lipid soluble or if they are structurally similar to substances that are normally transported into the brain,
they can achieve high concentrations in brain tissue. It has been proposed that one reason why the developing nervous
system may be differentially sensitive to some toxicants is that the blood-brain barrier is less effective than in
an adult. The effectiveness of the blood-brain barrier may also be changed by chemical-induced physiological events
such as metabolic acidosis and nutritional deprivation. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
2.5.3. Metabolism 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The central nervous system has a very high metabolic rate and, unlike other organs, the brain depends almost entirely
on glucose as a source of energy and raw material for the synthesis of other molecules (Damstra and Bondy, 1980). The
absence of an alternative energy source makes the CNS critically dependent on an uninterrupted supply of oxygen as
well as the proper functioning of enzymes that metabolize glucose. Substances can be toxic to the nervous system if
they perturb neuronal metabolism. Without glucose, nerve cells usually begin to die within minutes. Despite its
relatively small size, the energy demands of the brain require 14 percent of the heart's output and consumes about
18 percent of the oxygen absorbed by the lungs. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
2.5.4. Limited Regenerative Ability 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The nervous system has a combination of special features not found in other organ systems. It is composed of a variety
of metabolically active neurons and supporting cell types that interact through a multitude of complex chemical
mechanisms. Each cell type has its own functions and vulnerabilities. At the time of puberty, the system is fully developed
and neurogenesis (the birth of new neurons from cell division of precursor cells called neuroblasts) ceases. This
is in marked and significant contrast to almost all other tissues, where cell replacement is continual. 
<!-- PJG 0012 frnewline -->
It is this loss of neurogenesis that limits the nervous system's ability to recover from damage and influences the
plasticity of the system. Neurons are unable to regenerate following damage; therefore, they are no longer able to
perform their normal functions. Toxic damage to the brain or spinal cord that results in cell loss is usually permanent.
If nerve cell loss is concentrated in one of the CNS's functional subsystems, the outcome could be debilitating; for
example, a relatively small loss of neurons that use acetylcholine as their neurotransmitter may produce a profound
disturbance of memory. A relatively minor insult concentrated in a subsystem that relies on dopamine as its neurotransmitter
may drastically impair motor coordination. However, in response to injury, neurons are able to show considerable
plasticity both during development and after maturation. Damage to the nervous system alters connectivity between
the surviving neurons, permitting functional adjustments to occur to compensate for the damage. Such responsiveness
may, in and of itself, have profound consequences for neurological, behavioral, and related body functions. 
<!-- PJG 0012 frnewline -->
After damage to axons in the peripheral nerves, if the neurons are not damaged, the axons have the ability to regenerate
and to attempt to reach their original target site. This is the basis, for example, of the eventual return of sensation
and muscle control in a surgically reattached limb. Neurons in the CNS also have the ability to regenerate interrupted
axons; however, they have a much more difficult task in reaching their original targets due to both the presence of
scar tissue formed by proliferating glia and to the increased complexity of the connectivity in the CNS. 
<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00230 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
3. Methods for Assessing Human Neurotoxicity 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
3.1. Introduction 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This chapter outlines and discusses current methods for detecting neurotoxicity in humans. In contrast to studies
of neurotoxicity in animals where functional changes readily can be correlated with neuroanatomic and neurochemical
alterations, there are ethical and technical barriers to the direct observation of neuronal damage in humans. Neurotoxicity
in humans is most commonly measured by relatively noninvasive neurophysiologic and neurobehavioral methods that
assess cognitive, affective, sensory, and motor function. The evaluation of human neurotoxicity and the relevance
to risk assessment will be discussed within the context of clinical evaluation, epidemiologic/worksite studies,
and human laboratory exposure studies. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
3.2. Clinical Evaluation 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Neurobehavioral assessment methods are used extensively in clinical neurology and neuropsychology to evaluate
patients suspected of having neurologic disease. An extensive array of examiner-administered and paper and pencil
tasks are used to assess sensory, motor, cognitive, and affective functions and personality states/traits. Neurobehavioral
data are synthesized with information from neurophysiologic studies, imaging techniques, medical history, etc.,
to derive a working diagnosis. Clinical diagnostic approaches have provided a rich conceptual framework for understanding
the functions (and malfunctions) of the central and peripheral nervous systems and have formed the basis for the development
of methods for measuring the behavioral expression of nervous system disorders. Human neurobehavioral toxicology
has borrowed heavily from neurology and neuropsychology for concepts of nervous system impairment and functional
assessment methods. Neurobehavioral toxicology has adopted the neurologic/neuropsychologic model, using adverse
changes in behavioral function to assist in identifying chemically or drug-induced changes in nervous system processes.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.2.1. Neurologic Evaluation 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Assessment of neurobehavioral function by the clinical examination of a patient has long been used as a primary tool
in neurologic diagnosis. The domains of cognitive function, motor function, sensation, reflexes, and cranial nerve
function are a standard part of the clinical neurologic exam. Movement and gait, speech fluency and content, verbal
memory, deep tendon reflexes, muscle strength, symmetry of movement and strength, ocular movements, sensory function
(pressure, vibration, visual, auditory), motor coordination, and logical reasoning are only a few of the functions
assessed by neurologists (Denny-Brown et al., 1982). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Trained and experienced clinicians gather these data by observation, verbal exchange, and direct examination.
Neurologic exams are sensitive indicators of neurologic disease; the data have predictive value for the diagnosis
of underlying nervous system disease, and the methods have been extensively validated against other diagnostic
procedures (e.g., imaging, neurophysiologic testing), the course of the illness, and autopsy findings. Examination
of the patient in a semistructured procedure can yield a wealth of information and insights about functional impairment
and the underlying neuropathology.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00231 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.2.2. Neuropsychological Testing 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Neuropsychologists have developed quantitative methods to supplement clinical neurologic exam and laboratory
data for the diagnosis of neurologic disease. Currently, two assessment batteries, the Luria-Nebraska and the Halstead-Reitan,
and shorter versions are used in clinical practice. The batteries consist of subtests that quantify a wide spectrum
of cognitive, motor, sensory, intellectual, affective, and personality functions. The pattern of relative performance
on the subtests can be interpreted along with historical and medical data to suggest the presence or absence of neurologic
disease and the possible anatomic location of any focal lesions or degeneration. Clinical interpretation of the
data is enhanced by data on age-related population norms for many subtests and by the systematic observation of the
patient during testing. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Several neurotoxicity assessment batteries use components of neuropsychological tests and have adapted and shortened
analogs of some subtests. Tests derived from the Wechsler Adult Intelligence Scale_Revised (WAIS&hyph;R) have
been used frequently to assess neurobehavioral impairment from chemical agents, and other abbreviated variations
of neuropsychological battery subtests have been incorporated into neurobehavioral toxicity batteries and used
in field and laboratory studies. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.2.3. Applicability of Clinical Methods to Neurotoxicology Risk Assessment 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Neurologic and neuropsychologic methods have long been employed to identify the adverse health effects of environmental
workplace exposures. Peripheral neuropathies (with sensory and motor disturbances), encephalopathies, organic
brain syndromes, extrapyramidal syndromes, demyelination, autonomic changes, and dementia are well-characterized
consequences of acute and chronic exposure to chemical agents. The range of exposure conditions that produce clinical
signs of neurotoxicity also has been defined by using these clinical methods. It is very important to make external/internal
dose measurements in humans in order to determine the actual dose(s) which can cause unwanted effects. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Aspects of the clinical neurologic examination approach limit its usefulness for neurotoxicologic risk assessment.
Information obtained from the neurologic exam is mostly qualitative and descriptive rather than quantitative.
Estimates of the severity of functional impairment can be reliably placed into only three or four categories (for
example, mild, moderate, severe). Much of the assessment depends on the subjective judgment of the examiner; the
magnitude and symmetry of muscle strength are often judged by having the patient push against the resistance of the
examiner's hands. The datum is therefore the absolute and relative amount of muscle load sensed by the examiner in
his or her arms. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Compared with other methods, the clinical neurologic exam may be less sensitive in detecting early neurotoxicity
in peripheral sensory and motor nerves. While clinicians' judgments are equal in sensitivity to quantitative methods
in assessing the amplitude of tremor, tremor frequency is poorly quantified by clinicians. Thus, important aspects
of the clinical neurologic exam may be insufficiently quantified and lack sufficient sensitivity for detecting
early neurobehavioral toxicity produced by environmental or workplace exposure conditions. However, a neurologic
evaluation of persons with documented neurobehavioral impairment would be helpful for identifying nonchemical
causes, such as diabetes and cardiovascular insufficiency. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Administration of a neuropsychological battery also requires a trained technician, and interpretation requires
a trained and experienced neuropsychologist. Depending on the capabilities of the patient, 2 to 4 hours may be needed
to administer a full battery; 1 hour may be needed for the shorter screening versions. These practical considerations
may limit the usefulness of neuropsychological assessment in large field studies of suspected neurotoxicity. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In addition to logistical problems in administration and interpretation, neuropsychological batteries and neurologic
exams share two disadvantages with respect to neurotoxicity risk assessment. First, neurologic exams and neuropsychological
test batteries are designed to confirm and classify functional problems in individuals selected on the basis of signs
and symptoms identified by the patient, family, or other health professionals. Their usefulness in detecting low-base
rate impairment in workers or the general population maybe generally thought to be limited, decreasing the usefulness
of clinical assessment approaches for epidemiologic risk assessment. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Second, neurologic exams and neuropsychologic test batteries were largely developed to assess the functional correlates
of the most common forms of nervous system dysfunction: brain trauma, focal lesions, and degenerative conditions.
The clinical tests were primarily validated against these neurologic disease states. There has been insufficient
research to demonstrate which tests designed to assess functional expression of neurologic disease are most useful
in characterizing the modes of CNS impairment produced by chemical agents and drugs. More research is needed to validate
the usefulness of neuropsychologic test methods in neurotoxicology. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
3.3. Current Neurotoxicity Testing Methods 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.3.1. Neurobehavioral Methods 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Chemical agents directly or indirectly affect a wide range of nervous system activities. Many of these chemical actions
are expressed as alterations of behavior; Anger (1990a) lists 35 neurobehavioral effects of chemical exposure that
illustrate alterations in sensory, motor, cognitive, affective, and personality function. Professional judgment
is important in the interpretation of data from studies using neurobehavioral methods since some endpoints can be
subjective. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Dozens of tests of neurobehavioral function have been proposed or used in field or laboratory studies to assess the
neurotoxicity of chemical agents. Table 3&hyph;1 lists some frequently used tests of motor, sensory, cognitive,
and affective neurobehavioral function.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00232 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG 0012 frnewline -->

<TABLE>

<!-- PJG tableformat 2,L2,i1,s10,r20 -->

<!-- PJG ITAG l=95 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Table
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=1 -->
 3&hyph;1.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
_Neurobehavioral Methods 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Neurobehavioral 
<!-- PJG 007 0120 intable -->
function 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Test 
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=4 -->
Sensation 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Flicker Fusion. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=4 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Lanthony (color 
<!-- PJG 007 0120 intable -->
&blank;vision).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=4 -->
Motor/Dexterity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Pursuit Aiming. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=4 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Finger Tapping. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Postural Stability. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Reaction Time. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Santa Ana Peg Board. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=4 -->
Cognition
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Benton Visual Retention. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=4 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Continuous Performance Task. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Digit-Symbol. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Digit Span. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Dual Tasks. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Paired-Associate. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Symbol-Digit Task. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Wechsler Adult Intelligence Scale_Revised
<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=6 f=1 -->

<!-- PJG 0037 unknown -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
 (Components). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Wechsler Memory Scale.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=6 f=1 -->

<!-- PJG 0037 unknown -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Affect
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Profile of Mood States
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=6 f=1 -->

<!-- PJG 0037 unknown -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 (POMS). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00233 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In contrast to the individual focus in clinical evaluation, neurobehavioral tests primarily have been used to evaluate
differences between groups, comparing unexposed groups with persons environmentally or occupationally exposed
to a suspected neurotoxic agent. An ideal evaluation of groups for quantitative evidence of chemically induced neurobehavioral
impairment would involve the assessment of a wide variety of functions, but testing all possible neurobehavioral
functions that might be affected in a group of exposed workers, for example, would be impossible. Therefore, a testing
strategy has been to use limited number tests that sample representative neurobehavioral functional domains such
as 
<!-- PJG 0012 frnewline -->
dexterity, visual memory, and reaction time. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.3.1.1. Test batteries. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Many field and laboratory studies have selected neurobehavioral methods according to available information about
the spectrum of effects of the suspected neurotoxic agent(s). This focused strategy is useful for answering specific
questions about known neurotoxins. To identify unspecified neurotoxic effects in groups of workers or to characterize
the effects of less well-studied chemicals or mixtures of chemicals, several tests that sample a representative
range of functional domains have been grouped into test batteries. The advantage of a standardized battery is that
data from different study populations and chemical classes can be compared, and similarities in effects observed
(Johnson, 1987). Standardized batteries can be categorized into investigator-administered and computer-administered
types. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.3.1.2. Investigator-administered test batteries. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The WHO-recommended Neurobehavioral Core Test Battery (NCTB) (Johnson, 1987), the Finnish Institute of Occupational
Health (FIOH) (Hanninen, 1990), and the Pittsburgh Occupational Exposures Test Battery (POET) (Ryan et al., 1987)
are three commonly used batteries. The NCTB is frequently used in field 
<!-- PJG 0012 frnewline -->
studies worldwide and can be fit inside a medium-sized suitcase for transport. The NCTB consists of the following
tests: simple reaction time task, digit-symbol coding task, timed motor coordination test (Santa Ana pegboard),
digit span memory test, Benton Visual Retention test, pursuit aiming test, and the Profile of Mood States (POMS).
Based on factor-analytic studies (Hooisma et al., 1990), these tests are believed to measure the functional domains
of immediate memory, attention, dexterity/hand-eye coordination, reaction time, and mood. Long-term memory,
verbal and language functions, auditory sensation, judgment, and so forth are not assessed. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.3.1.3. Computerized test batteries. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Computerized tests and batteries have been developed for field and laboratory use. The Neurobehavioral Evaluation
System (NES) (Baker et al., 1985), MicroTox (Eckerman et al., 1985), the SPES (Iregren et al., 1985), and the NCTR Operant
Battery (Paule et al., 1990) are computerized systems developed for neurotoxicity assessment. Current versions
of the NES, for example, consist of about 15 different neurobehavioral tests, and the battery has been used in epidemiologic
studies of groups exposed to solvent, pesticide, and mercury, and in laboratory studies of NO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, ethanol, and toluene (Letz, 1990). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00234 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Although many computerized tests appear to tap similar neurobehavioral domains as 
<!-- PJG 0012 frnewline -->
noncomputerized batteries, the visual mode of presentation, the manual mode of response, and the emphasis on speed
of responding are believed to have led to significant differences in results obtained from computerized versus noncomputerized
forms of similar tests. Attempts to clarify the differences between computerized and noncomputerized test batteries
have met with difficulty. Although some tests are similar in each type of battery, size and duration of stimuli, presentation
and response modality, number of trials, and scoring vary arbitrarily, preventing direct comparison. An example
is the digit-symbol test on the NCTB and the symbol-digit test on the NES. Although almost identical in task requirements,
procedural and scoring differences prevent direct comparison of the results from these two tests. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Postural stability is an aspect of integrated sensory and motor function that increasingly is being evaluated in
clinical, epidemiologic, and laboratory investigations of effects of pesticides and solvents, and would be useful
for assessing therapeutic drug-induced movement disorders such as neuroleptics. Measurement of postural stability
requires a computer, special software, monitor, and a force transduction platform on which the subjects 
<!-- PJG 0012 frnewline -->
must stand (Dick et al., 1990). Mechanical and capacitive field methods for assessing the amplitude and frequency
of tremor also are seeing more frequent use. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
An advantage of computerized testing is the standardization of test presentation, but a disadvantage is the need
for delicate, expensive computers and measurement devices that require transport for field studies. Noncomputerized
test batteries may be less costly to purchase and easier to transport, enhancing their desirability in field studies,
but test administrators require training and small differences in test administration may affect the data.
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.3.2. Neurophysiologic Methods 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
With improvements in the capabilities and size of equipment, quantitative 
<!-- PJG 0012 frnewline -->
neurophysiologic measurement of sensory and motor function will be increasingly useful in human neurotoxicity
evaluations. A major advantage of these methods for risk assessment is that they can be assessed in both human and animal
subjects and the data can be interpreted in an homologous manner. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Electromyographic responses (EMG) and nerve conduction velocity (NCV) have been used in the assessment of peripheral
nerve neurotoxicity. Some techniques require that needle electrodes be placed beneath the skin for stimulation
and recording and are therefore somewhat uncomfortable for the subject. However, the methods are quantitative,
provide multiple endpoints of PNS function, and have clinical relevance. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The adverse effects of solvents, pesticides, and metals have been identified with EMG/NCV neurophysiologic measures.
Although not reduced as a function of duration of employment, maximum nerve conduction velocity (MCV) has been reported
to vary systematically with cumulative exposure to carbon disulfide (Johnson et al., 1983), suggesting that this
measure may be particularly valuable for quantitative risk assessment of some types of peripheral motor nerve toxicity.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Noninvasive neurophysiologic test methods used in neurotoxicity evaluations include the electroencephalogram
(EEG), visually evoked response (VER), somatosensory evoked potential (SEP), and the brainstem auditory evoked
response (BAER). The EEG is the summed electrical activity of neurons measured with scalp electrodes; voltage and
frequency are primary measures. Evoked methods employ specific eliciting stimuli applied to the sense organs to
measure nervous system electrical response. Visual patterns, sounds, and cutaneous stimuli are presented to the
subject, and ``evoked'' voltage changes in the nervous system are measured with skin electrodes. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
While EEGs were developed as a tool in the neurologic diagnosis of seizure disorders and other brain diseases, dose-related
EEG changes in chemically exposed (especially solvents and styrene) individuals have been noted (Seppalainen and
Harkonen, 1976). EEG measurement requires large recording devices that can be used in the laboratory or clinic, but
are difficult to use in field studies. However, compact computerized recording equipment 
<!-- PJG 0012 frnewline -->
has been developed, and automated spectral analyses of EEGs have recently been applied to neurotoxicity evaluation
(Piikivi and Tolonen, 1989). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In contrast to EEGs, evoked response technology is improving, and equipment, while expensive, is becoming more portable.
VERs have been used to detect the sensory toxicity of solvents and carbon monoxide in human subjects, and a relationship
has been suggested between BAER and blood lead levels in children exposed to lead-containing dust in the environment
(Otto and Hudnell, 1990). Evoked potentials also may be conditioned, allowing the use of sensory methods to investigate
associative processes. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Dose-response functions have been found with evoked methods. A curvilinear relationship was found between BAER
and blood lead concentrations in children (Otto and Hudnell, 1990), and a biphasic function described visual evoked
potential (VEP) latency and visual contrast sensitivity and perchloroethylene exposure concentration in a laboratory
study (Altmann et al., 1991). In the latter study, the direction of the response was jointly dependent on dose and stimulus
parameters. In addition, changes over time in the effect of the solvent on VEP were dose and stimulus parameter dependent.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Two important methodologic considerations are illustrated by BAER and VEP data. One is that low concentrations of
some chemical agents may produce effects (shorter latencies in these examples) that could be inaccurately interpreted
as facilitation rather than impairment. Changes in neuronal latencies in either direction could be a result of a neurotoxic
process. The second is that the detection of neurotoxic effects is dependent on dose-time-testing parameter interactions.
A thorough understanding of the effects of testing parameters on the dose-response relationship and the time course
of chemical effect will be necessary for interpreting neurotoxicity studies. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The development of neurophysiologic methods, such as evoked and conditioned potentials, for neurotoxicity risk
assessment should be encouraged. These methods provide relatively unambiguous quantitative data on sensory function
that may have clear implications for health, are influenced by fewer extraneous variables than are self-report and
neurobehavioral performance tests, and allow relatively direct extrapolation of effects between animals and humans.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00235 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.3.3. Neurochemical Methods 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
One of the major difficulties in risk assessment is estimating exposure parameters and 
<!-- PJG 0012 frnewline -->
the dose or body burden actually absorbed by the individual. In epidemiologic studies, the 
<!-- PJG 0012 frnewline -->
actual absorption and bioavailability of a chemical from an exposure are frequently unknown. 
<!-- PJG 0012 frnewline -->
Measurement of chemical concentrations in biologic fluids or tissues is one way to 
<!-- PJG 0012 frnewline -->
measure more precisely the concentration at the site(s) of toxic effect. In epidemiologic 
<!-- PJG 0012 frnewline -->
studies, this has been possible only for chronic exposure and for acute exposure to chemicals 
<!-- PJG 0012 frnewline -->
with long biologic half-lives in the body, such as lead, other metals, and bromides. Blood 
<!-- PJG 0012 frnewline -->
lead levels show correlations with neurobehavioral impairment, but blood lead levels are 
<!-- PJG 0012 frnewline -->
representative correlates of toxicity only for relatively acute doses. In children, for example, 
<!-- PJG 0012 frnewline -->
the majority of lead-related impairment is the result of chronic, rather than acute, absorption. 
<!-- PJG 0012 frnewline -->
The cumulative amount of lead sequestered in tissues (such as deciduous teeth) may be a 
<!-- PJG 0012 frnewline -->
more representative indicator of the area under the time-concentration curve. 
<!-- PJG 0012 frnewline -->
For chemicals with half-lives in the body too short for estimating absorbed dose, the 
<!-- PJG 0012 frnewline -->
biochemical products from the chemical or from the physiologic effects of the chemical may 
<!-- PJG 0012 frnewline -->
serve as an index of exposure. Serum enzyme concentrations (cholinesterase) and esterases 
<!-- PJG 0012 frnewline -->
in other tissues (lymphocyte target esterase) have been employed in field studies to detect 
<!-- PJG 0012 frnewline -->
pesticide exposure, while vanillylmandelic acid (product of catecholamine neurotransmitter 
<!-- PJG 0012 frnewline -->
biotransformation) and erythrocyte protoporphyrin concentrations have been used with 
<!-- PJG 0012 frnewline -->
varying success in differentiating between lead-exposed and control workers. The addition of 
<!-- PJG 0012 frnewline -->
similar ``exposure biomarker'' measures to laboratory studies may allow the development of 
<!-- PJG 0012 frnewline -->
quantitative estimates of absorbed dose under various exposure conditions. 
<!-- PJG 0012 frnewline -->
The measurement of metabolic products of neurotoxic agents may be extremely useful 
<!-- PJG 0012 frnewline -->
in risk assessment; an example comes from cancer risk assessment. Human data from the 
<!-- PJG 0012 frnewline -->
early 1970s on saturation of microsomal methylene chloride biotransformation to carbon 
<!-- PJG 0012 frnewline -->
monoxide (Stewart et al., 1972), along with subsequent animal carcinogenesis data garnered 
<!-- PJG 0012 frnewline -->
in the 1980s, provided a quantitative basis for a physiologically based pharmacokinetic model 
<!-- PJG 0012 frnewline -->
of methylene chloride cancer risk assessment (Andersen et al., 1991). The information on 
<!-- PJG 0012 frnewline -->
human CO pathway kinetics provided the homologous key that allowed extrapolation of risk 
<!-- PJG 0012 frnewline -->
from animals to humans on a comparative physiologic basis rather than using default 
<!-- PJG 0012 frnewline -->
assumptions. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.3.4. Imaging Techniques 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A number of recently developed computerized imaging techniques for evaluating brain 
<!-- PJG 0012 frnewline -->
activity and cerebral/peripheral blood flow have added valuable information to the neurologic 
<!-- PJG 0012 frnewline -->
diagnostic process. These imaging methods include thermography, positron emission 
<!-- PJG 0012 frnewline -->
tomography, passive neuromagnetic imaging (magnetoencephalography), magnetic resonance 
<!-- PJG 0012 frnewline -->
imaging, magnetic resonance spectroscopy, computerized tomography, doppler 
<!-- PJG 0012 frnewline -->
ultrasonography, and computerized EEG recording/analysis (brain electrical activity 
<!-- PJG 0012 frnewline -->
mapping). The research application of these invasive and noninvasive quantitative methods 
<!-- PJG 0012 frnewline -->
has primarily been in neurology, schizophrenia research, drug abuse, AIDS research and 
<!-- PJG 0012 frnewline -->
toxic encephalopathy (Hagstadius et al., 1989). Although the equipment for brain imaging is 
<!-- PJG 0012 frnewline -->
expensive and not portable, neuroimaging techniques promise to be valuable clinical and 
<!-- PJG 0012 frnewline -->
laboratory research tools in human neurotoxicology. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.3.5. Neuropathologic Methods 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Neuropathologic examination of nervous system tissue has been used to confirm data 
<!-- PJG 0012 frnewline -->
from clinical testing and to contribute to the understanding of mechanisms of action of 
<!-- PJG 0012 frnewline -->
neurotoxicity. Peripheral nerve biopsies have confirmed chemically induced peripheral 
<!-- PJG 0012 frnewline -->
neuropathies and evaluated rates of recovery (Fullerton, 1969). Postmortem examination of 
<!-- PJG 0012 frnewline -->
nervous tissue also has elucidated the neuropathological effects of carbon disulfide, 
<!-- PJG 0012 frnewline -->
clioquinol, and doxorubicin (Spencer and Schaumburg, 1980). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.3.6. Self-Report Assessment Methods 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Self-report measures relevant to neurotoxicity risk assessment consist of histories of 
<!-- PJG 0012 frnewline -->
symptoms, events, behaviors, and environmental conditions. Information is obtained by 
<!-- PJG 0012 frnewline -->
face-to-face interviews, structured interviews (often conducted for diagnostic purposes), 
<!-- PJG 0012 frnewline -->
medical histories, questionnaires, and survey instruments. 
<!-- PJG 0012 frnewline -->
Self-report instruments are the only means for measuring some symptoms and all 
<!-- PJG 0012 frnewline -->
interoceptive states, such as pain and nausea. Self-reports also are used to obtain information 
<!-- PJG 0012 frnewline -->
on behaviors and events (e.g., exposure conditions) especially when practical, legal, or 
<!-- PJG 0012 frnewline -->
ethical limitations prevent direct observation. 
<!-- PJG 0012 frnewline -->
Subjective symptoms elucidated from self-report instruments are responsive to dose. 
<!-- PJG 0012 frnewline -->
Hanninen et al. (1979) found that subjective symptoms were positively correlated with blood 
<!-- PJG 0012 frnewline -->
lead levels in exposed workers. Subjective pain estimations are correlated with dose and 
<!-- PJG 0012 frnewline -->
type of centrally and peripherally acting analgesics, and anxiety scores on a variety of scales 
<!-- PJG 0012 frnewline -->
are responsive to the size of the anxiolytic dose. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00236 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Symptom checklists are used in epidemiologic research to identify the pattern of 
<!-- PJG 0012 frnewline -->
subjective complaints, which can be used to guide the selection of objective assessment 
<!-- PJG 0012 frnewline -->
methods. The distribution of symptoms can be correlated with indices of exposure to 
<!-- PJG 0012 frnewline -->
determine if particular symptoms are more prevalent in exposed persons (Sjogren et al., 
<!-- PJG 0012 frnewline -->
1990). 
<!-- PJG 0012 frnewline -->
Self-report data are notable for biases that may influence them; these biases are well 
<!-- PJG 0012 frnewline -->
known in epidemiology, clinical practice, and social science. Even in the most superficial of 
<!-- PJG 0012 frnewline -->
questions, respondents may consciously or unknowingly bias the answer to fit what they 
<!-- PJG 0012 frnewline -->
believe to be the examiner's expectations. Details of objective events or subjective states are 
<!-- PJG 0012 frnewline -->
subject to alteration; recall and reporting of remembered occurrences may be biased to fit 
<!-- PJG 0012 frnewline -->
interpretations and expectations. The socioeconomic status, gender, and affiliation of the 
<!-- PJG 0012 frnewline -->
tester also have been identified as biasing variables. Bias occurs when information is 
<!-- PJG 0012 frnewline -->
requested about behaviors, beliefs, or feelings believed by the respondent to be socially 
<!-- PJG 0012 frnewline -->
undesirable or when reinforcement contingencies (e.g., litigation) strongly favor selective 
<!-- PJG 0012 frnewline -->
reporting. 
<!-- PJG 0012 frnewline -->
Biases in self-report data can be reduced by making the questionnaire anonymous or 
<!-- PJG 0012 frnewline -->
highly confidential; objective data can be used to validate self-reports. Ethnographic 
<!-- PJG 0012 frnewline -->
observations, objective measurement of behavior, biologic samples, and the observations of 
<!-- PJG 0012 frnewline -->
significant others are employed to validate self-report data. Consistent descriptions of events 
<!-- PJG 0012 frnewline -->
by several persons lend credence to the reliability of the report. Many clinical interviews 
<!-- PJG 0012 frnewline -->
and self-report assessment instruments include some mechanisms for detecting self-report 
<!-- PJG 0012 frnewline -->
bias, either by looking for endorsement of improbable behaviors, or by examining the 
<!-- PJG 0012 frnewline -->
consistency of information gathered in several ways or from several sources. Concordance 
<!-- PJG 0012 frnewline -->
among biologic indices, observations, and physical examinations increases the judged validity 
<!-- PJG 0012 frnewline -->
of self-reports. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.3.6.1. Mood scales. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Changes in mood and emotionality can be consequences of 
<!-- PJG 0012 frnewline -->
neurotoxicity. For example, case reports have identified mood changes from exposure to 
<!-- PJG 0012 frnewline -->
mercury, lead, solvents, and organophosphate insecticides. The Taylor Manifest Anxiety 
<!-- PJG 0012 frnewline -->
Scale and the Profile of Mood States (POMS) are standardized self-report assessment 
<!-- PJG 0012 frnewline -->
instruments for which there is some evidence of sensitivity to chemical insult. 
<!-- PJG 0012 frnewline -->
The POMS, a component of the Neurobehavioral Core Test Battery, is a self-report 
<!-- PJG 0012 frnewline -->
measure that asks respondents to use a 5-point scale to rate the magnitude of 65 subjective 
<!-- PJG 0012 frnewline -->
states, such as ``tense,'' ``relaxed,'' ``hopeless,'' ``guilty,'' etc., that they have experienced 
<!-- PJG 0012 frnewline -->
within the past week. The responses are scored according to six mood factors, and a Total 
<!-- PJG 0012 frnewline -->
Mood Disturbance Score also may be calculated. Liang et al. (1990) used the POMS to 
<!-- PJG 0012 frnewline -->
evaluate lead-exposed workers (mean blood lead concentration of 41 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
g/dL) from a battery 
<!-- PJG 0012 frnewline -->
plant and a control group from a fabric-weaving manufacturer. Exposed workers were 
<!-- PJG 0012 frnewline -->
significantly higher on tension, depression, anger, fatigue, and confusion scales. 
<!-- PJG 0012 frnewline -->
Mood scales were developed to aid in assessment of psychological disorders, such as 
<!-- PJG 0012 frnewline -->
depression, and to track treatment response. In addition, mood is modulated by metabolic 
<!-- PJG 0012 frnewline -->
and endocrine variables in health and disease and can change rapidly in response to 
<!-- PJG 0012 frnewline -->
interpersonal, workplace, and environmental events. The large number of nonchemical 
<!-- PJG 0012 frnewline -->
variables and the lability of mood make inclusion of carefully selected controls essential in 
<!-- PJG 0012 frnewline -->
using affect as an endpoint in neurotoxicity research. 
<!-- PJG 0012 frnewline -->
The validity of mood scales may be limited to the specific populations in which the 
<!-- PJG 0012 frnewline -->
validity studies were performed. As characterizations of internal states, the meaning of the 
<!-- PJG 0012 frnewline -->
descriptors in the POMS established for one culture may not be the same as the meaning of 
<!-- PJG 0012 frnewline -->
that concept or term in other cultures or in other language systems. There may be variations 
<!-- PJG 0012 frnewline -->
in interpretation of the terms by respondents across English-speaking subcultures, perhaps as 
<!-- PJG 0012 frnewline -->
a function of education or the size of the verbal community. While these differences may 
<!-- PJG 0012 frnewline -->
not impede a global clinical interpretation, the reduction in generalizability across study 
<!-- PJG 0012 frnewline -->
populations may be sufficient to decrease the usefulness of subjective scales in quantitative 
<!-- PJG 0012 frnewline -->
neurotoxicity risk assessment. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.3.6.2. Personality scales. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Minnesota Multiphasic Personality Inventory (MMPI), the 
<!-- PJG 0012 frnewline -->
Cattell 16 PF, and the Eysenck Personality Inventory have occasionally been used in 
<!-- PJG 0012 frnewline -->
neurotoxicity research. Exposed and nonexposed groups have differed on several scales 
<!-- PJG 0012 frnewline -->
derived from these standardized questionnaires. The diagnostic power of the MMPI, for 
<!-- PJG 0012 frnewline -->
example, is not in the individual scales but in the pattern of scores on the 10 clinical and 3 
<!-- PJG 0012 frnewline -->
validity scales. Because interpretation of the MMPI requires a trained diagnostician with 
<!-- PJG 0012 frnewline -->
experience in the population of interest, it is less likely to be useful in quantitative 
<!-- PJG 0012 frnewline -->
neurotoxicity assessment. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
3.4. Approaches to Neurotoxicity Assessment 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00237 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.4.1. Epidemiologic Studies 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Epidemiology has been defined as ``the study of the distributions and determinants of 
<!-- PJG 0012 frnewline -->
disease and injuries in human populations'' (Mausner and Kramer, 1985). Knowing the 
<!-- PJG 0012 frnewline -->
frequency of illness in groups and the factors that influence the distribution is the tool of 
<!-- PJG 0012 frnewline -->
epidemiology that allows the evaluation of causal inference with the goal of prevention and 
<!-- PJG 0012 frnewline -->
cure of disease. Epidemiologic studies are a means of evaluating the effects of neurotoxic 
<!-- PJG 0012 frnewline -->
substances in human populations, but such studies are limited because they must be 
<!-- PJG 0012 frnewline -->
performed shortly after exposure if the effect is acute. Most often these effects are suspected 
<!-- PJG 0012 frnewline -->
to be a result of occupational exposures due to the increased opportunity for exposure to 
<!-- PJG 0012 frnewline -->
industrial and other chemicals. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.4.1.1. Case reports. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The first type of human study undertaken is the case report or case 
<!-- PJG 0012 frnewline -->
series, which can identify cases of a disease and are reported by clinicians or discerned 
<!-- PJG 0012 frnewline -->
through active or passive surveillance, usually in the workplace. For example, the 
<!-- PJG 0012 frnewline -->
neurological hazards of exposure to Kepone, dimethylaminopropionitrile, and methyl-n-butyl 
<!-- PJG 0012 frnewline -->
ketone were first reported as case studies by physicians who noted an unusual cluster of 
<!-- PJG 0012 frnewline -->
diseases in persons later found to have been exposed to these chemicals (Cone et al., 1987). 
<!-- PJG 0012 frnewline -->
However, case histories where exposure involved a single neurotoxic agent, though 
<!-- PJG 0012 frnewline -->
informative, are rare in the literature; for example, farmers are exposed to a wide variety of 
<!-- PJG 0012 frnewline -->
potentially neurotoxic pesticides. Careful case histories assist in identifying common risk 
<!-- PJG 0012 frnewline -->
factors, especially when the association between the exposure and disease is strong, the mode 
<!-- PJG 0012 frnewline -->
of action of the agent is biologically plausible, and clusters occur in a limited period of time. 
<!-- PJG 0012 frnewline -->
Case reports are inexpensive compared with other types of epidemiologic studies and 
<!-- PJG 0012 frnewline -->
can be obtained more quickly than more complex studies. They provide little information 
<!-- PJG 0012 frnewline -->
about disease frequency or population at risk, but their importance has been clearly 
<!-- PJG 0012 frnewline -->
demonstrated, particularly in accidental poisoning or acute exposure to high levels of 
<!-- PJG 0012 frnewline -->
toxicant. They remain an important source of index cases of new diseases and for 
<!-- PJG 0012 frnewline -->
surveillance in occupational settings. These studies require confirmation by additional 
<!-- PJG 0012 frnewline -->
epidemiologic research employing other study design. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.4.1.2. Cross-sectional studies. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In cross-sectional studies or surveys, both the disease and 
<!-- PJG 0012 frnewline -->
suspected risk factors are ascertained at the same time and the findings are useful in 
<!-- PJG 0012 frnewline -->
generating hypotheses. A group of people is interviewed, examined, and tested at a single 
<!-- PJG 0012 frnewline -->
point in time to ascertain a relationship between a disease and a neurotoxic exposure. This 
<!-- PJG 0012 frnewline -->
study design does not allow the investigator to determine whether the disease or the exposure 
<!-- PJG 0012 frnewline -->
came first, rendering it less useful in estimating risk. These studies are intermediate in cost 
<!-- PJG 0012 frnewline -->
and time required to complete compared with case reports and more complex analytical 
<!-- PJG 0012 frnewline -->
studies. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.4.1.3. Case-control (retrospective) studies. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Last (1986) defines a case-control study as 
<!-- PJG 0012 frnewline -->
one that ``starts with the identification of persons with the disease (or other outcome variable) 
<!-- PJG 0012 frnewline -->
of interest, and a suitable control population (comparison, reference) group of persons 
<!-- PJG 0012 frnewline -->
without the disease.'' He states that the relationship of an ``attribute'' to the disease is 
<!-- PJG 0012 frnewline -->
measured by comparing the diseased with the nondiseased with regard to how frequently the 
<!-- PJG 0012 frnewline -->
attribute is present in each of the groups. The cases are assembled from a population of 
<!-- PJG 0012 frnewline -->
persons with and without exposure and the comparison group is selected from the same 
<!-- PJG 0012 frnewline -->
population; the relative distribution of the potential risk factor (exposure) in both groups is 
<!-- PJG 0012 frnewline -->
evaluated by computing an odds ratio that serves as an estimate of the strength of the 
<!-- PJG 0012 frnewline -->
association between the disease and the potential risk factor. The statistical significance of 
<!-- PJG 0012 frnewline -->
the ratio is determined by calculating a p-value and is used to approximate relative risk. 
<!-- PJG 0012 frnewline -->
The case-control approach to the study of potential neurotoxins in the environment has 
<!-- PJG 0012 frnewline -->
provided a great deal of information. In his recent text, Valciukas (1991) notes that the 
<!-- PJG 0012 frnewline -->
case-control approach is the strategy of choice when no other environmental or biological 
<!-- PJG 0012 frnewline -->
indicator of neurotoxic exposure is available. He further states: ``Considering the fact that 
<!-- PJG 0012 frnewline -->
for the vast majority of neurotoxic chemical compounds, no objective biological indicators of 
<!-- PJG 0012 frnewline -->
exposure are available (or if they are, their half-life is too short to be of any practical value), 
<!-- PJG 0012 frnewline -->
the case-control paradigm is a widely accepted strategy for the assessment of toxic 
<!-- PJG 0012 frnewline -->
causation.'' The case-control study design, however, can be very susceptible to bias. The 
<!-- PJG 0012 frnewline -->
potential sources of bias are numerous and can be specific to a particular study, and will be 
<!-- PJG 0012 frnewline -->
discussed only briefly here. Many of these biases also can be present in cross-sectional 
<!-- PJG 0012 frnewline -->
studies. For example, recall bias or faulty recall of information by study subjects in a 
<!-- PJG 0012 frnewline -->
questionnaire-based study can distort the results of the study. Analysis of the 
<!-- PJG 0012 frnewline -->
case-comparison study design assumes that the selected cases are representative persons with 
<!-- PJG 0012 frnewline -->
the disease_either all cases with the disease or a representative sample of them have been 
<!-- PJG 0012 frnewline -->
ascertained. It further assumes that the control or comparison group is representative of the 
<!-- PJG 0012 frnewline -->
nondiseased population (or that the prevalence of the characteristic under study is the same in 
<!-- PJG 0012 frnewline -->
the control group as in general population). Failure to satisfy these assumptions may result 
<!-- PJG 0012 frnewline -->
in selection bias, but violation of assumptions does not necessarily invalidate the study 
<!-- PJG 0012 frnewline -->
results. 
<!-- PJG 0012 frnewline -->
An additional source of bias in case-control studies is the presence of confounding 
<!-- PJG 0012 frnewline -->
variables, i.e., factors known to be associated with the exposure and causally related to the 
<!-- PJG 0012 frnewline -->
disease under study. These must be controlled either in the design of the study by matching 
<!-- PJG 0012 frnewline -->
cases to controls on the basis of the confounding factor or in the analysis of the data by using 
<!-- PJG 0012 frnewline -->
statistical techniques such as stratification or regression. Matching requires time to identify 
<!-- PJG 0012 frnewline -->
an adequate number of potential controls to distinguish those with the proper characteristics, 
<!-- PJG 0012 frnewline -->
while statistical control of confounding requires a larger study. 
<!-- PJG 0012 frnewline -->
The definition of exposure is critical in epidemiologic studies. In occupational 
<!-- PJG 0012 frnewline -->
settings, exposure assessment is based on the job assignment of the study subjects, but can be 
<!-- PJG 0012 frnewline -->
more precise if detailed company records allow the development of exposure profiles. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00238 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.4.1.4. Prospective (cohort, followup) studies.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In a prospective study design, a healthy 
<!-- PJG 0012 frnewline -->
group of people is assembled and followed forward in time and observed for the development 
<!-- PJG 0012 frnewline -->
of disease. Such studies are invaluable for determining the time course for development of 
<!-- PJG 0012 frnewline -->
disease (e.g., followup studies performed in various cities on the effects of lead on child 
<!-- PJG 0012 frnewline -->
development). This approach allows the direct estimate of risks attributed to a particular 
<!-- PJG 0012 frnewline -->
exposure since disease incidence rates in the cohort are determined and allows the study of 
<!-- PJG 0012 frnewline -->
chronic effects of exposure. One major strength of the cohort design is that it allows the 
<!-- PJG 0012 frnewline -->
calculation of rates to determine the excess risk associated with an exposure. Also, biases 
<!-- PJG 0012 frnewline -->
are reduced by obtaining information before the disease develops. This approach, however, 
<!-- PJG 0012 frnewline -->
can be very time-consuming and costly. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In cohort studies information bias can be introduced when individuals provide 
<!-- PJG 0012 frnewline -->
distorted information about their health because they know their exposure status and may 
<!-- PJG 0012 frnewline -->
have been told of the expected health effects of the exposure under study. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A special type of cohort study is the retrospective cohort study in which the 
<!-- PJG 0012 frnewline -->
investigator goes back in time to select the study groups and traces them over time, often to 
<!-- PJG 0012 frnewline -->
the present. The studies usually involve specially exposed groups and have provided much 
<!-- PJG 0012 frnewline -->
assistance in estimating risks due to occupational exposures. Occupational retrospective 
<!-- PJG 0012 frnewline -->
cohort studies rely on company records of past and current employees that include 
<!-- PJG 0012 frnewline -->
information on the dates of employment, age at employment, date of departure, and whether 
<!-- PJG 0012 frnewline -->
diseased (or dead in the case of mortality studies). Workers can then be classified by 
<!-- PJG 0012 frnewline -->
duration and degree of exposure. A retrospective cohort study was performed in which a 
<!-- PJG 0012 frnewline -->
cohort of 1,790 bricklayers and 2,601 men exposed to paint solvents was retrospectively 
<!-- PJG 0012 frnewline -->
identified and, if a disability pension had been awarded, the subjects were examined for 
<!-- PJG 0012 frnewline -->
evidence of presenile dementia. This study found a rate ratio of 3.4 for presenile dementia 
<!-- PJG 0012 frnewline -->
among the painters as compared with the bricklayers (Johnson, 1987). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.4.2. Human Laboratory Exposure Studies 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Neurotoxicity assessment has an advantage not afforded the evaluation of other toxic 
<!-- PJG 0012 frnewline -->
endpoints, such as cancer or reproductive toxicity, in that the effects of some chemicals are 
<!-- PJG 0012 frnewline -->
short in duration and reversible. Under certain circumstances, it is ethically possible to 
<!-- PJG 0012 frnewline -->
perform human laboratory exposure studies and obtain data relevant to the risk assessment 
<!-- PJG 0012 frnewline -->
process. Information from experimental human exposure studies has been used to set 
<!-- PJG 0012 frnewline -->
occupational exposure limits, mostly for organic solvents that can be inhaled. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Laboratory exposure studies have contributed to risk assessment and the setting of 
<!-- PJG 0012 frnewline -->
exposure limits for several solvents and other chemicals with acute reversible effects. These 
<!-- PJG 0012 frnewline -->
chemicals include methylene chloride, perchloroethylene, trichloroethylene, and p-xylene 
<!-- PJG 0012 frnewline -->
(Dick and Johnson, 1986). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Human exposure studies offer advantages over epidemiologic field studies. Combined 
<!-- PJG 0012 frnewline -->
with appropriate biological sampling (breath or blood), it is possible to calculate body 
<!-- PJG 0012 frnewline -->
concentrations, to examine toxicokinetics, and identify metabolites. Bioavailability, 
<!-- PJG 0012 frnewline -->
elimination, dose-related changes in metabolic pathways, individual variability, time course 
<!-- PJG 0012 frnewline -->
of effects, interactions between chemicals, interactions between chemical and 
<!-- PJG 0012 frnewline -->
environmental/biobehavioral factors (stressors, workload/respiratory rate) are some processes 
<!-- PJG 0012 frnewline -->
that can be evaluated in laboratory studies. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Other goals of laboratory studies include the indepth characterization of effects, the 
<!-- PJG 0012 frnewline -->
development of new assessment methods, and the examination of the sensitivity, specificity, 
<!-- PJG 0012 frnewline -->
and reliability of neurobehavioral assessment methods across chemical classes. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The laboratory is the most appropriate setting for the study of environmental and 
<!-- PJG 0012 frnewline -->
biobehavioral variables that affect the action of chemical agents. The effects of ambient 
<!-- PJG 0012 frnewline -->
temperature, task difficulty, the rate of ongoing behavior, conditioning variables, 
<!-- PJG 0012 frnewline -->
tolerance/sensitization, sleep deprivation, motivation, etc., can be studied. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00239 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.4.2.1. Methodologic aspects.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
From a methodologic standpoint, human laboratory studies 
<!-- PJG 0012 frnewline -->
can be divided into two categories_between-subjects and within-subjects designs. In the 
<!-- PJG 0012 frnewline -->
former, the neurobehavioral performance of exposed volunteers is compared with that of 
<!-- PJG 0012 frnewline -->
nonexposed participants. In the latter, preexposure performance is compared with 
<!-- PJG 0012 frnewline -->
neurobehavioral function under the influence of the chemical or drug. Within-subjects 
<!-- PJG 0012 frnewline -->
designs have the advantage of requiring fewer participants, eliminating individual differences 
<!-- PJG 0012 frnewline -->
as a source of variability, and controlling for chronic mediating variables, such as caffeine 
<!-- PJG 0012 frnewline -->
use and educational achievement. A disadvantage of the within-subjects design is that 
<!-- PJG 0012 frnewline -->
neurobehavioral tests must be administered more than once. Practice on many 
<!-- PJG 0012 frnewline -->
neurobehavioral tests often leads to improved performance that may confound the effect of 
<!-- PJG 0012 frnewline -->
the chemical/drug. It is important to allow a sufficient number of test sessions in the 
<!-- PJG 0012 frnewline -->
preexposure phase of the study to allow performance on all tests to achieve a relatively stable 
<!-- PJG 0012 frnewline -->
baseline level. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.4.2.2. Human subject selection factors.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Participants in laboratory exposure studies may 
<!-- PJG 0012 frnewline -->
be recruited from populations of persons already exposed to the chemical/drug or from naive 
<!-- PJG 0012 frnewline -->
populations. Although the use of exposed volunteers has ethical advantages, can militate 
<!-- PJG 0012 frnewline -->
against novelty effects, and allows evaluation of tolerance/sensitization, finding an accessible 
<!-- PJG 0012 frnewline -->
exposed population in reasonable proximity to the laboratory is difficult. Naive participants 
<!-- PJG 0012 frnewline -->
are more easily recruited, but may differ significantly in important characteristics from a 
<!-- PJG 0012 frnewline -->
representative sample of exposed persons. Naive volunteers are often younger, healthier, 
<!-- PJG 0012 frnewline -->
and better educated than the populations exposed environmentally, in the workplace, or 
<!-- PJG 0012 frnewline -->
pharmacotherapeutically. For example, phase I drug trial data from relatively young and 
<!-- PJG 0012 frnewline -->
healthy volunteers may not adequately predict the incidence of neurotoxic side effects in 
<!-- PJG 0012 frnewline -->
older persons with chronic health problems. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.4.2.3. Exposure conditions and chemical classes.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Compared with workplace and 
<!-- PJG 0012 frnewline -->
environmental exposures, laboratory exposure conditions can be controlled more precisely, 
<!-- PJG 0012 frnewline -->
but exposure periods are much shorter. Generally only one or two relatively pure chemicals 
<!-- PJG 0012 frnewline -->
are studied for several hours while the population of interest may be exposed to multiple 
<!-- PJG 0012 frnewline -->
chemicals containing impurities for months or years. Laboratory studies are therefore better 
<!-- PJG 0012 frnewline -->
at identifying and characterizing effects with acute onset and the selective effects of pure 
<!-- PJG 0012 frnewline -->
agents. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Most laboratory studies of neurobehavioral function have employed individual 
<!-- PJG 0012 frnewline -->
solvents, combinations of two solvents, or very low concentrations of chemicals released 
<!-- PJG 0012 frnewline -->
from household and office materials (volatile organic compounds). This selection is 
<!-- PJG 0012 frnewline -->
primarily because solvent effects are reversible, because there are wide margins of safety for 
<!-- PJG 0012 frnewline -->
acute effects of solvents, because solvents can be administered via inhalation methods that 
<!-- PJG 0012 frnewline -->
allow calculation of body concentrations by breath sampling methods that do not require 
<!-- PJG 0012 frnewline -->
needle sticks, because over 1 million workers may have occupational solvent exposure, and 
<!-- PJG 0012 frnewline -->
because of the extensive use of solvents in household products. Chemicals studied in the 
<!-- PJG 0012 frnewline -->
laboratory over the past 40 years have included ozone, NO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, CO, styrene, lead, anesthetic 
<!-- PJG 0012 frnewline -->
gases, pesticides, irritants, chlorofluorocarbon compounds, and propylene glycol dinitrite. 
<!-- PJG 0012 frnewline -->
Caffeine, diazepam, and ethanol have been used in laboratory studies as positive control 
<!-- PJG 0012 frnewline -->
substances. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.4.2.4. Test methods.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Neurobehavioral test methods may be selected according to several 
<!-- PJG 0012 frnewline -->
strategies. A test battery that examines multiple neurobehavioral functions may be more 
<!-- PJG 0012 frnewline -->
useful for screening and the initial characterization of acute effects. Selected neurobehavioral 
<!-- PJG 0012 frnewline -->
tests that measure a more limited number of functions in multiple ways may be more useful 
<!-- PJG 0012 frnewline -->
for elucidating mechanisms or validating specific effects. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.4.2.5. Controls.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Both chemical and behavioral control procedures are valuable for 
<!-- PJG 0012 frnewline -->
examining the specificity of the effects. A concordant effect among different measures of the 
<!-- PJG 0012 frnewline -->
same neurobehavioral function (e.g., reaction time) and a lack of effect on some other 
<!-- PJG 0012 frnewline -->
measures of psychomotor function (e.g., untimed manual dexterity) would increase the 
<!-- PJG 0012 frnewline -->
confidence in a selective effect on motor speed and not on attention or on nonspecific motor 
<!-- PJG 0012 frnewline -->
function. Likewise, finding concordant effects among similar chemical or drug classes along 
<!-- PJG 0012 frnewline -->
with different effects from dissimilar classes would support the specificity of chemical effect. 
<!-- PJG 0012 frnewline -->
For example, finding that the effects of a solvent were similar to those of ethanol but not 
<!-- PJG 0012 frnewline -->
caffeine would support the specificity of solvent effects on a given measure of neurotoxicity. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.4.2.6. Ethical issues.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Most human exposure studies in the laboratory have been justified 
<!-- PJG 0012 frnewline -->
on the basis of data indicating that the chemical or drug exposure produces only temporary 
<!-- PJG 0012 frnewline -->
and reversible functional effects. The use of occupationally, environmentally, or 
<!-- PJG 0012 frnewline -->
therapeutically exposed populations as a source of participants also makes the risks from 
<!-- PJG 0012 frnewline -->
research exposure small relative to nonlaboratory sources of risk. Protection of human 
<!-- PJG 0012 frnewline -->
subjects is also provided by the informed consent process; the health risks (known and 
<!-- PJG 0012 frnewline -->
unknown) and benefits of the research are thoroughly explained to each participant, who may 
<!-- PJG 0012 frnewline -->
terminate participation in the study at any time. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Despite safeguards, several chemicals and drugs thought at the time of the exposure 
<!-- PJG 0012 frnewline -->
study to produce only temporary neurobehavioral effects are now (20 years later) suspected 
<!-- PJG 0012 frnewline -->
of being potential human carcinogens on the basis of animal and human data (e.g., methylene 
<!-- PJG 0012 frnewline -->
chloride, perchloroethylene). Other chemicals, however, are now thought to be less 
<!-- PJG 0012 frnewline -->
carcinogenic or otherwise less toxic in humans than once believed. Rapid advances in all 
<!-- PJG 0012 frnewline -->
areas of toxicology make it difficult to communicate, to potential subjects, reliable 
<!-- PJG 0012 frnewline -->
information about the likelihood of long-term, latent, or delayed adverse effects on health 
<!-- PJG 0012 frnewline -->
subsequent to the study. The communication of uncertainty about potential long-term effects 
<!-- PJG 0012 frnewline -->
to research participants is essential if human exposure studies are to be conducted ethically 
<!-- PJG 0012 frnewline -->
and are to continue their contributions to neurotoxicology and risk assessment. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
3.5. Assessment of Developmental Neurotoxicity 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.5.1. Developmental Deficits 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
While adult neurotoxicology evaluates the effects of chemical exposure on relatively 
<!-- PJG 0012 frnewline -->
stable nervous system structure and function, developmental neurotoxicology addresses the 
<!-- PJG 0012 frnewline -->
special vulnerabilities of the young and the old. Neurobehavioral assessment of chemical 
<!-- PJG 0012 frnewline -->
neurotoxicity is complicated by having to measure functional impairment within a sequential 
<!-- PJG 0012 frnewline -->
progression of emergence, maturation, and gradual decline of nervous system capabilities. 
<!-- PJG 0012 frnewline -->
Methods in developmental neurotoxicity assessment must reflect the diversity of 
<!-- PJG 0012 frnewline -->
neurobehavioral functions, from neonates to the elderly. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Exposure of pregnant women to alcohol, drugs of abuse, therapeutic drugs, nicotine, 
<!-- PJG 0012 frnewline -->
and environmental chemicals may result in the immediate or delayed appearance of 
<!-- PJG 0012 frnewline -->
neurobehavioral impairment in children (Kimmel, 1988; Nelson, 1991a). Postnatal exposure 
<!-- PJG 0012 frnewline -->
of children to chemical agents in the environment, such as lead, also may impair IQ and 
<!-- PJG 0012 frnewline -->
other indices of neurobehavioral function (Needleman et al., 1979). Neurotoxic effects may 
<!-- PJG 0012 frnewline -->
impair speech and language, attention, general intelligence, ``state'' regulation and 
<!-- PJG 0012 frnewline -->
responsiveness to external stimulation, learning and memory, sensory and motor skills, 
<!-- PJG 0012 frnewline -->
visuospatial processing, affect and temperament, and responsiveness to nonverbal social 
<!-- PJG 0012 frnewline -->
stimuli. Chemical neurotoxicity may be manifested as decreases in functional capabilities or 
<!-- PJG 0012 frnewline -->
delays in normative developmental progression. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Neurotoxic effects are not limited to direct exposure of the fetus or child to the 
<!-- PJG 0012 frnewline -->
chemical. Animal studies suggest that altered neurobehavioral development in offspring may 
<!-- PJG 0012 frnewline -->
result from exposure of males (Joffe and Soyka, 1981) and females to chemical substances 
<!-- PJG 0012 frnewline -->
prior to conception. In this case, altered postnatal development may reflect chemical 
<!-- PJG 0012 frnewline -->
influences on mechanisms of inheritance, copulatory behavior, nutritional status, hormonal 
<!-- PJG 0012 frnewline -->
status, or the uterine environment. In animals and humans, chemical exposure of parents 
<!-- PJG 0012 frnewline -->
may indirectly impair postnatal development through changes in milk composition, parenting 
<!-- PJG 0012 frnewline -->
behaviors, and other aspects of the environment. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00240 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In older adults the normal aging process alters the response to neurotoxicants. Both 
<!-- PJG 0012 frnewline -->
pharmacodynamic and pharmacokinetic changes may underlie altered sensitivities to the 
<!-- PJG 0012 frnewline -->
neurotoxic effects of drugs and chemicals. An example well known in geriatric medicine is 
<!-- PJG 0012 frnewline -->
the apparent increase in sensitivity of the elderly to the toxic effects of anxiolytics (Salzman, 
<!-- PJG 0012 frnewline -->
1981). Decreases in biotransformation rate and renal elimination of parent drug and active 
<!-- PJG 0012 frnewline -->
metabolites, not related to disease processes, may partially account for the increased 
<!-- PJG 0012 frnewline -->
vulnerability (Friedel, 1978). Chronic disease states in older persons may result in decreased 
<!-- PJG 0012 frnewline -->
functional capabilities and increased vulnerability to neurotoxic effects. Chronic diseases 
<!-- PJG 0012 frnewline -->
also may prompt pharmacotherapy that may impair neurobehavioral function. 
<!-- PJG 0012 frnewline -->
Cardiovascular, psychopharmacologic, and antineoplastic medications may result in patterns 
<!-- PJG 0012 frnewline -->
of neurobehavioral impairment not typically seen in younger individuals.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.5.2. Methodologic Considerations 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Standardized methods are being developed for pediatric neurotoxicity assessment. 
<!-- PJG 0012 frnewline -->
Neurobehavioral functions emerge during developmental phases from neonatal stage through 
<!-- PJG 0012 frnewline -->
secondary school, and nervous system insult may be reflected not only in impairment of 
<!-- PJG 0012 frnewline -->
emergent functions, but also as delays in the appearance of new functions. Both the severity 
<!-- PJG 0012 frnewline -->
and type of deficit are affected by the dose and duration of exposure (Nelson, 1991b), and 
<!-- PJG 0012 frnewline -->
different sensitivities to chemical effects may be exhibited at different stages of nervous 
<!-- PJG 0012 frnewline -->
system development. Early episodes of exposure may produce structural damage to the 
<!-- PJG 0012 frnewline -->
nervous system that may not be developmentally expressed in behavior for several months or 
<!-- PJG 0012 frnewline -->
years. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The selection of appropriate testing methods and conditions is more important when 
<!-- PJG 0012 frnewline -->
assessing children because of shorter attention spans and increased dependence on parental 
<!-- PJG 0012 frnewline -->
and environmental supports. In addition, because of the increasing complexity of functional 
<!-- PJG 0012 frnewline -->
capabilities during early development, only a few tests appropriate for infants can be validly 
<!-- PJG 0012 frnewline -->
readministered to older children. Given the complexity of these variables, the task of 
<!-- PJG 0012 frnewline -->
devising sensitive, reliable, and valid assessment instruments or batteries for pediatric 
<!-- PJG 0012 frnewline -->
populations will be challenging. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Assessment methods in older adults must be capable of distinguishing chemical and 
<!-- PJG 0012 frnewline -->
drug effects from the effects of aging processes and chronic disease states (Crook et al., 
<!-- PJG 0012 frnewline -->
1983). Assessment methods must be valid and reliable with repeated administration across a 
<!-- PJG 0012 frnewline -->
significant portion of the lifespan, and take into consideration the time (days, months, or 
<!-- PJG 0012 frnewline -->
years) that may intervene between exposure/insult and the expression of neurotoxicity as 
<!-- PJG 0012 frnewline -->
functional impairment. Research on nonexposed populations to develop age-appropriate 
<!-- PJG 0012 frnewline -->
normative scores for neurobehavioral functions will be important for the interpretation of 
<!-- PJG 0012 frnewline -->
assessment instruments. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Environmental exposure to neurotoxic chemicals and drugs is correlated with 
<!-- PJG 0012 frnewline -->
socioeconomic and ethnic status. Assessment methods will therefore have to be adapted to 
<!-- PJG 0012 frnewline -->
diverse ethnic, cultural, and language groups. While gender differences in early 
<!-- PJG 0012 frnewline -->
development have been noted, differential responses of males and females to neurotoxicants 
<!-- PJG 0012 frnewline -->
have been less well explored and should receive attention. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
3.6. Issues in Human Neurotoxicology Test Methods 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.6.1. Risk Assessment Criteria for Neurobehavioral Test Methods 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The value of human neurobehavioral test methods for quantitative risk assessment is 
<!-- PJG 0012 frnewline -->
related to the number of the following criteria that can be met: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
a. Demonstrate sensitivity to the kinds of neurobehavioral impairment produced by 
<!-- PJG 0012 frnewline -->
chemicals; that is, able to detect a difference between exposed and nonexposed populations in 
<!-- PJG 0012 frnewline -->
field studies or between exposure and nonexposure periods in human laboratory research or 
<!-- PJG 0012 frnewline -->
within exposed populations over time. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
b. Show specificity for neurotoxic chemical effects and not be unduly responsive to a 
<!-- PJG 0012 frnewline -->
host of other nonchemical factors, and show specificity for the neurobehavioral function 
<!-- PJG 0012 frnewline -->
believed to be measured by the test method. 
<!-- PJG 0012 frnewline -->
c. Demonstrate adequate reliability (consistency of measurement over time) and 
<!-- PJG 0012 frnewline -->
validity (concordance with other behavioral, physiologic, biochemical, or anatomic measures 
<!-- PJG 0012 frnewline -->
of neurotoxicity). 
<!-- PJG 0012 frnewline -->
d. Show graded amounts of neurobehavioral change as a function of exposure 
<!-- PJG 0012 frnewline -->
parameter, absorbed dose, or body burden along some ordinal or continuous metric (dose 
<!-- PJG 0012 frnewline -->
response). 
<!-- PJG 0012 frnewline -->
e. For representative classes or subclasses of CNS/PNS-active chemicals, identify 
<!-- PJG 0012 frnewline -->
single effects or patterns of impairment across several tests or functional domains that are 
<!-- PJG 0012 frnewline -->
reasonably consistent from study to study (structure-activity). 
<!-- PJG 0012 frnewline -->
f. Be amenable to the development of a procedurally similar counterpart that can be 
<!-- PJG 0012 frnewline -->
used to assess homologous behaviors in animals. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00241 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
g. Whenever it is relevant, care must be taken to insure to the extent possible that 
<!-- PJG 0012 frnewline -->
subjects are blind to the variate of interest (Benignus, 1993). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.6.1.1. Sensitivity. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Individual neurobehavioral tests and test batteries have detected 
<!-- PJG 0012 frnewline -->
differences between exposed and nonexposed populations in epidemiologic studies and in 
<!-- PJG 0012 frnewline -->
laboratory studies. Effects have been detected by neurobehavioral methods at concentrations 
<!-- PJG 0012 frnewline -->
thought by other kinds of evaluation not to produce neurotoxicity. Workplace exposure 
<!-- PJG 0012 frnewline -->
limits to many chemicals have been set on the basis of neurobehavioral studies. While the 
<!-- PJG 0012 frnewline -->
overall sensitivity of neurobehavioral methods is sufficient to be useful in neurotoxicology 
<!-- PJG 0012 frnewline -->
risk assessment, some methods are notably insensitive across several chemical classes while 
<!-- PJG 0012 frnewline -->
the sensitivity of other neurobehavioral tests varies according to the spectrum of neurotoxic 
<!-- PJG 0012 frnewline -->
effects of the chemical or drug. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sensitivity is sometimes negatively correlated with reliability; selecting for tests that 
<!-- PJG 0012 frnewline -->
show little change over time may also select for tests that are not sensitive to neurotoxic 
<!-- PJG 0012 frnewline -->
insult. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Having more control over the testing environment and using a repeated measures 
<!-- PJG 0012 frnewline -->
design may decrease variability and increase statistical power, but these tactics may introduce 
<!-- PJG 0012 frnewline -->
other problems. There is some suggestion that experience in highly structured laboratory 
<!-- PJG 0012 frnewline -->
environments with explicit stimulus conditions may reduce the sensitivity of humans and 
<!-- PJG 0012 frnewline -->
animals to the effects of drugs and chemicals, and the sensitivity of neurobehavioral 
<!-- PJG 0012 frnewline -->
measures to impairment by a chemical or drug may depend on neurobehavioral training 
<!-- PJG 0012 frnewline -->
history (Terrace, 1963; Brady and Barrett, 1986). Sensitivity may also be decreased if 
<!-- PJG 0012 frnewline -->
baseline behaviors are stable and well practiced or an escape/avoidance procedure is 
<!-- PJG 0012 frnewline -->
employed. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The systematic introduction of stimulus or response changes to induce transitional 
<!-- PJG 0012 frnewline -->
behaviors, such as in a transitional state or repeated learning paradigms, may be one way to 
<!-- PJG 0012 frnewline -->
retain the advantage of a stable baseline, have sufficient sensitivity, and avoid practice effects 
<!-- PJG 0012 frnewline -->
(Anger and Setzer, 1979). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.6.1.2. Specificity. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
There are two kinds of specificity in neurobehavioral assessment of 
<!-- PJG 0012 frnewline -->
chemical or drug neurotoxicity. Chemical specificity refers to the ability of a test to reflect 
<!-- PJG 0012 frnewline -->
chemical or drug effects and to be relatively resistant to the influence of nonchemical 
<!-- PJG 0012 frnewline -->
variables. The second type of specificity refers to the ability of a test method to measure 
<!-- PJG 0012 frnewline -->
changes in a single neurobehavioral function (e.g., dexterity) or a restricted number of 
<!-- PJG 0012 frnewline -->
functions, rather than a broad range of functions (attention, reasoning, dexterity, and vision). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The neurobehavioral expression of neurotoxic chemical or drug effects is a function of 
<!-- PJG 0012 frnewline -->
the joint interaction of ongoing nervous system processes with the chemical substance and 
<!-- PJG 0012 frnewline -->
with biopsychosocial variables that also influence nervous system activity. In laboratory 
<!-- PJG 0012 frnewline -->
exposure studies numerous environmental, behavioral, and biologic variables can influence 
<!-- PJG 0012 frnewline -->
the type or magnitude of neurotoxic effects of chemical agents and drugs (MacPhail, 1990). 
<!-- PJG 0012 frnewline -->
These variables include ambient temperature, physical workload, task difficulty, the social 
<!-- PJG 0012 frnewline -->
and tangible reward characteristics of the laboratory setting, redundancy of stimuli, the rate 
<!-- PJG 0012 frnewline -->
and form of the behavioral response, conditioning factors, and the interoceptive stimulus 
<!-- PJG 0012 frnewline -->
properties of the chemicals. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The laboratory research participant's history and habits outside the laboratory also 
<!-- PJG 0012 frnewline -->
may affect chemical-neurobehavioral interactions by influencing the baseline level of 
<!-- PJG 0012 frnewline -->
performance on neurobehavioral tests or directly affecting the response of the CNS to the 
<!-- PJG 0012 frnewline -->
exposure. Age, gender, educational level, intellectual functioning, economic status, acute 
<!-- PJG 0012 frnewline -->
and chronic health conditions (including developmental or current neurologic conditions), 
<!-- PJG 0012 frnewline -->
alcohol/drug/tobacco effects or withdrawal, emotional status or significant life events, sleep 
<!-- PJG 0012 frnewline -->
deprivation, fatigue, and cultural factors are only a few of the variables that may affect 
<!-- PJG 0012 frnewline -->
performance in laboratory studies (Williamson, 1991; Cassitto et al., 1990). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The influence of these selection and biopsychosocial variables on the neurobehavioral 
<!-- PJG 0012 frnewline -->
effects of workplace chemicals is poorly understood, although their effects on drug-behavior 
<!-- PJG 0012 frnewline -->
interactions have been more thoroughly explored. Controlling or understanding chemical and 
<!-- PJG 0012 frnewline -->
nonchemical variables will be important for ensuring adequate specificity for risk assessment 
<!-- PJG 0012 frnewline -->
purposes. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.6.1.3. Reliability and validity. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Reliability refers to the ability of a given test to produce 
<!-- PJG 0012 frnewline -->
closely similar results when administered more than once over a period of time or in similar 
<!-- PJG 0012 frnewline -->
populations. Reliability is meaningful only with respect to the measurement of functions that 
<!-- PJG 0012 frnewline -->
would not be expected to change significantly over the time period. Test-retest reliability 
<!-- PJG 0012 frnewline -->
coefficients are between 0.6 and 0.9 (Beaumont, 1990) for most of the tests in the NCTB. 
<!-- PJG 0012 frnewline -->
With notable exceptions, other neurobehavioral tests have similar reliabilities. Reliabilities in 
<!-- PJG 0012 frnewline -->
the 0.8 to 0.9 range are usually thought acceptable. As reliability decreases, measurement 
<!-- PJG 0012 frnewline -->
error is more likely to mask neurotoxic chemical effects. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00242 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The validity of a given neurotoxicity test relies on evidence that it adequately 
<!-- PJG 0012 frnewline -->
measures the domain of interest and is not highly correlated with tests that are believed to 
<!-- PJG 0012 frnewline -->
measure unrelated functions. These convergent and divergent aspects of validity are 
<!-- PJG 0012 frnewline -->
frequently divided into construct, content, and criterion subcategories. Construct validity 
<!-- PJG 0012 frnewline -->
refers to the ability of a given test to measure the intended function or construct (e.g., 
<!-- PJG 0012 frnewline -->
attention), content to how well the test measures the major aspects of the function, and 
<!-- PJG 0012 frnewline -->
criterion to how highly the test correlates with other tests of the same function or predicts 
<!-- PJG 0012 frnewline -->
neurotoxic impairment after similar insult. 
<!-- PJG 0012 frnewline -->
Many neurobehavioral tests purport to measure the same or similar cognitive, 
<!-- PJG 0012 frnewline -->
sensory, or motor functions, but correlations between these tests under chemical exposure or 
<!-- PJG 0012 frnewline -->
control conditions can be disappointingly low. This is not surprising given the procedural 
<!-- PJG 0012 frnewline -->
differences that exist among neurobehavioral tests. Tests intended to measure the same 
<!-- PJG 0012 frnewline -->
function often have different presentation and response modalities (visual, verbal, manual), 
<!-- PJG 0012 frnewline -->
have differing numbers of trials or a different time limit, and have different methods for 
<!-- PJG 0012 frnewline -->
scoring the results. Many tests have such large procedural differences that direct comparison 
<!-- PJG 0012 frnewline -->
is difficult. Assessment of validity for neurobehavioral tests of specific constructs, such as 
<!-- PJG 0012 frnewline -->
attention, is further complicated in that sensory input, other cognitive processes, and motor 
<!-- PJG 0012 frnewline -->
responses are unavoidable contributors to the test result. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.6.1.4. Dose response. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Dose in this discussion refers to the measurement of chemical or 
<!-- PJG 0012 frnewline -->
metabolite concentrations in the body and to estimations of exposure. Both exposure 
<!-- PJG 0012 frnewline -->
assessment and biologic concentrations should be measured whenever possible. 
<!-- PJG 0012 frnewline -->
Dose-response relationships have been observed both in field and laboratory studies. Two 
<!-- PJG 0012 frnewline -->
recent human solvent exposure studies used lower exposure concentration that resulted in 
<!-- PJG 0012 frnewline -->
mucosal membrane effects reported by subjects as odors or irritation (Dick et al., 1992; 
<!-- PJG 0012 frnewline -->
Hjelm et al., 1990). Neurobehavioral impairment was not detected in these studies. A 
<!-- PJG 0012 frnewline -->
review of over 50 organic solvent human exposure experiments found that neurobehavioral 
<!-- PJG 0012 frnewline -->
impairment generally occurred at mean concentrations higher than those associated with 
<!-- PJG 0012 frnewline -->
irritation, although there was often overlap among the irritant and impairment concentration 
<!-- PJG 0012 frnewline -->
ranges (Dick, 1988). Defining neurotoxic dose-response relationships in humans decreases 
<!-- PJG 0012 frnewline -->
the uncertainties of extrapolation from animal data and allows a more accurate risk 
<!-- PJG 0012 frnewline -->
assessment. 
<!-- PJG 0012 frnewline -->
Recent human solvent exposure studies have employed low concentrations under 
<!-- PJG 0012 frnewline -->
which neurobehavioral impairment was not observed. Rather, these studies have primarily 
<!-- PJG 0012 frnewline -->
detected the effects of solvents on mucosal membranes reported by subjects as odors or 
<!-- PJG 0012 frnewline -->
irritation (Dick, unpublished observation). While these data may be relevant to setting 
<!-- PJG 0012 frnewline -->
workplace and environmental exposure limits, they can be expected to provide little 
<!-- PJG 0012 frnewline -->
information about the neurobehavioral impairment that occurs at higher concentrations. The 
<!-- PJG 0012 frnewline -->
relationship between irritant/odor concentration-effect functions and neurobehavioral 
<!-- PJG 0012 frnewline -->
impairment concentration-effect functions is not known, but it is probably not linear. 
<!-- PJG 0012 frnewline -->
Dose-dependent mechanisms of toxic effect can be expected to complicate risk extrapolation 
<!-- PJG 0012 frnewline -->
across the dose-response range in humans. 
<!-- PJG 0012 frnewline -->
A further complication in dose-response extrapolation is that low concentrations of 
<!-- PJG 0012 frnewline -->
chemicals may appear to improve performance as measured by neurobehavioral tests, while 
<!-- PJG 0012 frnewline -->
higher doses are more likely to impair performance. Improved performance does not 
<!-- PJG 0012 frnewline -->
necessarily indicate the absence of neurotoxicity; both increases and decreases in 
<!-- PJG 0012 frnewline -->
neurobehavioral performance may result from deleterious chemical interactions with neurons. 
<!-- PJG 0012 frnewline -->
Dose-response extrapolation is further complicated by the observation that facilitative or 
<!-- PJG 0012 frnewline -->
impairment effects within a given dosage range may occur at some parameters of the test 
<!-- PJG 0012 frnewline -->
stimulus or aspects of the response (response rate-dependent) but not at others (Altmann et 
<!-- PJG 0012 frnewline -->
al., 1991). Therefore, dose extrapolations are more difficult when there is uncertainty about 
<!-- PJG 0012 frnewline -->
the shape of the dose-response function (biphasic, linear, etc.) at the relevant test stimulus 
<!-- PJG 0012 frnewline -->
and response parameters. 
<!-- PJG 0012 frnewline -->
The risk assessment process with animal data involves extrapolation from the effects 
<!-- PJG 0012 frnewline -->
of high doses in animals to predict the effects of chronic low-dose exposure in humans. 
<!-- PJG 0012 frnewline -->
With data from laboratory studies of humans in a risk assessment, however, the extrapolation 
<!-- PJG 0012 frnewline -->
is in the other direction, from very low-dose laboratory exposure to predict the effects of 
<!-- PJG 0012 frnewline -->
chronic exposure at higher (but still low) concentrations in the environment and workplace. 
<!-- PJG 0012 frnewline -->
Low- to high-dose extrapolation within the same species may require different assumptions 
<!-- PJG 0012 frnewline -->
and risk assessment procedures. Although high-dose human exposures have occurred in 
<!-- PJG 0012 frnewline -->
accidents, those data are primarily descriptive in nature and cannot easily be plugged into a 
<!-- PJG 0012 frnewline -->
quantitative risk extrapolation process. Low dose laboratory data may be combined with data 
<!-- PJG 0012 frnewline -->
from epidemiologic studies of persons exposed to higher concentrations. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.6.1.5. Structure-activity. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Structure-activity relationships for well-known chemicals have 
<!-- PJG 0012 frnewline -->
largely been established by clinical methods (and animal studies) and verified by 
<!-- PJG 0012 frnewline -->
neurobehavioral and neurophysiologic testing. Although an area of active research, 
<!-- PJG 0012 frnewline -->
neurobehavioral testing of humans has not yet been able to identify reliable patterns of 
<!-- PJG 0012 frnewline -->
impairment among chemical classes. This endeavor has been hampered by most laboratory 
<!-- PJG 0012 frnewline -->
research having been limited to the evaluation of low concentrations of solvents and a few 
<!-- PJG 0012 frnewline -->
other reversible toxicants and by the exposure uncertainties, biases, and confounding 
<!-- PJG 0012 frnewline -->
variables found in cross-sectional or cohort field studies. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.6.2. Other Considerations in Risk Assessment 
<!-- PJG 0012 frnewline -->
3.6.2.1. Mechanisms of action 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Uncovering behavioral and neurophysiologic mechanisms 
<!-- PJG 0012 frnewline -->
of action is a potential contribution of human laboratory exposure studies to neurotoxicity 
<!-- PJG 0012 frnewline -->
risk assessment. For example, Stewart et al. (1972) demonstrated that methylene chloride 
<!-- PJG 0012 frnewline -->
was metabolized to carbon monoxide in humans, and further studies (Putz et al., 1979) found 
<!-- PJG 0012 frnewline -->
that CO production could account for some of the neurobehavioral impairment observed with 
<!-- PJG 0012 frnewline -->
that chemical. Recent human laboratory studies of solvents employed low concentrations that 
<!-- PJG 0012 frnewline -->
produced mucosal irritation and strong odor, but little neurobehavioral impairment (Dick, 
<!-- PJG 0012 frnewline -->
unpublished observation). The mechanisms of action that produce mucosal irritation and the 
<!-- PJG 0012 frnewline -->
neurotoxic mechanisms that are expressed in neurobehavioral impairment may be quite 
<!-- PJG 0012 frnewline -->
different. Data on mucosal irritation and odor may therefore provide limited information for 
<!-- PJG 0012 frnewline -->
a neurotoxicity risk assessment. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.6.2.2. Exposure duration 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A criticism of extrapolation from animal studies to human 
<!-- PJG 0012 frnewline -->
exposure conditions is that the effects of short-term exposure (months to 1&hyph;2 years) in 
<!-- PJG 0012 frnewline -->
animals may not accurately predict the effects of chronic exposure (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
&gt;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
10 years) in humans. 
<!-- PJG 0012 frnewline -->
Laboratory studies rarely expose human subjects to solvents for more than 4&hyph;6 hours per day 
<!-- PJG 0012 frnewline -->
for 2&hyph;5 days while environmental and workplace exposures of concern involve 6&hyph;8 hours of 
<!-- PJG 0012 frnewline -->
exposure per day for years. The uncertainties of extrapolating from relatively acute 
<!-- PJG 0012 frnewline -->
exposures to predict the risks from chronic exposure will not be eliminated by using human 
<!-- PJG 0012 frnewline -->
laboratory exposure data in risk assessment. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.6.2.3. Time-dependent effects 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The acute exposures that are possible in human laboratory 
<!-- PJG 0012 frnewline -->
studies may provide little information on chronic time-dependent neurobehavioral effects. 
<!-- PJG 0012 frnewline -->
The effects of initial exposure may remain the same, decrease (tolerance), or increase 
<!-- PJG 0012 frnewline -->
(sensitization) with continued or repeated exposure to the chemical. All effects will not 
<!-- PJG 0012 frnewline -->
change in unison; tolerance and sensitization may be observed simultaneously on different 
<!-- PJG 0012 frnewline -->
measures of neurobehavioral function. The multiple toxicodynamic effects of chemical 
<!-- PJG 0012 frnewline -->
exposure (neurobehavioral and other) seem to follow individual time courses suggestive of 
<!-- PJG 0012 frnewline -->
multiple mechanisms of action. In addition, the processes of tolerance and sensitization can 
<!-- PJG 0012 frnewline -->
be influenced by testing conditions and the nature of the behavioral task. 
<!-- PJG 0012 frnewline -->
One also must be concerned about latent effects that do not appear for some time after 
<!-- PJG 0012 frnewline -->
a brief exposure and ``silent'' cumulative neurotoxic effects that are not observable in acute 
<!-- PJG 0012 frnewline -->
human studies. Latent and silent effects not only bring up the possibility of unknown risks 
<!-- PJG 0012 frnewline -->
for human subjects, but also make more difficult the extrapolation of chronic neurotoxic risks 
<!-- PJG 0012 frnewline -->
on the basis of acute exposures. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00243 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Therefore, the acute exposure conditions possible in human laboratory studies may 
<!-- PJG 0012 frnewline -->
provide us with very limited information about the long-term effects of chronic exposure. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.6.2.4. Multiple exposures 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In the environment and the workplace, persons are seldom 
<!-- PJG 0012 frnewline -->
exposed to only a single chemical. Rather, they are most often exposed to complex mixtures 
<!-- PJG 0012 frnewline -->
of chemicals, the relative concentrations of which may vary over time. For example, one 
<!-- PJG 0012 frnewline -->
farmer had more than 50 different chemical products (pesticides, herbicides, solvents, metals, 
<!-- PJG 0012 frnewline -->
gases) with nervous system effects that he used, prepared, or stored in his work shed. 
<!-- PJG 0012 frnewline -->
Chemicals used in industrial processes may also contain impurities or contaminants that may 
<!-- PJG 0012 frnewline -->
produce neurotoxic effects or alter the neurotoxicity of the more abundant chemical species. 
<!-- PJG 0012 frnewline -->
Chemical mixtures may have additive or potentiating effects not predictable from studies of 
<!-- PJG 0012 frnewline -->
single chemicals (Strong and Garruto, 1991). Human laboratory exposure studies 
<!-- PJG 0012 frnewline -->
traditionally have employed one highly purified chemical or combinations of two chemicals 
<!-- PJG 0012 frnewline -->
(usually solvents) and thus may produce a spectrum of neurotoxic effects different from 
<!-- PJG 0012 frnewline -->
environmental and occupational exposures. 
<!-- PJG 0012 frnewline -->
Recently volatile organic compounds (VOCs) have been used in human exposure 
<!-- PJG 0012 frnewline -->
studies (Otto and Hudnell, 1991). VOCs consist of multiple volatile compounds administered 
<!-- PJG 0012 frnewline -->
at concentrations commonly found in indoor air from emissions by laminates, carpet, 
<!-- PJG 0012 frnewline -->
plastics, and other building and decorating materials. Although VOCs are thought to produce 
<!-- PJG 0012 frnewline -->
primarily mucosal irritation and odors, reports of ``sick building syndrome'' and individual 
<!-- PJG 0012 frnewline -->
sensitivity to indoor air contaminants suggest that other neurobehavioral mechanisms also 
<!-- PJG 0012 frnewline -->
may be operating.
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.6.2.5. Generalizability and individual differences 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The results of field studies and 
<!-- PJG 0012 frnewline -->
laboratory exposure studies are most valuable when they can be extrapolated to the general 
<!-- PJG 0012 frnewline -->
population. Studies conducted in male workers or in young, healthy volunteers may have 
<!-- PJG 0012 frnewline -->
limited applicability to women or to people in other age ranges. It therefore is important to 
<!-- PJG 0012 frnewline -->
conduct studies that include males and females of different ages and ethnic heritage. 
<!-- PJG 0012 frnewline -->
Culture-sensitive neurobehavioral test methods are being developed and validated in the 
<!-- PJG 0012 frnewline -->
United States and other countries. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
While it is important to increase the generalizability of results, it is equally important 
<!-- PJG 0012 frnewline -->
to know when results cannot be generalized. Studies should be specifically directed toward 
<!-- PJG 0012 frnewline -->
identifying subsets of individuals who are more or less sensitive to neurotoxic insult or differ 
<!-- PJG 0012 frnewline -->
in mode of expression. There are many examples of individual differences that alter 
<!-- PJG 0012 frnewline -->
response to chemicals and drugs: phenylketonurics are more sensitive to dietary tyramine 
<!-- PJG 0012 frnewline -->
and persons with variants of plasma pseudocholinesterase are more affected by some 
<!-- PJG 0012 frnewline -->
neuromuscular blocking agents. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.6.2.6. Veracity of neurobehavioral test results 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In most epidemiologic and human 
<!-- PJG 0012 frnewline -->
laboratory studies, research volunteers are highly motivated to perform well on tests of 
<!-- PJG 0012 frnewline -->
neurobehavioral function. Under voluntary conditions, actual neurobehavioral performance 
<!-- PJG 0012 frnewline -->
may serve as a reasonable index of nervous system capabilities. Some studies, however, are 
<!-- PJG 0012 frnewline -->
conducted in response to complaints of symptoms thought to be related to workplace, 
<!-- PJG 0012 frnewline -->
environmental, or therapeutic exposure to chemicals and drugs. The performance of research 
<!-- PJG 0012 frnewline -->
participants with symptoms and complaints may be significantly affected (consciously or 
<!-- PJG 0012 frnewline -->
unconsciously) by monetary rewards, emotional relief, or social gains from the validation of 
<!-- PJG 0012 frnewline -->
their complaints. Under these conditions, performance may or may not accurately reflect the 
<!-- PJG 0012 frnewline -->
capabilities of the nervous system and may lead to inaccurate conclusions about the 
<!-- PJG 0012 frnewline -->
magnitude of nervous system dysfunction or about putative chemical or drug etiologies. 
<!-- PJG 0012 frnewline -->
In addition to suboptimal performance engendered by potential reinforcers or rewards, 
<!-- PJG 0012 frnewline -->
research participants involved in disputes over suspected neurotoxic exposures or in litigation 
<!-- PJG 0012 frnewline -->
for monetary damages are likely to be experiencing significant emotional and behavioral 
<!-- PJG 0012 frnewline -->
reactions from situational sources that can alter the outcome of neurobehavioral assessment. 
<!-- PJG 0012 frnewline -->
Anxiety, depression, sleep disturbances, fatigue, worry, obsessive thoughts, and 
<!-- PJG 0012 frnewline -->
distractibility may contribute to less than optimal performance on motor and cognitive 
<!-- PJG 0012 frnewline -->
neurobehavioral tasks, especially where speed and sustained concentration are important. 
<!-- PJG 0012 frnewline -->
Under stressful conditions, it may be extremely difficult to differentiate between neurotoxic 
<!-- PJG 0012 frnewline -->
and situational sources of observed functional impairment. Functional neurobehavioral tests 
<!-- PJG 0012 frnewline -->
are not well equipped to distinguish between impairment from neurotoxicity and from 
<!-- PJG 0012 frnewline -->
nonchemical variables. The use of functional tests in symptomatic populations requires great 
<!-- PJG 0012 frnewline -->
care in interpretation. The development of validity scales and other control procedures for 
<!-- PJG 0012 frnewline -->
assessing nonchemical influences on performance is greatly needed. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3.6.3. Cross-Species Extrapolation 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Many neurobehavioral tests were developed according to constructs of human 
<!-- PJG 0012 frnewline -->
cognitive processes. The diverse measures of cognitive, sensory, and motor performance in 
<!-- PJG 0012 frnewline -->
humans are therefore not easily compared with neurobehavioral function in animals. While it 
<!-- PJG 0012 frnewline -->
may be possible to conceptually relate some animal and human neurobehavioral tests (e.g., 
<!-- PJG 0012 frnewline -->
grip strength or signal detection), many procedural differences prevent direct comparison 
<!-- PJG 0012 frnewline -->
between species. 
<!-- PJG 0012 frnewline -->
A more direct extrapolation from animals to man might be possible if the tests were 
<!-- PJG 0012 frnewline -->
chosen on the basis of procedural similarity rather than on a conceptual basis (Anger, 1991). 
<!-- PJG 0012 frnewline -->
Stebbins and colleagues (1975) were successful in developing homologous procedures in 
<!-- PJG 0012 frnewline -->
nonhuman primates for the psychophysical evaluation of antibiotic ototoxicity. Efforts to 
<!-- PJG 0012 frnewline -->
develop comparable tests of memory and other neurobehavioral functions in animals and 
<!-- PJG 0012 frnewline -->
humans are under way (Stanton and Spear, 1990, Paule et al., 1990), and such efforts may 
<!-- PJG 0012 frnewline -->
aid in cross-species extrapolation. Other procedurally defined methods, such as Pavlovian 
<!-- PJG 0012 frnewline -->
conditioning (Solomon and Pendlebury, 1988), operant conditioning (Cory-Slechta, 1990), 
<!-- PJG 0012 frnewline -->
signal detection, and psychophysical scaling techniques (Stebbins and Coombs, 1975), could 
<!-- PJG 0012 frnewline -->
also be used to facilitate interspecies risk extrapolation. Deriving comparable 
<!-- PJG 0012 frnewline -->
neurobehavioral assessment methods in animals and humans that will allow a more 
<!-- PJG 0012 frnewline -->
straightforward extrapolation across species is of paramount importance for neurotoxicity risk 
<!-- PJG 0012 frnewline -->
assessment. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00244 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
4. Methods to Assess Animal Neurotoxicity 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
4.1. Introduction 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
4.1.1. Role of Animal Models 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Determining the risk posed to human health from chemicals requires information about the potential toxicological
hazards and the expected levels of exposure. Some toxicological data can be derived directly from humans. Sources
of such information include accidental exposures to industrial chemicals, cases of food-related poisoning, epidemiological
studies, as well as clinical investigations. While human data are available from clinical trials for therapeutics
and they provide the most direct means of determining effects of potentially toxic substances, for other categories
of substances, it is generally difficult, expensive, and, in some cases, unethical to develop this type of information.
Quite often, the nature and extent of available human toxicological data are too incomplete to serve as the basis for
an adequate assessment of potential health hazards. Furthermore, for a majority of chemical substances human toxicological
data are simply not available. Consequently, for most toxicological assessments it is necessary to rely on information
derived from animal models, usually rats or mice. One of the primary functions of animal studies is to predict human
toxicity prior to human exposure. In some cases, species phylogenetically more similar to human, such as monkeys
or baboons, are used in neurotoxicological studies. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Biologically, animals resemble humans in many ways and can serve as adequate models for toxicity studies (Russell,
1991). This is particularly true with regard to the assessment of adverse effects to the nervous system, whereby animal
models provide a variety of useful information that helps minimize exposure of humans to the risk of neurotoxicity.
There are many approaches to testing for neurotoxicity, including whole animal (in vivo) testing and tissue/cell
culture (in vitro) testing. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
At present, in vivo animal studies currently serve as the principal approach to detect and characterize neurotoxic
hazard and to help identify factors affecting susceptibility to neurotoxicity. Data from animal studies are used
to supplement or clarify limited information obtained from clinical or epidemiological studies in humans, as well
as provide specific types of information not readily obtainable from humans due to ethical considerations. Frequently,
results from animal studies are used to guide the design of toxicological studies in humans. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In vitro tests have been proposed as a means of complementing whole animal tests, which could ultimately reduce the
number of animals used in routine toxicity testing. It also has been proposed that in vitro testing, when properly
developed, may be less time-consuming and more cost-effective than in vivo assessments (Goldberg and Frazier, 1989;
Atterwill and Walum, 1989). By understanding the biological structures or functions affected by toxic substances
in vitro, it also may be possible to predict neurotoxicological effects in the whole animal. An added advantage of
in vitro testing is the growing availability of human cell lines that could be used for directly assessing potential
neurotoxic effects on human tissue. The currently available strategies for in vitro testing have certain limitations,
including the inability to model neurobehavioral effects such as loss of memory or sensory dysfunction or to evaluate
effectively the influence of organ system interactions (e.g., neuronal, endocrinological, and immunological)
on the development and expression of neurotoxicity. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00245 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In using animal models to predict neurotoxic risk in humans, it is important to understand that the biochemical and
physiological mechanisms that underlie human biological processes, particularly those involving neurological
and psychological functions, are very complex and are sometimes difficult, if not impossible, to model exactly in
a lower species. While this caveat does not preclude extrapolating the results of animal studies to humans, it does
highlight the importance of using valid animal models in well-designed experimental studies. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
4.1.2. Validity of Animal Models 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Whether animal tests or methods actually measure what they are intended to measure, whether the data from such tests
can be obtained reliably, and whether such data can be logically extrapolated to humans are problems for most disciplines
in toxicology. Various proposals have been made for the standardization and validation of methods used in neurotoxicological
research. It is generally agreed that validation is an ongoing process that establishes the credibility of a test,
building an increasing level of confidence in the effective utility of any model of evaluation. The credibility of
a method, as it applies to testing, is usually discussed within several different contexts, including construct
validity, criterion validity, predictive validity, and detection accuracy. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Construct validity concerns the ability of a method to measure selectively a particular biological function and
not other dimensions. Construct validity is frequently established empirically. For example, sensory dysfunction
such as hearing loss is reported by humans exposed to some chemicals, and tests are designed to detect and quantify
those changes. Such tests are designed to measure changes in auditory function, while other sensations are unaffected
(Tilson, 1987; Moser, 1990). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Criterion validity refers to the ability of a method to measure a characteristic relative to some standard. For example,
Horvath and Frantik (1973) noted that the significance of a test measurement as an index of an actual treatment effect
should be validated relative to the effects of a defined reference substance or positive control. Furthermore, each
specific test or type of effect may require an appropriate reference substance for which the given type of effect is
a determining factor of the toxicity. Use of reference agents has obvious advantages in the assessment of unknown
chemicals. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Predictive validity refers to the ability of a method to predict effects from an incomplete or partial data set. An
animal model of neurotoxicity with good predictive validity would reliably predict neurotoxicity in humans, i.e.,
the animal to human extrapolation would be good. There are several examples in neurotoxicology where animal models
have been developed based on neurotoxicological reports from humans. Presumably, the predictive validity of such
models would enable detecting similar kinds of effects produced by uncharacterized chemicals having a similar mechanism
of action. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
It has been proposed (Tilson and Cabe, 1978) that the most logical approach to validate animal methods in neurotoxicology
is to evaluate chemicals with and without known neurotoxicity in humans in tests designed for animals (predictive
validity). By using such an approach, it is possible to generate a profile of effects characteristic of each type of
neurotoxicant (criterion validity). This profile could then be used to assess the construct validity of various
tests. That is, procedures assumed to measure the same neurobiological dimension should show similar effects; measures
designed to detect changes in other functions should not be affected. This approach to test validation has been described
as the multitrait-multimethod process of validation (Campbell and Fiske, 1959). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Of particular importance in establishing the credibility of a method is the accuracy of detecting a treatment-related
effect (Gad, 1989). Accuracy is a function of two interacting elements, specificity and sensitivity. Specificity
is the ability of a test to respond positively only when the toxic endpoint of interest is present. Sensitivity is the
ability to detect a change when present. This aspect depends on the inherent design of the procedure and experiment.
Increasing the specificity of a test may reduce the possibility of classifying a chemical as neurotoxic when, in fact,
it is not (false positive), but it may increase the probability of missing a true neurotoxicant (false negative).
Increasing sensitivity of a test may reduce the possibility of false negatives, but may increase the probability
of false positives. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
4.1.3. Special Considerations in Animal Models 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4.1.3.1. Susceptible populations. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Like most other measures of toxicological effect, neurotoxic endpoints are subject to a number of experimental variables
that may affect susceptibility to the biological effects of toxicants. In this regard, genetic variation (Festing,
1991) is a particularly important issue in neurotoxicology. For example, most neurotoxicological assessments
are carried out with only one or two species. This may pose problems, however, since species may differ in sensitivity
to neurotoxicants. For example, nonhuman primates are more sensitive than rats (Boyce et al., 1984) or mice (Heikkila
et al., 1984) to the neurodegenerative effects of MPTP, a byproduct in the illicit synthesis of a meperidine analog
(Langston et al., 1983). In the assessment of delayed neuropathology produced by some cholinesterase inhibitors,
it is well known that hens are much more sensitive than rodents (Cavanagh, 1954; Abou-Donia, 1981, 1983). In addition,
rat strains also may be differentially sensitive to some neurotoxicants (Moser et al., 1991). Although it is preferred
that more than one species be tested, the cost required for routine multispecies testing must be considered. Whenever
possible, the choice of animal models should take into account differences in species with regard to pharmacodynamic,
genetic composition and sensitivity to neurotoxic agents. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In addition to species, other factors such as gender of the test animal must be taken into consideration. Some toxic
substances may have a greater neurotoxicological effect in one gender (Squibb et al., 1981; Matthews et al., 1990).
Thus, screening evaluations frequently require both male and female animals. Another important variable is the
age of the animal (Veronesi et al., 1990). Whether a chemical produces neurotoxicity may depend on the maturational
stage of the organism (Rodier, 1986). Most preliminary assessments are designed to provide information on adults,
which have the greatest probability of being exposed. However, populations undergoing rapid maturation or aged
individuals may be especially vulnerable to neurotoxic agents. Longitudinal studies that assess both genders at
any stage of development address many of the problems associated with differentially sensitive populations. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00246 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=81 g=1 f=1 -->
4.1.3.2. Dosing scenario. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The dosing strategy used in experimental studies is an important 
<!-- PJG 0012 frnewline -->
variable in the development and expression of neurotoxicity (WHO, 1986). Some 
<!-- PJG 0012 frnewline -->
neurotoxicants can produce neurotoxicity following a single exposure, while others require 
<!-- PJG 0012 frnewline -->
repeated dosing. Repeated dosing represents the typical pattern of human exposure to many 
<!-- PJG 0012 frnewline -->
chemical substances. Significant differences in response may occur when an acutely toxic 
<!-- PJG 0012 frnewline -->
quantity of material is administered over different exposure periods. For some 
<!-- PJG 0012 frnewline -->
neurotoxicants the onset of neurotoxicity can occur immediately after dosing, while others 
<!-- PJG 0012 frnewline -->
may require time after exposure for the toxicity to develop. Effects of repeated exposure 
<!-- PJG 0012 frnewline -->
may result in a progressive alteration in nervous system function or structure, while latent or 
<!-- PJG 0012 frnewline -->
residual effects may be discovered only in association with age-related changes or after 
<!-- PJG 0012 frnewline -->
suitable environmental or pharmacological challenge (Zenick, 1983; MacPhail et al., 1983). 
<!-- PJG 0012 frnewline -->
To ensure adequate assessment of neurotoxicity, study designs should include multiple dosing 
<!-- PJG 0012 frnewline -->
regimens, e.g., repeated exposure, with appropriate dose-to-response intervals of testing. 
<!-- PJG 0012 frnewline -->
Conduct of neurotoxicological evaluations in studies utilizing excessively toxic doses should 
<!-- PJG 0012 frnewline -->
be avoided. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
4.1.3.3. Other factors. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
There are a number of other factors that should be considered in the 
<!-- PJG 0012 frnewline -->
design and interpretation of studies using animal models (WHO, 1986). Design factors 
<!-- PJG 0012 frnewline -->
include such issues as using properly trained personnel to conduct the studies, the use of 
<!-- PJG 0012 frnewline -->
appropriate numbers of animals per group to achieve reliable statistical significance, and 
<!-- PJG 0012 frnewline -->
controlling the time-of-day variability. Time of testing relative to exposure is also important 
<!-- PJG 0012 frnewline -->
for assessing neurotoxic endpoints such as behavior, and experiments should be designed to 
<!-- PJG 0012 frnewline -->
generate a time course of effects, including recovery of function, if any. Housing is an 
<!-- PJG 0012 frnewline -->
important environmental design factor, because animals housed individually and animals 
<!-- PJG 0012 frnewline -->
housed in groups can respond differently to toxic agents. Temperature, as an experimental 
<!-- PJG 0012 frnewline -->
variable, may also affect the outcome of neurotoxicological studies. The responsiveness to 
<!-- PJG 0012 frnewline -->
some chemicals (e.g., triethyltin, methamphetamine) varies with ambient temperature (Dyer 
<!-- PJG 0012 frnewline -->
and Howell, 1982; Bowyer et al., 1992). Some neurobiological endpoints, such as sensory 
<!-- PJG 0012 frnewline -->
evoked potentials, can be influenced by the endogenous temperature of the animal (Dyer, 
<!-- PJG 0012 frnewline -->
1987). Therefore, changes in body temperature, whether due to fluctuations in ambient 
<!-- PJG 0012 frnewline -->
temperature or to some chemically induced effect such as inhibition of sweating, can 
<!-- PJG 0012 frnewline -->
confound the interpretation of measures such as evoked responses unless proper controls are 
<!-- PJG 0012 frnewline -->
included in the experimental design.
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
Because a variety of other physiological changes can influence neuronal functions, it 
<!-- PJG 0012 frnewline -->
is important to recognize that chemical-related neurotoxicity could result from treatment-induced physiological
changes, such as altered nutritional state (WHO, 1986). As part of a 
<!-- PJG 0012 frnewline -->
neurotoxicological profile, correlative measures, such as relative and absolute organ weights, 
<!-- PJG 0012 frnewline -->
food and water consumption, and body weight and weight gain, may be signs of 
<!-- PJG 0012 frnewline -->
physiological change associated with systemic toxicity and may be useful in determining the 
<!-- PJG 0012 frnewline -->
relative contribution of general toxicity. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
4.1.3.4. Statistical considerations. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Experimental designs for neurotoxicological studies are 
<!-- PJG 0012 frnewline -->
frequently complex, with two or more major variables (e.g., gender, time of testing) varying 
<!-- PJG 0012 frnewline -->
in any single experiment. In addition, such studies typically generate varying types of data, 
<!-- PJG 0012 frnewline -->
including continuous, dichotomous, and rank-order data. Knowledge and experience in 
<!-- PJG 0012 frnewline -->
experimental design and statistical analyses are important. There are several key statistical 
<!-- PJG 0012 frnewline -->
concepts that should be understood in neurotoxicological studies (WHO, 1986; Gad, 1989). 
<!-- PJG 0012 frnewline -->
The power, or probability, of a study to detect a true effect is dependent on the size of the 
<!-- PJG 0012 frnewline -->
study group, the frequency of the outcome variable in the general population, and the 
<!-- PJG 0012 frnewline -->
magnitude of effect to be identified. Statistical evaluation of a treatment-related effect 
<!-- PJG 0012 frnewline -->
involves the consideration of two factors or types of errors to be avoided. A Type I error 
<!-- PJG 0012 frnewline -->
refers to the attribution of an exposure-related neurotoxicological effect when none has 
<!-- PJG 0012 frnewline -->
occurred (false positive), while a Type II error refers to the failure to attribute an effect 
<!-- PJG 0012 frnewline -->
when an exposure-related effect has actually occurred (false negative). In general, the 
<!-- PJG 0012 frnewline -->
probability of a Type I error should not exceed 5 percent and the probability of a Type II 
<!-- PJG 0012 frnewline -->
error should not exceed 20 percent. Power is defined as one minus the probability of a Type 
<!-- PJG 0012 frnewline -->
II error.
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
Determination of power also requires knowledge of the difference in magnitude of 
<!-- PJG 0012 frnewline -->
outcome measures observed between exposed and control groups and the variability of the 
<!-- PJG 0012 frnewline -->
outcome measure among subjects. The sample size required to achieve a given level of 
<!-- PJG 0012 frnewline -->
statistical power increases as variability increases or the difference between groups decreases. 
<!-- PJG 0012 frnewline -->
Continuous data (i.e., magnitude, rate, amplitude), if found to be normally 
<!-- PJG 0012 frnewline -->
distributed, can be analyzed with a general linear model using a grouping factor of dose and, 
<!-- PJG 0012 frnewline -->
if necessary, repeated measures across time. Post hoc comparisons between control and 
<!-- PJG 0012 frnewline -->
other treatment groups can be made following tests for overall significance. In the case of 
<!-- PJG 0012 frnewline -->
multiple endpoints within a series of evaluations, correction for multiple observations (e.g., 
<!-- PJG 0012 frnewline -->
Bonferroni's) might be necessary. 
<!-- PJG 0012 frnewline -->
Descriptive data (categorical) and rank data can be analyzed using standard 
<!-- PJG 0012 frnewline -->
nonparametric techniques. In some cases, if it is believed that the data fit the linear model, 
<!-- PJG 0012 frnewline -->
the categorical data modeling procedure can be used for weighted least-squares estimation of 
<!-- PJG 0012 frnewline -->
parameters for a wide range of general linear models, including repeated measures analyses. 
<!-- PJG 0012 frnewline -->
The weighted least-squares approach to categorical and rank data allows computation of 
<!-- PJG 0012 frnewline -->
statistics for testing the significance of sources of variation as reflected by the model. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
4.2. Tiered Testing in Neurotoxicology 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The utility of tiered testing as an efficient and cost-effective approach to evaluate 
<!-- PJG 0012 frnewline -->
chemical toxicity, including neurotoxicity, has been recognized (NRC, 1975). Briefly, first-tier tests are designed
to determine the presence or absence of neurotoxicity, while second- 
<!-- PJG 0012 frnewline -->
tier tests characterize the neurotoxic effect (NRC, 1992). There are at least two aspects of 
<!-- PJG 0012 frnewline -->
tiered testing, one involving the type of test used (Tilson, 1990a) and the other involving the 
<!-- PJG 0012 frnewline -->
dosing regimen (Goldberg and Frazier, 1989). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00247 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=81 g=1 f=1 -->
4.2.1. Type of Test 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Tests designed to measure the presence or absence of an effect are usually different 
<!-- PJG 0012 frnewline -->
from those used to assess the degree of toxicity or the lowest exposure level required to 
<!-- PJG 0012 frnewline -->
produce an effect (Tilson, 1990a). Screening procedures are first-tier tests that typically permit the testing
of many groups of animals. Such procedures may not require extensive 
<!-- PJG 0012 frnewline -->
resources and are usually simple to perform. However, these techniques may be labor 
<!-- PJG 0012 frnewline -->
intensive, provide subjective measures, yield semiquantitative data, and may not be as 
<!-- PJG 0012 frnewline -->
sensitive to subtle effects as those designed to characterize neurotoxic effects or second-tier 
<!-- PJG 0012 frnewline -->
tests. Specialized tests are usually more sensitive and employed in studies concerning 
<!-- PJG 0012 frnewline -->
mechanisms of action or the estimation of the lowest effective dose. Such testing procedures 
<!-- PJG 0012 frnewline -->
are usually referred to as secondary tests and may require special equipment and more 
<!-- PJG 0012 frnewline -->
extensive resources. Secondary tests are usually quantitative and yield graded or continuous 
<!-- PJG 0012 frnewline -->
data amenable to routine parametric statistical analyses.
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
Testing at the first tier is used to determine if a chemical might produce neurotoxicity 
<!-- PJG 0012 frnewline -->
following exposure, i.e., hazard detection. In this case, there may be little existing 
<!-- PJG 0012 frnewline -->
information concerning the neurotoxic potential of an agent. Examples of first-tier tests 
<!-- PJG 0012 frnewline -->
include functional observational batteries (FOB), including an evaluation of motor activity 
<!-- PJG 0012 frnewline -->
and routine neurohistopathology. For some chemicals or types of chemicals, there may be a 
<!-- PJG 0012 frnewline -->
specific interest in screening for a particular presumed mechanism of toxicity (e.g., inhibition 
<!-- PJG 0012 frnewline -->
of cholinesterase or neurotoxic esterase) or neurobiological response (e.g., a site-specific 
<!-- PJG 0012 frnewline -->
neuronal degeneration). In these cases, specific neurochemical or neuropathological 
<!-- PJG 0012 frnewline -->
endpoints can be used in conjunction with first-tier tests. It is desirable that tests selected for 
<!-- PJG 0012 frnewline -->
use in hazard detection provide a suitable level of sensitivity using the smallest number of 
<!-- PJG 0012 frnewline -->
animals necessary. 
<!-- PJG 0012 frnewline -->
A decision to test at the next tier is based on data suggesting that an agent produces 
<!-- PJG 0012 frnewline -->
neurotoxicity. The information used to make a decision to test a chemical at the secondary 
<!-- PJG 0012 frnewline -->
level can come from a variety of sources, including neurotoxicological data already in the 
<!-- PJG 0012 frnewline -->
literature, structure-activity relationships, data from first-tier testing, or following reports of 
<!-- PJG 0012 frnewline -->
specific neurotoxic effects in humans exposed to the agent. Testing at the secondary level 
<!-- PJG 0012 frnewline -->
includes detailed neuropathological evaluation as well as specific behavioral tests, e.g., 
<!-- PJG 0012 frnewline -->
procedures to assess learning and memory, or sensory function. Tests at the second tier 
<!-- PJG 0012 frnewline -->
usually measure the most sensitive endpoints of neurotoxicity, and are the most suitable for 
<!-- PJG 0012 frnewline -->
determining the no observable adverse effect level or benchmark dose. At this stage of 
<!-- PJG 0012 frnewline -->
testing, the use of a second species is considered to address the issue of cross-species 
<!-- PJG 0012 frnewline -->
extrapolation. At the present time, tiered testing approaches in neurotoxicology rely heavily 
<!-- PJG 0012 frnewline -->
on functional endpoints. It is possible that future testing protocols will employ a different 
<!-- PJG 0012 frnewline -->
strategy as more information concerning neurotoxic mechanisms of action become available 
<!-- PJG 0012 frnewline -->
and biologically based dose-response models are developed. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
4.2.2. Dosing Regimen 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Goldberg and Frazier (1989) have indicated that first-tier evaluations identify effects 
<!-- PJG 0012 frnewline -->
of substances following acute or repeated exposure over a wide range of doses. Measures 
<!-- PJG 0012 frnewline -->
are simple, focused on detection of effects, and results are used to help establish parameters 
<!-- PJG 0012 frnewline -->
for the second tier of testing. The subsequent stage(s) of tier testing are designed to 
<!-- PJG 0012 frnewline -->
characterize more fully the toxicity of repeated dosing. In this case, animals are exposed 
<!-- PJG 0012 frnewline -->
repeatedly or continuously to define the scope of toxicity, including latent or delayed effects, 
<!-- PJG 0012 frnewline -->
development of tolerance, and the reversibility of adverse effects. The subsequent stage(s) of 
<!-- PJG 0012 frnewline -->
testing also provide information about specific effects or study mechanisms of neurotoxicity. 
<!-- PJG 0012 frnewline -->
This tier uses methods appropriate to characterize the effects observed in the first tier of 
<!-- PJG 0012 frnewline -->
testing. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
4.3. Endpoints of Neurotoxicity 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
4.3.1. Introduction 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As applied to the safety assessment of chemical substances, neurotoxicity is any 
<!-- PJG 0012 frnewline -->
adverse change in the development, structure, or function of the central and peripheral 
<!-- PJG 0012 frnewline -->
nervous system following exposure to a chemical agent (Tilson, 1990b). Measures used in 
<!-- PJG 0012 frnewline -->
animal neurotoxicological studies are designed to assess these changes. Neurotoxicity can be 
<!-- PJG 0012 frnewline -->
described at multiple levels of organization, including chemical, anatomical, physiological, or 
<!-- PJG 0012 frnewline -->
behavioral levels. At the chemical level, for example, a neurotoxic substance might inhibit protein 
<!-- PJG 0012 frnewline -->
or transmitter synthesis, alter the flow of ions across cellular membranes, or prevent release 
<!-- PJG 0012 frnewline -->
of neurotransmitter from nerve terminals. Anatomical changes may include destruction of 
<!-- PJG 0012 frnewline -->
the neuron, axon, or myelin sheath. At the physiological level, neuronal responsiveness to 
<!-- PJG 0012 frnewline -->
stimulation might be enhanced by a decrease of inhibitory thresholds in the nervous system. 
<!-- PJG 0012 frnewline -->
Chemical-induced effects at the behavioral level can involve a variety of alterations in motor, 
<!-- PJG 0012 frnewline -->
sensory, or cognitive function, including increases or decreases in frequency or accuracy of 
<!-- PJG 0012 frnewline -->
responding. Although behavioral and neurophysiological endpoints may be very sensitive 
<!-- PJG 0012 frnewline -->
indicators of neurotoxicity, they can be influenced by other factors. The uncertainties 
<!-- PJG 0012 frnewline -->
associated with data from functional endpoints can be reduced if interpreted within the 
<!-- PJG 0012 frnewline -->
context of other neurotoxicological measures (neurochemical or neuropathological) and 
<!-- PJG 0012 frnewline -->
systemic toxicity endpoints, particularly if such measures are taken concurrently. Behavioral 
<!-- PJG 0012 frnewline -->
effects that reflect an indirect effect secondary to systemic toxicities may also be considered 
<!-- PJG 0012 frnewline -->
adverse. Table 4&hyph;1 provides examples of potential endpoints of neurotoxicity at the 
<!-- PJG 0012 frnewline -->
behavioral, physiological, chemical, and structural levels. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00248 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<TABLE>

<!-- PJG tableformat 1,L1(,0,),p3,8/9,i1,xl50 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Table 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=1 -->
4&hyph;1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
._Examples of Potential Endpoints of Neurotoxicity
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Behavioral Endpoints:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=12 g=1 f=4 -->
Absence or altered occurrence, magnitude, or latency of sensorimotor reflex
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Altered magnitude of neurological measurements, such as grip strength or hindlimb splay
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Increases or decreases in motor activity
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Changes in rate or temporal patterning of schedule-controlled behavior
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Changes in motor coordination, weakness, paralysis, abnormal movement or posture, tremor, ongoing performance
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Changes in touch, sight, sound, taste, or smell sensations
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Changes in learning and memory
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Occurrence of seizures
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Altered temporal development of behaviors or reflex responses
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Autonomic signs
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=4 -->
Neurophysiological Endpoints:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=12 g=1 f=4 -->
Change in velocity, amplitude, or refractory period of nerve conduction
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Change in latency or amplitude of sensory-evoked potential
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Change in EEG pattern or power spectrum
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=4 -->
Neurochemical Endpoints:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=12 g=1 f=4 -->
Alterations in synthesis, release, uptake, degradation of neurotransmitters
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Alterations in second messenger associated signal transduction
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Alterations in membrane-bound enzymes regulating neuronal activity
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Decreases in brain AChE
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Inhibition of NTE
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Altered developmental patterns of neuro
<!-- PJG 0034 unknown -->
chemical systems
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Altered proteins (c fos, substance P)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=4 -->
Structural Endpoints:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=12 g=1 f=4 -->
Accumulation, proliferation, or rearrangement of structural elements
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Breakdown of cells
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
GFAP increases (adult)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Gross changes in morphology, including brain weight
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Discoloration of nerve tissue
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hemorrhage in nerve tissue
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00249 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=81 g=1 f=4 -->
4.3.2. Behavioral Endpoints
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Neurotoxicants produce a wide array of functional deficits, including motor, sensory, and learning or memory dysfunction
(WHO, 1986; Tilson and Mitchell, 1984). Many procedures have been devised to assess overt as well as relatively subtle
changes in those functions; hence their applicability to the detection of neurotoxicity and to hazard characterization.
Many of the behavioral tests have been developed and validated with well-characterized neurotoxicants. Behavioral
tests and agents that affect them have been reviewed recently (WHO, 1986; Cory-Slechta, 1989). Examples of such tests,
the nervous system function being measured, and neurotoxicants known to affect these measures are listed in Table
4&hyph;2.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 3,L2,i1,xs80,r140,r60 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Table 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=1 -->
4&hyph;2. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Examples of Specialized Tests to Measure Neurotoxicity
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Function
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Procedure
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Representative-agents
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Neuromuscular:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=4 -->
Weakness 
<!-- PJG 007 0104 intable -->
Grip strength; swimming endurance; suspension from rod; discriminative motor function; hindlimb splay 
<!-- PJG 007 0104 intable -->
n-hexane, methyl butylketone, carbaryl.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Incoordination 
<!-- PJG 007 0104 intable -->
Rotorod, gait measurements 
<!-- PJG 007 0104 intable -->
3-acetylpyridine, ethanol.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Tremor 
<!-- PJG 007 0104 intable -->
Rating scale, spectral analysis 
<!-- PJG 007 0104 intable -->
Chlordecone, Type I pyrethroids, DDT.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Myoclonia, spasms 
<!-- PJG 007 0104 intable -->
Rating scale, spectral analysis 
<!-- PJG 007 0104 intable -->
DDT, Type II pyrethroids.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Sensory:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=4 -->
Auditory 
<!-- PJG 007 0104 intable -->
Discriminated conditioning Reflex modification 
<!-- PJG 007 0104 intable -->
Toluene, trimethyltin.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Visual toxicity 
<!-- PJG 007 0104 intable -->
Discriminated conditioning 
<!-- PJG 007 0104 intable -->
Methyl mercury.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Somatosensory toxicity 
<!-- PJG 007 0104 intable -->
Discriminated conditioning 
<!-- PJG 007 0104 intable -->
Acrylamide.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Pain sensitivity 
<!-- PJG 007 0104 intable -->
Discriminated conditioning (titration); functional observational battery 
<!-- PJG 007 0104 intable -->
Parathion.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Olfactory toxicity 
<!-- PJG 007 0104 intable -->
Discriminated conditioning 
<!-- PJG 007 0104 intable -->
3-methylindole methyl
<!-- PJG 0034 unknown -->
bro
<!-- PJG 0034 unknown -->
mide.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Learning/Memory:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=4 -->
Habituation 
<!-- PJG 007 0104 intable -->
Startle reflex 
<!-- PJG 007 0104 intable -->
Diisopropyl-flurophosphate (DFP).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Classical conditioning 
<!-- PJG 007 0104 intable -->
Nictitating membrane 
<!-- PJG 007 0104 intable -->
Aluminum.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=4 -->
&blank; 
<!-- PJG 007 0104 intable -->
Conditioned flavor aversion 
<!-- PJG 007 0104 intable -->
Carbaryl.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&blank; 
<!-- PJG 007 0104 intable -->
Passive avoidance 
<!-- PJG 007 0104 intable -->
Trimethyltin, IDPN.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&blank; 
<!-- PJG 007 0104 intable -->
Olfactory conditioning 
<!-- PJG 007 0104 intable -->
Neonatal trimethyltin.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=4 -->
Operant or instrumental conditioning 
<!-- PJG 007 0104 intable -->
One-way avoidance 
<!-- PJG 007 0104 intable -->
Chlordecone.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=4 -->
&blank; 
<!-- PJG 007 0104 intable -->
Two-way avoidance 
<!-- PJG 007 0104 intable -->
Neonatal lead.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&blank; 
<!-- PJG 007 0104 intable -->
Y-maze avoidance 
<!-- PJG 007 0104 intable -->
Hypervitaminosis A.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&blank; 
<!-- PJG 007 0104 intable -->
Biel water maze 
<!-- PJG 007 0104 intable -->
Styrene.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&blank; 
<!-- PJG 007 0104 intable -->
Morris water maze 
<!-- PJG 007 0104 intable -->
DFP.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&blank; 
<!-- PJG 007 0104 intable -->
Radial arm maze 
<!-- PJG 007 0104 intable -->
Trimethyltin.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&blank; 
<!-- PJG 007 0104 intable -->
Delayed matching to sample 
<!-- PJG 007 0104 intable -->
DFP.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&blank; 
<!-- PJG 007 0104 intable -->
Repeated acquisition 
<!-- PJG 007 0104 intable -->
Carbaryl.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&blank; 
<!-- PJG 007 0104 intable -->
Visual discrimination learning 
<!-- PJG 007 0104 intable -->
Lead.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00250 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=81 g=1 f=4 -->
4.3.2.1. Functional observational batteries.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
 Functional observational batteries are first-tier 
<!-- PJG 0012 frnewline -->
tests designed to detect and quantify major overt behavioral, physiological, and other 
<!-- PJG 0012 frnewline -->
neurotoxic effects (Moser, 1989). A number of batteries have been used (Tilson and Moser, 
<!-- PJG 0012 frnewline -->
1992), each consisting of tests generally intended to evaluate various aspects of sensorimotor 
<!-- PJG 0012 frnewline -->
function. Most FOB are similar to clinical neurological examinations that rate presence or 
<!-- PJG 0012 frnewline -->
absence and, in some cases, the relative degree of neurological signs. A typical FOB, as 
<!-- PJG 0012 frnewline -->
summarized in Table 4&hyph;3, evaluates several functional domains, including neuromuscular 
<!-- PJG 0012 frnewline -->
(i.e., weakness, incoordination, gait, and tremor), sensory (i.e., audition, vision, and 
<!-- PJG 0012 frnewline -->
somatosensory), and autonomic (i.e., pupil response and salivation) function. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 3,L1(,0,),p8,8/9,i1,xl100,xl100,xl100 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Table 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=1 -->
4&hyph;3.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
_Summary of Measures in the Functional Observational Battery and the Type of Data Produced by Each 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1&blank;
<!-- PJG 007 0150 intable -->
1&blank;
<!-- PJG 007 0150 intable -->
1&blank;
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Home cage and open field 
<!-- PJG 007 0104 intable -->
Manipulative 
<!-- PJG 007 0104 intable -->
Physiologic 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=4 -->
Posture (D) 
<!-- PJG 007 0104 intable -->
Ease of removal (R) 
<!-- PJG 007 0104 intable -->
Body temperature (I) 
<!-- PJG 0012 frnewline -->
Convulsions, tremors (D) 
<!-- PJG 007 0104 intable -->
Handling reactivity (R) 
<!-- PJG 007 0104 intable -->
Body weight (I) 
<!-- PJG 0012 frnewline -->
Palpebral closure (R) 
<!-- PJG 0012 frnewline -->
Lacrimation (R) 
<!-- PJG 007 0104 intable -->
Approach response (R) 
<!-- PJG 0012 frnewline -->
Piloerection (Q) 
<!-- PJG 007 0104 intable -->
Click response (R) 
<!-- PJG 0012 frnewline -->
Salivation (R) 
<!-- PJG 007 0104 intable -->
Touch response (R) 
<!-- PJG 0012 frnewline -->
Vocalizations (Q) 
<!-- PJG 007 0104 intable -->
Tail pinch response (R) 
<!-- PJG 0012 frnewline -->
Rearing (C) 
<!-- PJG 007 0104 intable -->
Righting reflex (R) 
<!-- PJG 0012 frnewline -->
Urination (C) 
<!-- PJG 007 0104 intable -->
Landing foot splay (I) 
<!-- PJG 0012 frnewline -->
Defecation (C) 
<!-- PJG 007 0104 intable -->
Forelimb grip strength (I) 
<!-- PJG 0012 frnewline -->
Gait (D, R) 
<!-- PJG 007 0104 intable -->
Hindlimb grip strength (I) 
<!-- PJG 0012 frnewline -->
Arousal (R) 
<!-- PJG 007 0104 intable -->
Pupil response (Q) 
<!-- PJG 0012 frnewline -->
Mobility (R) 
<!-- PJG 0012 frnewline -->
Stereotypy (D) 
<!-- PJG 0012 frnewline -->
Bizarre behavior (D) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->
D = descriptive data; R = rank order data; Q = quantal data; 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->
I = interval data; C = count data 
<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00251 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=4 -->
The major advantages of FOB tests are that they can be administered within the 
<!-- PJG 0012 frnewline -->
context of other ongoing toxicological tests and provide some indication of the possible 
<!-- PJG 0012 frnewline -->
neurological alterations produced by exposure. Potential problems include insufficient 
<!-- PJG 0012 frnewline -->
interobserver reliability, difficulty in defining certain endpoints, and the tendency toward 
<!-- PJG 0012 frnewline -->
observer bias. The latter can be controlled by using observers unaware of the actual 
<!-- PJG 0012 frnewline -->
treatment of the subjects. Some FOB tests may not be very sensitive to agent-induced 
<!-- PJG 0012 frnewline -->
sensory loss (i.e., vision, audition) or alterations in cognitive or integrative processes such as 
<!-- PJG 0012 frnewline -->
learning and memory. FOB data may be used to trigger experiments performed at the next 
<!-- PJG 0012 frnewline -->
tier of testing. 
<!-- PJG 0012 frnewline -->
FOB data may be interval, ordinal, or continuous (Creason, 1989). The relevance of 
<!-- PJG 0012 frnewline -->
statistically significant test results from an FOB is judged according to the number of signs 
<!-- PJG 0012 frnewline -->
affected, the dose(s) at which neurotoxic signs are observed, and the nature, severity, and 
<!-- PJG 0012 frnewline -->
persistence of the effects. Data from the FOB may provide presumptive evidence of adverse 
<!-- PJG 0012 frnewline -->
effects and neurotoxicity. If only a few unrelated measures in the FOB are affected or the 
<!-- PJG 0012 frnewline -->
effects are unrelated to dose, there is less concern about neurotoxic potentials of a chemical. 
<!-- PJG 0012 frnewline -->
If dose is associated with other overt signs of toxicity, including systemic toxicity, large 
<!-- PJG 0012 frnewline -->
decreases in body weight, or debilitation, the data must be interpreted carefully. In cases 
<!-- PJG 0012 frnewline -->
where several related measures in a battery of tests are affected and the effects appear to be 
<!-- PJG 0012 frnewline -->
dose dependent, the level of concern about the potential of a chemical is higher. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=4 -->
4.3.2.2. Motor activity. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Movement within a defined environment is a naturally occurring 
<!-- PJG 0012 frnewline -->
response and can be affected by environmental agents. Motor activity represents a broad 
<!-- PJG 0012 frnewline -->
class of behaviors involving coordinated participation of sensory, motor, and integrative 
<!-- PJG 0012 frnewline -->
processes. Motor activity measurements are noninvasive and can be used to evaluate the 
<!-- PJG 0012 frnewline -->
effects of acute and repeated exposure to chemicals (MacPhail et al., 1989). Motor activity 
<!-- PJG 0012 frnewline -->
measurements have also been used in humans to evaluate disease states, including disorders 
<!-- PJG 0012 frnewline -->
of the nervous system (Goldstein and Stein, 1985). The assessment of motor activity is often 
<!-- PJG 0012 frnewline -->
included in first-tier evaluations, either as part of the FOB or as a separate quantitated 
<!-- PJG 0012 frnewline -->
measurement. 
<!-- PJG 0012 frnewline -->
There are many different types of activity measurement devices, differing in size, 
<!-- PJG 0012 frnewline -->
shape, and method of movement detection (MacPhail et al., 1989). Because of the accuracy 
<!-- PJG 0012 frnewline -->
and ease of calibration, devices with photocells are widely used. In general, situating the 
<!-- PJG 0012 frnewline -->
apparatus to minimize extraneous noise, movements, or lights usually requires that the 
<!-- PJG 0012 frnewline -->
recording devices be placed in light- and sound-attenuating chambers during the testing 
<!-- PJG 0012 frnewline -->
period. A number of different factors, including age, gender, and time of day, can affect 
<!-- PJG 0012 frnewline -->
motor activity, and should be controlled or counterbalanced. Different strains of animals 
<!-- PJG 0012 frnewline -->
may have significantly different basal levels of activity, making comparisons across studies 
<!-- PJG 0012 frnewline -->
difficult. A major factor in activity studies is the duration of the testing session. Motor 
<!-- PJG 0012 frnewline -->
activity levels are generally highest at the beginning of the session and decrease to a low 
<!-- PJG 0012 frnewline -->
level throughout the session. The rate of decline during the test session is frequently termed 
<!-- PJG 0012 frnewline -->
``habituation.'' 
<!-- PJG 0012 frnewline -->
Motor activity measurements are typically included as part of a battery of tests to 
<!-- PJG 0012 frnewline -->
detect or characterize neurotoxicity. Agent-induced alterations in motor activity associated 
<!-- PJG 0012 frnewline -->
with overt signs of toxicity (e.g., loss of body weight, systemic toxicity) or occurring in non-dose-related fashion
are of less concern than changes that are dose dependent, related to 
<!-- PJG 0012 frnewline -->
structural or other functional changes in the nervous system, or occur in the absence of life-threatening toxicity
and are generally convincing evidence of neurotoxicity. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=4 -->
4.3.2.3. Neuromotor function. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Motor dysfunction is a common neurotoxic effect, and 
<!-- PJG 0012 frnewline -->
many different types of tests have been devised to measure time- and dose-dependent effects. 
<!-- PJG 0012 frnewline -->
Anger (1984) reported 14 motor effects of 89 substances, which could be classified into four 
<!-- PJG 0012 frnewline -->
categories: weakness, incoordination, tremor, and myoclonia or spasms. Chemical-induced 
<!-- PJG 0012 frnewline -->
changes in motor function can be determined with relatively simple techniques such as the 
<!-- PJG 0012 frnewline -->
FOB. More specialized tests to assess weakness include measures of grip strength, 
<!-- PJG 0012 frnewline -->
swimming endurance, suspension from a hanging rod, discriminitive motor function, and 
<!-- PJG 0012 frnewline -->
hindlimb splay. Rotarod and gait assessments measure incoordination, while rating scales 
<!-- PJG 0012 frnewline -->
and spectral analysis techniques quantify tremor and other abnormal movements (Tilson and 
<!-- PJG 0012 frnewline -->
Mitchell, 1984). 
<!-- PJG 0012 frnewline -->
An example of a second-tier procedure to assess motor function has been described by 
<!-- PJG 0012 frnewline -->
Newland (1988), who trained squirrel monkeys to hold a bar within specified limits (i.e., 
<!-- PJG 0012 frnewline -->
displacement) to receive positive reinforcement. The bar was also attached to a rotary 
<!-- PJG 0012 frnewline -->
device, which allowed measurement of chemical-induced tremor. Spectral analysis was used 
<!-- PJG 0012 frnewline -->
to characterize the tremor, which was found to be similar to that seen in humans exposed to 
<!-- PJG 0012 frnewline -->
neurotoxicants or with such neurologic diseases as Parkinson's disease. 
<!-- PJG 0012 frnewline -->
Incoordination and performance changes can be assessed with procedures that measure 
<!-- PJG 0012 frnewline -->
chemical-induced alterations in force (Fowler, 1987). The accuracy of performance may 
<!-- PJG 0012 frnewline -->
reflect neuromotor function and is sensitive to the debilitating effects of many psychoactive 
<!-- PJG 0012 frnewline -->
drugs (Walker et al., 1981; Newland, 1988). Gait, an index of coordination, has been 
<!-- PJG 0012 frnewline -->
measured in rats under standardized conditions and can be a sensitive indication of specific 
<!-- PJG 0012 frnewline -->
damage to the basal ganglia and motor cortex (Hruska et al., 1979) as well as damage to the 
<!-- PJG 0012 frnewline -->
spinal cord and peripheral nervous system. 
<!-- PJG 0012 frnewline -->
Procedures to characterize chemical-induced motor dysfunction have been used 
<!-- PJG 0012 frnewline -->
extensively in neurotoxicology. Most require preexposure training (including alterations of 
<!-- PJG 0012 frnewline -->
motivational state) of experimental animals, but such tests might be useful, in as much as 
<!-- PJG 0012 frnewline -->
similar procedures are often used in assessing humans. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=4 -->
4.3.2.4. Sensory function. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Alterations in sensory processes (e.g., paresthesias and visual or 
<!-- PJG 0012 frnewline -->
auditory impairments) are frequently reported signs or symptoms in humans exposed to 
<!-- PJG 0012 frnewline -->
toxicants (Anger, 1984). Several approaches have been devised to measure sensory deficits. 
<!-- PJG 0012 frnewline -->
Data from tests of sensory function must be interpreted within the context of changes in body 
<!-- PJG 0012 frnewline -->
weight, body temperature, and other physiological endpoints. Furthermore, many tests 
<!-- PJG 0012 frnewline -->
assess the behavioral response of an animal to a specific sensory stimulus; such responses are 
<!-- PJG 0012 frnewline -->
usually motor movements that could be directly affected by chemical exposure. Thus, care 
<!-- PJG 0012 frnewline -->
must be taken to determine whether proper controls were included to eliminate the possibility 
<!-- PJG 0012 frnewline -->
that changes in response to a sensory stimulus may have been related to agent-induced motor 
<!-- PJG 0012 frnewline -->
dysfunction. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00252 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Several first-tier testing procedures have been devised to screen for overt sensory 
<!-- PJG 0012 frnewline -->
deficits. Many rely on orientation or the response of an animal to a stimulus. Such tests are 
<!-- PJG 0012 frnewline -->
usually included in the FOB used in screening (e.g., tail-pinch or click responses). 
<!-- PJG 0012 frnewline -->
Responses are usually recorded as being either present, absent, or changed in magnitude 
<!-- PJG 0012 frnewline -->
(Moser, 1989; O'Donoghue, 1989). Screening tests for sensory deficits are typically not 
<!-- PJG 0012 frnewline -->
suitable to characterize chemical-induced changes in acuity or fields of perception. The 
<!-- PJG 0012 frnewline -->
characterization of sensory deficits usually necessitates psychophysical methods that study the 
<!-- PJG 0012 frnewline -->
relationship between the physical dimensions of a stimulus and the behavioral response it 
<!-- PJG 0012 frnewline -->
generates (Maurissen, 1988). 
<!-- PJG 0012 frnewline -->
One second-tier approach to the characterization of sensory function involves the use 
<!-- PJG 0012 frnewline -->
of reflex-modification techniques (Crofton, 1990). Chemical-induced changes in the stimulus 
<!-- PJG 0012 frnewline -->
frequency or threshold required to inhibit a reflex are taken as possible changes in sensory 
<!-- PJG 0012 frnewline -->
function. Prepulse inhibition has been used only recently in neurotoxicology (Fechter and 
<!-- PJG 0012 frnewline -->
Young, 1983) and can be used to assess sensory function in humans as well as in 
<!-- PJG 0012 frnewline -->
experimental animals. 
<!-- PJG 0012 frnewline -->
Various behavioral procedures require that a learned response occur only in the 
<!-- PJG 0012 frnewline -->
presence of a specific stimulus (i.e., discriminated or conditioned responding). Chemical-induced changes in
sensory function are determined by altering the physical characteristics of 
<!-- PJG 0012 frnewline -->
the stimulus (e.g., magnitude or frequency) and measuring the alteration in response rate or 
<!-- PJG 0012 frnewline -->
accuracy. In an example of the use of a discriminated conditional response to assess 
<!-- PJG 0012 frnewline -->
chemical-induced sensory dysfunction, Maurissen et al. (1983) trained monkeys to respond to 
<!-- PJG 0012 frnewline -->
the presence of a vibratory or electric stimulus applied to the fingertip. Repeated dosing 
<!-- PJG 0012 frnewline -->
with acrylamide produced a persistent decrease in vibration sensitivity; sensitivity to electric 
<!-- PJG 0012 frnewline -->
stimulation was unimpaired. That pattern of sensory dysfunction corresponded well to 
<!-- PJG 0012 frnewline -->
known sensory deficits in humans. Discriminated conditional response procedures have been 
<!-- PJG 0012 frnewline -->
used to assess the ototoxicity produced by toluene (Pryor et al., 1983) and the visual toxicity 
<!-- PJG 0012 frnewline -->
produced by methylmercury (Merigan, 1979). 
<!-- PJG 0012 frnewline -->
Procedures to characterize chemical-induced sensory dysfunction have been used often 
<!-- PJG 0012 frnewline -->
in neurotoxicology. As in the case of most procedures designed to characterize nervous 
<!-- PJG 0012 frnewline -->
system dysfunction, training and motivational factors can be confounding factors. Many tests 
<!-- PJG 0012 frnewline -->
designed to assess sensory function for laboratory animals can also be applied with some 
<!-- PJG 0012 frnewline -->
adaptation to humans. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=4 -->
4.3.2.5. Learning and memory.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Learning and memory disorders are neurotoxic effects of 
<!-- PJG 0012 frnewline -->
particular importance. Impairment of memory is reported fairly often by adult humans as a 
<!-- PJG 0012 frnewline -->
consequence of toxic exposure. Behavioral deficits in children have been caused by lead 
<!-- PJG 0012 frnewline -->
exposure (Smith et al., 1989), and it is hypothesized (Calne et al., 1986) that chronic low-level exposure to toxic
agents may have a role in the pathogenesis of senile dementia. 
<!-- PJG 0012 frnewline -->
Learning can be defined as an enduring change in the mechanisms of behavior that 
<!-- PJG 0012 frnewline -->
results from experience with environmental events (Domjan and Burkhard, 1986). Memory 
<!-- PJG 0012 frnewline -->
is a change that can be either short-lasting or long-lasting (Eckerman and Bushnell, 1992). 
<!-- PJG 0012 frnewline -->
Alterations in learning and memory must be inferred from changes in behavior. However, 
<!-- PJG 0012 frnewline -->
changes in learning and memory must be separated from other changes in behavior that do 
<!-- PJG 0012 frnewline -->
not involve cognitive or associative processes (e.g., motor function, sensory capabilities, and 
<!-- PJG 0012 frnewline -->
motivational factors), and an apparent toxicant-induced change in learning or memory should 
<!-- PJG 0012 frnewline -->
be demonstrated over a range of stimuli and conditions. Before it is concluded that a 
<!-- PJG 0012 frnewline -->
toxicant alters learning and memory, effects should be confirmed in a second learning 
<!-- PJG 0012 frnewline -->
procedure. It is well known that lesions in the brain can inhibit learning. It is also known 
<!-- PJG 0012 frnewline -->
that some brain lesions can facilitate some types of learning by removing behavioral 
<!-- PJG 0012 frnewline -->
tendencies (e.g., inhibitory responses due to stress) that moderate the rate of learning under 
<!-- PJG 0012 frnewline -->
normal circumstances. A discussion of learning procedures and examples of chemicals that 
<!-- PJG 0012 frnewline -->
can affect learning and memory have appeared in recent reviews (Heise, 1984; WHO, 1986; 
<!-- PJG 0012 frnewline -->
Peele and Vincent, 1989). 
<!-- PJG 0012 frnewline -->
One simple index of learning and memory, which can be measured as a first-tier 
<!-- PJG 0012 frnewline -->
endpoint, is habituation. Habituation is defined as a gradual decrease in the magnitude or 
<!-- PJG 0012 frnewline -->
frequency of a response after repeated presentations of a stimulus. A toxicant can affect 
<!-- PJG 0012 frnewline -->
habituation by increasing or decreasing the number of stimulus presentations needed to 
<!-- PJG 0012 frnewline -->
produce response decrements (Overstreet, 1977). Although habituation is a very simple form 
<!-- PJG 0012 frnewline -->
of learning, it can also be perturbed by a number of chemical effects not related to learning. 
<!-- PJG 0012 frnewline -->
A more complicated approach to studying the effects of a chemical on learning and 
<!-- PJG 0012 frnewline -->
memory involves the pairing of a novel stimulus with a second stimulus that produces a 
<!-- PJG 0012 frnewline -->
known, observable, and quantifiable response (i.e., classical ``Pavlovian'' conditioning). The 
<!-- PJG 0012 frnewline -->
novel stimulus is known as the conditioned stimulus, and the second, eliciting stimulus is the 
<!-- PJG 0012 frnewline -->
unconditioned stimulus. With repeated pairings of the two stimuli, the conditioned stimulus 
<!-- PJG 0012 frnewline -->
comes to elicit a response similar to the response elicited by the unconditioned stimulus. The 
<!-- PJG 0012 frnewline -->
procedure has been used in behavioral pharmacology and, to a lesser extent, in 
<!-- PJG 0012 frnewline -->
neurotoxicology. Neurotoxicants that interfere with learning and memory would alter the 
<!-- PJG 0012 frnewline -->
number of presentations of the pair of stimuli required to produce conditioning or learning. 
<!-- PJG 0012 frnewline -->
Memory would be tested by determining how long after the last presentation of the two 
<!-- PJG 0012 frnewline -->
stimuli the conditioned stimulus would still elicit a response (Yokel, 1983). Other classically 
<!-- PJG 0012 frnewline -->
conditioned responses known to be affected by psychoactive or neurotoxic agents are 
<!-- PJG 0012 frnewline -->
conditioned taste aversion (Riley and Tuck, 1985) and conditioned suppression (Chiba and 
<!-- PJG 0012 frnewline -->
Ando, 1976). 
<!-- PJG 0012 frnewline -->
Second-tier procedures to assess learning or memory typically involve the pairing of a 
<!-- PJG 0012 frnewline -->
response with a stimulus that increases the probability of future response through 
<!-- PJG 0012 frnewline -->
reinforcement. Response rate can be increased by using positive reinforcement or removing 
<!-- PJG 0012 frnewline -->
negative reinforcement. Learning is usually assessed by determining the number of 
<!-- PJG 0012 frnewline -->
presentations or trials needed to produce a defined frequency of response. Memory can be 
<!-- PJG 0012 frnewline -->
defined specifically as the maintenance of a stated frequency of response after initial training. 
<!-- PJG 0012 frnewline -->
Neurotoxicants may adversely affect learning by increasing or decreasing the number of 
<!-- PJG 0012 frnewline -->
presentations required to achieve the designated criterion. Decrements in memory may be 
<!-- PJG 0012 frnewline -->
indicated by a decrease in the probability or frequency of a response at some time after initial 
<!-- PJG 0012 frnewline -->
training. Toxicant-induced changes in learning and memory should be interpreted within the 
<!-- PJG 0012 frnewline -->
context of possible toxicant-induced changes in sensory, motor, and motivational factors. 
<!-- PJG 0012 frnewline -->
Examples of instrumental learning procedures used in neurotoxicology are repeated 
<!-- PJG 0012 frnewline -->
acquisition (Schrot et al., 1984), passive and active avoidance, Y-maze avoidance, spatial 
<!-- PJG 0012 frnewline -->
mazes (radial-arm maze), and delayed matching to sample (Heise, 1984; WHO, 1986; Tilson 
<!-- PJG 0012 frnewline -->
and Mitchell, 1984). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00253 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=81 g=1 f=4 -->
4.3.2.6. Schedule-controlled behavior.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Another type of second-tier procedure is schedule-controlled operant behavior (SCOB), which involves the maintenance
of behavior 
<!-- PJG 0012 frnewline -->
(performance) by response-dependent reinforcement (Rice, 1988). Different patterns of 
<!-- PJG 0012 frnewline -->
behavior and response rates are controlled by the relationship between response and later 
<!-- PJG 0012 frnewline -->
reinforcement. SCOB affords a measure of learned behavior and with appropriate 
<!-- PJG 0012 frnewline -->
experimental design may be useful for studying chemical-induced effects on motor, sensory, 
<!-- PJG 0012 frnewline -->
and cognitive function. 
<!-- PJG 0012 frnewline -->
The primary endpoints for evaluation are agent-induced changes in response rate or 
<!-- PJG 0012 frnewline -->
frequency and the temporal pattern of responding. Response rate is usually related to an 
<!-- PJG 0012 frnewline -->
objective response, such as lever press or key peck, and differs according to the schedule of 
<!-- PJG 0012 frnewline -->
reinforcement. Response rates are expressed per unit of time. For some classes of 
<!-- PJG 0012 frnewline -->
chemicals, the direction of an effect on response rate can differ between low and high doses. 
<!-- PJG 0012 frnewline -->
Agent-induced changes in temporal pattern of responding can occur independently of changes 
<!-- PJG 0012 frnewline -->
in the rate and require analysis of the distribution of responses relative to reinforcement 
<!-- PJG 0012 frnewline -->
schedule. 
<!-- PJG 0012 frnewline -->
SCOB has been used to study the effects of psychoactive drugs on behavior and is 
<!-- PJG 0012 frnewline -->
sensitive to many neurotoxicants, including methylmercury, solvents, pesticides, acrylamides, 
<!-- PJG 0012 frnewline -->
carbon monoxide, and organic and inorganic lead (Paule and McMillan, 1984; MacPhail 
<!-- PJG 0012 frnewline -->
1985; Cory-Slechta, 1989; Rice, 1988). The experimental animal often serves as its own 
<!-- PJG 0012 frnewline -->
control, and the procedure provides an opportunity to study a few animals extensively over a 
<!-- PJG 0012 frnewline -->
relatively long period. SCOB typically requires motivational procedures, such as food 
<!-- PJG 0012 frnewline -->
deprivation, and training sessions are usually required to establish a stable baseline of 
<!-- PJG 0012 frnewline -->
responding. Because of its sensitivity to neuroactive chemicals, SCOB has great potential for 
<!-- PJG 0012 frnewline -->
use in second-tier assessments. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=4 -->
4.3.3. Neurophysiological Endpoints of Neurotoxicity 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Neurophysiological studies are those that assess function either directly through 
<!-- PJG 0012 frnewline -->
measurements of the electrical activity of the nervous system (electrophysiology) or indirectly 
<!-- PJG 0012 frnewline -->
through measurements of peripheral organ functions controlled or modulated by the nervous 
<!-- PJG 0012 frnewline -->
system (general physiology) (Dyer, 1987). When performed properly, neurophysiological 
<!-- PJG 0012 frnewline -->
techniques provide information on the integrity of defined portions of the nervous system. 
<!-- PJG 0012 frnewline -->
Many of the endpoints used in animals have also been used in humans to determine chemical-induced alterations in neurophysiological
function. 
<!-- PJG 0012 frnewline -->
The term ``electrophysiology'' refers to the set of neurophysiological procedures that 
<!-- PJG 0012 frnewline -->
study neural function through the direct measurement of the electrical activity generated by 
<!-- PJG 0012 frnewline -->
the nervous system (Dyer, 1987). A variety of electrophysiological procedures are available 
<!-- PJG 0012 frnewline -->
for application to neurotoxicological problems, which range in scale from procedures that 
<!-- PJG 0012 frnewline -->
employ microelectrodes to study the function of single nerve cells or restricted portions of 
<!-- PJG 0012 frnewline -->
them, to procedures that employ macroelectrodes to perform simultaneous recordings of the 
<!-- PJG 0012 frnewline -->
summed activity of many cells. The latter types of procedures have historically been used in 
<!-- PJG 0012 frnewline -->
studies to detect or characterize the potential neurotoxicity of agents of regulatory interest. 
<!-- PJG 0012 frnewline -->
Several macroelectrode procedures are discussed below. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00254 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=81 g=1 f=4 -->
4.3.3.1. Nerve conduction studies. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Nerve conduction studies are generally performed on peripheral nerves and can be useful in investigations of possible
peripheral neuropathy. Most peripheral nerves contain mixtures of both individual sensory and motor nerve fibers,
which may or may not be differentially sensitive to neurotoxicants. It is possible to distinguish sensory from motor
effects in peripheral nerve studies by measuring activity in purely sensory nerves such as the sural to study sensory
effects or by measuring the muscle response evoked by nerve stimulation to measure motor effects. While a number of
endpoints can be recorded, the most commonly used variables are (1) Nerve conduction velocity, and (2) response amplitude.
In well-controlled studies, decreases in nerve conduction velocity typically are evidence of neurotoxicity (Dyer,
1987). While a decrease in nerve conduction velocity is a reliable measure of demyelination, it frequently occurs
rather late in the course of axonal degradation because normal conduction velocity may be maintained for some time
in the face of axonal degeneration. For this reason, a measurement of normal nerve conduction velocity does not necessarily
rule out peripheral axonal degeneration if other signs of peripheral nerve dysfunction are present. Increases in
conduction velocity of adult organisms following treatment with neurotoxic compounds, in the absence of hypothermia,
are atypical responses and may, in fact, reflect experimental or statistical errors. Decreases in response amplitude
reflect a loss of active nerve fibers, and may occur prior to decreases in conduction velocity in the course of peripheral
neuropathy. Hence changes in response amplitude may be more sensitive measurements of axonal degeneration than
conduction velocity. Measurements of response amplitude, however, are more variable and require careful experimental
techniques, a larger sample size, and greater statistical power than measurements of velocity to detect changes.
Alterations in peripheral nerve function are associated with abnormal peripheral sensations such as numbness,
tingling, or burning or with motor impairments such as weakness. Examples of compounds that alter peripheral nerve
function in humans or experimental animals at some level of exposure include acrylamide, carbon disulfide, hexacarbons,
lead, and some organophosphates. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=4 -->
4.3.3.2. Sensory evoked potentials. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Sensory evoked potentials are electrophysiological procedures that involve measuring the response elicited by
the presentation of a defined sensory stimulus such as a tone, a light, or a brief electrical pulse to the skin. Sensory
evoked potentials reflect sensory function, and can be used to investigate visual, auditory, or somatosensory (body
sensation) systems (Rebert, 1983; Mattsson and Albee, 1988). The data are in the form of a voltage record over time,
which can be quantified in several ways. Commonly, the positive and negative voltage peaks are identified and measured
as to their latency (time from stimulus onset) and amplitude (voltage). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Changes in peak amplitudes or equivalent measures reflect changes in the magnitude of the neural population that
is responsive to stimulation. Both increases and decreases in amplitude are possible following exposure to neurotoxicants
because (1) The brain normally operates in a careful balance between excitatory and inhibitory systems, and disruption
of this balance can produce either positive or negative shifts in the voltages recorded in evoked potential experiments,
and (2) excitatory or inhibitory neural activity is translated into a positive or negative deflection in the sensory
evoked potential depending on the physical orientation of the electrode with respect to the tissue generating the
response, which is frequently unknown. Within any given sensory system, the neural circuits that generate the different
evoked potential peaks differ as a function of peak latency. In general, early latency peaks reflect the transmission
of afferent sensory information, and changes in either the latency or amplitude of these peaks generally indicate
a neurotoxic change that is likely to be reflected in deficits in sensory perception. The later latency peaks, in general,
reflect not only the sensory input, but also the more nonspecific factors such as the behavioral state of the subject
including such factors as arousal level, habituation, or sensitization. Thus, the neurotoxicological significance
of changes in later latency evoked potential peaks must be interpreted in light of the behavioral status of the subject.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=4 -->
4.3.3.3. Convulsions. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Observable behavioral convulsions in animals may be indicative of central nervous system seizure activity. However,
behavioral convulsions that occur only at lethal or near lethal dose levels may reflect an indirect effect secondary
to systemic toxicity and not directly on the nervous system. Convulsions occurring at dose levels that are clearly
sublethal, and in the absence of apparent systemic toxicity, are more likely due to a direct effect on the nervous system.
In such cases, neurophysiological recordings of electrical activity in the brain that are indicative of seizures
may provide additional evidence of direct neurotoxicity. In addition to producing seizures, chemicals may also
affect seizure susceptibility, altering the frequency, severity, duration, or threshold for eliciting seizures
produced through other means. Such changes can occur after acute exposure or after repeated exposure to dose levels
below the acute threshold, and are considered neurotoxic. Agents that produce convulsions include lindane, DDT,
pyrethroids, and trimethyltin (WHO, 1986). Some agents, including many solvents, act to raise the threshold for
eliciting seizures through other means or otherwise act to reduce the severity or duration of the elicited convulsions.
These agents are difficult to classify as neurotoxic based on such data, but frequently have other effects on which
a determination of neurotoxic potential can be based. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=4 -->
4.3.3.4. Electroencephalography (EEG) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
EEG analysis is used widely in clinical settings for the diagnosis of neurological disorders and less often for the
detection of subtle toxicant-induced dysfunction (WHO, 1986; Eccles, 1988). The basis for the use of EEG in either
setting is the relationship between specific patterns of EEG waveforms and specific behavioral states. Because
states of alertness and the stages of sleep are associated with distinct patterns of electrical activity in the brain,
it is generally thought that arousal level can be evaluated by monitoring the EEG. Dissociation of EEG activity and
behavior can, however, occur after exposure to certain chemicals. Normal patterns of transition between sleep stages
or between sleeping and waking states are known to remain disturbed for prolonged periods of time following exposure
to certain chemical classes (e.g., organophosphates). Changes in the pattern of the EEG can be elicited by stimuli
producing arousal (e.g., lights, sounds) and neuroactive drugs. In studies with toxicants, changes in EEG pattern
can sometimes precede alterations in other objective signs of neurotoxicity. EEG experiments must be done under
highly controlled conditions, and the neurotoxicological significance of chemical-induced changes in the EEG
in the absence of other signs of neurotoxicity must be considered on a case-by-case basis. Many chemicals, including
metals, solvents, and pesticides, would be expected to affect the EEG. 
<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00255 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=81 g=1 f=4 -->
4.3.3.5. Electromyography (EMG). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
EMG involves making electrical recordings from muscle and has been used extensively in human clinical studies in
the diagnosis of certain diseases of the muscle (WHO, 1986). Changes in the EMG include amplitude and firing frequency
of spontaneous firing; evoked muscle responses to nerve stimulation can be used to study alterations in the neuromuscular
junction. EMG has been used to study toxicant-induced changes in neuromuscular function, including organophosphate
insecticides, methyl
<!-- PJG 0034 unknown -->

<!-- PJG 0034 unknown -->

<!-- PJG 0034 unknown -->
 n-butyl ketone, and botulinum and tetanus toxin. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=4 -->
4.3.3.6. Spinal reflex excitability. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Segmental spinal monosynaptic and polysynaptic reflexes are relatively simple functions in the central nervous
system that can be evaluated by quantitative techniques (WHO, 1986). Many of the procedures used in animals are similar
to procedures used clinically to perform neurological tests in humans. One approach infers the functional state
of a reflex arc from either the latency and magnitude of the reflex response evoked by stimuli of predetermined intensity
or from the stimulus intensity required to elicit a detectable response (i.e., the threshold). This approach is used
best in a screening context and the significance of effects in this test should be considered on a case-by-case basis.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A second more involved approach records electrophysiologically the time required for a stimulus applied to a peripheral
nerve to reach the spinal cord and return to the site of the original stimulation. Data from this procedure can indicate
the excitability of the motoneuron pool, an effect seen with many volatile solvents. Although this approach is more
invasive and time-consuming than the noninvasive procedure, it provides better data concerning the possible site
of action. In addition, the manner in which the invasive procedure is carried out (i.e., in decerebrated animals)
precludes repeated testing on the same animal. The significance of effects in this procedure should also be considered
on a case-by-case basis. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=4 -->
4.3.4. Neurochemical Endpoints of Neurotoxicity 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Neuronal function within the nervous system is dependent on synthesis and release of specific neurotransmitters
and activation of their receptors in specific neuronal pathways. With few exceptions, neurochemical measurements
are invasive and therefore used infrequently in human risk assessment. There are many different neurochemical endpoints
that could be measured in neurotoxicological studies (Bondy, 1986; Mailman, 1987; Morell and Mailman, 1987). Neurotoxicants
can interfere with the ionic balance of a neuron, act as a cytotoxicant after being transported into a nerve terminal,
block uptake of neurotransmitter precursors, act as a metabolic poison, overstimulate receptors, block transmitter
release, and inhibit transmitter degradation. Table 4&hyph;4 lists several chemicals with known neurochemical
effects. Many neuroactive agents can increase or decrease neurotransmitter levels in the brain. Dose-related changes
on these endpoints may indicate a chemical effect on the nervous system, but the neurotoxicological significance
of such changes must be interpreted in the context of other signs of neurotoxicity. 
<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00256 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<TABLE>

<!-- PJG tableformat 2,L2,i1,s100,xs110 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Table 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=1 -->
4&hyph;4._
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Neurotoxicants With Known Neurochemical Mechanisms 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Site of attack
<!-- PJG 007 0150 intable -->
1Examples
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
1. Neurotoxicants acting on ionic balance 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=4 -->
A. Inhibit sodium entry
<!-- PJG 007 0104 intable -->
Tetrodotoxin.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. Block closing of sodium channel
<!-- PJG 007 0104 intable -->
p,p1_DDT, pyrethroids (I).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
C. Increase permeability to sodium
<!-- PJG 007 0104 intable -->
Batrachotoxin.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
D. Increase intracellular calcium
<!-- PJG 007 0104 intable -->
Chlordecone.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=4 -->
2. Cytotoxicants_depend on uptake into nerve terminal
<!-- PJG 007 0104 intable -->
MPTP. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. Uptake blockers
<!-- PJG 007 0104 intable -->
Hemicholinium.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. Metabolic poisons
<!-- PJG 007 0104 intable -->
Cyanide.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
5. Receptor hyperactivators
<!-- PJG 007 0104 intable -->
Domoic acid.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
6. Transmitter release (ACh) blockers
<!-- PJG 007 0104 intable -->
Botulinum toxin.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
7. Transmitter degradation (ACh) inhibitors
<!-- PJG 007 0104 intable -->
Organophosphates, carbamates.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
8. Microtubule disruptors
<!-- PJG 007 0104 intable -->
Vincristine.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00257 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Some chemicals, such as the organophosphate and carbamate insecticides, are known to interfere with a specific enzyme,
acetylcholinesterase (AChE) (Costa, 1988). Inhibition of this enzyme in brain may be considered evidence of neurotoxicity,
whereas decreases in AChE in the blood, which can be easily determined in humans, are only suggestive of a neurotoxic
effect. A subset of organophosphate agents produces organophosphate-induced delayed neuropathy (OPIDN) after
acute or repeated exposure. Neurotoxic esterase (or neuropathy target enzyme, NTE) has been associated with agents
that produce OPIDN (Johnson, 1990).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The ultimate functional significance of many biochemical changes is not known; therefore it may be difficult to determine
if a specific biochemical change can be considered adverse or convincing evidence of neurotoxicity. Any such change,
however, is potentially adverse and each determination of adversity requires a judgment to be made. Likewise, the
absence of specific biochemical testing protocols does not mean biochemical changes are of no concern, but instead
reflects a lack of understanding of the significance of changes at the biochemical level.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=4 -->
4.3.5. Structural Endpoints of Neurotoxicity 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
The central nervous system (brain and spinal cord) comprises nerve cells or neurons, which consist of a neuronal body,
axon, and dendritic processes. Various types of neuropathological lesions may be classified according to their
nature or the site where they are found (WHO, 1986; Krinke, 1989; Griffin, 1990). Lesions may be classified as neuropathy
(changes in the neuronal body), axonopathy (changes in the axons), myelinopathy (changes in the myelin sheaths),
neurodegeneration (changes in the nerve terminals), and peripheral neuropathy (changes in the peripheral nerves).
For axonopathies, a more precise location of the changes should be described (i.e., proximal, central, or distal
axonopathy). In some cases, agents produce neuropathic conditions that resemble naturally occurring neurodegenerative
disorders in humans (WHO, 1986). Table 4&hyph;5 lists examples of such chemicals, their known site of action, the
type of neuropathology produced, and the disease or condition that each typifies.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00258 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<TABLE>

<!-- PJG tableformat 4,L2,i1,s75,xs80,xs60,xs100 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Table 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=1 -->
4&hyph;5._
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Examples of Known Neuropathic Agents 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Site of attack
<!-- PJG 007 0150 intable -->
1Neuropathology
<!-- PJG 007 0150 intable -->
1Corresponding neurotoxicant
<!-- PJG 007 0150 intable -->
1Disease or neurodegenerative condition
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=4 -->
Neuron cell body
<!-- PJG 007 0104 intable -->
Neuronopathy
<!-- PJG 007 0104 intable -->
Methylmercury
<!-- PJG 007 0104 intable -->
Minamata disease.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=4 -->
&blank;
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 007 0104 intable -->
A.E.T.T.
<!-- PJG 007 0104 intable -->
Ceroid lipofuscinoses.
<!-- PJG 0012 frnewline -->
&blank;
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 007 0104 intable -->
Quinolinic acid
<!-- PJG 007 0104 intable -->
Huntington's disease.
<!-- PJG 0012 frnewline -->
&blank;
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 007 0104 intable -->
3-acetylpridine
<!-- PJG 007 0104 intable -->
Cerebellar ataxia.
<!-- PJG 0012 frnewline -->
&blank;
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l
<!-- PJG 007 0104 intable -->
Aluminum
<!-- PJG 007 0104 intable -->
Alzheimer's disease.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=4 -->
Nerve terminal
<!-- PJG 007 0104 intable -->
Neurodegeneration
<!-- PJG 007 0104 intable -->
MPTP
<!-- PJG 007 0104 intable -->
Parkinson's disease.
<!-- PJG 0012 frnewline -->
Schwann cell myelin
<!-- PJG 007 0104 intable -->
Myelinopathy
<!-- PJG 007 0104 intable -->
Lead Buckthorn toxin
<!-- PJG 007 0104 intable -->
Neuropathy of meta
<!-- PJG 0034 unknown -->
chro
<!-- PJG 0034 unknown -->
matic leuko
<!-- PJG 0034 unknown -->
dys
<!-- PJG 0034 unknown -->
trophy.
<!-- PJG 0012 frnewline -->
Central-peripheral distal axon
<!-- PJG 007 0104 intable -->
Distal axonopathy
<!-- PJG 007 0104 intable -->
Acrylamide Hexacarbons Carbon disulfide
<!-- PJG 007 0104 intable -->
Vitamin deficiency.
<!-- PJG 0012 frnewline -->
Central axons
<!-- PJG 007 0104 intable -->
Central axonopathy
<!-- PJG 007 0104 intable -->
Clioquinol
<!-- PJG 007 0104 intable -->
Subacute myelooptico-neuropathy.
<!-- PJG 0012 frnewline -->
Proximal axon 
<!-- PJG 007 0104 intable -->
Proximal axonopathy
<!-- PJG 007 0104 intable -->
B,B
<!-- PJG 0020 minuteslatlong -->
&rsquo;-imminodi-proprionitrile
<!-- PJG 007 0104 intable -->
Motor neuron disease.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00259 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=4 -->
In general, chemical effects lead to two types of primary cellular alteration: (l) the accumulation, proliferation,
or rearrangement of structural elements (e.g., intermediate filaments, microtubules) or organelles (mitochondria)
and (2) the breakdown of cells, in whole or in part. The latter can be associated with regenerative processes that may
occur during chemical exposure. Such changes are considered to be neurotoxic. 
<!-- PJG 0012 frnewline -->
While most neurotoxic damage is evident at the microscopic level, gross changes in morphology can be reflected by
a significant change in the weight of the brain. Weight changes (absolute or relative to body weight), discoloration,
discrete or massive cerebral hemorrhage, or obvious lesions in nerve tissue are generally considered neurotoxic
effects. 
<!-- PJG 0012 frnewline -->
Chemical-induced injury to the central nervous system is associated with astrocytic hypertrophy at the site of damage.
Assays of glial fibrillary acidic protein (GFAP), the major intermediate filament protein of astrocytes, has been
proposed as a biomarker of this response (O'Callaghan, 1988). A number of chemicals known to injure the central nervous
system, including trimethyltin, methylmercury, cadmium, 3-acetylpyridine, and MPTP, have been shown to increase
GFAP. In addition, increases in GFAP may be seen at dosages below those necessary to produce cytopathology as determined
by Nissl-based stains used in standard neuropathological examinations. Because increases in GFAP may be an early
indicator of neuronal injury in the adult, exposure level-dependent increases in GFAP should be viewed with concern.

<!-- PJG 0012 frnewline -->
Chemical-induced alterations in the structure of the nervous system are generally considered neurotoxic effects.
To ensure reliable data, it is important that neuropathological studies minimize fixation artifacts and potential
differences in the section(s) of the nervous system sampled and control for variability due to the age, sex, and body
weight of the subject (WHO, 1986). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=4 -->
4.3.6. Developmental Neurotoxicity 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Exposure to chemicals during development can result in effects other than death, gross structural abnormality,
or altered growth. There are several instances in which functional alterations have resulted from exposure during
the period between conception and sexual maturity (Riley and Vorhees, 1986; Vorhees, 1987). Table 4&hyph;6 lists
several examples of chemicals known to produce developmental neurotoxicity in experimental animals. Animal models
of developmental neurotoxicity have been shown to be sensitive to several environmental chemicals known to produce
developmental toxicity in humans, including lead, ethanol, methylmercury, and PCBs (Kimmel et al., 1990). 
<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 2,L1(,0,),p3,8/9,i1,xl50,xl50 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Table 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=1 -->
4&hyph;6._
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Partial List of Agents Believed to Have Developmental Neurotoxicity
<!-- PJG 007 0150 intable -->
1&blank;
<!-- PJG 007 0150 intable -->
1&blank;
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=4 -->
Alcohols
<!-- PJG 007 0104 intable -->
Methanol, ethanol 
<!-- PJG 0012 frnewline -->
Antimitotics
<!-- PJG 007 0104 intable -->
X-radiation, azacytidine 
<!-- PJG 0012 frnewline -->
Insecticides
<!-- PJG 007 0104 intable -->
DDT, kepone, organophosphates 
<!-- PJG 0012 frnewline -->
Metals
<!-- PJG 007 0104 intable -->
Lead, methylmercury, cadmium 
<!-- PJG 0012 frnewline -->
Polyhalogenated hydrocarbons
<!-- PJG 007 0104 intable -->
PCB, PBB 
<!-- PJG 0012 frnewline -->
Psychoactive drugs
<!-- PJG 007 0104 intable -->
Cocaine, phenytoin 
<!-- PJG 0012 frnewline -->
Solvents
<!-- PJG 007 0104 intable -->
Carbon disulfide, toluene 
<!-- PJG 0012 frnewline -->
Vitamins
<!-- PJG 007 0104 intable -->
Vitamin A
<!-- PJG /ITAG -->

</TABLE>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00260 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Sometimes functional defects are observed at dose levels below those at which other 
<!-- PJG 0012 frnewline -->
indicators of developmental toxicity are evident (Rodier, 1986). Such effects may be 
<!-- PJG 0012 frnewline -->
transient or reversible in nature, but generally are considered adverse effects. Data from 
<!-- PJG 0012 frnewline -->
postnatal studies, when available, are considered useful for further assessment of the relative 
<!-- PJG 0012 frnewline -->
importance and severity of findings in the fetus and neonate. Often, the long-term 
<!-- PJG 0012 frnewline -->
consequences of adverse developmental outcomes noted at birth are unknown and further data 
<!-- PJG 0012 frnewline -->
on postnatal development and function are necessary to determine the full spectrum of 
<!-- PJG 0012 frnewline -->
potential developmental effects. Useful data also can be derived from well-conducted 
<!-- PJG 0012 frnewline -->
multigeneration studies, although the dose levels used in these studies may be much lower 
<!-- PJG 0012 frnewline -->
than those in studies with shorter-term exposure. 
<!-- PJG 0012 frnewline -->
Much of the early work in developmental neurotoxicology was related to behavioral 
<!-- PJG 0012 frnewline -->
evaluations. Recent advances in this area have been reviewed in several publications (Riley 
<!-- PJG 0012 frnewline -->
and Vorhees, 1986; Kimmel et al., 1990). Several expert groups have focused on the 
<!-- PJG 0012 frnewline -->
functions that should be included in a behavioral testing battery, including sensory systems, 
<!-- PJG 0012 frnewline -->
neuromotor development, locomotor activity, learning and memory, reactivity and 
<!-- PJG 0012 frnewline -->
habituation, and reproductive behavior. No testing battery has fully addressed all of these 
<!-- PJG 0012 frnewline -->
functions, but it is important to include as many as possible, and several testing batteries 
<!-- PJG 0012 frnewline -->
have been developed and evaluated for use in testing. 
<!-- PJG 0012 frnewline -->
Direct extrapolation of functional developmental effects to humans is limited in the 
<!-- PJG 0012 frnewline -->
same way as for other endpoints of developmental toxicity, i.e., by the lack of knowledge 
<!-- PJG 0012 frnewline -->
about underlying toxicological mechanisms and their significance. It can be assumed that 
<!-- PJG 0012 frnewline -->
functional effects in animal studies indicate the potential for altered development in humans, 
<!-- PJG 0012 frnewline -->
although the types of developmental effects seen in experimental animal studies will not 
<!-- PJG 0012 frnewline -->
necessarily be the same as those that may be produced in humans. Thus, when data from 
<!-- PJG 0012 frnewline -->
functional developmental toxicity studies are encountered for particular agents, they should 
<!-- PJG 0012 frnewline -->
be considered in the risk assessment process. 
<!-- PJG 0012 frnewline -->
Agents that produce developmental neurotoxicity at a dose that is not toxic to the 
<!-- PJG 0012 frnewline -->
maternal animal are of special concern because the developing organism is affected but 
<!-- PJG 0012 frnewline -->
toxicity is not apparent in the adult. More commonly, however, adverse developmental 
<!-- PJG 0012 frnewline -->
effects are produced only at doses that cause minimal maternal toxicity; in these cases, the 
<!-- PJG 0012 frnewline -->
developmental effects are still considered to represent developmental toxicity and should not 
<!-- PJG 0012 frnewline -->
be discounted as secondary to maternal toxicity. At doses causing excessive maternal 
<!-- PJG 0012 frnewline -->
toxicity (that is, significantly greater than the minimal toxic dose), information on 
<!-- PJG 0012 frnewline -->
developmental effects may be difficult to interpret and of limited value. Current information 
<!-- PJG 0012 frnewline -->
is inadequate to assume that developmental effects at maternally toxic doses result only from 
<!-- PJG 0012 frnewline -->
maternal toxicity; it may be that the mother and developing organism are sensitive to that 
<!-- PJG 0012 frnewline -->
dose level. Moreover, whether developmental effects are secondary to maternal toxicity or 
<!-- PJG 0012 frnewline -->
not, the maternal effects may be reversible while effects on the offspring may be permanent. 
<!-- PJG 0012 frnewline -->
These are important considerations for agents to which humans may be exposed at minimally 
<!-- PJG 0012 frnewline -->
toxic levels either voluntarily or involuntarily, because several agents are known to produce 
<!-- PJG 0012 frnewline -->
adverse developmental effects at minimally toxic doses in adult humans (e.g., smoking, 
<!-- PJG 0012 frnewline -->
alcohol). 
<!-- PJG 0012 frnewline -->
Although interpretation of functional developmental neurotoxicity data may be limited 
<!-- PJG 0012 frnewline -->
at present, it is clear that functional effects must be evaluated in light of other toxicity data, 
<!-- PJG 0012 frnewline -->
including other forms of developmental toxicity (e.g., structural abnormalities, perinatal 
<!-- PJG 0012 frnewline -->
death, and growth retardation). The level of confidence in an adverse effect may be as 
<!-- PJG 0012 frnewline -->
important as the type of change seen, and confidence may be increased by such factors as 
<!-- PJG 0012 frnewline -->
replicability of the effect either in another study of the same function or by convergence of 
<!-- PJG 0012 frnewline -->
data from tests that purport to measure similar functions. A dose-response relationship is 
<!-- PJG 0012 frnewline -->
considered an important measure of chemical effect; in the case of functional effects, both 
<!-- PJG 0012 frnewline -->
monotonic and biphasic dose-response curves are likely, depending on the function being 
<!-- PJG 0012 frnewline -->
tested. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=4 -->
4.3.7. Physiological and Neuroendocrine Endpoints 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
One of the key roles played by the nervous system is to orchestrate the general 
<!-- PJG 0012 frnewline -->
physiological functions of the body to help maintain homeostasis. To this end, the nervous 
<!-- PJG 0012 frnewline -->
system and many of the peripheral organ systems are integrated and functionally 
<!-- PJG 0012 frnewline -->
interdependent. For example, specific neuronal processes are intimately involved in 
<!-- PJG 0012 frnewline -->
maintaining or modulating respiration, cardiovascular function, body temperature, and 
<!-- PJG 0012 frnewline -->
gastrointestinal function. Because many peripheral organ functions involve neuronal 
<!-- PJG 0012 frnewline -->
components, changes in such physiological endpoints as blood pressure, heart rate, EKG, 
<!-- PJG 0012 frnewline -->
body temperature, respiration, lacrimation, or salivation may indirectly reflect possible 
<!-- PJG 0012 frnewline -->
treatment-related effects on the functional integrity of the nervous system. However, since 
<!-- PJG 0012 frnewline -->
physiological endpoints also depend on the integrity of the related peripheral organ itself, 
<!-- PJG 0012 frnewline -->
changes in physiological function also may reflect a systemic toxicity involving that organ. 
<!-- PJG 0012 frnewline -->
Consequently, the neurotoxicological significance of a physiological change must be 
<!-- PJG 0012 frnewline -->
interpreted within the context of other signs of toxicity. A variety of general physiological 
<!-- PJG 0012 frnewline -->
procedures can be applied to neurotoxicological problems. These procedures range in scale 
<!-- PJG 0012 frnewline -->
from simple measurements, for example, of body temperature, respiration, lacrimation, 
<!-- PJG 0012 frnewline -->
salivation, urination, and defecation, which may be included in routine functional 
<!-- PJG 0012 frnewline -->
observational batteries used for chemical screening, to more involved procedures involving 
<!-- PJG 0012 frnewline -->
measurements of blood pressure, endocrine responses, cardiac function, gastrointestinal 
<!-- PJG 0012 frnewline -->
function, etc. The latter would be more appropriate for second-level tests to characterize the 
<!-- PJG 0012 frnewline -->
scope of chemically related toxicity. 
<!-- PJG 0012 frnewline -->
The central nervous system also regulates the outflow of the endocrine system, which 
<!-- PJG 0012 frnewline -->
together with the influence of the autonomic nervous system, can affect immunologic 
<!-- PJG 0012 frnewline -->
function (WHO, 1986). Hormonal balance results from the integrated action of the 
<!-- PJG 0012 frnewline -->
hypothalamus, located in the central nervous system, and the pituitary, which regulates 
<!-- PJG 0012 frnewline -->
activities of endocrine target organs. Each site is susceptible to disruption by neurotoxic 
<!-- PJG 0012 frnewline -->
agents. Neuroendocrine dysfunction may occur because of a disturbance in the regulation 
<!-- PJG 0012 frnewline -->
and modulation of the neuroendocrine feedback systems. One major indicator of 
<!-- PJG 0012 frnewline -->
neuroendocrine function is secretions of hormones from the pituitary. Hormones from the 
<!-- PJG 0012 frnewline -->
anterior pituitary are important for reproduction (follicle-stimulating hormone, luteinizing 
<!-- PJG 0012 frnewline -->
hormone), growth (thyroid-stimulating hormone), and response to stress (adrenocorticotropic 
<!-- PJG 0012 frnewline -->
hormone). Hypothalamic control of anterior pituitary secretions occurs through the release 
<!-- PJG 0012 frnewline -->
of hypothalamic-hypophysiotropic hormones. Hormones from the posterior hypothalamus 
<!-- PJG 0012 frnewline -->
(prolactin, melanocyte-stimulating hormone, and growth hormone) are also involved in a 
<!-- PJG 0012 frnewline -->
number of important bodily functions. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00261 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Many types of behaviors (e.g., reproductive behaviors, sexually dimorphic behaviors) 
<!-- PJG 0012 frnewline -->
are dependent on the integrity of the hypothalamic-pituitary system, which could represent an 
<!-- PJG 0012 frnewline -->
important site for neurotoxic action. Pituitary secretions arise from a number of different 
<!-- PJG 0012 frnewline -->
cell types in this gland and neurotoxicants could affect these cells either directly or 
<!-- PJG 0012 frnewline -->
indirectly. Morphological changes in follicular cells, chromophobe cells, somatotropic cells, 
<!-- PJG 0012 frnewline -->
prolactin cells, gonadotropic cells, follicle-stimulating hormone secreting cells, luteinizing 
<!-- PJG 0012 frnewline -->
hormone-containing cells, thyrotropic cells, and cortico cells might be associated with 
<!-- PJG 0012 frnewline -->
adverse effects on the pituitary, which could ultimately affect behavior and the functioning of 
<!-- PJG 0012 frnewline -->
the nervous system. 
<!-- PJG 0012 frnewline -->
Biochemical changes in the hypothalamus also may be used as indices of potential 
<!-- PJG 0012 frnewline -->
changes in neuroendocrine function. However, the neuroendocrine significance of changes in 
<!-- PJG 0012 frnewline -->
hypothalamic neurotransmitters and neuropeptides is usually only inferential and data must be 
<!-- PJG 0012 frnewline -->
considered on a case-by-case basis. 
<!-- PJG 0012 frnewline -->
Most anterior pituitary hormones are subject to negative feedback control by 
<!-- PJG 0012 frnewline -->
peripheral endocrine glands and, if neurotoxicants modify peripheral secretions, 
<!-- PJG 0012 frnewline -->
neuroendocrine changes can result from this altered feedback. Modifications in the 
<!-- PJG 0012 frnewline -->
functioning of these endocrine secretions could occur after toxic exposure; a number of 
<!-- PJG 0012 frnewline -->
agents have been shown to alter blood levels of glucocorticoids, thyroxine, estrogen, 
<!-- PJG 0012 frnewline -->
corticosterone, and testosterone. Although such changes are not necessarily due to direct 
<!-- PJG 0012 frnewline -->
neuroendocrine effects, target organ changes often can be a first indication of neuroendocrine 
<!-- PJG 0012 frnewline -->
changes. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=4 -->
4.3.8. Other Considerations 
<!-- PJG 0012 frnewline -->
4.3.8.1. Structure-activity relationship. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Because of a general lack of epidemiologic or 
<!-- PJG 0012 frnewline -->
toxicologic data on most chemical substances, attempts have been made in toxicology to 
<!-- PJG 0012 frnewline -->
predict activities based on chemical structure. The basis for inference from structure-activity 
<!-- PJG 0012 frnewline -->
relationships (SARs) can be either comparison with structures known to have biologic activity 
<!-- PJG 0012 frnewline -->
or knowledge of structural requirements of a receptor or macromolecular site of action. 
<!-- PJG 0012 frnewline -->
However, given the complexity of the nervous system and the lack of information on biologic 
<!-- PJG 0012 frnewline -->
mechanisms of neurotoxic action, there are relatively few well-characterized SARs in 
<!-- PJG 0012 frnewline -->
neurotoxicology. Since SARs cannot be used to rule out all neurotoxic activity, it is not 
<!-- PJG 0012 frnewline -->
acceptable to use them as a basis for excluding potential neurotoxicity. Caution is warranted 
<!-- PJG 0012 frnewline -->
in interpreting SARs in anything other than the most preliminary analyses. Use of SARs 
<!-- PJG 0012 frnewline -->
requires detailed knowledge not only of structure, but also of each critical step in the 
<!-- PJG 0012 frnewline -->
pathogenetic mechanism of neurotoxic injury. Such knowledge is still generally unavailable. 
<!-- PJG 0012 frnewline -->
SAR approaches are more successful when the range of possible sites of action or 
<!-- PJG 0012 frnewline -->
mechanisms of action is narrow. Thus, SARs have had more use in relation to 
<!-- PJG 0012 frnewline -->
carcinogenicity and mutagenicity than in other kinds of toxicity. The SAR approaches used 
<!-- PJG 0012 frnewline -->
in the development of novel neuropharmacologic structures deserve consideration in 
<!-- PJG 0012 frnewline -->
neurotoxicology, but their utility depends on a better understanding of neurotoxic mechanisms. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=4 -->
4.3.8.2. In vitro methods. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
In vitro procedures for testing have practical advantages, but 
<!-- PJG 0012 frnewline -->
studies must be done to correlate the results with responses in whole animals. One 
<!-- PJG 0012 frnewline -->
advantage of validated in vitro tests is that they minimize the use of live animals. Some of 
<!-- PJG 0012 frnewline -->
the more developed in vitro tests might be simple and might not have to be conducted by 
<!-- PJG 0012 frnewline -->
highly trained personnel, but, as with many in vivo tests, the analysis and interpretation of 
<!-- PJG 0012 frnewline -->
results are likely to require expertise. Experience with the Ames test for mutagenesis 
<!-- PJG 0012 frnewline -->
confirms the advantages of in vitro procedures, but also illustrates the problems that arise 
<!-- PJG 0012 frnewline -->
when an assay is used to predict an endpoint that is not exactly what it measures (e.g., 
<!-- PJG 0012 frnewline -->
carcinogenicity rather than specific aspects of genotoxicity). In vitro changes can be markers 
<!-- PJG 0012 frnewline -->
for toxicity, even when the structural or functional consequences are not known or predicted. 
<!-- PJG 0012 frnewline -->
In addition, in vitro methods can examine the more evolutionarily conserved elements of the 
<!-- PJG 0012 frnewline -->
nervous system and improve neurotoxicity detection and could also provide suitable systems 
<!-- PJG 0012 frnewline -->
for studying developmental neurotoxicity. 
<!-- PJG 0012 frnewline -->
A broad range of tissue-culture systems are available for assessing the neurologic 
<!-- PJG 0012 frnewline -->
impact of environmental agents, including cell lines, dissociated cell cultures, reaggregate 
<!-- PJG 0012 frnewline -->
cultures, explant cultures, and organ cultures (Veronesi, 1991). 
<!-- PJG 0012 frnewline -->
Neuronal and glial cell lines are used extensively in neurobiology and have potential 
<!-- PJG 0012 frnewline -->
for neurotoxicological studies. They consist of populations of continuously dividing cells 
<!-- PJG 0012 frnewline -->
that, when treated appropriately, stop dividing and exhibit differentiated neuronal or glial 
<!-- PJG 0012 frnewline -->
properties. Neuronal lines can develop electric excitability, chemosensitivity, axon 
<!-- PJG 0012 frnewline -->
formation, neurotransmitter synthesis and secretion, and synapse formation. Large quantities 
<!-- PJG 0012 frnewline -->
of cells can be generated routinely to develop extensive dose-response or other quantitative 
<!-- PJG 0012 frnewline -->
data. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00262 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=4 -->
When neural tissue, typically from fetal animals, is dissociated into a suspension of 
<!-- PJG 0012 frnewline -->
single cells, and the suspension is inoculated into tissue-culture dishes, the neurons and glia 
<!-- PJG 0012 frnewline -->
survive, grow, and establish functional neuronal networks. Such preparations have been 
<!-- PJG 0012 frnewline -->
made from most regions of the CNS and exhibit highly differentiated, site-specific properties 
<!-- PJG 0012 frnewline -->
that constitute an in vitro model of different portions of the CNS. Most of the neuronal 
<!-- PJG 0012 frnewline -->
transmitter and receptor phenotypes can be demonstrated, and a variety of synaptic 
<!-- PJG 0012 frnewline -->
interactions can be studied. Glial cells are also present, and neuroglial interactions are a 
<!-- PJG 0012 frnewline -->
prominent feature of the cultures. A substantial battery of assays (neurochemical and 
<!-- PJG 0012 frnewline -->
neurophysiologic) is now available to assess the development of the cultures and to indicate 
<!-- PJG 0012 frnewline -->
toxic effects of test agents added to the culture medium. Relatively pure populations of 
<!-- PJG 0012 frnewline -->
different cell types can be isolated and cultured, so that effects on specific cell types can be 
<!-- PJG 0012 frnewline -->
assessed independently. Pure glial cells or neurons, or even specific neural categories, can 
<!-- PJG 0012 frnewline -->
be prepared in this way and studied separately, or interaction between neurons and glial cells 
<!-- PJG 0012 frnewline -->
can be studied at high resolution. The neurobiologic measures used to assess the effect of 
<!-- PJG 0012 frnewline -->
any agent can be very specific (for example, activity of neurotransmitter-related enzyme or 
<!-- PJG 0012 frnewline -->
binding of a receptor ligand) or global (for example, neuron survival or concentration of glial 
<!-- PJG 0012 frnewline -->
fibrillary acidic protein). The two-dimensional character of the preparations makes them 
<!-- PJG 0012 frnewline -->
particularly suited for morphologic evaluation, and detailed electrophysiologic studies are 
<!-- PJG 0012 frnewline -->
readily performed. The toxic effects and mechanisms of anticonvulsants, excitatory amino 
<!-- PJG 0012 frnewline -->
acids, and various metals and divalent cations have been assessed with these preparations. 
<!-- PJG 0012 frnewline -->
The cerebellar granular cell culture system, for example, has been exploited recently in 
<!-- PJG 0012 frnewline -->
studies of the mechanism of alkyllead toxicity (Verity et al., 1990). 
<!-- PJG 0012 frnewline -->
A related preparation made from single-cell suspensions of neural tissue is the 
<!-- PJG 0012 frnewline -->
reaggregate culture. Instead of being placed in culture dishes and allowed to settle onto the 
<!-- PJG 0012 frnewline -->
surface of the dishes, the cells are kept in suspension by agitation; under appropriate 
<!-- PJG 0012 frnewline -->
conditions, they stick to one another and form aggregates of controllable size and 
<!-- PJG 0012 frnewline -->
composition. Typically, the cells in an aggregate organize and exhibit intercellular relations 
<!-- PJG 0012 frnewline -->
that are a function of, and bear some resemblance to, the brain region that was the source of 
<!-- PJG 0012 frnewline -->
the cells. The cells establish a three-dimensional, often laminated structure. Reaggregate 
<!-- PJG 0012 frnewline -->
cultures lend themselves to large-scale, quantitative experiments in which neurobiologic 
<!-- PJG 0012 frnewline -->
variables can be examined, although morphologic and ligand-binding studies are performed 
<!-- PJG 0012 frnewline -->
less readily than with surface cultures. 
<!-- PJG 0012 frnewline -->
Organotypic explant cultures also are closely related to the intact nervous system. 
<!-- PJG 0012 frnewline -->
Small pieces or slices of neural tissue are placed in culture and can be maintained for long 
<!-- PJG 0012 frnewline -->
periods with substantial maintenance of structural and cell-cell relations of intact tissue. 
<!-- PJG 0012 frnewline -->
Specific synaptic relations develop and can be maintained and evaluated, both 
<!-- PJG 0012 frnewline -->
morphologically and electrophysiologically. Because all regions of the nervous system are 
<!-- PJG 0012 frnewline -->
amenable to this sort of preparation, it is possible to analyze toxic agents that are active only 
<!-- PJG 0012 frnewline -->
in specific regions of the central or peripheral nervous system. Explants can be made from 
<!-- PJG 0012 frnewline -->
relatively thin slices of neural tissue, so detailed morphologic and intracellular 
<!-- PJG 0012 frnewline -->
electrophysiologic studies are possible. Their anatomic integrity is such that they capture 
<!-- PJG 0012 frnewline -->
many of the cell-cell interactions characteristic of the intact nervous system while allowing a 
<!-- PJG 0012 frnewline -->
direct, continuing evaluation of the effects of a potentially neurotoxic compound added to the 
<!-- PJG 0012 frnewline -->
culture medium. The process of myelination has been studied extensively in explant cultures, 
<!-- PJG 0012 frnewline -->
and considerable neurotoxicologic information has been gained. A preparation similar to an 
<!-- PJG 0012 frnewline -->
explant culture is the organ culture, in which an entire organ, such as the inner ear or a 
<!-- PJG 0012 frnewline -->
ganglion, rather than slices or fragments, is grown in vitro. Obviously, only structures so 
<!-- PJG 0012 frnewline -->
small that their viability is not compromised can be treated in this way. 
<!-- PJG 0012 frnewline -->
In general, the technical ease of maintaining a culture varies inversely with the degree 
<!-- PJG 0012 frnewline -->
to which it captures a spectrum of in vivo characteristics of nervous system behavior. The 
<!-- PJG 0012 frnewline -->
problem of biotransformation of potentially neurotoxic compounds is shared by all, although 
<!-- PJG 0012 frnewline -->
the more complete systems (explant or organ cultures) might alleviate this problem in 
<!-- PJG 0012 frnewline -->
specific instances. In many culture systems, complex and ill-defined additives_such as fetal 
<!-- PJG 0012 frnewline -->
calf serum, horse serum, and human placental serum_are used to promote cell survival. A 
<!-- PJG 0012 frnewline -->
number of thoroughly described synthetic media are now available, however, and such fully 
<!-- PJG 0012 frnewline -->
defined culture systems can be used where necessary. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00263 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=4 -->
5. Neurotoxicology Risk Assessment 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=4 -->
5.1. Introduction 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Risk assessment is an empirically based process used to estimate the risk that 
<!-- PJG 0012 frnewline -->
exposure of an individual or population to a chemical, physical, or biological agent will be 
<!-- PJG 0012 frnewline -->
associated with an adverse effect. Generally, such effects can be quantified and the relative 
<!-- PJG 0012 frnewline -->
probability of their occurrence can be calculated. The risk assessment process usually 
<!-- PJG 0012 frnewline -->
involves four steps: hazard identification, dose-response assessment, exposure assessment, 
<!-- PJG 0012 frnewline -->
and risk characterization (NRC, 1983). Risk management is the process that applies 
<!-- PJG 0012 frnewline -->
information obtained through the risk assessment process to determine whether the assessed 
<!-- PJG 0012 frnewline -->
risk should be reduced and, if so, to what extent (NRC, 1983). In some cases, risk is the 
<!-- PJG 0012 frnewline -->
only factor considered in a decision to regulate exposure to a substance. Alternatively, the 
<!-- PJG 0012 frnewline -->
risk posed by a substance is weighed against social, ethical, and medical benefits and 
<!-- PJG 0012 frnewline -->
economic and technological factors in formulating a risk management decision. The risk-
<!-- PJG 0012 frnewline -->
balancing approach is used by some agencies to consider the benefits as well as the risks 
<!-- PJG 0012 frnewline -->
associated with unrestricted or partially restricted use of a substance. The purpose of this 
<!-- PJG 0012 frnewline -->
chapter is to describe the risk assessment process as it has currently evolved in 
<!-- PJG 0012 frnewline -->
neurotoxicology and present available options for quantitative risk assessment. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=4 -->
5.2. The Risk Assessment Process 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=4 -->
5.2.1. Hazard Identification 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Agents that adversely affect the neurophysiological, neurochemical, or structural 
<!-- PJG 0012 frnewline -->
integrity of the nervous system or the integration of nervous system function expressed as 
<!-- PJG 0012 frnewline -->
modified behavior may be classified as neurotoxicants (Tilson, 1990b). For hazard 
<!-- PJG 0012 frnewline -->
identification, the best or most generalizable studies would measure these changes in humans. 
<!-- PJG 0012 frnewline -->
With the exclusion of therapeutic agents, information on effects in humans is usually derived 
<!-- PJG 0012 frnewline -->
from case reports of accidental exposures and epidemiological studies. This type of data 
<!-- PJG 0012 frnewline -->
affords less certainty regarding generalizability as well as less specific exposure information. 
<!-- PJG 0012 frnewline -->
As discussed in chapter 4, a common alternative method of data generation for hazard 
<!-- PJG 0012 frnewline -->
identification is the use of animal models. Animal models that measure behavioral, 
<!-- PJG 0012 frnewline -->
neurophysiological, neurochemical, and structural effects have been developed and validated. 
<!-- PJG 0012 frnewline -->
Studies that employ these models to evaluate specific potential hazards are used to predict the 
<!-- PJG 0012 frnewline -->
outcome of exposure to the same hazard in humans. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=4 -->
5.2.1.1. Human studies 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Information obtained through the evaluation of human exposure 
<!-- PJG 0012 frnewline -->
data provides direct identification of neurotoxic hazards. This type of information is 
<!-- PJG 0012 frnewline -->
generally available from clinical trials required for the approval of therapeutic products for 
<!-- PJG 0012 frnewline -->
human use. For the purposes of risk assessment of nontherapeutic substances, data on effects 
<!-- PJG 0012 frnewline -->
of exposure to humans come primarily from two types of studies, case reports and 
<!-- PJG 0012 frnewline -->
epidemiological (Friedlander and Hearn, 1980) (see chapter 3). Case studies can supply 
<!-- PJG 0012 frnewline -->
evidence of an agent's toxicity, but are often limited by both the qualitative nature of the 
<!-- PJG 0012 frnewline -->
signs and symptoms reported and the nature of the exposure data. Epidemiological studies 
<!-- PJG 0012 frnewline -->
can provide data on the types of neurotoxic effects and the possible susceptibilities of certain 
<!-- PJG 0012 frnewline -->
populations. Under appropriate considerations, they can generally provide convincing and 
<!-- PJG 0012 frnewline -->
reliable evidence of potential human neurotoxicity. As with case studies, however, often 
<!-- PJG 0012 frnewline -->
only qualitative estimates of exposure can be obtained. Controlled laboratory studies have 
<!-- PJG 0012 frnewline -->
the potential to provide adequate exposure and effects data for accurate hazard identification, 
<!-- PJG 0012 frnewline -->
but ethical considerations place moral and practical restrictions on such studies except in 
<!-- PJG 0012 frnewline -->
those instances where direct benefit to the subjects, as in the case of therapeutic agents, may 
<!-- PJG 0012 frnewline -->
be expected. Excluding instances of therapeutic product development, most studies are 
<!-- PJG 0012 frnewline -->
limited to measuring the effects of acute, rather than long-term, exposure. This limits their 
<!-- PJG 0012 frnewline -->
utility in risk assessment because the effect of long-term, low-level exposure to a potentially 
<!-- PJG 0012 frnewline -->
toxic agent is often the issue of concern. 
<!-- PJG 0012 frnewline -->
Methods available to evaluate neurotoxicity in humans include examination of 
<!-- PJG 0012 frnewline -->
neurophysiological and behavioral parameters. Specific tests to measure neuromuscular 
<!-- PJG 0012 frnewline -->
strength and coordination, alterations in sensation, deficits in learning and memory, changes 
<!-- PJG 0012 frnewline -->
in mood and personality, and disruptions of autonomic function are frequently employed (see 
<!-- PJG 0012 frnewline -->
chapter 3). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=4 -->
5.2.1.2. Animal studies 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
As discussed in chapter 4, animal models for many endpoints of 
<!-- PJG 0012 frnewline -->
neurotoxicity are available and widely used for hazard identification. Data from animal 
<!-- PJG 0012 frnewline -->
studies are frequently extrapolated to humans. For example, if exposure to an agent 
<!-- PJG 0012 frnewline -->
produces neuropathology in an animal model, damage to a comparable structure in humans is 
<!-- PJG 0012 frnewline -->
predicted. Similarly, biochemical and physiological effects observed in animals are 
<!-- PJG 0012 frnewline -->
commonly extrapolated to humans. Agents that produce alterations in the levels of specific 
<!-- PJG 0012 frnewline -->
enzymes in one animal species generally have the same effect in other species, including 
<!-- PJG 0012 frnewline -->
humans. Neurophysiological endpoints also tend to be affected by the same manipulations 
<!-- PJG 0012 frnewline -->
across species. Thus, an agent interfering with nerve conduction in an animal study is often 
<!-- PJG 0012 frnewline -->
assumed to have the same effect in humans. Behavioral studies in animals are also applied to 
<!-- PJG 0012 frnewline -->
human hazard identification, although the correspondence between methods employed in 
<!-- PJG 0012 frnewline -->
animals and humans is sometimes not as obvious. For this reason, behavioral methods 
<!-- PJG 0012 frnewline -->
developed for neurotoxic hazard identification need to be considered on a case-by-case basis. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=4 -->
5.2.1.3. Special issues 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
5.2.1.3.1. Animal-to-human extrapolation. The use of animal data to identify hazard to 
<!-- PJG 0012 frnewline -->
humans is not without controversy. Relative sensitivity across species as well as between 
<!-- PJG 0012 frnewline -->
sexes is a constant concern. Overly conservative risk assessments, based on the assumption 
<!-- PJG 0012 frnewline -->
that humans are always more sensitive than a tested animal species, can result in poor risk 
<!-- PJG 0012 frnewline -->
management decisions. Conversely, an assumption of equivalent sensitivity in a case where 
<!-- PJG 0012 frnewline -->
humans actually are more sensitive to a given agent can result in underregulation that might 
<!-- PJG 0012 frnewline -->
have a negative impact on human health. 
<!-- PJG 0012 frnewline -->
5.2.1.3.2. Susceptible populations. A related controversy concerns the use of data collected 
<!-- PJG 0012 frnewline -->
from adult organisms, animal or human, to predict hazards in potentially more sensitive 
<!-- PJG 0012 frnewline -->
populations, such as the very young and the elderly, or in other groups, such as the 
<!-- PJG 0012 frnewline -->
chronically ill. In some cases, identification of neurotoxicity hazard does not generally 
<!-- PJG 0012 frnewline -->
include subjects from either end of the human life span or from other than healthy subjects. 
<!-- PJG 0012 frnewline -->
Uncertainty factors are used to adjust for more sensitive populations. In addition, single or 
<!-- PJG 0012 frnewline -->
multigeneration reproductive studies in animals may provide a source of information on 
<!-- PJG 0012 frnewline -->
neurological disorders, behavioral changes, autonomical dysfunction, neuroanatomical 
<!-- PJG 0012 frnewline -->
anomalies, and other signs of neurotoxicity in the developing animal (chapter 4). 
<!-- PJG 0012 frnewline -->
5.2.1.3.3. Reversibility. For the most part, the basic principles of hazard identification are 
<!-- PJG 0012 frnewline -->
the same for neurotoxicity as for any adverse effect on health. One notable exception, 
<!-- PJG 0012 frnewline -->
however, concerns the issue of reversibility and the special consideration that must be given 
<!-- PJG 0012 frnewline -->
to the inherent redundancy and plasticity of the nervous system. 
<!-- PJG 0012 frnewline -->
For many health effects, temporary, as opposed to permanent, effects are repaired 
<!-- PJG 0012 frnewline -->
during a true recovery. Damage to many organ systems, if not severe, can be spontaneously 
<!-- PJG 0012 frnewline -->
repaired. For example, damaged liver cells that may result in impaired liver function often 
<!-- PJG 0012 frnewline -->
can be replaced with new cells that function normally. The resulting restoration of liver 
<!-- PJG 0012 frnewline -->
function can be viewed as recovery. In the central nervous system, cells generally do not 
<!-- PJG 0012 frnewline -->
recover from severe damage and new cells do not replace them. When nervous system 
<!-- PJG 0012 frnewline -->
recovery is observed, it may represent compensation requiring activation of cells that were 
<!-- PJG 0012 frnewline -->
previously performing some other function, reactive synaptogenesis, or recovery of 
<!-- PJG 0012 frnewline -->
moderately injured cells. While a damaged liver may recover due to the addition of new 
<!-- PJG 0012 frnewline -->
cells, severe damage to nervous system cells results in a net loss of cells. This loss of 
<!-- PJG 0012 frnewline -->
compensatory capacity may not be noticed for many years and, when it does appear, it may 
<!-- PJG 0012 frnewline -->
be manifest in a way seemingly unrelated to the original neurotoxic event. Lack of ability to 
<!-- PJG 0012 frnewline -->
recover from a neurotoxic event later in life or premature onset of signs of normal aging may 
<!-- PJG 0012 frnewline -->
result. It is therefore important to consider the possibility that significant damage to the 
<!-- PJG 0012 frnewline -->
nervous system may have occurred in experiments where effects appear to be reversible. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00264 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=81 g=1 f=4 -->
5.2.1.3.4. Weight of evidence. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
A ``weight of evidence'' approach to identifying an agent as 
<!-- PJG 0012 frnewline -->
a neurotoxic hazard is almost always necessary. With the exception of therapeutic products, 
<!-- PJG 0012 frnewline -->
a single, complete, controlled study of an agent's effects on the nervous system, conducted in 
<!-- PJG 0012 frnewline -->
an appropriate representative sample of humans, is rarely, if ever, possible. Rather, those 
<!-- PJG 0012 frnewline -->
individuals charged with identifying hazard are usually confronted with a collection of 
<!-- PJG 0012 frnewline -->
imperfect studies, often providing conflicting data (Barnes and Dourson, 1988). 
<!-- PJG 0012 frnewline -->
There are several possible approaches, depending on the quality of the evidence. 
<!-- PJG 0012 frnewline -->
Two examples are the use of data from only the most sensitive species tested and the use of 
<!-- PJG 0012 frnewline -->
data from only species responding most like the human for any given endpoint. In assessing 
<!-- PJG 0012 frnewline -->
neurotoxicity of therapeutic products, when human data are available and neurotoxic 
<!-- PJG 0012 frnewline -->
endpoints detected in animals can be clinically measured, the human findings supersede those 
<!-- PJG 0012 frnewline -->
of the nonclinical data base. Assuming that all available evidence is to be included, 
<!-- PJG 0012 frnewline -->
considerations necessary for formulating a conclusion include the relative weights that should 
<!-- PJG 0012 frnewline -->
be given to positive and negative studies. Sometimes positive studies are given more weight 
<!-- PJG 0012 frnewline -->
than negative ones, even when the quality of the studies is comparable. Experimental design 
<!-- PJG 0012 frnewline -->
factors such as the species tested, the number and gender of subjects evaluated, and the 
<!-- PJG 0012 frnewline -->
duration of the test are given different weights when data from different studies are 
<!-- PJG 0012 frnewline -->
combined. The route of exposure in a given study and its relevance to expected routes of 
<!-- PJG 0012 frnewline -->
human exposure are often a weighted factor. The issue of statistical significance is 
<!-- PJG 0012 frnewline -->
frequently debated. Some argue that an effect occurring at a statistically insignificant level 
<!-- PJG 0012 frnewline -->
may nevertheless represent a biologically or toxicologically significant event, and should be 
<!-- PJG 0012 frnewline -->
afforded the same weight as if the finding were statistically significant. In general, however, 
<!-- PJG 0012 frnewline -->
only statistically significant measures should be considered in hazard identification. The 
<!-- PJG 0012 frnewline -->
power of various statistical measures is also considered. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=4 -->
5.2.2. Dose-Response Assessment 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
In the second step of the risk assessment process, the dose-response assessment, the 
<!-- PJG 0012 frnewline -->
relationship between the extent of damage or toxicity and dose of a toxic substance for 
<!-- PJG 0012 frnewline -->
various conditions of exposure is determined. Because several different kinds of responses 
<!-- PJG 0012 frnewline -->
may be elicited by a single agent, more than one dose-response relationship may need to be 
<!-- PJG 0012 frnewline -->
developed (e.g., neurochemical and morphological parameters). 
<!-- PJG 0012 frnewline -->
When quantitative human dose-effect data are not available for a sufficient range of 
<!-- PJG 0012 frnewline -->
exposures, other methods must be used to estimate exposure levels likely to produce adverse 
<!-- PJG 0012 frnewline -->
effects in humans. In the absence of human data, the dose-response assessment may be 
<!-- PJG 0012 frnewline -->
based on tests performed in laboratory animals. Evidence for a dose-response relationship is 
<!-- PJG 0012 frnewline -->
an important criterion in assessing neurotoxicity, although this may be based on limited data 
<!-- PJG 0012 frnewline -->
from standard studies that often use only three dose groups and a control group (Barnes and 
<!-- PJG 0012 frnewline -->
Dourson, 1988). 
<!-- PJG 0012 frnewline -->
The most frequently used approach for risk assessment of neurotoxicants and other 
<!-- PJG 0012 frnewline -->
noncancer endpoints is the uncertainty- or safety-factor approach (Barnes and Dourson, 1988; 
<!-- PJG 0012 frnewline -->
Kimmel, 1990). For example, within the EPA, this approach involves the determination of 
<!-- PJG 0012 frnewline -->
reference doses (RfDs) by dividing a no observed adverse effect level (NOAEL) by 
<!-- PJG 0012 frnewline -->
uncertainty factors that presumably account for interspecies differences in sensitivity (Barnes 
<!-- PJG 0012 frnewline -->
and Dourson, 1988). Generally, an uncertainty factor of 10 is used to allow for the 
<!-- PJG 0012 frnewline -->
potentially higher sensitivity in humans than in animals and another uncertainty factor of 10 
<!-- PJG 0012 frnewline -->
is used to allow for variability in sensitivity among humans. Hence, the RfD is equal to the 
<!-- PJG 0012 frnewline -->
NOAEL divided by 100. If the NOAEL cannot be established, it is replaced by the lowest 
<!-- PJG 0012 frnewline -->
observed adverse effect level (LOAEL) in the RfD calculation and an additional uncertainty 
<!-- PJG 0012 frnewline -->
factor of 10 is introduced (i.e., the RfD equals the LOAEL divided by 1000). 
<!-- PJG 0012 frnewline -->
If more than one effect is observed in the animal bioassays, the effect occurring at the 
<!-- PJG 0012 frnewline -->
lowest dose in the most sensitive animal species and gender is generally used as the basis for 
<!-- PJG 0012 frnewline -->
estimating the RfD (OTA, 1990). Sometimes, different RfDs can be calculated, depending 
<!-- PJG 0012 frnewline -->
on endpoint or species selected. Selection of safety factors may be influenced by several 
<!-- PJG 0012 frnewline -->
considerations, including data available from humans, weight of evidence, type of toxic 
<!-- PJG 0012 frnewline -->
insult, and probability of variations in responses among susceptible populations (e.g., very 
<!-- PJG 0012 frnewline -->
young or very old). Established guidelines have been accepted by several agencies that use 
<!-- PJG 0012 frnewline -->
the safety-factor approach to account for intraspecies variability, cross-species extrapolation, 
<!-- PJG 0012 frnewline -->
and exposure duration. In some instances, comparisons between these predicted values and 
<!-- PJG 0012 frnewline -->
experimental data have been conducted and the results appear comparable for some selected 
<!-- PJG 0012 frnewline -->
examples (Dourson and Stara, 1983; McMillan, 1987). 
<!-- PJG 0012 frnewline -->
The uncertainty-factor approach is based on the assumption that a threshold does 
<!-- PJG 0012 frnewline -->
exist, that there is a dose below which an effect does not change in incidence or severity. 
<!-- PJG 0012 frnewline -->
The threshold concept is complicated and controversial. As described by Sette and MacPhail 
<!-- PJG 0012 frnewline -->
(1992), there are several different ways in which the term threshold is used. Thresholds are 
<!-- PJG 0012 frnewline -->
defined, in part, by the limit of detection of an assay. As the sensitivity of the analytical 
<!-- PJG 0012 frnewline -->
method or bioassay is improved, the threshold might be adjusted downward, indicating that 
<!-- PJG 0012 frnewline -->
the true threshold had not been previously determined. 
<!-- PJG 0012 frnewline -->
Another problem inherent with an observation of no discernible effects at low doses is 
<!-- PJG 0012 frnewline -->
that it is impossible to determine whether the risk is actually zero (i.e., the dose is below a 
<!-- PJG 0012 frnewline -->
threshold dose) or whether the statistical resolving power of a study is inadequate to detect 
<!-- PJG 0012 frnewline -->
small risks (Gaylor and Slikker, 1992). Every study has a statistical limit of detection that 
<!-- PJG 0012 frnewline -->
depends on the number of individuals or animals involved. For example, it would be 
<!-- PJG 0012 frnewline -->
relatively unusual to conduct an experiment on a neurotoxicant with as many as 100 animals 
<!-- PJG 0012 frnewline -->
per dose. If no deleterious effects were observed in 100 animals at a particular dose, it 
<!-- PJG 0012 frnewline -->
might be concluded that this dose level is below the threshold dose. However, we can only 
<!-- PJG 0012 frnewline -->
be 95 percent confident that the true risk is less than 0.03. That is, if 3 percent of the 
<!-- PJG 0012 frnewline -->
animals in a population actually develop a toxic effect at this dose, there is a 5 percent 
<!-- PJG 0012 frnewline -->
chance that a group of 100 animals would not show any effect. The observation of no toxic 
<!-- PJG 0012 frnewline -->
effects in an extremely large sample of 1,000 animals only indicates with 95 percent 
<!-- PJG 0012 frnewline -->
confidence that the true risk is less than 0.003, etc. Because thresholds cannot be 
<!-- PJG 0012 frnewline -->
realistically demonstrated, they are therefore assumed. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00265 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=4 -->
The notion of threshold may be useful in explaining mechanisms associated with 
<!-- PJG 0012 frnewline -->
specific types of toxicity. What little is known about mechanisms of neurotoxicity suggests 
<!-- PJG 0012 frnewline -->
that both threshold and nonthreshold scenarios are possible (Silbergeld, 1990). However, for 
<!-- PJG 0012 frnewline -->
one of the most studied neurotoxicants, lead, there has been a steady decline in exposure 
<!-- PJG 0012 frnewline -->
levels shown to have effects, suggesting to some that no threshold dose is apparent (Bondy, 
<!-- PJG 0012 frnewline -->
1985). Sette and MacPhail (1992) also consider the threshold as a mathematical assumption 
<!-- PJG 0012 frnewline -->
and as a population sensitivity and conclude that ``the idea of no threshold seems 
<!-- PJG 0012 frnewline -->
experimentally untestable.&blank;.&blank;.&blank;.'' 
<!-- PJG 0012 frnewline -->
The RfD approach relies on single experimental observations (the NOAEL or 
<!-- PJG 0012 frnewline -->
LOAEL) instead of complete dose-response curve data to calculate risk estimations. 
<!-- PJG 0012 frnewline -->
Chemical interactions with biological systems are often specific, stereoselective, and 
<!-- PJG 0012 frnewline -->
saturable. Examples include enzyme-substrate binding leading to substrate metabolism, 
<!-- PJG 0012 frnewline -->
transport, and receptor-binding, any or all of which may be a requirement of an agent's 
<!-- PJG 0012 frnewline -->
effect or toxicity. Therefore, a chemical's dose-response curve may not be linear. The 
<!-- PJG 0012 frnewline -->
certainty of low-dose extrapolation has been determined to be markedly affected by the shape 
<!-- PJG 0012 frnewline -->
of the dose-response curve (Food and Drug Administration Advisory Committee on Protocols 
<!-- PJG 0012 frnewline -->
for Safety Evaluation, 1971). Therefore, the appropriate use of dose-response curve data 
<!-- PJG 0012 frnewline -->
should enhance the certainty of risk estimations when thresholds are not assumed or 
<!-- PJG 0012 frnewline -->
determined. 
<!-- PJG 0012 frnewline -->
Dose-response models have generated considerable interest as more appropriate and 
<!-- PJG 0012 frnewline -->
quantitative alternatives to the safety-factor approach in risk assessment. Rather than 
<!-- PJG 0012 frnewline -->
routinely applying a ``fixed'' safety factor to the NOAEL (based on a single dose) to obtain a 
<!-- PJG 0012 frnewline -->
``safe'' dose, another approach uses data from the entire dose-response curve. 
<!-- PJG 0012 frnewline -->
Two fundamentally different approaches in the use of dose-response data to estimate 
<!-- PJG 0012 frnewline -->
risk have been developed. Dews and coworkers (Dews, 1986; Glowa and Dews, 1987; 
<!-- PJG 0012 frnewline -->
Glowa et al., 1983) and Crump (1984) demonstrated an approach in which they used 
<!-- PJG 0012 frnewline -->
information on the shape of the dose-response curve to estimate levels of exposure associated 
<!-- PJG 0012 frnewline -->
with relatively small effects (i.e., a 1, 5, or 10 percent change in a biological endpoint). 
<!-- PJG 0012 frnewline -->
Both Dews and Crump fit a mathematical function to the data and provided an estimate of the 
<!-- PJG 0012 frnewline -->
variability in exposure levels associated with a relatively small effect. 
<!-- PJG 0012 frnewline -->
An alternative approach developed by Gaylor and Slikker (1990) first establishes a 
<!-- PJG 0012 frnewline -->
mathematical relationship between a biological effect and the dose of a given chemical. The 
<!-- PJG 0012 frnewline -->
second step determines the distribution (variability) of individual measurements of biological 
<!-- PJG 0012 frnewline -->
effects about the dose-response curve. The third step statistically defines an adverse or 
<!-- PJG 0012 frnewline -->
``abnormal'' level of a biological effect in an untreated population. The fourth step estimates 
<!-- PJG 0012 frnewline -->
the probability of an adverse or abnormal level as a function of dose utilizing the information 
<!-- PJG 0012 frnewline -->
from the first three steps. The advantages of these dose-response models are that they 
<!-- PJG 0012 frnewline -->
encourage the generation and use of data needed to define a complete dose-response curve. 
<!-- PJG 0012 frnewline -->
Although more quantitative dose-response assessment models have emerged in recent 
<!-- PJG 0012 frnewline -->
years, uncertainty remains as to what biological endpoints from which species with what 
<!-- PJG 0012 frnewline -->
dosing regimen should be analyzed. Within a species, a given agent may produce a variety 
<!-- PJG 0012 frnewline -->
of effects, including neurochemical, neuropathological, and behavioral effects. In other 
<!-- PJG 0012 frnewline -->
instances, a chemical may produce alterations of one endpoint but not others (Slikker et al., 
<!-- PJG 0012 frnewline -->
1989). Species selection may also dramatically affect the outcome of risk assessments. The 
<!-- PJG 0012 frnewline -->
Parkinson-like syndrome produced by single doses of MPTP in the human or nonhuman 
<!-- PJG 0012 frnewline -->
primate is not observed in rats given comparable MPTP doses (Kopin and Markey, 1988). 
<!-- PJG 0012 frnewline -->
Although endpoint and species selection appear to have a tremendous effect on the outcome 
<!-- PJG 0012 frnewline -->
of an assessment, only a few studies have systematically investigated the effect on assessment 
<!-- PJG 0012 frnewline -->
outcome of varying either the species or the endpoint within a species (McMillan, 1987; 
<!-- PJG 0012 frnewline -->
Hattis and Shapiro, 1990; Gaylor and Slikker, 1992). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00266 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=81 g=1 f=4 -->
5.2.3. Exposure Assessment 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
This step of the risk assessment process determines the source, route, dose, and 
<!-- PJG 0012 frnewline -->
duration of human exposure to an agent. The results of the dose-response assessment are 
<!-- PJG 0012 frnewline -->
combined with an estimate of human exposure to obtain a quantitative estimate of risk. As 
<!-- PJG 0012 frnewline -->
either the effect of or the exposure to an agent approaches zero, the risk of neurotoxicity 
<!-- PJG 0012 frnewline -->
approaches zero. It should be recognized that exposures to multiple agents may produce 
<!-- PJG 0012 frnewline -->
synergistic or additive effects. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Exposure can occur via many routes, including ingestion, inhalation, or contact with 
<!-- PJG 0012 frnewline -->
skin. Sources of exposure may include soil, food, air, water, or intended vehicle (e.g., drug 
<!-- PJG 0012 frnewline -->
formulation). The degree of exposure may be strongly influenced by a number of factors, 
<!-- PJG 0012 frnewline -->
for example, the occupation of the individual involved. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The duration of exposure (i.e., acute or chronic) and interval of exposure (i.e., 
<!-- PJG 0012 frnewline -->
episodic or continuous) are variables of exposure that are common to all types of risk 
<!-- PJG 0012 frnewline -->
assessments, including carcinogenicity (OSTP, 1985). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Although not routinely used, biological markers or biomarkers of exposure could 
<!-- PJG 0012 frnewline -->
theoretically improve the exposure assessment process and, thereby, improve the overall risk 
<!-- PJG 0012 frnewline -->
assessment of neurotoxicants. Exposure biomarkers may include either the quantitation of 
<!-- PJG 0012 frnewline -->
exogenous agents or the complex of endogenous substances and exogenous agents within the 
<!-- PJG 0012 frnewline -->
system (Committee on Biological Markers, 1987). A limited number of examples of 
<!-- PJG 0012 frnewline -->
biomarkers of exposure have been reviewed by Slikker (1991) and include blood or dentine 
<!-- PJG 0012 frnewline -->
lead concentrations (Needleman, 1987), cerebrospinal fluid concentrations of dopamine 
<!-- PJG 0012 frnewline -->
metabolites following MPTP administration (Kopin and Markey, 1988), cerebrospinal fluid 
<!-- PJG 0012 frnewline -->
concentrations of a serotonin metabolite following MDMA exposure (Ricaurte et al., 1986), 
<!-- PJG 0012 frnewline -->
and serum esterase concentrations following organophosphate exposure (Levine et al., 
<!-- PJG 0012 frnewline -->
1986). The use of muscarinic receptor binding in peripheral plasma lymphocytes has also 
<!-- PJG 0012 frnewline -->
been described as a potential biomarker of exposure for the organophosphates (Costa et al., 
<!-- PJG 0012 frnewline -->
1990). These examples suggest that biomarkers of exposure are available for some agents, 
<!-- PJG 0012 frnewline -->
but more effort will be required to demonstrate that these biomarkers can routinely be used 
<!-- PJG 0012 frnewline -->
to improve the exposure assessment process. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=4 -->
5.2.4. Risk Characterization 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
The final step of the risk assessment process combines the hazard identification, the 
<!-- PJG 0012 frnewline -->
dose-response assessment, and the exposure assessment to produce the characterization of 
<!-- PJG 0012 frnewline -->
risk. As previously stated, the current practice is to divide the NOAEL by the appropriate 
<!-- PJG 0012 frnewline -->
safety factor to obtain the RfD. The magnitudes of the safety factors used to determine RfDs 
<!-- PJG 0012 frnewline -->
[interspecies extrapolation (10), intraspecies extrapolation (10), and acute vs. chronic 
<!-- PJG 0012 frnewline -->
exposure (10) = 1000] are based more on conservative estimates than on actual data 
<!-- PJG 0012 frnewline -->
(Sheehan et al., 1989; McMillan, 1987) and have been questioned for empirical reasons 
<!-- PJG 0012 frnewline -->
(Gaylor and Slikker, 1990). Uncertainty factors may be decreased as more data become 
<!-- PJG 0012 frnewline -->
available. Modifying factors are also employed under certain circumstances to account for 
<!-- PJG 0012 frnewline -->
the completeness of data sets. Along with this RfD numerical value, any uncertainties and 
<!-- PJG 0012 frnewline -->
assumptions inherent in the risk assessment should also be stated (OTA, 1990). Although the 
<!-- PJG 0012 frnewline -->
RfD provides a single numerical value, it does not provide information concerning the 
<!-- PJG 0012 frnewline -->
uncertainty of this number nor does the RfD approach attempt to estimate the potential risk 
<!-- PJG 0012 frnewline -->
as a function of dose or consider the potential risk at the NOAEL. The risk at the NOAEL 
<!-- PJG 0012 frnewline -->
generally is greater than zero and has been estimated to be as high as about 5 percent 
<!-- PJG 0012 frnewline -->
(Crump, 1984; Gaylor, 1989). Concern has been expressed that the application of the RfD 
<!-- PJG 0012 frnewline -->
approach to all neurotoxicants is unlikely to be biologically defensible in light of mechanistic 
<!-- PJG 0012 frnewline -->
data (NRC, 1992). Several other quantitative risk assessment procedures have recently 
<!-- PJG 0012 frnewline -->
emerged as alternatives to the RfD approach (Kimmel and Gaylor, 1988). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Quantitative risk assessment may be defined as a data-based process that uses dose-response information and measurements
of human exposure to arrive at estimates of risk. 
<!-- PJG 0012 frnewline -->
Assumptions are required to extrapolate results from high to low doses, to extrapolate from 
<!-- PJG 0012 frnewline -->
animal results to humans, and to extrapolate across different routes and durations of 
<!-- PJG 0012 frnewline -->
exposure. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In a step toward quantitative risk assessment, Crump (1984) suggested the use of a 
<!-- PJG 0012 frnewline -->
benchmark dose defined as ``a statistical lower confidence limit corresponding to a small 
<!-- PJG 0012 frnewline -->
increase in effect over the background level.'' The benchmark dose is determined with a 
<!-- PJG 0012 frnewline -->
mathematical model and is less affected by the particular shape of the dose-response curve. 
<!-- PJG 0012 frnewline -->
Although the benchmark approach avoids several problems inherent in the RfD approach 
<!-- PJG 0012 frnewline -->
(e.g., lack of precision in defining the LOAEL; Kimmel, 1990), the same final step of 
<!-- PJG 0012 frnewline -->
dividing by arbitrary safety factors is obligatory. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Another approach to quantitative risk assessment is the statistical or curve-fitting 
<!-- PJG 0012 frnewline -->
approach. If quantal information concerning the proportion of response at a given dose is 
<!-- PJG 0012 frnewline -->
available but mechanistic information is lacking, statistical models can be used to fit 
<!-- PJG 0012 frnewline -->
population data (Wyzga, 1990). This approach has been used to fit various models to data of 
<!-- PJG 0012 frnewline -->
lead toxicity. The data were sufficient to allow discrimination of several models in terms of 
<!-- PJG 0012 frnewline -->
goodness of fit; the nerve-conduction velocity data from children exposed to environmental 
<!-- PJG 0012 frnewline -->
lead as a function of blood lead concentration fit a ``hockey-stick'' type dose-response curve 
<!-- PJG 0012 frnewline -->
rather than a logistic or quadratic model (Schwartz et al., 1988). These statistical approaches 
<!-- PJG 0012 frnewline -->
not only provide a method to extrapolate data to lower exposure conditions but also can 
<!-- PJG 0012 frnewline -->
provide circumstantial evidence to support a proposed mechanism of action. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The development of quantitative risk assessment approaches depends, in part, on the 
<!-- PJG 0012 frnewline -->
availability of information on the mechanism of action and pharmacokinetics of the agent in 
<!-- PJG 0012 frnewline -->
question. In the development of a biologically based, dose-response model for MDMA 
<!-- PJG 0012 frnewline -->
neurotoxicity, Slikker and Gaylor (1990) considered several factors, including the 
<!-- PJG 0012 frnewline -->
pharmacokinetics of the parent chemical, the target tissue concentrations of the parent 
<!-- PJG 0012 frnewline -->
chemical or its bioactivated proximate toxicant, the uptake kinetics of the parent chemical or 
<!-- PJG 0012 frnewline -->
metabolite into the target cell and membrane interactions, and the interaction of the chemical 
<!-- PJG 0012 frnewline -->
or metabolite with presumed receptor site(s). Because these theoretical factors contain a 
<!-- PJG 0012 frnewline -->
saturable step due to limited amounts of required enzyme, reuptake, or receptor site(s), a 
<!-- PJG 0012 frnewline -->
nonlinear, saturable dose-response curve was predicted. In this case of neurochemical effects 
<!-- PJG 0012 frnewline -->
of MDMA in the rodent, saturation mechanisms were hypothesized and indeed saturation 
<!-- PJG 0012 frnewline -->
curves provided relatively good fits to the experimental results. The conclusion was that use 
<!-- PJG 0012 frnewline -->
of dose-response models based on plausible biological mechanisms provide more validity to 
<!-- PJG 0012 frnewline -->
prediction than purely empirical models. Concomitant with attempts to develop quantitative 
<!-- PJG 0012 frnewline -->
risk assessment procedures, it is imperative that regulatory policy or risk management 
<!-- PJG 0012 frnewline -->
procedures also be developed to use appropriately the type of data generated by quantitative 
<!-- PJG 0012 frnewline -->
risk assessment. However, until alternative risk assessment procedures have been validated, 
<!-- PJG 0012 frnewline -->
the available RfD approach with its limitations will most likely continue to be used. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=4 -->
5.3. Generic Assumptions and Uncertainty Reduction 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
The purpose of risk assessment is to determine the risk associated with human 
<!-- PJG 0012 frnewline -->
exposure to a hazard. The quality of the data from toxicological studies differs. In the case 
<!-- PJG 0012 frnewline -->
of therapeutic products where human effects information is available, risk assessments rely 
<!-- PJG 0012 frnewline -->
primarily on the result of controlled clinical trials. Even when clinical trial data are 
<!-- PJG 0012 frnewline -->
available, however, conducting a risk assessment is complicated by many uncertainties. In 
<!-- PJG 0012 frnewline -->
the face of these uncertainties, conservative assumptions are usually made at several steps in 
<!-- PJG 0012 frnewline -->
the risk assessment process. For example, unless adequate clinical data are available, the 
<!-- PJG 0012 frnewline -->
most sensitive experimental species is frequently used. While conservative assumptions may 
<!-- PJG 0012 frnewline -->
lead to a risk assessment that adequately protects the human population, this may result in an 
<!-- PJG 0012 frnewline -->
increased financial burden on the public (e.g., manufacturing costs or loss of jobs); even then 
<!-- PJG 0012 frnewline -->
it is impossible to be certain that the total population will be protected. Conversely, errors 
<!-- PJG 0012 frnewline -->
leading to allowable exposure levels that are too high reduce the safety margin for human 
<!-- PJG 0012 frnewline -->
health and increase health care costs. Thus, there are compelling public health and economic 
<!-- PJG 0012 frnewline -->
reasons to obtain more precise risk assessments; all assumptions cannot be completely 
<!-- PJG 0012 frnewline -->
eliminated, but the degree of uncertainty associated with certain specific assumptions can at 
<!-- PJG 0012 frnewline -->
least be reduced (Sheehan et al., 1989). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00267 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Risk assessment for neurotoxicity shares many common features with other noncancer 
<!-- PJG 0012 frnewline -->
toxicities such as developmental toxicity and immunotoxicity. As such, there are several 
<!-- PJG 0012 frnewline -->
generic assumptions that apply to all traditional, noncancer endpoint risk assessment 
<!-- PJG 0012 frnewline -->
procedures (Table 5&hyph;1). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 1,L1(,0,),p8,8/9,i1,s50 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Table 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=1 -->
5&hyph;1._
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
General Assumptions That Underlie Traditional Risk Assessments
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=5 f=1 -->
a,b
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1&blank;
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
1. A threshold dose exists for noncancer endpoints. 
<!-- PJG 0012 frnewline -->
2. NOAEL/LOAEL uncertainty- or safety-factor approaches are reasonable. 
<!-- PJG 0012 frnewline -->
3. Variability in the toxic response to the chemical exposure is not due to a heterogeneous population response. 
<!-- PJG 0012 frnewline -->
4. Average dose or total dose is a reasonable measure of exposure when doses are not 
<!-- PJG 0012 frnewline -->
equivalent in time, rate, or route of administration and the average (or total) dose is 
<!-- PJG 0012 frnewline -->
proportional to adverse effect. 
<!-- PJG 0012 frnewline -->
5. Structure-activity correlations can be used to predict human toxicity. 
<!-- PJG 0012 frnewline -->
6. The mechanism of action is the same at all doses for all species. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=5 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
aThis is not intended to be an exhaustive list. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=5 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
bModified from Sheehan et al., 1989. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00268 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
One approach to reducing some of the uncertainties is to critically define and examine 
<!-- PJG 0012 frnewline -->
the assumptions made in the risk assessment process. Several of the more generic of these 
<!-- PJG 0012 frnewline -->
assumptions are listed in Table 5&hyph;1. Despite their diversity, these assumptions share the 
<!-- PJG 0012 frnewline -->
attribute of being partially replaceable by factual information. If, for example, the 
<!-- PJG 0012 frnewline -->
assumption of 100 percent absorption of a toxicant from a contaminated food source is 
<!-- PJG 0012 frnewline -->
replaced by data demonstrating that 90 percent of the toxicant is not biologically available 
<!-- PJG 0012 frnewline -->
under human exposure conditions, then a revised risk assessment could allow a 10-fold 
<!-- PJG 0012 frnewline -->
greater exposure from that source; i.e., the former risk assessment was too conservative by a 
<!-- PJG 0012 frnewline -->
factor of 10. As another example, many risk assessments employ data from two species. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
If experimental animals and humans absorb or metabolize the same fraction of a dose, 
<!-- PJG 0012 frnewline -->
the potency estimate would not change when extrapolating from animals to humans. 
<!-- PJG 0012 frnewline -->
Therefore, it is necessary to have information on both human and animal rates before 
<!-- PJG 0012 frnewline -->
changes in potency estimates are made. If a toxicant acts via a reactive intermediate and 
<!-- PJG 0012 frnewline -->
humans produce 10-fold more of the intermediate than either of the test species under similar 
<!-- PJG 0012 frnewline -->
conditions, then allowable human exposure should be decreased 10-fold (i.e., the allowable 
<!-- PJG 0012 frnewline -->
exposure levels are 10-fold too high) or an increased danger to human health exists. These 
<!-- PJG 0012 frnewline -->
findings could then replace the ``most sensitive species'' principle with facts concerning 
<!-- PJG 0012 frnewline -->
relevant human exposure and susceptibility. In these examples, the identification of the 
<!-- PJG 0012 frnewline -->
assumption helps define research needs or knowledge gaps (Sheehan et al., 1989). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In general, the knowledge gaps are many and complex, but some can be filled with 
<!-- PJG 0012 frnewline -->
practical solutions. The combination of ample dose-response data and a quantitative risk 
<!-- PJG 0012 frnewline -->
assessment process can eliminate assumptions 1 (existence of a threshold) and 2 
<!-- PJG 0012 frnewline -->
(reasonableness of safety factors) of the six generic assumptions (Table 5&hyph;1). The uncertainty 
<!-- PJG 0012 frnewline -->
of assumption 4 (exposure comparisons) could be at least reduced with the proper application 
<!-- PJG 0012 frnewline -->
of appropriate pharmacokinetic data. Likewise, the uncertainty of generic assumption 3 
<!-- PJG 0012 frnewline -->
(variability of heterogeneous populations) can theoretically be reduced with the use of 
<!-- PJG 0012 frnewline -->
biomarkers of exposure and biomarkers of effect, to more accurately define the relationship 
<!-- PJG 0012 frnewline -->
between exposure and biological effect in a large population. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Many assumptions remain, however, and uncertainty reduction by filling knowledge 
<!-- PJG 0012 frnewline -->
gaps will ultimately require greater understanding of biological mechanisms underlying 
<!-- PJG 0012 frnewline -->
neurotoxicity. A single risk assessment model may not be adequate for all conditions of 
<!-- PJG 0012 frnewline -->
exposure, for all endpoints, or for all agents. Risk assessment models of the future may well 
<!-- PJG 0012 frnewline -->
include biomarkers of both effect and exposure as well as biologically based mechanistic 
<!-- PJG 0012 frnewline -->
considerations derived from both epidemiologic and experimental test system data. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00269 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
6. General Summary 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
It is now generally accepted that some chemicals, including industrial agents, 
<!-- PJG 0012 frnewline -->
pesticides, therapeutic agents, drugs of abuse, food-related chemicals, and cosmetic 
<!-- PJG 0012 frnewline -->
ingredients, can have adverse effects on the structure and function of the nervous system. It 
<!-- PJG 0012 frnewline -->
has recently been proposed that exposure to neurotoxicants might also be associated with Parkinsonism and Alzheimer's
disease. Several Federal agencies have initiated research 
<!-- PJG 0012 frnewline -->
programs in neurotoxicology, developed neurotoxicology testing guidelines, and used 
<!-- PJG 0012 frnewline -->
neurotoxic endpoints to regulate chemicals in the environment and workplace. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The scientific basis for identifying and characterizing chemical-induced neurotoxicity 
<!-- PJG 0012 frnewline -->
has advanced rapidly during the last several years. The manifestation of neurotoxicity 
<!-- PJG 0012 frnewline -->
depends on the relationship between exposure (applied dose) and the dose at the site of toxic 
<!-- PJG 0012 frnewline -->
action (delivered or target dose) and response. Chemical-induced changes in the structure or 
<!-- PJG 0012 frnewline -->
function of the nervous system at the cellular or molecular level can be observed as 
<!-- PJG 0012 frnewline -->
alterations in sensory, motor, or cognitive function at the level of the whole organism. 
<!-- PJG 0012 frnewline -->
Several important features about the nervous system make it particularly vulnerable to 
<!-- PJG 0012 frnewline -->
chemical insult, including differential susceptibilities at different stages of maturation, the 
<!-- PJG 0012 frnewline -->
presence of blood brain and nerve barriers that may be the target of toxic action, high 
<!-- PJG 0012 frnewline -->
metabolic rate, and limited regenerative capability following damage. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Methods devised to detect and quantify agent-induced changes in nervous system 
<!-- PJG 0012 frnewline -->
function in humans include clinical evaluations and neurotoxicity testing methods such as 
<!-- PJG 0012 frnewline -->
neurobehavioral, neurophysiological, neurochemical, imaging, and self-reporting procedures. 
<!-- PJG 0012 frnewline -->
Experimental approaches used in human neurotoxicology include epidemiological studies and, 
<!-- PJG 0012 frnewline -->
to a limited extent, human laboratory exposure studies. There are several important 
<!-- PJG 0012 frnewline -->
unresolved issues in human neurotoxicology, including the development of commonly 
<!-- PJG 0012 frnewline -->
accepted risk assessment criteria and animal-to-human extrapolation. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
It is generally assumed that if physical or chemical-induced neurotoxicity is observed 
<!-- PJG 0012 frnewline -->
in animal models, then neurotoxicity will be produced in humans. Considerable research has 
<!-- PJG 0012 frnewline -->
been performed to demonstrate the validity of many animal models in an experimental 
<!-- PJG 0012 frnewline -->
context and to show predictive validity. Methods in animal neurotoxicology are frequently 
<!-- PJG 0012 frnewline -->
used in a tier-testing framework with simpler, more cost-effective tests to screen or identify 
<!-- PJG 0012 frnewline -->
neurotoxic potential. In hazard identification, the presence of neurotoxicity at the first tier is 
<!-- PJG 0012 frnewline -->
used to make decisions about subsequent development of a chemical or about the need to 
<!-- PJG 0012 frnewline -->
conduct additional experiments to define the level at which neurotoxicity will be observed. 
<!-- PJG 0012 frnewline -->
A number of methods have been devised for studies in animal neurotoxicology, including 
<!-- PJG 0012 frnewline -->
neurobehavioral, neurophysiological, neurochemical, and neuroanatomical techniques. It is 
<!-- PJG 0012 frnewline -->
known that the neuroendocrine system may be affected adversely by neurotoxicants and that 
<!-- PJG 0012 frnewline -->
there are populations that are differentially vulnerable to neurotoxic agents. Considerable 
<!-- PJG 0012 frnewline -->
research is in progress to employ structure-activity relationships to predict neurotoxicity and 
<!-- PJG 0012 frnewline -->
newly developed in vitro procedures are being used to augment or complement currently 
<!-- PJG 0012 frnewline -->
existing in vivo approaches. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Principles of risk assessment for neurotoxicity are evolving rapidly. At the present 
<!-- PJG 0012 frnewline -->
time, neurotoxicity risk assessment is generally limited to qualitative hazard identification. 
<!-- PJG 0012 frnewline -->
Neurotoxicological risk assessments have been generally based on a no observed adverse 
<!-- PJG 0012 frnewline -->
effect level and uncertainty factors. As with other noncancer endpoints, there is a need to 
<!-- PJG 0012 frnewline -->
consider more information about the shape of the dose-response curve and mechanisms of 
<!-- PJG 0012 frnewline -->
effect in quantitative neurotoxicology risk assessment. Research is needed to develop 
<!-- PJG 0012 frnewline -->
dose-response models that incorporate biologic information and mechanistic hypotheses into 
<!-- PJG 0012 frnewline -->
quantitative extrapolation of dose-response relationships across species and from high to low 
<!-- PJG 0012 frnewline -->
dose exposures. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00270 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=74 g=1 f=1 -->
7. References
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Abou-Donia MB. Organophosphorus ester-induced delayed neurotoxicity. Ann Rev Pharmacol Toxicol 1981; 21:511&hyph;548.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Abou-Donia MB. Toxicokinetics and metabolism of delayed neurotoxic organophosphorous esters. Neurotoxicology
1983; 4:113&hyph;130. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Aibara K. Introduction to the Diagnosis of Mycotoxicosis. In: Richards JL, Thurston JR, eds. Diagnosis of Mycotoxicoses.
Dordrecht, Netherlands: Martinus Nijhoff Publishers, 1986:3&hyph;8. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Altmann J, Schardt H, Wiegand H. Selective effects of acute repeated solvent exposure on the visual system. Arbete
och Halsa 1991; 35:67&hyph;69. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Andersen ME, Clewell HJ, Gargas ML, MacNaughton MG, Reitz RH, Nolan RJ, McKenna MJ. Physiologically based pharmacokinetic
modeling with dichloromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humans.
Toxicol Appl Pharmacol 1991; 108:14&hyph;27. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Anderson-Brown T, Slotkin TA, Seidler FJ. Cocaine acutely inhibits DNA synthesis in developing rat brain regions:
evidence for direct actions. Brain Res 1990; 537:197&hyph;202. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Anger WK. Neurobehavioral testing of chemicals; impact on recommended standard. Neurobehav Toxicol Teratol 1984;
6:147&hyph;153. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Anger WK. Worksite behavioral research: results, sensitive methods, test batteries and the transition from laboratory
data to human health. Neurotoxicology 1990a; 11:629&hyph;720. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Anger WK. Human neurobehavioral toxicology testing. In: Russell RW, Flattau PE, Pope AM, eds. Behavioral Measures
of Neurotoxicity. Washington, DC: National Academy Press, 1990b. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Anger WK. Animal test systems to study behavioral dysfunctions of neurodegenerative disorders. Neurotoxicology
1991; 12:403&hyph;414. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Anger WK, Setzer JV. Effects of oral and intramuscular carbaryl administrations on repeated chain acquisition in
monkeys. J Toxicol Environ Health 1979; 5:793&hyph;808. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Annau Z, Eccles CU. Prenatal exposure. In: Annau A, ed. Neurobehavioral Toxicology. Baltimore: Johns Hopkins University
Press, 1986:153&hyph;169. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Atterwill CK, Walum E. Neurotoxicology in vitro: model systems and practical applications. Toxic In Vitro 1989;
3:159&hyph;161. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bacon CW, Bennett RM, Hinton DM. Scanning electron microscopy of Fusarium moniliforme within asymptomatic corn
kernels and kernels associated with leukoencephalomalacia. Plant Disease 1992; 76:144&hyph;148. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Baker EL, Letz RE, Fidler AT, Shalat S, Plantamura D, Lyndon M. A computer based neurobehavioral evaluation system
for occupational and environmental epidemiology: methodology and validation studies. Neurobehav Toxicol Teratol
1985; 7:369&hyph;377. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Barnes DG, Dourson M. Reference dose (RfD): description and use in health risk assessments. Regul Toxicol Pharmacol
1988; 8:471&hyph;486. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Beaumont JG. Neurobehavioral tests: problems, potential, and prospects. In: Russell RW, Flatteau PE, Pope AM, eds.
Behavioral Measures of Neurotoxicity. Washington, DC: National Academy Press, 1990. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bell, I.R., Millers, C. and Schwartz, G.E. An olfactory-limbic model of multiple chemical sensitivity syndrome:
Possible relationships to kindling and affective spectrum disorders. Biol. Psychiat. 1992; 32:218&hyph;242.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bellinger D, Leviton A, Waterneaux C, Needleman H, Rabinowitz M. Longitudinal analyses of prenatal and postnatal
lead exposure and early cognitive development. N Engl J Med 1987; 316:1037&hyph;1043. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Benignus, V. Importance of experimenter-blind procedure in neurotoxicology. Neurotoxicol. Teratol. 1993; 15:45&hyph;49.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Berde B, Schield HO. Ergot alkaloids and related compounds. In: Handbook of Experimental Pharmacology. Berlin,
Heidelberg, New York: Springer-Verlag, 1978:49. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bhattacharyya TK, Dayal VS. Ototoxicity and noise-drug interaction. J Otolaryngol 1984; 13:361&hyph;366. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bidstrup PL. Toxicity of Mercury and Its Compounds. Amsterdam: Elsevier Scientific Publishing Company, 1964. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Boettcher FA, Henderson D, Gratton MA, Danielson RW, Byrne CD. Synergistic interactions of noise and other ototraumatic
agents. Ear Hear 1987; 8:192&hyph;212. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bondy SC. Special considerations for neurotoxicological research. CRC Crit Rev Toxicol 1985; 14:381&hyph;402.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bondy SC. The biochemical evaluation of neurotoxic damage. Fund Appl Toxicol 1986; 6:208&hyph;216. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bove FJ. The Story of Ergot. Basel, Switzerland: S. Karger AG, 1970. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bowyer JF, Tank AW, Newport GD, Slikker W, Ali SF, Holson RR. The influence of environmental temperature on the transient
levels of methamphetamine on dopamine levels and dopamine release in rat striatum. J Pharmacol Exp Ther 1992, in press.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Boyce S, Kelly E, Reavill C, Jenner P, Marsen CD. Repeated administration of N-methyl-4-phenyl-1,2,5,6-tetra-hydropyridine
to rats is not toxic to striatal dopamine neurons. Biochem Pharmacol 1984; 33:1747&hyph;1752. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Brady LS, Barrett JE. Drug-behavior interaction history: modification of the effects of morphine on punished behavior.
J Exp Anal Behav 1986; 45:221&hyph;228. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Calne DB, Eisen A, McGeer E, Spencer PS. Alzheimer's disease, Parkinson's disease, and motoneurone disease: a biotrophic
interaction between ageing and environment? Lancet 1986; II(8515):1067&hyph;1070. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Cannon SB, Veazsy JM, Jackson RS, Burse VW, Hayes C, Straub WE, Landrigan PJ, Liddle JA. Epidemic kepone poisoning
in chemical workers. Am J Epidemiol 1978; 107:529&hyph;537. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Campbell DT, Fiske DW. Convergent and discriminant validation by the multitrain-multimethod matrix. Psychol Bull
1959; 56:81&hyph;91. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Cassells DAK, Dodds EC. Tetra-ethyl lead poisoning. Brit Med J 1946; 2:4479&hyph;4483. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Cassitto MG, Camerino D, Hanninen H, Anger WK. International collaboration to evaluate the WHO neurobehavioral
core test battery. In: Johnson B, Anger WK, Durao A, Xintaras C, eds. Advances in Neurobehavioral Toxicology: Applications
in Environmental and Occupational Health. Chelsea: Lewis Publishers, 1990. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Cavanagh JB. The toxic effects of tri-ortho-cresyl phosphate on the nervous system: an experimental study on hens.
J Neurol Neurosurg Psychiat 1954; 17:163&hyph;172. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Centers for Disease Control (CDC). Preventing lead poisoning in young children. U.S. Department of Health and Human
Services, Centers for Disease Control, Atlanta, GA, 1991. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Centers for Disease Control (CDC). Prevention of leading work-related diseases and injuries. MMUR, 1986; 35(8).

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00271 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Chang LW. Mercury. In: Spencer PS, Schaumburg HH, eds. Experimental and Clinical Neurotoxicology. Baltimore: Williams
and Wilkins, 1980:508&hyph;526. 
<!-- PJG 0012 frnewline -->
Chiba S, Ando K. Effects of chronic administration of kanamycin on conditioned suppression to auditory stimulus
in rats. Jpn J Pharmacol 1976; 26:41&hyph;426. 
<!-- PJG 0012 frnewline -->
Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988; 1:623&hyph;634. 
<!-- PJG 0012 frnewline -->
Committee on Biological Markers of the National Research Council. Biological markers in environmental health research.
Environ Health Perspect 1987; 74:3&hyph;9. 
<!-- PJG 0012 frnewline -->
Cone JE, Reeve GR, Landrigan PJ. Clinical and epidemiological studies. In: Tardiff RG, Rodricks JV, eds. Toxic Substances
and Human Risk. New York: Plenum Press, 1987. 
<!-- PJG 0012 frnewline -->
Cook DG, Fahn S, Brait KA. Chronic manganese intoxication. Arch Neurol 1974; 30:59&hyph;71. 
<!-- PJG 0012 frnewline -->
Cory-Slechta DA. Behavioral measures of neurotoxicity. Neurotoxicology 1989; 10:271&hyph;296. 
<!-- PJG 0012 frnewline -->
Cory-Slechta DA. Bridging experimental animal and human behavioral toxicology studies. In: Russell RW, Flattau
PE, Pope AM, eds. Behavioral Measures of Neurotoxicity. Washington, DC: National Academy Press, 1990. 
<!-- PJG 0012 frnewline -->
Costa LG. Interactions of neurotoxicants with neurotransmitter systems. Toxicology 1988; 49:359&hyph;366. 
<!-- PJG 0012 frnewline -->
Costa LG, Kaylor G, Murphy SD. In vitro and in vivo modulation of cholinergic muscarinic receptors in rat lymphocytes
and brain by cholinergic agents. Int J Immunopharmacol 1990; 8:1267&hyph;75. 
<!-- PJG 0012 frnewline -->
Creason JP. Data evaluation and statistical analysis of functional observational battery data using a linear models
approach. J Am Coll Toxicol 1989; 8:157&hyph;169. 
<!-- PJG 0012 frnewline -->
Crofton KM. Reflex modification and the detection of toxicant-induced auditory dysfunction. Neurotoxicol Teratol
1990; 12:461&hyph;468. 
<!-- PJG 0012 frnewline -->
Crook T, Ferris S, Bartus R, eds. Assessment in Geriatric Psychopharmacology. New Canaan, NY: Mark Powley Associates,
1983. 
<!-- PJG 0012 frnewline -->
Crump KS. A new method for determining allowable daily intakes. Fund Appl Toxicol 1984; 4:854&hyph;871. 
<!-- PJG 0012 frnewline -->
Cushner IM. Maternal behavior and perinatal risks: alcohol, smoking, and drugs. Ann Rev Pub Health 1981; 2:201&hyph;218.

<!-- PJG 0012 frnewline -->
Damstra T, Bondy SC. The current status and future of biochemical assays for neurotoxicity. In: Spencer PS, Schaumburg
HH, eds. Experimental and Clinical Neurotoxicity. Baltimore: Williams and Wilkins, 1980:820&hyph;833. 
<!-- PJG 0012 frnewline -->
Davies PW. The action potential. In: Mountcastle VB, ed. Medical Physiology, 12th edition. St. Louis: C.V. Mosby,
1968:1094&hyph;1120. 
<!-- PJG 0012 frnewline -->
Davis CS, Richardson RJ. Organophosphorous compounds. In: Spencer PS, Schaumburg HH, eds. Experimental and Clinical
Neurotoxicology. Baltimore: Williams and Wilkins, 1980:527&hyph;544. 
<!-- PJG 0012 frnewline -->
Denny-Brown D, Dawson DM, Tyler HR. Handbook of Neurological Examination and Case Recording (3rd ed). Cambridge:
Harvard University Press, 1982. 
<!-- PJG 0012 frnewline -->
Dews PB. On the assessment of risk. In: Krasnegor N, Gray J, Thompson T, eds. Developmental Behavioral Pharmacology.
Hillsdale, NJ: Lawrence Erlbaum Associates, 1986:53&hyph;65. 
<!-- PJG 0012 frnewline -->
Dick, RB. Short duration exposure to organic solvents: the relationship between neurobehavioral test results and
other indicators. Neurotoxicol. Teratol. 1988; 10:35&hyph;50. 
<!-- PJG 0012 frnewline -->
Dick RB, Johnson BL. Human experimental studies. In: Annau Z, ed. Neurobehavioral Toxicology. Baltimore: Johns
Hopkins University Press, 1986. Dick RB, Bhattacharya A, Shukla R. Use of a computerized postural sway measurement
system for neurobehavioral toxicology. Neurotoxicol Teratol 1990; 12:1&hyph;6. 
<!-- PJG 0012 frnewline -->
Dick, RB, Krieg, EF, Setzer, J, Taylor, B. Neurobehavioral effects from acute exposure to methyl isobutyl ketone
and methyl ethyl ketone. Fund. Appl. Toxicol. 1992; 19:453&hyph;473. 
<!-- PJG 0012 frnewline -->
Domjan M, Burkhard B. The Principles of Learning and Memory. Monterey, CA: Cole, 1986. 
<!-- PJG 0012 frnewline -->
Dourson ML, Stara JF. Regulatory history and experimental support of uncertainty (safety) factors. Regul Toxicol
Pharmacol 1983; 3:224&hyph;238. 
<!-- PJG 0012 frnewline -->
Dyer RS. Macrophysiological assessment of organometal neurotoxicity. In: Tilson H, Sparber SB, eds. Neurotoxicants
and Neurobiological Function. New York: Wiley, 1987:137&hyph;184. 
<!-- PJG 0012 frnewline -->
Dyer RS, Howell WE. Triethyltin: ambient temperature alters visual system toxicity. Neurobehav Toxicol Teratol
1982; 4:267&hyph;271. 
<!-- PJG 0012 frnewline -->
Eccles CU. EEG correlates of neurotoxicity. Neurotoxicol Teratol 1988; 10:423&hyph;428. 
<!-- PJG 0012 frnewline -->
Eckerman DA, Bushnell PJ. The neurotoxicology of cognition: Attention, learning and memory. In: Tilson H, Mitchell
CL, eds. Neurotoxicology. New York: Raven Press, 1992:213&hyph;270. 
<!-- PJG 0012 frnewline -->
Eckerman DA, Caroll JB, Foree D, Gullion CM, Lansman M, Long ER, Waller MB, Wallsten TS. An approach to brief field testing
for neurotoxicity. Neurobehav Toxicol Teratol 1985; 7:387&hyph;393. 
<!-- PJG 0012 frnewline -->
Ecobichon DJ, Joy RM. Pesticides and Neurologic Disease. Boca Raton: CRC Press, 1982. 
<!-- PJG 0012 frnewline -->
Fechter LD, Young JS. Discrimination of auditory from non-auditory toxicity by reflex modification audiometry:
effects of triethyltin. Toxicol Appl Pharmacol 1983; 70:216&hyph;227. 
<!-- PJG 0012 frnewline -->
Festing MFW. Genetic factors in neurotoxicology and neuropharmacology: a critical evaluation of the use of genetics
as a research tool. Experientia 1991; 12:1877&hyph;1888. 
<!-- PJG 0012 frnewline -->
Fisher F. Neurotoxicology and government regulation of chemicals in the United States. In: Spencer PS, Schaumburg
HH, eds. Experimental and Clinical Neurotoxicology. Baltimore: Williams and Wilkins, 1980:874&hyph;882. 
<!-- PJG 0012 frnewline -->
Food and Drug Administration Advisory Committee on Protocols for Safety Evaluation: Panel on carcinogenesis report
on cancer testing in the safety evaluation of food additives and pesticides. Toxicol Appl Pharmacol 1971; 20:419&hyph;438.

<!-- PJG 0012 frnewline -->
Fowler SC. Force and duration of operant response and dependent variables in behavioral pharmacology. In: Thompson
T, Dews PB, eds. Advances in Behavioral Pharmacology. New York: Erlbaum, 1987. 
<!-- PJG 0012 frnewline -->
Freed DM, Kandel E. Long-term occupational exposure and the diagnosis of dementia. Neurotoxicology 1988; 9:391&hyph;400.

<!-- PJG 0012 frnewline -->
Friedel RO. Pharmacokinetics in the geropsychiatric patient. In: Lipton, M., Usdin, E., Killam, K., eds. Psychopharmacology:
A Generation of Progress. New York: Raven Press, 1978. 
<!-- PJG 0012 frnewline -->
Friedlander BR, Hearn HT. Epidemiologic considerations in studying neurotoxic disease. In: Spencer PS, Schaumburg
HH, eds. Experimental and Clinical Neurotoxicology. Baltimore: Williams and Wilkins, 1980:650&hyph;662. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00272 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Fullerton PM. Electrophysiological and histological observations on peripheral nerves in 
<!-- PJG 0012 frnewline -->
acrylamide poisoning in man. J Neurol Neurosurg Psychiat 1969; 32:186. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Gad SC. Principles of screening in toxicology with special emphasis on applications to 
<!-- PJG 0012 frnewline -->
neurotoxicology. J Am Coll Toxicol 1989; 8:21&hyph;27. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Gallagher RT, Hawkes AD, Steyn PS, Vlleggaar R. Tremorgenic neurotoxins from perennial ryegrass causing ryegrass
staggers disorders of livestock: structure and elucidation of Lolitrem. Chem Soc Chem Comm 1984; 18:614&hyph;616.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Gaylor DW. Quantitative risk analysis for quantal reproductive and developmental effects. Environ Health Perspect
1989; 79:243&hyph;246. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Gaylor DW, Slikker W Jr. Risk assessment for neurotoxic effects. Neurotoxicology 1990; 11:211&hyph;218. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Gaylor D, Slikker W Jr. Risk assessment for neurotoxicants. In: Tilson H, Mitchell C, eds. Neurotoxicology. New York:
Raven Press, 1992:331&hyph;343. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Glowa JR, Dews PB. Behavioral toxicology of volatile organic solvents. IV. Comparison of the behavioral effects
of acetone, methyl ethyl ketone, ethyl acetate, carbon disulfide, and toluene on the responding of mice. J Am Coll
Toxicol 1987; 6:461&hyph;469. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Glowa J, DeWeese J, Natale ME, Holland JJ. Behavioral toxicology of volatile organic solvents. I. Methods: acute
effects. J Am Coll Toxicol 1983; 2:175&hyph;185. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Goldberg AM, Frazier JM. Alternatives to animals in toxicity testing. Sci Amer 1989; 261:24&hyph;30. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Goldstein MK, Stein GH. Ambulatory activity in chronic disease. In: Tryon WH, ed. Behavioral Assessment in Behavioral
Medicine. New York: Springer Publishing Co., 1985:160&hyph;162. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Griffin JW. Basic pathologic processes in the nervous system. Toxicologic Pathology 1990; 18:83&hyph;88. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hagstadius, S, Orbaek, P, Risberg, J, Lindgren, M. Regional cerebral blood flow at the time of diagnosis of chronic
toxic encephalopathy induced by organic solvent exposure and after the cessation of exposure. Scand. J. Work Environ.
Health, 1989; 15:130&hyph;135. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hammerschlag R, Brady S. Axonal transport and the neuronal cytockeleton. In: Siegal GJ, Agranoff BW, Albers RW, Molinoff
PB, eds. Basic Neurochemistry. New York: Raven Press, 1989:457&hyph;478. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hanninen H. Methods in behavioral toxicology: current test batteries and need for development. In: Russell RW, Flattau
PE, Pope AM, eds. Behavioral Measures of Neurotoxicity. Washington, DC: National Academy Press, 1990. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hanninen H, Mantere P, Hernberg S, Seppalainen AM, Kock B. Subjective symptoms in low-level exposure to lead. Neurotoxicology
1979; 1:333&hyph;347. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hattis D, Shapiro K. Analysis of dose/time/response relationships for chronic toxic effects: the case of acrylamide.
Neurotoxicology 1990; 11:219&hyph;236. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
HAZDAT. ATSDR Database. Agency for Toxic Substances and Disease Registry, Atlanta, GA, 1992. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Heikkila RE, Hess A, Duvoisin RC. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine
in mice. Science 1984; 224:1451&hyph;1453. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Heise GA. Behavioral methods for measuring effects of drugs on learning and memory in animals. Med Res Rev 1984; 4:535&hyph;558.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hill RM, Tennyson LM. Maternal drug therapy: effect on fetal and neonatal growth and neurobehavior. Neurotoxicology
1986; 7:121&hyph;140. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hjelm, EW, Hagberg, M, Iregren, A, Lof, A. Exposure to methyl isobutyl ketone: toxicants and occurrence of irritative
and CNS symptoms in man. Int. Arch. Occup. Environ. Health, 1990; 62:19&hyph;26. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hooisma J, Emmen HH, Kulig BM, Muijser H, Poortvliet D, Letz R. Factor analysis of tests from the neurobehavioral evaluation
system and the WHO neurobehavioral core test battery. In: Johnson B, Anger WK, Durao A, Xintaras C, eds. Advances in
Neurobehavioral Toxicology: Applications in Environmental and Occupational Health. Chelsea: Lewis Publishers,
1990. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Horvath M, Frantik E. Quantitative interpretation of experimental toxicological data: the use of reference substances.
In: Horvath M, ed. Adverse Effects of Environmental Chemicals and Psychotropic Drugs. Amsterdam: Elsevier, 1973:11&hyph;21.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hruska RE, Kennedy S, Silbergeld EK. Quantitative aspects of normal locomotion in rats. Life Sci 1979; 25:171&hyph;179.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hutchings DE, Fico TA, Dow-Edwards DL. Prenatal cocaine: maternal toxicity, fetal effects and locomotor activity
of rat offspring. Neurotoxicol Teratol 1989; 11:65&hyph;69. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Iregren A, Gamberale F, Kjellberg A. A microcomputer-based behavioral testing system. In: Neurobehavioral Methods
in Occupational and Environmental Health. Copenhagen: World Health Organization, 1985. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Joffe JM, Soyka LF. Effects of drug exposure on male reproductive processes and progeny. Period Biol 1981; 83:351&hyph;362.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Johnson MK. Organophosphates and delayed neuropathy_Is NTE alive and well? Toxicol Appl Pharmacol 1990; 102:385&hyph;399.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Johnson BL. Prevention of neurotoxic illness in working populations. New York: Wiley, 1987. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Johnson BL, Boyd J, Burg JR, Lee ST, Xintaras C, Albright BE. Effects on the peripheral nervous system of workers exposed
to carbon disulfide. Neurotoxicology 1983; 4:53&hyph;66. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Jones KL, Smith DW. Recognition of the fetal alcohol syndrome in early infancy. Lancet 1973; 2:999&hyph;1001. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Katzman R. Blood-brain-CSF barriers. In: Siegal GJ, ed. Basic Neurochemistry. Boston: Little, Brown and Company,
1976:414&hyph;428. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Kimmel CA. Current status of behavioral teratology: science and regulation. CRC Critical Reviews in Toxicology
1988; 19:1&hyph;10. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Kimmel CA. Quantitative approaches to human risk assessment for noncancer health effects. Neurotoxicology 1990;
11:189&hyph;198. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Kimmel CA, Gaylor DW. Issues in qualitative and quantitative risk analysis for developmental toxicology. Risk Analysis
1988; 8:15&hyph;20. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Kimmel CA, Rees DC, Francis EZ. Qualitative and quantitative comparability of human and animal developmental neurotoxicology.
Teratology 1990; 12:175&hyph;292. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Klaassen CD. Absorption, distribution, and excretion of toxicants. In: Doull J, Klaassen CD, Amdur M, eds. Toxicology:
The Basic Science of Poisonings. New York: MacMillan, 1980:28&hyph;55. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Kopin IJ, Markey SP. MPTP toxicity: implications for research in Parkinson's disease. Ann Rev Neurosci 1988; 11:91&hyph;96.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Krinke GJ. Neuropathologic screening in rodent and other species. J Am Coll Toxicol 1989; 8:141&hyph;155. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00273 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Kurata H. Mycotoxins and mycotoxicoses: overview. In: Pohland AE, Dowell VR Jr, Richards JL, eds. Microbial Toxins
in Foods and Feeds, Cellular and Molecular Modes of Action. New York: Plenum Press, 1990:249&hyph;259. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis.
Science 1983; 219:979&hyph;980. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Last JM. Epidemiology and health information. In: Last JM, ed. Maxcy-Rosenau Public Health and Preventive Medicine.
New York: Appleton-Century-Crofts, 1986. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Letz R. The neurobehavioral evaluation system: an international effort. In: Johnson B, Anger WK, Durao A, Xintaras
C, eds. Advances in Neurobehavioral Toxicology: Applications in Environmental and Occupational Health. Chelsea:
Lewis Publishers, 1990. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Levine MS, Fox NL, Thompson B, Taylor W, Darlington AC, Van Der Hoeden J, Emmett EA, Rutten W. Inhibition of esterase
activity and an undercounting of circulating monocytes in a population of production workers. J Occup Med 1986; 28:207&hyph;211.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Liang Y&hyph;X, Chen Z&hyph;Q, Sun R&hyph;K, Fan Y&hyph;F, Yu J&hyph;H. Application of the WHO 
<!-- PJG 0012 frnewline -->
neurobehavioral core test battery and other neurobehavioral screening methods. In: Johnson B, Anger WK, Durao A,
Xintaras C, eds. Advances in Neurobehavioral Toxicology: Applications in Environmental and Occupational Health.
Chelsea: Lewis Publishers, 1990. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Lim DJ. Effects of noise and ototoxic drugs at the cellular level in the cochlea: a review. Am J Otolaryngol 1986; 7:73&hyph;99.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Little RE, Anderson KW, Ervin CH, Worthington-Roberts B, Clarren SK. Maternal alcohol use during breast-feeding
and infant mental and motor development at one year. N Engl J Med 1989; 321:425&hyph;430. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Lowndes HE, Baker T. Toxic site of action in distal axonopathies. In: Spencer PS, Schaumburg HH, eds. Experimental
and Clinical Neurotoxicology. Baltimore: Williams and Wilkins, 1980:193&hyph;205. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
MacPhail RC. Effects of pesticides on schedule-controlled behavior. In: Seiden LS, Balster RL, eds. Behavioral
Pharmacology: The Current Status. New York: Alan R. Liss, 1985:519&hyph;535. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
MacPhail RC. Environmental modulation of neurotoxicity. In: Russell RW, Flattau PE, Pope AM, eds. Behavioral Measures
of Neurotoxicity. Washington, DC: National Academy Press, 1990. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
MacPhail RC, Crofton KM, Reiter LW. Use of environmental challenges in behavioral toxicology. Fed Proc 1983; 42:3196&hyph;3200.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
MacPhail RC, Peele DB, Crofton KM. Motor activity and screening for neurotoxicity. J. Am Coll Toxicol 1989; 8:117&hyph;125.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Mailman RB. Mechanisms of CNS injury in behavioral dysfunction. Neurotoxicol Teratol 1987; 9:417&hyph;426. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Matthews HB, Dixon D, Herr DW, Tilson HA. Subchronic toxicity studies indicate that tris(2-chloroethyl)phosphate
administration results in lesions in the rat hippocampus. Toxicol Indust Health 1990; 6:1&hyph;15. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Mattsson JL, Albee RR. Sensory evoked potentials in neurotoxicology. Neurotoxicol Teratol 1988; 10:435&hyph;443.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Maurissen JP. Quantitative sensory assessment in toxicology and occupational medicine: applications, theory
and critical appraisal. Toxicol Lett 1988; 43:321&hyph;343. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Maurissen JP, Weiss B, Davis HT. Somatosensory thresholds in monkeys exposed to acrylamide. Toxicol Appl Pharmacol
1983; 71:266&hyph;279. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Mausner JS, Kramer S. Epidemiology_An Introductory Text (2nd ed). Philadelphia: W.B. Saunders Co., 1985. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
McMillan DE. Risk assessment for neurobehavioral toxicity. Environ Health Perspect 1987; 76:155&hyph;161. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Merigan WH. Effects of toxicants on visual systems. Neurobehav Toxicol 1979; 1 (Suppl.):15&hyph;22. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Morell P, Mailman RB. Selective and nonselective effects of organometals on brain neurochemistry. In: Tilson HA,
Sparber SB, eds. Neurotoxicants and Neurobiological Function: Effects of Organoheavy Metals. New York: Wiley,
1987:201&hyph;230. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Moser VC. Screening approaches to neurotoxicity: a functional observational battery. J Am Coll Toxicol 1989; 8:85&hyph;93.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Moser VC. Approaches for assessing the validity of a functional observational battery. Neurotoxicol Teratol 1990;
12:483&hyph;488. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Moser VC, McDaniel KL, Phillips PM. Rat strain and stock comparisons using a functional observational battery: baseline
values and effects of amitraz. Toxicol Appl Pharmacol 1991; 108:267&hyph;283. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
National Institute for Occupational Safety and Health (NIOSH). NIOSH Recommendations for Occupational Safety
and Health: Compendium of Policy Documents and Statement. DHHS Pub. No. 92&hyph;100, 1992. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
National Research Council, Committee on Toxicology. Effects on behavior. In: Principles for Evaluating Chemicals
in the Environment. Washington, DC: National Academy of Sciences, 1975. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
National Research Council (NRC). Risk Assessment in the Federal Government. Washington, DC: National Academy Press,
1983. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
National Research Council (NRC). Toxicity Testing: Strategies to Determine Needs and Priorities. Washington,
DC: National Academy of Sciences, 1984. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
National Research Council (NRC). Environmental Neurotoxicology. Washington, DC: National Academy Press, 1992.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Needleman HL. Introduction: biomarkers in neurodevelopmental toxicology. Environ Health Perspect 1987; 74:149&hyph;152.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Needleman HL. Lessons from the history of childhood blumbism for pediatric 
<!-- PJG 0012 frnewline -->
neurotoxicology. In: Johnson BL, Anger WK, Durano A, Xintaras C, eds. Advances in Neurobehavioral Toxicology: Application
in Experimental and Occupational Health. Chelsea: Lewis Publishers, 1990:331&hyph;337. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Needleman HL, Gunnoe CE, Leviton A. Deficits in psychologic and classroom performance of children with elevated
blood lead levels. N Engl J Med 1979; 300:689&hyph;695. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Nelson BK. Evidence for behavioral teratogenicity in humans. J Appl Toxicol 1991a; 11:33&hyph;37. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Nelson BK. Selecting exposure parameters in developmental neurotoxicity assessments. Neurotoxicol Teratol 1991b;
13:569&hyph;573. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Newland MC. Quantification of motor function in toxicology. Toxicol Lett 1988; 43:295&hyph;319. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
O'Callaghan JP. Neurotypic and gliotypic proteins as biochemical markers of neurotoxicity. Neurotoxicol Teratol
1988; 10:445&hyph;452. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
O'Donoghue JL. Screening for neurotoxicity using a neurologically based examination and neuropathology. J Am Coll
Toxicol 1989; 8:97&hyph;116. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00274 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Office of Science and Technology Policy (OST). Chemical carcinogens: a review of the 
<!-- PJG 0012 frnewline -->
science and its associated principles. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
 1985:1&hyph;85. 
<!-- PJG 0012 frnewline -->
Office of Technology Assessment (OTA). Neurotoxicity: identifying and controlling poisons 
<!-- PJG 0012 frnewline -->
of the nervous system. U.S. Congress. Office of Technology Assessment (OTA&hyph;BA&hyph;436), 
<!-- PJG 0012 frnewline -->
Washington, DC: U.S. Government Printing Office, 1990. 
<!-- PJG 0012 frnewline -->
Otto DA, Hudnell HK. Electrophysiological systems for neurotoxicity field testing: PEARL 
<!-- PJG 0012 frnewline -->
II and alternatives. In: Johnson B, Anger WK, Durao A, Xintaras C, eds. Advances in 
<!-- PJG 0012 frnewline -->
Neurobehavioral Toxicology: Applications in Environmental and Occupational Health. 
<!-- PJG 0012 frnewline -->
Chelsea: Lewis Publishers, 1990. 
<!-- PJG 0012 frnewline -->
Otto DA, Hudnell HK. Problems in studying low level solvent mixtures. Arbete och Halsa 
<!-- PJG 0012 frnewline -->
1991; 35:35&hyph;38. 
<!-- PJG 0012 frnewline -->
Overstreet DH. Pharmacological approaches to habituation of the acoustic startle response in 
<!-- PJG 0012 frnewline -->
rats. Physiol Psychol 1977; 5:230&hyph;238. 
<!-- PJG 0012 frnewline -->
Pardridge WM. Recent advances in blood-barrier transport. Ann Rev Pharmacol Toxicol 
<!-- PJG 0012 frnewline -->
1988; 28:25&hyph;39. 
<!-- PJG 0012 frnewline -->
Paule MG, Forrester TM, Maher MA, Cranmer JM, Allen RR. Monkey versus human 
<!-- PJG 0012 frnewline -->
performance in the NCTR operant test battery. Neurotoxicol Teratol 1990; 12:503&hyph;507. 
<!-- PJG 0012 frnewline -->
Paule MG, McMillan DE. Incremental repeated acquisition in the rat: acute effects of 
<!-- PJG 0012 frnewline -->
drugs. Pharmacol Biochem Behav 1984; 21:431&hyph;439. 
<!-- PJG 0012 frnewline -->
Pearson DT, Dietrich KN. The behavioral toxicology and teratology of childhood: models, 
<!-- PJG 0012 frnewline -->
methods, and implications for intervention. Neurotoxicology 1985; 6:165&hyph;182. 
<!-- PJG 0012 frnewline -->
Peele DB, Vincent A. Strategies for assessing learning and memory, 1978&hyph;1987: a 
<!-- PJG 0012 frnewline -->
comparison of behavioral toxicology, psychopharmacology and neurobiology. Neurosci 
<!-- PJG 0012 frnewline -->
Biobehav Rev 1989; 13:33&hyph;38. 
<!-- PJG 0012 frnewline -->
Perl TM, Bedard L, Kosatsky T, Hockin JC, Todd ECD, Remis RS. An outbreak of toxic 
<!-- PJG 0012 frnewline -->
encephalopathy caused by eating mussels contaminanted with domoic acid. N Engl J Med 
<!-- PJG 0012 frnewline -->
1990; 322:1775&hyph;1780. 
<!-- PJG 0012 frnewline -->
Peters, A, Palay, SL, Webster, H. def. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=3 -->
The Fine Structure of the Nervous System. Neurons 
<!-- PJG 0012 frnewline -->
and Their Supporting Cells
<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
, 3rd Ed. New York: Oxford University Press, 1991. 
<!-- PJG 0012 frnewline -->
Piikivi L, Tolonen U. EEG findings in chloralkali workers subjected to low long term 
<!-- PJG 0012 frnewline -->
exposure to mercury vapor. Br J Ind Med 1989; 46:30&hyph;35. 
<!-- PJG 0012 frnewline -->
Politis MJ, Schaumburg HH, Spencer PS. Neurotoxicity of selected chemicals. In: Spencer 
<!-- PJG 0012 frnewline -->
PS, Schaumburg HH, eds. Experimental and Clinical Neurotoxicology. Baltimore: Williams 
<!-- PJG 0012 frnewline -->
and Wilkins, 1980: 613&hyph;630. 
<!-- PJG 0012 frnewline -->
Pryor G, Dickinson J, Howd RA, Rebert CS. Transient cognitive deficits and high- 
<!-- PJG 0012 frnewline -->
frequency hearing loss in weanling rats exposed to toluene. Neurobehav Toxicol Teratol 
<!-- PJG 0012 frnewline -->
1983; 5:53&hyph;57. 
<!-- PJG 0012 frnewline -->
Putz VR, Johnson BL, Setzer JV. A comparative study of the effects of carbon monoxide 
<!-- PJG 0012 frnewline -->
and methylene chloride on human performance. J Environ Path Toxicol 1979; 2:97&hyph;112. 
<!-- PJG 0012 frnewline -->
Raine CS. Neurocellular anatomy. In: Siegal GJ, Agranoff BW, Albers RW, Molinoff PB, 
<!-- PJG 0012 frnewline -->
eds. Basic Neurochemistry. New York: Raven Press, 1989:3&hyph;34. 
<!-- PJG 0012 frnewline -->
Rao BL, Husain A. Presence of cyclopiazonic acid in Kodo millet (Paspalum scrobiculatum) 
<!-- PJG 0012 frnewline -->
causing 'Kodua poisoning' in man and its production by associated fungi. Mycopathologia 
<!-- PJG 0012 frnewline -->
1985; 89:177&hyph;180. 
<!-- PJG 0012 frnewline -->
Rebert CS. Multisensory evoked potentials in experimental and applied neurotoxicology. 
<!-- PJG 0012 frnewline -->
Neurobehav Toxicol Teratol 1983; 5:659&hyph;671. 
<!-- PJG 0012 frnewline -->
Reiter LW. Neurotoxicology in regulatory and risk assessment. Develop Pharmacol Therap 
<!-- PJG 0012 frnewline -->
1987; 10:354&hyph;368. 
<!-- PJG 0012 frnewline -->
Ricaurte GA, Delanney LE, Weiner SG, Irwin I, Langston JW. 5-Hydroxyindoleacetic acid 
<!-- PJG 0012 frnewline -->
in cerebrospinal fluid reflects serotonergic damage induced by 3,4- 
<!-- PJG 0012 frnewline -->
methylenedioxymethamphetamine in CNS of nonhuman primates. Brain Res 1986; 474:359&hyph;363. 
<!-- PJG 0012 frnewline -->
Rice DC. Quantification of operant behavior. Toxicol Lett 1988; 43:361&hyph;379. 
<!-- PJG 0012 frnewline -->
Riley AL, Tuck DL. Conditioned taste aversions: a behavioral index of toxicity. Ann NY 
<!-- PJG 0012 frnewline -->
Acad Sci 1985; 443:272&hyph;292. 
<!-- PJG 0012 frnewline -->
Riley EP, Vorhees CV, eds. Handbook of Behavioral Teratology. New York: Plenum 
<!-- PJG 0012 frnewline -->
Press, 1986. 
<!-- PJG 0012 frnewline -->
Rodier PM. Time of exposure and time of testing in developmental neurotoxicology. 
<!-- PJG 0012 frnewline -->
Neurotoxicology 1986; 7:69&hyph;76. 
<!-- PJG 0012 frnewline -->
Rodier P. Developmental neurotoxicology. Toxicologic Pathol 1990; 18:89&hyph;95. 
<!-- PJG 0012 frnewline -->
Russell RW. Essential roles for animal models in understanding human toxicities. Neurosci 
<!-- PJG 0012 frnewline -->
Biobehav Rev 1991; 15:7&hyph;11. 
<!-- PJG 0012 frnewline -->
Ryan CM, Morrow LA, Bromet EJ, Parkinson DK. Assessment of neuropsychological 
<!-- PJG 0012 frnewline -->
dysfunction in the workplace: normative data from the Pittsburgh Occupational Exposures 
<!-- PJG 0012 frnewline -->
Test Battery. J Clin Exp Neuropsychol 1987; 9:665&hyph;679. 
<!-- PJG 0012 frnewline -->
Salzman C. Antianxiety agents. In: Crook T, Cohen G, eds. Physicians' Handbook on 
<!-- PJG 0012 frnewline -->
Psychotherapeutic Drug Use in the Aged. New Canaan, NY: Mark Powley Associates, 
<!-- PJG 0012 frnewline -->
1981. 
<!-- PJG 0012 frnewline -->
Schrot J, Thomas JR, Robertson RF. Temporal changes in repeated acquisition behavior 
<!-- PJG 0012 frnewline -->
after carbon monoxide exposure. Neurobehav Toxicol Teratol 1984; 6:23&hyph;28. 
<!-- PJG 0012 frnewline -->
Schwartz J, Landrigan PF, Feldman RG, Silbergeld EK, Baker EL, Von Lindern IH. 
<!-- PJG 0012 frnewline -->
Threshold effect in lead-induced peripheral neuropathy. J Pediatr 1988; 11:212&hyph;217. 
<!-- PJG 0012 frnewline -->
Seppalainen AM, Haltia M. Carbon disulfide. In: Spencer PS, Schaumburg HH, eds. 
<!-- PJG 0012 frnewline -->
Experimental and Clinical Neurotoxicology. Baltimore: Williams and Wilkins, 1980:356&hyph;373. 
<!-- PJG 0012 frnewline -->
Seppalainen AM, Harkonen H. Neurophysiological findings among workers occupationally 
<!-- PJG 0012 frnewline -->
exposed to styrene. Scand J Work Environ Health 1976; 2:140. 
<!-- PJG 0012 frnewline -->
Sette WF, MacPhail RC. Qualitative and quantitative issues in assessment of neurotoxic 
<!-- PJG 0012 frnewline -->
effects. In: Tilson H, Mitchell C, eds. Neurotoxicology. New York: Raven Press, 
<!-- PJG 0012 frnewline -->
1992:345&hyph;361. 
<!-- PJG 0012 frnewline -->
Sheehan DM, Young JF, Slikker W Jr, Gaylor DW, Mattison DR. Workshop on risk 
<!-- PJG 0012 frnewline -->
assessment in reproductive and developmental toxicology: addressing the assumptions and 
<!-- PJG 0012 frnewline -->
identifying the research needs. Regulat Toxicol Pharmacol 1989; 10:110&hyph;122. 
<!-- PJG 0012 frnewline -->
Silbergeld EK. Maternally mediated exposure of the fetus: in utero exposure to lead and 
<!-- PJG 0012 frnewline -->
other toxins. Neurotoxicology 1986; 7:557&hyph;568. 
<!-- PJG 0012 frnewline -->
Silbergeld EK. Developing formal risk assessment methods for neurotoxicants: an 
<!-- PJG 0012 frnewline -->
evaluation of the state of the art. In: Johnson BL, Anger WK, Durao A, Xintaras C, eds. 
<!-- PJG 0012 frnewline -->
Advances in Neurobehavioral Toxicology: Applications in Environmental and Occupational 
<!-- PJG 0012 frnewline -->
Health. Chelsea: Lewis, 1990:133&hyph;148. 
<!-- PJG 0012 frnewline -->
Sjogren B, Gustavsson P, Hogstedt C. Neuropsychiatric symptoms among welders exposed 
<!-- PJG 0012 frnewline -->
to neurotoxic metals. Brit J Indust Med 1990; 47:704&hyph;707. 
<!-- PJG 0012 frnewline -->
Slikker W Jr. Biomarkers of neurotoxicity: an overview. Recent advances on biomarker 
<!-- PJG 0012 frnewline -->
research. Biomed Environ Sci 1991; 4:192&hyph;196. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00275 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Slikker W Jr, Gaylor DW. Biologically based dose-response model for neurotoxicity risk assessment. Korean J Toxicol
1990; 6:204&hyph;213.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Slikker W Jr, Holson RR, Ali SF, Kolta MG, Paule MG, Scallet AC, McMillan DE, Bailey JR, Hong JS, Scalzo FM. Behavioral
and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate. Neurotoxicology 1989;
10:529&hyph;542.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Smith MA, Grant LD, Sors AI, eds. Lead Exposure and Child Development: An International Assessment. Dordrecht, Netherlands:
Kluwer Academic Publishers, 1989.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Solomon PR, Pendlebury WW. A model systems approach to age-related memory disorders. Neurotoxicology 1988; 9:443&hyph;462.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Spencer PS, Schaumburg HH, eds. Experimental and Clinical Neurotoxicology. Baltimore: Williams and Wilkins Co,
1980.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Spencer PS, Nunn PB, Hugon J, Ludolph AC, Ross SM, Roy DN, Robertson RC. Guam amyotrophic lateral sclerosis-Parkinsonism-dementia
linked to a plant excitant neurotoxin. Science 1987; 237:517&hyph;522.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Squibb, RE, Tilson, HA, Meyer, OA, Lamartiniere, CA. Neonatal exposure to monosodium glutamate alter the neurobehavioral
performance of adult rats. Neurotoxicology, 1991; 2:471&hyph;484.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Stanton ME, Spear LP. Comparability of endpoints across species in developmental neurotoxicity. Neurotoxicol
Teratol 1990; 12:261&hyph;268.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Stebbins WC, Coombs C. Behavioral assessment of ototoxicity in nonhuman primates. In: Weiss B, Laties VG, eds. Behavioral
Toxicology. New York: Plenum Press, 1975.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sterman AB, Schaumburg HH. Neurotoxicity of selected drugs. In: Spencer PS, Schaumburg HH, eds. Experimental and
Clinical Neurotoxicology. Baltimore: Williams and Wilkins, 1980:593&hyph;612.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Stewart RD, Fisher TN, Hosko R. Experimental human exposure to methylene chloride. Arch Environ Health 1972; 25:342&hyph;348.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Strong MJ, Garruto RM. Potentiation in the neurotoxic induction of experimental chronic neurodegenerative disorders:
n-butyl benzenesulfonamide and aluminum chloride. Neurotoxicology 1991; 12:415&hyph;426.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Suzuki K. Special vulnerabilities of the developing nervous system to toxic substances. In: Spencer PS, Schaumburg
HH, eds. Experimental and Clinical Neurotoxicology. Baltimore: Williams and Wilkins, 1980:48&hyph;61.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Terrace HS. Errorless discrimination learning in the pigeon: Effects of chlorpromazine and imipramine. Science
1963; 140:318&hyph;319.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Thompson FN Jr, Porter JK. Tall fescue toxicosis in cattle: could there be a public health problem. Vet Human Toxicol
1990; 32:51&hyph;57.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Tilson HA, Cabe PA. Strategy for the assessment of neurobehavioral consequences of environmental factors. Environ
Health Perspect 1978; 26:287&hyph;299.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Tilson HA. Practical considerations in establishing valid and sensitive neurobehavioral test methods. Zbl Bakt
Hyg B 1987; 185:10&hyph;15.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Tilson HA. Screening for neurotoxicity: principles and practices. J Am Coll Toxicol 1989; 8:13&hyph;17.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Tilson HA. Behavioral indices of neurotoxicity. Toxicologic Pathology 1990a; 18:96&hyph;104.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Tilson HA. Neurotoxicology in the 1990s. Neurotoxicol Teratol 1990b; 12:293&hyph;300.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Tilson HA, Mitchell CL. Neurotoxicants and adaptive responses of the nervous system. Fed Proc 1983; 42:3189&hyph;3190.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Tilson HA, Mitchell CL. Neurobehavioral techniques to assess the effects of chemicals on the nervous system. Ann
Rev Pharmacol Toxicol 1984; 24:25&hyph;50.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Tilson HA, Moser VC. Comparison of screening approaches. Neurotoxicology 1992; 13:1&hyph;14.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
United States Environmental Protection Agency (U.S. EPA). Neurotoxicity Testing Guidelines. Springfield, VA:
National Technical Information Service, 1991.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Valciukas JA. Foundations of Environmental and Occupational Neurotoxicology. New York: Van Nostrand Reinhold,
1991.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Veronesi B. The use of cell culture for evaluating neurotoxicity. In: Tilson HA, Mitchell CL, eds. New York: Raven
Press, 1991:21&hyph;50.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Veronesi B, Jones K, Pope C. The neurotoxicity of subchronic acetylcholinesterase (AChE) inhibition in rat hippocampus.
Toxicol Appl Pharmacol 1990; 104:440&hyph;456.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Verity MA, Sarafian TS, Guerra W, Ettinger A, Sharp J. Ionic modulation of triethyllead neurotoxicity in cerebellar
granule cell culture. Neurotoxicology 1990; 11:415&hyph;426.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Vorhees CV. Reliability, sensitivity and validity of indices of neurotoxicity. Neurotoxicol Teratol 1987; 9:445&hyph;464.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Waddell, WJ. The science of toxicology and its relevance to MC5. Reg. Toxicol. Pharmacol. 1993; 18:13&hyph;22.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Walker CH, Faustman WO, Fowler SC, Kazar DB. A multivariate analysis of some operant variables used in behavioral
pharmacology. Psychopharmacology 1981; 74:182&hyph;186.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Weiss B. Risk assessment: The insidious nature of neurotoxicity and the aging basis. Neurotoxicology 1990; 11:305&hyph;313.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Williamson AM. The influence of subject characteristics on the identification of acute effects of solvent exposure.
Arbete och Halsa 1991; 35:14&hyph;18.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Willis WD Jr, Grossman RG. Neurotransmission. In: Medical Neurobiology. St. Louis: C.V. Mosby, 1973:457.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
World Health Organization (WHO). Principles and Methods for the Assessment of Neurotoxicity Associated with Exposure
to Chemicals. Environmental Health Criteria Document 60. Geneva: World Health Organization, 1986.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Wyllie TD, Morehouse LC. Mycotoxic Fungi, Mycotoxins, Mycotoxicoses, An Encyclopedic Handbook. New York: Marcel
Dekker, Inc., 1978, Vols. 1&hyph;3.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Wyzga R. Towards quantitative risk assessment for neurotoxicity. Neurotoxicology 1990; 11:199&hyph;208.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Yokel RA. Repeated systemic aluminum exposure effects on classical conditioning of the rabbit. Neurobehav Toxicol
Teratol 1983; 5:41&hyph;46.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Yokel RA, Provan SD, Meyer JJ, Campbell SR. Aluminum intoxication and the victim of Alzheimer's disease: similarities
and differences. Neurotoxicology 1988; 9:429&hyph;442.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Zenick H. Use of pharmacological challenge to disclose neurobehavioral deficits. Fed Proc 1983; 42:3191&hyph;3195
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
Prepared by
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Working Party on Neurotoxicology
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Subcommittee on Risk Assessment
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Federal Coordinating Council on Science, Engineering, and Technology
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Lawrence W. Reiter, USEPA, Chair
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hugh A. Tilson, USEPA, Executive Secretary
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
John Dougherty, NIOSH
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
G. Jean Harry, NIEHS
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Carol J. Jones, OSHA
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Suzanne McMaster, USEPA
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
William Slikker, NCTR/FDA
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Thomas J. Sobotka, FDA
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00276 </DOCNO>
<PARENT> FR940817-2-00113 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=74 g=1 f=1 -->
Ad Hoc Interagency Committee on Neurotoxicology
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
William Boyes, U.S. Environmental Protection Agency
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Joy Cavagnaro, Food and Drug Administration
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Selene Chou, Agency for Toxic Substances and Disease Registry
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Murray Cohn, U.S. Consumer Product Safety Commission
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Joseph F. Contrera, Food and Drug Administration
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Miriam Davis, National Institute of Environmental Health Sciences, National Institutes of Health
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Joseph DeGeorge, Food and Drug Administration
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Robert Dick, National Institute for Occupational Safety and Health
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
John Dougherty, National Institute for Occupational Safety and Health
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Lynda Erinoff, National Institute on Drug Abuse
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Joseph P. Hanig, Food and Drug Administration
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
G. Jean Harry, National Institute of Environmental Health Sciences
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
David G. Hattan, Food and Drug Administration
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Norman A. Krasnegor, National Institutes of Health
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Robert C. MacPhail, U.S. Environmental Protection Agency
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Suzanne McMaster, U.S. Environmental Protection Agency
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Lakshmi C. Mishra, U.S. Consumer Product Safety Commission
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Andres Negro-Vilar, National Institute of Environmental Health Sciences
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
James K. Porter, U.S. Department of Agriculture/Agricultural Research Service
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Lawrence W. Reiter, U.S. Environmental Protection Agency
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Jane Robens, U.S. Department of Agriculture/Agricultural Research Service
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Barry Rosloff, Food and Drug Administration
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Harry Salem, U.S. Army Chemical Research, Development, and Engineering Center
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bernard A. Schwetz, National Institute of Environmental Health Sciences
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
William F. Sette, U.S. Environmental Protection Agency
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
William Slikker, Jr., National Center for Toxicological Research
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
D. Stephen Snyder, National Institute on Aging
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Thomas J. Sobotka, Food and Drug Administration
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hugh A. Tilson, U.S. Environmental Protection Agency
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Mildred Williams-Johnson, Agency for Toxic Substances and Disease Registry 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20033 Filed 8&hyph;16&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6560&hyph;50&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00277 </DOCNO>
<PARENT> FR940817-2-00114 </PARENT>
<TEXT>
 
<!-- PJG FTAG 4717 -->

<!-- PJG STAG 4717 -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Wednesday
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
August 17, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=1 -->
Part VIII
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=04 g=1 f=1 -->
Department of Transportation
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=05 g=1 f=1 -->
Maritime Administration
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=05 g=1 f=1 -->
Voluntary Intermodal Sealift Agreement; Notice
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->

<!-- PJG /FTAG -->

<!-- PJG FTAG 4701 -->

<!-- PJG STAG 4701 -->

<!-- PJG ITAG l=90 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=1 -->
&blank;/&blank;Vol. 59, No. 158&blank;/&blank;Wednesday, August 17, 1994&blank;/&blank;Notices
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF TRANSPORTATION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Maritime Administration</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=55 g=1 f=1 -->
Voluntary Intermodal Sealift Agreement 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=2 -->
Agency: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Maritime Administration, 
<!-- PJG 0012 frnewline -->
Department of Transportation. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
Action: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of Voluntary 
<!-- PJG 0012 frnewline -->
Intermodal Sealift Agreement (VISA). 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The Maritime Administration (MARAD) announces establishment of the Voluntary Intermodal Sealift Agreement (VISA),
pursuant to section 708 of the Defense Production Act of 1950, as amended (50 U.S.C. App. 2158). This is a new voluntary
agreement and is issued in accordance with the provisions of 44 CFR part 332. The purpose of VISA is to make intermodal
shipping services/systems, including ships, ships' space, intermodal equipment and related management services,
available to the Department of Defense as required to support the emergency deployment and sustainment of U.S. military
forces through cooperation among the maritime industry, the Department of Transportation and the Department of
Defense. Through advance arrangements in joint planning it is intended that the participants will provide capacity
to support a significant portion of surge and sustainment requirements in dry cargo or intermodal equipment emergencies.

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Mr. Thomas M.P. Christensen, Director, Office of National Security Plans, Room Pl&hyph;1303, Maritime Administration,
400 Seventh Street SW., Washington DC 20590, (202) 366&hyph;5900, Fax (202) 488&hyph;0941. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The complete, draft text of VISA is published below. Copies of VISA and the associated application form are being sent,
unsolicited, to U.S.-owned companies which provide intermodal shipping services/systems. Copies also are available
to the public upon request. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
NOTICE OF MEETING: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
An open meeting for the purpose of developing the final text of VISA will convene at 2 p.m., Wednesday, August 31, 1994,
in Room 10234, Nassif Building, U.S. Department of Transportation, 400 Seventh Street, SW., Washington, DC 20590.
Representatives of the maritime and intermodal transportation industry and interested members of the public are
invited to attend. Telephonic or facsimile notice of intent to attend, given to the point of contact above, will assure
adequate seating and more convenient access at security-controlled entrances. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
TEXT OF THE VOLUNTARY INTERMODAL SEALIFT AGREEMENT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Standby Voluntary Agreement under Public Law 774, 81st Congress, as amended; ``Voluntary Intermodal Sealift Agreement''
(VISA). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->

<!-- PJG /FTAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00278 </DOCNO>
<PARENT> FR940817-2-00114 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=74 g=1 f=1 -->
Table of Contents 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
ABBREVIATIONS 
<!-- PJG 0012 frnewline -->
DEFINITIONS 
<!-- PJG 0012 frnewline -->
PREFACE 
<!-- PJG 0012 frnewline -->
VOLUNTARY INTERMODAL SEALIFT AGREEMENT 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
I. PURPOSE 
<!-- PJG 0012 frnewline -->
II. AUTHORITIES 
<!-- PJG 0012 frnewline -->
III. GENERAL 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
A. Need for this Agreement 
<!-- PJG 0012 frnewline -->
B. History of this Agreement 
<!-- PJG 0012 frnewline -->
C. Participation 
<!-- PJG 0012 frnewline -->
D. Effective Date and Duration of Participation 
<!-- PJG 0012 frnewline -->
E. Withdrawal from this Agreement 
<!-- PJG 0012 frnewline -->
F. Standby Period 
<!-- PJG 0012 frnewline -->
G. Rules and Regulations 
<!-- PJG 0012 frnewline -->
H. Modification/Amendment of this Agreement 
<!-- PJG 0012 frnewline -->
I. Administrative Expenses 
<!-- PJG 0012 frnewline -->
J. Record Keeping 
<!-- PJG 0012 frnewline -->
K. Requisition of Ships of Non-Participants 
<!-- PJG 0012 frnewline -->
L. Plan of Action 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
IV. ANTITRUST DEFENSE 
<!-- PJG 0012 frnewline -->
V. BREACH OF CONTRACT DEFENSE 
<!-- PJG 0012 frnewline -->
VI. TERMS AND CONDITIONS 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
A. Agreement by Participant 
<!-- PJG 0012 frnewline -->
B. Pooling Resources 
<!-- PJG 0012 frnewline -->
C. Equitable Contribution of Shipping Capacity 
<!-- PJG 0012 frnewline -->
D. Equitable Contribution of Intermodal Equipment 
<!-- PJG 0012 frnewline -->
E. Enrollment of Ships and Equipment 
<!-- PJG 0012 frnewline -->
F. Compensation 
<!-- PJG 0012 frnewline -->
G. War Risk Insurance 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
VII. INTERMODAL SEALIFT COORDINATING COMMITTEE 
<!-- PJG 0012 frnewline -->
VIII. ACTIVATION OF THIS AGREEMENT 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
A. Determination of Necessity 
<!-- PJG 0012 frnewline -->
B. Intermodal Sealift Coordinating Committee 
<!-- PJG 0012 frnewline -->
C. The Representative of the Secretary of Defense 
<!-- PJG 0012 frnewline -->
D. Ship and Space Chartering 
<!-- PJG 0012 frnewline -->
E. Leases of Intermodal Equipment 
<!-- PJG 0012 frnewline -->
F. Management Service Contracts 
<!-- PJG 0012 frnewline -->
G. Termination of Charters, Leases and Other 
<!-- PJG 0012 frnewline -->
Contractual Arrangements 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
IX. JOINT PLANNING IN THE STANDBY PERIOD 
<!-- PJG 0012 frnewline -->
X. PLAN OF ACTION: DEVELOPMENT MEETING 
<!-- PJG 0012 frnewline -->
XI. APPLICATION AND AGREEMENT 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
ABBREVIATIONS 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
``USCINCTRANS''_Commander-in-Chief, United States Transportation Command 
<!-- PJG 0012 frnewline -->
``DOD''_Department of Defense 
<!-- PJG 0012 frnewline -->
``DOT''_Department of Transportation 
<!-- PJG 0012 frnewline -->
``FEMA''_Federal Emergency Management Agency 
<!-- PJG 0012 frnewline -->
``FTC''_Federal Trade Commission 
<!-- PJG 0012 frnewline -->
``MARAD''_Maritime Administration, DOT 
<!-- PJG 0012 frnewline -->
``MSC''_Military Sealift Command 
<!-- PJG 0012 frnewline -->
``NDRF''_National Defense Reserve Fleet maintained by MARAD 
<!-- PJG 0012 frnewline -->
``RRF''_Ready Reserve Force component of the NDRF 
<!-- PJG 0012 frnewline -->
``SecDef''_Secretary of Defense 
<!-- PJG 0012 frnewline -->
``USTRANSCOM''_United States Transportation Command 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00279 </DOCNO>
<PARENT> FR940817-2-00114 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=73 g=1 f=1 -->
DEFINITIONS 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
``Administrator''_Maritime Administrator. 
<!-- PJG 0012 frnewline -->
``Attorney General''_Attorney General of the United States. 
<!-- PJG 0012 frnewline -->
``Chairman''_Chairman of the FTC. 
<!-- PJG 0012 frnewline -->
``Committee''_Intermodal Sealift Coordinating Committee 
<!-- PJG 0012 frnewline -->
``Controlling interest''_more than a 50 percent interest by stock ownership or otherwise. 
<!-- PJG 0012 frnewline -->
``Director''_Director of FEMA. 
<!-- PJG 0012 frnewline -->
``Intermodal equipment''_containers (including flat racks and seasheds), chassis, trailers, tractors, lifts,
cranes and other ancillary items. 
<!-- PJG 0012 frnewline -->
``Intermodal shipping services/systems''_includes ships, ship's space, intermodal equipment, terminals, related
management services, and any parts of the foregoing. 
<!-- PJG 0012 frnewline -->
``Management services''_management expertise and experience, intermodal terminal management, information
resources and control and tracking systems. 
<!-- PJG 0012 frnewline -->
``Participant''_a signatory party to this Agreement, and otherwise as defined in this Agreement, III.C. 
<!-- PJG 0012 frnewline -->
``Representative of SecDef''_USTRANSCOM. 
<!-- PJG 0012 frnewline -->
``Secretary''_Secretary of Transportation. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00280 </DOCNO>
<PARENT> FR940817-2-00114 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Preface 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Pursuant to the authority contained in section 708 of the 
<!-- PJG 0012 frnewline -->
Defense Production Act of 1950, as amended (50 U.S.C. App. 2158) (Section 708), the Administrator, after consultation
with representatives of ocean carriers providing intermodal shipping services/systems and with representatives
of companies which lease containers, chassis and other intermodal equipment, has developed this standby agreement
for voluntary contribution of intermodal shipping services/systems needed to meet national defense requirements.

<!-- PJG 0012 frnewline -->
USTRANSCOM procures commercial shipping capacity to meet normal peacetime requirements for ships and intermodal
shipping services/systems through arrangements with common carriers (including services contracts), with contract
carriers and by charter. DOD, through USTRANSCOM, maintains and operates a fleet of ships owned by or under charter
to the Federal government, in sufficient numbers to meet those logistic needs of the military services which cannot
be met by commercial service. Ships of the RRF may be selectively activated for peacetime military tests and exercises,
and to satisfy military surge operational requirements which cannot be met by commercial shipping in time of war,
national emergency, or military contingency. Foreign-flag shipping may be used if no U.S.-flag ships can meet the
operational requirement. Through advance arrangements in joint planning described in IX. of this Agreement, it
is intended that Participants will provide capacity to support a significant portion of surge and sustainment requirements
in dry cargo and intermodal equipment emergencies. 
<!-- PJG 0012 frnewline -->
In time of war or national emergency, ships may be requisitioned under authority of section 902 of the Merchant Marine
Act, 1936, as amended (46 App. U.S.C. 1242) (Section 902). 
<!-- PJG 0012 frnewline -->
In some military contingency operations, more shipping capacity and related services may be required than are available
under peacetime arrangements, but general mobilization of shipping by requisition may not be appropriate. This
Agreement provides for the voluntary contribution of intermodal shipping services/systems in such a way as to distribute
the burden of such contributions in proportion to the capacity owned and controlled by each Participant. 
<!-- PJG 0012 frnewline -->
This Agreement will provide DOD with access to privately-owned intermodal shipping services/systems, will provide
door-to-door intermodal capacity, will create a pool of vessels, vessel capacity and intermodal equipment needed
in support of national defense activities and will provide Participants a defense to civil and criminal action for
violation of antitrust laws in carrying out this Agreement. 
<!-- PJG 0012 frnewline -->
This Agreement establishes the terms, conditions and general procedures under which each Participant agrees voluntarily
to make intermodal shipping services/systems available at the request of the Administrator. 
<!-- PJG 0012 frnewline -->
This Agreement is designed to create close working relationships among the Administrator, USTRANSCOM and Participants
through which military needs and the needs of the civil economy can be met by cooperative action. Participants are
allowed maximum flexibility to adjust commercial operations by cooperation, rationalization of services and pooling
of vessels, vessel capacity and intermodal equipment,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
 Provided,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 such measures are approved, in advance, by the Administrator. 
<!-- PJG 0012 frnewline -->
The shipping capacity made available voluntarily under this Agreement may be supplemented by ships requisitioned,
under Section 902, from non-Participants in this Agreement and from Participants. 
<!-- PJG 0012 frnewline -->
The containers and chassis made available voluntarily under this Agreement may be supplemented by services and equipment
accessed by the Administrator through the provisions of 46 CFR Part 340. 
<!-- PJG 0012 frnewline -->
The SecDef will be asked to concur in this Agreement at the appropriate stage. SecDef will be asked to approve this Agreement
as a sealift readiness program for the purpose of section 909 of the Merchant Marine Act, 1936, as amended (46 App. U.S.C.
1248) (Section 909). Withdrawal from or termination of participation in this Agreement does not excuse a Participant
from Section 909 or any other provision of law if said withdrawn or terminated Participant is otherwise subject thereto.

<!-- PJG 0012 frnewline -->
The Director, after consultation with the Attorney General and the Chairman, has concurred in this Agreement. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Voluntary Intermodal Sealift Agreement 
<!-- PJG 0012 frnewline -->
I. Purpose 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This Agreement establishes procedures for the contribution of intermodal shipping services/systems to satisfy
DOD needs. This Agreement will change from standby to active status upon a joint determination by the Secretary and
SecDef that a dry cargo shipping capacity emergency or an intermodal equipment emergency affecting the national
defense exists; that the defense requirement cannot be met by voluntary arrangements other than this Agreement;
and that the requirement can be met more efficiently by activating this Agreement than by requisitioning ships under
Section 902. 
<!-- PJG 0012 frnewline -->
This Agreement includes all intermodal shipping services/systems and all intermodal ship types, including container,
partial container, container/bulk, container/roll-on/roll-off, roll-on/roll-off and barge carrier (LASH,
SeaBee, etc.). Breakbulk ships may be enrolled in this Agreement at the discretion of the Administrator. When consideration
is being given to diverting intermodal shipping services/systems from commercial to defense use, an ocean carrier's
entire contribution will be considered. The object of this Agreement is to promote and facilitate the use of entire
intermodal transportation systems and to maximize DOD's use of commercial transportation resources while at the
same time attempting to minimize disruption to commercial operations. The Agreement does, however, provide for
the utilization of components of such systems (e.g., particular ship types) as necessary. Through advanced arrangements
developed during peacetime joint planning described in section IX of this Agreement, it is intended that Participants
will provide capability to support a significant portion of surge and sustainment requirements in dry cargo intermodal
equipment emergencies. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Authorities 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00281 </DOCNO>
<PARENT> FR940817-2-00114 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 708 of the Defense Production Act, as amended (50 U.S.C. App. 2158); Executive Order 12919, 59 FR 29525, June
7, 1994; Executive Order 12148, 3 CFR 1979 Comp., p. 412, as amended; 44 CFR Part 332; DOT Order 1900.8; 46 CFR Part 340.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Section 501 of Executive Order 12919 delegated the authority of the President under Section 708 to the Secretary,
among others. By DOT Order 1900.8, the Secretary delegated to the Administrator the authority under which this Agreement
is sponsored. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
III. General 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Need for this Agreement
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_1. The Administrator has found, in accordance with Section 708(c)(1), that conditions exist which may pose a direct
threat to the national defense of the United States or its preparedness programs and, under the provisions of Section
708, has certified to the Attorney General that a standby voluntary agreement for utilization of intermodal shipping
services/systems is necessary for the national defense. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. The quantity of military dry cargo (unit equipment, sustaining supplies and ammunition) to be moved for support
of a military contingency, national emergency, or war in a foreign area could exceed the shipping capacity normally
available for charter or use from the commercial sector. It is desirable to avoid the disruptive effects of ship requisition
and of intermodal equipment allocation so long as military requirements can be met by voluntary cooperation between
the maritime industry and the Federal government. The Attorney General, in consultation with the Chairman, has issued
a finding that dry cargo capacity to meet national defense requirements cannot be provided by the industry through
a voluntary agreement having less anti-competitive effects or without a voluntary agreement. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
History of this Agreement
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_The concept of this Agreement originated in discussions between MARAD and DOD officials on arrangements to promote
timely availability of ships, equipment and management services needed to operate them. Most U.S.-flag shipping
companies operate ships as part of an integrated land/ocean transportation system. In times of emergency, DOD needs
not only vessels and intermodal equipment, but also the management expertise to operate such assets as transportation
systems. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
It is anticipated that the Merchant Marine Act, 1936, as amended (46 App. U.S.C. 1101 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
et seq
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
.) will be amended in accordance with H.R. 4003 to provide for operating agreements between vessel owners or operators
and the Secretary. This Agreement will constitute an Emergency Preparedness Program within the meaning of the amended
Title VI of the Act proposed in H.R. 4003. This Agreement will constitute a sealift readiness program when approved
by the SecDef and will meet all the conditions set forth under Section 909. An ocean carrier which is a Participant in
this Agreement is eligible for award of a Shipping Agreement or a Container Agreement from MSC without enrollment
in any other program. An ocean carrier eligible to participate in this Agreement but which elects not to do so is subject
to enrollment in the MSC Sealift Readiness Program (SRP) if it (1) receives operating-differential subsidy or construction-differential
subsidy or (2) wishes to carry DOD cargo. A carrier, while a Participant in this Agreement, will be subject only to the
provisions of this Agreement and not to the provisions of the SRP. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
C. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Participation
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_1. An ocean carrier may become a Participant by submitting an executed copy of the form referenced in XI. below. Any
ocean carrier organized under the laws of a State of the United States, or the District of Columbia, may be a Participant.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. A company which owns, or has obtained through lease, intermodal equipment may become a Participant by submitting
an executed copy of the form referenced in XI. below. Such a company must be organized under the laws of a State of the
United States or the District of Columbia. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. The term ``Participant'' includes the entity signing this Agreement and all United States subsidiaries and affiliates
of that entity which own, operate, charter, or lease ships and intermodal equipment in the regular course of their
business and in which the entity holds a controlling interest. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. The term ``Participant'' also includes the controlled non-domestic subsidiaries and affiliates of the entity
signing this Agreement; 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Provided
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, that the Administrator grants specific approval for their inclusion. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
5. An entity having an operating agreement with the Secretary shall be a ``Participant.'' 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
6. An entity electing to place itself in a readiness program, such as Section 909 or Section 1202(c) of the Merchant
Marine Act, 1936, as amended (46 App. U.S.C. 1282(c)), shall, upon signing this Agreement, be a ``Participant.''

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00282 </DOCNO>
<PARENT> FR940817-2-00114 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
7. Periodically, a list of Participants will be published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
D. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective Date and Duration of Participation
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_Participation in this Agreement is effective upon execution of the application form by both the Participant and
the Administrator, or their designees, and remains in effect until terminated by the Administrator, the Attorney
General, or the Director, on due notice by letter, telegram, or publication in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, or until the Participant withdraws. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
E. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Withdrawal from this Agreement
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_A Participant may withdraw from this Agreement, subject to fulfillment of obligations incurred under this Agreement
prior to the date such withdrawal becomes effective, by giving 30 days written notice to the Administrator; 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Provided however
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, that a Participant having an operating agreement with the Secretary will not withdraw from this Agreement during
the period the operating agreement is in effect. Withdrawal from this Agreement will not deprive a Participant of
an antitrust defense otherwise available to it in accordance with Section 708. Withdrawal by a Participant subject
to authorities referred to in C.6. above merely revives direct application of those authorities to the Participant
at withdrawal. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
F. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Standby Period
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_The ``standby period'' is the interval between the effective date of the Administrator's acceptance of an application
and the date of activation of this Agreement as prescribed in VIII. below. The Administrator's acceptance of an application
does not have or imply any constraint or other effect on the Participant's business operations during the standby
period. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
G. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Rules and Regulations
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_A Participant acknowledges and agrees to abide by all provisions of Section 708, and regulations related thereto
which are promulgated by the Secretary, the Attorney General, the Chairman and the Director. Standards and procedures
pertaining to voluntary agreements have been promulgated in 44 CFR Part 332. Note is taken that 46 CFR Part 340 establishes
procedures for assigning the priority for use and the allocation of shipping services, containers and chassis. The
Administrator will inform Participants of new and amended rules and regulations as they are issued. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
H. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Modification/Amendment of this Agreement
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_The Attorney General may modify this Agreement, in writing, after consultation with the Chairman and the Administrator.
The Administrator may modify this Agreement, in writing, with the concurrence or at the direction of the Director
after consultation with the Attorney General and the Chairman. Modifications initiated by the Administrator will
be submitted to the Director with the concurrence of the representative of SecDef. If modification of IX. below is
proposed, the Administrator will also seek the concurrence of USTRANSCOM. USTRANSCOM or a Participant may propose
amendments to this Agreement at any time. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
I. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Administrative Expenses
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_Administrative and out-of-pocket expenses incurred by a Participant during the standby period shall be borne solely
by the Participant. Such expenses may include, among other things, traveling to meetings, making reports of owned,
chartered and leased intermodal ships and equipment as contemplated in VI.E. below and keeping records as contemplated
in III.J. below. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
J. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Record Keeping
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_1. MARAD and USTRANSCOM have primary responsibility for maintaining records in accordance with 44 CFR Part 332.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. The Director of MARAD's Office of National Security Plans shall be the official custodian of records related to
the carrying out of this Agreement. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. In accordance with 44 CFR 332.3(d), a Participant shall maintain for five (5) years all minutes of meetings, transcripts,
records, documents and other data, including any communications with other Participants or with any other member
of the industry or their representatives, related to the carrying out of this Agreement. Each Participant agrees
to make available to the Administrator, the Attorney General, the Director and the Chairman for inspection and copying
at reasonable times and upon reasonable notice any item that the Participant is required hereby to maintain. Any record
maintained by MARAD or USTRANSCOM under this subsection shall be available for public inspection and copying unless
exempted on the grounds specified in 5 U.S.C. 552(b) (1), (3) and (4) or identified as privileged and confidential
information in accordance with Section 708(e). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
K. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Requisition of Ships of Non-Participants
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_The Administrator may requisition ships of non-Participants to supplement capacity made available under this
Agreement and to balance the economic burden of defense support among ocean carriers. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
L. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Plan of Action
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_The Participants, under the leadership of the Administrator, or the Administrator's designee, shall adopt one
or more documents to implement this Agreement. Documents to implement this Agreement shall be styled ``Plan of Action.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
IV. Antitrust Defense 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A. Under the provisions of Section 708, each Participant in this Agreement shall have available as a defense to any
civil or criminal action brought under the antitrust laws (or any similar law of any State) with respect to any action
taken to develop or carry out this Agreement or a Plan of Action, that such act was taken in the course of developing or
carrying out this Agreement or a Plan of Action and that the Participant complied with the provisions of Section 708
and any regulation thereunder, and acted in accordance with the terms of this Agreement or a Plan of Action. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. This defense shall not be available to the Participant for any action occurring after termination of this Agreement.
Nor shall it be available upon the modification of this Agreement with respect to any subsequent action that is beyond
the scope of the modified text of this Agreement, except that no such modification shall be accomplished in a way that
will deprive the Participant of antitrust defense for the fulfillment of obligations incurred. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
C. The defense shall be available only if and to the extent that the person asserting it demonstrates that the action
was within the scope of this Agreement or a Plan of Action. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
D. The person asserting the defense bears the burden of proof. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00283 </DOCNO>
<PARENT> FR940817-2-00114 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
E. The defense shall not be available if the person against whom it is asserted shows that the action was taken for the
purpose of violating the antitrust laws. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
F. As appropriate, the Administrator will support applications by Participants to the Federal Maritime Commission
or the Interstate Commerce Commission to exempt this Agreement and any Plan of Action from the operation of statutes
administered by either agency. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
V. Breach of Contract Defense 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Under the provisions of Section 708, in any action in any Federal or State court for breach of contract, there shall
be available as a defense that the alleged breach of contract was caused predominantly by action taken by a Participant
during an emergency to carry out this Agreement or a Plan of Action. Such defense shall not release the party asserting
it from any obligation under applicable law to mitigate damages to the greatest extent possible. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
VI. Terms and Conditions 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Agreement by Participant
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_1. Each Participant agrees to contribute intermodal shipping services/systems in accordance with this Agreement
and any Plan of Action applicable to the Participant and at such times and in such amounts as the Administrator shall
determine to be necessary to meet essential needs of DOD for transportation of military supplies and equipment during
the period this Agreement is activated. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Participant agrees to provide all necessary elements to operate the intermodal transportation services/systems
it contributes. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. Each participant agrees to provide, on request, management services needed to operate the contributed intermodal
transportation services/systems; including inland container and trailer and other services, for the movement
to and from ports of equipment which is owned, operated, or controlled by a Participant. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. Whenever possible, the Participant which owns, operates, or controls a ship or ship capacity contributed will
provide the intermodal equipment and management services needed to utilize the ship at full efficiency. However,
upon the recommendation of the Committee and at the Administrator's discretion, the ships and intermodal equipment
of a Participant may be placed under the operational management and control of another Participant. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Pooling Resources
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_Each Participant agrees to make intermodal shipping services/systems and intermodal equipment available to other
Participants when requested by the Administrator, on the advice of the Committee. Such requests will be made in order
to meet the defense requirement, to ensure that overall contributions are made on a proportionate basis, and to assure
that no Participant is unduly hampered in meeting the needs of the civil economy consistent with priorities established
by the President. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Participants may agree to cooperate, to rationalize services and to pool intermodal assets in order to meet the defense
requirement, equalize the burden of the contribution and insure continued support to the civil economy; 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Provided,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 however, that such activities involving Participants in the normal course of business when this Agreement has not
been activated and not to facilitate meeting requirements or requests of the Administrator are not covered by this
Agreement. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
C. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Equitable Contribution of Shipping Capacity
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_1. Each Participant agrees to contribute ships and ship's space under this Agreement in accordance with VIII.B.1.
and 2. below. The contribution should be in the proportion of its ``controlled tonnage'' in each shipping capacity
category to the total ``controlled tonnage'' of all Participants in each such category. Because exact proportions
may not be feasible, and because unique requirements for a particular category of ships or capacity may arise, each
Participant agrees that variations are permissible at the discretion of the Administrator. Any Participant may
offer to increase its contribution. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. ``Controlled tonnage'' consists of: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
a. Ships which are owned or chartered in by a Participant and documented under United States law; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
b. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
PLUS 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
non-U.S.-documented feeder ships, in which a Participant or any of its subsidiaries or controlled affiliates has
a controlling interest and which are operated as an extension of U.S.-flag line haul service; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
c. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
PLUS 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
any other non-U.S.-flag ships which a Participant may offer to designate as ``controlled tonnage'' and to which the
Administrator agrees; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
d. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
LESS 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
ships owned or controlled by a Participant which are chartered, leased, or contracted out to others for remaining
periods of at least six months from the effective date of activation of this Agreement and for which there is no termination
clause for war, national emergency, or military contingency. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. The laws of the country of documentation may require the approval of that government before ships on its register
can be covered by this Agreement. The Participant agrees to make a good faith effort to obtain the required approval.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. The categories of ships are: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
a. Roll-on/roll-off (RO/RO) ships. RO/RO ships which do not have installed ramps should be supplied with portable
ramps, to the extent practicable, by the Participant. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
b. Combination container-RO/RO ships. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
c. Barge carriers (LASH, SeaBee, etc.) The appropriate number of lighters should be supplied to operate the vessel
at full efficiency. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
d. Containerships, both self-sustaining and non-self-sustaining. Three containers should be provided per container
space. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
e. Partial containerships and container bulk. Three containers should be provided per container space. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
f. Breakbulk ships. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
5. The contribution of each Participant shall be calculated by the Administrator as soon as possible after this Agreement
is activated. The following standards will be used to determine proportionate contributions of ``controlled tonnage'':

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
a. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
RO/RO ships
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_Square feet (meters) of cargo deck area. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00284 </DOCNO>
<PARENT> FR940817-2-00114 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
b. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Combination container_RO/RO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_Square feet (meters) and container capacity (expressed in twenty-foot equivalent units). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
c. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Barge Carrier
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_Cargo deadweight capacity. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
d. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Partial containerships and container bulk
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_Cargo deadweight. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
e. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Self-sustaining containerships
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_Total below deck and on deck container capacity (expressed in twenty-foot equivalent units). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
f. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Non-self-sustaining containerships
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_Total below deck and on deck container capacity (expressed in twenty-foot equivalent units). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
g. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Breakbulk ships
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_Cargo deadweight. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
6. A ship on charter to a Participant shall not be subject to contribution under this Agreement in the case where the
period of contribution would be longer than the remaining term of the Participant's charter or in a case where the contribution
would otherwise breach the terms of the charter party, but such tonnage shall be included in the calculation of the
Participant's controlled tonnage. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
7. The ``controlled tonnage'' of each Participant shall be divided into two categories: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
a. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Level I
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_Vessels of the Participant which are: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
i. Subject to Title VI of the Merchant Marine Act, 1936, as amended (46 App. U.S.C. 1171 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
et seq.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
) It is anticipated that Title VI will be amended in accordance with H.R. 4003 to provide for operating agreements between
vessel owners or operators and the Secretary. Vessels covered by an operating agreement are in Level I. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
ii. Otherwise required by law to be made available to meet national defense requirements. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
b. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Level II
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_All other vessels of the Participant. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Level I vessels shall be provided immediately in response to the call of the Administrator and instructions of the
Administrator are to be observed with the utmost dispatch. Level I vessels will be called into service before Level
II vessels. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Level II vessels shall be provided according to the schedule set forth in the call of the Administrator. Level II vessels
will be called into service if and when Level I vessels actually provided are not sufficient to meet the emergency.
A Participant may offer Level II vessels for service as Level I vessels. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
8. Other than the specific use of ships described in VI.C.2.b. (foreign-flag feeder vessels), it is expected that
vessels covered by an operating agreement will be utilized to the maximum extent possible for line haul service to
meet DOD requirements. When a specific ship covered by an operating agreement is removed from regular service to meet
DOD requirements, a foreign-flag ship may be employed to replace the ship taken from regular service. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
9. The Administrator retains the right under law to requisition ships of Participants. A Participant's ships which
are directly requisitioned by the United States or which are under other U.S. Government voluntary arrangements
shall be credited against the Participant's proportionate contribution under this Agreement. Ships on charter
to DOD when this Agreement is activated shall not be so credited. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
D. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Equitable Contribution of Intermodal Equipment_ 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. ``Controlled intermodal equipment'' shall mean such equipment as is needed in the operation of a Participant's
intermodal shipping system and which a Participant owns or leases. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. During the standby period, the Administrator shall determine the inventory of controlled intermodal equipment
as of a specific date each year. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. When an ocean carrier Participant contributes containerships or partial containerships, or capacity, it will
provide containers in accordance with VI.C.4. above and chassis as specified in a Plan of Action. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. Each Participant agrees to contribute intermodal equipment as provided in a Plan of Action, which may require contribution
in the proportion of its inventory of each type of equipment to the total inventory of that type held by all Participants;
Provided
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, that, at the discretion of the Administrator, on the advice of the Committee, when a Participant contributes specialized
equipment which is not available from all Participants, its proportionate share of common types of equipment may
be adjusted so that its overall contribution is in approximately the same proportion to its total available inventory
as are the overall contributions of other Participants to their available inventories. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00285 </DOCNO>
<PARENT> FR940817-2-00114 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
5. Prior to calls for contributions of intermodal equipment, the Administrator, on the advice of the Committee, will
determine the portion and types of equipment to be acquired from the ship operating companies and the portion and types
of equipment to be acquired from leasing companies. 
<!-- PJG 0012 frnewline -->
6. A Participant may contribute intermodal equipment in excess of its proportionate share with the approval of the
Administrator, after consultation with the Committee. 
<!-- PJG 0012 frnewline -->
E. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Enrollment of Ships and Equipment_
<!-- PJG 0012 frnewline -->
1. The Administrator will maintain a record of ships and equipment enrolled under this Agreement according to a Plan
of Action. A schedule of ships and equipment which are owned and which are controlled by an applicant and which the applicant
proposes for enrollment will be attached to the form referenced in VIII. below. Ships and equipment will be enrolled
on the date this Agreement becomes effective for the Participant. Participants will notify the Administrator of
all changes to the schedule semi-annually on June 30 and December 31. 
<!-- PJG 0012 frnewline -->
2. The Administrator will make the enrollment data available to USTRANSCOM. 
<!-- PJG 0012 frnewline -->
3. Information which a Participant identifies as privileged and confidential shall be withheld from public disclosure
in accordance with Section 708(h)(3) and section 705(e) of the Defense Production Act of 1950, as amended (50 U.S.C.
App. 2155), and 44 CFR Part 332. 
<!-- PJG 0012 frnewline -->
4. Enrolled ships are required to comply with 46 CFR Part 307, Establishment of Mandatory Position Reporting System
for Vessels. 
<!-- PJG 0012 frnewline -->
F. Compensation_
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. The Administrator shall, in consultation with Participants and with the concurrence of USTRANSCOM, promulgate
a methodology for determining rates of compensation under this Agreement. The methodology will be developed as a
separate Plan of Action. 
<!-- PJG 0012 frnewline -->
2. Employing the forms, including terms and conditions, found in the Plan of Action developed under this Agreement,
and the compensation determined in accordance with the rate methodology (VI.F.1 and implementing Plan of Action),
the Administrator or his designee, or USTRANSCOM or its designee, shall execute charters, leases and other contractual
arrangements which implement this Agreement upon its activation. 
<!-- PJG 0012 frnewline -->
G. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
War Risk Insurance_
<!-- PJG 0012 frnewline -->
1. SecDef will either reimburse for additional commercial war risk insurance or provide no-premium government war
risk insurance, subject to the provisions of Section 1205 of the Merchant Marine Act, 1936, as amended (46 App.U.S.C.
1285(a)) upon activation of this Agreement. 
<!-- PJG 0012 frnewline -->
2. Each ship enrolled under this Agreement shall be eligible for U.S. Government war risk insurance and for an interim
insurance binder under the provisions of 46 CFR Part 308, notwithstanding restrictions on eligibility set out in
Subpart A thereof. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=3 -->
VII. Intermodal Sealift Coordinating Committee 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
There shall be an Intermodal Sealift Coordinating Committee comprising the Administrator or his designee, USCINCTRANS
or his designee and a representative from each of the Participants. The functions of the Committee are described in
VIII and IX below. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=3 -->
VIII. Activation of This Agreement 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
A. Determination of Necessity_
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This Agreement shall be activated upon a joint determination by the Secretary and SecDef that a dry cargo shipping
capacity emergency or an intermodal equipment emergency affecting the national defense exists, and that the defense
requirements cannot be met more effectively and timely without activation of this Agreement. A dry cargo shipping
capacity emergency and an intermodal equipment emergency will be deemed to exist when dry cargo shipping capacity
and intermodal equipment required to support operations of U.S. Forces outside the continental United States cannot
be supplied through the commercial market or other voluntary arrangements. The Administrator shall notify the Attorney
General and the Chairman when such a determination is made. 
<!-- PJG 0012 frnewline -->
B. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Intermodal Sealift Coordinating Committee_
<!-- PJG 0012 frnewline -->
1. The Administrator or his designee shall chair the Committee, and will be assisted by a USTRANSCOM staff member.
Upon activation of this Agreement, the Administrator or his designee shall convene a meeting of the Committee for
the purposes of advising participants of DOD requirements, soliciting recommendations regarding the implementation
of this Agreement in accordance with previous joint planning, and identifying any special circumstances affecting
participants' contributions. The Administrator or his designee will administer this Agreement and will apportion
the contributions of dry cargo capacity and management services by the Participants to meet DOD requirements. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00286 </DOCNO>
<PARENT> FR940817-2-00114 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=3 -->
2. If any necessary Plan of Action has not been adopted at the time of activation of this Agreement, the Administrator
shall assure completion of such Plan of Action in order to meet DOD requirements. 
<!-- PJG 0012 frnewline -->
3. The Committee Chair shall: 
<!-- PJG 0012 frnewline -->
a. Notify the Attorney General, the Chairman, the Director and all Participants of the time, place and nature of each
meeting and of the proposed agenda of each meeting to be held to implement this Agreement; 
<!-- PJG 0012 frnewline -->
b. Provide for publication in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of a notice of the time, place and nature of each such meeting. If a meeting is open, a 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 notice will be published reasonably in advance of the meeting. If a meeting is closed, a 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 notice will be published within ten (10) days after the meeting and will include the reasons for closing the meeting;

<!-- PJG 0012 frnewline -->
c. Establish the agenda for each meeting and be responsible for adherence to the agenda; 
<!-- PJG 0012 frnewline -->
d. Provide for a full and complete transcript or other record of each meeting and provide one copy each of transcript
or other record to the Attorney General, the Chairman, the Director, all Participants and the designated staff member
of DOD; and 
<!-- PJG 0012 frnewline -->
e. Take necessary action to protect confidentiality of data discussed with or obtained from Participants. 
<!-- PJG 0012 frnewline -->
C. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
The Representative of the Secretary of Defense
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_USTRANSCOM is the SecDef's representative in the implementation of this Agreement. 
<!-- PJG 0012 frnewline -->
D. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Ship and Space Chartering_
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Charters or other agreements for ships, ship space or intermodal shipping services/systems will be executed, as
specified in the relevant Plan of Action. 
<!-- PJG 0012 frnewline -->
E. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Leases of Intermodal Equipment
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_Lease agreements for intermodal equipment will be executed, as specified in the relevant Plan of Action. 
<!-- PJG 0012 frnewline -->
F. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Management Service Contracts
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_Management service contracts will be executed, as specified in the relevant Plan of Action. 
<!-- PJG 0012 frnewline -->
G. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Termination of Charters, Leases and Other Contractual Arrangements 
<!-- PJG 0012 frnewline -->
1. USTRANSCOM will notify the Administrator as far in advance as possible of the prospective termination of charters,
leases, management service contracts or other contractual arrangements under this Agreement. 
<!-- PJG 0012 frnewline -->
2. If this Agreement is superseded by the general requisitioning of ships, the Administrator, as a matter of discretion,
may replace charters made under this Agreement with charters made under requisition. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=3 -->
IX. Joint Planning in the Standby Period 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
A. Chairmanship
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_During the standby period, when engaged in the planning described in IX.B., the Committee will be co-chaired by MARAD
and USTRANSCOM. 
<!-- PJG 0012 frnewline -->
B. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Planning_
<!-- PJG 0012 frnewline -->
1. During the standby period the Committee may be convened to: 
<!-- PJG 0012 frnewline -->
a. Develop a Plan of Action to implement this Agreement; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00287 </DOCNO>
<PARENT> FR940817-2-00114 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=3 -->
b. Consider amendments to this Agreement or a Plan of Action; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
c. Engage in joint planning to meet military requirements for intermodal shipping services/systems; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
d. Test readiness under this Agreement to meet requirements by participating in exercises, including military-sponsored
exercises; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
e. Evaluate capabilities under this Agreement to meet requirements; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
f. Discuss methods for improving procedures under this Agreement in order to meet requirements. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Meetings for joint planning will be convened annually during the standby period, or more frequently if the co-Chairmen
so determine. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
C. Security Measures
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
_The Administrator, in cooperation with USTRANSCOM and with appropriate security measures, will provide for sharing
of wartime planning information with Participants, to enable Participants to plan their wartime commitment. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
X. Plan of Action: Development Meeting 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Administrator shall convene the Committee within ninety days of the effective date of the first Participant's
VISA. The purpose shall be to develop a Plan of Action to implement this Agreement. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
XI. Application and Agreement 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Administrator has adopted a form on which intermodal ship operators and intermodal equipment leasing companies
may apply to become a Participant in this Agreement (``Application and Agreement to Participate in the Voluntary
Intermodal Sealift Agreement''). The form incorporates by reference the terms of this Agreement. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
By order of the Maritime Administrator. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Date: August 12, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
James E. Saari, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Secretary, Maritime Administration. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00288 </DOCNO>
<PARENT> FR940817-2-00114 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=85 g=1 f=1 -->
United States of America Department of Transportation Maritime Administration
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Application and Agreement to Participate in the Voluntary Intermodal Sealift Agreement 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The applicant identified below hereby applies to participate in the Maritime Administration's voluntary agreement
entitled ``Voluntary Intermodal Sealift Agreement.'' The text of said Agreement is published in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=7 f=2 -->
XX
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=7 f=2 -->
XXX
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=7 f=2 -->
XXX
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, 19
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=7 f=2 -->
XX
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. This Agreement is authorized under Section 708 of the Defense Production Act of 1950, as amended (50 U.S.C. App. 2158).
Regulations governing this Agreement appear at 44 CFR Part 332 and are reflected at 49 CFR Subtitle A. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Applicant hereby acknowledges and agrees to the incorporation by reference into this Application and Agreement
of the entire text of the Voluntary Intermodal Sealift Agreement published in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=7 f=2 -->
XX
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=7 f=2 -->
XXXX
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=7 f=2 -->
XXX
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, 19
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=7 f=2 -->
XX
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, as though said text were physically recited herein. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Applicant, as a Participant, agrees to comply with the provisions of Section 708 of the Defense Production Act
of 1950, as amended, the regulations at 44 CFR Part 332 and as reflected at 49 CFR Subtitle A, and the terms of the Voluntary
Intermodal Sealift Agreement. Further, the Applicant, as a Participant, subject to the request of the Maritime Administrator,
hereby agrees to voluntarily make vessels, intermodal equipment and management of intermodal transportation systems
available for use 
<!-- PJG 0012 frnewline -->
by the Department of Defense and to other Participants in this Agreement for the purpose of meeting national defense
requirements. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
Attest: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=77 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=1 -->
(Applicant-Corporate Name)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
(CORPORATE SEAL)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=77 g=1 f=1 -->
Effective Date: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=77 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=1 -->
(Secretary)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
(SEAL)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=77 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=1 -->
(Applicant-Corporate Name)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=77 g=1 f=1 -->
By: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=1 -->
&blank;&blank;(Signature)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=77 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=1 -->
(Position Title)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=26 g=1 f=1 -->
UNITED STATES OF AMERICA DEPARTMENT OF TRANSPORTATION MARITIME ADMINISTRATION
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=77 g=1 f=1 -->
By: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=77 g=7 f=2 -->
XXXXXXX
<!-- PJG /ITAG -->

<!-- PJG ITAG l=77 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=1 -->
&blank;&blank;(Maritime Administrator
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;20196 Filed 8&hyph;16&hyph;94; 8:45 am] 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;81&hyph;P 
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940817-2-00289 </DOCNO>
<PARENT> FR940817-2-00115 </PARENT>
<TEXT>
</TEXT>
</DOC>



